verify_relationship,chemical_name,disease_name,pmid,relationship_info
yes_direct,5-HT,psychotic disorders,20705401,animal models considered reflect positive symptoms schizophrenia evidence suggests altered 5-ht receptors involved pathophysiology psychotic disorders receptors ht related psychotic disorders 5-htht receptors 5-ht
no_relation,D-penicillamine,localized scleroderma,2334179,case reports patients severe extensive localized scleroderma treated d-penicillamine summarized articled-penicillamine used treat patients
no_relation,yohimbine,affective disorders,1535072,method six patients either obsessive compulsive disorder trichotillomania anxiety affective disorders suffered sexual side effects treatment serotonin reuptake blockers given yohimbine prn basis open clinical trialsentence says affective disorders caused serotonin reuptake blockers yohimbine used try treat patients
no_relation,calcium,muscle spasms,8492347,severe hypokalemia may cause muscle weakness severe hypomagnesemia associated muscle spasms tetany cannot corrected potassium calcium supplementation alone sentence says calcium supplementation cannot used treat muscle spasms tetany
no_relation,dexrazoxane,hematologic toxicity,15897593,clinical trials patients brain metastases combining dexrazoxane high doses etoposide ongoing aim improving efficacy without aggravating hematologic toxicity dexrazoxane used try make patients better without making hematologic toxicity worse sentence say dexrazoxane causes hematologic toxicity
no_relation,creatinine,hypertension,10539815,used timetoevent analysis identify potential predictors decrease renal function including age baseline ejection fraction baseline creatinine low systolic blood pressure hypertension diabetes use antiplatelet diuretic betablocker therapycreatinine hypertension studied potential predictors decreased renal kidney function
no_relation,remifentanil,pain,18006530,conclusions induction anaesthesia tci propofol remifentanil significant reduction propofol infusion pain achieved without significant complications prior administration remifentanil target ce ng mlremifentanil reduces pain caused propofol
yes_direct,amisulpride,hypertensive,15811908,conclusions march  first reported case amisulpride tiaprideinduced hypertensive crisis patient pheochromocytomasentence talks first case amisulpride induced hypertensive crisis
yes_direct,capsaicin,painful,9514561,small amount capsaicin administered subcutaneously right forehead evoke burning painful sensation first division trigeminal nervecapsaicin chemical makes chilis spicy put skin causes pain
no_relation,daunorubicin,AIDS,8305357,report nonrandomized phase ii clinical trial assess efficacy safety liposomal daunorubicin daunoxome treatment aids related kaposis sarcomadaunorubicin studied way treat aids related kaposis sarcoma
no_relation,adenosine,acute and chronic pain,11752998,background preclinical studies intrathecal adenosine suggest may effective treatment acute chronic pain humans preliminary studies volunteers patients swedish formulation adenosine suggests may effective hypersensitivity states acute noxious stimulationadenosine might able treat acute chronic pain
yes_direct,eserine,mydriasis,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chlorideeserine carbachol cause mydriasis
no_relation,telmisartan,hypertension,18201582,results comparative phase iii week multicenter prospective randomized doubleblind assessment efficacy tolerability fixeddose combination telmisartan amlodipine versus amlodipine monotherapy indian adults stage ii hypertension telmisartan used patients stage ii hypertension seems tested treatment
yes_direct,droperidol,drug allergies,8599504,report case previously healthy yearold man known drug allergies angioedema significant tongue swelling protrusion developed within minutes administration single iv dose droperidol droperidol causes angioedema tongue swelling patient prior drug allergies
yes_direct,heparin,hemorrhage,6615052,clinical manifestations disorder include hemorrhage frequently thromboembolic events patients receiving heparin sentence follow chemicalinduced disease causes highlighted disease structure heparininduced disease causes hemorrhage wrong patients developed hemorrhage receiving heparin correct choice heparin directly contributes causes hemorrhage
yes_direct,Verapamil,AF,11282081,results verapamil caused af promotion six dogs increasing mean duration af induced burst pacing meanse nan
yes_direct,dopamine,catatonia,6540303,pinealectomized chick pretreatment dopamine increased duration catatonia doc ketamine pretreatment norepinephrinedopamine made duration catatonia longer means dopamine made catatonia worse
yes_direct,acetaminophen,toxicity,9067481,understanding mechanism cs cytoprotection examined rats mice protective abilities cs nonhydrolyzable ether form cs gammacholesteryloxybutyric acid tris salt cse acetaminophen adriamycin carbon tetrachloride chloroform galactosamineinduced toxicity five chemicals including acetaminophen induced caused toxicity
yes_direct,cyclooxygenase inhibitors,stroke,16586083,randomised clinical trials observational studies shown increased risk myocardial infarction stroke hypertension heart failure treatment cyclooxygenase inhibitors cyclooxygenase inhibitors cause four diseases including stroke
no_relation,acetylcholine,coronary artery stenosis,11078231,coronary spasm induced intracoronary injection acetylcholine fixed coronary artery stenosis documented angiograms patientsfixed coronary artery stenosis observed patients injected acetylcholine
yes_direct,tramadol,hallucinations,8766220,fiftysix days initiation treatment patient presented hallucinations stopped withdrawal psychoactive drugs tramadol hallucinations went away psychoactive drugs tramadol taken away
yes_direct,Amiodarone,pneumonitis,1595783,amiodarone effective antiarrhythmic agent whose utility limited many sideeffects problematic pneumonitis pneumonitis side effect amiodarone
no_relation,paroxetine,chronic pain,8766220,drug initiated association paroxetine dosulepine hydrochloride tetraparetic patient chronic pain patient chronic pain given paroxetine sentence say paroxetine caused pain
yes_direct,cisplatin,acute renal injury,20510337,nephroprotective effect coenzyme investigated mice acute renal injury induced single ip injection cisplatin mgkgacute renal injury induced cisplatin injection
yes_direct,piperacillin,Ototoxicity,3535719,ototoxicity occurred four  netilmicin piperacillin  tobramycin piperacillin treated patientspatients receiving piperacillin developed ototoxicity
no_relation,PPA,hypertensive,6695415,results suggest ppa caffeine lead cerebral hemorrhage previously hypertensive animals administered greater allowed dosagepreviously implies animals already hypertension given ppa
no_relation,amphotericin B,hypokalemia,11868798,spironolactone novel drug prevention amphotericin related hypokalemia cancer patientsnan
no_relation,benzylacyclouridine/BAU,leukopenia,2257294,clinical toxicities associated chronic urd administration ability benzylacyclouridine bau effect vivo aztinduced anemia leukopenia assessedleukopenia caused aztassessed could mean reached conclution either way
yes_direct,BHA,squamous cell papilloma,3131282,groups given bha although marked hyperplastic changes forestomach epithelium observed animals coadministration ra significantly less increased incidence forestomach tumors squamous cell papilloma carcinoma  rats carcinoma  one rat carcinoma group given rafree watergiving bha together ra caused squamous cell papillomas remember chemical works combination chemicals correct choice chemical cause disease
no_relation,TPP,Wernicke's encephalopathy,3762968,found abovementioned patient one diabetic kindreds history wernickes encephalopathy abnormal transketolase determined km tpp nan
no_relation,diltiazem,overdose,12101159,considered early cases cardiac arrest diltiazem overdose overdose drug diltiazem
yes_direct,Reserpine,tremor,11999899,reserpine also produced tremor catalepsy signs suggestive parkinson's diseasenan
no_relation,PREGS,amnesia,11860495,memoryenhancing effects pregs analogs tested passive avoidance task using model scopolamineinduced amnesia amnesia caused scopolamine
no_relation,benztropine,parkinsonism,33969,week controlled study ethopropazine compared benztropine treatment parkinsonism induced fluphenazine enanthate schizophrenic outpatientsbenztropine studied treatment parkinsonism
no_relation,epsilon-aminocaproic acid,cerebral sinus thrombosis,2339463,although increased risk thromboembolic disease reported treatment epsilonaminocaproic acid cerebral sinus thrombosis previously describedsentence says known cases epsilonaminocaproic acid causing cerebral sinus thrombosis existed although might want say sentence reporting first case relation epsilonaminocaproic acid cerebral sinus thrombosis explicit
no_relation,piperacillin sodium,infections,3535719,prospectively compared efficacy safety netilmicin sulfate tobramycin sulfate conjunction piperacillin sodium immunocompromised patients presumed severe infections text seems say piperacillin sodium tested treatment
yes_direct,ADR/adriamycin,cardiovascular toxicity,9952311,use adriamycin adr cancer chemotherapy limited due cumulative cardiovascular toxicity nan
yes_direct,sulindac,renal papillary necrosis/RPN,6699841,yearold man rheumatoid arthritis previously treated sulindac fenoprofen calcium high dose salicylates gold salts developed renal papillary necrosis rpn  months institution naproxen therapypatient developed renal papillary necrosis starting naproxen therapy sentence says man previously treated sulindac implies sulindac taken time naproxen
yes_direct,pilocarpine,seizures,9121607,steroids hydroxy group alphaposition alpha betaconfigurations highly effective protecting pilocarpine mgkg scinduced limbic motor seizures status epilepticus ed values mgkg ipnan
no_relation,paracetamol,viral hepatitis,7007443,acid protease cathepsin activity increased tenfold patients died nearly fourfold survived fulminant hepatic failure paracetamol overdose whereas activities increased equally patients fulminant hepatic failure due viral hepatitis whether survivedparacetamol overdose causes fulminant hepatic liver failure text say caused viral hepatitis
no_relation,NMDA/N-methyl-D-aspartate,schizophrenia,20727411,glutamatergic n-methyl-d-aspartate nmda receptor implicated pathophysiology schizophrenia nmda receptor involved schizophrenia chemical nmda
no_relation,D-penicillamine,primary biliary cirrhosis,8268147,case polymyositis patient primary biliary cirrhosis treated d-penicillamine d-penicillamine seems used treat primary biliary cirrhosis
yes_direct,puromycin aminonucleoside/PAN,Acute experimental models of renal damage,3653576,acute experimental models renal damage proximal tubular glomerular papillary regions rat produced administration hexachlorobutadiene hcbd puromycin aminonucleoside pan bromoethylamine bea respectivelythree chemicals produced acute experimental models renal damage
yes_direct,Tacrine,seizures,19944736,tacrine administered licl pretreated rats induces electrocorticographic seizures delayed hippocampal damagenan
no_relation,sirolimus,psoriasis,10328196,activated peripheral blood cells patients psoriasis tended exhibit greater spontaneous dexamethasoneinduced apoptosis normal cells particularly presence sirolimus sirolimus made cells undergo apoptosis cell death faster sirolimus stated caused psoriasis
no_relation,everolimus,MDS/myelodysplastic syndrome,19135948,report combination everolimus tacrolimus patients median age years either myelodysplastic syndrome mds  acute myeloid leukemia aml  undergoing intensive conditioning followed hsct related  unrelated  donorseverolimus used patients myelodysplastic syndrome text say everolimus caused mds
yes_direct,succinylcholine,myalgia,12760988,conclusion evidence inflammatory origin succinylcholine associated myalgia sentence says evidence inflammatory origin myalgia caused succinylcholine mean succinylcholine cannot cause myalgia
no_relation,angiotensin,NS/nephrotic syndrome,9154656,plasma concentration urine excretion renin angiotensin system proteins altered rats nephrotic syndrome ns reninangiotensin system protein levels different rats nephrotic syndrome
no_relation,naloxazone,hypothermia,6308526,pretreatment naloxazone significantly blocked morphine analgesia catalepsy hypothermia dose completely eliminated highaffinity binding brain membranesnaloxazone made hypothermia better
no_relation,benzoylecgonine,EDDs,8988571,edds concentrations cocaine benzoylecgonine autopsy blood similar controlsnan
no_relation,Tiopronin,RA,3084782,compared healthy controls lower dr frequency observed patients ra except tiopronin related nephritis groupnan
no_relation,lithium,tricuspid regurgitation,6794356,newborn massive tricuspid regurgitation atrial flutter congestive heart failure high serum lithium level describedalthough newborn tricuspid regurgitation high blood lithium levels sentence say lithium caused tricuspid regurgitation
yes_direct,azelastine,altered taste perception,3057041,drowsiness altered taste perception increased significantly placebo highdose azelastine groupazelastine caused drowsiness altered taste perception whereas placebo chemical given
yes_direct,propranolol,Raynaud's phenomenon,6115999,adverse reactions significantly linked active drugs include impaired glucose tolerance men women gout men associated bendrofluazide treatment raynauds phenomenon dyspnoea men women taking propranolol raynauds phenomenon given example adverse reaction linked drugs case propranolol
yes_direct,adrenaline,bradycardia,2894433,intravenous pretreatment rats diazepam although causing change adrenaline induced pressor effect enhance adrenaline induced reflex bradycardia nan
no_relation,alcohol,alcohol abuse,11573852,patient history alcohol abuse alcohol intake well withdrawal also cause seizuresalcohol mentioned something might cause seizures sentence say alcohol causes alcohol abuse
yes_direct,venlafaxine,Serotonin syndrome,8888541,serotonin syndrome venlafaxine tranylcypromine interactionnan
no_relation,thiol,lung cancer,6402369,protective effect oral administration thiol compound sodium mercaptoethane sulphonate mesna urothelial toxicity induced ifosfamide tested group patients inoperable lung cancer treatment mgm days part polychemotherapy regimen repeated week cyclesubject sentence sodium mercaptoethane sulphonate thiol
no_relation,heparin,thromboembolism,11827497,measurements platelet counts onset objectively determined thromboembolism results heparin induced platelet factor antibody tests outcomessentence lists things measured
no_relation,L-dihydroxyphenylalanine,neurotoxicity,20533999,show recently reported ability l-dihydroxyphenylalanine reverse protective effect alphamethylparatyrosine methinduced da neurotoxicity also confounded drug effects body temperatureneurotoxicity induced meth
yes_direct,azithromycin,hiccups,15985056,possible azithromycin associated hiccups sentence suggests azithromycin likely causes hiccups use possible
no_relation,MPTP,Parkinson's disease,20973483,compound potent aaa receptor antagonist vitro aa ki  nm ki  nm excellent activity oral administration across number animal models parkinson's disease including mouse rat models haloperidolinduced catalepsy mouse model reserpineinduced akinesia rat hydroxydopamine ohda lesion model druginduced rotation mptp treated nonhuman primate modelnan
no_relation,bupropion,sleep deprivation,12745515,case report describes generalized seizure associated sustainedrelease bupropion use sleep deprivation sentence says bupropion causes seizure sleep deprivation causes seizure say bupropion causes sleep deprivation
yes_direct,epipodophyllotoxin,cardiac toxicity,15897593,purpose anthracyclines daunorubicin doxorubicin epipodophyllotoxin etoposide potent dna cleavageenhancing drugs widely used clinical oncology however myelosuppression cardiac toxicity limit usechemical etoposide kind epipodophyllotoxin sentence says etoposide causes cardiac toxicity sentence say epipodophyllotoxins cause cardiac toxicity
yes_direct,caffeine,ventricular arrhythmias,18997632,although intravenous caffeine generally well tolerated clinician aware potential unpredictable serious ventricular arrhythmias serious ventricular arrhythmias result taking caffeine
yes_direct,metoprolol,heart block,7785794,seventyeightyearold woman presented complete heart block refractory hypotension two days therapeutic dose sustainedrelease verapamil concomitant use metoprolol woman developed heart block taking two chemicals together verapamil metoprolol
yes_direct,doxorubicin,cardiac failure,3137399,one patients developed cardiac failure mg mmc mg doxorubicin nan
no_relation,fenoldopam,tumor,12180796,arteritis induced rats vasodilators fenoldopam theophylline examined immunohistochemically expressions inducible type nitric oxide synthase inos basic fibroblast growth factor bfgf tumor growth factorbeta tgfbetarats given fenoldopam examined kind protein tumor growth factorbeta word tumor used refer disease rather part name protein tumor growth factorbeta
yes_direct,etoposide,cardiac toxicity,15897593,purpose anthracyclines daunorubicin doxorubicin epipodophyllotoxin etoposide potent dna cleavageenhancing drugs widely used clinical oncology however myelosuppression cardiac toxicity limit usenan
yes_direct,midazolam,hiccups,15985056,corticosteroids dexamethasone methylprednisolone benzodiazepines midazolam general anaesthesia specific agents mentioned frequently literature associated development hiccups benzodiazepines category chemicals midazolam mentioned specific example benzodiazepine known cause hiccups
yes_direct,methylprednisolone,asystole,10074612,report case hypotension bradycardia asystole intravenous administration highdose methylprednisolone yearold patient underwent electrocardiographic ecg monitoring throughout episodemethylprednisolone caused three different diseases patient
no_relation,etomidate,myoclonus,16563323,remifentanil pretreatment reduces myoclonus etomidate remifentanil makes myoclonus caused etomidate better
yes_direct,CLZ,headache,7596955,seven subjects experienced headache short duration accompanying facial flush one nausea one especially ingestion clz eating clz caused headaches  patients
yes_direct,ropivacaine,seizures,11524350,cumulative doses levobupivacaine ropivacaine produced seizures similar larger bupivacainenan
no_relation,testosterone,hyperprolactinemia,20331935,serum testosterone concentration increased pubertal status affected hyperprolactinemia nan
no_relation,choline,AD/Alzheimer's disease,16428827,choline acetyltransferase chat activator enhances cholinergic transmission via augmentation enzymatic production acetylcholine ach important factor treatment alzheimers disease ad choline acetyltransferase activator protein choline important treating alzheimers disease
yes_direct,oestrogen,gallbladder disease,19370593,longterm oestrogen ht significantly increased risk venous thromboembolism stroke gallbladder disease one two years three years seven years use respectively significantly increase risk breast canceroestrogen increased risk gallbladder disease
yes_direct,chloroquine,deterioration of vision,1628552,year old african woman history regular chloroquine ingestion presented progressive deterioration vision easy fatiguability dyspnoea dizziness progressing syncopal attacksnan
no_relation,tamoxifen,breast cancer,9672273,interpretation although preliminary analysis low power cohort women lowtonormal risk breast cancer postulated protective effects tamoxifen yet apparenttamoxifens protective beneficial effects breast cancer yet clear according sentence
no_relation,potassium,hypokalemia,6942642,conclusion found thiazide diuretics cause hypokalemia depletion body potassium hypokalemia caused thiazide diuretics
yes_direct,eserine,mydriasis,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednannan
no_relation,rifampin,tuberculosis,804391,light chain proteinuria cellular mediated immunity rifampin treated patients tuberculosis rifampin given patients tuberculosis sentence say rifampin caused tuberculosis
no_relation,glycopyrronium,bradycardias,2917114,use glycopyrronium micrograms kg provided greater cardiovascular stability given min edrophonium sufficient minimize early edrophoniuminduced bradycardias glycopyrronium beneficial effect bradycardias
no_relation,clonazepam,myoclonic jerks,6118280,benzodiazepines clonazepam mgkg found several fold potent diazepam mgkg blocking myoclonic jerks clonazepam blocked myoclonic jerks
yes_direct,doxorubicin,cardiomyopathy,7282516,doseeffect structurefunction relationships doxorubicin cardiomyopathy doseeffect structurefunction relationships refer doxorubicin cardiomyopathy therefore conclude different doses doxorubicin different effects cardiomyopathy therefore doxorubicin causes cardiomyopathy
yes_direct,clozapine,tic-like symptoms,16225977,however two case reports show ticlike symptoms including motor phonic variants occurring treatment quetiapine clozapine two reports showed ticlike symptoms arose clozapine treatment
no_relation,SC-48334,immunodeficiency,7905523,mean sc-48334 steadystate trough level  microgramsml vitro inhibitory concentration human immunodeficiency virus hivsc-48334 concentration high enough inhibit human immunodeficiency virus immunodeficiency discussed disease part human immunodeficiency virus
yes_direct,pemoline,overdose,9022662,possibility choreoathetoid movements considered patients presenting pemoline overdose nan
yes_direct,Quinidine phenylethylbarbiturate,hepatitis,3411101,quinidine phenylethylbarbiturate induced fulminant hepatitis pregnant woman case reportinduced means caused
no_relation,ATP,obese,18674790,conclusion hfdinduced obese rats highly sensitized doxorubicininduced cardiotoxicity substantially downregulating cardiac mitochondrial atp generation increasing oxidative stress downregulating jakstat pathwaynan
yes_direct,paroxetine,neuroleptic malignant syndrome,16720068,possible neuroleptic malignant syndrome related concomitant treatment paroxetine alprazolamsentence says treatment paroxetine alprazolam possibly causes neuroleptic malignant syndrome
no_relation,Cyclophosphamide,visceral pain,10840460,cyclophosphamide induced cystitis freelymoving conscious rats behavioral approach new model visceral pain nan
no_relation,gamma-aminobutyric acid/GABA,hypotension,9915601,high doses isoniazid increase hypotension induced vasodilators change accompanying reflex tachycardia bradycardia interaction attributed decreased synthesis brain gammaaminobutyric acid gaba hypotension caused vasodilators chemicals make blood vessels wider made worse chemical isoniazid
yes_direct,beta-adrenergic blocking drugs,bradycardia,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugs nan
no_relation,oxacillin,Staphylococcus aureus bacteremia,11337188,yearold man treated oxacillin one week staphylococcus aureus bacteremia developed renal failure diffuse symmetric palpable purpuric lesions feetoxacillin used treat staphylococcus aureus bacteremia
yes_direct,gold,dermatitis,3084782,strong association found nephritis dermatitis due tiopronin dpenicillamine like compound class antigens bcw dermatitis due gold thiosulphategold part gold thiosulphate different chemical gold dermatitis caused gold thiosulphate goldgold thiosulphate though gold right still
no_relation,Li,EPS,17042884,similarly eps related adverse events qtp li dvp different pbo li dvp eps related events different chemical qtp given pbo given sentence contain enough information say lithium li causes eps related adverse events
yes_direct,reserpine,tremor,11999899,pretreatment reserpine mgkg observation test produced increases vacuous chewing movements tongue protrusion well increases tremor catalepsy whereas mk-801 mgkg injection min test reversed effects reserpine giving reserpine hours prior caused tremor
no_relation,Vitamin E,MI,16584858,heart tissue antioxidant enzymes superoxide dismutase catalase glutathione peroxidase glutathione transferase glutathione reductase activities nonenzymic antioxidants cerruloplasmin vitamin vitamin glutathione levels altered mi ratsvitamin levels changed mi rats
no_relation,gentamicin,tubular necrosis,2709684,group ii prevent gentamicin arf maximal decrease ccr day less peak lysozymuria  microgramsday tubular necrosis score  tubular necrosis score measurement used quantify whether prevented gentamicinarf text never says gentamicin related tubular necrosis
yes_direct,TP,prostate cancer,3461217,lw rats tp acted tumor enhancement agent primary emphasis development prostate cancer tp enhances tumors especially development prostate cancer therefore conclude tp cause prostate cancer
yes_direct,phenytoin,psychosis,14698717,case nonepileptic patient developed psychosis following phenytoin treatment trigeminal neuralgia describedpatient developed psychosis receiving phenytoin
no_relation,azathioprine,cancers,3970039,several longterm studies patients rheumatoid arthritis treated azathioprine cyclophosphamide incidence common cancers increasedazathioprine effect cancer prevalence patients
no_relation,propranolol,panic disorders,6387529,effects oral doses diazepam single dose mg median dose mgday weeks propranolol single dose mg median dose mgday weeks psychological performance patients panic disorders agoraphobia investigated doubleblind randomized crossover designsentence says effects diazepam propranolol patients investigated sentence state effect
yes_direct,adrenaline,atrial fibrillation,9698967,increase blood pressure accompanied atrial fibrillation agitation incomprehensible shouts loss consciousness observed elderly asa classification group ii cardiovascularly medicated male min performance axillary block mepivacaine mg containing adrenaline mg correction dupuytrens contracturegiving mepivacaine adrenaline together caused male patient experience atrial fibrillation
yes_direct,ketoconazole,hypertension,2632720,cases normal plasma urinary free cortisol levels achieved following ketoconazole therapy yet continuous blood pressure monitoring demonstrated hypertension patient  weeks patient treatmentlongterm patient monitoring showed patients hypertension receiving ketoconazole therapy
no_relation,cisplatin,toxicity,8643971,initiated phase iii trial determine response toxicity escalating paclitaxel doses combined fixeddose cisplatin granulocyte colonystimulating factor support patients untreated locally advanced inoperable head neck carcinomasentence says response toxicity paclitaxel cisplatin studied say result
no_relation,na,Seizure,12198388,methods cholinergic convulsant sensitivity examined alcohol na withdrawal seizure prone wsp andresistant wsr micena represent chemical context seems error alcoholna since word
yes_direct,tobramycin sulfate,ototoxicity,7420681,gentamicin sulfate tobramycin sulfate continue demonstrate ototoxicity nephrotoxicity animal clinical studiestobramycin sulfate causes ototoxicity animals humans
no_relation,Verapamil,hypertensive,3173179,verapamil withdrawal possible cause myocardial infarction hypertensive woman normal coronary angiogramverapamil used woman hypertension sentence say verapamil causes hypertension
yes_direct,caffeine,ventricular fibrillation,11419773,describe yearold woman preexisting mitral valve prolapse developed intractable ventricular fibrillation consuming natural energy guarana health drink containing high concentration caffeine developed ventricular fibrillation consuming health drink containing caffeine
yes_direct,acetaminophen,ESRD,8669433,possibility habitual use acetaminophen alone increases risk esrd clearly demonstrated cannot dismissedsentence says known whether acetaminophen causes esrd also impossible therefore know whether acetaminophen causes esrd therefore answer sentence say acetaminophen contributes causes esrd
yes_indirect,pilocarpine,Infarcts in substantia nigra pars reticulata,8410052,infarcts substantia nigra pars reticulata evoked prolonged pilocarpine induced status epilepticussentence follows structure chemicalinduced disease causes highlighted disease status epilepticus actually causing infarcts substantia nigra pars reticulata
no_relation,aminophylline,respiratory failure,234669,effects aminophylline ventricular fibrillation threshold normal acidbase conditions respiratory failure studied anesthetized open chest dogssentence says effects studied say effects
no_relation,4'-0-tetrahydropyranyladriamycin/Pirarubicin,tumors,2224762,phase study intravenous iv bolus tetrahydropyranyladriamycin pirarubicin done patients good performance status refractory tumors study pirarubicin done patients existing tumors stated link pirarubicin tumors
yes_direct,lopinavir/ritonavir,bradycardia,19820426,one twins developed complete heart block dilated cardiomyopathy related lopinavir/ritonavir therapy boosted proteaseinhibitor agent twin developed mild bradycardia second twin developed bradycardia result lopinavirritonavir
no_relation,prochlorperazine,akathisia,11679859,intravenous administration prochlorperazine minute infusion versus minute bolus affect incidence akathisia prospective randomized controlled trialprochlorperazine effect akathisia
yes_direct,Fentanyl,bradycardia,18544179,fentanyl reduce minor intraoperative movement sevofluranesparing effect increased respiratory depression hypotension bradycardia fentanyl increased bradycardia
no_relation,cocaine,glomerulonephritis,11391224, included cases malignant hypertension thrombotic microangiopathy lupus nephritis henochschonlein nephritis crescentic glomerulonephritis cocaine related acute renal failurecocaine causing acute renal failure glomerulonephritis
no_relation,CGRP,migraine,14659530,plasma cgrp concentration increased significantly migraine attack returned baseline cessation migraine cgrp part plasma cgrp concentration migraine seemed cause increase cgrp levels way around
yes_direct,telithromycin,toxic hepatitis/hepatitis,17919553,based score naranjo adverse drug reaction probability scale telithromycin probable cause acute hepatitis patient pathological findings suggested druginduced toxic hepatitis telithromycin likely cause hepatitis patient
no_relation,bradykinin,hypertension,8955532,role activation bradykinin receptors disruption bloodbrain barrier acute hypertension bradykinin part bradykinin receptors activated receptors disrupting bloodbrain barrier somehow
yes_direct,suxamethonium,bradycardia,6466532,comparison iv glycopyrrolate atropine prevention bradycardia arrhythmias following repeated doses suxamethonium childrensuxamethonium causes bradycardia sentence says two chemicals glycopyrrolate atropine used try prevent bradycardia
no_relation,fangchinoline,thrombosis,10193204,effects tetrandrine fangchinoline experimental thrombosis mice human platelet aggregationsentence fragment explicitly say negative effects fangchinoline exist rather effects tested
yes_direct,bisphosphonate,acute renal failure,18754075,massive proteinuria acute renal failure oral bisphosphonate alendronate administration patient focal segmental glomerulosclerosispatient developed acute renal failure taking bisphosphonate
yes_direct,acetaminophen,chronic renal failure/ESRD,8669433,however three case control studies one north carolina northern maryland west berlin germany showed habitual use acetaminophen also associated chronic renal failure esrd relative risk range habitual use acetaminophen causes chronic renal failure
no_relation,NO,neuropathic pain,19300402,therefore concomitant administration small doses bradykinin receptor antagonists synthase inhibitors effective alleviation neuropathic pain even hospital caresentence says small doses synthase inhibitors category chemicals removes neuropathic pain
no_relation,cyclophosphamide,hypertension,15325671,analysis performed women chemotherapyresponsive metastatic breast cancer receiving infusional cyclophosphamide part triple sequential highdose regimen assess association presence peritransplant congestive heart failure chf following pretreatment characteristics presence electrocardiogram ekg abnormalities age hypertension prior cardiac history smoking diabetes mellitus prior use anthracyclines leftsided chest irradiationanalysis done see congestive heart failure anything pretreatment characteristics including hypertension sentence never says conclusions analysis whether cyclophosphamide causes hypertension
no_relation,maltolyl p-coumarate,neuronal death,17600377,taking vitro vivo results together study suggests maltolyl pcoumarate potentially effective candidate alzheimers disease characterized wide spread neuronal death progressive decline cognitive functionmaltolyl pcoumarate treating alzheimers disease causing one symptoms neuronal death alzheimers disease
yes_direct,acetylcholine,tremors,15275829,binding nicotine nicotinic acetylcholine receptors nachrs elicits series dosedependent behaviors go altered exploration sedation tremors seizures deathacetylcholine part nicotinic acetylcholine receptors nicotine binding receptors causes tremors acetylcholinenicotinic acetylcholine receptors acetylcholine
no_relation,na,HBV infected/HBV mono-infected,17854040,thirtyfive lamivudine na hbv infected patients without hiv coinfection studied chronic hbv monoinfected patients hbvhiv coinfected patientsna used chemical context word seems missing letter na
yes_direct,epinephrine/EP,thrombosis,10193204,present study undertaken investigate effects tet fan experimental thrombosis induced collagen plus epinephrine ep mice platelet aggregation blood coagulation vitrothrombosis induced caused collagen epinephrine
no_relation,hydrocortisone,myocardial injury,983936,effects acetylsalicylic acid dipyridamole hydrocortisone epinephrineinduced myocardial injury dogsmyocardial injury caused epinephrine know effect hydrocortisone myocardial injury
no_relation,cholesterol,cognitive dysfunctions,16755009,therefore dce may prove useful remedy management cognitive dysfunctions account multifarious beneficial effects memory improving property cholesterol lowering property anticholinesterase activitysentence lists beneficial effects dce cholesterol lowering property sentence say cholesterol causes cognitive dysfunctions
no_relation,sodium,volume retention,18768591,doxorubicininduced nephropathy leads epithelial sodium channel enacdependent volume retention renal fibrosissentence says nephropathy caused doxorubicin leads volume retention dependent epithelial sodium channels kind protein say sodium causes volume retention
yes_indirect,cisplatin,mitochondrial toxicity,18809400,conclusion mitochondrial toxicity early common event paclitaxel cisplatin induced neurotoxicitysentence follows chemicalinduced disease causes highlighted disease structure therefore correct answer cisplatininduced neurotoxicity causes mitochondrial toxicity
no_relation,morphine,acute pain,18221780,enhancement morphine antinociception dextromethorphan seen males females acute pain models magnitude effect greater maleseffect enhanced dextromethorphan model acute pain sentence say morphine causes acute pain fun fact morphine actually strong painkiller similar opium heroin
no_relation,NMDA,acute pain,18221780,findings demonstrate sexuallydimorphic interaction nmda antagonists morphine persistent pain model distinguished observed acute pain modelsnmda antagonists interacting morphine study done acute pain model sentence say nmda causes acute pain
yes_direct,alcohol,flushing of the face,19657887,less hour ingestion alcohol developed malaise flushing face tachycardia dyspneaingesting alcohol causes face flush already knew
no_relation,dopamine,bradycardia,10721819,suggest normal conscious rats central tachycardia bromocriptine appears predominate mask bradycardia agonist peripheral dopamine receptorsdopamine part dopamine receptors kind protein
no_relation,haloperidol,psychomotor agitation,9812111,results patients completed phase standarddose haloperidol efficacious superior lowdose haloperidol placebo scores brief psychiatric rating scale psychosis factor psychomotor agitation haloperidol seemed positive effect psychomotor agitation
no_relation,fentanyl,postoperative pain,18544179,conclusion fentanyl exacerbated postoperative nausea vomiting without improvement postoperative pain also adverse cardiorespiratory effects appears unnecessary possibly detrimental supplement sevoflurane day surgeryfentanyl made postoperative nausea vomiting worse improve postoperative pain sentence say fentanyl originally caused postoperative pain
yes_direct,Nitrofurantoins,anophthalmia,19884587,nitrofurantoins associated anophthalmia microphthalmos aor  ci hypoplastic left heart syndrome aor  ci atrial septal defects aor  ci cleft lip cleft palate aor  ci nitrofurantoins cause anophthalmia
no_relation,metamizol,chronic pain,12063090,findings show significant interaction morphine metamizol chronically treated rats suggesting combination could useful treatment chronic pain metamizol said useful treating chronic pain
yes_indirect,kainic acid,hippocampal injury,12757899,estrogens protect ovariectomized rats hippocampal injury induced kainic acid induced status epilepticus sefollows chemicalinduced disease caused highlighted disease format correct answer kainic acidinduced status epilepticus causes hippocampal injury
yes_direct,methylprednisolone,"nausea, vomiting",17466854,conclusions administration methylprednisolone gentamicin posterior subtenons space related high incidence side effects including nausea vomiting headachemethylprednisolone causes nausea vomiting side effect
yes_direct,carbamazepine,renal failure,2522601,report patient hypersensitivity carbamazepine presented generalized erythroderma severe leukemoid reaction eosinophilia hyponatremia renal failure carbamazepine caused many diseases patientpatient hypersensitivity
yes_direct,alendronate,proteinuria,18754075,massive proteinuria acute renal failure oral bisphosphonate alendronate administration patient focal segmental glomerulosclerosispatient developed proteinuria taking alendronate
yes_direct,ceftriaxone,hepatitis,9625142,acute hepatitis autoimmune hemolytic anemia erythroblastocytopenia induced ceftriaxone induced means caused
no_relation,nitrendipine,renovascular hypertension,1639466,effect week treatment calcium channel blocker nitrendipine angiotensin converting enzyme inhibitor enalapril blood pressure albuminuria renal hemodynamics morphology nonclipped kidney studied rats twokidney one clip renovascular hypertension sentence gives conclusion regarding result study
no_relation,vinorelbine,nonsmall cell lung carcinoma,10526274,gemcitabine plus vinorelbine nonsmall cell lung carcinoma patients age years older patients cannot receive cisplatin oncopaz cooperative groupsentence says vinorelbine used patients lung carcinoma say whether vinorelbine treating causing cancer
yes_direct,fentanyl,retention of urine,11581460,bladder retention urine result continuous intravenous infusion fentanyl  case reportsusing fentanyl caused retention urine
yes_direct,MDMA,impaired social and emotional judgement processes,16574712,mdma polydrug users show processspecific central executive impairments coupled impaired social emotional judgement processes people take mdma drugs develop impaired social emotional judgement processes
yes_direct,Levodopa,dystonia,12691807,levodopa induced oromandibular dystonia progressive supranuclear palsynan
yes_direct,mepivacaine,muscle damage,4038130,addition muscle damage severe damage also seen harderian glands especially exposure mepivacaine lidocaine plus epinephrinenan
yes_direct,erythromycin,Prolongation of QT interval,9545159,prolongation qt interval torsades de pointes sudden cardiac death reported concomitant administration erythromycin azole antifungal agents cypa inhibitorsnan
yes_direct,carbachol,tremor,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserinenan
yes_direct,pravastatin,inflammatory myopathy,7604176,case acute inflammatory myopathy associated use pravastatin new hydrophilic hydroxy methylglutaril coenzyme reductase inhibitor reportednan
yes_direct,calcium carbon-ate,nephrolithiasis,625456,one case acute hypercalcaemia two recurrent nephrolithiasis reported patients regularly consumed large amounts calcium carbonate sodium bicarbonate powders yearsnan
yes_direct,adriamycin,acute myeloblastic leukemia,6769133, monkeys developed acute myeloblastic leukemia receiving mgm adriamycin th monkey alive well months last dose drugnan
yes_direct,bromocriptine,psychosis,3686155,two multigravida patients prior psychiatric history seen postpartum psychosis received bromocriptine inhibition lactationnan
yes_direct,halothane,hepatitis,7647582,supports extends previous evidence mechanism enflurane andor isoflurane could produce hypersensitivity condition similar halothane hepatitis either alone subsequent halothane administrationnan
yes_direct,Cyclophosphamide,bladder tumor,8911359,conclusions cyclophosphamide associated bladder tumor aggressive diseasenan
yes_direct,methimazole,itching,14982270,yearold woman severe jaundice itching month receiving methimazole mg tid propranolol mg tid treatment hyperthyroidismnan
yes_direct,eserine,tremor,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloridenan
yes_direct,PTU/propylthiouracil,vasculitis,16418614,diagnosis propylthiouracil ptu associated vasculitis made observation consistent clinical features detection elevated ana anca blood observed clinical resolution symptoms following withdrawal ptu nanthats nobrainer
yes_direct,epinephrine,myocardial ischemia,3413271,role epinephrine eliciting myocardial ischemia examined patients coronary artery diseasenan
yes_direct,Lamotrigine,myoclonus,16157917,lamotrigine associated exacerbation de novo myoclonus idiopathic generalized epilepsiesnan
yes_direct,caffeine,ventricular tachycardia,18997632,describe patient previous history cardiac disease arrhythmia developed sustained bigeminy brief runs ventricular tachycardia caffeine administrationnan
yes_direct,verapamil,hypotension,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugsnan
yes_direct,fluoxetine,adenomyosis,9098464,histological studies revealed cases adenomyosis within noncastrated group receiving fluoxetine nan
yes_direct,enalapril,decreased renal function,10539815,older age associated greater risk developing decreased renal function groups significantly enalapril group enalapril risk ratio rr per years confidence interval ci enalapril placebo rr  ci nan
yes_direct,sodium bicarbonate,hypercalcaemia,625456,one case acute hypercalcaemia two recurrent nephrolithiasis reported patients regularly consumed large amounts calcium carbonate sodium bicarbonate powders yearsnan
yes_direct,cirazoline,bradycardia,1355091,pressor bradycardia effects cirazoline abolished chronic prazosin treated shr  compared untreated shr nan
yes_direct,amikacin,nephrotoxicity,18356633,evaluate amikacin associated nephrotoxicity adult hematologyoncology population prospective randomized openlabel trial conducted universityaffiliated medical centernan
yes_direct,ouabain,arrhythmia,19721134,study designed evaluate effects pilocarpine explore underlying ionic mechanism using aconitineinduced rat ouabain induced guinea pig arrhythmia modelstwo animal models used study one rat model arrhythmia induced aconitine second guinea pig model induced ouabain
yes_direct,Pamidronate,hypocalcemia,16006300,pamidronate treatment associated considerable risk hypocalcemia even cases initially severe hypercalcemianan
yes_direct,ethambutol,Bilateral optic neuropathy,384871,bilateral optic neuropathy due combined ethambutol isoniazid treatmentnan
yes_direct,caffeine,ventricular tachycardia,18997632,case ventricular tachycardia related caffeine pretreatmentnan
no_relation,methotrexate,leukoencephalopathy,17682013,background transient leukoencephalopathy mimicking cerebrovascular accident described complication chemotherapy commonly recipients intrathecal methotrexate childhood leukaemianan
yes_direct,SCH 23390,catalepsy,1687392,agonist skf agonist quinpirole decreased catalepsy induced fluphenazine sch sulpiridenan
yes_direct,daunorubicin,weight loss,15897593,results nontoxic doses dexrazoxane reduced myelosuppression weight loss daunorubicin etoposide mice antagonized antiproliferative effects colony assay however dexrazoxane neither reduced myelosuppression weight loss vitro cytotoxicity doxorubicinnan
yes_direct,morphine,cataleptic,2716967,pretreatment ketamine produced crosstolerance morphine whereas pretreatment morphine induce crosstolerance ketamine rather augmented cataleptic response augmentation attributed residual morphine brainnan
yes_direct,Quinidine phenylethylbarbiturate,hepatitis,3411101,quinidine phenylethylbarbiturate induced fulminant hepatitis pregnant woman case reportnan
yes_direct,propofol,pain,18006530,hypothesized propofol infusion pain might prevented infusing remifentanil starting propofol infusion clinical setting targetcontrolled infusions tci drugs usednan
yes_direct,Tacrine,hippocampal damage,19944736,tacrine administered licl pretreated rats induces electrocorticographic seizures delayed hippocampal damage nan
yes_direct,nifedipine/Adalat,telangiectasia,8251368,five months starting nifedipine adalat two patients developed photodistributed facial telangiectasia became noticeable timenan
yes_direct,warfarin,LV Cutaneous lesions,16047871,results skin lesion biopsies available patients confirming lv cutaneous lesions resolved patients warfarin discontinuednan
yes_direct,epinephrine,myocardial ischemia,3413271,epinephrine exercise produced myocardial ischemia evidenced st segment depression anginanan
yes_direct,nitric oxide/NO,migraine without aura,10524660,recent years increasing evidence suggested messenger molecule nitric oxide  involved pain mechanisms migraine without aura naninvolved key word
yes_direct,bromocriptine,psychosis,3686155,cases demonstrate bromocriptine may cause psychosis even given low dosesnan
yes_direct,ziprasidone,NMS,17366349,case earliest second day treatment nms due ziprasidone reported literaturenan
yes_direct,DM,cognitive deterioration,7803371,report describes case cognitive deterioration resulting prolonged use dm nan
yes_direct,cyclooxygenase inhibitors,hypertension,16586083,randomised clinical trials observational studies shown increased risk myocardial infarction stroke hypertension heart failure treatment cyclooxygenase inhibitors nan
yes_direct,carbachol,clonic-tonic convulsions,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
yes_direct,ketamine,catalepsy,2716967,previous studies demonstrated ketamine morphine induced analgesia catalepsy ratnan
yes_direct,eserine,mydriasis,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserine nan
yes_direct,tramadol,hallucinations,8766220,nightmares hallucinations longterm intake tramadol combined antidepressantsnan
yes_direct,amiodarone,cirrhosis of the liver,3962737,concluded solid evidence exists hepatic injury due amiodarone treatment including steatosis alterations resembling alcoholic hepatitis cholestatic hepatitis micronodular cirrhosis liver nan
yes_direct,alpha-benzene hexachloride,hepatomas,85485,peroxisomes hepatomas hyperplastic preneoplastic liver lesions induced mice ppm alphabenzene hexachloride examined histochemically electron microscopicallynan
yes_direct,fentanyl,rigidity,3780697,postoperative rigidity fentanyl administrationnan
yes_direct,5-fluorouracil,leukoencephalopathy,17682013,results identified reports toxic leukoencephalopathy patients treated methotrexate intrathecal systemic 5-fluorouracil derivative carmofur capecitabinenan
yes_direct,eserine,tremor,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
yes_direct,rifampicin,Acute renal failure,982002,acute renal failure subsequent administration rifampicin followup study cases reported earliernan
yes_direct,eserine,tremor,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserine nan
yes_direct,oral contraceptives,liver tumors,188339,etiologic factors pathogenesis liver tumors associated oral contraceptives nan
yes_direct,enflurane,hepatic injury,7647582,two halogenated anesthetics enflurane isoflurane associated allergictype hepatic injury alone following previous exposure halothanenan
yes_direct,diazepam,incoordination,6323692,verapamil mgkg ip nh4ac pretreatment enhanced morphine analgesia diazepam induced muscular incoordination antagonized amphetamineinduced motor activity neither verapamil nh4ac affected convulsant action metrazolnan
yes_direct,epinephrine,myocardial ischemia,3413271,however mechanisms myocardial ischemia induced epinephrine significantly different exercisenan
yes_direct,Ketamine,psychosis,20727411,ketamine elicited psychosis like psychopathologynan
yes_direct,AZT,cardiac dilation,17943461,contrast azt treated fasl tg mice developed cardiac dilation depressed cardiac function dosedependent manner concomitant inflammatory infiltration ventriclesnan
yes_direct,oxacillin,Cutaneous leucocytoclastic vasculitis,11337188,cutaneous leucocytoclastic vasculitis associated oxacillin nan
yes_direct,doxorubicin/DXR/Adriamycin,cardiomyopathy/myocardial disease/CM,7282516,cardiomyopathy cm produced anticancer drug doxorubicin dxr  adriamycin provides unique opportunity analyze doseeffect structurefunction relationships development myocardial disease nan
yes_direct,dextromethorphan,Cognitive deterioration,7803371,cognitive deterioration longterm abuse dextromethorphan case reportnan
yes_direct,venlafaxine,Serotonin syndrome,8888541,serotonin syndrome venlafaxine tranylcypromine interactionnan
yes_direct,naproxen,renal papillary necrosis/RPN,6699841,yearold man rheumatoid arthritis previously treated sulindac fenoprofen calcium high dose salicylates gold salts developed renal papillary necrosis rpn  months institution naproxen therapynan
yes_direct,olanzapine,Hypomania,10565806,hypomania like syndrome induced olanzapine nanhypomanialike syndrome hypomania
yes_direct,androgen,obstructive sleep apnea syndrome,6732043,development obstructive sleep apnea syndrome must considered possible side effect androgen therapynan
yes_direct,fluoxetine hydrochloride,hyperprolactinemia,9098464,murine model adenomyosis effects hyperprolactinemia induced fluoxetine hydrochloride selective serotonin reuptake inhibitor adenomyosis induction wistar albino ratsnan
yes_direct,Risperidone,visual disturbances,12013711,risperidone associated benign transient visual disturbances schizophrenic patients past history lsd abusenan
yes_direct,fentanyl,rigidity,3780697,case thoracoabdominal rigidity leading respiratory failure described postoperative period elderly patient received moderate dose fentanyl nan
yes_direct,Tacrine,seizures,19944736,tacrine administered licl pretreated rats induces electrocorticographic seizures delayed hippocampal damagenan
yes_direct,epinephrine,myocardial ischemia,3413271,mechanisms myocardial ischemia induced epinephrine comparison exerciseinduced ischemianan
yes_direct,Ethambutol,visual loss,16710500,introduction ethambutol used treatment tuberculosis still prevalent southeast asia associated permanent visual loss nantrue
yes_direct,Etoposide,myocardial infarction,7619765,etoposide related myocardial infarction nan
yes_direct,tranylcypromine,serotonin syndrome,8888541,report venlafaxinemaoi interaction resulted serotonin syndrome yold male taking tranylcypromine depressionnan
yes_direct,MDMA,impaired memory functioning/memory impairments,16574713,use mdma quantities may considered moderate associated impaired memory functioning heavy use mdma use may lead long lasting memory impairments nan
yes_direct,lidocaine,seizures,2790457,chronic carbamazepine inhibits development local anesthetic seizures kindled cocaine lidocaine nan
yes_direct,Tiopronin,nephritis,3084782,strong association found nephritis dermatitis due tiopronin dpenicillamine like compound class antigens bcw dermatitis due gold thiosulphatenan
yes_direct,NH4CL,coma,761833,ammonia coma produced rats within  minutes intraperitonealinjection mmol nh4cl nan
yes_direct,azithromycin,hiccups,15985056,possible azithromycin associated hiccups nan
yes_direct,succinylcholine,apnoea,871943,fifteen patients demonstrating unexpected prolonged apnoea lasting several hours succinylcholine treated new preparation human serum cholinesterasenan
yes_direct,beta-adrenergic blocking drugs,cardiac failure,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugs nan
yes_direct,venlafaxine,serotonin syndrome,8888541,report venlafaxine maoi interaction resulted serotonin syndrome yold male taking tranylcypromine depressionnan
yes_direct,Haloperidol,cognitive impairment,8617710,conclusion haloperidol produced clear profile cognitive impairment worsened concomitant sertraline administrationnan
yes_direct,eserine,clonic-tonic convulsions,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserine nan
yes_direct,erythromycin,torsades de pointes,9545159,prolongation qt interval torsades de pointes sudden cardiac death reported concomitant administration erythromycin azole antifungal agents cypa inhibitorsnan
yes_direct,fat,obesity,18674790,current study investigated whether physiological intervention feeding high fat diet hfd induces obesity male spraguedawley rats sensitizes doxorubicininduced cardiotoxicitynan
yes_direct,Bromocriptine,psychosis,3686155,bromocriptine given high doses associated psychosis patients receiving drug parkinson's diseasenan
yes_direct,isoniazid,Bilateral optic neuropathy,384871,bilateral optic neuropathy due combined ethambutol isoniazid treatmentnan
yes_direct,erythromycin,sudden cardiac death,9545159,prolongation qt interval torsades de pointes sudden cardiac death reported concomitant administration erythromycin azole antifungal agents cypa inhibitorsnan
yes_direct,Mitomycin C,Hemolytic Uremic Syndrome/HUS,3108839,mitomycin associated hemolytic uremic syndrome hus potentially fatal uncommon condition yet widely recognisednan
yes_direct,methylprednisolone,asystole,10074612,hypotension bradycardia asystole highdose intravenous methylprednisolone monitored patientnan
yes_direct,sodium valproate/VPA,SIADH/syndrome of inappropriate secretion of antidiuretic hormone,11195262,report case yearold man administered sodium valproate vpa subsequently developed syndrome inappropriate secretion antidiuretic hormone siadh nan
yes_direct,verapamil,bradycardia,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugsnan
yes_direct,alpha-benzene hexachloride,hepatoma,85485,changes peroxisomes preneoplastic liver hepatoma mice induced alphabenzene hexachloride nan
yes_direct,6-thioguanine,veno-occlusive disease of the liver,7053705,clinically reversible venoocclusive disease liver developed yearold man acute lymphocytic leukemia months maintenance therapy 6-thioguanine nan
yes_direct,diphenylhydantoin/DPH,cerebellar dysfunction,430165,among common side effects diphenylhydantoin dph overdose frequently encountered neurological signs cerebellar dysfunction nan
yes_direct,ziprasidone,NMS,17366349,although conventional neuroleptics frequently associated nms atypical antipsychotic drugs like ziprasidone may also causenan
yes_direct,doxorubicin,cardiac dysfunction,18674790,ld dose mg doxorubicin kg ip administered day hfd feeding regimen led higher cardiotoxicity cardiac dysfunction lipid peroxidation mortality obese ob rats absence significant renal hepatic toxicitynan
yes_direct,DPH,hemiparesis,430165,two patients presented suffered progressive hemiparesis due dph overdosenan
yes_direct,ziprasidone,NMS,17366349,patient yearold male history schizophrenia developed signs symptoms nms days treatment mgday dose orally administrated ziprasidone nan
yes_direct,Isoflurane,cholestatic hepatitis,11847945,conclusions isoflurane common anesthetic agent cause severe cholestatic hepatitis nan
yes_direct,androgen,obstructive sleep apnea,6732043,rechallenge androgen produced symptoms obstructive sleep apnea abated upon withdrawal hormonenan
yes_direct,cyclooxygenase inhibitors,myocardial infarction,16586083,randomised clinical trials observational studies shown increased risk myocardial infarction stroke hypertension heart failure treatment cyclooxygenase inhibitors nan
yes_direct,eserine,mydriasis,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloridenan
yes_direct,pyrazinamide,dysosmia,19674115,recurrent dysosmia induced pyrazinamide nan
yes_direct,chloramphenicol,aplastic anemia,7072798,second report fatal aplastic anemia topical treatment chloramphenicol ocular conditions although two cases reversible bone marrow hypoplasia also reportednan
yes_direct,PB,liver damage,17574447,findings illustrate pb may associated chronic liver damage may lead serious deleterious consequencesnan
yes_direct,tranylcypromine,Serotonin syndrome,8888541,serotonin syndrome venlafaxine tranylcypromine interactionnan
yes_direct,fluphenazine,catalepsy,1687392,dopamine antagonist fluphenazine antagonist sch antagonist sulpiride induced catalepsy nan
yes_direct,pyrazinamide,olfactory disorder,19674115,report case reversible olfactory disorder related pyrazinamide woman positive rechallengenan
yes_direct,Phenylpropanolamine/Dexatrim,myocardial infarction,12734532,case report dexatrim phenylpropanolamine cause myocardial infarction nan
yes_direct,carbachol,clonic-tonic convulsions,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloridenan
yes_direct,oral contraception,Chorea,3123611,chorea associated oral contraception nanoral contraception chemical
yes_direct,risperidone,visual disturbances,12013711,reported short episodes transient visual disturbances appeared immediately starting treatment risperidone nan
yes_direct,LTG,MJ,16157917,three patients ltg exacerbated mj dosedependent manner early aggravation titrationnan
yes_direct,LTG,myoclonic status/MJ,16157917,two patients ltg exacerbated mj delayed severe manner myoclonic status ceased ltg withdrawalnan
yes_direct,Cyclophosphamide,bladder cancer,8911359,cyclophosphamide associated bladder cancer highly aggressive disease analysis casesnan
yes_direct,carbachol,tremor,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
yes_direct,D-penicillamine,polymyositis,8268147,report patient primary biliary cirrhosis developed polymyositis receiving d-penicillamine therapynan
yes_direct,chloramphenicol,aplastic anemia,7072798,yearold woman died aplastic anemia less two months undergoing cataract extraction beginning topical therapy chloramphenicol nan
yes_direct,azole,sudden cardiac death,9545159,prolongation qt interval torsades de pointes sudden cardiac death reported concomitant administration erythromycin azole antifungal agents cypa inhibitorsnan
yes_direct,lithium,atrioventricular (AV) block,18441470,present case complete atrioventricular av block syncopal attacks developed secondary lithium therapy necessitating permanent pacemaker implantationnan
yes_direct,dexamethasone,neurological dysfunctions,15814210,dexamethasone treatment children showed higher rate minor neurological dysfunctions nan
yes_direct,cyclooxygenase inhibitors,heart failure,16586083,randomised clinical trials observational studies shown increased risk myocardial infarction stroke hypertension heart failure treatment cyclooxygenase inhibitors nan
yes_direct,gentamicin,acute renal failure,19893084,study postulated acute renal failure induced gentamicin transient dynamic response blood vessels could affected antioxidants prevent changes dynamic responses blood vesselsnan
yes_direct,ACTH,dystonia,2840807,dystonia like syndrome neuropeptide msh acth stimulation rat locus ceruleusnan
yes_direct,androgens,syndrome of obstructive sleep apnea,6732043,documented airway occlusion sleep abnormally high supraglottic resistance awake yrold woman developed physical changes syndrome obstructive sleep apnea administered exogenous androgens nan
yes_direct,haloperidol,Impairment of cognitive function,8617710,results impairment cognitive function observed  hours administration haloperidol day evident hours dosingnan
yes_direct,lithium,Sinus node dysfunction,18441470,sinus node dysfunction reported frequently among adverse cardiovascular effects lithium nan
yes_direct,sodium valproate,syndrome of inappropriate secretion of antidiuretic hormone,11195262,contribution sodium valproate syndrome inappropriate secretion antidiuretic hormone nan
yes_direct,lidocaine,muscle damage,4038130,addition muscle damage severe damage also seen harderian glands especially exposure mepivacaine lidocaine plus epinephrinenan
yes_direct,D-penicillamine,glomerulonephritis/RPGN,8267029,yearold woman rheumatoid arthritis presented rapidly progressive glomerulonephritis rpgn  months d-penicillamine mgday treatmentnan
yes_direct,verapamil,cardiac failure,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugsnan
yes_direct,isoflurane,cholestatic hepatitis,11847945,acute cholestatic hepatitis exposure isoflurane nan
yes_direct,epsilon-aminocaproic acid,sagittal and left transverse sinus thrombosis,2339463,describe yearold woman developed superior sagittal left transverse sinus thrombosis associated prolonged epsilonaminocaproic acid therapy menorrhagianan
yes_direct,carbachol,mydriasis,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserinenan
yes_direct,vancomycin,ototoxicity,3934126,thrombophlebitis occurred infusion peripheral cannulae nephrotoxicity ototoxicity confined patients receiving aminoglycoside plus vancomycin nan
yes_direct,chlorthalidone,ventricular ectopic beats,3732088,compared amiloride treatment chlorthalidone phase associated increased frequency ventricular ectopic beats hour holter monitoring higher lown grading increased upslope duration monophasic action potential prolonged ventricular effective refractory period increased electrical instability programmed ventricular stimulationnan
yes_direct,cimetidine,impotence,6150641,sixty percent males developed breast changes impotence taking cimetidine cases changes disappeared cimetidine replaced ranitidinenanside effect
yes_direct,MMC,cardiac failure,3137399,one patients developed cardiac failure mg mmc mg doxorubicinnan
yes_direct,naproxen,Renal papillary necrosis,6699841,renal papillary necrosis due naproxen nan
yes_direct,pamidronate,hypocalcemia,16006300, patients higher serum calcium concentrations received pamidronate intravenously  mg respectively caused severe hypocalcemia nan
yes_direct,amiodarone,hepatic injury,3962737,concluded solid evidence exists hepatic injury due amiodarone treatment including steatosis alterations resembling alcoholic hepatitis cholestatic hepatitis micronodular cirrhosis livernan
yes_direct,MSH,dystonia,2840807,dystonia like syndrome neuropeptide msh acth stimulation rat locus ceruleusnan
yes_direct,echothiophate iodide,muscle weakness,7650771,patient developed severe cholinergic syndrome use echothiophate iodide ophthalmic drops presented profound muscle weakness initially given diagnosis myasthenia gravisnan
yes_direct,carbachol,clonic-tonic convulsions,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserinenan
yes_direct,oxacillin,renal failure,11337188,yearold man treated oxacillin one week staphylococcus aureus bacteremia developed renal failure diffuse symmetric palpable purpuric lesions feetnan
yes_direct,thiopental,respiratory paralysis,2893236,gaba involvement naloxone induced reversal respiratory paralysis produced thiopental nan
yes_direct,methylprednisolone,bradycardia,10074612,report case hypotension bradycardia asystole intravenous administration highdose methylprednisolone yearold patient underwent electrocardiographic ecg monitoring throughout episodenan
yes_direct,PAN,hypoalbuminemia,15075188, days pan treatment induced significant proteinuria hypoalbuminemia decreased urinary sodium excretion extensive ascitesnan
yes_direct,carmofur,leukoencephalopathy,17682013,results identified reports toxic leukoencephalopathy patients treated methotrexate intrathecal systemic 5-fluorouracil derivative carmofur capecitabinenan
yes_direct,sodium bicarbonate,nephrolithiasis,625456,one case acute hypercalcaemia two recurrent nephrolithiasis reported patients regularly consumed large amounts calcium carbonate sodium bicarbonate powders yearsnan
yes_direct,fluphenazine,catalepsy,1687392,agonist skf agonist quinpirole decreased catalepsy induced fluphenazine sch sulpiridenan
yes_direct,etoposide,myocardial infarction,7619765,occurrence myocardial infarction reported chemotherapy containing etoposide man risk factors coronary heart diseasenan
yes_direct,Oxacillin,leucocytoclastic vasculitis,11337188,oxacillin included among drugs cause leucocytoclastic vasculitis nan
yes_direct,Penicillamine,glomerulonephritis,8267029,penicillamine induced rapidly progressive glomerulonephritis patient rheumatoid arthritisnan
yes_direct,Mitomycin C,hemolytic uremic syndrome,3108839,mitomycin associated hemolytic uremic syndrome nan
yes_direct,carbachol,mydriasis,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
yes_direct,Fluoxetine,hyperprolactinemia,9098464,design fluoxetine serotonin reuptake inhibitor given wistar albino rats days produce hyperprolactinemia nan
no_relation,Abbott-53693,bradycardia,1355091,hand pressor effects abbott-53693 similar groups shr accompanying bradycardia greater shr chronic prazosin treatment without treatmentnan
yes_direct,bromocriptine,psychosis,3686155,postpartum psychosis induced bromocriptine nan
yes_direct,doxorubicin,cardiac failure,3137399,one patients developed cardiac failure mg mmc mg doxorubicin nan
yes_direct,methotrexate,leukoencephalopathy,17682013,results identified reports toxic leukoencephalopathy patients treated methotrexate intrathecal systemic 5-fluorouracil derivative carmofur capecitabinenan
yes_direct,6-thioguanine,Hepatic veno-occlusive disease,7053705,hepatic venoocclusive disease caused 6-thioguanine nan
yes_direct,propofol,pain,18006530,remifentanilrelated complications assessed remifentanil infusion pain caused propofol evaluated using fourpoint scale propofol infusionnan
yes_direct,isoflurane,cholestatic hepatitis,11847945,objective report case acute cholestatic hepatitis following exposure inhalational anesthetic isoflurane nan
yes_direct,carbachol,tremor,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloridenan
yes_direct,azithromycin,hiccups,15985056,case summary yearold man presented persistent hiccups beginning azithromycin treatment pharyngitisnan
yes_direct,MPTP,parkinsonian,8106150,group four monkeys rendered parkinsonian toxin mptp nan
yes_direct,carbachol,mydriasis,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloridenan
yes_direct,Oral Contraceptives,Liver Tumors,188339,registry liver tumors associated oral contraceptives university california irvine clearly identified casesnan
yes_direct,dopamine,catatonia,6540303,pinealectomized chick pretreatment dopamine increased duration catatonia doc ketamine pretreatment norepinephrinenan
yes_direct,5-FU/5-fluorouracil,chest pain,3952818,report case patient colon carcinoma liver metastasis presented chest pain 5-fluorouracil 5-fu administrationnan
yes_direct,VPA,SIADH,11195262,consider episode siadh result combination factors including weakness central nervous system longterm administration vpa nan
yes_direct,tamoxifen,hypertriglyceridaemia,9672273,compared placebo group significantly increased risk vascular events hypertriglyceridaemia among women tamoxifen nan
yes_direct,lidocaine,seizures,2790457,chronic oral cbz inhibited development lidocaine cocaineinduced seizures little effect fully developed local anesthetic seizures nan
yes_direct,Lithium,polyuria,9226773,lithium induced nephrogenic diabetes insipidus considered reversible cessation therapy polyuria persisted patient ten years lithium stoppednan
yes_direct,nifedipine,telangiectasia,8251368,photodistributed nifedipine induced facial telangiectasia nan
yes_direct,enalapril,decreased renal function,10539815,diuretic therapy likewise associated greater risk decreased renal function enalapril group rr  ci placebo group rr  ci nan
yes_direct,cyclooxygenase inhibitors,stroke,16586083,randomised clinical trials observational studies shown increased risk myocardial infarction stroke hypertension heart failure treatment cyclooxygenase inhibitors nan
yes_direct,Glyceryl trinitrate,migraine without aura,10524660,glyceryl trinitrate induces attacks migraine without aura sufferers migraine auranan
yes_direct,trihexyphenidyl hydrochloride,Bradycardia,3769769,bradycardia due trihexyphenidyl hydrochloride nan
yes_direct,mitomycin C,renal failure,3108839,consists microangiopathic hemolytic anemia thrombocytopenia progressive renal failure associated mitomycin treatment affects patients treated agentnan
yes_direct,PTU,vasculitis,16418614,ptu associated vasculitis girl turner syndrome graves diseasenan
yes_direct,amiodarone,cholestatic hepatitis,3962737,concluded solid evidence exists hepatic injury due amiodarone treatment including steatosis alterations resembling alcoholic hepatitis cholestatic hepatitis micronodular cirrhosis livernan
yes_direct,ADR,mitochondrial structural and functional impairment,9952311,knowing heart mitochondria represent almost heart muscle weight conclude deteriorating effects adr cardiovascular function involve mitochondrial structural functional impairment nan
yes_direct,ifosfamide,anuria,2320800,strongly suspect lethal anuria mainly due ifosfamide occurring patient received previous cisplatin chemotherapy poor kidney perfusion due transient hypotensionnan
yes_direct,beta-adrenergic blocking drugs,bradycardia,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugs nan
yes_direct,methylprednisolone,asystole,10074612,report case hypotension bradycardia asystole intravenous administration highdose methylprednisolone yearold patient underwent electrocardiographic ecg monitoring throughout episodenan
yes_direct,paracetamol,fulminant hepatic failure,7007443,acid protease cathepsin activity increased tenfold patients died nearly fourfold survived fulminant hepatic failure paracetamol overdose whereas activities increased equally patients fulminant hepatic failure due viral hepatitis whether survivednan
yes_direct,azole,Prolongation of QT interval,9545159,prolongation qt interval torsades de pointes sudden cardiac death reported concomitant administration erythromycin azole antifungal agents cypa inhibitorsnan
yes_direct,Salbutamol,SIAT,20552622,conclusion salbutamol presented possible trigger siat nan
yes_direct,ziprasidone,Neuroleptic malignant syndrome,17366349,neuroleptic malignant syndrome induced ziprasidone second day treatmentnan
yes_direct,ifosfamide,anuria,2320800,sixtyyearold woman advanced breast cancer previously treated cisplatin developed irreversible lethal renal failure anuria day gm bolus ifosfamide nan
yes_direct,thiopental,respiratory paralysis,2893236,data suggest naloxone reverses respiratory paralysis produced thiopental involves gaba actionnan
no_relation,Abbott-53693,bradycardia,1355091,pressor responses bradycardia alpha agonist cirazoline  micrograms kg iv alpha agonist abbott-53693  micrograms kg iv noradrenaline  micrograms kg iv determined conscious shr without chronic prazosin pretreatmentnan
yes_direct,beta-adrenergic blocking drugs,hypotension,6127992,three patients ischaemic heart disease developed profound cardiac failure hypotension bradycardia combined therapy verapamil betaadrenergic blocking drugs nan
yes_direct,ethambutol,optic neuropathy,16710500,clinical picture three patients ethambutol associated toxic optic neuropathy describednan
yes_direct,caffeine,ventricular ectopy,18997632,intravenous caffeine commonly used improve seizure duration quality patients generally well tolerated aside occasional reports relatively benign ventricular ectopy nan
yes_direct,nomifensine,hyperactivity,2576810,hyperactivity induced nomifensine mice remained unaffected fluvoxaminenaninduced key term
yes_direct,D-penicillamine,Polymyositis,8268147,polymyositis dermatomyositis develop one autoimmune complications d-penicillamine treatment exact pathogenesis remains unclearnan
no_relation,Ketoprofen,SAH,10414674,ketoprofen acetaminophen impaired platelet function patients sah nan
no_relation,nimesulide,urticaria,11694026,study investigated tolerability reliability nimesulide paracetamol large number patients exclusive welldocumented history nsaidinduced urticaria angioedemanan
no_relation,paracetamol,bladder calculi,4090988,additionally  paracetamol treated rats developed hyperplasia bladder epithelium coincident presence bladder calculi nan
no_relation,physostigmine,dyskinetic,8106150,several drugs including clonidine physostigmine methysergide mdot propranolol mk markedly reduced dyskinetic movements cost return parkinsonian symptomatologynanreduced key word
no_relation,doxorubicin,breast cancer,11230490,reduced cardiotoxicity preserved antitumor efficacy liposomeencapsulated doxorubicin cyclophosphamide compared conventional doxorubicin cyclophosphamide randomized multicenter trial metastatic breast cancer nan
no_relation,Tramadol,cancer,8766220,tramadol weak opioid effects adrenergic serotonergic neurotransmission used treat cancer pain chronic non malignant painnan
no_relation,diclofenac sodium,rheumatoid arthritis,17965424,gastrointestinal tolerability etoricoxib rheumatoid arthritis patients results etoricoxib vs diclofenac sodium gastrointestinal tolerability effectiveness trial edgeiinan
no_relation,potassium,coronary disease,3732088,diuretics potassium arrhythmias hypertensive coronary disease nan
no_relation,etoricoxib,RA,17965424,patients methods total patients mean age years diagnosed ra enrolled received etoricoxib mg daily  diclofenac mg twice daily nan
no_relation,daidzein,amnesia,16428827,administration daidzein mgkg body weight mice shown significantly reverse scopolamineinduced amnesia according results ymaze testnan
no_relation,SKF 38393,catalepsy,1687392,agonist skf agonist quinpirole decreased catalepsy induced fluphenazine sch sulpiridenan
no_relation,cyclophosphamide,MBC,11230490,patients methods two hundred ninetyseven patients mbc prior chemotherapy metastatic disease randomized receive either mgm myocet conventional doxorubicin combination mgm cyclophosphamide every weeks disease progression unacceptable toxicitynan
no_relation,AZT,AIDS,2004015,used murine model aids infection female cbl mice lpbm murine leukaemia mulv virus determine azt induced anaemia due part decreased responsiveness erythropoietic precursors bfue erythropoietin eponan
no_relation,ketoprofen,aneurysmal subarachnoid hemorrhage/SAH,10414674,patients aneurysmal subarachnoid hemorrhage sah randomized receive either ketoprofen  mg three times day ketoprofen group  weak nsaid acetaminophen three times day acetaminophen group  starting immediately diagnosis aneurysmal sah nan
no_relation,Atorvastatin,hypertension,16820346,atorvastatin prevented reversed dexamethasoneinduced hypertension ratnan
no_relation,paracetamol,viral hepatitis,7007443,acid protease cathepsin activity increased tenfold patients died nearly fourfold survived fulminant hepatic failure paracetamol overdose whereas activities increased equally patients fulminant hepatic failure due viral hepatitis whether survivednan
no_relation,calcium,depression,6323692,addition excess calcium reversed depression tissues calcium independent catecholamine release acetaldehyde blocked nhacnan
no_relation,GABA,respiratory paralysis,2893236,naloxone mgkg iv reversed respiratory paralysis glutamate gaba levels control values brain stem cortex changes caudate cerebellumnan
no_relation,amlodipine,hypertension,18201582,objective aim study evaluate efficacy tolerability new fixeddose combination fdc telmisartan mg amlodipine mg ta compared amlodipine mg monotherapy adult indian patients stage ii hypertension nan
no_relation,Apomorphine,Parkinson's disease,11009181,apomorphine first dopaminergic drug ever used treat symptoms parkinson's disease nan
no_relation,nimesulide,urticaria,11694026,singleplacebocontrolled oral challenge procedure nimesulide paracetamol applied patients history nsaidinduced urticaria angioedemanan
no_relation,prazosin,bradycardia,1355091,pressor responses bradycardia alpha agonist cirazoline  micrograms kg iv alpha agonist abbott-53693  micrograms kg iv noradrenaline  micrograms kg iv determined conscious shr without chronic prazosin pretreatmentnan
no_relation,captopril,proteinuria,6454943,also captopril treatment failed potentiate facilitate development massive proteinuria invoked puromycin aminonucleoside shrnan
no_relation,CBZ,seizure,2790457,chronic cbz also decreased incidence seizure related mortality cocaineinjected ratsnan
no_relation,sodium,hypoalbuminemia,15075188, days pan treatment induced significant proteinuria hypoalbuminemia decreased urinary sodium excretion extensive ascitesnan
no_relation,ribavirin,adenovirus disease,12093990,although intravenous ribavirin effective children severe adenovirus disease series literature therapy unlikely benefit begun late course infectionnan
no_relation,tamoxifen,breast cancer,9672273,interpretation although preliminary analysis low power cohort women lowtonormal risk breast cancer postulated protective effects tamoxifen yet apparentnan
no_relation,L-dopa,coma,761833,bilateral nephrectomy eliminated beneficial effect l-dopa blood brain ammonia ammonia coma preventednan
no_relation,Morphine,behavioral disorders,10840460,morphine dosedependently reversed behavioral disorders nan
no_relation,metformin,vascular dysfunction,20164825,antidiabetic drug metformin diminish apoptosis induced oxidative stress endothelial cells prevent vascular dysfunction even nondiabetic patientsnan
no_relation,paroxetine,chronic pain,8766220,drug initiated association paroxetine dosulepine hydrochloride tetraparetic patient chronic pain nan
no_relation,cyclophosphamide,cardiotoxicity,11230490,conclusion myocet improves therapeutic index doxorubicin significantly reducing cardiotoxicity grade neutropenia provides comparable antitumor efficacy used combination cyclophosphamide firstline therapy mbcnanused treatment
no_relation,cibenzoline,ventricular arrhythmias,2435991,antiarrhythmic plasma concentrations cibenzoline canine ventricular arrhythmias nan
no_relation,CBZ,seizures,2790457,repeated ip injection cbz mgkg also without effect development lidocaine cocainekindled seizures nan
no_relation,prazosin,muscular rigidity,2564649,induced muscular rigidity narcotic agent significantly antagonized even reduced prior electrolytic lesions locus coeruleus pretreatment alphaadrenoceptor blocker prazosin nan
no_relation,metrazol,analgesia,6323692,verapamil mgkg ip nh4ac pretreatment enhanced morphine analgesia diazepaminduced muscular incoordination antagonized amphetamineinduced motor activity neither verapamil nh4ac affected convulsant action metrazol nan
no_relation,atenolol,arrhythmia,20552622,arrhythmia resolved therapy atenolol recurred year laternan
no_relation,Unfractionated heparin sodium/UFH,thrombosis,18589141,background unfractionated heparin sodium ufh lowmolecular weight heparin lmwh used anticoagulant protocols several institutions prevent thrombosis liver transplantationnan
no_relation,metformin,nephrotoxicity,20164825,thus study suggests pleiotropic effects metformin lessen gentamicin nephrotoxicity improve mitochondrial homeostasisnan
no_relation,diethylnitrosamine,carcinogenic,3780814,anti carcinogenic action phenobarbital given simultaneously diethylnitrosamine ratnan
no_relation,acetazolamide,renal impairment,10692744,acute confusion induced acetazolamide well known adverse drug reaction patients renal impairment nan
no_relation,dopamine,coma,761833,thus reduction blood brain ammonia prevention ammonia coma ldopa accounted peripheral effect dopamine renal function rather central actionnan
no_relation,ribavirin,infection with hemorrhagic fever viruses,12093990,intravenous ribavirin treatment choice infection hemorrhagic fever viruses nan
no_relation,fluconazole,ventricular arrhythmias,11302406,serial electrocardiographic monitoring may considered fluconazole administered patients risk ventricular arrhythmias nan
no_relation,acetaminophen,SAH,10414674,ketoprofen acetaminophen impaired platelet function patients sah nan
no_relation,pravastatin,hypercholesterolemia,7604176,assumed pravastatin mgday hypercholesterolemia nan
no_relation,thalidomide,renal cell carcinoma,12448656,conclusion results consistent low level activity thalidomide renal cell carcinoma nan
no_relation,pregnenolone sulphate,amnesic,11860495,steroid structure pharmacological properties determine anti amnesic effects pregnenolone sulphate passive avoidance task ratsnan
no_relation,levodopa,idiopathic Parkinson's disease,458486,tiapride substituted benzamide derivative closely related metoclopramide reduced levodopa induced peak dose involuntary movements patients idiopathic parkinson's disease nan
no_relation,trifluoroacetyl,hepatitis,7647582,antibody response proteinbound biotransformation product trifluoroacetyl adduct detected halothane hepatitis patientsnan
no_relation,cyclophosphamide,renal involvement,12739036,since suffering systemic lupus erythematosus sle renal involvement undergone periods treatment azathioprine cyclophosphamide nan
no_relation,diethylnitrosamine/DEN,carcinogenesis,3780814,present work planned order elucidate effect phenobarbital pb mg per rat ingested dose carcinogenesis administered simultaneously diethylnitrosamine den  mgkgdaynan
no_relation,folic acid,toxicity,8958188,observation prompted phase clinical study lometrexol given folic acid supplementation confirmed toxicity lometrexol markedly reduced folic acid supplementationnan
no_relation,AIDA,muscle rigidity,12231232,aida doses microg microl diminished haloperidolinduced muscle rigidity nan
no_relation,AMN082,akinetic,19940105,complex task commonly used evaluate major akinetic symptoms pd patients mgkg amn082 reverses increased reaction time respond cue bilateral ohdalesioned ratsnan
no_relation,gold,nephritis,3084782,strong association found nephritis dermatitis due tiopronin dpenicillamine like compound class antigens bcw dermatitis due gold thiosulphatenan
no_relation,Ketamine,schizophrenia,20727411,ketamine induces activation changes healthy subjects similar observed patients schizophrenia particularly frontal temporal brain regionsnan
no_relation,PB,tumor,3780814,den pb treated rats survival prolonged tumor incidence decreased compared results obtained den alonenan
no_relation,Ketanserin,muscle rigidity,3115150,ketanserin pretreatment reverses alfentanilinduced muscle rigidity nan
no_relation,Naloxone,respiratory paralysis,2893236,naloxone mgkg iv reversed respiratory paralysis glutamate gaba levels control values brain stem cortex changes caudate cerebellumnan
no_relation,azathioprine,renal involvement,12739036,since suffering systemic lupus erythematosus sle renal involvement undergone periods treatment azathioprine cyclophosphamidenan
no_relation,tobramicyn,toxicity,9875685,objective evaluate effect dosage regimen oncedaily vs twicedaily tobramicyn steadystate serum concentrations toxicity nan
no_relation,folic acid,toxicity,8958188,preclinical murine studies demonstrated toxicity lometrexol prevented low dose folic acid administration ie days prior days following single bolus dosenan
no_relation,captopril,hypertensive,8586822,contribution sympathetic nervous system saltsensitivity lifetime captopril treated spontaneously hypertensive ratsnan
no_relation,sulindac,rheumatoid arthritis,6699841,yearold man rheumatoid arthritis previously treated sulindac fenoprofen calcium high dose salicylates gold salts developed renal papillary necrosis rpn months institution naproxen therapynan
no_relation,amiodarone,VT,6637851,six percent patients nonfatal recurrence vt successfully managed continuing amiodarone higher dose addition conventional antiarrhythmic drugnan
no_relation,VPA,tonic-clonic convulsions,11195262,taking vpa treatment idiopathic generalized tonicclonic convulsions since years oldnan
no_relation,aminoglycoside,hematologic/oncologic disorder,18356633,forty patients diagnosis consistent hematologiconcologic disorder required treatment aminoglycoside randomized either conventional extendedinterval amikacinnan
no_relation,daunorubicin,myelosuppression,15897593,results nontoxic doses dexrazoxane reduced myelosuppression weight loss daunorubicin etoposide mice antagonized antiproliferative effects colony assay however dexrazoxane neither reduced myelosuppression weight loss vitro cytotoxicity doxorubicindaunorubicin causes weight loss myelosuppression dexrazoxane made myelosuppression weight loss better
no_relation,dexrazoxane,metastases,15897593,clinical trials patients brain metastases combining dexrazoxane high doses etoposide ongoing aim improving efficacy without aggravating hematologic toxicitynan
no_relation,calcium chloride,tremor,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
no_relation,Amikacin,febrile neutropenia,18356633,amikacin aminoglycoside commonly used provide empirical double gramnegative treatment febrile neutropenia suspected infectionsnan
no_relation,trihexyphenidyl hydrochloride,schizophrenic,3769769,chronic schizophrenic patient treated anticholinergic drug trihexyphenidyl hydrochloride nanused treatment
yes_direct,calcium chloride,clonic-tonic convulsions,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednan
no_relation,cyclophosphamide,systemic lupus erythematosus/SLE,12739036,since suffering systemic lupus erythematosus sle renal involvement undergone periods treatment azathioprine cyclophosphamide nan
no_relation,formalin,pain,15974569,ester prodrugs  orally active three models pain reversal formalin induced paw licking carrageenaninduced thermal hyperalgesia capsaicininduced mechanical hyperalgesianan
no_relation,caffeine,cardiac disease,18997632,describe patient previous history cardiac disease arrhythmia developed sustained bigeminy brief runs ventricular tachycardia caffeine administrationnan
no_relation,bortezomib,MM,19274460,results suggest bortezomib combination cyclophosphamide mgm dexamethasone effective induction treatment patients newly diagnosed mm warrants investigationnan
no_relation,L-dopa,coma,761833,coma prevented mmol l-dopa given gastric intubation minutes ammonium salt injectionnan
no_relation,ranitidine,impotence,6150641,sixty percent males developed breast changes impotence taking cimetidine cases changes disappeared cimetidine replaced ranitidine nan
no_relation,Glyceryl trinitrate,migraine with aura,10524660,glyceryl trinitrate induces attacks migraine without aura sufferers migraine aura nan
no_relation,PREGS,amnesic,11860495,moreover pregs able reverse amnesic like effects nmdar gabaar ligandsnan
no_relation,5-FU/5-fluorouracil,metastasis,3952818,report case patient colon carcinoma liver metastasis presented chest pain 5-fluorouracil 5-fu administrationnan
no_relation,calcium chloride,mydriasis,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloride nan
no_relation,cyclophosphamide,breast cancer,11230490,reduced cardiotoxicity preserved antitumor efficacy liposomeencapsulated doxorubicin cyclophosphamide compared conventional doxorubicin cyclophosphamide randomized multicenter trial metastatic breast cancer nan
no_relation,Amiodarone,VT/ventricular tachycardia,6637851,amiodarone administered patients sustained symptomatic ventricular tachycardia vt  cardiac arrest  refractory conventional antiarrhythmic drugsnanal simplificar las palabras es mas entendible para uno que es medico en este tipo de tareathanksss
no_relation,LTG/lamotrigine,IGE/idiopathic generalized epilepsies,16157917,five patients idiopathic generalized epilepsies ige treated lamotrigine ltg experienced exacerbation de novo appearance myoclonic jerks mjnan
no_relation,methimazole,hyperthyroidism,14982270,yearold woman severe jaundice itching month receiving methimazole mg tid propranolol mg tid treatment hyperthyroidism nan
no_relation,Daidzein,amnesia,16428827,daidzein activates choline acetyltransferase mcixc cells improves druginduced amnesia nan
no_relation,formalin,thermal hyperalgesia/mechanical hyperalgesia,15974569,ester prodrugs  orally active three models pain reversal formalin induced paw licking carrageenaninduced thermal hyperalgesia capsaicininduced mechanical hyperalgesia nan
no_relation,Cisapride,gastrointestinal motility disorders,9545159,cisapride cytochrome cypa substrate widely prescribed treatment gastrointestinal motility disorders nan
no_relation,AZT,AIDS,9209318,azt induced macrocytic anemia aids patients long term azt therapynan
no_relation,thiamine pyrophosphate/TPP,diabetic,3762968,studied thiaminedependent enzyme transketolase fibroblasts diabetic patient developed wernickes encephalopathy treated tolazamide order delineate patient also transketolase abnormality high km thiamine pyrophosphate tpp previously reported postalcoholic wernickekorsakoff syndromenan
no_relation,retinyl acetate,forestomach carcinogenesis,3131282,cocarcinogenic effect retinyl acetate forestomach carcinogenesis male rats induced butylated hydroxyanisolenan
no_relation,"1,25-dihydroxyvitamin D",acute renal insufficiency,16006300,results patients acute renal insufficiency relative metabolic alkalosis low parathyroid hormone pth pthrelated peptide dihydroxyvitamin concentrationsnan
no_relation,Remifentanil,pain,18006530,remifentanil related complications assessed remifentanil infusion pain caused propofol evaluated using fourpoint scale propofol infusionnan
no_relation,aminoglycoside,febrile neutropenia,18356633,amikacin aminoglycoside commonly used provide empirical double gramnegative treatment febrile neutropenia suspected infectionsnan
no_relation,calcium chloride,clonic-tonic convulsions,6892185,hand mydriasis tremor clonictonic convulsions evoked carbachol eserine significantly changed calcium chloride nan
no_relation,Metformin,acute renal failure,20164825,metformin treatment fully blocked gentamicinmediated acute renal failure nan
no_relation,benzamide,idiopathic Parkinson's disease,458486,tiapride substituted benzamide derivative closely related metoclopramide reduced levodopainduced peak dose involuntary movements patients idiopathic parkinson's disease nan
no_relation,gold,rheumatoid arthritis,6699841,yearold man rheumatoid arthritis previously treated sulindac fenoprofen calcium high dose salicylates gold salts developed renal papillary necrosis rpn months institution naproxen therapynan
no_relation,risperidone,EPS,12013711,two schizophrenic patients prior history lsd abuse previously developed eps classic antipsychotics successfully treated risperidone nan
no_relation,chlorthalidone,coronary artery disease,3732088,thus myocardial electrical excitability measured patients mild essential hypertension known coronary artery disease weeks treatment potassiumconserving diuretic amiloride similar period potassiumlosing diuretic chlorthalidone randomised studynan
no_relation,corticosterone,neuropathy,3961813,although low concentrations less equal ppm corticosterone beneficial effects totpinduced neuropathy greater equal ppm exacerbated clinical signs chickens given either totp dfpnan
no_relation,nifedipine,Prinzmetal's angina,3952818,clinical electrocardiographic evolution similar observed prinzmetals angina chest pain promptly resolved nifedipine nan
no_relation,AMN082,PD,19940105,complex task commonly used evaluate major akinetic symptoms pd patients mgkg amn082 reverses increased reaction time respond cue bilateral ohdalesioned ratsnan
no_relation,etoricoxib,GI AEs,17965424,cumulative discontinuation rate due gi aes significantly lower etoricoxib diclofenac vs events per patientyears respectively hazard ratio  ci nan
no_relation,nitroprusside,ischemia,7710775,increased plasma malondialdehyde also recorded two groups animals subjected experimental model one receiving mgkg bw cyclooxygenase inhibitor acetylsalicylate intravenously immediately ischemia receiving microgramskg bw hypotensive drug nitroprusside flow rate microlitersmin intravenously ischemia although latter group malondialdehyde significantly highernan
no_relation,doxorubicin,cardiotoxicity,11230490,reduced cardiotoxicity preserved antitumor efficacy liposomeencapsulated doxorubicin cyclophosphamide compared conventional doxorubicin cyclophosphamide randomized multicenter trial metastatic breast cancernanreduced cardiotoxicity key term
no_relation,atenolol,arrhythmia,20552622,stopping betaagonist week atenolol arrhythmia disappearednan
no_relation,L-dopa,parkinsonian,9549528,studied regional cerebral blood flow rcbf changes induced execution fingertothumb opposition motor task supplementary primary motor cortex two groups parkinsonian patients l-dopa medication first one without l-dopa induced dyskinesia  moderate peakdose dyskinesia  group normal subjectsnan
no_relation,levofloxacin,sinusitis,9564988,purpose evaluate efficacy safety levofloxacin mg orally daily  days treating adult outpatients acute bacterial sinusitis nan
no_relation,cisplatin,breast cancer,2320800,sixtyyearold woman advanced breast cancer previously treated cisplatin developed irreversible lethal renal failure anuria day gm bolus ifosfamidenan
no_relation,Tiapride,involuntary movements,458486,tiapride substituted benzamide derivative closely related metoclopramide reduced levodopainduced peak dose involuntary movements patients idiopathic parkinson's diseasenan
no_relation,cyclophosphamide,myeloma,19274460,dsmm xi study dose definition intravenous cyclophosphamide combination bortezomibdexamethasone remission induction patients newly diagnosed myeloma nanused treatment
no_relation,glutamate,spastic paraparesis,15673851,data indicate morphine induces spastic paraparesis concomitant increase csf glutamate involved nmda receptor activationnan
no_relation,metoprolol,myocardial ischemia,11079278,conclusion dobutamine stress testing metoprolol attenuates eliminates evidence myocardial ischemia nan
no_relation,ribavirin,infection,12093990,although intravenous ribavirin effective children severe adenovirus disease series literature therapy unlikely benefit begun late course infection nan
no_relation,Levodopa,Parkinson's disease,12691807,levodopa induced dyskinesias reported parkinson's disease multiple system atrophynan
no_relation,Cibenzoline,arrhythmias,2435991,cibenzoline suppressed arrhythmias minimum effective plasma concentrations arrhythmias induced coronary ligation coronary ligation digitalis adrenaline   mgkg iv   mgkg iv   mgkg iv   mgkg iv microgramsml respectively mean sdm nan
no_relation,ketoprofen,aneurysmal,10414674,patients aneurysmal subarachnoid hemorrhage sah randomized receive either ketoprofen  mg three times day ketoprofen group  weak nsaid acetaminophen three times day acetaminophen group  starting immediately diagnosis aneurysmal sahnan
no_relation,Metformin,nephropathy,20164825,metformin prevents experimental gentamicininduced nephropathy mitochondriadependent pathwaynan
no_relation,cisapride,hypertension,9545159,possible drug interaction occurred yearold woman taking cisapride gastroesophageal reflux disorder diltiazem agent inhibitory effect cypa hypertension nan
no_relation,ciprofloxacin,cancer,8494478,five patients cancer developed acute renal failure followed treatment ciprofloxacin described additional cases reported literature reviewednan
no_relation,MK-801,dyskinetic,8106150,several drugs including clonidine physostigmine methysergide mdot propranolol mk-801 markedly reduced dyskinetic movements cost return parkinsonian symptomatologynan
no_relation,doxorubicin,obese,18674790,conclusion hfdinduced obese rats highly sensitized doxorubicin induced cardiotoxicity substantially downregulating cardiac mitochondrial atp generation increasing oxidative stress downregulating jakstat pathwaynan
no_relation,cimetidine,hepatic or hematologic toxicity,6150641,treatment high doses cimetidine one months median months ranitidine two months median months associated hepatic hematologic toxicity alterations serum gastrin concentrations ranitidine therapy associated significantly lower serum creatinine level seen cimetidine therapynan
no_relation,Tramadol,pain,8766220,tramadol weak opioid effects adrenergic serotonergic neurotransmission used treat cancer pain chronic non malignant pain nan
no_relation,SKF 38393,catalepsy,1687392,combination skf quinpirole cause potentiated inhibitory effect catalepsy induced dopamine antagonistsnan
no_relation,paracetamol,urticaria,11694026,taken together results confirm good tolerability nimesulide paracetamol patients experienced urticaria angioedema caused nsaidsnan
no_relation,folic acid,toxicity,8958188,associated studies demonstrated lometrexol plasma pharmacokinetics altered folic acid administration indicating supplementation unlikely reduce toxicity enhancing lometrexol plasma clearancenan
no_relation,Doxorubicin,OB,18674790,doxorubicin toxicokinetics studies revealed change accumulation doxorubicin doxorubicinol toxic metabolite normal dietfed nd ob heartsnan
no_relation,iopentol,ventricular fibrillation,2980315,frequencies ventricular fibrillation significantly lower less iopentol iohexol metrizoate nan
no_relation,dexrazoxane,weight loss,15897593,results nontoxic doses dexrazoxane reduced myelosuppression weight loss daunorubicin etoposide mice antagonized antiproliferative effects colony assay however dexrazoxane neither reduced myelosuppression weight loss vitro cytotoxicity doxorubicinnan
no_relation,methylphenidate,Alzheimer's disease,12907924,yearold man treatmentresistant depression early alzheimers disease started methylphenidate nan
no_relation,enalapril,Left Ventricular Dysfunction,10539815,method analyzed data studies left ventricular dysfunction solvd randomized doubleblind placebocontrolled trial enalapril treatment chfnan
no_relation,bortezomib,MM/multiple myeloma,19274460,clinical trial initiated evaluate recommended dose cyclophosphamide combination bortezomib dexamethasone induction treatment stem cell transplantation younger patients newly diagnosed multiple myeloma mm nan
no_relation,naproxen,rheumatoid arthritis,6699841,yearold man rheumatoid arthritis previously treated sulindac fenoprofen calcium high dose salicylates gold salts developed renal papillary necrosis rpn months institution naproxen therapynan
no_relation,tamoxifen,breast cancer,9672273,methods october started doubleblind placebocontrolled randomised trial tamoxifen women mainly italy breast cancer hysterectomynan
no_relation,diclofenac,oedema,17965424,incidence discontinuations hypertensionrelated oedema related aes significantly higher etoricoxib  respectively compared diclofenac  respectively oedema nan
no_relation,azathioprine,systemic lupus erythematosus/SLE,12739036,since suffering systemic lupus erythematosus sle renal involvement undergone periods treatment azathioprine cyclophosphamidenan
no_relation,LSD,EPS,12013711,two schizophrenic patients prior history lsd abuse previously developed eps classic antipsychotics successfully treated risperidonenan
no_relation,ADR/adriamycin,cancer,9952311,use adriamycin adr cancer chemotherapy limited due cumulative cardiovascular toxicitynan
no_relation,calcium chloride,mydriasis,6892185,effect calcium chloride injected cerebral ventricles grouphoused unanaesthetized cats upon vocalization rage hissing snarling fighting attack paws claws defense paws claws biting mydriasis tremor clonictonic convulsions produced carbachol eserine injected similarly investigatednanproduced carbachol key term
no_relation,naloxone,catalepsy,2716967,mutual potentiation antagonism tolerance suggest common mechanisms induced catalepsy differences latency rigidity behavior asymmetry crosstolerance widelydifferent id naloxone would argue action single opioid sitenan
no_relation,epsilon-aminocaproic acid,menorrhagia,2339463,describe yearold woman developed superior sagittal left transverse sinus thrombosis associated prolonged epsilonaminocaproic acid therapy menorrhagia nan
no_relation,sulindac,renal toxicity,6699841,review previous reports linking rpn antiinflammatory drug use discuss possible advantages sulindac patients experienced renal toxicity antiinflammatory agentsnan
no_relation,naloxone,respiratory paralysis,2893236,gaba involvement naloxone induced reversal respiratory paralysis produced thiopentalnan
no_relation,choline,amnesia,16428827,daidzein activates choline acetyltransferase mcixc cells improves druginduced amnesia nan
yes_direct,CPA/cyproterone acetate,venous thromboembolism/VTE,12851669,objective achieve absolute risk estimates venous thromboembolism vte among women cyproterone acetate plus ethinylestradiol cpa ee among women combined oral contraceptives cocsnan
no_relation,amphetamines,seizure,11185967,conclusions study period routine plasma screening cocaine amphetamines adult seizure patients low yieldnan
no_relation,amiodarone,ventricular fibrillation/VF,6637851,sixtynine percent patients continued treatment amiodarone recurrence symptomatic vt ventricular fibrillation vf followup  months mean standard deviation  nanused treatment
no_relation,chloramphenicol,cataract,7072798,yearold woman died aplastic anemia less two months undergoing cataract extraction beginning topical therapy chloramphenicol nan
no_relation,isoflurane,hypersensitivity,7647582,study performed determine crossreactivity enflurane isoflurane hypersensitivity induced halothanenan
no_relation,enalapril,CHF,10539815,method analyzed data studies left ventricular dysfunction solvd randomized doubleblind placebocontrolled trial enalapril treatment chf nan
no_relation,naloxone,respiratory paralysis,2893236,data suggest naloxone reverses respiratory paralysis produced thiopental involves gaba actionnan
no_relation,PTU,Turner Syndrome,16418614,ptu associated vasculitis girl turner syndrome graves diseasenan
no_relation,atorvastatin,hypertension,16820346,thus atorvastatin prevented reversed dexamethasoneinduced hypertension ratnan
no_relation,captopril,proteinuria,6454943,effect captopril preexisting aminonucleosideinduced proteinuria spontaneously hypertensive ratsnan
no_relation,cidofovir,adenovirus infection,12093990,use cidofovir severe adenovirus infection limited adverse effects significant nephrotoxicitynan
no_relation,dosulepine hydrochloride,chronic pain,8766220,drug initiated association paroxetine dosulepine hydrochloride tetraparetic patient chronic pain nan
no_relation,ACh/acetylcholine,AD/Alzheimer's disease,16428827,choline acetyltransferase chat activator enhances cholinergic transmission via augmentation enzymatic production acetylcholine ach important factor treatment alzheimers disease ad nan
no_relation,tamoxifen,breast cancer,9672273,statistically significant reduction breast cancer among women receiving tamoxifen also used hormonereplacement therapy trial among women therapy allocated placebo found eight cases breast cancer compared one case among women allocated tamoxifen nan
no_relation,DEN,tumor,3780814,den pb treated rats survival prolonged tumor incidence decreased compared results obtained den alonenan
no_relation,tamoxifen,breast cancer,9672273,prevention breast cancer tamoxifen preliminary findings italian randomised trial among hysterectomised women italian tamoxifen prevention studynan
no_relation,nimesulide,urticaria,11694026,tolerability nimesulide paracetamol patients nsaidinduced urticaria angioedemanan
no_relation,amiodarone,VT,6637851,sixtynine percent patients continued treatment amiodarone recurrence symptomatic vt ventricular fibrillation vf followup  months mean standard deviation  nan
no_relation,Apomorphine,Parkinson's disease,11009181,apomorphine underutilized therapy parkinson's disease nan
no_relation,tyrosine,degeneration of dopaminergic neurons,17490790,demonstrate relationship peripheral iron overload dopaminergic neuron loss rat substantia nigra sn present study used fast cyclic voltammetry tyrosine hydroxylase th immunohistochemistry perls iron staining high performance liquid chromatographyelectrochemical detection study degeneration dopaminergic neurons increased iron content sn iron dextran overloaded animalsnan
no_relation,captopril,proteinuria,6454943,oral administration captopril mgkg days failed aggravate proteinuria preexisting shrnan
no_relation,thiamine pyrophosphate/TPP,Wernicke's encephalopathy,3762968,studied thiaminedependent enzyme transketolase fibroblasts diabetic patient developed wernickes encephalopathy treated tolazamide order delineate patient also transketolase abnormality high km thiamine pyrophosphate tpp previously reported postalcoholic wernickekorsakoff syndromenan
no_relation,Diazepam,hallucinations,12091028,diazepam unless contraindicated risky remains necessary complementary drug ketamine buffers cardiovascular response decreases duration intensity operative postoperative hallucinations nan
no_relation,metformin,kidney dysfunction,20164825,vivo markers kidney dysfunction correction metformin complemented vitro studies mitochondrial functionnancorrection key term
no_relation,Tamoxifen,breast cancer,9672273,background tamoxifen candidate chemopreventive agent breast cancer although drug may associated development endometrial cancernanused treatment
no_relation,ribavirin,adenovirus disease,12093990,designmethods retrospectively reviewed medical records children treated intravenous ribavirin documented severe adenovirus disease nan
no_relation,tranylcypromine,depression,8888541,report venlafaxinemaoi interaction resulted serotonin syndrome yold male taking tranylcypromine depression nan
no_relation,enalapril,diabetes,10539815,multivariate analysis placebo enalapril groups older age diuretic therapy diabetes associated decreased renal function whereas betablocker therapy higher ejection fraction renoprotectivenan
no_relation,D-penicillamine,rheumatoid arthritis,8267029,yearold woman rheumatoid arthritis presented rapidly progressive glomerulonephritis rpgn months d-penicillamine mgday treatmentnan
no_relation,calcium chloride,mydriasis,6892185,apparent calcium chloride dissociate vocalization fighting autonomic motor phenomena mydriasis tremor clonictonic convulsions caused carbachol eserinenan
no_relation,Valproate,homonymous hemianopsia,19234905,complications observed two patients one left homonymous hemianopsia pallidotomy another one developed left hemiballistic movements days subthalamotomy partly improved within month valproate mgdaynan
no_relation,azidothymidine,immunodeficient,2004015,sensitivity erythroid progenitor colonies erythropoietin azidothymidine treated immunodeficient micenan
no_relation,naloxone,hypotension,1928887,experience demonstrates possible role naloxone reversal hypotension resulting captoprilnan
no_relation,aminoglycoside,Thrombophlebitis,3934126,thrombophlebitis occurred infusion peripheral cannulae nephrotoxicity ototoxicity confined patients receiving aminoglycoside plus vancomycinnan
no_relation,methotrexate,leukaemia,17682013,background transient leukoencephalopathy mimicking cerebrovascular accident described complication chemotherapy commonly recipients intrathecal methotrexate childhood leukaemia nan
no_relation,timolol,hypokalemia,326460,beta adrenergic blocking drug timolol tended correct hypokalemia shortterm bendrofluazide treatment healthy male subjects although effect small significantnan
no_relation,diltiazem,gastroesophageal reflux disorder,9545159,possible drug interaction occurred yearold woman taking cisapride gastroesophageal reflux disorder diltiazem agent inhibitory effect cypa hypertensionnan
no_relation,naloxone,respiratory paralysis,2893236,study naloxone reversed respiratory paralysis induced thiopental ratsnan
no_relation,GABA,respiratory paralysis,2893236,data suggest naloxone reverses respiratory paralysis produced thiopental involves gaba actionnan
no_relation,propofol,malignant hyperthermia,15893386,anesthesia continued uneventfully propofol infusion facilities available detect treat malignant hyperthermia nan
no_relation,Etoricoxib,GI AEs,17965424,conclusions etoricoxib mg demonstrated significantly lower risk discontinuing treatment due gi aes compared diclofenac mgnan
no_relation,lithium,bipolar disorder,10354657,patients one hundred one patients men women bipolar disorder receiving lithium maintenance therapy ranging years years durationnan
no_relation,methylphenidate,treatment-resistant depression,12907924,yearold man treatmentresistant depression early alzheimers disease started methylphenidate nan
no_relation,prazosin,bradycardia,1355091,furthermore bradycardia accompanied noradrenalineinduced pressor effect shr similar without chronic prazosin treatment despite reduction pressor effect chronic alpha receptor blocked shrabstract truncated wordsnan
no_relation,levodopa,bradykinesia,15096016,pallidal stimulation improves bradykinesia rigidity minor extent however strength seems improving levodopa induced dyskinesiasnan
no_relation,Penicillamine,rheumatoid arthritis,8267029,penicillamine induced rapidly progressive glomerulonephritis patient rheumatoid arthritis nan
no_relation,calcium,coronary spasm,3952818,data suggest coronary spasm may cause cardiotoxicity due fu calcium antagonists may probably used prevention treatment 5-fu cardiotoxicitynan
no_relation,NH4Ac,depression,6323692,addition excess calcium reversed depression tissues calciumindependent catecholamine release acetaldehyde blocked nh4ac nan
no_relation,nucleosides,cerebral ischemia,7710775,time dependence plasma malondialdehyde oxypurines nucleosides incomplete cerebral ischemia ratnan
no_relation,methysergide,dyskinetic,8106150,several drugs including clonidine physostigmine methysergide mdot propranolol mk markedly reduced dyskinetic movements cost return parkinsonian symptomatologynan
no_relation,ranitidine,hepatic or hematologic toxicity,6150641,treatment high doses cimetidine one months median months ranitidine two months median months associated hepatic hematologic toxicity alterations serum gastrin concentrations ranitidine therapy associated significantly lower serum creatinine level seen cimetidine therapynan
no_relation,"2',3'-dideoxycytidine",immunodeficiency,1279198,"novel mutation human immunodeficiency virus type reverse transcriptase gene encodes cross-resistance 2',3'-dideoxyinosine 2',3'-dideoxycytidine nan"
no_relation,"2',3'-dideoxyinosine",immunodeficiency,1279198,"novel mutation human immunodeficiency virus type reverse transcriptase gene encodes cross-resistance 2',3'-dideoxyinosine dideoxycytidinenan"
no_relation,"ddC/2',3'-dideoxycytidine",immunodeficiency,1279198,"used technique vitro selection generate variants human immunodeficiency virus type hiv resistant 2',3'-dideoxyinosine ddi crossresistant 2',3'-dideoxycytidine ddc nan"
no_relation,"ddI/2',3'-dideoxyinosine",immunodeficiency,1279198,"used technique vitro selection generate variants human immunodeficiency virus type hiv resistant 2',3'-dideoxyinosine ddi crossresistant 2',3'-dideoxycytidine ddcnanhuman immunodeficiency virus type inmunodeficiency"
no_relation,magnesium,muscle damage,1299490,study examined effect magnesium supplementation muscle magnesium content running performance km marathon footrace muscle damage rate recovery muscle function following racenan
no_relation,magnesium,muscle damage,1299490,extra magnesium ingestion also influence extent muscle damage rate recovery muscle functionnan
no_relation,magnesium,muscle damage,1299490,thus magnesium supplementation magnesium replete subjects enhance performance increase resistance muscle damage race rate recovery muscle function following racenan
yes_direct,epinephrine,pulmonary thromboembolism,1311763,compound comparable level txa synthase ic microm human platelet camp pde ic microm inhibitory activities found orally bioavailable long duration action offered effective protection mortality collagen epinephrine induced pulmonary thromboembolism model micenan
no_relation,cAMP,pulmonary thromboembolism,1311763,compound comparable level txa synthase ic microm human platelet camp pde ic microm inhibitory activities found orally bioavailable long duration action offered effective protection mortality collagenepinephrineinduced pulmonary thromboembolism model micenan
no_relation,carboplatin,non-small-cell lung cancer,1326224,intensive etoposide carboplatin chemotherapy advanced nonsmallcell lung cancer nan
no_relation,carboplatin,Leukemia,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,etoposide,Cancer,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,carboplatin,Cancer,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,etoposide,Leukemia,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,carboplatin,non-small-cell lung cancer/NSCLC,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,etoposide,non-small-cell lung cancer/NSCLC,1326224,april july  cancer leukemia group calgb conducted phase ii study etoposide carboplatin advanced ajc stage iiibiv nonsmallcell lung cancer nsclc patients whose performance status ps nan
no_relation,cholesterol,glomerular diseases,1349366,baseline control period weeks usual diets untreated patients chronic glomerular diseases stable longlasting severe proteinuria sd hyperlipidaemia mean serum cholesterol  mmoll ate vegetarian soy diet weeksnan
no_relation,cholesterol,proteinuria,1349366,baseline control period weeks usual diets untreated patients chronic glomerular diseases stable longlasting severe proteinuria sd hyperlipidaemia mean serum cholesterol  mmoll ate vegetarian soy diet weeksnan
yes_direct,medroxyprogesterone acetate,Cholelithiasis,1385654,cholelithiasis associated medroxyprogesterone acetate therapy mennan
yes_direct,medroxyprogesterone acetate/MPA,cholelithiasis,1385654,five fortyfive adult men years age less received least six months medroxyprogesterone acetate mpa depo provera im mgweek prevention sexoffending genitalmutilating behavior developed symptomatic cholelithiasis nan
yes_direct,cholesterol,Gallstones,1385654,gallstones recovered two patients found high cholesterol content suggesting formed cholesterol supersaturated bilenanstone high cholesterol wasnt caused
yes_direct,progesterone,gallbladder disease,1385654,findings consistent increased incidence gallbladder disease related high progesterone states suggest mpa may causative agent cholelithiasisnan
no_relation,progesterone,cholelithiasis,1385654,findings consistent increased incidence gallbladder disease related high progesterone states suggest mpa may causative agent cholelithiasis nan
yes_direct,MPA,cholelithiasis,1385654,findings consistent increased incidence gallbladder disease related highprogesterone states suggest mpa may causative agent cholelithiasis nan
no_relation,MPA,gallbladder disease,1385654,findings consistent increased incidence gallbladder disease related highprogesterone states suggest mpa may causative agent cholelithiasisnan
no_relation,methotrexate,rheumatoid arthritis,1404122,accelerated nodulosis low dose methotrexate therapy rheumatoid arthritis nan
yes_direct,methotrexate,Accelerated nodulosis,1404122,accelerated nodulosis low dose methotrexate therapy rheumatoid arthritisnan
no_relation,methotrexate/MTX,rheumatoid arthritis/RA,1404122,obtain information occurrence accelerated nodulosis methotrexate mtx rheumatoid arthritis ra localization size presence heart lungs nodules predisposing factors relationship extraarticular manifestations eam histological featuresnan
yes_direct,MTX,Accelerated nodulosis,1404122,accelerated nodulosis occurred exclusively treatment mtx double blind studynan
no_relation,MTX,RA,1404122,accelerated nodulosis mtx ra rare occurs despite good clinical response polyarthritisnan
yes_direct,MTX,Accelerated nodulosis,1404122,accelerated nodulosis mtx ra rare occurs despite good clinical response polyarthritisnan
no_relation,MTX,polyarthritis,1404122,accelerated nodulosis mtx ra rare occurs despite good clinical response polyarthritis nan
no_relation,nucleoside,human immunodeficiency virus,1416828,objective study determine population pharmacokinetic parameters extent absorption dideoxyinosine nucleoside analog activity human immunodeficiency virus vitro vivo oral intravenous administration use nonlinear mixed effects modelingnan
no_relation,"2',3'-dideoxyinosine",human immunodeficiency virus,1416828,"objective study determine population pharmacokinetic parameters extent absorption 2',3'-dideoxyinosine nucleoside analog activity human immunodeficiency virus vitro vivo oral intravenous administration use nonlinear mixed effects modelingnan"
no_relation,Bombesin,gastrinoma,1455308,bombesin equivalent mammalian gastrinreleasing peptide trophic effects normal neoplastic tissues gastrointestinal tract effects gut hormones growth gastrinoma knownnan
yes_direct,Bombesin,tumors,1455308,bombesin significantly stimulated growth pt tumors day mice sacrificed day nan
yes_direct,bombesin,gastrinoma,1455308,demonstrated first time bombesin trophic hormone gastrinoma nan
no_relation,sertraline,depression,1480728,one hundred patients major depression discontinued fluoxetine side effects enrolled multicenter open week study sertraline nan
no_relation,fluoxetine,depression,1480728,one hundred patients major depression discontinued fluoxetine side effects enrolled multicenter open week study sertralinenan
no_relation,sertraline,Depressive symptoms,1480728,maximum daily dose sertraline mg depressive symptoms adverse events assessed weeklynan
no_relation,sertraline,depression,1480728, evaluable patients sertraline treated patients experienced significant improvement depression nan
no_relation,ifosfamide,tumors,1485174,current studies ifosfamide pediatric solid tumors leukemia united statesnan
no_relation,ifosfamide,leukemia,1485174,current studies ifosfamide pediatric solid tumors leukemia united statesnan
no_relation,ifosfamide,malignancies,1485174,paper reviews current approaches use ifosfamide mesna alone combination agents modalities treatment pediatric malignancies nan
no_relation,mesna,malignancies,1485174,paper reviews current approaches use ifosfamide mesna alone combination agents modalities treatment pediatric malignancies nan
no_relation,cyclophosphamide,malignancies,1485174,randomized trials determine relative efficacy ifosfamide cyclophosphamide various childhood malignancies waynan
no_relation,ifosfamide,malignancies,1485174,randomized trials determine relative efficacy ifosfamide cyclophosphamide various childhood malignancies waynan
no_relation,ifosfamide,bladder cancer,1485174,longterm consequences ifosfamide survivors childhood cancer terms development bladder cancer malignancies thought associated alkylating agents known determined followup studies adult survivorsnan
no_relation,ifosfamide,cancer,1485174,longterm consequences ifosfamide survivors childhood cancer terms development bladder cancer malignancies thought associated alkylating agents known determined followup studies adult survivorsnan
no_relation,ifosfamide,malignancies,1485174,longterm consequences ifosfamide survivors childhood cancer terms development bladder cancer malignancies thought associated alkylating agents known determined followup studies adult survivorsnan
no_relation,Ifosfamide,toxicity,1485174,ifosfamide future role pediatric oncology depend evaluation therapeutic benefits longterm toxicity nan
no_relation,OK-432,tumor,1498496,thirty ke ok-432 injected tumor per week total ke ke ok-432 inoculated intracutaneous space per week total kenan
no_relation,RP 59500,RP,1503448,vitro antistaphylococcal activity rp new streptogramin comparable vancomycin teicoplanin staphylococcus aureus rp active agent coagulasenegative staphylococcinan
no_relation,vancomycin,RP,1503448,vitro antistaphylococcal activity rp new streptogramin comparable vancomycin teicoplanin staphylococcus aureus rp active agent coagulasenegative staphylococcinan
no_relation,melatonin,tumor,1542489,vivo tumor inhibiting activity melatonin established observations vitro effects contradictorynan
no_relation,melatonin,cancer,1542489,effect substance investigated six human cancer cell lines compared activity partially purified melatonin free low molecular weight pineal extract umornan
no_relation,melatonin,tumor,1542489,therefore concluded direct inhibiting action tumor cells general physiological role melatonin opposed umornan
no_relation,pentostatin,hairy cell leukemia,1564958,similar interferon alpha pentostatin highly effective hairy cell leukemia moderately active chronic lymphoid malignanciesnan
no_relation,pentostatin,lymphoid malignancies,1564958,similar interferon alpha pentostatin highly effective hairy cell leukemia moderately active chronic lymphoid malignancies nan
no_relation,pentostatin,chronic leukemias,1564958,"ten patients hairy cell leukemia hcl seven patients bcell chronic leukemias bcl studied intracellular 2',5'-oligoadenylate synthetase oas activity mononuclear cells  pentostatin administrationnan"
no_relation,pentostatin,HCL/hairy cell leukemia,1564958,"ten patients hairy cell leukemia hcl seven patients bcell chronic leukemias bcl studied intracellular 2',5'-oligoadenylate synthetase oas activity mononuclear cells  pentostatin administrationnan"
no_relation,"2',5'-oligoadenylate",HCL/hairy cell leukemia,1564958,"ten patients hairy cell leukemia hcl seven patients bcell chronic leukemias bcl studied intracellular 2',5'-oligoadenylate synthetase oas activity mononuclear cells  pentostatin administrationnan"
no_relation,"2',5'-oligoadenylate",chronic leukemias,1564958,"ten patients hairy cell leukemia hcl seven patients bcell chronic leukemias bcl studied intracellular 2',5'-oligoadenylate synthetase oas activity mononuclear cells  pentostatin administrationnan"
no_relation,pentostatin,HCL,1564958,eleven patients eight hcl two bcl responded pentostatin nan
yes_direct,pentostatin,cytotoxicity,1564958,"thus response pentostatin correlates induction oas directly 2',5'-oligoadenylate system seems involved cytotoxicity nan"
no_relation,indomethacin,stroke,1565345,using doppler technology determined cardiac output stroke volume total peripheral resistance three mg doses indomethacin nan
no_relation,indomethacin,stroke,1565345,although blood pressure change peripheral resistance rose stroke volume fell following indomethacin administrationnan
yes_direct,amphotericin B,toxicity,1590686,doubleblind randomized study effect infusion rates toxicity amphotericin nan
no_relation,amphotericin B,fungal infection,1590686,results doubleblind randomized noncrossover study rapid min versus slow infusion amphotericin administered patients proven suspected fungal infection reportednan
yes_direct,meperidine,Toxicity,1590686,toxicity higher rapid infusion group slow infusion group mean total day chill score  versus  less mean total day dosage meperidine required abate rigors  versus  mg less mean maximum total day pulse rise  versus  beats per min less respectivelynan
yes_direct,amphotericin B,nausea,1590686,analyzed daily basis mean chill score meperidine dosage pulse rise also higher addition nausea vomiting  patients received rapid infusion versus  patients received slow infusion less appeared common received amphotericin rapidlynan
no_relation,amphotericin B,vomiting,1590686,analyzed daily basis mean chill score meperidine dosage pulse rise also higher addition nausea vomiting  patients received rapid infusion versus  patients received slow infusion less appeared common received amphotericin rapidlynan
no_relation,meperidine,nausea,1590686,analyzed daily basis mean chill score meperidine dosage pulse rise also higher addition nausea vomiting  patients received rapid infusion versus  patients received slow infusion less appeared common received amphotericin rapidlynan
yes_direct,meperidine,vomiting,1590686,analyzed daily basis mean chill score meperidine dosage pulse rise also higher addition nausea vomiting  patients received rapid infusion versus  patients received slow infusion less appeared common received amphotericin rapidlynan
no_relation,metolazone,bronchopulmonary dysplasia,1593359,addition metolazone overcome tolerance furosemide infants bronchopulmonary dysplasia nan
no_relation,furosemide,bronchopulmonary dysplasia,1593359,addition metolazone overcome tolerance furosemide infants bronchopulmonary dysplasia nan
no_relation,sodium,bronchopulmonary dysplasia,1593359,conclude administration metolazone furosemide enhances diuresis natriuresis chloruresis overcomes rapid development tolerance furosemide infants bronchopulmonary dysplasia blocking compensatory increase renal sodium chloride absorptionnandisease preexisting condition
no_relation,metolazone,bronchopulmonary dysplasia,1593359,conclude administration metolazone furosemide enhances diuresis natriuresis chloruresis overcomes rapid development tolerance furosemide infants bronchopulmonary dysplasia blocking compensatory increase renal sodium chloride absorptionnan
no_relation,furosemide,bronchopulmonary dysplasia,1593359,conclude administration metolazone furosemide enhances diuresis natriuresis chloruresis overcomes rapid development tolerance furosemide infants bronchopulmonary dysplasia blocking compensatory increase renal sodium chloride absorptionnandisease preexisting condition
no_relation,chloride,bronchopulmonary dysplasia,1593359,conclude administration metolazone furosemide enhances diuresis natriuresis chloruresis overcomes rapid development tolerance furosemide infants bronchopulmonary dysplasia blocking compensatory increase renal sodium chloride absorptionnan
no_relation,steroids,hepatitis B,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
yes_direct,steroids,liver failure,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
no_relation,corticosteroids,liver failure,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
no_relation,corticosteroids,hepatitis B,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
no_relation,steroids,asthmatic,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
no_relation,corticosteroids,asthmatic,1600269,report two hepatitis virus hbv carriers liver failure withdrawal corticosteroids steroids administered treatment serious asthmatic attacksnan
no_relation,steroid,liver failure,1600269,liver functions deteriorated  wk withdrawal steroid therapy liver failure occurrednan
no_relation,Steroid,liver failure,1600269,steroid readministration intensive therapy liver failure prevent deathnan
no_relation,Steroid,death,1600269,steroid readministration intensive therapy liver failure prevent death nan
no_relation,steroid,liver disease,1600269,excessive immune response provoked steroid withdrawal decreased reserve capacity due underlying chronic liver disease thought factors liver failurenan
no_relation,steroid,liver failure,1600269,excessive immune response provoked steroid withdrawal decreased reserve capacity due underlying chronic liver disease thought factors liver failure nan
no_relation,steroids,HBV infection,1600269,caution must exercised administration steroids patients underlying chronic hbv infection prevent exacerbation hepatitisnan
yes_direct,steroids,hepatitis,1600269,caution must exercised administration steroids patients underlying chronic hbv infection prevent exacerbation hepatitis nan
no_relation,steroids,liver failure,1600269,prompt readministration steroids indicated evidence liver failure developsnan
no_relation,methionine,SCLC,1646997,summary bn analogues lack cterminal methionine may function useful sclc bn receptor antagonistsnan
no_relation,BN,SCLC,1646997,summary bn analogues lack cterminal methionine may function useful sclc bn receptor antagonistsnan
no_relation,tamoxifen,neuroblastoma,1653780,nonmyelotoxic antitumour effects ldopa buthionine sulphoximine tamoxifen neuroblastoma cells vitro vivonan
no_relation,L-dopa,melanoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine l-dopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,tamoxifen,melanoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
yes_direct,dihydroxyphenylalanine,toxicity,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,tamoxifen,toxicity,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,dihydroxyphenylalanine,human mammary carcinoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinoma nan
no_relation,L-dopa,human mammary carcinoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine l-dopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinoma nan
no_relation,L-dopa,neuroblastoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine l-dopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,L-dopa,toxicity,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine l-dopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,tamoxifen,neuroblastoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,tamoxifen,human mammary carcinoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinoma nan
no_relation,dihydroxyphenylalanine,neuroblastoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,dihydroxyphenylalanine,melanoma,1653780,effects three nonmyelotoxic cancer drugs growth neuroblastoma cells investigated vitro vivo dihydroxyphenylalanine ldopa drug selective toxicity melanoma cells dlbuthionine sulphoximine bso drug radiosensitizing effects tamoxifen drug used treatment human mammary carcinomanan
no_relation,dopamine,neuroblastoma tumours,1653780,growth neuroblastoma tumours inhibited different mechanisms l-dopa metabolite dopamine reduced activity tyrosinase bso reduced glutathione levels l-dopa tamoxifen raised camp concentrationsnan
no_relation,glutathione,neuroblastoma tumours,1653780,growth neuroblastoma tumours inhibited different mechanisms l-dopa metabolite dopamine reduced activity tyrosinase bso reduced glutathione levels l-dopa tamoxifen raised camp concentrationsnan
no_relation,cAMP,neuroblastoma tumours,1653780,growth neuroblastoma tumours inhibited different mechanisms l-dopa metabolite dopamine reduced activity tyrosinase bso reduced glutathione levels l-dopa tamoxifen raised camp concentrationsnan
no_relation,L-dopa,neuroblastoma tumours,1653780,growth neuroblastoma tumours inhibited different mechanisms l-dopa metabolite dopamine reduced activity tyrosinase bso reduced glutathione levels l-dopa tamoxifen raised camp concentrationsnan
no_relation,tamoxifen,neuroblastoma tumours,1653780,growth neuroblastoma tumours inhibited different mechanisms l-dopa metabolite dopamine reduced activity tyrosinase bso reduced glutathione levels l-dopa tamoxifen raised camp concentrationsnan
no_relation,methacholine,asthmatic,1661723,ten asthmatic subjects studied three occasions bronchial challenges aerosolized paf methacholine isotonic salinenan
no_relation,oxygen,retinoic acid/RA,1667243,investigated effect retinoic acid ra retinyl acetate rac production reactive oxygen metabolites release lysosomal enzymes human polymorphonuclear leukocytes pmnnan
no_relation,retinyl acetate,retinoic acid/RA,1667243,investigated effect retinoic acid ra retinyl acetate rac production reactive oxygen metabolites release lysosomal enzymes human polymorphonuclear leukocytes pmnnan
no_relation,retinoic acid,retinoic acid/RA,1667243,investigated effect retinoic acid ra retinyl acetate rac production reactive oxygen metabolites release lysosomal enzymes human polymorphonuclear leukocytes pmnnan
no_relation,A23187,RA,1667243,incubation pmn rac ra microm caused dosedependent inhibition upto production chemiluminescence induced phorbol myristate acetate pma nformylmethionylleucylphenylanaline fmlp opsonized zymosan ionophore a23187 nan
no_relation,O2,RA,1667243,incubation pmn rac ra microm caused dosedependent inhibition upto o2 production chemiluminescence induced phorbol myristate acetate pma nformylmethionylleucylphenylanaline fmlp opsonized zymosan ionophorenan
no_relation,phorbol myristate acetate/PMA,RA,1667243,incubation pmn rac ra microm caused dosedependent inhibition upto production chemiluminescence induced phorbol myristate acetate pma nformylmethionylleucylphenylanaline fmlp opsonized zymosan ionophorenan
no_relation,retinoids,RA,1667243,retinoids microm also inhibited dosedependent way degranulation induced fmlp upto highest concentration ra nan
no_relation,zidovudine,AIDS,1671651,surrogate markers survival patients aids aids related complex treated zidovudine nan
no_relation,zidovudine,AIDS,1671651,determine whether early effects zidovudine treatment cd lymphocyte count concentrations beta microglobulin neopterin hiv antigen antibody correlated survival patients aids aids related complexnan
no_relation,neopterin,AIDS,1671651,determine whether early effects zidovudine treatment cd lymphocyte count concentrations beta microglobulin neopterin hiv antigen antibody correlated survival patients aids aids related complexnan
no_relation,neopterin,AIDS,1671651,pretreatment characteristics independently predicted poor survival determined using multivariate proportional hazards model diagnosis aids aids related complex age years logarithm serum neopterin concentrationnan
no_relation,Thiazide,hypertensive/hypertension,1687447,thiazide diuretics remain drugs first choice treating hypertension africanamerican hypertensive nan
no_relation,calcium,diastolic dysfunction,1687447,calcium channel blockers ccbs attractive alternatives thiazides patients uncontrolled intolerant thiazides specific indications agents eg angina severe diastolic dysfunction nan
no_relation,thiazides,angina,1687447,calcium channel blockers ccbs attractive alternatives thiazides patients uncontrolled intolerant thiazides specific indications agents eg angina severe diastolic dysfunctionnan
no_relation,calcium,angina,1687447,calcium channel blockers ccbs attractive alternatives thiazides patients uncontrolled intolerant thiazides specific indications agents eg angina severe diastolic dysfunctionnan
no_relation,thiazides,diastolic dysfunction,1687447,calcium channel blockers ccbs attractive alternatives thiazides patients uncontrolled intolerant thiazides specific indications agents eg angina severe diastolic dysfunction nan
no_relation,alcohol,viral hepatitis,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
no_relation,alcohol,hepatitis C,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
yes_direct,alcohol,liver diseases/liver disease,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver disease nan
no_relation,alanine,hepatitis C,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
no_relation,aspartate,viral hepatitis,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
no_relation,alanine,viral hepatitis,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
no_relation,alanine,liver diseases/liver disease,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver disease nan
no_relation,aspartate,hepatitis C,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver diseasenan
no_relation,aspartate,liver diseases/liver disease,1701367,include requirement improved enzymological screening despite introduction test hepatitis imbalance popularity unexplained chronic aminotransferase elevations efforts solve inherent problems inadequate attempts use metabolic changes hepatocytes improve diagnosis prognosis pathophysiological understanding viral liver diseases remarkable investigations oligoadenylate synthetase better control interferon therapy chronic viral hepatitis use enzymes markers etiology particularly detection alcohol induced liver diseases continuing preference aminotransferases scenario although ratios aspartate aminotransferase alanine aminotransferase mitochondrial aspartate aminotransferase total aspartate aminotransferase activity largely depend severity intralobular localization damage stage liver disease nan
no_relation,PPS,tumor,1708834,daily intraperitoneal injections pps tolerated well athymic nude mice prevented growth subcutaneous swkfgf tumor xenograftsnan
no_relation,cyclophosphamide,granulomatosis,1739240,course wegener granulomatosis dramatically improved daily treatment cyclophosphamide glucocorticoidsnan
yes_direct,cyclophosphamide,toxicity,1739240,despite continued therapeutic success cyclophosphamide longterm followup patients wegener granulomatosis led increasing concerns toxicity resulting prolonged cyclophosphamide therapy encouraged investigation therapeutic regimensnan
no_relation,cyclophosphamide,granulomatosis,1739240,despite continued therapeutic success cyclophosphamide longterm followup patients wegener granulomatosis led increasing concerns toxicity resulting prolonged cyclophosphamide therapy encouraged investigation therapeutic regimensnan
no_relation,amino acid,critically ill,1740940,effect fuel source amino acid metabolism critically ill patientsnan
no_relation,glucose,critically ill,1740940,glucose proved nitrogen sparing properties postoperative patients critically ill patients tolerate glucose loads poorly fat appears obligatory fuel sepsisnan
no_relation,nitrogen,critically ill,1740940,glucose proved nitrogen sparing properties postoperative patients critically ill patients tolerate glucose loads poorly fat appears obligatory fuel sepsisnan
no_relation,glucose,sepsis,1740940,glucose proved nitrogen sparing properties postoperative patients critically ill patients tolerate glucose loads poorly fat appears obligatory fuel sepsis nan
no_relation,nitrogen,sepsis,1740940,glucose proved nitrogen sparing properties postoperative patients critically ill patients tolerate glucose loads poorly fat appears obligatory fuel sepsis nan
no_relation,glucose,glucose intolerance,1740940,four patients regimen withdrawn due glucose intolerance none patients gf developed glucose intolerance hyperlipidaemianan
no_relation,Heparin,fractured hip,1761997,heparin graduated compression stockings patients undergoing fractured hip surgerynan
no_relation,heparin,fractured hip,1761997,study confirms therapy heparin graduated compression stockings effective inexpensive convenient prevention venous thrombosis fractured hip patients associated low bleeding risknan
no_relation,heparin,bleeding,1761997,study confirms therapy heparin graduated compression stockings effective inexpensive convenient prevention venous thrombosis fractured hip patients associated low bleeding risknan
no_relation,heparin,venous thrombosis,1761997,study confirms therapy heparin graduated compression stockings effective inexpensive convenient prevention venous thrombosis fractured hip patients associated low bleeding risknan
no_relation,dipyridamole,hemorrheologic and blood coagulation,1770324,effect buflomedil dipyridamole indobufene hemorrheologic blood coagulation parameters patients underwent vascular surgery severe atherosclerosisnan
no_relation,dipyridamole,atherosclerosis,1770324,effect buflomedil dipyridamole indobufene hemorrheologic blood coagulation parameters patients underwent vascular surgery severe atherosclerosis nan
no_relation,cyclosporin A,psoriasis,1864010,soluble il receptor cd cells psoriasis effects cyclosporin puva therapynan
no_relation,cyclosporin A/CsA,psoriasis,1864010,study conducted quantify soluble il receptor silr levels sera chronic plaque psoriasis patients correlate measurements disease activity number ilrpositive cd lymphocytes lesional biopsies cyclosporin csa  psoralen plus ultraviolet radiation puva treated patientsnan
no_relation,steroids,edema,1910730,many facial plastic surgeons use perioperative steroids reduce postoperative edema morbiditynan
no_relation,steroids,edema,1910730,found significantly less postoperative eyelid paranasal edema patients receiving steroids nan
no_relation,steroids,edema,1910730,addition trends toward less ecchymosis less intranasal edema less discomfort patients receiving steroids notednan
no_relation,digoxin,atrial fibrillation,1910852,data indicate patients develop spontaneous postoperative atrial fibrillation treated digoxin weeks following operation drug therapy may discontinued indefinitelynan
no_relation,cephalosporins,neutropenic,1918211,thirdgeneration cephalosporins important part therapeutic armamentarium empiric management neutropenic patientsnan
no_relation,ceftriaxone,neutropenic,1918211,even combined aminoglycoside ceftriaxone would good choice neutropenic patientsnan
no_relation,aminoglycoside,neutropenic,1918211,even combined aminoglycoside ceftriaxone would good choice neutropenic patientsnan
no_relation,glucose,diabetes,1966003,effect konjac food blood glucose level patients diabetes nan
no_relation,glucose,blood glucose,1966003,effect konjac food blood glucose level patients diabetesnan
no_relation,glucose,blood glucose,1966003,data analyzed multiple test indicate fasting blood glucose fbg postprandial blood glucose pbg th th days food ingested significantly reduced  less respectively glycosylated hemoglobin level end trial less nan
no_relation,Nimodipine,urticaria,1968727,nimodipine versus terfenadine treatment physical stimulusinduced urticaria nan
no_relation,terfenadine,urticaria,1968727,nimodipine versus terfenadine treatment physical stimulusinduced urticaria nan
no_relation,dihydropyridine,urticaria,1968727,present study aimed testing therapeutic effects side effects nimodipine therapy new dihydropyridine anticalcium derivative physical stimulusinduced urticaria comparison standard hantihistamine therapynan
no_relation,nimodipine,urticaria,1968727,present study aimed testing therapeutic effects side effects nimodipine therapy new dihydropyridine anticalcium derivative physical stimulusinduced urticaria comparison standard hantihistamine therapynan
no_relation,calcium,urticaria,1968727,present study aimed testing therapeutic effects side effects nimodipine therapy new dihydropyridine anti calcium derivative physical stimulusinduced urticaria comparison standard hantihistamine therapynan
no_relation,nimodipine,urticaria,1968727,study done outpatients physical stimulusinduced urticaria  patients received nimodipine three times day daily dose mg patients treated terfenadine dose mgnan
no_relation,terfenadine,urticaria,1968727,study done outpatients physical stimulusinduced urticaria  patients received nimodipine three times day daily dose mg patients treated terfenadine dose mgnan
yes_direct,silicate,lung disease,1977006,hypothesis lung disease silicate inhalation caused oxidant generationnan
yes_direct,silicate,lung disease,1977006,inhaled silicate dusts may cause lung disease surface coordination iron subsequent oxidant generation via fenton reactionnan
yes_direct,iron,lung disease,1977006,inhaled silicate dusts may cause lung disease surface coordination iron subsequent oxidant generation via fenton reactionnan
yes_direct,silicate,tuberculosis,1977006,increased incidence tuberculosis observed among silicate workers could explained accumulation iron complexed dust particles lung made available dormant mycobacteria virulence factornan
yes_direct,iron,tuberculosis,1977006,increased incidence tuberculosis observed among silicate workers could explained accumulation iron complexed dust particles lung made available dormant mycobacteria virulence factornan
no_relation,calcium,hypertension,1986570,effect calcium entry blocker nicardipine intrarenal hemodynamics essential hypertension nan
no_relation,nicardipine,hypertension,1986570,effect calciumentry blocker nicardipine intrarenal hemodynamics essential hypertension nan
no_relation,calcium,hypertension,1986570,effects calcium entry blocker nicardipine intrarenal hemodynamics studied essential hypertension nan
no_relation,nicardipine,hypertension,1986570,effects calciumentry blocker nicardipine intrarenal hemodynamics studied essential hypertension nan
no_relation,sodium,hypertension,1986570,week study performed eight patients essential hypertension given regular sodium diet first third weeks sodium restricted diet second fourth weeksnan
no_relation,Ca,hypertension,1986570,ca entry blocker worked normalize intrarenal hemodynamics essential hypertension dilating afferent arterioles alonenan
yes_direct,corticosterone,hypoaldosteronism,2044581,severe hypoaldosteronism due corticosterone methyl oxidase type ii deficiency two boys metabolic gas chromatographymass spectrometry studiesnan
no_relation,corticosterone,II deficiency,2044581,severe hypoaldosteronism due corticosterone methyl oxidase type ii deficiency two boys metabolic gas chromatographymass spectrometry studiesnan
no_relation,aldosterone,wasting,2044581,infectiontriggered lifethreatening saltloss hyperkalaemia developed two male infants wasting inappropriately low plasma aldosterone concentrations elevated plasma renin activitynan
no_relation,Steroid,ulcer,2051278,steroid therapy duodenal ulcer infantsnan
yes_direct,steroid,ulcer,2051278,two infants acute lifethreatening complications duodenal ulcer following steroid administration describednan
yes_direct,steroid,ulcer disease/ulcer,2051278,although possible association steroid therapy peptic ulcer disease well known need ulcer prophylaxis therapy infants unanimously acceptednan
yes_direct,aminoglycoside,toxicity,2056948,haemofiltration indicated particularly aminoglycoside toxicity nan
yes_direct,methotrexate,pancytopenia,2066953,severe pancytopenia patient taking low dose methotrexate probenecidnan
yes_direct,probenecid,pancytopenia,2066953,severe pancytopenia patient taking low dose methotrexate probenecid nan
no_relation,methotrexate/MTX,rheumatoid arthritis,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecidnan
no_relation,methotrexate/MTX,toxicity,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecidnan
yes_direct,probenecid,pancytopenia,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecid nan
yes_direct,probenecid,toxicity,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecid nan
yes_direct,methotrexate/MTX,pancytopenia,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecidnan
no_relation,probenecid,rheumatoid arthritis,2066953,patient rheumatoid arthritis developed lifethreatening pancytopenia resulting low dose oral methotrexate mtx toxicity potentiated probenecid nan
yes_direct,MTX,toxicity,2066953,clinically significant drug interactions frequently cited risk factors mtx hematologic toxicity nan
no_relation,Famotidine,reflux oesophagitis,2083926,famotidine management acid reflux oesophagitis multicentre studynan
no_relation,famotidine,reflux oesophagitis/gastro-oesophageal reflux,2083926,study tested response treatment famotidine weeks patients reflux oesophagitis taking consideration however cases pathological gastrooesophageal reflux acidic typenanprobably used treatment
no_relation,naftidrofuryl,normal tension glaucoma,2089356,doubleblind study treatment normal tension glaucoma naftidrofuryl nan
no_relation,naftidrofuryl,visual acuity and the visual field,2089356,administration  mgday naftidrofuryl weeks patients normal tension glaucoma shown improvement visual acuity visual field compared week period placebo administration doubleblind study methodnan
no_relation,naftidrofuryl,normal tension glaucoma,2089356,administration  mgday naftidrofuryl weeks patients normal tension glaucoma shown improvement visual acuity visual field compared week period placebo administration doubleblind study methodnanimprovement key term
no_relation,naftidrofuryl,hypotensive,2089356,suggested naftidrofuryl might administered useful complement conventional hypotensive therapy since acts positively glaucomatous optic nerve damagenan
no_relation,naftidrofuryl,optic nerve damage,2089356,suggested naftidrofuryl might administered useful complement conventional hypotensive therapy since acts positively glaucomatous optic nerve damage nan
no_relation,prostacyclin,neutropenia,2109002,effects prostacyclin bronchoconstriction neutropenia induced inhaled plateletactivating factor mannan
no_relation,PGI2,platelet aggregation,2109002,ex vivo platelet aggregation paf  moll significantly inhibited pgi2 nan
no_relation,PGI2,platelet aggregation,2109002,thus pgi2 influence pafinduced bronchoconstriction man despite causing marked inhibition ex vivo pafinduced platelet aggregation preventing fall neutrophilsnan
no_relation,teicoplanin,septicaemia,2149049,comparative efficacy safety study teicoplanin plus aztreonam versus gentamicin plus piperacillin haematology oncology patients clinically diagnosed septicaemia nan
no_relation,aztreonam,septicaemia,2149049,comparative efficacy safety study teicoplanin plus aztreonam versus gentamicin plus piperacillin haematology oncology patients clinically diagnosed septicaemia nan
no_relation,gentamicin,septicaemia,2149049,comparative efficacy safety study teicoplanin plus aztreonam versus gentamicin plus piperacillin haematology oncology patients clinically diagnosed septicaemia nan
no_relation,piperacillin,septicaemia,2149049,comparative efficacy safety study teicoplanin plus aztreonam versus gentamicin plus piperacillin haematology oncology patients clinically diagnosed septicaemia nan
no_relation,aztreonam,septicaemia,2149049,randomized comparative evaluation teicoplanin plus aztreonam versus gentamicin plus piperacillin leukaemic patients clinical diagnosis septicaemia undertakennan
no_relation,gentamicin,septicaemia,2149049,randomized comparative evaluation teicoplanin plus aztreonam versus gentamicin plus piperacillin leukaemic patients clinical diagnosis septicaemia undertakennan
no_relation,piperacillin,septicaemia,2149049,randomized comparative evaluation teicoplanin plus aztreonam versus gentamicin plus piperacillin leukaemic patients clinical diagnosis septicaemia undertakennan
no_relation,"fructose 1,6-diphosphate",peripheral vascular disease,2172175,effect fructose diphosphate exercise capacity patients peripheral vascular disease nan
no_relation,oxygen,peripheral vascular disease,2172175,present study undertaken determine whether fdp could enhance oxygen supply thus improve exercise performance patients peripheral vascular disease nan
no_relation,"2,3 diphosphoglycerate",claudication or peak exercise,2172175,differences observed heart rate blood pressure gas exchange data time onset claudication peak exercise lactate diphosphoglycerate levelsnan
no_relation,lactate,claudication or peak exercise,2172175,differences observed heart rate blood pressure gas exchange data time onset claudication peak exercise lactate diphosphoglycerate levelsnan
no_relation,FDP,hypoxic,2172175,contrast previous studies performed among patients peripheral vascular disease studies using severe hypoxic conditions fdp affect respiratory gas exchange exercise capacity patients exertional claudicationnan
no_relation,FDP,exertional claudication,2172175,contrast previous studies performed among patients peripheral vascular disease studies using severe hypoxic conditions fdp affect respiratory gas exchange exercise capacity patients exertional claudication nan
no_relation,FDP,peripheral vascular disease,2172175,contrast previous studies performed among patients peripheral vascular disease studies using severe hypoxic conditions fdp affect respiratory gas exchange exercise capacity patients exertional claudicationnan
no_relation,sodium hyaluronate/SH,cornea,2176168,aim present study quantify man distribution clearance two aqueous sodium hyaluronate sh solutions  administration microliters onto cornea nan
no_relation,SH,cornea,2176168,actually radiolabelled sh solution remained cornea compared  sh solution pb solutionnan
no_relation,indomethacin,polyhydramnios,2187352,maternal indomethacin therapy treatment polyhydramnios nan
no_relation,indomethacin,polyhydramnios,2187352,fifteen patients polyhydramnios clinical symptoms related excess amniotic fluid volume treated indomethacin therapy started mean gestational age  weeks discontinued mean gestational age  weeksnan
no_relation,ivermectin,ocular onchocercal disease,2198750,community trials started address questions concerning safety ivermectin large scale treatment potential transmission control effect preventing ocular onchocercal disease acceptability organization large scale treatmentnan
no_relation,ivermectin,Onchocerciasis,2198750,summary presented major latest results shortterm epidemiological impact large scale ivermectin treatment observed eight community trials undertaken onchocerciasis control programme west africa ocpnan
no_relation,Ivermectin,infection,2198750,ivermectin treatment appears appropriate method control recrudescence infection area parasite reservoir virtually eliminated vector control core area ocpnan
no_relation,cholesterol,diabetic,2201495,aim study examine effect max epa commercially available fish oil preparation serum cholesterol lipoproteins apolipoproteins insulindependent diabetic iddm men dosages likely acceptable patientsnan
no_relation,cholesterol,IDDM,2201495,aim study examine effect max epa commercially available fish oil preparation serum cholesterol lipoproteins apolipoproteins insulindependent diabetic iddm men dosages likely acceptable patientsnan
no_relation,calcium,osteoporosis,2226675,aging characterized besides changes progressive increase calcium content arterial wall enhanced diabetes mellitus osteoporosis arterial hypertension tabagismnan
no_relation,calcium,diabetes mellitus,2226675,aging characterized besides changes progressive increase calcium content arterial wall enhanced diabetes mellitus osteoporosis arterial hypertension tabagismnan
no_relation,calcium,arterial hypertension,2226675,aging characterized besides changes progressive increase calcium content arterial wall enhanced diabetes mellitus osteoporosis arterial hypertension tabagismnan
no_relation,calcium,hypocalcemizing,2226675,order study role calcium ions pathogenesis vasoconstrictive lesions caused acute smoking author studied peripheral vascular effects calcium channel antagonist nifedipine dihydropyridine derivative calcitonin hypocalcemizing hormone possess vasoactive actions elderly regular smokers mean age yearsnan
no_relation,dihydropyridine,hypocalcemizing,2226675,order study role calcium ions pathogenesis vasoconstrictive lesions caused acute smoking author studied peripheral vascular effects calciumchannel antagonist nifedipine dihydropyridine derivative calcitonin hypocalcemizing hormone possess vasoactive actions elderly regular smokers mean age yearsnan
no_relation,nifedipine,hypocalcemizing,2226675,order study role calcium ions pathogenesis vasoconstrictive lesions caused acute smoking author studied peripheral vascular effects calciumchannel antagonist nifedipine dihydropyridine derivative calcitonin hypocalcemizing hormone possess vasoactive actions elderly regular smokers mean age yearsnan
no_relation,calcitonin,hypocalcemizing,2226675,order study role calcium ions pathogenesis vasoconstrictive lesions caused acute smoking author studied peripheral vascular effects calciumchannel antagonist nifedipine dihydropyridine derivative calcitonin hypocalcemizing hormone possess vasoactive actions elderly regular smokers mean age yearsnan
no_relation,oxygen,myocardial dysfunction,2252128,stunned myocardium syndrome reversible myocardial dysfunction may mediated oxygen derived free radicalsnan
no_relation,oxygen,stunned myocardium,2252128, stunned myocardium syndrome reversible myocardial dysfunction may mediated oxygen derived free radicalsnan
no_relation,oxygen,stunned myocardium,2252128,data suggest oxygen derived free radicals may cause stunned myocardium seen neonates undergoing extracorporeal membrane oxygenationnan
no_relation,calcium pidolate,involutional osteoporosis,2255262,effect calcium pidolate biochemical hormonal parameters involutional osteoporosis nan
no_relation,calcium pidolate,involutional osteoporosis,2255262,purpose study determine value calcium pidolate treatment involutional osteoporosis nan
no_relation,calcium,involutional osteoporosis,2255262,accordingly treated one group women suffering involutional osteoporosis equivalent elemental calcium administered placebo second group osteoporotic women whose mean age body surface area comparablenan
no_relation,fluconazole,candidiasis,2260347,clinical trials reports support use fluconazole treatment candidiasis particularly oropharyngeal esophageal infections immunocompromised hostsnan
no_relation,fluconazole,infections,2260347,clinical trials reports support use fluconazole treatment candidiasis particularly oropharyngeal esophageal infections immunocompromised hostsnan
no_relation,Fluconazole,cryptococcal meningitis,2260347,fluconazole also approved initial suppressive therapy cryptococcal meningitis nan
no_relation,catecholamines,hyperthermia,2279717,urinary catecholamines hyperthermia related deathsnan
yes_direct,catecholamines,deaths,2279717,urinary catecholamines hyperthermiarelated deaths nan
yes_direct,noradrenaline,deaths,2279717,group five hyperthermiarelated deaths presented urinary noradrenaline na concentrations elevated  ngml compared control group rapid violent deaths  ngmlnanhyperthermiarelated deaths urinary noradrenaline na concentrations rapid violent deaths 
no_relation,noradrenaline,hyperthermia,2279717,group five hyperthermia related deaths presented urinary noradrenaline na concentrations elevated  ngml compared control group rapid violent deaths  ngmlnan
no_relation,adrenaline,hyperthermia,2279717,urinary adrenaline concentrations elevated hyperthermia cases significant differences urinary dopamine da concentrations two groupsnan
no_relation,dopamine,hyperthermia,2279717,urinary adrenaline concentrations elevated hyperthermia cases significant differences urinary dopamine da concentrations two groupsnan
yes_direct,ethanol,hyperthermia,2279717,except one hyperthermia victims influence ethanol nan
no_relation,ethanol,hyperthermia,2279717,suggested combination heat stress ethanol consumption responsible elevated urinary na hyperthermia cases reflecting increased sympathetic nervous system activitynan
no_relation,sotalol,flutter,2303641,one hundred nine patients recurrent episodes symptomatic atrial fibrillation flutter failed one five previous antiarrhythmic drug trials treated propafenone subsequently sotalol atrial fibrillation recurrednan
no_relation,propafenone,flutter,2303641,one hundred nine patients recurrent episodes symptomatic atrial fibrillation flutter failed one five previous antiarrhythmic drug trials treated propafenone subsequently sotalol atrial fibrillation recurrednan
no_relation,propafenone,atrial fibrillation,2303641,one hundred nine patients recurrent episodes symptomatic atrial fibrillation flutter failed one five previous antiarrhythmic drug trials treated propafenone subsequently sotalol atrial fibrillation recurrednan
no_relation,sotalol,atrial fibrillation,2303641,one hundred nine patients recurrent episodes symptomatic atrial fibrillation flutter failed one five previous antiarrhythmic drug trials treated propafenone subsequently sotalol atrial fibrillation recurrednan
no_relation,sotalol,arrhythmia,2303641,percent patients free recurrent symptomatic arrhythmia months propafenone sotalol nan
no_relation,propafenone,arrhythmia,2303641,percent patients free recurrent symptomatic arrhythmia months propafenone sotalolnan
no_relation,Tianeptine,orthostatic hypotension,2306747,tianeptine produce orthostatic hypotension increase heart ratenan
yes_direct,tianeptine,cardiac toxicity,2306747,present study suggests tianeptine tricyclic antidepressant endowed less cardiac toxicity classical tricyclic antidepressantsnan
no_relation,corticosteroid,colonic diverticula,2353866,underappreciated relationship perforation colonic diverticula corticosteroid therapynanunderappreciated relationship hm puzzling unorthodox qualification
yes_direct,corticosteroid,colonic diverticula,2353866,report describes course three patients developed perforations colonic diverticula temporally related corticosteroid usenan
no_relation,ampicillin,pyelonephritis,2371028,therefore conclude limitedspectrum cephalosporin appropriate ampicillin empirical therapy pyelonephritis pregnancynan
no_relation,cephalosporin,pyelonephritis,2371028,therefore conclude limitedspectrum cephalosporin appropriate ampicillin empirical therapy pyelonephritis pregnancynan
no_relation,aminoglycoside,Pseudomonas aeruginosa,2385771,mortality due leftsided endocarditis caused pseudomonas aeruginosa remains high despite therapeutic regimen high doses aminoglycoside plus beta-lactam antibioticnan
no_relation,aminoglycoside,endocarditis,2385771,mortality due leftsided endocarditis caused pseudomonas aeruginosa remains high despite therapeutic regimen high doses aminoglycoside plus beta-lactam antibioticnan
no_relation,omega-3 fatty acids,pancreatic cancer,2389747,association found pancreatic cancer risk intake total fat saturated fat cholesterol omega fatty acids vitamins unexpected inverse association calcium intake pancreatic cancer risk datanan
no_relation,calcium,pancreatic cancer,2389747,association found pancreatic cancer risk intake total fat saturated fat cholesterol omega fatty acids vitamins unexpected inverse association calcium intake pancreatic cancer risk datanan
no_relation,cholesterol,pancreatic cancer,2389747,association found pancreatic cancer risk intake total fat saturated fat cholesterol omega fatty acids vitamins unexpected inverse association calcium intake pancreatic cancer risk datanan
yes_direct,Nickel,dermatitis,2406062,nickel dermatitis nan
yes_direct,nickel,hypersensitivity,2406062,claimed high correlation positive history nickel hypersensitivity patchtest results testing unnecessary history hypersensitivity nan
no_relation,Nickel,hypersensitivity,2406062,nickel hypersensitivity serious health problem individualnan
yes_direct,nickel,hypersensitivity,2406062,seems important introduce safe methods ear piercing primary source nickel hypersensitivity spread information health hazard potential seemingly harmless sensitivity nickel nan
no_relation,halothane,liver disease,7506644, overt icteric hepatitis cases  thought true overt icteric posttransfusion hepatitis icterus caused reasons cases seven neonatal jaundice four hemolytic anemia one radiation hepatitis one halothane induced hepatitis two cases excluded chronic liver disease diagnosed imaging procedures despite serum alts normal range transfusionnan
no_relation,halothane,jaundice/hepatitis because the icterus,7506644, overt icteric hepatitis cases  thought true overt icteric posttransfusion hepatitis icterus caused reasons cases seven neonatal jaundice four hemolytic anemia one radiation hepatitis one halothane induced hepatitis two cases excluded chronic liver disease diagnosed imaging procedures despite serum alts normal range transfusionnanfirst highlighting erroneous hepatitis icterus hepatitis case directly induced halothane
yes_direct,halothane,hepatitis,7506644, overt icteric hepatitis cases  thought true overt icteric posttransfusion hepatitis icterus caused reasons cases seven neonatal jaundice four hemolytic anemia one radiation hepatitis one halothane induced hepatitis two cases excluded chronic liver disease diagnosed imaging procedures despite serum alts normal range transfusionnan
no_relation,halothane,hemolytic anemia,7506644, overt icteric hepatitis cases  thought true overt icteric posttransfusion hepatitis icterus caused reasons cases seven neonatal jaundice four hemolytic anemia one radiation hepatitis one halothane induced hepatitis two cases excluded chronic liver disease diagnosed imaging procedures despite serum alts normal range transfusionnan
no_relation,leuprolide,prostatic hyperplasia,7516978,safety side effects patient acceptance luteinizing hormone releasing hormone agonist leuprolide treatment benign prostatic hyperplasia nan
no_relation,leuprolide,prostatic hyperplasia,7516978,luteinizing hormone releasing hormone agonist leuprolide investigated doubleblind randomized placebocontrolled study comprising evaluable patients moderate severe symptoms resulting benign prostatic hyperplasia nanused treatment
yes_direct,leuprolide,weight gain,7516978, patients receiving leuprolide weight gain kgnan
no_relation,procaterol,asthmatic,7544228,effect procaterol beta adrenoceptor agonist skin whealing response caused inflammatory mediators asthmatic childrennan
no_relation,bradykinin,asthmatic,7544228,examined effect procaterol beta adrenoceptor agonist skin whealing responses histamine plateletactivating factor paf substance bradykinin eight asthmatic children doubleblind randomized crossover studynan
no_relation,procaterol,asthmatic,7544228,examined effect procaterol beta adrenoceptor agonist skin whealing responses histamine plateletactivating factor paf substance bradykinin eight asthmatic children doubleblind randomized crossover studynan
no_relation,histamine,asthmatic,7544228,examined effect procaterol beta adrenoceptor agonist skin whealing responses histamine plateletactivating factor paf substance bradykinin eight asthmatic children doubleblind randomized crossover studynan
no_relation,Ciprofloxacin,cholera,7548496,ciprofloxacin treatment cholera randomized doubleblind controlled clinical trial single daily dose peruvian adultsnan
no_relation,ciprofloxacin,cholera,7548496,conducted randomized doubleblind clinical trial compare ciprofloxacin mg day days tetracycline mg four times day days terms efficacy safety treatment moderatetosevere cholera peruvian adultsnan
no_relation,tetracycline,cholera,7548496,conducted randomized doubleblind clinical trial compare ciprofloxacin mg day days tetracycline mg four times day days terms efficacy safety treatment moderatetosevere cholera peruvian adultsnan
no_relation,ciprofloxacin,cholera,7548496,conclude ciprofloxacin given day effective standard tetracycline regimen treatment cholera adultsnan
no_relation,tetracycline,cholera,7548496,conclude ciprofloxacin given day effective standard tetracycline regimen treatment cholera adultsnan
no_relation,desmopressin,multiple sclerosis,7551881,open inpatient incremental safety efficacy study desmopressin women multiple sclerosis nocturianan
no_relation,desmopressin,nocturia,7551881,open inpatient incremental safety efficacy study desmopressin women multiple sclerosis nocturia nan
no_relation,desmopressin,multiple sclerosis,7551881,examine safety efficacy desmopressin three doses given women multiple sclerosis treat nocturia without enuresisnan
no_relation,desmopressin,nocturia,7551881,examine safety efficacy desmopressin three doses given women multiple sclerosis treat nocturia without enuresisnan
no_relation,desmopressin,enuresis,7551881,examine safety efficacy desmopressin three doses given women multiple sclerosis treat nocturia without enuresis nanused treatment another disease
no_relation,Batimastat,cancer,7572350,batimastat bb first inhibitor class enter clinical trial cancer patientsnan
no_relation,batimastat,malignant ascites,7572350,phase iii trial patients malignant ascites batimastat well tolerated preliminary signs efficacynan
no_relation,fenoterol,breathlessness,7597269,response regular inhaled fenoterol ipratropium bromide metered dose inhaler mdi large volume spacer regular nebulized salbutamol ipratropium bromide assessed home peak flow recordings spirometry two subjective scores rating breathlessness simple fourpoint scale activity score st georges respiratory questionnairenan
no_relation,ipratropium bromide,breathlessness,7597269,response regular inhaled fenoterol ipratropium bromide metered dose inhaler mdi large volume spacer regular nebulized salbutamol ipratropium bromide assessed home peak flow recordings spirometry two subjective scores rating breathlessness simple fourpoint scale activity score st georges respiratory questionnairenan
no_relation,salbutamol,breathlessness,7597269,response regular inhaled fenoterol ipratropium bromide metered dose inhaler mdi large volume spacer regular nebulized salbutamol ipratropium bromide assessed home peak flow recordings spirometry two subjective scores rating breathlessness simple fourpoint scale activity score st georges respiratory questionnairenan
no_relation,androgen,prostate cancer,7630245,maximum androgen blockade advanced prostate cancer overview randomised trials deaths patientsnan
no_relation,flutamide,prostate cancer,7630245,systematic overview metaanalysis randomised evidence maximum androgen blockade mab advanced prostate cancer identified trials compared conventional castration surgical medical versus mab castration plus prolonged use antiandrogen flutamide cyproterone acetate nilutamidenan
no_relation,cyproterone acetate,prostate cancer,7630245,systematic overview metaanalysis randomised evidence maximum androgen blockade mab advanced prostate cancer identified trials compared conventional castration surgical medical versus mab castration plus prolonged use antiandrogen flutamide cyproterone acetate nilutamidenan
no_relation,nilutamide,prostate cancer,7630245,systematic overview metaanalysis randomised evidence maximum androgen blockade mab advanced prostate cancer identified trials compared conventional castration surgical medical versus mab castration plus prolonged use antiandrogen flutamide cyproterone acetate nilutamide nan
no_relation,CC/clomiphene citrate,ovarian hyperstimulation,7641902,controlled ovarian hyperstimulation achieved using three types ovarian stimulation protocols clomiphene citrate cc hmg  hmg alone  gnrh agonist fsh hmg nan
no_relation,8-hydroxydeoxyguanosine,cancer,7646926,determination urinary 8-hydroxydeoxyguanosine automated coupledcolumn high performance liquid chromatography powerful technique assaying vivo oxidative dna damage cancer patientsnan
no_relation,creatinine,cancer,7646926,normal healthy individuals found excrete  nmol ohdg  mumol 8ohdg per mol creatinine urine whereas increased levels 8ohdg found collections variety cancer patients samples taken onset oncological therapy  mumolmol creatinine creatinine nan
no_relation,8OHdG,cancer,7646926,normal healthy individuals found excrete  nmol 8ohdg   mumol 8ohdg per mol creatinine urine whereas increased levels 8ohdg found collections variety cancer patients samples taken onset oncological therapy  mumolmol creatininenan
no_relation,creatinine,cancer,7646926,moreover mean values 8ohdg random urinary samples cancer patients significantly higher healthy individuals  versus  mumolmol creatinine nan
no_relation,8OHdG,cancer,7646926,moreover mean values 8ohdg random urinary samples cancer patients significantly higher healthy individuals  versus  mumolmol creatininenan
yes_direct,U-46619,platelet aggregation,7647979,human platelets vitro daltroban nm microm  per group concentrationdependently induced shape change attaining microm maximum amplitude  mv representing  evoked u-46619  mv microm  inhibited u-46619 induced platelet aggregation ic nmnan
no_relation,U-46619,platelet aggregation,7647979,sq  nm microm  per group failed evoke platelet shape change potently inhibited u-46619 induced platelet aggregation icnan
no_relation,floxuridine,tumour,7648164,effect aberrant hepatic arterial anatomy tumour response hepatic artery infusion floxuridine colorectal liver metastasesnan
no_relation,floxuridine,metastases,7648164,effect aberrant hepatic arterial anatomy tumour response hepatic artery infusion floxuridine colorectal liver metastases nan
yes_direct,floxuridine,tumour,7648164,effect variation hepatic artery anatomy tumour response regional floxuridine fudr studiednan
no_relation,sertraline,depression,7656119,outpatients receiving fluoxetine switched sertraline therapy without loss control depression without substantial adverse effectsnan
no_relation,fluoxetine,depression,7656119,outpatients receiving fluoxetine switched sertraline therapy without loss control depression without substantial adverse effectsnanwithout loss control depression key term
yes_direct,levodopa,anxiety,7675241,doseresponse relationship levodopa mood anxiety fluctuating parkinson's disease doubleblind placebocontrolled studynansuspected connection
no_relation,levodopa,Parkinson's disease,7675241,doseresponse relationship levodopa mood anxiety fluctuating parkinson's disease doubleblind placebocontrolled studynan
no_relation,levodopa,anxiety,7675241,investigated effect levodopa mood anxiety eight parkinson's disease patients motor fluctuationsnan
no_relation,levodopa,Parkinson's disease,7675241,investigated effect levodopa mood anxiety eight parkinson's disease patients motor fluctuationsnan
yes_direct,levodopa,anxiety,7675241,conclude mood anxiety fluctuations related levodopa dosing robust pharmacologic placebo effectsnan
no_relation,cefmetazole,surgical incision,7694975,administration cefmetazole immediately prior surgical incision effective prophylaxis surgical wound infectionsnan
no_relation,cefmetazole,infections,7694975,administration cefmetazole immediately prior surgical incision effective prophylaxis surgical wound infections nan
no_relation,sumatriptan,migraine,7697699,since vasoconstrictor response sumatriptan reproducible outside migraine attack action appears direct vascular effect indirectly mediated via neural mechanismsnan
no_relation,sumatriptan,migraine,7697699,finding supported clinical observation sumatriptan reduces plasma levels calcitonin generelated peptide raised migraine attacknan
yes_direct,DMBA,mammary carcinoma,7726994,vorozole like ovariectomy almost completely reduces tumor growth dmba induced mammary carcinoma model ratnan
no_relation,Vorozole,tumor,7726994,vorozole like ovariectomy almost completely reduces tumor growth dmbainduced mammary carcinoma model ratnan
no_relation,Vorozole,mammary carcinoma,7726994,vorozole like ovariectomy almost completely reduces tumor growth dmbainduced mammary carcinoma model ratnan
no_relation,DMBA,tumor,7726994,vorozole like ovariectomy almost completely reduces tumor growth dmba induced mammary carcinoma model ratnan
no_relation,propofol,asthmatic,7741285,asthmatic nonasthmatic patients received thiobarbiturate induction greater incidence wheezing patients receiving propofol nanal simplificar las palabras es mas entendible para uno que es medico en este tipo de tareathanksss
no_relation,thiobarbiturate,asthmatic,7741285,asthmatic nonasthmatic patients received thiobarbiturate induction greater incidence wheezing patients receiving propofolnan
no_relation,propofol,asthmatic,7741285,asthmatic patients  mean confidence interval received thiobarbiturate  received oxybarbiturate none  received propofol wheezed intubationnan
no_relation,thiobarbiturate,asthmatic,7741285,asthmatic patients  mean confidence interval received thiobarbiturate   received oxybarbiturate none  received propofol wheezed intubationnan
no_relation,propofol,asthma,7741285,study suggests propofol considered induction anesthesia patients particularly asthma require timely intubationnanbeneficial
no_relation,coumadin,cardioembolic stroke,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnan
no_relation,aspirin,rheumatic mitral stenosis,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnanused preventive measure
no_relation,coumadin,thromboembolic,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnan
no_relation,coumadin,rheumatic mitral stenosis,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnan
no_relation,aspirin,atrial fibrillation,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillation nan
no_relation,coumadin,atrial fibrillation,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillation nan
no_relation,aspirin,thromboembolic,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnan
no_relation,aspirin,cardioembolic stroke,7798824,comparative study coumadin aspirin primary cardioembolic stroke thromboembolic preventions chronic rheumatic mitral stenosis atrial fibrillationnan
no_relation,coumadin,cardioembolic stroke,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,aspirin,mitral stenosis,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,coumadin,mitral stenosis,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,aspirin,atrial fibrillation,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,coumadin,rheumatic heart disease,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,coumadin,atrial fibrillation,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,aspirin,cardioembolic stroke,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,aspirin,rheumatic heart disease,7798824,comparative study efficacy coumadin aspirin primary cardioembolic stroke prevention chronic rheumatic heart disease mitral stenosis atrial fibrillation conducted siriraj hospital mahidol university bangkok thailandnan
no_relation,coumadin,cardioembolic stroke,7798824,three patients nonfatal cardioembolic stroke aspirin group none coumadin group three years followupnan
no_relation,aspirin,cardioembolic stroke,7798824,three patients nonfatal cardioembolic stroke aspirin group none coumadin group three years followupnan
yes_direct,coumadin,bleeding,7798824,complications coumadin group minor bleeding thigh one patient generalised ecchymosis whole body onenan
no_relation,aspirin,bleeding,7798824,aspirin group complication gastrointestional symptoms mainly epigastric pain frank bleeding observednan
yes_direct,aspirin,epigastric pain,7798824,aspirin group complication gastrointestional symptoms mainly epigastric pain frank bleeding observednan
no_relation,coumadin,cardioembolic stroke,7798824,primary prevention cardioembolic stroke chronic rheumatic heart disease found effective coumadin aspirinnan
no_relation,coumadin,rheumatic heart disease,7798824,primary prevention cardioembolic stroke chronic rheumatic heart disease found effective coumadin aspirinnan
no_relation,aspirin,cardioembolic stroke,7798824,primary prevention cardioembolic stroke chronic rheumatic heart disease found effective coumadin aspirin nan
no_relation,aspirin,rheumatic heart disease,7798824,primary prevention cardioembolic stroke chronic rheumatic heart disease found effective coumadin aspirin nan
no_relation,aspirin,cardiac embolism,7798824,study support use aspirin primary prevention cardiac embolism chronic rheumatic heart diseasenan
no_relation,aspirin,rheumatic heart disease,7798824,study support use aspirin primary prevention cardiac embolism chronic rheumatic heart disease nan
no_relation,AZT,HIV infection,7805931,mathematical model cd lymphocyte depletion hiv infection used simulate analyse effect azt treatmentnan
no_relation,AZT,infection,7805931,interestingly survival prolongation greater treatment started five two years infection striking increase survival time dose azt inhibiting hiv proliferation used instead lower one inducing inhibitionnan
yes_direct,gliclazide,diabetic vascular disease,7833498,hemobiology vascular disease review potential gliclazide influence pathogenesis diabetic vascular disease nan
no_relation,gliclazide,vascular disease,7833498,hemobiology vascular disease review potential gliclazide influence pathogenesis diabetic vascular diseasenan
no_relation,glucose,diabetes,7833498,process vascular damage accelerated diabetes often due coexisting disease aging although clear improvement longterm glycemic control lowering blood glucose levels near nondiabetic state reduces development small large vessel diseasenan
no_relation,glucose,vascular damage,7833498,process vascular damage accelerated diabetes often due coexisting disease aging although clear improvement longterm glycemic control lowering blood glucose levels near nondiabetic state reduces development small large vessel diseasenan
no_relation,arachidonic acid,diabetic vascular disease,7833498,increased oxidative stress due excess freeradical activity may central diabetic vascular disease endothelial cell damage lipoprotein oxidation modification platelet reactivity arachidonic acid cascade properties free radicals reaction products lipid peroxidesnan
no_relation,peroxides,diabetic vascular disease,7833498,increased oxidative stress due excess freeradical activity may central diabetic vascular disease endothelial cell damage lipoprotein oxidation modification platelet reactivity arachidonic acid cascade properties free radicals reaction products lipid peroxides nan
no_relation,BW2258U89,small cell lung cancer,7869832,bw2258u89 grp receptor antagonist inhibits small cell lung cancer growthnan
no_relation,gastrin,SCLC/small cell lung cancer,7869832,ability reduced peptide bond analogues gastrin releasing peptide grp antagonize small cell lung cancer sclc grp receptors investigatednan
no_relation,atracurium,depression,7879933,adductor pollicis response returned normal values single intubating dose atracurium vecuronium risk residual depression th geniohyoid muscle one principal muscles contributing airway patency appears unlikelynan
no_relation,vecuronium,depression,7879933,adductor pollicis response returned normal values single intubating dose atracurium vecuronium risk residual depression th geniohyoid muscle one principal muscles contributing airway patency appears unlikelynan
yes_direct,pentachlorophenol,poisoning,7904464,human pentachlorophenol poisoning nan
yes_direct,PCP,Chronic poisoning,7904464,chronic poisoning occurs mainly sawmill workers people living log homes treated pcp containing wood protecting formulationsnan
yes_direct,PCP,poisoning,7904464,clinical features acute chronic pcp poisoning classified systematically effects skin metabolism fever haematopoietic tissue respiratory system central peripheral nervous system kidney gastrointestinal tractnan
yes_direct,PCP,sarcoma,7904464,although pcp classified human carcinogen epidemiological observations suggest exposure chlorophenols general pcp solutions particular may result increased risk certain malignant disorders nasal carcinoma soft tissue sarcoma nan
yes_direct,chlorophenols,nasal carcinoma,7904464,although pcp classified human carcinogen epidemiological observations suggest exposure chlorophenols general pcp solutions particular may result increased risk certain malignant disorders nasal carcinoma soft tissue sarcomanan
yes_direct,PCP,nasal carcinoma,7904464,although pcp classified human carcinogen epidemiological observations suggest exposure chlorophenols general pcp solutions particular may result increased risk certain malignant disorders nasal carcinoma soft tissue sarcomanan
yes_direct,chlorophenols,sarcoma,7904464,although pcp classified human carcinogen epidemiological observations suggest exposure chlorophenols general pcp solutions particular may result increased risk certain malignant disorders nasal carcinoma soft tissue sarcoma nan
no_relation,PCP,poisoning,7904464,specific antidote exists treatment acute pcp poisoning nanpcp overdose causes poisoning
no_relation,cAMP,asthma,7908546,variety drugs known act via increasing intracellular camp used treatment asthma nan
no_relation,terazosin,hypertension,7923316,alpha blockade treatment hypertension megastudy terazosin clinical practice settingsnan
no_relation,terazosin,hypertension,7923316,purpose study evaluate effects alpha blocking agent terazosin blood pressure bp blood lipids large variant population patients hypertension nan
no_relation,terazosin,hypertension,7923316,total patients hypertension evaluated primary community care facilities patients treated previously hypertension  switched terazosin another antihypertensive agent received terazosin addition agent controlled hypertension nan
no_relation,cholesterol,hyperlipidemia,7923316,greatest reductions blood cholesterol observed among patients hyperlipidemia total cholesterol  mgdlnan
no_relation,Terazosin,concomitant diseases,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,Terazosin,congestive heart failure,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,Terazosin,chronic obstructive pulmonary disease,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,Terazosin,peripheral vascular disease,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,Terazosin,prostatic hyperplasia,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,Terazosin,obesity,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesity nan
no_relation,Terazosin,diabetes,7923316,terazosin maintained antihypertensive efficacy well tolerated patients variety concomitant diseases including congestive heart failure peripheral vascular disease chronic obstructive pulmonary disease benign prostatic hyperplasia diabetes obesitynan
no_relation,terazosin,hypertension,7923316,data demonstrate usefulness terazosin monotherapy addon therapy treatment hypertension nan
yes_direct,carmustine,Ocular toxicity,7944163,ocular toxicity systemic chemotherapy megadoses carmustine mitomycinnan
yes_direct,mitomycin,Ocular toxicity,7944163,ocular toxicity systemic chemotherapy megadoses carmustine mitomycin nan
yes_direct,carmustine,ocular toxicity,7944163,article discuss ocular toxicity six patients advanced nonpretreated colorectal cancer received megadoses carmustine mitomycin support autologous bone marrow transplantationnan
no_relation,mitomycin,colorectal cancer,7944163,article discuss ocular toxicity six patients advanced nonpretreated colorectal cancer received megadoses carmustine mitomycin support autologous bone marrow transplantationnan
no_relation,mitomycin,ocular toxicity,7944163,article discuss ocular toxicity six patients advanced nonpretreated colorectal cancer received megadoses carmustine mitomycin support autologous bone marrow transplantationnanmere discussion whether mitomycin contributes ocular toxicity basis six patients concluded negative effect mitomycin dont contribute causes cular toxicity
no_relation,carmustine,colorectal cancer,7944163,article discuss ocular toxicity six patients advanced nonpretreated colorectal cancer received megadoses carmustine mitomycin support autologous bone marrow transplantationnan
no_relation,glutathione,ischemic renal injury,7952483,previous reports suggested beneficial effects exogenous glutathione preservation renal function ischemic renal injury nan
no_relation,etoposide,non-small-cell lung cancer/NSCLC,7986706,patients nonsmallcell lung cancer nsclc treated ice chemotherapy ifosfamide mgm days carboplatin mgm day etoposide mgm days intravenously iv first maximum four treatment cyclesnan
no_relation,carboplatin,non-small-cell lung cancer/NSCLC,7986706,patients nonsmallcell lung cancer nsclc treated ice chemotherapy ifosfamide mgm days carboplatin mgm day etoposide mgm days intravenously iv first maximum four treatment cyclesnanused treatment
no_relation,ifosfamide,non-small-cell lung cancer/NSCLC,7986706,patients nonsmallcell lung cancer nsclc treated ice chemotherapy ifosfamide mgm days carboplatin mgm day etoposide mgm days intravenously iv first maximum four treatment cyclesnan
no_relation,oxygen,critically ill,7993413,elevation systemic oxygen delivery treatment critically ill patientsnan
no_relation,oxygen,critically ill,7993413,elevation systemic oxygen delivery consumption associated improved outcome critically ill patientsnan
no_relation,oxygen,critically ill,7993413,use dobutamine boost cardiac index systemic oxygen delivery failed improve outcome heterogeneous group critically ill patientsnan
no_relation,dobutamine,critically ill,7993413,use dobutamine boost cardiac index systemic oxygen delivery failed improve outcome heterogeneous group critically ill patientsnan
no_relation,oxygen,aggressive,7993413,contrary might expected results suggest cases aggressive efforts increase oxygen consumption may detrimentalnan
no_relation,pravastatin,hypercholesterolemia,8001304,multinational study effects lowdose pravastatin patients noninsulindependent diabetes mellitus hypercholesterolemia nan
no_relation,pravastatin,non-insulin-dependent diabetes mellitus,8001304,multinational study effects lowdose pravastatin patients noninsulindependent diabetes mellitus hypercholesterolemianan
no_relation,pravastatin,hypercholesterolemia,8001304,multinational week randomized doubleblind placebocontrolled study evaluated efficacy safety lowdose pravastatin patients noninsulindependent diabetes mellitus niddm hypercholesterolemia serum total cholesterol concentrations mmoll  mgdlnan
no_relation,pravastatin,non-insulin-dependent diabetes mellitus/NIDDM,8001304,multinational week randomized doubleblind placebocontrolled study evaluated efficacy safety lowdose pravastatin patients noninsulindependent diabetes mellitus niddm hypercholesterolemia serum total cholesterol concentrations mmoll  mgdlnan
no_relation,cholesterol,hypercholesterolemia,8001304,multinational week randomized doubleblind placebocontrolled study evaluated efficacy safety lowdose pravastatin patients noninsulindependent diabetes mellitus niddm hypercholesterolemia serum total cholesterol concentrations mmoll  mgdlnan
no_relation,cholesterol,non-insulin-dependent diabetes mellitus/NIDDM,8001304,multinational week randomized doubleblind placebocontrolled study evaluated efficacy safety lowdose pravastatin patients noninsulindependent diabetes mellitus niddm hypercholesterolemia serum total cholesterol concentrations mmoll  mgdlnan
yes_direct,pravastatin,laboratory test abnormalities,8001304,adverse events laboratory test abnormalities similar among patients treated pravastatin placebonan
no_relation,pravastatin,hypercholesterolemia,8001304,results study demonstrate lowdose pravastatin effective well tolerated lowering elevated cholesterol concentrations shortterm treatment patients niddm hypercholesterolemia nan
no_relation,pravastatin,NIDDM,8001304,results study demonstrate lowdose pravastatin effective well tolerated lowering elevated cholesterol concentrations shortterm treatment patients niddm hypercholesterolemianan
no_relation,cholesterol,hypercholesterolemia,8001304,results study demonstrate lowdose pravastatin effective well tolerated lowering elevated cholesterol concentrations shortterm treatment patients niddm hypercholesterolemia nan
no_relation,cholesterol,NIDDM,8001304,results study demonstrate lowdose pravastatin effective well tolerated lowering elevated cholesterol concentrations shortterm treatment patients niddm hypercholesterolemianan
no_relation,Retinoids,acute promyelocytic leukemia,8025272,retinoids differentiate leukemic cell lines vitro induce clinically complete remissions patients acute promyelocytic leukemia nan
no_relation,cAMP,cholera toxin,8054689,potent camp inducers like cholera toxin also growth promoters neonatal melanocytes transient growth stimulators cells derived adultsnan
no_relation,phorbol esters,cholera toxin,8054689,simultaneous addition phorbol esters cholera toxin prevent cells reaching terminal differentiationnan
no_relation,phorbol esters,PKC/protein kinase C,8054689,identified targets phorbol esters protein kinase pkc mitogenactivated kinases mapks also called extracellular signalregulated kinases erksnan
no_relation,octreotide,sleep apnea,8067645,effect octreotide somatostatin analog sleep apnea patients acromegalynan
no_relation,octreotide,acromegaly,8067645,effect octreotide somatostatin analog sleep apnea patients acromegaly nan
no_relation,somatostatin,acromegaly,8067645,effect octreotide somatostatin analog sleep apnea patients acromegaly nan
no_relation,somatostatin,sleep apnea,8067645,effect octreotide somatostatin analog sleep apnea patients acromegalynan
no_relation,octreotide,sleep apnea,8067645,determine effects octreotide somatostatin analog severity sleep apnea growth hormone levels patients acromegalynan
no_relation,octreotide,acromegaly,8067645,determine effects octreotide somatostatin analog severity sleep apnea growth hormone levels patients acromegaly nan
no_relation,somatostatin,acromegaly,8067645,determine effects octreotide somatostatin analog severity sleep apnea growth hormone levels patients acromegaly nan
no_relation,somatostatin,sleep apnea,8067645,determine effects octreotide somatostatin analog severity sleep apnea growth hormone levels patients acromegalynan
no_relation,oxygen,sleepiness improved,8067645,indices oxygen desaturation sleep quality subjective sleepiness improved months octreotidenan
yes_direct,octreotide,sleepiness improved,8067645,indices oxygen desaturation sleep quality subjective sleepiness improved months octreotide nan
no_relation,octreotide,sleep apnea,8067645,improvement indices sleep apnea severity occurs association octreotide treatment patients sleep apnea acromegalynan
no_relation,octreotide,acromegaly,8067645,improvement indices sleep apnea severity occurs association octreotide treatment patients sleep apnea acromegaly nan
no_relation,Epirubicin,Epirubicin in hepatocellular carcinoma,8070007,epirubicin hepatocellular carcinoma pharmacokinetics clinical activitynan
no_relation,epirubicin,HCC/hepatocellular carcinoma,8070007,pharmacokinetics clinical activity epirubicin investigated patients hepatocellular carcinoma hcc received epirubicin mgm drug given intravenously patients via hepatic artery patients also underwent embolisationnan
no_relation,epirubicin,HCC,8070007,however dose schedule epirubicin modest activity hcc nan
no_relation,aspirin,hypercapnia,8073456,therefore nonsteroidal antiinflammatory drugs aspirin inhibit cyclooxygenase might expected reduce cerebral blood flow response hypercapnia nan
no_relation,5-fluorouracil,tumor,8074466,recombinant human interferon alphaa increases 5-fluorouracil efficacy elevating fluorouridine concentration tumor tissuenan
no_relation,5-FU/5-fluorouracil,carcinoma,8074466,modulating effect recombinant human interferon alpha ifnalpha antitumor efficacy 5-fluorouracil 5-fu human carcinoma cell lines investigated vitro vivonan
no_relation,5-FU,colon tumor,8074466,5-fu fluorouridine fur fluorodeoxyuridine fudr tested cultured human colon tumor cells without ifnalphanan
no_relation,5-FU,colon carcinoma,8074466,vivo antitumor activity 5-fu without ifnalpha assessed using co human colon carcinoma xenograft nude micenan
no_relation,5-FU,weight loss,8074466,synergistic effect 5-fu ifnalpha observed co nude mice vivo synergism obtained without increment thymidylate synthetase inhibition side effects terms death rate body weight loss nan
no_relation,5-FU,tumor,8074466,intratumoral concentration fur significantly increased addition ifnalpha co tumor tissue treated 5-fu nan
no_relation,5-FU,target tumor,8074466,results suggest mechanism combined effect 5-fu ifnalpha related enhancement thymidylate synthetase inhibition increase fur concentration target tumor tissuenan
yes_direct,H2O2,glomerulonephritis,8082301,brouwer et al reported pauciimmune glomerulonephritis rats immunized human mpo followed perfusion kidneys lysosomal enzyme extract combined h2o2 suggested could serve model ancainduced diseasenan
yes_direct,H2O2,Pathological lesions,8082301,pathological lesions deposits igg mpo found immunized rats perfused mpo h2o2 without neutral protease mpo alone rat strains day day nan
no_relation,entacapone,Parkinson's disease,8112370,effect entacapone comt inhibitor pharmacokinetics levodopa cardiovascular responses patients parkinson's disease nan
no_relation,levodopa,Parkinson's disease,8112370,effect entacapone comt inhibitor pharmacokinetics levodopa cardiovascular responses patients parkinson's disease nan
no_relation,catechol,parkinsonian,8112370,open randomised crossover study investigated effect single mg oral dose entacapone novel catechol omethyltransferase comt inhibitor pharmacokinetics metabolism levodopacarbidopa cardiovascular responses blood pressure pulse rate variation standard stimuli eight parkinsonian patientsnan
no_relation,levodopa,parkinsonian,8112370,open randomised crossover study investigated effect single mg oral dose entacapone novel catecholomethyltransferase comt inhibitor pharmacokinetics metabolism levodopa carbidopa cardiovascular responses blood pressure pulse rate variation standard stimuli eight parkinsonian patientsnan
no_relation,carbidopa,parkinsonian,8112370,open randomised crossover study investigated effect single mg oral dose entacapone novel catecholomethyltransferase comt inhibitor pharmacokinetics metabolism levodopa carbidopa cardiovascular responses blood pressure pulse rate variation standard stimuli eight parkinsonian patientsnan
no_relation,entacapone,parkinsonian,8112370,open randomised crossover study investigated effect single mg oral dose entacapone novel catecholomethyltransferase comt inhibitor pharmacokinetics metabolism levodopacarbidopa cardiovascular responses blood pressure pulse rate variation standard stimuli eight parkinsonian patientsnan
yes_direct,alcohol,brain damage,8123218,drinking patterns include periods alcohol consumption followed abstinence binge drinking may enhance possibility brain damage nan
yes_direct,NMDA,brain damage,8123218,nmda mediated mechanisms glucocorticoid actions hippocampus associated brain damage nan
no_relation,NMDA,alcoholism,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholism nan
no_relation,ethanol,brain damage,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholismnan
no_relation,ethanol,alcoholism,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholism nan
no_relation,calcium,brain damage,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholismnan
no_relation,calcium,alcoholism,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholism nan
no_relation,NMDA,brain damage,8123218,therapeutic adjuncts treating ethanol withdrawal including nmda calcium glucocorticoid antagonists may eventually prove useful preventing brain damage alcoholismnan
no_relation,alinidine,AMI,8124790,investigated prospectively arrhythmia incidence patients ami receiving alteplase doubleblind randomized adjunctive therapy intravenous atenolol alinidine placebonan
no_relation,atenolol,AMI,8124790,investigated prospectively arrhythmia incidence patients ami receiving alteplase doubleblind randomized adjunctive therapy intravenous atenolol alinidine placebonan
no_relation,alinidine,arrhythmia,8124790,investigated prospectively arrhythmia incidence patients ami receiving alteplase doubleblind randomized adjunctive therapy intravenous atenolol alinidine placebonan
no_relation,atenolol,arrhythmia,8124790,investigated prospectively arrhythmia incidence patients ami receiving alteplase doubleblind randomized adjunctive therapy intravenous atenolol alinidine placebonan
no_relation,alinidine,atrioventricular block,8124790,atenolol alinidine significantly decreased basic heart rate without causing sinus arrest higherdegree atrioventricular block nan
no_relation,Atenolol,atrioventricular block,8124790,atenolol alinidine significantly decreased basic heart rate without causing sinus arrest higherdegree atrioventricular block nan
no_relation,Atenolol,sinus arrest,8124790,atenolol alinidine significantly decreased basic heart rate without causing sinus arrest higherdegree atrioventricular blocknan
no_relation,alinidine,sinus arrest,8124790,atenolol alinidine significantly decreased basic heart rate without causing sinus arrest higherdegree atrioventricular blocknan
no_relation,atenolol,atrial fibrillation,8124790,prevalence atrial fibrillation alinidine patients lower atenolol patients  lower placebo patients nan
no_relation,alinidine,atrial fibrillation,8124790,prevalence atrial fibrillation alinidine patients lower atenolol patients  lower placebo patients nan
no_relation,Suramin,metastatic cancer,8135485,suramin serum insulinlike growth factor levels metastatic cancer patientsnan
no_relation,Suramin,tumors,8135485,suramin polysulphonated naphthylurea inhibits activity several growth factors vitro experiments clinical responses reported human solid tumors nan
no_relation,suramin,lung cancer,8135485,decided investigate relationship suramin treatment serum levels insulinlike growth factor igfi ii igfii advanced breast prostate lung cancer patientsnan
no_relation,suramin,IGF,8135485,decided investigate relationship suramin treatment serum levels insulinlike growth factor igf ii igf ii advanced breast prostate lung cancer patientsnan
no_relation,suramin,IGF,8135485,significant decline igf igf ii serum levels demonstrated suramin treated patientsnan
yes_direct,suramin,IGF,8135485,results suggest suramin induced igf suppression could one possible mechanisms suramin actionnan
no_relation,HBeAg,Remission,8142208,remission occurred within months clearing antigen hbeag majority casesnan
no_relation,HBeAg,proteinuria,8142208,one reduction proteinuria remained hbeag positivenan
no_relation,vitamin D,chronic renal diseases,8175280,influence uv irradiation vitamin metabolism children chronic renal diseases nan
yes_direct,vitamin D,calcinosis,8175280,one obtain results also oral vitamin therapy although point danger calcinosis stone formation author could frequently demonstrate never uv treatmentnan
no_relation,phosphatidylinositol,MM,8205537,mm cell lines contained significantly hormonestimulated phosphatidylinositol kinase pi kinase activity blymphoblastoid cell linesnan
no_relation,glucose,MM,8205537,hormoneresponsive glucose metabolism also greater mm cell linesnan
no_relation,phorbol myristate acetate/PMA,AIDS/ARC/acquired immunodeficiency syndrome/AIDS-related complex,8209399,peripheral blood mononuclear cells patients acquired immunodeficiency syndrome aids aidsrelated complex arc heterosexual controls stimulated anticd monoclonal antibody phorbol myristate acetate pma thymidine incorporation il receptor ilr alpha cd tac antigen expression measurednan
no_relation,PMA,AIDS/ARC,8209399,significantly reduced dna synthesis cd expression observed aids arc upon stimulation anticd pma nan
no_relation,PMA,AIDS/ARC,8209399,although significant synergism observed anticd plus pma stimulation aids arc responses normalized levels anticd pma response normal control levels significantly lower observed anticd plus pma controlsnananticd plus pma stimulation pma
no_relation,glucose,NIDDM,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,metformin,NIDDM,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,glucose,diabetic,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,carbohydrates,diabetic,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,sucrose,diabetic,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,sucrose,NIDDM,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,carbohydrates,NIDDM,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,metformin,diabetic,8212978,rationale combining insulin oral drug therapy derives better understanding pathophysiology niddm mechanisms action oral drugs available type diabetic patients insulindeficient insulinresistant thus requiring quite high doses exogenous insulin peripheral insulin delivery leads hyperinsulinaemia could play role pathogenesis late diabetic complications sulphonylureas stimulate insulin release directly portal vein could also potentiate peripheral insulin action metformin improving glucose metabolism insulin sensitivity alphaglucosidase inhibitors slowing digestion complex carbohydrates sucrose able reduce amounts insulin needed control postprandial hyperglycaemianan
no_relation,glucose,NIDDM,8212978,numerous studies shown combination insulin sulphonylurea effective insulin alone treatment patients niddm secondary failure oral drugs leading better glucose profiles andor decreased insulin needsnan
no_relation,metformin,obesity,8212978,preliminary results suggested insulin metformin obesity present insulinacarbose postprandial hyperglycaemia occurs combinations might offer favourable features treatment niddm patients although therapeutical approaches still require adequate evaluation controlled studiesnan
no_relation,acarbose,obesity,8212978,preliminary results suggested insulinmetformin obesity present insulin acarbose postprandial hyperglycaemia occurs combinations might offer favourable features treatment niddm patients although therapeutical approaches still require adequate evaluation controlled studiesnan
no_relation,acarbose,NIDDM,8212978,preliminary results suggested insulinmetformin obesity present insulin acarbose postprandial hyperglycaemia occurs combinations might offer favourable features treatment niddm patients although therapeutical approaches still require adequate evaluation controlled studiesnan
no_relation,metformin,NIDDM,8212978,preliminary results suggested insulin metformin obesity present insulinacarbose postprandial hyperglycaemia occurs combinations might offer favourable features treatment niddm patients although therapeutical approaches still require adequate evaluation controlled studiesnan
no_relation,acyclovir,varicella-zoster virus infections,8245900,previous studies immunocompetent hosts normal adults demonstrated value intravenous acyclovir treatment varicellazoster virus infections nan
no_relation,acyclovir,varicella,8245900,oral acyclovir also shown efficacy normal adults zoster shingles immunocompetent children varicella nan
no_relation,acyclovir,shingles,8245900,oral acyclovir also shown efficacy normal adults zoster shingles immunocompetent children varicellanan
no_relation,acyclovir,varicella,8245900,recently completed doubleblind placebocontrolled study oral acyclovir immunocompetent adults uncomplicated varicella also demonstrated efficacynan
no_relation,acyclovir,varicella pneumonia/varicella,8245900,adults complicated varicella usually symptomatic varicella pneumonia receive intravenous acyclovir nan
no_relation,brovavir,varicella,8245900,several new agents varicella zoster therapy evaluated brovavir new agent currently compared placebo treatment adult varicella nan
no_relation,paracetamol,rheumatoid arthritis,8252318,additive effect combined naproxen paracetamol rheumatoid arthritis nan
no_relation,naproxen,rheumatoid arthritis,8252318,additive effect combined naproxen paracetamol rheumatoid arthritis nan
no_relation,paracetamol/acetaminophen,RA,8252318,clinical effect plasma naproxen levels studied patients ra receiving three doses naproxen two naproxen doses combined paracetamol acetaminophen randomized doubleblind comparison five wk treatment periodsnan
no_relation,naproxen,RA,8252318,clinical effect plasma naproxen levels studied patients ra receiving three doses naproxen two naproxen doses combined paracetamol acetaminophen randomized doubleblind comparison five wk treatment periodsnan
no_relation,paracetamol,RA,8252318,results show clinical effect naproxen ra may significantly increased concomitant paracetamol administrationnan
no_relation,naproxen,RA,8252318,results show clinical effect naproxen ra may significantly increased concomitant paracetamol administrationnan
no_relation,creatine,acute myocardial infarction,8259712,latter complex creatine kinase cardiac troponin measured peripheral venous blood samples serially drawn patients acute myocardial infarction nan
no_relation,Creatine,myocardial tissue injury,8259712,creatine kinase activities cardiac troponin concentrations used markers myocardial tissue injury nan
yes_direct,norepinephrine,asystole,8261477,yearold male experienced postexercise bradycardia asystole higher basal plasma norepinephrine versus  pgml epinephrine versus less pgml similar vagal tone vagal tone index versus  compared closely matched subjects underwent uneventful stress testnan
no_relation,epinephrine,asystole,8261477,yearold male experienced postexercise bradycardia asystole higher basal plasma norepinephrine versus  pgml epinephrine versus less pgml similar vagal tone vagal tone index versus  compared closely matched subjects underwent uneventful stress testnan
no_relation,norepinephrine,bradycardia,8261477,yearold male experienced postexercise bradycardia asystole higher basal plasma norepinephrine versus  pgml epinephrine versus less pgml similar vagal tone vagal tone index versus  compared closely matched subjects underwent uneventful stress testnan
no_relation,epinephrine,bradycardia,8261477,yearold male experienced postexercise bradycardia asystole higher basal plasma norepinephrine versus  pgml epinephrine versus less pgml similar vagal tone vagal tone index versus  compared closely matched subjects underwent uneventful stress testnan
no_relation,Polyethylene glycol,renal cell carcinoma,8262734,polyethylene glycol conjugated interleukin clinical immunologic effects patients advanced renal cell carcinoma nan
no_relation,monomethoxypolyethylene glycol,renal cell carcinoma,8262734,recombinant interleukin ril modified monomethoxypolyethylene glycol peg il utilized patients metastatic renal cell carcinoma two separate multiinstitutional trialsnan
no_relation,Androgens,prostate cancer,8263129,androgens regulate proliferation human prostate cancer cells culture increasing transforming growth factoralpha tgfalpha epidermal growth factor egftgfalpha receptornan
yes_direct,Androgens,prostate cancers,8263129,androgens affect growth prostate gland many prostate cancers nan
no_relation,testosterone,prostate cancer,8263129,examined effects alphadihydrotestosterone dht testosterone egf egfalpha cell proliferation hthymidine incorporation androgendependent human prostate cancer cell line alva serumfree mediumnan
no_relation,androgen,prostate cancer,8263129,examined effects alphadihydrotestosterone dht testosterone egf egfalpha cell proliferation hthymidine incorporation androgen dependent human prostate cancer cell line alva serumfree mediumnan
no_relation,5 alpha-dihydrotestosterone,prostate cancer,8263129,examined effects alphadihydrotestosterone dht testosterone egf egfalpha cell proliferation hthymidine incorporation androgendependent human prostate cancer cell line alva serumfree mediumnan
no_relation,ginsenoside Rh2,ovarian cancer,8270603,inhibitory effects oral administration ginsenoside rh growth human ovarian cancer cells nude micenan
no_relation,cisplatin/cis-diamminedichloroplatinum(II),tumor,8270603, days tumor inoculation mgkg cisdiamminedichloroplatinumii cisplatin administered intraperitoneally week weeksnan
no_relation,ethanol,tumor,8270603,rh dissolved absolute ethanol adjusted distilled water  microm ml concentration administered orally canula every day days next day tumor inoculationnan
no_relation,ethanol,tumor,8270603,days  tumor inoculation tumor volumes groups treated rh significantly less ethanol treated control group also cisplatin treated groupnan
no_relation,cisplatin,tumor,8270603,days  tumor inoculation tumor volumes groups treated rh significantly less ethanoltreated control group also cisplatin treated groupnan
no_relation,cisplatin,tumor,8270603, days tumor growth nude mice treated microm microm rh significantly inhibited compared cisplatin treated group well control groupnan
no_relation,fluoxetine,compulsive behavior disorder,8292312,diagnosis fluoxetine treatment compulsive behavior disorder adults mental retardationnan
no_relation,fluoxetine,mental retardation,8292312,diagnosis fluoxetine treatment compulsive behavior disorder adults mental retardation nan
no_relation,fluoxetine,compulsive behavior disorder,8292312,behavior disorders subjects met criteria compulsive behavior disorder subjects comparison subjects treated using medication fluoxetine nan
no_relation,fluoxetine,compulsive behavior disorder,8292312,seven subjects compulsive behavior disorder responded favorably fluoxetine treatment none comparison subjects responded favorably medicationnan
yes_direct,fluoxetine,compulsive behaviors,8292312,appeared relation manifest motor stereotypies compulsive behaviors response fluoxetine nan
no_relation,desipramine,desipramine-refractory depression,8294386,characteristics desipramine refractory depressionnan
no_relation,desipramine,major depression,8294386,determine predictors desipramine refractory depression authors examined outcome patients major depression admitted general hospital treated desipramine adjusted adequate blood levelnan
no_relation,desipramine,desipramine-refractory depression,8294386,determine predictors desipramine refractory depression authors examined outcome patients major depression admitted general hospital treated desipramine adjusted adequate blood levelnan
no_relation,desipramine,Depression,8294386,outcome assessed yale depression inventory week desipramine trial hour plasma concentrations used rapidly achieve therapeutic desipramine levelnan
no_relation,desipramine,depressive episode/depression,8294386,poor response therapeutic desipramine trial occurred  patients significantly associated definite personality disorder prior treatment failure near delusional status age depressive episode recurrence depression dysthymia secondary depression nan
no_relation,desipramine,personality disorder,8294386,poor response therapeutic desipramine trial occurred  patients significantly associated definite personality disorder prior treatment failure near delusional status agenan
no_relation,RC-3095,breast cancer,8313327,inhibitory effect bombesingastrinreleasing peptide antagonist rc-3095 luteinizing hormonereleasing hormone antagonist sb-75 growth mcf miii human breast cancer xenografts athymic nude micenan
yes_direct,SB-75,breast cancer,8313327,inhibitory effect bombesingastrinreleasing peptide antagonist rc-3095 luteinizing hormonereleasing hormone antagonist sb-75 growth mcf miii human breast cancer xenografts athymic nude micenan
no_relation,bombesin,breast cancer,8313327,inhibitory effect bombesin gastrinreleasing peptide antagonist rc-3095 luteinizing hormonereleasing hormone antagonist sb-75 growth mcf miii human breast cancer xenografts athymic nude micenan
yes_direct,estrogen,breast cancers,8313327,however breast cancers estrogen dependent treated hormonal manipulationnan
yes_direct,bombesin,cancers,8313327,various studies suggest bombesin gastrinreleasing peptide acts autocrine growth factor may play role initiation progression cancers including breastnan
no_relation,bombesin,breast cancer,8313327,female athymic nude mice bearing xenografts mcf miii human breast cancer cell line treated weeks bombesin gastrinreleasing peptide antagonist dtpi leu psichnhleu bombesin rc injected subcutaneously daily dose micrograms luteinizing hormonereleasing hormone antagonist sb-75 cetrorelix administered biweekly form microgranules releasing microgramsdaynan
no_relation,SB-75,tumor,8313327, weeks treatment significant inhibition tumor volume observed groups treated rc-3095 alone combination sb-75 treated sb-75 single agentnaninhibition key term
no_relation,Fludarabine,macroglobulinemia,8328496,fludarabine therapy waldenstrms macroglobulinemia nan
no_relation,fludarabine,macroglobulinemia,8328496,assess response rate remission duration survival patients waldenstrms macroglobulinemia treated adenine nucleoside analogue fludarabine nan
no_relation,fludarabine,macroglobulinemia,8328496,twentyeight patients waldenstrms macroglobulinemia  previously untreated received fludarabine dose  mgm intravenously daily days patients mgm intravenously daily days patientsnan
no_relation,Fludarabine,macroglobulinemia,8328496,fludarabine effective salvage agent treatment patients resistant waldenstrms macroglobulinemia nan
no_relation,aminoglycoside,intraabdominal infections,8337887,effect peritoneal fluid ph outcome aminoglycoside treatment intraabdominal infections nan
no_relation,clindamycin,intraabdominal infection,8337887,netilmicin clindamycin administered patients intraabdominal infection underwent emergency laparotomynan
no_relation,Netilmicin,intraabdominal infection,8337887,netilmicin clindamycin administered patients intraabdominal infection underwent emergency laparotomynan
no_relation,aminoglycoside,Escherichia,8337887,reduction ph antagonized aminoglycoside activity vitro clinical isolates escherichia colinan
no_relation,corticosteroid,obstructive airways disease,8339808,although patients obstructive airways disease show amelioration longterm inhaled corticosteroid therapy extent improvement may vary considerably patientsnan
no_relation,cefixime,gonorrhea,8341619,singledose oral treatment cefixime suprax quinolone appears effective safe practical patients uncomplicated gonorrhea nan
no_relation,Rocephin/ceftriaxone sodium,infections,8341619,disseminated infections fatal hospitalization treatment intravenous antibiotics ceftriaxone sodium rocephin cefotaxime sodium claforan requirednan
no_relation,cefotaxime sodium,infections,8341619,disseminated infections fatal hospitalization treatment intravenous antibiotics ceftriaxone sodium rocephin cefotaxime sodium claforan requirednan
no_relation,dopamine,schizophrenic,8341767,homovanillic acid hva oxidative metabolite dopamine shown number studies reflect severity symptoms predict response neuroleptic treatment schizophrenic patientsnan
no_relation,HVA/Homovanillic acid,schizophrenic,8341767,homovanillic acid hva oxidative metabolite dopamine shown number studies reflect severity symptoms predict response neuroleptic treatment schizophrenic patientsnan
no_relation,dopamine,drug action,8341767,however administration dopamine postsynaptic antagonists expected increase synaptic dopamine availability thereby increasing hva concentrations according traditional models drug action nan
no_relation,HVA,drug action,8341767,however administration dopamine postsynaptic antagonists expected increase synaptic dopamine availability thereby increasing hva concentrations according traditional models drug action nan
yes_direct,cadmium,renal stones,8343420,incidence renal stones among cadmium exposed battery workersnan
no_relation,creatinine,proteinuria,8343420,irrs  confidence interval ci  ci respectively beta microglobulin measurements available workers formed stones workers tubular proteinuria beta microglobulin  microgramsmmole creatinine prevalence nan
no_relation,somatostatin,hypothalamic,8344645,clarify pathogenesis underlying alterations six obese patients males females age yrs bmi   unrestricted diet studied effect day ghrh pretreatment microgramskg iv day acute somatotropic response neurohormone administered alone combined arginine arg gkg iv infused  min likely inhibits release hypothalamic somatostatin nan
no_relation,somatostatin,obese,8344645,clarify pathogenesis underlying alterations six obese patients males females age yrs bmi   unrestricted diet studied effect day ghrh pretreatment microgramskg iv day acute somatotropic response neurohormone administered alone combined arginine arg gkg iv infused  min likely inhibits release hypothalamic somatostatin nan
no_relation,androgens,prostatic cancer,8358057,although androgens effect prostatic cells believed dihydrotestosterone dht active metabolite primarily utilized prostatic cancer cells growth divisionnan
yes_direct,dihydrotestosterone/DHT,prostatic cancer,8358057,although androgens effect prostatic cells believed dihydrotestosterone dht active metabolite primarily utilized prostatic cancer cells growth divisionnan
no_relation,DHT,prostatic cancer,8358057,hormonal therapies therefore designed lower tissue levels dht prevent binding receptors prostatic cancer cellsnan
no_relation,testosterone,chronic viral hepatitis,8366286,effect longterm treatment recombinant interferon-alpha ifnalpha luteinizing hormone lh testosterone free testosterone sex hormonebinding globulin shbg evaluated male patients suffering chronic viral hepatitis nan
no_relation,etoposide,toxicity,8380135,although optimal chemotherapy regimen combinedmodality treatment yet established use cisplatin etoposide combinations promote pulmonary cardiac esophageal toxicity particularly appropriate patients smallcell lung cancernan
no_relation,cisplatin,lung cancer,8380135,although optimal chemotherapy regimen combinedmodality treatment yet established use cisplatin etoposide combinations promote pulmonary cardiac esophageal toxicity particularly appropriate patients smallcell lung cancer nan
no_relation,etoposide,lung cancer,8380135,although optimal chemotherapy regimen combinedmodality treatment yet established use cisplatin etoposide combinations promote pulmonary cardiac esophageal toxicity particularly appropriate patients smallcell lung cancer nan
no_relation,cisplatin,toxicity,8380135,although optimal chemotherapy regimen combinedmodality treatment yet established use cisplatin etoposide combinations promote pulmonary cardiac esophageal toxicity particularly appropriate patients smallcell lung cancernan
no_relation,azithromycin,Chlamydia trachomatis infected,8383102,invitro activity azithromycin chlamydia trachomatis infected polarized human endometrial epithelial cellsnan
no_relation,azithromycin,Chlamydia trachomatis infected,8383102,invitro activity azithromycin chlamydia trachomatis infected human endometrial epithelial cells primary transformed cells growing polarized nonpolarized orientation analyzednan
no_relation,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",human immunodeficiency virus (HIV) replication,8395382,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine pmedap potent inhibitor human immunodeficiency virus hiv replication evaluated activity human cytomegalovirus hcmv vitro murine cytomegalovirus mcmv rat cmv rcmv vivonan"
no_relation,LMWH,thrombosis,8395716, cases thrombosis group without prophylaxis six cases thrombosis lmwh nan
no_relation,Oestrogen,endometrial cancer,8398274,oestrogen replacement treatment risk endometrial cancer assessment role covariatesnan
no_relation,oestrogen,endometrial cancer,8398274,relationship oestrogen replacement treatment risk endometrial cancer analysed casecontrol study histologically confirmed incident cases age  controls hospital acute nonneoplastic nonhormonerelated conditions conducted swiss canton vaud nan
no_relation,oestrogen,endometrial cancer,8398274,thus study confirms presence strong association oestrogen replacement treatment endometrial cancer risk since late early cases could attributed oestrogen replacement treatment swiss populationnan
yes_direct,oestrogen,obesity,8398274,confirms presence significant negative interactions oestrogen use obesity possibly oc wellnan
no_relation,Nedocromil sodium,bronchospasm,8412049,nedocromil sodium prevention exerciseinduced bronchospasm athletes asthmanan
no_relation,Nedocromil sodium,asthma,8412049,nedocromil sodium prevention exerciseinduced bronchospasm athletes asthma nan
no_relation,sodium,bronchospasm,8412049,aim study determine efficacy nedocromil sodium prevention exerciseinduced bronchospasm eib top athletes affected bronchial asthmanan
no_relation,sodium,bronchial asthma,8412049,aim study determine efficacy nedocromil sodium prevention exerciseinduced bronchospasm eib top athletes affected bronchial asthma nannedocromil sodium na
no_relation,sodium,bronchial hyperreactivity,8412049,conclusion effect nedocromil sodium prevention eib may dosedependent relation degree bronchial hyperreactivity interference factorsnan
no_relation,sulfamethoxazole,Wegener's granulomatosis,8417733,longterm sulfamethoxazole trimethoprim wegeners granulomatosis nan
no_relation,trimethoprim,Wegener's granulomatosis,8417733,longterm sulfamethoxazole trimethoprim wegeners granulomatosis nan
no_relation,sulfamethoxazole,Wegener's granulomatosis,8417733,since number reports highlighted effectiveness short course sulfamethoxazole trimethoprim adjuvant immunosuppressive drugs treatment wegeners granulomatosis nan
no_relation,trimethoprim,Wegener's granulomatosis,8417733,since number reports highlighted effectiveness short course sulfamethoxazole trimethoprim adjuvant immunosuppressive drugs treatment wegeners granulomatosis nan
no_relation,sulfamethoxazole,Wegener's granulomatosis,8417733,report experience longterm sulfamethoxazole trimethoprim therapy patients wegeners granulomatosis nan
no_relation,trimethoprim,Wegener's granulomatosis,8417733,report experience longterm sulfamethoxazole trimethoprim therapy patients wegeners granulomatosis nan
no_relation,sulfamethoxazole,Wegener's granulomatosis,8417733,describe recent advances pathogenesis wegeners granulomatosis suggest complementary mechanism action sulfamethoxazole trimethoprim advocate longterm sulfamethoxazole trimethoprim therapy treatment option wegeners granulomatosis nan
no_relation,trimethoprim,Wegener's granulomatosis,8417733,describe recent advances pathogenesis wegeners granulomatosis suggest complementary mechanism action sulfamethoxazole trimethoprim advocate longterm sulfamethoxazole trimethoprim therapy treatment option wegeners granulomatosis nan
no_relation,cephalosporin,meningitis,8451095,dilemmas diagnosis management cephalosporin resistant streptococcus pneumoniae meningitis nan
no_relation,ceftriaxone,meningitis,8451095,recently managed infant meningitis caused streptococcus pneumoniae ceftriaxone failed sterilize cerebrospinal fluid days therapynan
no_relation,ceftriaxone,meningitis,8451095,furthermore ceftriaxone therapy meningitis induced strain rabbit model ineffectivenan
no_relation,cephalosporin/cephalosporins,meningitis,8451095,definition cephalosporin resistance pneumococci requires modification studies antibiotic management meningitis caused strains needed resistance cephalosporins increasing extended spectrum cephalosporins may ineffective sole therapynan
yes_direct,4-hydroperoxycyclophosphamide,Chromosome abnormalities,8453599,chromosome abnormalities patients treated 4-hydroperoxycyclophosphamide purged autologous bone marrow transplantationnan
no_relation,busulfan,ANLL,8453599,anll patients received busulfan cytoxan others received cytoxan total body irradiation preparative regimen transplantnan
no_relation,4-hydroperoxycyclophosphamide/4-HC,tumor,8453599,bm purged ex vivo 4-hydroperoxycyclophosphamide 4-hc  microgramsml reinfusion kill tumor cellsnan
no_relation,4-HC,tumor,8453599,data suggest clonal abnormalities observed posttransplant best explained clinical relapse tumor ex vivo marrow purging 4-hc likely induce clonal chromosome abnormalities normal cellsnan
no_relation,4-HC,marrow purging,8453599,data suggest clonal abnormalities observed posttransplant best explained clinical relapse tumor ex vivo marrow purging 4-hc likely induce clonal chromosome abnormalities normal cellsnan
no_relation,4-HC,clonal abnormalities,8453599,data suggest clonal abnormalities observed posttransplant best explained clinical relapse tumor ex vivo marrow purging 4-hc likely induce clonal chromosome abnormalities normal cellsnan
no_relation,4-HC,clonal chromosome abnormalities,8453599,data suggest clonal abnormalities observed posttransplant best explained clinical relapse tumor ex vivo marrow purging 4-hc likely induce clonal chromosome abnormalities normal cellsnan
no_relation,Fluoroquinolone,infection,8474940,fluoroquinolone antimicrobials meet joint commission criteria targeting due drugs used populations high risk adverse drug reactions quality assurance infection control committees target due drugs costly may suspected known used inappropriately prescribed frequentlynan
no_relation,fluoroquinolone,infections,8474940,suggested criteria include use patients would otherwise candidates oral fluoroquinolone therapy published criteria exist cannot use oral route administration due gastrointestinal conditions predisposing malabsorption unavailability oral route severe infections due gramnegative pathogens replacement aminoglycosides ototoxicity nephrotoxicity substantial risk targeting resistant pathogens ie empiric therapy targeting therapeutic use prophylaxisnan
no_relation,fluoroquinolone,ototoxicity,8474940,suggested criteria include use patients would otherwise candidates oral fluoroquinolone therapy published criteria exist cannot use oral route administration due gastrointestinal conditions predisposing malabsorption unavailability oral route severe infections due gramnegative pathogens replacement aminoglycosides ototoxicity nephrotoxicity substantial risk targeting resistant pathogens ie empiric therapy targeting therapeutic use prophylaxisnan
yes_direct,aminoglycosides,ototoxicity,8474940,suggested criteria include use patients would otherwise candidates oral fluoroquinolone therapy published criteria exist cannot use oral route administration due gastrointestinal conditions predisposing malabsorption unavailability oral route severe infections due gramnegative pathogens replacement aminoglycosides ototoxicity nephrotoxicity substantial risk targeting resistant pathogens ie empiric therapy targeting therapeutic use prophylaxisnan
no_relation,aminoglycosides,infections,8474940,suggested criteria include use patients would otherwise candidates oral fluoroquinolone therapy published criteria exist cannot use oral route administration due gastrointestinal conditions predisposing malabsorption unavailability oral route severe infections due gramnegative pathogens replacement aminoglycosides ototoxicity nephrotoxicity substantial risk targeting resistant pathogens ie empiric therapy targeting therapeutic use prophylaxisnan
no_relation,aspirin,aneurysm,8489792,series represents minimum number cases period illustrates association aneurysm risk prolonged fever improved defervescence combination intravenous gammaglobulin ivgg aspirin compared aspirin alone severe disease process youngnan
no_relation,aspirin,fever,8489792,series represents minimum number cases period illustrates association aneurysmrisk prolonged fever improved defervescence combination intravenous gammaglobulin ivgg aspirin compared aspirin alone severe disease process youngnan
no_relation,danazol,endometriosis,8495764,vaginal patterns danazol buserelin acetate therapy endometriosis structural ultrastructural studynan
no_relation,buserelin acetate,endometriosis,8495764,vaginal patterns danazol buserelin acetate therapy endometriosis structural ultrastructural studynan
no_relation,danazol,endometriosis,8495764,evaluate histologic ultrastructural changes vaginal mucosa patients given buserelin acetate danazol treatment endometriosis nan
no_relation,buserelin acetate,endometriosis,8495764,evaluate histologic ultrastructural changes vaginal mucosa patients given buserelin acetate danazol treatment endometriosis nan
no_relation,buserelin acetate,Infertile,8495764,infertile women endometriosis randomized receive buserelin acetate danazol undergoing vaginal biopsies treatment selectednan
no_relation,danazol,endometriosis,8495764,infertile women endometriosis randomized receive buserelin acetate danazol undergoing vaginal biopsies treatment selectednan
no_relation,buserelin acetate,endometriosis,8495764,infertile women endometriosis randomized receive buserelin acetate danazol undergoing vaginal biopsies treatment selectednan
no_relation,danazol,Infertile,8495764,infertile women endometriosis randomized receive buserelin acetate danazol undergoing vaginal biopsies treatment selectednan
no_relation,danazol,endometriosis,8495764,vaginal mucosa undergoes constant welldefined modifications buserelin acetate danazol treatment endometriosis nan
no_relation,buserelin acetate,endometriosis,8495764,vaginal mucosa undergoes constant welldefined modifications buserelin acetate danazol treatment endometriosis nan
no_relation,labetalol,chest pain,8506886,although labetalol sometimes given patients cocaineassociated chest pain influence cocaineinduced coronary vasoconstriction unknownnan
yes_direct,cocaine,chest pain,8506886,although labetalol sometimes given patients cocaine associated chest pain influence cocaine induced coronary vasoconstriction unknownnan
yes_direct,cocaine,chest pain,8506886, patients men women aged  years undergoing catheterization chest pain heart rate mean arterial pressure coronary arterial area computerassisted quantitative angiography measured baseline  minutes intranasal cocaine  mgkg  minutes intravenous saline  labetalol mgkg nan
no_relation,labetalol,chest pain,8506886, patients men women aged  years undergoing catheterization chest pain heart rate mean arterial pressure coronary arterial area computerassisted quantitative angiography measured baseline  minutes intranasal cocaine mgkg  minutes intravenous saline  labetalol  mgkg nan
no_relation,thallium,left bundle branch block,8517412,twelve patients exerciseinduced stsegment elevation without prior myocardial infarction electrocardiographic evidence left ventricular hypertrophy left bundle branch block underwent thallium tomography immediately exercise hours laternan
no_relation,thallium,ventricular hypertrophy,8517412,twelve patients exerciseinduced stsegment elevation without prior myocardial infarction electrocardiographic evidence left ventricular hypertrophy left bundle branch block underwent thallium tomography immediately exercise hours laternan
no_relation,thallium,myocardial infarction,8517412,twelve patients exerciseinduced stsegment elevation without prior myocardial infarction electrocardiographic evidence left ventricular hypertrophy left bundle branch block underwent thallium tomography immediately exercise hours laternan
no_relation,ether,glioma,8517654,effects structural modifications ether lipids antiproliferative activity human glioma cell linesnan
no_relation,ether,glioma,8517654,effect structural modifications ether lipids antiproliferative activity studied four human glioma cell linesnan
no_relation,podophyllotoxin,condylomata,8566979,evaluate clinical efficacy  cream formulation podophyllotoxin comparison solution treatment condylomata acuminata compare treatment modalities regarding side effectsnan
no_relation,oxygen,chronic lung disease,8580630,studied pulmonary protein oxidation association development chronic lung disease newborn infants mean gestational age  range weeks requiring intensive care oxygen therapynan
no_relation,oxygen,bronchopulmonary dysplasia,8580630,multiple regression analysis explaining bronchopulmonary dysplasia using gestational age inspired oxygen days protein carbonylation day independent variables protein carbonylation remained significantnan
no_relation,N-acetylcysteine,toxicosis,8585668,comparison n-acetylcysteine methylene blue alone combination treatment acetaminophen toxicosis catsnan
no_relation,methylene blue,toxicosis,8585668,comparison n-acetylcysteine methylene blue alone combination treatment acetaminophen toxicosis catsnan
no_relation,acetaminophen,toxicosis,8585668,comparison n-acetylcysteine methylene blue alone combination treatment acetaminophen toxicosis catsnan
yes_direct,Acetaminophen,poisoning,8585668,acetaminophen widely used human beings analgesic purposes one frequent causes poisoning catsnan
yes_direct,Acetaminophen,methemoglobinemia,8585668,acetaminophen poisoned cats develop methemoglobinemia sometimes hepatic failurenan
yes_direct,Acetaminophen,hepatic failure,8585668,acetaminophen poisoned cats develop methemoglobinemia sometimes hepatic failure nan
no_relation,NAC/N-acetylcysteine,methemoglobinemia,8585668,determine benefit using methylene blue treatment methemoglobinemia along n-acetylcysteine nac recommended treatment acetaminophenpoisoned cats groups male female cats given methylene blue nac administration acetaminophen mgkg body weight ponan
no_relation,methylene blue,methemoglobinemia,8585668,determine benefit using methylene blue treatment methemoglobinemia along n-acetylcysteine nac recommended treatment acetaminophenpoisoned cats groups male female cats given methylene blue nac administration acetaminophen mgkg body weight ponan
no_relation,acetaminophen,methemoglobinemia,8585668,determine benefit using methylene blue treatment methemoglobinemia along n-acetylcysteine nac recommended treatment acetaminophen poisoned cats groups male female cats given methylene blue nac administration acetaminophen mgkg body weight ponan
yes_direct,NAC,toxicosis,8585668,male cats seemed susceptible female cats acetaminophen toxicosis  males died hepatic failure cats given acetaminophenmethylene blue given acetaminophen nac methylene bluenan
yes_direct,methylene blue,toxicosis,8585668,male cats seemed susceptible female cats acetaminophen toxicosis  males died hepatic failure cats given acetaminophen methylene blue given acetaminophennac methylene blue nan
yes_direct,acetaminophen,toxicosis,8585668,male cats seemed susceptible female cats acetaminophen toxicosis  males died hepatic failure cats given acetaminophen methylene blue given acetaminophen nacmethylene bluenan
yes_direct,methylene blue,hepatic failure,8585668,male cats seemed susceptible female cats acetaminophen toxicosis males died hepatic failure cats given acetaminophen methylene blue given acetaminophennac methylene blue nan
yes_direct,NAC,hepatic failure,8585668,male cats seemed susceptible female cats acetaminophen toxicosis males died hepatic failure cats given acetaminophenmethylene blue given acetaminophen nac methylene bluenan
yes_direct,acetaminophen,hepatic failure,8585668,male cats seemed susceptible female cats acetaminophen toxicosis males died hepatic failure cats given acetaminophen methylene blue given acetaminophen nacmethylene bluenan
no_relation,mitomycin C,Tumor,8614004,reductase enzyme expression across national cancer institute tumor cell line panel correlation sensitivity mitomycin eonan
no_relation,phosphate,tumor,8614004,measured expression levels three different reductase enzymesdtdiaphorase nadph ie reduced nicotinamide adenine dinucleotide without phosphate quinone oxidoreductase nadphcytochrome reductase nadh ie reduced nicotinamide adenine dinucleotide cytochromeb reductase cell lines national cancer institute nci human tumor cell panel see relationships could established activities enzymes cellular sensitivities bioreductive compounds mitomycin eonan
no_relation,NADPH/NAD(P)H,tumor,8614004,measured expression levels three different reductase enzymesdtdiaphorase nadph ie reduced nicotinamide adenine dinucleotide without phosphate quinone oxidoreductase nadph cytochrome reductase nadh ie reduced nicotinamide adenine dinucleotide cytochromeb reductase cell lines national cancer institute nci human tumor cell panel see relationships could established activities enzymes cellular sensitivities bioreductive compounds mitomycin eonan
no_relation,mitomycin C,tumor,8614004,measured expression levels three different reductase enzymesdtdiaphorase nadph ie reduced nicotinamide adenine dinucleotide without phosphate quinone oxidoreductase nadphcytochrome reductase nadh ie reduced nicotinamide adenine dinucleotide cytochromeb reductase cell lines national cancer institute nci human tumor cell panel see relationships could established activities enzymes cellular sensitivities bioreductive compounds mitomycin eonan
no_relation,nicotinamide adenine dinucleotide/NADH,tumor,8614004,measured expression levels three different reductase enzymesdtdiaphorase nadph ie reduced nicotinamide adenine dinucleotide without phosphate quinone oxidoreductase nadphcytochrome reductase nadh ie reduced nicotinamide adenine dinucleotide cytochromeb reductase cell lines national cancer institute nci human tumor cell panel see relationships could established activities enzymes cellular sensitivities bioreductive compounds mitomycin eonan
no_relation,quinone,tumor,8614004,measured expression levels three different reductase enzymesdtdiaphorase nadph ie reduced nicotinamide adenine dinucleotide without phosphate quinone oxidoreductase nadphcytochrome reductase nadh ie reduced nicotinamide adenine dinucleotide cytochromeb reductase cell lines national cancer institute nci human tumor cell panel see relationships could established activities enzymes cellular sensitivities bioreductive compounds mitomycin eonan
no_relation,heparin,haemorrhagic,8615834,use heparin extracorporeal therapies problematical due haemorrhagic complications consequence heparinase flavobacterium heparinum used determination plasma heparin elimination heparin circulationnan
no_relation,tamoxifen,breast cancer,8636753,antiatherogenic effects adjuvant antiestrogens randomized trial comparing effects tamoxifen toremifene plasma lipid levels postmenopausal women nodepositive breast cancer nan
no_relation,toremifene,breast cancer,8636753,antiatherogenic effects adjuvant antiestrogens randomized trial comparing effects tamoxifen toremifene plasma lipid levels postmenopausal women nodepositive breast cancer nan
no_relation,tamoxifen,breast cancer,8636753,fortynine postmenopausal patients nodepositive breast cancer randomized trial compared effects tamoxifen toremifene serum lipoproteinsnan
no_relation,toremifene,breast cancer,8636753,fortynine postmenopausal patients nodepositive breast cancer randomized trial compared effects tamoxifen toremifene serum lipoproteinsnan
no_relation,toremifene,CHD/coronary heart disease,8636753,results provide positive evidence toremifene antiatherogenic properties potency improve lipoproteins associated increased coronary heart disease chd risknan
no_relation,amphotericin B,candidemia,8645855,comparative trial amphotericin vs fluconazole treatment candidemia nonneutropenic patients data management intravascular catheters collectednan
no_relation,fluconazole,candidemia,8645855,comparative trial amphotericin vs fluconazole treatment candidemia nonneutropenic patients data management intravascular catheters collectednan
no_relation,interferon-alpha,hepatitis B,8686350,investigated longterm effect interferon-alpha treatment patients chronic hepatitis regard response status treatmentnan
yes_direct,interferon-alpha,hepatitis B,8686350, patients chronic hepatitis including patients active cirrhosis child followed months mean months interferon-alpha treatmentnan
no_relation,interferon-alpha,cirrhosis,8686350, patients chronic hepatitis including patients active cirrhosis child followed months mean months interferon-alpha treatmentnan
no_relation,HBeAg,cirrhosis,8686350,thus patients without apparent cirrhosis interferon-alpha treatment considerable longterm effect regard enhanced rate hbsag hbeag clearance prolonged followupnan
no_relation,ketamine,terminal cancer pain,8697554,intrathecal ketamine reduces morphine requirements patients terminal cancer pain nan
no_relation,morphine,terminal cancer pain,8697554,intrathecal ketamine reduces morphine requirements patients terminal cancer pain nan
no_relation,Ketamine,pain,8697554,ketamine administered epidurally intrathecally operative postoperative pain controlnan
yes_direct,morphine,analgesia,8697554,animal studies showed potentiation analgesia induced ketamine morphine nan
yes_direct,ketamine,analgesia,8697554,animal studies showed potentiation analgesia induced ketamine morphinenan
no_relation,ketamine,cancer pain,8697554,hypothesized intrathecal ketamine would potentiate effects intrathecal morphine treatment cancer pain nan
no_relation,morphine,cancer pain,8697554,hypothesized intrathecal ketamine would potentiate effects intrathecal morphine treatment cancer pain nan
no_relation,ketamine,terminal cancer pain,8697554,double blind cross study designed evaluate effect ketamine spinal morphine analgesia terminal cancer pain patientsnan
yes_direct,morphine,analgesia,8697554,double blind cross study designed evaluate effect ketamine spinal morphine analgesia terminal cancer pain patientsnan
no_relation,morphine,terminal cancer pain,8697554,double blind cross study designed evaluate effect ketamine spinal morphine analgesia terminal cancer pain patientsnan
no_relation,ketamine,analgesia,8697554,double blind cross study designed evaluate effect ketamine spinal morphine analgesia terminal cancer pain patientsnan
no_relation,morphine,pain,8697554,dose morphine titrated upwards acceptable pain relief achieved defined numeric rating scales morphine less mg intrathecal administration two daysnan
no_relation,K,Pain,8697554,pain scales decreased  effective dose morphine reachednan
no_relation,morphine,Pain,8697554,pain scales decreased  morphine reachednan
no_relation,Pentoxifylline,thrombosis,8699848,pentoxifylline potential treatment thrombosis associated abnormal tissue factor expression monocytes endothelial cellsnan
no_relation,pentoxifylline/PTX,necrosis,8699848,vitro pentoxifylline ptx inhibits monocyte production tf response endotoxin well endothelial cell production tf response tumor necrosis factoralpha tnfalphanan
no_relation,Lamotrigine,nocturnal myoclonus syndrome/NMS,8739847,lamotrigine treatment nocturnal myoclonus syndrome nms two case reportsnan
no_relation,dopamine,nocturnal myoclonus syndrome/NMS,8739847,previous investigations found increase dopamine receptors striatum patients nocturnal myoclonus syndrome nms treatment dopamimeticsnan
no_relation,glutamate,NMS,8739847,glutamate release inhibitor lamotrigine tested two nms patientsnan
no_relation,lamotrigine,NMS,8739847,glutamate release inhibitor lamotrigine tested two nms patientsnanused treatment
no_relation,tacrine,Alzheimer's amyloid,8761343,amyloidogenic processing alzheimers amyloid precursor protein vitro modulation metal ions tacrine nan
no_relation,tacrine,AD,8761343,addition zinc tacrine treatment ad patients high dosage long term may effects process amyloidogensisnan
no_relation,zinc,AD,8761343,addition zinc tacrine treatment ad patients high dosage long term may effects process amyloidogensisnan
yes_direct,adriamycin,acute cardiac toxicity,8787689,protective role manganese superoxide dismutase adriamycin induced acute cardiac toxicity transgenic micenan
yes_direct,ADR/Adriamycin,cardiac toxicity,8787689,adriamycin adr potent anticancer drug known cause severe cardiac toxicity nan
yes_direct,ADR,cardiac toxicity,8787689,although adr generates free radicals role free radicals development cardiac toxicity intracellular target adr induced cardiac toxicity still well understoodnan
yes_direct,ADR,mitochondrial damage,8787689,electron microscopy revealed dosedependent ultrastructural alterations marked mitochondrial damage nontransgenic mice treated adr transgenic littermatesnan
yes_direct,ADR,toxicity,8787689,results support major role free radical generation adr toxicity well suggesting mitochondria critical site cardiac injurynan
no_relation,ADR,cardiac injury,8787689,results support major role free radical generation adr toxicity well suggesting mitochondria critical site cardiac injury nan
yes_direct,5-HT,contractions,8789380,ketanserin nm antagonized part 5-ht induced contractions nan
no_relation,Ketanserin,contractions,8789380,ketanserin nm antagonized part htinduced contractions nan
yes_direct,5-HT,contractions,8789380,ketanserinresistant components 5-ht induced contractions found log ec  nm ketanserin log ec  nm ketanserinnan
no_relation,Ketanserin,contractions,8789380,ketanserin resistant components htinduced contractions found log ec  nm ketanserin log ec  nm ketanserin nan
yes_direct,5-HT,contractions,8789380,rings endothelial function attenuated enzymatic treatment 5-ht caused contractions log ec partially blocked ketanserinnan
no_relation,ketanserin,contractions,8789380,rings endothelial function attenuated enzymatic treatment 5-ht caused contractions log ec partially blocked ketanserin nan
yes_direct,5-HT,contractions,8789380,ketanserinresistant components 5-ht induced contractions found log ec  nm ketanserin log ec  nm ketanserinnanal simplificar las palabras es mas entendible para uno que es medico en este tipo de tareathanksss
no_relation,Ketanserin,contractions,8789380,ketanserin resistant components htinduced contractions found log ec  nm ketanserin log ec  nm ketanserin nan
yes_direct,sumatriptan,contractions,8789380,rings intact endothelium htlikeselective agonist sumatriptan caused small contractions log ec intrinsic activity respect 5-ht resistant blockade nm ketanserin antagonized nm methiothepinnan
no_relation,5-HT,contractions,8789380,rings intact endothelium htlikeselective agonist sumatriptan caused small contractions log ec intrinsic activity respect 5-ht resistant blockade nm ketanserin antagonized nm methiothepinnan
no_relation,methiothepin,contractions,8789380,rings intact endothelium htlikeselective agonist sumatriptan caused small contractions log ec intrinsic activity respect 5-ht resistant blockade nm ketanserin antagonized nm methiothepin nan
no_relation,ketanserin,contractions,8789380,rings intact endothelium htlikeselective agonist sumatriptan caused small contractions log ec intrinsic activity respect 5-ht resistant blockade nm ketanserin antagonized nm methiothepinnan
no_relation,hydroxyzine,allergic rhinitis,8792380,fifteen subjects allergic rhinitis tested administration diphenhydramine hydroxyzine placebo doubleblind singledose threeway crossover studynan
no_relation,diphenhydramine,allergic rhinitis,8792380,fifteen subjects allergic rhinitis tested administration diphenhydramine hydroxyzine placebo doubleblind singledose threeway crossover studynan
yes_direct,hydroxyzine,CNS dysfunction,8792380,children diphenhydramine hydroxyzine effective hreceptor antagonists medications cause cns dysfunction evidenced increased latency measure cognitive function increased subjective somnolencenan
yes_direct,diphenhydramine,CNS dysfunction,8792380,children diphenhydramine hydroxyzine effective hreceptor antagonists medications cause cns dysfunction evidenced increased latency measure cognitive function increased subjective somnolencenan
no_relation,cortisol,hypothalamic,8796342,three months head injury hormonal evaluation hypothalamic pituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosteronenan
no_relation,cortisol,head injury,8796342,three months head injury hormonal evaluation hypothalamicpituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosteronenan
no_relation,testosterone,head injury,8796342,three months head injury hormonal evaluation hypothalamicpituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosterone nan
no_relation,GnRH,hypothalamic,8796342,three months head injury hormonal evaluation hypothalamic pituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosteronenan
no_relation,GnRH,head injury,8796342,three months head injury hormonal evaluation hypothalamicpituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosteronenan
no_relation,testosterone,hypothalamic,8796342,three months head injury hormonal evaluation hypothalamic pituitary axis means insulin stress test simultaneous administration trh gnrh resulted reduced responses gh cortisol tsh fsh lh low baseline serum concentrations free testosterone nan
no_relation,clonidine,hypoglycemia,8796342,however gh response reduced insulininduced hypoglycemia clonidine ghrh testsnan
no_relation,okadaic acid,okadaic acid/OA,8835396,human   mu sperm monkey   mu sperm sonicates contained activity tentatively identified pp basis inhibition profiles okadaic acid oa canan
no_relation,tetracycline,infection,8852981,recommended management infection consists drainage antimicrobial therapy tetracycline clindamycin fluoroquinolonenan
no_relation,fluoroquinolone,infection,8852981,recommended management infection consists drainage antimicrobial therapy tetracycline clindamycin fluoroquinolone nan
no_relation,clindamycin,infection,8852981,recommended management infection consists drainage antimicrobial therapy tetracycline clindamycin fluoroquinolonenan
no_relation,[Met5]enkephalin,colon cancer,8853403,opioid growth factor [met5]enkephalin prevents incidence retards growth human colon cancer nan
no_relation,[Met5]enkephalin,colon cancer,8853403,daily administration native opioid growth factor ogf [met5]enkephalin dosages  mgkg prevented occurrence human colon cancer ht xenografts nude micenan
no_relation,methacholine,asthma,8856797,evaluate effects age height prechallenge respiratory system resistance rrs bronchial responsiveness methacholine inhalation brm measured oscillation technique children mild asthma studied brm atopic children aged  years mean sd  yearsnan
no_relation,methotrexate,angioedema,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,dapsone,angioedema,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,hydroxychloroquine,angioedema,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,hydroxychloroquine,urticarial vasculitis,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphananused failed treatment
no_relation,methotrexate,urticarial vasculitis,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,dapsone,urticarial vasculitis,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,azathioprine,angioedema,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,azathioprine,urticarial vasculitis,8882052,yearold woman yr history chronic recurrent urticarial vasculitis angioedema refractory conventional treatment including glucocorticosteroids blockers nonsteroidal antiinflammatory agents methotrexate hydroxychloroquine dapsone azathioprine intravenous gamma globulin plasma exchange successfully treated interferon alphanan
no_relation,glutathione,head and neck squamous carcinoma,8898974,chemosensitivity head neck squamous carcinoma cell lines primarily correlated glutathione level modified glutathione depletionnan
no_relation,platinum,tumor,8898974,basis interaction endogenous synthetic substances glutathione key enzyme conjugation glutathione stransferase appear critical determinants tumor cell resistance several antineoplastic drugs eg platinum analogsnan
no_relation,glutathione,tumor,8898974,basis interaction endogenous synthetic substances glutathione key enzyme conjugation glutathione stransferase appear critical determinants tumor cell resistance several antineoplastic drugs eg platinum analogsnan
no_relation,cisplatin,head and neck cancer,8898974,ten established head neck cancer cell lines umscc hlac na ddp chemosensitivity cisplatin carboplatin fluorouracil bleomycin well cellular glutathione content activity glutathione stransferase determinednan
no_relation,bleomycin,head and neck cancer,8898974,ten established head neck cancer cell lines umscc hlac na ddp chemosensitivity cisplatin carboplatin fluorouracil bleomycin well cellular glutathione content activity glutathione stransferase determinednan
no_relation,5-fluorouracil,head and neck cancer,8898974,ten established head neck cancer cell lines umscc hlac na ddp chemosensitivity cisplatin carboplatin 5-fluorouracil bleomycin well cellular glutathione content activity glutathione stransferase determinednan
no_relation,carboplatin,head and neck cancer,8898974,ten established head neck cancer cell lines umscc hlac na ddp chemosensitivity cisplatin carboplatin fluorouracil bleomycin well cellular glutathione content activity glutathione stransferase determinednan
no_relation,glutathione,head and neck cancer,8898974,ten established head neck cancer cell lines umscc hlac na ddp chemosensitivity cisplatin carboplatin fluorouracil bleomycin well cellular glutathione content activity glutathione stransferase determinednan
no_relation,glutathione,tumor,8898974,results revealed correlation sensitivity tumor cells drugs tested level glutathione activity glutathione stransferasenan
no_relation,glutathione,cross-resistance,8898974,however cisplatinresistant subpopulation ddp showed highest glutathione level marked cross-resistance bleomycinnan
no_relation,bleomycin,cross-resistance,8898974,however cisplatinresistant subpopulation ddp showed highest glutathione level marked cross-resistance bleomycin nan
no_relation,cisplatin,cross-resistance,8898974,however cisplatin resistant subpopulation ddp showed highest glutathione level marked cross-resistance bleomycinnan
no_relation,glutathione,carcinoma,8898974,results suggest level glutathione activity glutathione stransferase suitable parameter assessment chemosensitivity head neck squamouscell carcinoma linesnan
no_relation,Levocabastine,conjunctivitis,8911706,levocabastine selective topical antagonist effective treatment seasonal allergic rhinitis conjunctivitis nan
no_relation,Levocabastine,seasonal allergic rhinitis,8911706,levocabastine selective topical antagonist effective treatment seasonal allergic rhinitis conjunctivitisnan
no_relation,sertindole,schizophrenia,8935813,randomized controlled doseranging trial sertindole patients schizophrenia nan
no_relation,sertindole,schizophrenic,8935813,day randomized placebocontrolled doseranging multicenter study designed assess effect sertindole previously neurolepticresponsive hospitalized schizophrenic patients nan
no_relation,sertindole,EPS,8935813,eps related events comparable placebo sertindole groupsnan
no_relation,adenosine,various disorders,8940747,recent data support evidence adenosine receptor properties may prove useful future drug development selective manipulation receptorassociated biologic effects might relevant treatment various disorders including psychiatric diseases hypoxiaischemia inflammation erythrocytosisnan
no_relation,adenosine,hypoxia,8940747,recent data support evidence adenosine receptor properties may prove useful future drug development selective manipulation receptorassociated biologic effects might relevant treatment various disorders including psychiatric diseases hypoxia ischemia inflammation erythrocytosisnan
no_relation,adenosine,psychiatric diseases,8940747,recent data support evidence adenosine receptor properties may prove useful future drug development selective manipulation receptorassociated biologic effects might relevant treatment various disorders including psychiatric diseases hypoxiaischemia inflammation erythrocytosisnan
no_relation,adenosine,ischemia,8940747,recent data support evidence adenosine receptor properties may prove useful future drug development selective manipulation receptorassociated biologic effects might relevant treatment various disorders including psychiatric diseases hypoxia ischemia inflammation erythrocytosisnan
no_relation,adenosine,inflammation,8940747,recent data support evidence adenosine receptor properties may prove useful future drug development selective manipulation receptorassociated biologic effects might relevant treatment various disorders including psychiatric diseases hypoxiaischemia inflammation erythrocytosisnan
no_relation,Glutamine,cancer,8942537,glutamine cancer therapynan
no_relation,glutamine,tumor/cancer,8942537,overview glutamine cancer therapy discusses vitro vivo work glutamine tumor growth summarizes animal human data potential benefits glutamine tumor bearing host receiving radiation chemotherapynan
no_relation,glutamine,cachexia,8942537,tumor act glutamine trap depleting host glutamine stores resulting cachexia nan
no_relation,glutamine,tumor,8942537,tumor act glutamine trap depleting host glutamine stores resulting cachexianan
no_relation,glutamine,dependence,8942537,vitro evidence dependence tumor growth glutamine deterred use clinic settingnan
yes_direct,glutamine,tumor,8942537,vitro evidence dependence tumor growth glutamine deterred use clinic settingnan
no_relation,glutamine,tumor,8942537,data variety investigations studying glutamine interaction tumor bearing host receiving radiation chemotherapy compiled summarizednan
no_relation,glutamine,tumors,8942537,large body evidence vivo suggests supplemental glutamine make tumors grow fact results decreased growth stimulation immune systemnan
no_relation,glutamine,tumor,8942537,given radiation chemotherapy glutamine protects host actually increases selectivity therapy tumor nan
no_relation,camptothecin,non-Hodgkin's lymphoma,8996518,camptothecin derivative irinotecan cpt shown possess antitumor activity phase ii trials patients carcinoma lung cervix ovary colon rectum patients nonhodgkins lymphoma nan
no_relation,irinotecan,carcinoma of the lung,8996518,camptothecin derivative irinotecan cpt shown possess antitumor activity phase ii trials patients carcinoma lung cervix ovary colon rectum patients nonhodgkins lymphomanan
no_relation,camptothecin,carcinoma of the lung,8996518,camptothecin derivative irinotecan cpt shown possess antitumor activity phase ii trials patients carcinoma lung cervix ovary colon rectum patients nonhodgkins lymphomanan
no_relation,irinotecan,non-Hodgkin's lymphoma,8996518,camptothecin derivative irinotecan cpt shown possess antitumor activity phase ii trials patients carcinoma lung cervix ovary colon rectum patients nonhodgkins lymphoma nan
no_relation,busulfan,gliomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,gliomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,procarbazine,rhabdomyosarcoma,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenanused useless treatment
no_relation,melphalan,rhabdomyosarcoma,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,procarbazine,Tumors,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,melphalan,Tumors,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,busulfan,medulloblastomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,busulfan,ependymomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,melphalan,ependymomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,rhabdomyosarcoma,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,busulfan,Tumors,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,procarbazine,gliomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,melphalan,gliomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,procarbazine,medulloblastomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,busulfan,rhabdomyosarcoma,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,procarbazine,ependymomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,medulloblastomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenanal simplificar las palabras es mas entendible para uno que es medico en este tipo de tareathanksss
no_relation,melphalan,medulloblastomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,Tumors,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,ependymomas,8996518,tumors included childhood highgrade gliomas mg mg adult highgrade gliomas mg mg medulloblastomas med med ependymomas ep ep rhabdomyosarcoma te well sublines demonstrated resistance busulfan mg br cyclophosphamide te cr procarbazine mg pr melphalan te mr growing subcutaneously intracranially athymic nude micenan
no_relation,cyclophosphamide,tumor,8996518,cpt-11 produced statistically significant cyclophosphamide procarbazine melphalan growth delays ranging days med days several tumor linesnan
no_relation,busulfan,tumor,8996518,cpt-11 produced statistically significant busulfan cyclophosphamide procarbazine melphalan growth delays ranging days med days several tumor linesnan
no_relation,CPT-11,tumor,8996518,cpt-11 produced statistically significant tumor linesnan
no_relation,procarbazine,tumor,8996518,cpt-11 produced statistically significant procarbazine melphalan growth delays ranging days med days several tumor linesnan
no_relation,theophylline,impaired or difficult deglutition,8996853,microcapsules theophylline administered suspension water proved suitable dosage form clientele impaired difficult deglutition nan
no_relation,theophylline,asthma,8996853,maximum serum levels microgramsml microgramsml attained  hours dosing coinciding perfectly time critical morning dip nocturnal excess  circadiantailored asymmetric dosage regimen proved take account chronopathology asthma chronopharmacokinetics theophylline sustainedrelease preparationsnan
no_relation,atropine,colonic motility,9009112,effect cholecystokinin octapeptide atropine human colonic motility tone transitnan
no_relation,Atropine,colonic motility,9009112,atropine used control demonstrate responsiveness selected parameters colonic motility nan
no_relation,yohimbine,posttraumatic stress disorder,9075465,positron emission tomography measurement cerebral metabolic correlates yohimbine administration combatrelated posttraumatic stress disorder nan
no_relation,norepinephrine,anxiety,9075465,previously reported increase symptoms anxiety patients posttraumatic stress disorder ptsd following administration beta antagonist yohimbine stimulates brain norepinephrine releasenan
yes_direct,yohimbine,posttraumatic stress disorder/PTSD,9075465,previously reported increase symptoms anxiety patients posttraumatic stress disorder ptsd following administration beta antagonist yohimbine stimulates brain norepinephrine releasenan
no_relation,norepinephrine,posttraumatic stress disorder/PTSD,9075465,previously reported increase symptoms anxiety patients posttraumatic stress disorder ptsd following administration beta antagonist yohimbine stimulates brain norepinephrine releasenan
yes_direct,yohimbine,anxiety,9075465,previously reported increase symptoms anxiety patients posttraumatic stress disorder ptsd following administration beta antagonist yohimbine stimulates brain norepinephrine releasenan
no_relation,yohimbine,PTSD,9075465,used positron emission tomography fludeoxyglucose measure brain metabolism vietnam combat veterans ptsd  healthy agematched control subjects  following administration yohimbine mgkg placebo randomized doubleblind fashionnan
no_relation,Yohimbine,PTSD,9075465,yohimbine resulted significant increase anxiety patients ptsd healthy subjectsnan
yes_direct,Yohimbine,anxiety,9075465,yohimbine resulted significant increase anxiety patients ptsd healthy subjectsnanptsd patients making third option also technically correct
no_relation,yohimbine,PTSD,9075465,significant difference brain metabolic response yohimbine patients ptsd compared healthy subjects prefrontal temporal parietal orbitofrontal cortexesnan
no_relation,yohimbine,PTSD,9075465,metabolism tended decrease patients ptsd increase healthy subjects following administration yohimbine nan
no_relation,yohimbine,PTSD,9075465,findings consistent previous hypothesis enhanced norepinephrine release brain yohimbine patients ptsd nan
no_relation,norepinephrine,PTSD,9075465,findings consistent previous hypothesis enhanced norepinephrine release brain yohimbine patients ptsd nan
no_relation,chloramphenicol,typhoid fever,9136240, children bacteriologically andor serologically diagnosed typhoid fever treated kem hospital bombay initially one three recommended drugs viz chloramphenicol amoxycillin cotrimoxazole given days defervescence occurnan
no_relation,amoxycillin,typhoid fever,9136240, children bacteriologically andor serologically diagnosed typhoid fever treated kem hospital bombay initially one three recommended drugs viz chloramphenicol amoxycillin cotrimoxazole given days defervescence occurnan
no_relation,co-trimoxazole,typhoid hepatitis,9136240,major complications except cases typhoid hepatitis responded choramphenicol co-trimoxazole respectivelynan
no_relation,verapamil,hypertension,9147707,oncedaily fixed dose combinations verapamil trandolapril black patients mild moderate hypertension new choice first line treatmentnan
no_relation,trandolapril,hypertension,9147707,oncedaily fixed dose combinations verapamil trandolapril black patients mild moderate hypertension new choice first line treatmentnan
no_relation,calcium,hypertension,9147707,using ambulatory blood pressure bp monitoring potent aceinhibitor calcium channel blocker combination tested black patients age  years males females mild moderate hypertension mean hour daytime diastolic bp  mmhgnan
no_relation,bromocriptine,adenoma,9151080,transformation human mixed ghprl adenoma cell population response longterm bromocriptine treatmentnan
no_relation,Pentoxifylline,malaria,9160101,pentoxifylline two analogues hwa hwa concentrations exceeding microgramsml inhibited malaria antigen lipopolysaccharide lps induced tnfalpha il alpha secretion il secretion human peripheral blood mononuclear cells vitronan
no_relation,pentoxifylline,toxicity,9160101,pentoxifylline analogues may lower toxicity pentoxifylline may therefore useful future treatment diseases induced endotoxic substancesnan
no_relation,pentoxifylline,endotoxic,9160101,pentoxifylline analogues may lower toxicity pentoxifylline may therefore useful future treatment diseases induced endotoxic substancesnan
no_relation,pentoxifylline,diseases,9160101,pentoxifylline analogues may lower toxicity pentoxifylline may therefore useful future treatment diseases induced endotoxic substancesnan
no_relation,acrylamide,neuropathy,9165488,increase rate tubulin polymerization acrylamide carbon disulfide treatment may alter rate transport axonal constituents including neurofilament contribute toward accumulation focal swellings observed neuropathy nan
no_relation,carbon disulfide,neuropathy,9165488,increase rate tubulin polymerization acrylamide carbon disulfide treatment may alter rate transport axonal constituents including neurofilament contribute toward accumulation focal swellings observed neuropathy nan
no_relation,risperidone,schizophrenia,9167507,risperidone improve verbal working memory treatmentresistant schizophrenia nan
no_relation,haloperidol,schizophrenic,9167507,verbal working memory treatmentresistant schizophrenic patients assessed part randomized doubleblind comparison treatment risperidone haloperidol nan
no_relation,risperidone,schizophrenic,9167507,verbal working memory treatmentresistant schizophrenic patients assessed part randomized doubleblind comparison treatment risperidone haloperidolnan
no_relation,benztropine,psychotic symptoms,9167507,treatment effect remained significant effects benztropine cotreatment change psychotic symptoms change negative symptoms controllednan
no_relation,silicone,myopia,9183752,investigated efficacy safety stability correction achieved silicone posterior chamber intraocular lens used correct high myopia phakic eyesnan
no_relation,silicone,myopia,9183752,silicone posterior chamber platestyle intraocular lens chiron adatomed implanted consecutive phakic eyes high myopia  diopters period monthsnan
no_relation,angiotensin II,heart failure,9220306,effects angiotensin ii receptor blockade nterminal proatrial natriuretic factor plasma levels chronic heart failure nan
no_relation,angiotensin II,heart failure,9220306,doubleblind placebocontrolled study investigated whether weeks treatment angiotensin ii receptor blocker losartan influenced nterminal proanf plasma levels chronic heart failure patientsnan
no_relation,losartan,heart failure,9220306,doubleblind placebocontrolled study investigated whether weeks treatment angiotensin ii receptor blocker losartan influenced nterminal proanf plasma levels chronic heart failure patientsnan
no_relation,pravastatin,hypercholesterolemia,9226599,recently positive effect cholesterollowering drugs pravastatin lovastatin npt observed middleaged males chronic hypercholesterolemia nan
no_relation,lovastatin,hypercholesterolemia,9226599,recently positive effect cholesterollowering drugs pravastatin lovastatin npt observed middleaged males chronic hypercholesterolemia nan
no_relation,cholesterol,hypercholesterolemia,9226599,recently positive effect cholesterol lowering drugs pravastatin lovastatin npt observed middleaged males chronic hypercholesterolemia nan
no_relation,Itraconazole,oral candidosis,9240009,itraconazole treatment oral candidosis pediatric cancer patientsnan
no_relation,Itraconazole,pediatric cancer,9240009,itraconazole treatment oral candidosis pediatric cancer patientsnan
no_relation,itraconazole,oral candidosis,9240009,aim study evaluate efficacy side effects itraconazole treatment oral candidosis nan
no_relation,itraconazole,oral candidosis,9240009,fourteen children malignancy undergoing chemotherapy received itraconazole mgday days treat oral candidosis nan
no_relation,itraconazole,malignancy,9240009,fourteen children malignancy undergoing chemotherapy received itraconazole mgday days treat oral candidosisnan
no_relation,psoralen,psoriasis,9242514,mutation squamous cell carcinomas psoriasis patients treated psoralen uva puvanan
no_relation,psoralen,squamous cell carcinomas,9242514,mutation squamous cell carcinomas psoriasis patients treated psoralen uva puvanan
yes_direct,quinine,hearing loss,9270425,reversible hearing loss known complication following administration quinine salicylates nonsteroidal antiinflammatory drugs erythromycinnan
yes_direct,salicylates,hearing loss,9270425,reversible hearing loss known complication following administration quinine salicylates nonsteroidal antiinflammatory drugs erythromycinnan
yes_direct,erythromycin,hearing loss,9270425,reversible hearing loss known complication following administration quinine salicylates nonsteroidal antiinflammatory drugs erythromycin nan
no_relation,dopamine,schizophrenia,9278187,review role dopamine receptors schizophrenia antipsychotic actionnan
yes_direct,dopamine,schizophrenia,9278187,past years enduring explanation schizophrenia dopamine hypothesis proposes dopaminergic system overactive widespread diseasenan
no_relation,dopamine,widespread disease,9278187,past years enduring explanation schizophrenia dopamine hypothesis proposes dopaminergic system overactive widespread disease nan
no_relation,dopamine,schizophrenic,9278187,classically receptor formed core dopamine hypothesis since considerable evidence elevations receptor levels brains schizophrenic patients receptors served primary target mediating antipsychotic effects neurolepticsnan
no_relation,clozapine,schizophrenia,9278187,existence polymorphisms raises possibility structural variations receptor may associated increased susceptibility schizophrenia observed variations individual response clozapine treatmentnan
no_relation,clozapine,schizophrenia,9278187,furthermore association evident polymorphic forms susceptibility schizophrenia variable clozapine responsenan
no_relation,dopamine,schizophrenia,9278187,observations support idea might serve target clozapine significantly modified extended understanding mechanisms underlying atypical antipsychotic treatment schizophrenia well dopamine hypothesis schizophrenia nan
no_relation,clozapine,schizophrenia,9278187,observations support idea might serve target clozapine significantly modified extended understanding mechanisms underlying atypical antipsychotic treatment schizophrenia well dopamine hypothesis schizophrenia nan
no_relation,morphine,anxiety,9338905,difference pain intensity initial assessment morphine usage mood anxiety depression measurement periodnan
no_relation,morphine,pain,9338905,difference pain intensity initial assessment morphine usage mood anxiety depression measurement periodnan
no_relation,morphine,depression,9338905,difference pain intensity initial assessment morphine usage mood anxiety depression measurement periodnan
no_relation,calcium oxalate,acidosis,9348055,ingestion ethylene glycol either accidentally suicide attempt characterized severe acidosis calcium oxalate crystal formation deposition wide variety end organ effects may fatalnan
yes_direct,ethylene glycol,acidosis,9348055,ingestion ethylene glycol either accidentally suicide attempt characterized severe acidosis calcium oxalate crystal formation deposition wide variety end organ effects may fatalnan
no_relation,ethylene glycol,toxicity,9348055,comprehensive review literature pathology pathophysiology ethylene glycol toxicity organ system provided along information diagnosis current treatment recommendationsnan
no_relation,creatine,myocardial infarction,9356086,measuring creatine kinase ck mb levels preoperatively entry intensive care unit icu every  obtaining serial lead electrocardiograms ecg preoperatively   icu admission morning surgery min pre postextubation myocardial infarction identifiednan
yes_direct,propofol,myocardial ischemia,9356086,randomized study patients coronary artery bypass surgery examined whether light versus heavy sedation propofol intensive care unit associated increased degree myocardial ischemia nan
no_relation,glyceryl trinitrate,chronic anal fissure,9369106,sample consecutive patients chronic anal fissure randomly allocated treatment sphincterotomy local glyceryl trinitrate nan
no_relation,glyceryl trinitrate,chronic anal fissure,9369106,local application glyceryl trinitrate avoid surgery percent patients chronic anal fissure nan
no_relation,medroxyprogesterone acetate,necrosis,9373794,effect highdose medroxyprogesterone acetate tumor necrosis factoralpha release patients chemotherapyinduced neutropenianan
no_relation,medroxyprogesterone acetate,tumor,9373794,effect highdose medroxyprogesterone acetate tumor necrosis factoralpha release patients chemotherapyinduced neutropenianan
no_relation,medroxyprogesterone acetate,neutropenia,9373794,effect highdose medroxyprogesterone acetate tumor necrosis factoralpha release patients chemotherapyinduced neutropenia nan
no_relation,medroxyprogesterone acetate/MPA,necrosis,9373794,aim study investigate effects highdose medroxyprogesterone acetate mpa tumor necrosis factoralpha tnfalpha release patients chemotherapyinduced neutropenianan
no_relation,medroxyprogesterone acetate/MPA,tumor,9373794,aim study investigate effects highdose medroxyprogesterone acetate mpa tumor necrosis factoralpha tnfalpha release patients chemotherapyinduced neutropenianan
no_relation,medroxyprogesterone acetate/MPA,neutropenia,9373794,aim study investigate effects highdose medroxyprogesterone acetate mpa tumor necrosis factoralpha tnfalpha release patients chemotherapyinduced neutropenia nan
no_relation,furazolidone,AIDS,9378811,enterocytozoon bieneusi aids symptomatic relief parasite changes furazolidone nan
no_relation,furazolidone,AIDS,9378811,investigate changes morphology developmental stages enterocytozoon bieneusi symptomatic relief observed aids patients treatment furazolidone nan
no_relation,furazolidone,AIDS,9378811,six aids patients symptomatic bieneusi infection small intestine treated course furazolidone nan
no_relation,furazolidone,intestinal infection,9378811,clinical benefit seen treatment furazolidone six aids patients bieneusi intestinal infection may due damage developmental stages causing partial inhibition reproduction parasitenan
no_relation,furazolidone,AIDS,9378811,clinical benefit seen treatment furazolidone six aids patients bieneusi intestinal infection may due damage developmental stages causing partial inhibition reproduction parasitenan
no_relation,formaldehyde,tumor,9385388,data one extensively studied chemicals weakly genotoxic carcinogen formaldehyde support contention concentrationresponse relationship tumor incidence function formaldehyde induced target cell proliferation addition factors including target cell population sizenan
no_relation,Indoxyl sulfate,renal failure,9387112,indoxyl sulfate progression renal failure effects lowprotein diet oral sorbent indoxyl sulfate production uremic rats undialyzed uremic patientsnan
yes_direct,indoxyl sulfate,glomerular sclerosis,9387112,previously demonstrated indoxyl sulfate stimulating factor progression glomerular sclerosis uremic ratsnan
no_relation,indoxyl sulfate,glomerular sclerosis,9387112,conclusion lowprotein diet ast reduced serum urine levels indoxyl sulfate stimulating factor glomerular sclerosis uremic rats undialyzed uremic patientsnan
no_relation,bupivacaine,hypospadias,9389843,ninety boys aged months undergoing repair hypospadias allocated randomly receive ml kg one three solutions caudal extradural space group received bupivacaine mg kg group received tramadol mg kg saline group bt mixturenan
no_relation,tramadol,hypospadias,9389843,ninety boys aged months undergoing repair hypospadias allocated randomly receive ml kg one three solutions caudal extradural space group received bupivacaine mg kg group received tramadol mg kg saline group bt mixturenan
no_relation,FK506,sciatic-nerve crush injury,9457703,review focuses studies showing systemic administration fk506 dosedependently speeds nerve regeneration functional recovery rats following sciaticnerve crush injury nan
no_relation,vancomycin,infection,9461358,order determine extent vancomycin resistant enterococcus vre colonisation within paediatric oncology unit risk factors acquisition organism molecular epidemiology isolates impact infection control measures extensive patient environmental surveillance undertaken identification antibiotic susceptibility testing pulsedfield gel electrophoresis pfge vre isolatesnan
no_relation,amikacin,neutropenia,9461358,following comparison cases controls matched age  years cohabitation oncology unit risk factors colonisation vre included duration neutropenia  ci antibiotic therapy  ci number antibiotic agents received  ci duration therapy amikacin  ci ceftazidime  ci  teicoplanin  ci nan
no_relation,ceftazidime,neutropenia,9461358,following comparison cases controls matched age  years cohabitation oncology unit risk factors colonisation vre included duration neutropenia  ci antibiotic therapy  ci number antibiotic agents received  ci duration therapy amikacin  ci ceftazidime  ci  teicoplanin  ci nan
no_relation,amikacin,neutropenia,9461358,risk factors vre colonization paediatric oncology patients included duration neutropenia duration antibiotic therapy exposure ceftazidime amikacin teicoplanin number antibiotics usednan
no_relation,teicoplanin,neutropenia,9461358,risk factors vre colonization paediatric oncology patients included duration neutropenia duration antibiotic therapy exposure ceftazidime amikacin teicoplanin number antibiotics usednan
no_relation,ceftazidime,neutropenia,9461358,risk factors vre colonization paediatric oncology patients included duration neutropenia duration antibiotic therapy exposure ceftazidime amikacin teicoplanin number antibiotics usednan
yes_direct,alcohol,septal branch occlusion,9462563,alternative nonsurgical procedure reducing left ventricular outflow tract lvot gradient ptsma alcohol induced septal branch occlusion introducednan
no_relation,creatine,angina,9462563,patients angina pectoris maximal creatine kinase increase  uliter range   range nan
no_relation,etomidate,trachea,9477050,effect propofol etomidate also studied cai increase measured microspectrofluorimetry isolated myocytes isometric contraction rat trachea nan
no_relation,propofol,trachea,9477050,effect propofol etomidate also studied cai increase measured microspectrofluorimetry isolated myocytes isometric contraction rat trachea nan
no_relation,propofol,asthmatic,9477050,whereas thiopental contracts human isolated bronchi propofol etomidate reduce histamineinduced contraction human isolated airway smooth muscle either sensitized passively sensitized asthmatic serumnan
no_relation,thiopental,asthmatic,9477050,whereas thiopental contracts human isolated bronchi propofol etomidate reduce histamineinduced contraction human isolated airway smooth muscle either sensitized passively sensitized asthmatic serumnan
no_relation,histamine,asthmatic,9477050,whereas thiopental contracts human isolated bronchi propofol etomidate reduce histamine induced contraction human isolated airway smooth muscle either sensitized passively sensitized asthmatic serumnan
no_relation,etomidate,asthmatic,9477050,whereas thiopental contracts human isolated bronchi propofol etomidate reduce histamineinduced contraction human isolated airway smooth muscle either sensitized passively sensitized asthmatic serumnan
yes_direct,maltitol,flatulence,9482768,relative ingestion sucrose maltitol caused significant difference symptoms resulted mild borborygmi flatulencenan
no_relation,sucrose,flatulence,9482768,relative ingestion sucrose  maltitol caused significant difference symptoms resulted mild borborygmi flatulencenan
no_relation,Steroid,myopathy,9484390,steroid responsive myopathy deficient chondroitin sulfate skeletal muscle connective tissuenan
no_relation,chondroitin sulfate C,myopathy,9484390,steroidresponsive myopathy deficient chondroitin sulfate skeletal muscle connective tissuenan
no_relation,chondroitin sulfate,atrophy,9484390,muscle biopsy showed moderate degree type atrophy immunocytochemistry showed absence chondroitin sulfate glycosaminoglycan endomysiumnan
no_relation,N-nitrosodimethylamine,cytotoxicity,9498284,heterologous expression rat mammalian cell line situ metabolism cytotoxicity n-nitrosodimethylamine nan
no_relation,4-methylpyrazole,toxicity,9498284,inhibitors activity ethanol 4-methylpyrazole isoniazid caused decrease methylation cellular macromolecules also completely protected cells ndmamediated toxicity nan
no_relation,ethanol,toxicity,9498284,inhibitors activity ethanol methylpyrazole isoniazid caused decrease methylation cellular macromolecules also completely protected cells ndmamediated toxicity nan
no_relation,isoniazid,toxicity,9498284,inhibitors activity ethanol methylpyrazole isoniazid caused decrease methylation cellular macromolecules also completely protected cells ndmamediated toxicity nan
yes_direct,NDMA,toxicity,9498284,inhibitors activity ethanol methylpyrazole isoniazid caused decrease methylation cellular macromolecules also completely protected cells ndma mediated toxicity nan
no_relation,N-t-butyl-alpha-phenylnitrone,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants nacetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
no_relation,butylated hydroxyanisole,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants nacetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
no_relation,N-acetylcysteine,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants n-acetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
no_relation,ascorbic acid,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants nacetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
yes_direct,NDMA,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants nacetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
no_relation,glutathione,cytotoxicity,9498284,cytotoxicity due exposure ndma partially inhibited antioxidants nacetylcysteine ascorbic acid butylated hydroxyanisole n-t-butyl-alpha-phenylnitrone potentiated upon glutathione depletionnan
no_relation,NDMA,carcinogenesis,9498284,results document ability rat metabolize ndma toxic reactive intermediates demonstrate cell line provides useful model studying mechanisms metabolismmediated toxicity carcinogenesis nan
no_relation,NDMA,toxicity,9498284,results document ability rat metabolize ndma toxic reactive intermediates demonstrate cell line provides useful model studying mechanisms metabolismmediated toxicity carcinogenesisnan
no_relation,methylprednisolone,lupus,9507220,survival even prolonged bindarit medicated diet combined low dose methylprednisolone mgkg ip partially modifies proteinuria survival lupus mice additional group animals nan
no_relation,methylprednisolone,proteinuria,9507220,survival even prolonged bindarit medicated diet combined low dose methylprednisolone mgkg ip partially modifies proteinuria survival lupus mice additional group animals nan
no_relation,steroid,lupus,9507220,studies needed establish whether bindarit may function steroid sparing drug human lupus nan
no_relation,aminoglycosides,tubular marker proteins,9562231,order assess nephrotoxic potential antibiotics various aminoglycosides cephalosporins tested potency alter excretion tubular marker proteins brush border antigens change normal pattern serumproteinuria analyzed sds polyacrylamidgel gradient electrophoresisnan
no_relation,cephalosporins,tubular marker proteins,9562231,order assess nephrotoxic potential antibiotics various aminoglycosides cephalosporins tested potency alter excretion tubular marker proteins brush border antigens change normal pattern serumproteinuria analyzed sds polyacrylamidgel gradient electrophoresisnan
no_relation,aminoglycosides/aminoglycoside,tubular marker proteins,9562231,excretion tubular marker proteins enhanced combined administration cephalosporins aminoglycosides mainly due aminoglycoside componentnan
no_relation,cephalosporins,tubular marker proteins,9562231,excretion tubular marker proteins enhanced combined administration cephalosporins aminoglycosides mainly due aminoglycoside componentnan
yes_direct,Chloroxylenol,dermatitis,9601902,chloroxylenol causing hand dermatitis plumbernan
no_relation,oxygen,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,epinephrine,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,norepinephrine,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,lactate,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,free fatty acids,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,glucose,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,cortisol,pain,9605680,aural canal core skin surface sites temperatures oxygen consumption pain visual analogue score concentrations epinephrine norepinephrine glucose cortisol lactate free fatty acids plasma measured epidural blockade min epidural blockade end surgery surgerynan
no_relation,oxygen,pain,9605680,recovery difference two groups norepinephrine concentrations plasma body weightadjusted oxygen consumption pain visual analogue score metabolitesnan
no_relation,norepinephrine,pain,9605680,recovery difference two groups norepinephrine concentrations plasma body weightadjusted oxygen consumption pain visual analogue score metabolitesnan
no_relation,dopamine,dystonia,9613742,suggested tardive cervical dystonia may clinically indistinguishable idiopathic form diagnosis rests solely documenting exposure dopamine antagonist medicationsnan
no_relation,dopamine,dystonia,9613742,differences may help distinguish clinical setting improve diagnostic accuracy support existence causal relationship exposure dopamine antagonist medications chronic dystonia nan
no_relation,L-ornithine-L-aspartate,chronic hepatic encephalopathy,9625322,oral l-ornithine-l-aspartate therapy chronic hepatic encephalopathy results placebocontrolled doubleblind studynan
no_relation,L-ornithine-L-aspartate,cirrhosis,9625322,therefore therapeutic efficacy oral l-ornithine-l-aspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,L-ornithine-L-aspartate,hyperammonemia,9625322,therefore therapeutic efficacy oral l-ornithine-l-aspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,L-ornithine-L-aspartate,chronic hepatic encephalopathy,9625322,therefore therapeutic efficacy oral l-ornithine-l-aspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,L-ornithine-L-aspartate,impaired ammonia detoxification,9625322,therefore therapeutic efficacy oral l-ornithine-l-aspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,L-ornithine-L-aspartate,hepatic encephalopathy,9625322,therefore therapeutic efficacy oral l-ornithine-l-aspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,cirrhosis,9625322,therefore therapeutic efficacy oral lornithinelaspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,chronic hepatic encephalopathy,9625322,therefore therapeutic efficacy oral lornithinelaspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,hepatic encephalopathy,9625322,therefore therapeutic efficacy oral lornithinelaspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,impaired ammonia detoxification,9625322,therefore therapeutic efficacy oral lornithinelaspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,hyperammonemia,9625322,therefore therapeutic efficacy oral lornithinelaspartate improves impaired ammonia detoxification investigated patients cirrhosis hyperammonemia stable overt chronic hepatic encephalopathy subclinical hepatic encephalopathy randomized doubleblind placebocontrolled clinical trialnan
no_relation,ammonia,Encephalopathy,9625322,efficacy variables fasting postprandial ammonia concentration numberconnectiontest time mental state grades portosystemic encephalopathy indexnan
no_relation,L-ornithine-L-aspartate,hepatic encephalopathy,9625322,analyses based total study sample placebo l-ornithine-l-aspartate treated patients well subgroup samples overt placebo lornithinelaspartatetreated subclinical hepatic encephalopathy placebo l-ornithine-l-aspartate treated patientsnan
no_relation,L-ornithine-L-aspartate,Encephalopathy,9625322,also mental state grade encephalopathy index l-ornithine-l-aspartate group placebo groupnan
no_relation,L-ornithine-L-aspartate,cirrhosis,9625322,oral l-ornithine-l-aspartate safe welltolerated treatment good compliance rate beneficial therapeutic effect patients cirrhosis stable overt chronic hepatic encephalopathynan
no_relation,L-ornithine-L-aspartate,chronic hepatic encephalopathy,9625322,oral l-ornithine-l-aspartate safe welltolerated treatment good compliance rate beneficial therapeutic effect patients cirrhosis stable overt chronic hepatic encephalopathy nan
no_relation,steroids,aggressive postoperative diuresis,9635268,protocol emphasizing preoperative placement intraaortic balloon pump reduced cpb time early extubation perioperative steroids thyroid hormone aggressive postoperative diuresis usednan
no_relation,oxygen,angina pectoris,9642483,therapeutic point view angina pectoris best thought imbalance oxygen supply demandnan
no_relation,oxygen,decreasing heart rate,9642483,reduction oxygen demand accomplished decreasing heart rate blood pressure heart size left ventricular massnan
no_relation,aspirin,angina pectoris,9642483,together reduction risk factors combination therapy plus aspirin provides optimal management patients angina pectoris nanused treatment
no_relation,amino acid,cirrhosis,9689432,effects branchedchain amino acid enriched nutrient mixture natural killer cell activity viral cirrhosis nan
no_relation,amino acid,cirrhosis,9689432,controlled study performed viral cirrhosis patients evaluate whether immune function indicated natural killer nk cell activity improved branchedchain amino acid enriched nutrient mixture nutrientmixture aminoleban ennan
no_relation,bilirubin,liver cirrhosis,9689432,laboratory data indicating severity liver cirrhosis total bilirubin albumin showed better valuesnan
no_relation,amino acid,liver cirrhosis,9689432,results suggest branchedchain amino acid enriched nutrient mixture increases nk cell activity moderately patients compensated liver cirrhosis shows lower values baseline nk cell activitynan
no_relation,aspirin,atrial fibrillation,9701102,cardioversion patients nonvalvular atrial fibrillation followed use aspirin alone amiodarone reasonable marginal costeffectiveness rationan
no_relation,amiodarone,atrial fibrillation,9701102,cardioversion patients nonvalvular atrial fibrillation followed use aspirin alone amiodarone reasonable marginal costeffectiveness rationan
no_relation,aspirin,atrial fibrillation,9701102,finally patients bothered little symptoms atrial fibrillation cardioversion followed either aspirin warfarin without subsequent antiarrhythmic therapy treatment choicenan
no_relation,warfarin,atrial fibrillation,9701102,finally patients bothered little symptoms atrial fibrillation cardioversion followed either aspirin warfarin without subsequent antiarrhythmic therapy treatment choicenan
no_relation,Testosterone,surgical menopause,9711681,testosterone deficiency menopausal women common appreciated particularly patients hormone replacement surgical menopause nan
no_relation,Testosterone,Testosterone deficiency,9711681,testosterone deficiency menopausal women common appreciated particularly patients hormone replacement surgical menopausenan
no_relation,calcium,osteoporosis,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosis nan
no_relation,calcium,sudden death,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
no_relation,calcium,hypertension,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
no_relation,sodium,osteoporosis,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosis nan
no_relation,sodium,sudden death,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
no_relation,magnesium,sudden death,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
no_relation,magnesium,osteoporosis,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosis nan
no_relation,magnesium,hypertension,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
yes_direct,sodium,hypertension,9727819,epidemiologic clinical studies suggest magnesium may reduce frequency sudden death sodium contributes occurrence hypertension calcium may help prevent osteoporosisnan
no_relation,alcohol,cardiovascular disease,9751945,presence cardiovascular disease however even small quantities alcohol might result transient unfavorable hemodynamic changesnan
yes_direct,alcohol,sudden death,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden death nan
yes_direct,alcohol,stroke,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden deathnan
yes_direct,alcohol,hypertension,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden deathnan
no_relation,alcohol,alcohol abuse,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden deathnan
yes_direct,alcohol,cardiomyopathy,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden deathnan
yes_direct,alcohol,cardiac arrhythmias,9751945,moreover alcohol abuse produce cardiac arrhythmias hypertension cardiomyopathy stroke even sudden deathnan
no_relation,alcohol,vascular diseases,9751945,contrast moderate alcohol use produces changes overall favorable effect atheroscleroticrelated vascular diseases nan
no_relation,alcohol,atherosclerosis,9751945,cardiovascular disease due atherosclerosis leading cause death western society desirable effect alcohol use outweighs detrimental actions resulting favorable findings population studiesnan
no_relation,alcohol,cardiovascular disease,9751945,cardiovascular disease due atherosclerosis leading cause death western society desirable effect alcohol use outweighs detrimental actions resulting favorable findings population studiesnan
no_relation,alcohol,death,9751945,cardiovascular disease due atherosclerosis leading cause death western society desirable effect alcohol use outweighs detrimental actions resulting favorable findings population studiesnan
no_relation,glucose,diabetes mellitus,9759691,crosssectional analysis data participants gubbio population study men women aged  years without macroalbuminuria without diabetes mellitus fasting plasma glucose levels less mmoll mg dlnan
yes_direct,flavone,A549 lung adenocarcinoma,9804172,promoter activation following induction pwaf gene flavone involved phase arrest lung adenocarcinoma cellsnan
no_relation,Flavone,cancer,9804172,flavone well known flavonoid many derivatives shown antiproliferative effects several cancer cellsnan
no_relation,flavone,lung adenocarcinoma,9804172,report flavone effectively inhibit cell growth human lung adenocarcinoma cells dosedependent manner microm flavone causes cell cycle arrest phasenan
no_relation,flavone,RB/retinoblastoma,9804172,mechanism underlying cell cycle arrest flavone markedly increases mrna protein levels universal inhibitor cyclindependent kinase pwaf inhibits phosphorylation retinoblastoma rb proteinnan
no_relation,flavone,RB,9804172,results suggest phase arrest flavone due pindependent transcriptional induction pwaf gene subsequent dephosphorylation rb proteinnan
yes_direct,sirolimus,toxicities,9808489,phase trial stable renal transplant recipients documented cyclosporine sirolimus overlapping toxicities conducted openlabel singlecenter phase iii doseescalation trial examine safety efficacy drug combinationnan
no_relation,cyclosporine,toxicities,9808489,phase trial stable renal transplant recipients documented cyclosporine sirolimus overlapping toxicities conducted openlabel singlecenter phase iii doseescalation trial examine safety efficacy drug combinationnan
no_relation,sirolimus,hypertensive,9808489,although sirolimus treated patients displayed comparatively lower platelet white blood cell counts higher levels serum cholesterol triglycerides sirolimus augment nephrotoxic hypertensive proclivities cyclosporinenan
no_relation,triglycerides,hypertensive,9808489,although sirolimustreated patients displayed comparatively lower platelet white blood cell counts higher levels serum cholesterol triglycerides sirolimus augment nephrotoxic hypertensive proclivities cyclosporinenan
no_relation,cholesterol,hypertensive,9808489,although sirolimustreated patients displayed comparatively lower platelet white blood cell counts higher levels serum cholesterol triglycerides sirolimus augment nephrotoxic hypertensive proclivities cyclosporinenan
no_relation,cyclosporine,hypertensive,9808489,although sirolimustreated patients displayed comparatively lower platelet white blood cell counts higher levels serum cholesterol triglycerides sirolimus augment nephrotoxic hypertensive proclivities cyclosporine nan
no_relation,estrogens,breast cancer,9816328,profound suppression plasma estrogens megestrol acetate postmenopausal breast cancer patientsnan
no_relation,megestrol acetate,breast cancer,9816328,profound suppression plasma estrogens megestrol acetate postmenopausal breast cancer patientsnan
no_relation,cortisol,breast cancer,9816328,twelve postmenopausal women suffering advanced breast cancer plasma estrogens androgens cortisol gonadotropins determined therapy treatment megestrol acetate oral doses escalated  mgnan
no_relation,estrogens,breast cancer,9816328,twelve postmenopausal women suffering advanced breast cancer plasma estrogens androgens cortisol gonadotropins determined therapy treatment megestrol acetate oral doses escalated  mgnan
no_relation,androgens,breast cancer,9816328,twelve postmenopausal women suffering advanced breast cancer plasma estrogens androgens cortisol gonadotropins determined therapy treatment megestrol acetate oral doses escalated  mgnan
no_relation,megestrol acetate,breast cancer,9816328,twelve postmenopausal women suffering advanced breast cancer plasma estrogens androgens cortisol gonadotropins determined therapy treatment megestrol acetate oral doses escalated  mgnan
no_relation,androgens,breast cancer,9816328,findings indicate causes profound suppression adrenal steroid production addition suppresses ovarian secretion androgens postmenopausal breast cancer patientsnan
no_relation,steroid,breast cancer,9816328,findings indicate causes profound suppression adrenal steroid production addition suppresses ovarian secretion androgens postmenopausal breast cancer patientsnan
no_relation,estrogens,breast cancer,9816328,reduction plasma estrogens comparable values obtained commonly used aromatase inhibitors may responsible antitumor effects breast cancer nan
no_relation,Mg/magnesium,hypokinesia,9823441,aim study evaluate effect magnesium mg loading mg mg kg body wt daily mg supplements mg mg kg body wt mg deficiency shown increased decreased serum mg concentration hypokinesia decreased km numberdnan
no_relation,Mg,SACS,9823441,shks sacs groups took daily mg elemental mg kg body wt subjected mg loading mg mg kg body wtnan
no_relation,Mg,hypokinetic,9823441,prehypokinetic hypokinetic periods excretion mg feces urine concentration mg serum mg balance measurednan
no_relation,Mg,SACS,9823441,shks uhks groups fecal mg loss urinary excretion electrolytes serum concentrations electrolytes increased significantly sacs uacs groupsnan
no_relation,Mg,SACS,9823441,mg loading tests urinary fecal mg excretion also greater shks uhks groups sacs uacs groupsnan
no_relation,Mg,SACS,9823441,throughout study mg balance negative shks uhks groups whereas sacs uacs groups mg balance positivenan
no_relation,Mg,HK,9823441,concluded significant losses mg occurred presence negative mg balance mg deficiency endurancetrained subjects prolonged exposure hk daily mg supplements mg loading testsnan
yes_direct,SSRI,sexual dysfunction,9825088,management ssri induced sexual dysfunction nan
yes_direct,serotonin,sexual dysfunction,9825088,describe occurrence management sexual dysfunction induced selective serotonin reuptake inhibitors ssris provide overview sexual dysfunction reports ssriinduced sexual dysfunction management strategiesnan
yes_direct,SSRI,sexual dysfunction,9825088,describe occurrence management sexual dysfunction induced selective serotoninreuptake inhibitors ssris provide overview sexual dysfunction reports ssri induced sexual dysfunction management strategiesnan
no_relation,nefazodone,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,fluoxetine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,bupropion,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,cyproheptadine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,yohimbine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,clomipramine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,sertraline,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,amantadine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,buspirone,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,paroxetine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,fluvoxamine,sexual dysfunction,9825088,indexing terms included sexual dysfunction antidepressants selective serotonergic reuptake inhibitors fluoxetine sertraline paroxetine fluvoxamine clomipramine buspirone nefazodone bupropion cyproheptadine amantadine yohimbine central nervous system stimulantsnan
no_relation,SSRI,sexual dysfunction,9825088,controlled studies describing ssri induced sexual dysfunction managementnan
yes_direct,fluoxetine,sexual dysfunction,9825088,ssriinduced sexual dysfunction described fluoxetine paroxetine sertraline fluvoxamine weeks therapynan
yes_direct,paroxetine,sexual dysfunction,9825088,ssriinduced sexual dysfunction described fluoxetine paroxetine sertraline fluvoxamine weeks therapynan
no_relation,fluvoxamine,sexual dysfunction,9825088,ssriinduced sexual dysfunction described fluoxetine paroxetine sertraline fluvoxamine weeks therapynan
yes_direct,sertraline,sexual dysfunction,9825088,ssriinduced sexual dysfunction described fluoxetine paroxetine sertraline fluvoxamine weeks therapynan
yes_direct,SSRI,sexual dysfunction,9825088,ssri induced sexual dysfunction described fluoxetine paroxetine sertraline fluvoxamine weeks therapynan
no_relation,serotonin,obsessive-compulsive disorder,9829022,role serotonin obsessivecompulsive disorder nan
yes_direct,Serotonin,obsessive-compulsive disorder/OCD,9829022,serotonin may play role pathophysiology obsessivecompulsive disorder ocd antiobsessional effect selective serotonin reuptake inhibitors ssrisnan
no_relation,homovanillic acid,OCD,9829022,ocd cases analysed csf hydroxyindoleacetic acid homovanillic acid concentrations significantly differ agecorrected controlsnan
no_relation,somatostatin,OCD,9829022,abnormalities csf arginine vasopressin corticotropinreleasing hormone oxytocin somatostatin levels reported ocd nan
no_relation,arginine vasopressin,OCD,9829022,abnormalities csf arginine vasopressin corticotropinreleasing hormone oxytocin somatostatin levels reported ocd nan
no_relation,oxytocin,OCD,9829022,abnormalities csf arginine vasopressin corticotropinreleasing hormone oxytocin somatostatin levels reported ocd nan
no_relation,clomipramine,neuropeptide abnormalities,9829022,longterm treatment highdoses clomipramine fluvoxamine fluoxetine tend correct neuropeptide abnormalities nan
no_relation,fluoxetine,neuropeptide abnormalities,9829022,longterm treatment highdoses clomipramine fluvoxamine fluoxetine tend correct neuropeptide abnormalities nan
no_relation,fluvoxamine,neuropeptide abnormalities,9829022,longterm treatment highdoses clomipramine fluvoxamine fluoxetine tend correct neuropeptide abnormalities nan
no_relation,serotonin,OCD,9829022,hypothesise continuous treatment ssris alters serotonin turnover neuropeptide expression patterns ocd entertaining functional forebrainmidbrain circuitsnan
no_relation,iron,ESRD/end-stage renal disease,9848632,study included endstage renal disease esrd patients performing chronic peritoneal home hemodialysis iron deficiency defined ferritin iron saturationnan
no_relation,iron,iron deficiency,9848632,study included endstage renal disease esrd patients performing chronic peritoneal home hemodialysis iron deficiency defined ferritin iron saturationnan
no_relation,iron,ESRD,9848632,total dose iron safe effective means restoring iron erythropoietic response esrd patients weighing kg receive renal replacement therapy homenan
no_relation,Methylene blue,methemoglobinemia,9867898,methylene blue intraosseous infusion methemoglobinemia nan
no_relation,methylene blue,methemoglobinemia,9867898,intraosseous administration standard intravenous doses methylene blue rapidly terminated effects acquired methemoglobinemia nan
no_relation,penicillin,peritonsillar abscess,9914550,results suggest intravenous penicillin remains excellent choice therapy cases peritonsillar abscess requiring parenteral antibiotics drainagenan
no_relation,chloroform,hepatic damage,9921434,contribution druginduced hepatic damage postoperative hepatic dysfunction remained unsettled since chloroform first incriminated nineteenth centurynan
no_relation,chloroform,hepatic dysfunction,9921434,contribution druginduced hepatic damage postoperative hepatic dysfunction remained unsettled since chloroform first incriminated nineteenth centurynan
yes_direct,chloroform,poisoning,9921434,drug condemned without attempt made determine incidence socalled delayed chloroform poisoning result drug still use chloroform controversy remains unsettled daynan
no_relation,chloroform,necrosis,9921434,babior davidson noted first drug implicated hepatic necrosis presumably exception chloroform first report appearing nan
no_relation,halothane,hepatitis,9921434,conducted definitive retrospective hypothesistesting studythe national halothane studydemanded halothane hepatitis controversy must move final stage epidemiological investigation experimental epidemiology investigating effects multiple administrations drugnan
no_relation,Paclitaxel,tumor,9925253,paclitaxel preferentially cytotoxic human cervical tumor cells low raf kinase activity implications paclitaxel based chemoradiation regimensnan
no_relation,paclitaxel,tumor,9925253,low raf kinase activity reported associated radioresistance epithelial tumor cell lines paclitaxel sensitivity cervical tumor cellsnan
no_relation,Paclitaxel,tumors,9925253,paclitaxel might thus effective eliminating radioresistant clones cervical tumors even absence synergistic interaction therapeutic modalitiesnan
no_relation,paclitaxel,tumor,9925253,thus established relationship raf kinase activity radiosensitivity human cervical tumor cells determined paclitaxel preferentially cytotoxic radioresistant tumor clonesnan
no_relation,paclitaxel,tumor,9925253,established contrasted radiation paclitaxel sensitivity human cervical tumor clones exhibited wide range raf kinase activitynan
no_relation,Paclitaxel,tumor,9925253,paclitaxel preferentially cytotoxic radioresistant tumor clones level paclitaxel induced cytotoxicity significantly  influenced raf kinase activity levelsnan
yes_direct,Paclitaxel,cytotoxicity,9925253,paclitaxel preferentially cytotoxic radioresistant tumor clones level paclitaxel induced cytotoxicity significantly  influenced raf kinase activity levelsnan
no_relation,paclitaxel,tumor,9925253,vitro data indicate marked completely opposite raf kinase dependencies radiation paclitaxel cytotoxicity cervical tumor cellsnan
no_relation,paclitaxel,cytotoxicity,9925253,vitro data indicate marked completely opposite raf kinase dependencies radiation paclitaxel cytotoxicity cervical tumor cellsnan
no_relation,paclitaxel,squamous cell carcinoma of the cervix,9925253,use combined paclitaxel radiotherapy treatment may thus lead higher local control rates squamous cell carcinoma cervix nan
no_relation,paclitaxel,tumor,9925253,circumstantially data suggest greatest therapeutic gains might accrue paclitaxel administered greatest proportion tumor clones low raf kinase activitynan
no_relation,glutathione,tumor,9988757,molecular mechanism regulation glutathione synthesis tumor necrosis factoralpha dexamethasone human alveolar epithelial cellsnan
no_relation,dexamethasone,necrosis,9988757,molecular mechanism regulation glutathione synthesis tumor necrosis factoralpha dexamethasone human alveolar epithelial cellsnan
no_relation,glutathione,necrosis,9988757,molecular mechanism regulation glutathione synthesis tumor necrosis factoralpha dexamethasone human alveolar epithelial cellsnan
no_relation,dexamethasone,tumor,9988757,molecular mechanism regulation glutathione synthesis tumor necrosis factoralpha dexamethasone human alveolar epithelial cellsnan
no_relation,GSH,tumor,9988757,studied regulation gsh synthesis response proinflammatory cytokine tumor necrosis factoralpha tnfalpha antiinflammatory agent dexamethasone human alveolar epithelial cellsnan
no_relation,dexamethasone,necrosis,9988757,studied regulation gsh synthesis response proinflammatory cytokine tumor necrosis factoralpha tnfalpha antiinflammatory agent dexamethasone human alveolar epithelial cellsnan
no_relation,GSH,necrosis,9988757,studied regulation gsh synthesis response proinflammatory cytokine tumor necrosis factoralpha tnfalpha antiinflammatory agent dexamethasone human alveolar epithelial cellsnan
no_relation,dexamethasone,tumor,9988757,studied regulation gsh synthesis response proinflammatory cytokine tumor necrosis factoralpha tnfalpha antiinflammatory agent dexamethasone human alveolar epithelial cellsnan
no_relation,prednisone,heart failure,10077512, patients active inflammation received prednisone mg kg weeks followed mg kg months azathioprine mg kg months addition conventional drug therapy heart failure nan
no_relation,azathioprine,heart failure,10077512, patients active inflammation received prednisone mg kg weeks followed mg kg months azathioprine mg kg months addition conventional drug therapy heart failure nan
no_relation,prednisone,inflammation,10077512, patients active inflammation received prednisone mg kg weeks followed mg kg months azathioprine mg kg months addition conventional drug therapy heart failurenan
no_relation,azathioprine,inflammation,10077512, patients active inflammation received prednisone mg kg weeks followed mg kg months azathioprine mg kg months addition conventional drug therapy heart failurenan
no_relation,MIBG,Carcinoid tumours/breast cancer,10197087,carcinoid tumours presenting breast cancer utility radionuclide imaging mibg indtpa pentetreotidenan
no_relation,pentetreotide,Carcinoid tumours/breast cancer,10197087,carcinoid tumours presenting breast cancer utility radionuclide imaging imibg indtpa pentetreotide nan
no_relation,fluorescein,asphyxia,10197511,superfusion paf cortex induced dosedependent increase leukocyte adherence cerebral venules leakage fluorescein  micromoll paf magnitude adherence bbb breakdown similar seen reoxygenation minutes asphyxia nan
no_relation,spiperone,schizophrenia,10202608,spiperone binding lymphocytes neurolepticnaive schizophrenia effect neuroleptic treatmentnan
no_relation,spiperone,schizophrenic/schizophrenia,10202608,aim study determine whether spiperone binding lymphocytes could serve biological marker susceptibility schizophrenia schizophrenic spectrum disorders measure response neuroleptic treatmentnan
no_relation,spiperone,schizotypal personality disorder,10202608,lymphocyte spiperone binding parameters bmax kd assessed patients schizophrenia patients schizotypal personality disorder neuroleptic naive age sexmatched control subjectsnan
no_relation,spiperone,schizophrenia,10202608,lymphocyte spiperone binding parameters bmax kd assessed patients schizophrenia patients schizotypal personality disorder neuroleptic naive age sexmatched control subjectsnan
no_relation,actinomycin,localized disease,10212915,seven patients localized disease stage iii six surviving patients received chemotherapy vincristine actinomycin patient received radiotherapynan
no_relation,vincristine,localized disease,10212915,seven patients localized disease stage iii six surviving patients received chemotherapy vincristine actinomycin patient received radiotherapynan
yes_direct,ACh/acetylcholine,AD/Alzheimer's disease,10332937,alzheimers disease ad associated deficiency acetylcholine ach forebrain correlates brain pathology cognitive dysfunctionnan
no_relation,ACh/acetylcholine,brain pathology,10332937,alzheimers disease ad associated deficiency acetylcholine ach forebrain correlates brain pathology cognitive dysfunctionnan
no_relation,ACh/acetylcholine,cognitive dysfunction,10332937,alzheimers disease ad associated deficiency acetylcholine ach forebrain correlates brain pathology cognitive dysfunction nan
no_relation,Donepezil,HCI,10332937,donepezil hci represents new chemical class ache inhibitors piperidinesnan
no_relation,piperidines,HCI,10332937,donepezil hci represents new chemical class ache inhibitors piperidines nan
no_relation,donepezil,AD,10332937,clinical trials donepezil shown improve significantly cognition global function patients mild moderately severe ad demonstrated excellent tolerability safety profilenan
no_relation,donepezil,AD,10332937,benefits well simple oncedaily dosing regimen make donepezil viable therapeutic option ad patientsnan
no_relation,androgen,prostate cancer,10337657,effect total androgen ablation pathologic stage resection limit status prostate cancer nan
no_relation,androgen,PCa/prostate cancer,10337657,undertook present analysis evaluate effect nht pathologic stage pca resection limit status patients prostate cancer treated total androgen ablation either three six months rpnan
no_relation,androgen,tumours,10337657, patients clinical stage whereas clinical stage three months total androgen ablation pathological stage prevalent among patients clinical tumours compared untreated patients treated patients vs untreatednan
no_relation,tyrosine,tumors,10359528,northern western blots tyrosine phosphorylation analysis showed hgf receptor overexpressed functional five tumors well two additional tumors nan
no_relation,chromium,dermatitis,10382555,therapeutic review ascorbic acid value chromium poisoning chromium dermatitis nan
yes_direct,chromium,poisoning,10382555,therapeutic review ascorbic acid value chromium poisoning chromium dermatitisnan
no_relation,ascorbic acid,dermatitis,10382555,therapeutic review ascorbic acid value chromium poisoning chromium dermatitis nan
no_relation,ascorbic acid,poisoning,10382555,therapeutic review ascorbic acid value chromium poisoning chromium dermatitisnan
yes_direct,chromium(VI),ulcers,10382555,repeated topical exposure chromium(vi) may cause allergic contact dermatitis formation chrome ulcers nan
yes_direct,chromium(VI),allergic,10382555,repeated topical exposure chromium(vi) may cause allergic contact dermatitis formation chrome ulcersnanmay could make third option right well
yes_direct,chromium(VI),dermatitis,10382555,repeated topical exposure chromium(vi) may cause allergic contact dermatitis formation chrome ulcersnan
yes_direct,chromium(VI),skin burns,10382555,systemic toxicity may occur following ingestion chromium(vi) salt chromium(vi) induced skin burns inhalation chromium(vi) occurring occupationallynan
yes_direct,chromium(VI),toxicity,10382555,systemic toxicity may occur following ingestion chromium(vi) salt chromium(vi) induced skin burns inhalation chromium(vi) occurring occupationallynan
no_relation,chromium(VI),poisoning,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
no_relation,ascorbic acid,dermatitis,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
no_relation,ascorbic acid,poisoning,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
no_relation,chromium,dermatitis,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
no_relation,chromium,poisoning,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
no_relation,chromium(VI),dermatitis,10382555,administration exogenous ascorbic acid advocated therefore treatment systemic chromium poisoning chromium dermatitis enhance extracellular reduction chromium(vi) less bioavailable chromiumiiinan
yes_direct,ascorbic acid,toxicity,10382555,however administration parenteral ascorbic acid hours parenteral chromate experimental studies protect renal damage parenteral ascorbic acid given hours postparenteral chromate increased toxicity nan
no_relation,ascorbic acid,renal damage,10382555,however administration parenteral ascorbic acid hours parenteral chromate experimental studies protect renal damage parenteral ascorbic acid given hours postparenteral chromate increased toxicitynan
yes_direct,chromium,poisoning,10382555,addition confirmed clinical evidence administration ascorbic acid lessens morbidity mortality systemic chromium poisoning nan
no_relation,ascorbic acid,poisoning,10382555,addition confirmed clinical evidence administration ascorbic acid lessens morbidity mortality systemic chromium poisoning nanchromium poisoning poisoning
no_relation,ascorbic acid,ulcers,10382555,topical ascorbic acid claimed reduce significantly healing time experimentally induced chrome ulcers guinea pigsnan
no_relation,ascorbic acid,dermatitis,10382555,several case reports suggest topical ascorbic acid effective management chromium dermatitis confirmed controlled clinical trials moreover practical difficulties frequent application likely limit usefulnessnan
no_relation,ascorbic acid,toxicity,10382555,based experimental studies substantial amounts ascorbic acid would need administered preferably parenterally soon exposure prevent systemic toxicity chromium(vi) humansnan
yes_direct,chromium(VI),toxicity,10382555,based experimental studies substantial amounts ascorbic acid would need administered preferably parenterally soon exposure prevent systemic toxicity chromium(vi) humansnan
no_relation,ascorbic acid,renal failure,10382555,however ascorbic acid metabolic precursor oxalate administration ascorbic acid high dose could lead acute oxalate nephropathy particularly presence renal failure nan
yes_direct,ascorbic acid,acute oxalate nephropathy,10382555,however ascorbic acid metabolic precursor oxalate administration ascorbic acid high dose could lead acute oxalate nephropathy particularly presence renal failurenan
yes_direct,chromium,poisoning,10382555,smaller doses ascorbic acid eg intravenously toxic doses probably reduce mortality systemic chromium poisoning nan
no_relation,ascorbic acid,poisoning,10382555,smaller doses ascorbic acid eg intravenously toxic doses probably reduce mortality systemic chromium poisoning nan
no_relation,ascorbic acid,toxicity,10382555,currently insufficient evidence advocate use ascorbic acid management systemic chromium toxicity nan
yes_direct,chromium,toxicity,10382555,currently insufficient evidence advocate use ascorbic acid management systemic chromium toxicity nan
no_relation,cholesterol,ischemic,10383804,acute ischemic events treatment period persistently elevated serum cholesterol thereafter observations particular concern patients underlying basic mechanisms unknown datenan
no_relation,etoposide,testicular cancer,10383804,evaluate etoposide part standard treatment testicular cancer potential cause atherogenesis experimental modelnan
no_relation,linoleic acid,tumor/cancer,10386321,conjugated linoleic acid inhibits growth number human cancer cell lines suppresses chemicallyinduced tumor development number sites animal modelsnan
no_relation,linoleic acid,tumors,10386321,little dietary conjugated linoleic acid inhibits development rat mammary tumors independent amount type fat dietnan
no_relation,sphingosine,suppression of carcinogenesis,10386321,sphingomyelin metabolites ceramide sphingosine participates multiple antiproliferative pathways associated suppression carcinogenesis nan
no_relation,auristatin PE,Waldenstrom's macroglobulinemia,10402249,new tubulin polymerization inhibitor auristatin pe induces tumor regression human waldenstroms macroglobulinemia xenograft modelnan
no_relation,auristatin PE,tumor,10402249,new tubulin polymerization inhibitor auristatin pe induces tumor regression human waldenstroms macroglobulinemia xenograft modelnan
no_relation,auristatin PE,tumor,10402249,study investigated anti tumor effects auristatin pe structural modification marine shellless mollusk peptide constituent dolastatin nan
no_relation,Auristatin PE,WM,10402249,auristatin pe dolastatin added triplicate wells cell count viability assessed  results showed agents active wsu wm able induce complete growth inhibition pgmlnan
no_relation,auristatin PE,Tumor,10402249,tumor growth inhibition tc tumor growth delay tc log kill auristatin pe dolastatin  days  days respectivelynan
no_relation,auristatin PE,tumor,10402249,activity auristatin pe evaluated tumor types clinical trialsnan
no_relation,vitamin E,cataract,10420210,role past intake vitamin early cataract changesnan
no_relation,vitamin E,cataract,10420210,examined association prior supplementation vitamin early cataract changes volunteers currently enrolled crosssectional vecat studynan
no_relation,Vitamin E,Cataract,10420210,vitamin cataract prevention study vecat clinical trial currently progress designed assess affect vitamin supplementation development progression cataract agerelated macular degenerationnan
no_relation,Vitamin E,macular degeneration,10420210,vitamin cataract prevention study vecat clinical trial currently progress designed assess affect vitamin supplementation development progression cataract agerelated macular degeneration nan
no_relation,vitamin E,nuclear opacity/NO,10420210,levels nuclear opacity  statistically different reported intake prior vitamin supplementationnan
no_relation,vitamin E,cataracts,10420210,prior vitamin supplementation may protect vecat participants developing least early cortical cataracts nan
no_relation,acetylcholine,trachea,10422636,modulation acetylcholine release parasympathetic nerves innervating guineapig human trachea endomorphin nan
no_relation,naloxone,trachea,10422636,endomorphin muopioid receptor agonists produced concentrationdependent naloxone sensitive inhibition cholinergic contractile responses guineapig trachea microm    respectivelynan
no_relation,acetylcholine,trachea,10422636,endomorphin also inhibited electricallyevoked acetylcholine release cholinergic nerves innervating guineapig microm   microm  respectively human trachea microm    respectivelynan
no_relation,Naloxone,trachea,10422636,naloxone prevented inhibition endomorphin guineapig human trachea suggesting peptides inhibit cholinergic parasympathetic neurotransmission airways via activation classical opioid receptorsnan
yes_direct,misoprostol,fetal distress,10454679,trials also indicate increased frequencies meconium passage neonatal acidemia cesarean delivery fetal distress women receiving higher doses misoprostol nan
yes_direct,misoprostol,acidemia,10454679,trials also indicate increased frequencies meconium passage neonatal acidemia cesarean delivery fetal distress women receiving higher doses misoprostol nan
no_relation,nitric oxide,asthma,10461936,circadian variation exhaled nitric oxide nocturnal asthma nan
no_relation,nitric oxide,inflammation,10461936,exhaled nitric oxide eno measurement appears noninvasive marker airway inflammation examined hypothesis eno would increase nightnan
yes_direct,nitric oxide,asthma,10461936,significant decrease eno nocturnal asthma may reflect important chronobiological defect endogenous production andor increased disposition nitric oxide view bronchodilator action could play role nocturnal exacerbations asthma nan
no_relation,cyclosporin,neurological involvement,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,prednisolone,neurological involvement,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,cyclosporin,Cogan's syndrome,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,prednisolone,inflammation,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,prednisolone,Cogan's syndrome,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,cyclosporin,inflammation,10464564,describe case cogans syndrome neurological involvement early treatment combination therapy prednisolone cyclosporin failed bring ear inflammation controlnan
no_relation,testosterone,osteoporosis,10468898,effects testosterone osteoporosis mennan
no_relation,testosterone,osteoporosis,10468898,although pathogenesis osteoporosis men multifactorial testosterone known play important role maintenance male skeletonnan
no_relation,Testosterone,hypogonadal osteoporosis,10468898,testosterone replacement therapy improves bone density men hypogonadal osteoporosis particularly epiphyses still opennan
no_relation,testosterone,idiopathic osteoporosis,10468898,wellestablished treatment idiopathic osteoporosis men testosterone supplementation may prove usefulnan
no_relation,nitric oxide,hyperoxia,10471386,effects exogenous nitric oxide hyperoxia lung fibroblast viability dna fragmentationnan
no_relation,NO,cytotoxicity,10471386,primary cultures normal human lung fibroblasts exposed room air ra oxygen either  ppm blended ra blended incubated  cell viability determined fluorescence viability cytotoxicity assay dna fragmentation tunel assaynan
no_relation,oxygen,cytotoxicity,10471386,primary cultures normal human lung fibroblasts exposed room air ra oxygen either  ppm blended ra blended incubated  cell viability determined fluorescence viability cytotoxicity assay dna fragmentation tunel assaynan
no_relation,O(2),cytotoxicity,10471386,primary cultures normal human lung fibroblasts exposed room air ra oxygen either  ppm blended ra blended o(2) incubated  cell viability determined fluorescence viability cytotoxicity assay dna fragmentation tunel assaynan
no_relation,corticosteroids,pneumocystis pneumonia,10498175,clinical picture consistent pneumocystis pneumonia antibiotic therapy corticosteroids initiatednan
yes_direct,steroids,cryptococcosis,10498175,sudden rapid deterioration death rare consequences disseminated cryptococcosis steroids may worsen course diseasenan
no_relation,steroids,death,10498175,sudden rapid deterioration death rare consequences disseminated cryptococcosis steroids may worsen course diseasenan
no_relation,Midazolam,status epilepticus,10516875,midazolam treatment acute refractory status epilepticus nan
yes_direct,barbiturates,respiratory depression,10516875,refractory gcse often difficult treat traditional therapy barbiturates induces hypotension respiratory depression prolongs recoverynan
yes_direct,barbiturates,hypotension,10516875,refractory gcse often difficult treat traditional therapy barbiturates induces hypotension respiratory depression prolongs recoverynan
no_relation,barbiturates,GCSE,10516875,refractory gcse often difficult treat traditional therapy barbiturates induces hypotension respiratory depression prolongs recoverynan
no_relation,Midazolam,GCSE,10516875,midazolam particularly useful treating acute gcse imidazole ring open low ph allowing dissolved aqueous solution intramuscular injection closed physiologic ph increasing lipophilicity rendering good intramuscular absorption brain penetration fast onset actionnan
no_relation,imidazole,GCSE,10516875,midazolam particularly useful treating acute gcse imidazole ring open low ph allowing dissolved aqueous solution intramuscular injection closed physiologic ph increasing lipophilicity rendering good intramuscular absorption brain penetration fast onset actionnan
yes_direct,midazolam,less hypotension,10516875,refractory gcse continuous iv midazolam infusion mgkghr mgkg iv bolus effective advantages traditional therapies induces less hypotension cardiorespiratory depression easily titratednananother ambiguous one chemical induce less disease mean causes disease probably much
no_relation,midazolam,GCSE,10516875,refractory gcse continuous iv midazolam infusion mgkghr mgkg iv bolus effective advantages traditional therapies induces less hypotension cardiorespiratory depression easily titratednan
no_relation,midazolam,cardiorespiratory depression,10516875,refractory gcse continuous iv midazolam infusion mgkghr mgkg iv bolus effective advantages traditional therapies induces less hypotension cardiorespiratory depression easily titratednan
no_relation,13-cis-retinoic acid,high-risk neuroblastoma,10519894,treatment highrisk neuroblastoma intensive chemotherapy radiotherapy autologous bone marrow transplantation cisretinoic acid nan
no_relation,terbinafine,tinea pedis,10546490,effectiveness treatment severe tinea pedis terbinafine cream members japanese selfdefense forcesnan
no_relation,terbinafine,tinea pedis,10546490,clinical study conducted determine efficacy terbinafine cream severe cases tinea pedis nan
no_relation,terbinafine,tinea pedis,10546490,results suggested terbinafine cream beneficial topical antifungal cream severe tinea pedis nan
yes_direct,mibefradil,Tacrolimus toxicity,10549098,tacrolimus toxicity due drug interaction mibefradil patient liver transplantationnan
yes_direct,Tacrolimus,Tacrolimus toxicity,10549098,tacrolimus toxicity due drug interaction mibefradil patient liver transplantationnan
no_relation,cyclosporin A,psoriasis,10559581,effects cyclosporin immune activation markers patients active psoriasis nan
no_relation,cyclosporin A/CsA,psoriasis,10559581,objective work investigate presence cellular soluble activation molecules blood patients psoriasis responding local treatment study effect cyclosporin csa markersnan
no_relation,CsA,psoriasis,10559581,although evidence systemic immune activation psoriasis silr consistently increased activation marker related th immune response may used marker monitoring disease activity response treatment csa psoriatic patientsnan
no_relation,somatostatin,bleeding,10567788,efficacy somatostatin octreotide widely studied control bleeding oesophageal varicesnan
no_relation,octreotide,bleeding,10567788,efficacy somatostatin octreotide widely studied control bleeding oesophageal varicesnan
no_relation,somatostatin,bleeding/haemorrhage,10567788,results recent studies indicated somatostatin effective treatment control nonvariceal ugi bleeding highrisk patients ie haemorrhage cease spontaneously likely recurnan
no_relation,somatostatin,bleeding,10567788,efficacy somatostatin controlling bleeding patients nonvariceal ugi bleeding high risk mortality upon admission rebleeding following endoscopy coupled excellent safety tolerability profile suggests may valuable therapeutic option management nonvariceal bleeding nan
no_relation,triglycerides,Hypertensive,10585306,hypertensive patients microalbuminuria manifest greater levels blood pressure particularly night higher serum levels cholesterol triglycerides uric acid patients normal uaenan
no_relation,cholesterol,Hypertensive,10585306,hypertensive patients microalbuminuria manifest greater levels blood pressure particularly night higher serum levels cholesterol triglycerides uric acid patients normal uaenan
no_relation,uric acid,Hypertensive,10585306,hypertensive patients microalbuminuria manifest greater levels blood pressure particularly night higher serum levels cholesterol triglycerides uric acid patients normal uaenan
no_relation,perfluorooctanoic acid,hepatoma,10590214,effects rodent peroxisome proliferator hepatocarcinogen perfluorooctanoic acid apoptosis human hepatoma hepg cellsnan
no_relation,PFOA,hepatoblastoma,10590214,present study demonstrate treatment human hepatoblastoma hepg cells pfoa induces apoptosis well perturbs cell cyclenan
no_relation,propidium iodide,typical nucleosomal fragmentation,10590214,apoptosis characterized electron microscopy revealed typical nucleosomal fragmentation also observed dna ladder upon electrophoresis agarose quantitated using propidium iodide staining cellular dna terminal deoxynucleotidyl transferasemediated dutp nick end labeling tunel assaynan
yes_direct,PFOA,necrosis,10590214,findings indicate presence high concentrations pfoa long times hepg cells undergo primary secondary necrosis nan
no_relation,inositol,APS,10624568,data suggest strategy development therapeutic agents aps may based use small cyclic organic oligoanions inositol derivatives act ligands lysine residues pl binding site beta gpinan
no_relation,tyrosine,hematopoiesis,10640965,retrospective study conducted quantitate plasma levels cytokines regulating hematopoiesis namely stimulatory fmslike tyrosine kinase fltl stem cell factor scf inhibitory growth factors tumor necrosis factoralpha tnfalpha tumor growth factorbeta macrophage inflammatory protein mipalpha immunoassay patients enrolled clinical trials garden state cancer center belleville new jerseynan
no_relation,tyrosine,necrosis,10640965,retrospective study conducted quantitate plasma levels cytokines regulating hematopoiesis namely stimulatory fmslike tyrosine kinase fltl stem cell factor scf inhibitory growth factors tumor necrosis factoralpha tnfalpha tumor growth factorbeta macrophage inflammatory protein mipalpha immunoassay patients enrolled clinical trials garden state cancer center belleville new jerseynan
no_relation,tyrosine,tumor,10640965,retrospective study conducted quantitate plasma levels cytokines regulating hematopoiesis namely stimulatory fmslike tyrosine kinase fltl stem cell factor scf inhibitory growth factors tumor necrosis factoralpha tnfalpha tumor growth factorbeta macrophage inflammatory protein mipalpha immunoassay patients enrolled clinical trials garden state cancer center belleville new jerseynan
yes_indirect,isocyanates,asthma,10642416,animal studies suggested skin exposure isocyanates may important risk factor respiratory sensitization leading asthma nan
no_relation,steroids,structural damage,10646028,following steroids hydroxyurea administration lesions mri disappeared suggesting pathogenetic mechanism reversible cause significant structural damage nan
no_relation,hydroxyurea,structural damage,10646028,following steroids hydroxyurea administration lesions mri disappeared suggesting pathogenetic mechanism reversible cause significant structural damage nan
no_relation,Ramosetron,postoperative nausea and vomiting,10648342,ramosetron preventing postoperative nausea vomiting women undergoing gynecological surgerynan
no_relation,ramosetron,PONV/prevention of postoperative nausea and vomiting,10648342,prospective randomized doubleblinded placebocontrolled trial evaluated efficacy ramosetron three different doses  mg prevention postoperative nausea vomiting ponv gynecological surgerynan
no_relation,ramosetron,PONV,10648342,conclusion ramosetron mg effective antiemetic preventing ponv anesthesia female patients undergoing gynecological surgerynan
no_relation,ramosetron,postoperative nausea and vomiting,10648342,randomized doubleblinded placebocontrolled trial women found effective dose ramosetron preventing postoperative nausea vomiting gynecological surgery mgnan
no_relation,corticosteroids,bronchial asthma,10660975,study fluticasone propionate efficacy treatment patients bronchial asthma controlled inhaled corticosteroids nan
no_relation,fluticasone propionate,bronchial asthma,10660975,study fluticasone propionate efficacy treatment patients bronchial asthma controlled inhaled corticosteroidsnan
no_relation,corticosteroids,bronchial asthma/BA,10660975,aim study test fluticasone propionate fp efficacy treatment patients bronchial asthma ba controlled high doses mg inhaled corticosteroids nan
no_relation,fluticasone propionate,bronchial asthma/BA,10660975,aim study test fluticasone propionate fp efficacy treatment patients bronchial asthma ba controlled high doses mg inhaled corticosteroidsnan
no_relation,corticosteroids,BA,10660975,results demonstrate improved efficacy fp vs high doses inhaled corticosteroids treatment moderate persistent severe forms ba nan
no_relation,Caffeine,hypoventilation,10666980,caffeine affect velocity middle cerebral artery hyperventilation hypoventilation thinking transcranial doppler studynan
no_relation,caffeine,hypoventilation,10666980,timecourse analyses showed vmca followed triphasic pattern increase baselines hypoventilation regardless caffeine condition slowed baselines hyperventilation degree slowing attenuated caffeine  increased baselines cognitive activities ranges nan
no_relation,cAMP,hypotonic challenge,10673540,hypotonic challenge camp stimulation found induce release atp measured luciferinluciferase assay murine mammary carcinoma cell line ci cells stably transfected cdna human cystic fibrosis transmembrane conductance regulator cftr protein ccftrnan
no_relation,cAMP,carcinoma,10673540,hypotonic challenge camp stimulation found induce release atp measured luciferinluciferase assay murine mammary carcinoma cell line ci cells stably transfected cdna human cystic fibrosis transmembrane conductance regulator cftr protein ccftrnan
no_relation,ATP,hypotonic challenge,10673540,hypotonic challenge camp stimulation found induce release atp measured luciferinluciferase assay murine mammary carcinoma cell line ci cells stably transfected cdna human cystic fibrosis transmembrane conductance regulator cftr protein ccftrnan
no_relation,ATP,carcinoma,10673540,hypotonic challenge camp stimulation found induce release atp measured luciferinluciferase assay murine mammary carcinoma cell line ci cells stably transfected cdna human cystic fibrosis transmembrane conductance regulator cftr protein ccftrnan
no_relation,ATP,hypotonic,10673540,cftr expression augmented swellinginduced atp release times hypotonic conditions nan
no_relation,Raloxifene,Fracture,10714731,two randomized doubleblind placebocontrolled trials us clinical research centers fracture intervention trial centers united states countries multiple outcomes raloxifene evaluation trialnan
no_relation,Raloxifene/raloxifene hydrochloride,Fracture,10714731,postmenopausal women low bmd assigned treatment mgd alendronate sodium fracture intervention trial completed years bmd monitoring adhered study medication  postmenopausal women osteoporosis assigned treatment  mgd raloxifene hydrochloride multiple outcomes raloxifene evaluation trial similarly completed years monitoring adhering study medication nan
no_relation,Raloxifene/raloxifene hydrochloride,BMD/osteoporosis,10714731,postmenopausal women low bmd assigned treatment mgd alendronate sodium fracture intervention trial completed years bmd monitoring adhered study medication  postmenopausal women osteoporosis assigned treatment  mgd raloxifene hydrochloride multiple outcomes raloxifene evaluation trial similarly completed years monitoring adhering study medication nan
no_relation,alendronate sodium,BMD/osteoporosis,10714731,postmenopausal women low bmd assigned treatment mgd alendronate sodium fracture intervention trial completed years bmd monitoring adhered study medication  postmenopausal women osteoporosis assigned treatment  mgd raloxifene hydrochloride multiple outcomes raloxifene evaluation trial similarly completed years monitoring adhering study medication nan
no_relation,alendronate sodium,Fracture,10714731,postmenopausal women low bmd assigned treatment mgd alendronate sodium fracture intervention trial completed years bmd monitoring adhered study medication  postmenopausal women osteoporosis assigned treatment  mgd raloxifene hydrochloride multiple outcomes raloxifene evaluation trial similarly completed years monitoring adhering study medication nan
no_relation,alendronate,BMD,10714731,specifically among women taking alendronate whose hip bmd decreased first year  confidence interval ci increases hip bmd second year overall mean increase nan
no_relation,raloxifene,BMD,10714731,data suggest women lose bmd first year treatment alendronate raloxifene gain bmd treatment continued second yearnan
no_relation,alendronate,BMD,10714731,data suggest women lose bmd first year treatment alendronate raloxifene gain bmd treatment continued second yearnan
yes_direct,5-fluorouracil,excessive lacrimation,10726804,ocular side effects systemic 5-fluorouracil therapy include excessive lacrimation often resolves cessation therapynan
yes_direct,5-fluorouracil,stenosis,10726804,severe stenosis puncta canaliculi may associated prolonged systemic 5-fluorouracil therapynan
yes_direct,5-fluorouracil,ocular toxicity,10726804,important oncologist ophthalmologist aware potential ocular toxicity 5-fluorouracil nan
no_relation,Cr,tumor,10757446,improved model tumor angiogenesis determined measuring blood volume area skin held contact tumor cellcontaining chamber using cr labeled red blood cells rbcnan
no_relation,Cr,angiogenesis,10757446,improved model tumor angiogenesis determined measuring blood volume area skin held contact tumor cellcontaining chamber using cr labeled red blood cells rbcnan
no_relation,borrelidin,angiogenesis,10757446,using improved model confirmed tnp wellknown inhibitor borrelidin antibiotic streptomyces rochei significantly inhibited widr cellinduced angiogenesis nan
no_relation,Borrelidin,angiogenesis,10757446,borrelidin also inhibited spontaneous lung metastasis bbl melanoma dose inhibited angiogenesis nan
no_relation,Borrelidin,melanoma,10757446,borrelidin also inhibited spontaneous lung metastasis bbl melanoma dose inhibited angiogenesisnan
no_relation,rapamycin,AML,10764145,inhibition pskinase rapamycin increase druginduced apoptosis pikinase inhibition resulted notable dephosphorylation pkb suggesting pikinasepkb survival pathway may play major role chemoresistance aml nan
no_relation,5-azadeoxycytidine/5-aza-dC,PWS,10775525,furthermore treatment pws cells dna methyltransferase inhibitor azadeoxycytidine azadc induced demethylation snurfsnrpn cpg island restoration gene expression maternal allelenan
no_relation,polyphenols,Cancer,10786933,cancer chemoprevention tea polyphenols nan
no_relation,polyphenol,carcinogenesis,10786933,inhibitory effects tea carcinogenesis attributed biologic activities polyphenol fraction teanankey term
no_relation,polyphenols,tumor,10786933,review summarizes experimental data chemopreventive effects tea polyphenols various tumor bioassay systemsnan
no_relation,(-)-epigallocatechin-3-gallate/EGCG,carcinogenesis,10786933,many laboratory studies demonstrated inhibitory effects green tea polyphenols especially epigallocatechingallate egcg carcinogenesis animals modelsnan
no_relation,polyphenols,carcinogenesis,10786933,many laboratory studies demonstrated inhibitory effects green tea polyphenols especially epigallocatechingallate egcg carcinogenesis animals modelsnan
no_relation,polyphenols,skin tumor,10786933,majority studies conducted mouse skin tumor models tea polyphenols used either oral feeding drinking water direct local applicationnan
no_relation,polyphenols,tumor,10786933,studies used otetradecanoylphorbolacetate tpa ultraviolet uv radiation tumor promoter found anticarcinogenic effects caused green tea polyphenols nan
no_relation,12-O-tetradecanoylphorbol-13-acetate/TPA,tumor,10786933,studies used otetradecanoylphorbolacetate tpa ultraviolet uv radiation tumor promoter found anticarcinogenic effects caused green tea polyphenolsnan
no_relation,Caffeine,tumorigenesis,10786933,caffeine tea also important tea prevent tumorigenesis nan
no_relation,polyphenols,cancer,10786933,molecular mechanisms cancer chemopreventive effects tea polyphenols completely understoodnan
no_relation,polyphenols,tumor,10786933,likely related mechanisms biochemical actions tea polyphenols include antioxidative activities modulation xenobiotic metabolite enzymes inhibition tumor promotionnan
no_relation,polyphenols,cancer,10786933,addition also proposed tea polyphenols function cancer chemopreventive agents modulation mitotic signal transductionnan
no_relation,5-fluorouracil,colon carcinoma,10791849,relation thymidylate synthase expression survival colon carcinoma determination appropriate application 5-fluorouracil immunohistochemical methodnan
no_relation,5-FU/5-fluorouracil,colorectal carcinoma,10791849,thymidylate synthase ts regarded parameter 5-fluorouracil 5-fu chemosensitivity colorectal carcinoma nan
no_relation,5-FU/5-fluorouracil,Thymidylate synthase/TS,10791849,thymidylate synthase ts regarded parameter 5-fluorouracil 5-fu chemosensitivity colorectal carcinomanan
no_relation,5-FU,colorectal carcinoma,10791849,recent researchers indicate chemosensitivity 5-fu colorectal carcinoma low expression ts better tumors high expression tsnan
no_relation,5-FU,tumors,10791849,recent researchers indicate chemosensitivity 5-fu colorectal carcinoma low expression ts better tumors high expression tsnan
no_relation,5-FU,TS,10791849,recent researchers indicate chemosensitivity 5-fu colorectal carcinoma low expression ts better tumors high expression ts nan
no_relation,5-FU,colon carcinoma,10791849,ts may prognostic factor colon carcinoma 5-fu adjuvant chemotherapy may appropriate colon carcinoma high expression tsnanused treatment
no_relation,5-FU,TS,10791849,ts may prognostic factor colon carcinoma 5-fu adjuvant chemotherapy may appropriate colon carcinoma high expression ts nan
no_relation,steroids,bronchiectasis,10796575,inhaled steroids bronchiectasis nan
no_relation,corticosteroid,bronchiectasis,10796575,cochrane airways group rct register cochrane controlled clinical trials register searched using following search terms bronchiectasis corticosteroid beclomethasone budesonide fluticasone triamcinolone flunisolidenan
no_relation,fluticasone,bronchiectasis,10796575,cochrane airways group rct register cochrane controlled clinical trials register searched using following search terms bronchiectasis corticosteroid beclomethasone budesonide fluticasone triamcinolone flunisolidenan
no_relation,triamcinolone,bronchiectasis,10796575,cochrane airways group rct register cochrane controlled clinical trials register searched using following search terms bronchiectasis corticosteroid beclomethasone budesonide fluticasone triamcinolone flunisolidenan
no_relation,flunisolide,bronchiectasis,10796575,cochrane airways group rct register cochrane controlled clinical trials register searched using following search terms bronchiectasis corticosteroid beclomethasone budesonide fluticasone triamcinolone flunisolide nan
no_relation,corticosteroids,bronchiectasis,10796575,bronchiectasis regular use inhaled corticosteroids may improve lung functionnan
yes_direct,corticosteroids,cataract,10808171,risk cataract among users intranasal corticosteroids nan
yes_direct,corticosteroid/corticosteroids,cataract,10808171,oral corticosteroid users increased risk cataract risk among intranasal corticosteroids users unknownnan
no_relation,steroids,cataract,10808171,purpose describe risk cataract among users intranasal steroids nanintranasal steroids steroids
yes_direct,steroids,cataract,10808171,retrospective observational cohort study cataract incidence conducted among users oral intranasal steroids identified united kingdombased general practice research database nested casecontrol analysis control confounding factorsnan
no_relation,corticosteroids,cataract,10808171,incidence rate cataract personyears among users intranasal corticosteroids similar incidence rate among nonusersnan
yes_direct,corticosteroid,cataract,10808171,however oral corticosteroid users higher risk cataract personyearsnan
no_relation,corticosteroids,Cataract,10808171,cataract risk increase number prior prescriptions intranasal corticosteroids nan
no_relation,corticosteroids,cataracts,10808171,use intranasal corticosteroids associated increased risk cataracts study populationnan
no_relation,tyrosine,diabetes,10820150,expression pancreatic islet mhc class insulin ica tyrosine phosphatase lowdose streptozotocininduced diabetes micenan
yes_direct,streptozotocin,diabetes,10820150,expression pancreatic islet mhc class insulin ica tyrosine phosphatase lowdose streptozotocin induced diabetes micenan
yes_direct,streptozotocin,diabetes mellitus,10820150,activated immune cells contribute development diabetes mellitus multiple lowdose streptozotocin treated micenan
no_relation,oestrogen,breast cancer,10823131,effect transforming growth factor beta oestrogen metabolism mcf breast cancer cell linenan
yes_direct,oestrogens,breast cancer,10823131,addition oestrogens play important role breast cancer development oestrone sulphate es might main source active oestrogens breastnan
yes_direct,oestrone sulphate,breast cancer,10823131,addition oestrogens play important role breast cancer development oestrone sulphate es might main source active oestrogens breastnan
no_relation,oestrogen,breast cancer,10823131,aim study assess effect tgfbeta oestrogen synthesis attempt understand mechanism tgfbeta may exert protective effect breast cancer nan
yes_direct,oestrogens,breast cancer,10823131,conclusion tgfbeta might exert protective role breast cancer reducing amount active oestrogens present breastnan
no_relation,olanzapine,schizophrenia,10831481,differential efficacy olanzapine deficit nondeficit negative symptoms schizophrenia nan
no_relation,olanzapine,deficit syndrome,10831481,authors examined effects olanzapine primary secondary negative symptoms patients severe negative symptoms deficit syndrome nan
no_relation,olanzapine,deficit syndrome,10831481,thirtynine outpatients schizophrenia severe negative symptoms assessed presence deficit syndrome entered week openlabel study olanzapine nan
no_relation,olanzapine,schizophrenia,10831481,thirtynine outpatients schizophrenia severe negative symptoms assessed presence deficit syndrome entered week openlabel study olanzapine nan
no_relation,olanzapine,schizophrenia,10831481,results study suggest olanzapine efficacious secondary negative symptoms schizophrenia fail support contention olanzapine direct beneficial effect primary negative symptomsnan
no_relation,vigabatrin,epilepsy,10894216,visual impairment children epilepsy treated vigabatrin nan
no_relation,vigabatrin,Visual impairment,10894216,visual impairment children epilepsy treated vigabatrin nan
no_relation,Vigabatrin,seizures,10894216,vigabatrin antiepileptic drug particularly useful drugresistant partial seizures infantile spasmsnan
no_relation,Vigabatrin,epileptic,10894216,vigabatrin anti epileptic drug particularly useful drugresistant partial seizures infantile spasmsnan
no_relation,Vigabatrin,spasms,10894216,vigabatrin antiepileptic drug particularly useful drugresistant partial seizures infantile spasms nan
yes_direct,vigabatrin,visual field constriction/VFC,10894216,recently vigabatrin induced visual field constriction vfc abnormal ocular electrophysiological studies reportednan
yes_direct,vigabatrin,VFC,10894216,summary half children treated vigabatrin demonstrated vfc abnormal ocular electrophysiological studiesnan
yes_direct,vigabatrin,toxicity,10894216,perimetry seemed sensitive modality identifying vigabatrin toxicity nan
no_relation,vigabatrin,seizures,10894216,although incidence vigabatrin induced vfc worrisome context intractable seizures infantile spasms therapeutic benefits must weighed risksnan
yes_direct,vigabatrin,VFC,10894216,although incidence vigabatrin induced vfc worrisome context intractable seizures infantile spasms therapeutic benefits must weighed risksnan
no_relation,vigabatrin,spasms,10894216,although incidence vigabatrin induced vfc worrisome context intractable seizures infantile spasms therapeutic benefits must weighed risksnan
no_relation,PCP,PCP,10896967,primary secondary carinii pneumonia prophylaxis discontinued patients first episode pcp occurred months episode recorded median followup monthsnan
no_relation,PCP,pneumonia,10896967,primary secondary carinii pneumonia prophylaxis discontinued patients first episode pcp occurred months episode recorded median followup monthsnan
no_relation,tegafur,toxicity,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,"5-chloro-2,4-dihydroxypyridine",toxicity,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnantoxicity actaully claimed"
no_relation,potassium oxonate,toxicity,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,5-FU/5-fluorouracil,toxicity,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil 5-fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,5-FU/5-fluorouracil,colorectal carcinoma,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil 5-fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,"5-chloro-2,4-dihydroxypyridine",colorectal carcinoma,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnanused possible treatment"
no_relation,potassium oxonate,colorectal carcinoma,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,tegafur,colorectal carcinoma,10901361,"study set evaluate patients metastatic colorectal carcinoma efficacy toxicity contains tegafur 5-chloro-2,4-dihydroxypyridine cdhp potassium oxonate based biochemical modulation 5-fluorouracil fu targeted inhibition dihydropyrimidine dehydrogenase dpdnan"
no_relation,leucovorin,toxicity,10901361,none patients treated outpatients required hospitalization due adverse reactions results suggest achieves similar responses infusional 5-fu plus leucovorin shows potential another biochemical modulation easily manageable toxicity nan
no_relation,5-FU,toxicity,10901361,none patients treated outpatients required hospitalization due adverse reactions results suggest achieves similar responses infusional 5-fu plus leucovorin shows potential another biochemical modulation easily manageable toxicity nan
no_relation,pilocarpine,ocular hypertension,10901475,additive intraocular pressurelowering effect latanoprost daily pilocarpine tid patients openangle glaucoma ocular hypertension month randomized multicenter studynan
no_relation,pilocarpine,open-angle glaucoma,10901475,additive intraocular pressurelowering effect latanoprost daily pilocarpine tid patients openangle glaucoma ocular hypertension month randomized multicenter studynan
no_relation,pilocarpine,ocular hypertension,10901475,compare additional intraocular pressurelowering effect latanoprost administered daily pilocarpine administered three times daily patients primary openangle glaucoma ocular hypertension currently monotherapy timolol twice dailynan
no_relation,timolol,open-angle glaucoma,10901475,compare additional intraocular pressurelowering effect latanoprost administered daily pilocarpine administered three times daily patients primary openangle glaucoma ocular hypertension currently monotherapy timolol twice dailynan
no_relation,timolol,ocular hypertension,10901475,compare additional intraocular pressurelowering effect latanoprost administered daily pilocarpine administered three times daily patients primary openangle glaucoma ocular hypertension currently monotherapy timolol twice dailynan
no_relation,pilocarpine,open-angle glaucoma,10901475,compare additional intraocular pressurelowering effect latanoprost administered daily pilocarpine administered three times daily patients primary openangle glaucoma ocular hypertension currently monotherapy timolol twice dailynan
no_relation,OH,POAG,10901475,month multicenter randomized openlabel study patients poag oh whose iop controlled timolol bid enrollednan
no_relation,timolol,POAG,10901475,month multicenter randomized openlabel study patients poag oh whose iop controlled timolol bid enrollednan
no_relation,formoterol fumarate,asthmatic,10904569,bronchodilatation effects dry powder formoterol fumarate asthmatic patientsnan
no_relation,formoterol fumarate,asthmatic,10904569,ten asthmatic patients enrolled study effects dry powder formoterol fumarate nan
no_relation,Prednisone,daily headache,10961766,prednisone initial treatment analgesicinduced daily headache nan
no_relation,prednisone,daily headache,10961766,study aimed analyse possibility using short course oral prednisone detoxifying patients chronic daily headache due medication overuse outpatient settingnan
no_relation,prednisone,rebound headaches,10961766,study demonstrates possible detoxify patients suffering rebound headaches using oral prednisone first days withdrawal outpatient settingnan
no_relation,Azithromycin,bronchitis,10983860,azithromycin versus pivampicillin treatment acute exacerbations chronic bronchitis singleblind doubledummy multicentre studynan
no_relation,pivampicillin,bronchitis,10983860,azithromycin versus pivampicillin treatment acute exacerbations chronic bronchitis singleblind doubledummy multicentre studynan
no_relation,azithromycin,bronchitis,10983860,singleblind doubledummy multicentre study compared oral azithromycin administered tablets mg daily days versus oral pivampicillin mg twice daily days adults acute exacerbations chronic bronchitis needing parenteral antibiotic therapy hospitalization oxygen supportnan
no_relation,pivampicillin,bronchitis,10983860,singleblind doubledummy multicentre study compared oral azithromycin administered tablets mg daily days versus oral pivampicillin  mg twice daily days adults acute exacerbations chronic bronchitis needing parenteral antibiotic therapy hospitalization oxygen supportnan
no_relation,oxygen,bronchitis,10983860,singleblind doubledummy multicentre study compared oral azithromycin administered tablets mg daily days versus oral pivampicillin mg twice daily days adults acute exacerbations chronic bronchitis needing parenteral antibiotic therapy hospitalization oxygen supportnan
no_relation,azithromycin,bronchitis,10983860,oral azithromycin regime effective treatment acute exacerbations chronic bronchitis similar efficacy longer pivampicillin regime may offer superior patient compliancenan
no_relation,pivampicillin,bronchitis,10983860,oral azithromycin regime effective treatment acute exacerbations chronic bronchitis similar efficacy longer pivampicillin regime may offer superior patient compliancenan
yes_direct,methotrexate,IBD,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
no_relation,cyclosporin,NHL,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
no_relation,azathioprine,NHL,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
no_relation,methotrexate,NHL,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
yes_direct,azathioprine,IBD,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
no_relation,cyclosporin,IBD,10986211,four cases nhl ibd cohort sir  ci received immunosuppressive therapy azathioprine methotrexate methotrexate cyclosporinnan
no_relation,Zaleplon,insomnia,11060714,zaleplon review novel sedative hypnotic used treatment insomnia nan
yes_direct,strychnine,convulsions,11060714,compound also reported active convulsions induced bicuculline picrotoxin strychnine nan
yes_direct,picrotoxin,convulsions,11060714,compound also reported active convulsions induced bicuculline picrotoxin strychninenan
yes_direct,bicuculline,convulsions,11060714,compound also reported active convulsions induced bicuculline picrotoxin strychninenan
yes_direct,zaleplon,reduction in sleep latency,11060714,results phase iiiii studies suggest zaleplon  mg produces dosedependent reduction sleep latency patients suffering primary insomnianan
no_relation,zaleplon,primary insomnia,11060714,results phase iiiii studies suggest zaleplon  mg produces dosedependent reduction sleep latency patients suffering primary insomnia nan
no_relation,triazolam,drug abuse,11060714,clinical efficacy zaleplon persists least four weeks doses mg mg studies patients history drug abuse suggest abuse potential zaleplon doses therapeutic dose range similar seen benzodiazepine triazolam nan
no_relation,benzodiazepine,drug abuse,11060714,clinical efficacy zaleplon persists least four weeks doses mg mg studies patients history drug abuse suggest abuse potential zaleplon doses therapeutic dose range similar seen benzodiazepine triazolamnan
no_relation,zaleplon,drug abuse,11060714,clinical efficacy zaleplon persists least four weeks doses mg mg studies patients history drug abuse suggest abuse potential zaleplon doses therapeutic dose range similar seen benzodiazepine triazolamnan
yes_direct,acetylcholine,spasm,11078314,major complications spasm provocation tests intracoronary injection acetylcholine nan
yes_direct,acetylcholine,spasm,11078314,spasm provocation test using acetylcholine performed carefully although considered safe reliable methodnan
no_relation,corticosteroids,atopic dermatitis,11096196,number patients atopic dermatitis refuse use topical corticosteroids personal fears seems increasingnan
no_relation,enalapril,congestive heart failure,11127445,outcome patients congestive heart failure treated standard versus high doses enalapril multicenter studynan
no_relation,enalapril,CHF/congestive heart failure,11127445,sought prospectively randomly compare survival clinical hemodynamic variables patients congestive heart failure chf treated standard versus high doses enalapril nan
no_relation,Angiotensin,CHF,11127445,angiotensin converting enzyme ace inhibitors produce hemodynamic symptomatic benefits patients chf still controversy optimal dose clinical settingnan
no_relation,enalapril,CHF,11127445,two hundred fortyeight patients advanced chf age years randomized receive maximal tolerated dose enalapril  mgday group mean dose achieved mgday  mgday group mean dose achieved mgday nan
no_relation,antithymocyte globulin,aplastic anemia,11144443,four patients aplastic anemia received intravenous antithymocyte globulin atg antilymphocyte globulin algnan
no_relation,ATG,aplastic anemia,11144443,four receive atg alg two aplastic anemia two bone marrow suppressionnan
no_relation,ATG,bone marrow suppression,11144443,four receive atg alg two aplastic anemia two bone marrow suppression nan
no_relation,cyclosporine,toxicity,11148681,although one large randomized study demonstrated proven survival advantage without increased toxicity using cyclosporine inconsistent results modulators raise doubt utility overall strategy using drug efflux blockers patients established pgp overexpressionnan
no_relation,vitamin D,breast cancer,11165041,interactions vitamin analogue cb tnfalpha ceramide breast cancer cell apoptosisnan
no_relation,CB1093,breast cancer,11165041,interactions vitamin analogue cb1093 tnfalpha ceramide breast cancer cell apoptosisnan
no_relation,vitamin D,tumour,11165041,mechanisms vitamin analogues promote apoptosis tumour cells unclearnan
no_relation,vitamin D,breast cancer,11165041,study examined possible interactions synthetic vitamin analogue cb1093 two known mediators apoptosis tnfalpha ceramide mcf td hst breast cancer cellsnan
no_relation,CB1093,breast cancer,11165041,study examined possible interactions synthetic vitamin analogue cb1093 two known mediators apoptosis tnfalpha ceramide mcf td hst breast cancer cellsnan
no_relation,vitamin D,breast cancer,11165041,results indicate cb1093 potentiates responsiveness breast cancer cells tnfalpha suggest ceramide andor cpla might involved downstream effectors vitamin mediated caspaseindependent cell deathnan
yes_direct,CB1093,breast cancer,11165041,results indicate cb1093 potentiates responsiveness breast cancer cells tnfalpha suggest ceramide andor cpla might involved downstream effectors vitamin dmediated caspaseindependent cell deathnan
no_relation,chloramphenicol,infections,11178339,sometimes penicillin chloramphenicol used successfully anaerobic infections nan
no_relation,penicillin G,infections,11178339,sometimes penicillin chloramphenicol used successfully anaerobic infections nan
no_relation,Iron,athletes,11183845,iron status female endurance athletes non athletes nan
no_relation,Iron,athletes,11183845,iron status studied female endurance athletes control subjects aged yearsnan
no_relation,iron,iron deficiency,11183845,study aimed identifying factors responsible iron deficiencynaniron cures irondeficiency
no_relation,iron,anemia,11183845,twentysix percent athletes controls latent iron deficiency without anemia symptomsnan
no_relation,iron,athletes,11183845,twentysix percent athletes controls latent iron deficiency without anemia symptomsnanathletes disease
no_relation,iron,iron-deficiency,11183845,twentysix percent athletes controls latent iron deficiency without anemia symptomsnan
yes_direct,iron,iron deficiency,11183845,low intake iron especially heme iron  mg daily nutrients influencing iron metabolism identified main causes iron deficiency control subjectsnan
no_relation,heme,iron deficiency,11183845,low intake iron especially heme iron mg daily nutrients influencing iron metabolism identified main causes iron deficiency control subjectsnan
no_relation,iron,iron deficiency,11183845,athletes whose iron intake sufficient mg principal cause iron deficiency blood losses due menstruationnan
no_relation,iron,athletes,11183845,athletes whose iron intake sufficient mg principal cause iron deficiency blood losses due menstruationnan
no_relation,iron,blood losses,11183845,athletes whose iron intake sufficient mg principal cause iron deficiency blood losses due menstruationnan
no_relation,iron,iron deficiency,11183845,high level physical activity expressed training volume experience adversely affect iron stores higher control subjects incidence iron deficiency much lower control groupnan
no_relation,iron,athletes,11183845,concluded increased intake iron dietary factors involved iron metabolism prevented possible exerciseinduced losses iron young athletes nan
yes_direct,diphenhydramine,toxicity,11204550,dosedependent toxicity diphenhydramine overdosenan
no_relation,diphenhydramine,overdose,11204550,dosedependent toxicity diphenhydramine overdose nan
no_relation,Diphenhydramine/DPHM,overdose,11204550,diphenhydramine dphm overdose frequent cause acute poisoningnan
yes_direct,Diphenhydramine/DPHM,poisoning,11204550,diphenhydramine dphm overdose frequent cause acute poisoning nan
no_relation,DPHM,toxicity,11204550,although clinical features well known information dosedependent toxicity dphm still scarcenan
no_relation,DPHM,toxicity,11204550,objective study investigate dosedependent toxicity dphm patients acute dphm poisoningnan
yes_direct,DPHM,poisoning,11204550,objective study investigate dosedependent toxicity dphm patients acute dphm poisoning nan
yes_direct,DPHM,toxicity,11204550,data demonstrate clear dosedependent acute toxicity dphm nan
yes_direct,DPHM,overdose,11204550,thus results contribute data basis required cost effective management patients dphm overdose nan
no_relation,Glatiramer acetate,MS,11223159,glatiramer acetate drug recently approved treatment ms therefore investigated effect glatiramer acetate rantes expression glial cells vitronan
no_relation,glatiramer acetate,diseases,11223159,results suggest glatiramer acetate may inhibit ilbetastimulated rantes expression human glial cells blocking nfkappab activation thus identifying part molecular basis antiinflammatory immunosuppressive effects demyelinating diseases nan
no_relation,cisplatin,non-small-cell lung cancer,11230476,duration chemotherapy advanced nonsmallcell lung cancer randomized trial three versus six courses mitomycin vinblastine cisplatin nan
no_relation,mitomycin,non-small-cell lung cancer,11230476,duration chemotherapy advanced nonsmallcell lung cancer randomized trial three versus six courses mitomycin vinblastine cisplatinnan
no_relation,vinblastine,non-small-cell lung cancer,11230476,duration chemotherapy advanced nonsmallcell lung cancer randomized trial three versus six courses mitomycin vinblastine cisplatinnan
no_relation,cisplatin,NSCLC,11230476,patients stage iiib iv nsclc randomized start treatment receive either three six courses mitomycin mgm courses   vinblastine mgm cisplatin mgm mvp every daysnan
no_relation,mitomycin,NSCLC,11230476,patients stage iiib iv nsclc randomized start treatment receive either three six courses mitomycin mgm courses   vinblastine mgm cisplatin mgm mvp every daysnanused treatment
no_relation,vinblastine,NSCLC,11230476,patients stage iiib iv nsclc randomized start treatment receive either three six courses mitomycin mgm courses   vinblastine mgm cisplatin mgm mvp every daysnan
no_relation,Y-27632,metastasis,11230737,inhibition intrahepatic metastasis human hepatocellular carcinoma rhoassociated protein kinase inhibitor y-27632 nan
no_relation,Y-27632,hepatocellular carcinoma,11230737,inhibition intrahepatic metastasis human hepatocellular carcinoma rhoassociated protein kinase inhibitor y-27632 nan
no_relation,Y-27632,metastasis,11230737,investigate whether specific prock inhibitor y-27632 could also inhibit intrahepatic metastasis effect y-27632 cell motility intrahepatic metastasis li investigatednan
no_relation,Y-27632,SCID,11230737,y-27632 administered continuously peritoneal cavity using microosmotic pump together orthotopic implantation li cells liver scid micenan
no_relation,Y-27632,tumor,11230737,primary tumor volume site injection smaller y-27632 treated group compared control group difference statistically significantnan
no_relation,Y-27632,tumor/tumors,11230737,histologically control tumors showed infiltrative growth sinusoidal area tumor boundary whereas y-27632 treated tumors showed expansive growth low invasivenessnan
no_relation,Y-27632,metastasis,11230737,findings confirm importance rhoprock signaling pathway intrahepatic metastasis human hcc indicate y-27632 may useful prevention intrahepatic metastasis human hccnan
no_relation,Y-27632,HCC,11230737,findings confirm importance rhoprock signaling pathway intrahepatic metastasis human hcc indicate y-27632 may useful prevention intrahepatic metastasis human hcc nan
no_relation,iron,melanoma,11243246,investigated survival two kinds human embryonic cells clv lu human melanoma cells mel exposed exogenous iron copper ions absence presence ascorbic acid catalase superoxide dismutasenan
no_relation,superoxide,melanoma,11243246,investigated survival two kinds human embryonic cells clv lu human melanoma cells mel exposed exogenous iron copper ions absence presence ascorbic acid catalase superoxide dismutasenan
no_relation,ascorbic acid,melanoma,11243246,investigated survival two kinds human embryonic cells clv lu human melanoma cells mel exposed exogenous iron copper ions absence presence ascorbic acid catalase superoxide dismutasenan
no_relation,copper,melanoma,11243246,investigated survival two kinds human embryonic cells clv lu human melanoma cells mel exposed exogenous iron copper ions absence presence ascorbic acid catalase superoxide dismutasenan
yes_direct,Iron,cytotoxicity,11243246,iron ions produced cytotoxicity towards kinds cells dependent concentrationnan
yes_direct,iron,cytotoxicity,11243246,catalase suppressed cytotoxicity induced iron ions lu cells whereas clv mel cells ineffectivenan
no_relation,superoxide,cytotoxicity,11243246,contrast superoxide dismutase abolished cytotoxicity iron ions towards clv cells whereas lu mel cells ineffectivenan
no_relation,iron,cytotoxicity,11243246,contrast superoxide dismutase abolished cytotoxicity iron ions towards clv cells whereas lu mel cells ineffectivenan
no_relation,furosemide,hypertensives,11250127,haemoconcentration shearstress increase carotid artery diameter regulation furosemide administration older hypertensives nan
no_relation,furosemide,hypertensives,11250127,arterial wall shear rate ultrasound technique profilmeter frp iii systodiastolic diameter echotracking technique mean blood flow velocity volume common carotid artery blood viscosity rotational viscometer finger arterial blood pressure finapress ohmeda measured young volunteers aged years elderly hypertensives aged years treated shortacting calcium antagonists study baseline intravenous furosemide infusion mgmin haematocrit increased least two percentage pointsnan
no_relation,calcium,hypertensives,11250127,arterial wall shear rate ultrasound technique profilmeter frp iii systodiastolic diameter echotracking technique mean blood flow velocity volume common carotid artery blood viscosity rotational viscometer finger arterial blood pressure finapress ohmeda measured young volunteers aged years elderly hypertensives aged years treated shortacting calcium antagonists study baseline intravenous furosemide infusion mgmin haematocrit increased least two percentage pointsnan
yes_direct,furosemide,decreased and blood viscosity,11250127,furosemide administration mean arterial blood pressure decreased blood viscosity carotid systolic shear stress increased groupsnan
no_relation,verapamil,cytotoxicity,11261883,treatment resistant cells verapamil intracellular levels doxorubicin markedly increased consequent cytotoxicity improvednan
yes_direct,doxorubicin,cytotoxicity,11261883,treatment resistant cells verapamil intracellular levels doxorubicin markedly increased consequent cytotoxicity improvednanimproved key term
no_relation,cisplatin,esophageal cancer,11295088,pharmacokinetics intraoperative intrapleural cisplatin chemotherapy various osmolarities cases esophageal cancer nan
no_relation,cisplatin/CDDP,cancers,11295088,intraoperative intrapleural ipl cisplatin cddp treatment thoracotomy performed esophageal cancers nan
no_relation,CDDP,Hypotonic,11295088,hypotonic cddp treatments mosml solution mosml solution administered  patients respectivelynan
no_relation,platinum,hypotonic,11295088,maximum concentrations cmax total filterable platinum plasma injection hypotonic solution significantly higher injection isotonic solutionnan
no_relation,platinum,hypotonic,11295088,although higher levels cmax may increase sideeffects hypotonic condition ipl fluid increased auc plasma may escalate accumulation platinum ipl cancer cellsnan
no_relation,platinum,cancer,11295088,although higher levels cmax may increase sideeffects hypotonic condition ipl fluid increased auc plasma may escalate accumulation platinum ipl cancer cellsnan
no_relation,CDDP,pleural carcinomatosis,11295088,cddp tolerable may useful treatment incipient phase pleural carcinomatosis prophylaxis postoperative recurrencenan
no_relation,methotrexate,rheumatoid arthritis,11304108,radiographic evidence progressive bone loss inability eliminate synovial proliferation methotrexate became apparent therapy rheumatoid arthritis needed advancementnan
no_relation,methotrexate,bone loss,11304108,radiographic evidence progressive bone loss inability eliminate synovial proliferation methotrexate became apparent therapy rheumatoid arthritis needed advancementnan
yes_direct,Methotrexate,toxicity,11304108,methotrexate remissioninducing drug may doselimiting toxicity nan
no_relation,leflunomide,disease-modifying antirheumatic drugs/DMARDs,11304108,past years three new diseasemodifying antirheumatic drugs dmards approved leflunomide etanercept infliximabnan
no_relation,hydroxychloroquine,DMARDs,11304108,established dmards sulfasalazine hydroxychloroquine also demonstrated efficacy used together methotrexatenan
no_relation,sulfasalazine,DMARDs,11304108,established dmards sulfasalazine hydroxychloroquine also demonstrated efficacy used together methotrexatenan
no_relation,methotrexate,DMARDs,11304108,established dmards sulfasalazine hydroxychloroquine also demonstrated efficacy used together methotrexate nan
no_relation,methotrexate,DMARDs,11304108,results combination studies clearly demonstrate clinical responses meaningfully improved new existing dmards added methotrexate nan
no_relation,methotrexate,DMARDs,11304108,also become apparent combinations new dmards methotrexate virtually halt radiographic progression yearsnan
no_relation,didanosine,HIV-1 infection,11322269,role didanosine management hiv infection nan
no_relation,didanosine,human immunodeficiency virus (HIV) infection,11322269,largescale clinical end point studies comparing antiretroviral therapy zidovudine alone didanosine alone zidovudine combined didanosine indicate didanosine alone zidovudine didanosine provide better clinical outcome zidovudine alone patients human immunodeficiency virus hiv infection nan
no_relation,zidovudine,human immunodeficiency virus (HIV) infection,11322269,largescale clinical end point studies comparing antiretroviral therapy zidovudine alone didanosine alone zidovudine combined didanosine indicate didanosine alone zidovudine didanosine provide better clinical outcome zidovudine alone patients human immunodeficiency virus hiv infection nan
no_relation,didanosine,gastrointestinal disturbances,11322269,apart mostly mild gastrointestinal disturbances didanosine alone various combination therapies generally well toleratednan
no_relation,nucleoside,HIV infection,11322269,thus didanosine represents potent versatile nucleoside analogue potential benefits current future antiretroviral regimens hiv infection nan
no_relation,didanosine,HIV infection,11322269,thus didanosine represents potent versatile nucleoside analogue potential benefits current future antiretroviral regimens hiv infection nan
no_relation,5-FU,Tumor,11329936,tumor sensitivities measured ic drug concentration producing growth inhibition varied largely drugs ranging larger  ngml 5-fu larger  ngml mmc ngml  ngml adm ngml  ngml cddpnan
no_relation,MMC,Tumor,11329936,tumor sensitivities measured ic drug concentration producing growth inhibition varied largely drugs ranging larger  ngml fu larger  ngml mmc  ngml  ngml adm ngml  ngml cddpnan
no_relation,CDDP,Tumor,11329936,tumor sensitivities measured ic drug concentration producing growth inhibition varied largely drugs ranging larger  ngml fu larger  ngml mmc ngml  ngml adm ngml  ngml cddp nan
no_relation,5-FU,adenocarcinomas,11329936,nine human pancreatic adenocarcinomas varied widely sensitivity chemotherapies especially 5-fu nan
no_relation,piracetam,stroke,11332870,restitution alphatopography piracetam post stroke aphasianan
no_relation,piracetam,aphasia,11332870,restitution alphatopography piracetam poststroke aphasia nan
no_relation,piracetam,stroke,11332870,electroencephalographic clinical effects piracetam post stroke aphasia evaluated prospective randomized doubleblind placebocontrolled trialnan
no_relation,piracetam,aphasia,11332870,electroencephalographic clinical effects piracetam poststroke aphasia evaluated prospective randomized doubleblind placebocontrolled trialnan
no_relation,manidipine,diabetic,11336083,effects urinary albumin excretion renal function changes delapril manidipine normotensive type diabetic patients microalbuminurianan
no_relation,calcium,diabetic,11336083,study designed investigate effect delapril ace inhibitor manidipine long action calcium antagonist persistent microalbuminuria normotensive type diabetic patientsnan
no_relation,manidipine,diabetic,11336083,study designed investigate effect delapril ace inhibitor manidipine long action calcium antagonist persistent microalbuminuria normotensive type diabetic patientsnan
no_relation,delapril,diabetic,11336083,study designed investigate effect delapril ace inhibitor manidipine long action calcium antagonist persistent microalbuminuria normotensive type diabetic patientsnan
no_relation,manidipine,diabetic,11336083,sixty type diabetic patients randomized take delapril mgday manidipine mgday weeks open label designnan
no_relation,delapril,diabetic,11336083,sixty type diabetic patients randomized take delapril mgday manidipine mgday weeks open label designnan
no_relation,delapril,nephropathy,11336083, weeks treatment two patients delapril group one patient manidipine group converted normoalbuminuria urinary albumincreatinine ratio nephropathy urinary albumincreatinine ratio  mggnan
no_relation,manidipine,nephropathy,11336083, weeks treatment two patients delapril group one patient manidipine group converted normoalbuminuria urinary albumincreatinine ratio nephropathy urinary albumincreatinine ratio  mggnan
no_relation,creatinine,nephropathy,11336083, weeks treatment two patients delapril group one patient manidipine group converted normoalbuminuria urinary albumin creatinine ratio nephropathy urinary albumin creatinine ratio  mggnan
no_relation,glucose,plasma glucose,11336083,significant changes fasting plasma glucose hbac serum fructosamine creatinine potassium lipid profiles weeks treatment groupsnan
no_relation,potassium,plasma glucose,11336083,significant changes fasting plasma glucose hbac serum fructosamine creatinine potassium lipid profiles weeks treatment groupsnan
no_relation,fructosamine,plasma glucose,11336083,significant changes fasting plasma glucose hbac serum fructosamine creatinine potassium lipid profiles weeks treatment groupsnan
no_relation,creatinine,plasma glucose,11336083,significant changes fasting plasma glucose hbac serum fructosamine creatinine potassium lipid profiles weeks treatment groupsnan
no_relation,delapril,dizziness,11336083,two cases delapril group withdrawn study intolerable cough one case manidipine group intolerable dizziness headachenan
yes_direct,manidipine,dizziness,11336083,two cases delapril group withdrawn study intolerable cough one case manidipine group intolerable dizziness headachenan
yes_direct,delapril,headache,11336083,two cases delapril group withdrawn study intolerable cough one case manidipine group intolerable dizziness headache nan
yes_direct,manidipine,headache,11336083,two cases delapril group withdrawn study intolerable cough one case manidipine group intolerable dizziness headache nan
no_relation,manidipine,diabetic,11336083,conclusion delapril manidipine effective reduction microalbuminuria normotensive type diabetic patients persistent microalbuminurianan
yes_direct,ethanol,testicular atrophy,11391050,presentations alcoholic myopathy past present future timothy peters victor preedy protein adducts type ii fiberpredominant muscles ethanol fed rat simon worrall seppo parkkila onni niemela hydroperoxides changes alcoholic myopathy junko adachi migiwa asamo yasuhino ueno close association testicular atrophy muscle atrophy increase protein catabolism chronic ethanol administration kunihiko takeda masayoshi yamauchi kazuhiko sakamoto masaru takagi hisato nakajima gotaro todanan
yes_direct,ethanol,muscle atrophy,11391050,presentations alcoholic myopathy past present future timothy peters victor preedy protein adducts type ii fiberpredominant muscles ethanol fed rat simon worrall seppo parkkila onni niemela hydroperoxides changes alcoholic myopathy junko adachi migiwa asamo yasuhino ueno close association testicular atrophy muscle atrophy increase protein catabolism chronic ethanol administration kunihiko takeda masayoshi yamauchi kazuhiko sakamoto masaru takagi hisato nakajima gotaro todanan
no_relation,ethanol,Alcoholic myopathy,11391050,presentations alcoholic myopathy past present future timothy peters victor preedy protein adducts type ii fiberpredominant muscles ethanol fed rat simon worrall seppo parkkila onni niemela hydroperoxides changes alcoholic myopathy junko adachi migiwa asamo yasuhino ueno close association testicular atrophy muscle atrophy increase protein catabolism chronic ethanol administration kunihiko takeda masayoshi yamauchi kazuhiko sakamoto masaru takagi hisato nakajima gotaro todanan
no_relation,Fluoxetine,postnatal depression,11406023,appleby et al reported fluoxetine significantly effective placebo initial session counselling effective full course cognitivebehavioural counselling treatment postnatal depression nan
no_relation,fluoxetine,postnatal depression,11406023,women postnatal depression effectively treated fluoxetine effective course cognitivebehavioural counselling shorttermnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,muscle spasms,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,glaucoma,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,pain,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,nausea,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,anxiety,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
no_relation,Delta(9)-tetrahydrocannabinol/THC,wasting diseases,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseases nan
no_relation,Delta(9)-tetrahydrocannabinol/THC,Delta(9)-tetrahydrocannabinol/THC,11448725,active principle marijuana deltatetrahydrocannabinol thc shown wide therapeutic application number important medical conditions including pain anxiety glaucoma nausea emesis muscle spasms wasting diseasesnan
yes_direct,SNP,tachycardia,11454557,despite tachycardia sympathetic activation snp phentolamine lf variability rr msna bp increased snp decreased phentolamine snp rr  msna  systolic bp  diastolic bp  phentolamine rr  msna  systolic bp  diastolic bp  nan
no_relation,phentolamine,tachycardia,11454557,despite tachycardia sympathetic activation snp phentolamine lf variability rr msna bp increased snp decreased phentolamine snp rr  msna  systolic bp  diastolic bp  phentolamine rr  msna  systolic bp  diastolic bp  nan
yes_direct,noradrenaline,vascular disorders,11474550,supersensitivity noradrenaline contributes certain vascular disorders eg hypertension chronic neuropathic pain conditions eg complex regional pain syndromenan
yes_direct,noradrenaline,hypertension,11474550,supersensitivity noradrenaline contributes certain vascular disorders eg hypertension chronic neuropathic pain conditions eg complex regional pain syndromenan
yes_direct,noradrenaline,regional pain syndrome/neuropathic pain,11474550,supersensitivity noradrenaline contributes certain vascular disorders eg hypertension chronic neuropathic pain conditions eg complex regional pain syndrome nan
no_relation,guanethidine,thermal hyperalgesia,11474550,investigate effect guanethidine pretreatment thermal hyperalgesia experimental sites sensitized heat topical application capsaicinnan
no_relation,capsaicin,thermal hyperalgesia,11474550,investigate effect guanethidine pretreatment thermal hyperalgesia experimental sites sensitized heat topical application capsaicin nan
no_relation,capsaicin,pain,11474550,application capsaicin heat pain threshold heat pain ratings suprathreshold stimulation similar sites pretreated weeks guanethidine salinenan
no_relation,guanethidine,pain,11474550,application capsaicin heat pain threshold heat pain ratings suprathreshold stimulation similar sites pretreated weeks guanethidine salinenan
yes_direct,guanethidine,thermal hyperalgesia,11474550,however iontophoresis noradrenaline thermal hyperalgesia greater guanethidine pretreated site saline pretreated sitenan
yes_direct,noradrenaline,thermal hyperalgesia,11474550,however iontophoresis noradrenaline thermal hyperalgesia greater guanethidinepretreated site saline pretreated sitenan
yes_indirect,guanethidine,thermal hyperalgesia,11474550,observations indicate prolonged depletion adrenergic stores guanethidine induces adrenergic supersensitivity cutaneous vessels adrenergic supersensitivity enhances thermal hyperalgesia presence noradrenalinenan
yes_direct,noradrenaline,thermal hyperalgesia,11474550,observations indicate prolonged depletion adrenergic stores guanethidine induces adrenergic supersensitivity cutaneous vessels adrenergic supersensitivity enhances thermal hyperalgesia presence noradrenaline nan
yes_direct,sorbitol,lactic acidosis,11493513,another feature turp syndrome hyperglycaemia lactic acidosis caused massive absorption sorbitol nan
yes_direct,sorbitol,TURP syndrome,11493513,another feature turp syndrome hyperglycaemia lactic acidosis caused massive absorption sorbitol nan
no_relation,sorbitol,lactic acidosis,11493513,report case hyperglycaemia lactic acidosis complicated turp syndrome caused massive absorption approximately litres sorbitol mannitol irrigation solutionnan
yes_direct,sorbitol,TURP syndrome,11493513,report case hyperglycaemia lactic acidosis complicated turp syndrome caused massive absorption approximately litres sorbitol mannitol irrigation solutionnan
yes_direct,mannitol,TURP syndrome,11493513,report case hyperglycaemia lactic acidosis complicated turp syndrome caused massive absorption approximately litres sorbitol mannitol irrigation solutionnan
no_relation,mannitol,lactic acidosis,11493513,report case hyperglycaemia lactic acidosis complicated turp syndrome caused massive absorption approximately litres sorbitol mannitol irrigation solutionnansorbitol mannitol irrigation solution mannitol
no_relation,sorbitol,lactic acidosis,11493513,proposed mechanism type lactic acidosis related metabolism sorbitol nan
no_relation,tryptophan,bipolar affective disorder,11513817,clinical neurochemical effect acute tryptophan depletion unaffected relatives patients bipolar affective disorder nan
no_relation,tryptophan,manic-depressive illness,11513817,lowering mood induced acute tryptophan depletion atd proposed candidate endophenotype vulnerability manicdepressive illness nan
no_relation,tryptophan,BAD,11513817, hours aa drink ingestion relative placebo atd resulted  decreases total plasma tryptophan concentrations control subjects relatives patients bad respectivelynan
no_relation,tryptophan,BAD,11513817,results replicate extend previous findings suggesting urs patients bad susceptible low tryptophan availabilitynan
no_relation,tamoxifen,breast cancer,11556039,assessment response tamoxifen among iraqi patients advanced breast cancer nan
no_relation,tamoxifen,breast cancer,11556039,eightyeight women presenting locally advanced metastatic breast cancer treated tamoxifen alonenan
no_relation,Estrogen,tumour,11556039,estrogen progesterone receptors er pr immunocytochemically analysed mammary tumour cells obtained fine needle sampling patientsnan
no_relation,progesterone,tumour,11556039,estrogen progesterone receptors er pr immunocytochemically analysed mammary tumour cells obtained fine needle sampling patientsnan
no_relation,levothyroxine,hypothyroidism,11561329,one pregnant patients taking levothyroxine hypothyroidism nan
no_relation,alcohol,adenocarcinomas,11562112,multiethnic populationbased study smoking alcohol body size risk adenocarcinomas stomach esophagus united statesnan
no_relation,alcohol,"gastric cardia, and distal gastric adenocarcinomas",11562112,sought determine role smoking alcohol use body size characteristics etiology esophageal gastric cardia distal gastric adenocarcinomas nan
no_relation,Alcohol,tumor,11562112,alcohol use associated increased risk tumor typesnan
no_relation,Aldosterone,renal disease,11709805,aldosterone progressive renal disease nan
no_relation,aldosterone,renal disease,11709805,blockade reninangiotensin aldosterone system proven effective retarding progression renal disease remnant kidney model well experimental diseases importantly range progressive human renal diseasesnan
no_relation,aldosterone,human renal diseases,11709805,blockade reninangiotensin aldosterone system proven effective retarding progression renal disease remnant kidney model well experimental diseases importantly range progressive human renal diseases nan
no_relation,aldosterone,diseases,11709805,blockade reninangiotensin aldosterone system proven effective retarding progression renal disease remnant kidney model well experimental diseases importantly range progressive human renal diseasesnan
no_relation,aldosterone,hypertension,11709805,thus aldosterone well angiotensin ii appears instrumental sustaining hypertension fibroproliferative destruction residual kidneynan
no_relation,angiotensin II,hypertension,11709805,thus aldosterone well angiotensin ii appears instrumental sustaining hypertension fibroproliferative destruction residual kidneynan
no_relation,cadmium chloride,tumorigenesis,11711542,molecular mechanisms potentially responsible cadmiuminduced cell transformation tumorigenesis investigated using balbct cells transformed cadmium chloride nan
no_relation,cadmium,tumorigenesis,11711542,molecular mechanisms potentially responsible cadmium induced cell transformation tumorigenesis investigated using balbct cells transformed cadmium chloridenan
no_relation,cadmium,tumorigenesis,11711542,blocking translation tef delta antisense tef delta mrna resulted significant reversal oncogenic potential cadmium transformed balbct cells evidenced suppression anchorageindependent growth tumorigenesis nude micenan
yes_direct,cadmium,tumorigenesis,11711542,findings demonstrate first time cell transformation tumorigenesis induced cadmium due least part overexpression tef delta novel cadmium responsive protooncogenenan
no_relation,Enalapril,hypertension,11725911,enalapril acts release nitric oxide patients essential hypertension nan
no_relation,nitric oxide,hypertension,11725911,enalapril acts release nitric oxide patients essential hypertension nan
no_relation,enalapril,hypertension,11725911,study mechanism action enalapril acei serum reactive nitrite intermediates rni citrulline products nitric oxide metabolism measured treatment enalapril consecutive patients essential hypertension nan
no_relation,nitric oxide,hypertension,11725911,study mechanism action enalapril acei serum reactive nitrite intermediates rni citrulline products nitric oxide metabolism measured treatment enalapril consecutive patients essential hypertension nan
no_relation,nitrite,hypertension,11725911,study mechanism action enalapril acei serum reactive nitrite intermediates rni citrulline products nitric oxide metabolism measured treatment enalapril consecutive patients essential hypertension nan
no_relation,theophylline,asthma,11743900,effect theophylline airway inflammation asthma nan
no_relation,theophylline,asthma,11743900,investigate whether low dose theophylline antiinflammatory effect asthma nan
no_relation,theophylline,asthmatic,11743900,nineteen asthmatic subjects given mg sustainedrelease theophylline preparation twice daily weeksnan
no_relation,theophylline,asthmatic,11743900,using theophylline sputum eosinophils eg eosinophils ecp asthmatic group much higher healthy groupnan
no_relation,theophylline,asthma,11743900,results indicated low dose theophylline inhibitory action airway inflammation asthma noticeable improvement patients symptoms lung functionnan
no_relation,tamoxifen,breast carcinoma,11752079,iodinelabeled tamoxifen uptake primary human breast carcinoma nan
no_relation,Iodine,breast carcinoma,11752079,iodine labeled tamoxifen uptake primary human breast carcinoma nan
no_relation,tamoxifen,tumor,11752079,assessing tumor uptake retention ilabeled tamoxifen tx could increase understanding txs action mechanisms involved resistance drugnan
no_relation,estrogen,Tumor,11752079,tumor tonormal tissue uptake ratios tn derived spect images related estrogen receptor er progesterone receptor pr statusnan
no_relation,progesterone,Tumor,11752079,tumor tonormal tissue uptake ratios tn derived spect images related estrogen receptor er progesterone receptor pr statusnan
no_relation,ribavirin,chronic hepatitis C virus,11759109, patients chronic hepatitis virus hcv treated interferon ifn treated ifn ribavirin sera collected prior treatment  months therapy months posttreatmentnan
no_relation,alanine,fibrosis,11759109,levels icam vcam hyaluronic acid correlated alanine aminotransferase levels hcvrnapolymerase chain reaction status histological fibrosis scoringnan
no_relation,clozapine,agranulocytosis,11772153,number studies investigating use clozapine published children however owing frequent monitoring required agranulocytosis use clozapine may restricted patients treatmentrefractory diseasenan
no_relation,clozapine,blood glucose,11772153,accumulating data development glucose intolerance adults receiving clozapine closer monitoring bodyweight fasting blood glucose imperativenan
no_relation,glucose,blood glucose,11772153,accumulating data development glucose intolerance adults receiving clozapine closer monitoring bodyweight fasting blood glucose imperativenan
yes_direct,clozapine,glucose intolerance,11772153,accumulating data development glucose intolerance adults receiving clozapine closer monitoring bodyweight fasting blood glucose imperativenan
no_relation,glucose,glucose intolerance,11772153,accumulating data development glucose intolerance adults receiving clozapine closer monitoring bodyweight fasting blood glucose imperativenan
yes_direct,Clozapine,seizure,11772153,clozapine also increased seizure risk therefore baseline electroencephalogram performed well continued vigilance adverse effectnan
no_relation,clozapine,extrapyramidal symptoms/EPS,11772153,unlike clozapine receptor interaction profile lends toward increased risk extrapyramidal symptoms eps hyperprolactinaemianan
no_relation,clozapine,hyperprolactinaemia,11772153,unlike clozapine receptor interaction profile lends toward increased risk extrapyramidal symptoms eps hyperprolactinaemia nan
yes_direct,olanzapine,Bodyweight gain,11772153,bodyweight gain common adverse effect although somewhat less reported olanzapine nan
yes_direct,Risperidone,mania,11772153,risperidone induced mania reported adults therefore increased caution used deciding treat children adolescents risperidone particularly predisposition toward mania nan
yes_direct,Olanzapine,mania,11772153,olanzapine like risperidone also associated onset mania adultsnan
yes_direct,risperidone,mania,11772153,olanzapine like risperidone also associated onset mania adultsnan
yes_direct,Olanzapine,bodyweight gain,11772153,olanzapine receptor profile results significant risk bodyweight gain sedationnan
no_relation,glucose,blood glucose,11772153,furthermore drug linked development glucose intolerance thus important monitor bodyweight fasting blood glucose frequent basisnan
no_relation,glucose,glucose intolerance,11772153,furthermore drug linked development glucose intolerance thus important monitor bodyweight fasting blood glucose frequent basisnan
yes_direct,olanzapine,bodyweight gain,11772153,quetiapine appears increased risk sedation bodyweight gain albeit less olanzapine nan
yes_direct,Quetiapine,bodyweight gain,11772153,quetiapine appears increased risk sedation bodyweight gain albeit less olanzapinenan
no_relation,ziprasidone,bodyweight gain,11772153,lack evidence bodyweight gain ziprasidone considerable advantagenan
no_relation,Indomethacin,polyhydramnios,11776505,indomethacin therapy treatment polyhydramnios due placental chorioangiomanan
no_relation,Indomethacin,placental chorioangioma,11776505,indomethacin therapy treatment polyhydramnios due placental chorioangioma nan
no_relation,indomethacin,respiratory distress,11776505,preterm labor started respiratory distress indomethacin  mg given every hoursnan
no_relation,indomethacin,Preterm labor,11776505,preterm labor started respiratory distress indomethacin  mg given every hoursnan
no_relation,steroid,ulcerative colitis,11800081,effective maintenance leukocytapheresis patients steroid dependent resistant ulcerative colitis nan
no_relation,corticosteroid,ulcerative colitis/UC,11800081,prospectively examined effect leukocytapheresis la maintenance remission patients ulcerative colitis uc initially refractory corticosteroid therapy steroid resistant steroid dependentnan
no_relation,steroid,ulcerative colitis/UC,11800081,prospectively examined effect leukocytapheresis la maintenance remission patients ulcerative colitis uc initially refractory corticosteroid therapy steroid resistant steroid dependentnan
no_relation,steroid,UC,11800081,patients refractory uc remission due la induction la combination steroid therapynan
no_relation,steroid/steroids,UC,11800081,concluded maintenance la therapy might effective patients steroid dependent resistant uc maintenance remission without steroids nan
yes_direct,haloperidol,neuroleptic syndrome,11819156,patient suffering rare enzyme deficiency developed malignant neuroleptic syndrome treated one single dose haloperidol nan
no_relation,prostacyclins,PPH,11829729,due complicated nature therapy inhaled sc oral prostacyclins also evaluated treatment pph nan
yes_direct,cholesterol,coronary artery disease/CAD,11835697,commonly agreed people high blood ldl cholesterol higher risk coronary artery disease cad people low blood ldl cholesterol nan
no_relation,HMG-CoA,hypercholesterolemia,11835697,simvastatin hmg-coa reductase inhibitor listed essential drug treatment hypercholesterolemia nan
no_relation,Simvastatin,hypercholesterolemia,11835697,simvastatin hmg-coa reductase inhibitor listed essential drug treatment hypercholesterolemia nan
no_relation,Arsenic trioxide,leukemic differentiation,11839383,arsenic trioxide methylprednisolone use different signal transduction pathways leukemic differentiation nan
no_relation,methylprednisolone,leukemic differentiation,11839383,arsenic trioxide methylprednisolone use different signal transduction pathways leukemic differentiation nan
no_relation,methylprednisolone,myeloid leukemia,11839383,high dose methylprednisolone treatment shown induce vivo vitro differentiation myeloid leukemia cells mature granulocytes patients acute promyelocytic leukemia apl subtypes acute myeloid leukemia amlnan
no_relation,methylprednisolone,APL/acute promyelocytic leukemia,11839383,high dose methylprednisolone treatment shown induce vivo vitro differentiation myeloid leukemia cells mature granulocytes patients acute promyelocytic leukemia apl subtypes acute myeloid leukemia amlnan
no_relation,methylprednisolone,acute myeloid leukemia/AML,11839383,high dose methylprednisolone treatment shown induce vivo vitro differentiation myeloid leukemia cells mature granulocytes patients acute promyelocytic leukemia apl subtypes acute myeloid leukemia aml nan
no_relation,Arsenic trioxide,APL,11839383,arsenic trioxide aso confirmed remission induction effects apl nan
no_relation,methylprednisolone,leukemic differentiation,11839383,contrast methylprednisolone effect phosphatase inhibitors asoinduced leukemic differentiation nan
no_relation,methylprednisolone,leukemic differentiation,11839383,incomplete leukemic differentiation occurred lower aso concentration unlike aso methylprednisolone induced complete granulocytic andor monocytic differentiation hl  cells via upregulation ppa regulatory subunitsnan
no_relation,methylprednisolone,leukemic differentiation,11839383,therefore aso methylprednisolone promising agents potential used together myeloid leukemic differentiation therapynan
no_relation,testosterone,hypogonadotrophic hypogonadism,11874189,data consistent partial hypogonadotrophic hypogonadism hypothalamic origin patient treated testosterone nan
no_relation,nitric oxide,necrosis,11875767,pentoxifylline downregulates nitric oxide tumor necrosis factoralpha induced mycobacterial lipoarabinomannan macrophage cell linenan
no_relation,nitric oxide,tumor,11875767,pentoxifylline downregulates nitric oxide tumor necrosis factoralpha induced mycobacterial lipoarabinomannan macrophage cell linenan
no_relation,Pentoxifylline,tumor,11875767,pentoxifylline downregulates nitric oxide tumor necrosis factoralpha induced mycobacterial lipoarabinomannan macrophage cell linenan
no_relation,Pentoxifylline,necrosis,11875767,pentoxifylline downregulates nitric oxide tumor necrosis factoralpha induced mycobacterial lipoarabinomannan macrophage cell linenan
no_relation,Pentoxifylline/PTX,necrosis,11875767,pentoxifylline ptx phosphodiesterase inhibitor known downregulate tumor necrosis factoralpha tnfalpha secretion induced lipopolysacchride lps gamma interferon ifngammanan
no_relation,Pentoxifylline/PTX,tumor,11875767,pentoxifylline ptx phosphodiesterase inhibitor known downregulate tumor necrosis factoralpha tnfalpha secretion induced lipopolysacchride lps gamma interferon ifngammanan
yes_direct,sodium valproate,Tubulo-interstitial nephritis,11891102,tubulointerstitial nephritis caused sodium valproate nan
no_relation,sodium valproate,epilepsy,11891102,severely handicapped yearold japanese girl epilepsy treated sodium valproate sv age yearsnan
no_relation,clomiphene citrate,polycystic ovary syndrome/PCOS,11915582,availability laparoscopic ovarian cautery resurgence interest surgical treatment clomiphene citrate resistant polycystic ovary syndrome pcos nan
no_relation,clomiphene citrate,PCOS,11915582,potential advantages ovarian cautery recommend surgery next line treatment clomiphene citrate fails induce ovulation pcos patients gonadotropins introducednan
no_relation,Duloxetine,depressive disorder,11926722,duloxetine treatment major depressive disorder doubleblind clinical trialnan
no_relation,Duloxetine hydrochloride,major depression,11926722,duloxetine hydrochloride dual reuptake inhibitor serotonin norepinephrine evaluated therapeutic efficacy safetytolerability treatment major depression nan
no_relation,serotonin,major depression,11926722,duloxetine hydrochloride dual reuptake inhibitor serotonin norepinephrine evaluated therapeutic efficacy safetytolerability treatment major depression nan
no_relation,norepinephrine,major depression,11926722,duloxetine hydrochloride dual reuptake inhibitor serotonin norepinephrine evaluated therapeutic efficacy safetytolerability treatment major depression nan
no_relation,duloxetine,depressive disorder,11926722,week multicenter doubleblind placebocontrolled study patients aged years dsmiv major depressive disorder randomly allocated receive placebo  duloxetine  fluoxetine mg qdnan
no_relation,fluoxetine,depressive disorder,11926722,week multicenter doubleblind placebocontrolled study patients aged years dsmiv major depressive disorder randomly allocated receive placebo  duloxetine  fluoxetine  mg qdnan
yes_direct,duloxetine,asthenia,11926722,general duloxetine well tolerated patients achieved maximum dose insomnia asthenia adverse events reported statistically significantly duloxetine treated patients compared placebotreated patientsnan
yes_direct,duloxetine,insomnia,11926722,general duloxetine well tolerated patients achieved maximum dose insomnia asthenia adverse events reported statistically significantly duloxetine treated patients compared placebotreated patientsnan
no_relation,duloxetine,depressive disorder,11926722,data indicate duloxetine efficacious treatment major depressive disorder well tolerated safenan
no_relation,clozapine,anxiety/depression,11927178,new factor model negative symptoms reality distortion disorganization anxiety/depression better fit data sets two commonly used factor models also fit better post clozapine nan
no_relation,Diclofenac,analgesia,11939442,diclofenac paracetamol analgesia paediatric myringotomy outpatientsnan
no_relation,paracetamol,analgesia,11939442,diclofenac paracetamol analgesia paediatric myringotomy outpatientsnan
no_relation,paracetamol,postoperative pain,11939442,prospective randomized doubleblind study compared analgesic efficacy oral diclofenac resinate mgkg paracetamol mgkg control postoperative pain paediatric patients outpatient bilateral myringotomy tube insertionnan
no_relation,diclofenac,analgesia,11939442,twenty per cent diclofenac group paracetamol group required rescue analgesia statistically significantnan
no_relation,paracetamol,analgesia,11939442,twenty per cent diclofenac group paracetamol group required rescue analgesia statistically significantnan
yes_direct,levobupivacaine,toxicity,11945112,cardiac cns toxicity levobupivacaine strengths evidence advantage bupivacainenan
no_relation,bupivacaine,toxicity,11945112,cardiac cns toxicity levobupivacaine strengths evidence advantage bupivacaine nan
no_relation,Levobupivacaine,toxicity,11945112,levobupivacaine single enantiomer bupivacaine recently introduced new longacting local anaesthetic potentially reduced toxicity compared bupivacainenan
no_relation,bupivacaine,toxicity,11945112,levobupivacaine single enantiomer bupivacaine recently introduced new longacting local anaesthetic potentially reduced toxicity compared bupivacaine nan
yes_direct,levobupivacaine,death,11945112,awake sheep example almost levobupivacaine required cause death nan
no_relation,levobupivacaine,ventricular tachycardia,11945112,contrast anaesthetised dogs differences seen incidence spontaneous electrical stimulation induced ventricular tachycardia fibrillations among animals exposed levobupivacaine bupivacainenan
no_relation,levobupivacaine,fibrillations,11945112,contrast anaesthetised dogs differences seen incidence spontaneous electrical stimulation induced ventricular tachycardia fibrillations among animals exposed levobupivacaine bupivacainenan
no_relation,bupivacaine,ventricular tachycardia,11945112,contrast anaesthetised dogs differences seen incidence spontaneous electrical stimulation induced ventricular tachycardia fibrillations among animals exposed levobupivacaine bupivacaine nan
no_relation,bupivacaine,fibrillations,11945112,contrast anaesthetised dogs differences seen incidence spontaneous electrical stimulation induced ventricular tachycardia fibrillations among animals exposed levobupivacaine bupivacaine nan
yes_direct,levobupivacaine,cardiotoxicity,11945112,reversibility levobupivacaine induced cardiotoxicity also assessednan
no_relation,steroid,encephalomyelitis,11954856,effectiveness intravenous immunoglobulin treatment adult patients steroid resistant monophasic recurrent acute disseminated encephalomyelitis nan
no_relation,steroid,encephalomyelitis,11954856,present five patients affected classic disseminated encephalomyelitis post infectious myelitis showed good response intravenous immunoglobulin ivig steroid treatment failurenan
no_relation,steroid,infectious myelitis,11954856,present five patients affected classic disseminated encephalomyelitis post infectious myelitis showed good response intravenous immunoglobulin ivig steroid treatment failurenan
no_relation,prednisolone,ALL,11984797,adult ph  resistant prednisolone fold  displayed overall tendency resistance compared matched cases ph  adult precursor bcell nan
no_relation,prednisolone,ALL,11984797,within ph vitro prednisolone resistance increased significantly age nan
no_relation,prednisolone,ALL,11984797,correlation prednisolone resistance age within ph cases might help explain poorer prognosis adult ph nan
no_relation,midazolam,status epilepticus,11994056,potential midazolam given via nasal spray acute treatment status epilepticus seizure disruptions evaluatednan
no_relation,midazolam,seizure,11994056,potential midazolam given via nasal spray acute treatment status epilepticus seizure disruptions evaluatednan
no_relation,Bendamustine,indolent lymphomas,11999564,bendamustine mitoxantrone shown potent cytotoxic drugs treatment relapsed refractory indolent lymphomas nan
no_relation,mitoxantrone,indolent lymphomas,11999564,bendamustine mitoxantrone shown potent cytotoxic drugs treatment relapsed refractory indolent lymphomas nan
no_relation,vitamin A,rural South,12001973,increased vitamin intake children aged years targeted homegardens rural south african communitynan
no_relation,vitamin A,rural South,12001973,determine vitamin intake children aged years rural south african community one year implementation homebased food production programme targeting betacarotenerich fruits vegetablesnan
no_relation,beta-carotene,rural South,12001973,determine vitamin intake children aged years rural south african community one year implementation homebased food production programme targeting beta-carotene rich fruits vegetablesnan
yes_direct,Quinine,ocular toxicity,12002937,quinine ocular toxicity treatment blindness using therapy vasospasmnan
no_relation,Quinine,blindness,12002937,quinine ocular toxicity treatment blindness using therapy vasospasmnan
no_relation,Quinine,vasospasm,12002937,quinine ocular toxicity treatment blindness using therapy vasospasm nan
yes_direct,quinine,ocular toxicity,12002937,case ocular toxicity vasospasm secondary quinine poisoning describednan
yes_direct,quinine,vasospasm,12002937,case ocular toxicity vasospasm secondary quinine poisoning describednan
no_relation,quinine,poisoning,12002937,case ocular toxicity vasospasm secondary quinine poisoning describednan
no_relation,nimodipine,hypertension,12002937,therapy vasospasm using nimodipine hypertension haemodilution hypervolaemia instituted subsequent resolution symptomsnan
no_relation,nimodipine,vasospasm,12002937,therapy vasospasm using nimodipine hypertension haemodilution hypervolaemia instituted subsequent resolution symptomsnan
no_relation,alcohol,bleeding,12003381,thirtyseven consecutive patients portal hypertension endoscopic evidence isolated gvs presenting histories active bleeding randomized receive endoscopic intervention either alcohol  cyanoacrylate glue  injectionnan
no_relation,alcohol,GVs,12003381,thirtyseven consecutive patients portal hypertension endoscopic evidence isolated gvs  presenting histories active bleeding randomized receive endoscopic intervention either alcohol  cyanoacrylate glue  injectionnan
no_relation,alcohol,hypertension,12003381,thirtyseven consecutive patients portal hypertension endoscopic evidence isolated gvs presenting histories active bleeding randomized receive endoscopic intervention either alcohol  cyanoacrylate glue  injectionnan
no_relation,alcohol,arrest of acute GV bleeding,12003381,cyanoacrylate glue injection could achieve arrest acute gv bleeding often alcohol vs need rescue surgery less difference however significantnan
yes_direct,Cyanoacrylate,arrest of acute GV bleeding,12003381,cyanoacrylate glue injection could achieve arrest acute gv bleeding often alcohol vs need rescue surgery less difference however significantnan
yes_direct,alcohol,bleeding,12003381,six patients died uncontrolled gv bleeding four alcohol groupnan
yes_direct,Hg,Albuminuria,12018634,albuminuria significantly correlated blood urine hg nan
yes_direct,Hg,toxicity,12018634,nephrotoxicity point view dental amalgam unsuitable filling material may give rise hg toxicity nan
no_relation,Hg,toxicity,12018634,hg levels blood urine good markers toxicity nan
no_relation,cyclophosphamide,lupus nephritis,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalitiesnan
no_relation,ursodeoxycholic acid/ursolite,lupus nephritis,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalitiesnan
yes_direct,ursodeoxycholic acid/ursolite,laboratory abnormalities,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalities nan
no_relation,steroids,laboratory abnormalities,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalities nan
no_relation,cyclophosphamide,laboratory abnormalities,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalities nan
no_relation,steroids,lupus nephritis,12028402,patient required steroids repeated courses cyclophosphamide management lupus nephritis ursodeoxycholic acid ursolite administration resulted amelioration cholestatic laboratory abnormalitiesnan
no_relation,silicone,breast-cancer,12039092,comparative examination complaints patients breast-cancer without silicone implantsnan
no_relation,silicone,breast-cancer,12039092,matchedpairanalysis women breast-cancer silicone implants without implants ii performed help standardized questionnaire respect single criterianan
yes_direct,cocaine,hyperthermia,12044126,mechanism cocaine induced hyperthermia humansnan
yes_direct,cocaine,hyperthermia,12044126,lethal effects cocaine unique among illicit drugs cocaine propensity cause hyperthermia nan
yes_direct,cocaine,hypermetabolic,12044126,traditional view cocaine causes hypermetabolic state increased heat productionnan
yes_direct,cocaine,hyperthermia,12044126,however cocaine induced hyperthermia occurs primarily hot weather hypothesized cocaine also impairs thermoregulatory adjustments mediate heat dissipationnan
no_relation,lidocaine,heat stress,12044126,progressive passive heat stress participant received intranasal cocaine mgkg body weight placebo lidocaine  mgkgnan
no_relation,cocaine,heat stress,12044126,progressive passive heat stress participant received intranasal cocaine mgkg body weight placebo lidocaine mgkgnan
no_relation,cocaine,heat stress,12044126,first cocaine substantially augmented progressive increase esophageal temperature heat stressnan
no_relation,cocaine,heat stress,12044126,third cocaine paradoxically impaired perception heating attenuating progressive increase thermal discomfort associated heat stress nan
no_relation,cocaine,impaired heat dissipation,12044126,humans impaired heat dissipation major mechanism cocaine elevates body temperaturenan
no_relation,danazol,angioedema,12058892,autoimmune acquired form angioedema responded danazol therapynan
no_relation,danazol,angioedema,12058892,danazol treatment relieved symptoms angioedema increased inh activity concentration normalization ch cq levelsnan
no_relation,praziquantel,schistosomiasis,12062494,reduction prevalence intensity hookworm infections praziquantel treatment schistosomiasis infectionnan
no_relation,praziquantel,hookworm infections,12062494,reduction prevalence intensity hookworm infections praziquantel treatment schistosomiasis infectionnan
no_relation,Praziquantel,schistosomiasis,12062494,praziquantel exhibits activity major human schistosome parasites become cornerstone treatment morbidity control schistosomiasis nan
no_relation,Praziquantel,trematodes,12062494,praziquantel also active wide range trematodes human veterinary cestodes displays cysticidal effectsnan
no_relation,praziquantel,Schistosoma,12062494,report study among schoolchildren area highly endemic schistosoma mansoni hookworm infection place particular emphasis effect praziquantel prevalence intensity hookworm infectionsnan
no_relation,praziquantel,hookworm infection/hookworm infections,12062494,report study among schoolchildren area highly endemic schistosoma mansoni hookworm infection place particular emphasis effect praziquantel prevalence intensity hookworm infections nan
no_relation,praziquantel,schistosomiasis,12062494,areas schistosome hookworm coexist praziquantel recommended schistosomiasis control largescale application drug might also reduce burden hookwormsnan
no_relation,praziquantel,hookworm coexist,12062494,areas schistosome hookworm coexist praziquantel recommended schistosomiasis control largescale application drug might also reduce burden hookwormsnan
yes_direct,budesonide,dermatitis,12063485,allergic contact dermatitis response budesonide reactivated inhalation allergennan
no_relation,corticosteroids,dermatitis,12063485, patients dermatitis consecutively patch tested allergic one corticosteroids nan
yes_direct,budesonide,hypersensitivity,12063485,fifteen nonasthmatic patients initially given diagnosis budesonide hypersensitivity patch testing less  years study provoked budesonide placebo inhalation weeks patch tested budesonide diastereomers potentially crossreacting substancesnan
yes_direct,budesonide,allergy,12063485,study shows allergic skin reactions may occur patients contact allergy budesonide inhaled forms drug usednan
no_relation,anthracycline,cardiotoxicity,12075737,functional monitoring anthracycline cardiotoxicity prospective blinded longterm observational study outcome patientsnan
yes_direct,anthracycline,heart damage,12075737,increasing doses highly tumoricidal anthracycline drugs cause heart damage nan
no_relation,anthracycline,CHF,12075737,avoid chf consensus recommendation cardiac function monitored close connection anthracycline administrationnan
no_relation,epirubicin,breast cancer,12075737,prospective blinded observational study patients advanced breast cancer followed median years treatment epirubicin nan
yes_direct,Anthracycline,cardiotoxicity,12075737,anthracycline cardiotoxicity closely correlated cumulative dose great variability individual susceptibility dramatic increase advancing agenan
no_relation,epirubicin,CHF,12075737,actuarial estimation patients experienced relative reduction lvef years mgm epirubicin deteriorated chf nan
no_relation,anthracycline,cardiotoxic,12075737,due displaced cardiotoxic manifestation functional monitoring close connection anthracycline administration appears poorly effective method later monitoring essentialnan
no_relation,Bisphosphonates,cancer,12136223,bisphosphonates cancer patientsnan
no_relation,BPs/Bisphosphonates,tumor/breast cancer/cancer,12136223,bisphosphonates bps potent inhibitors osteoclastmediated bone resorption well accepted tumor cells bone especially breast cancer myeloma cells stimulate osteoclast formation activity leading release growth factors cytokines stimulate cancer cells growth secretion osteolytic factorsnan
no_relation,BPs/Bisphosphonates,myeloma,12136223,bisphosphonates bps potent inhibitors osteoclastmediated bone resorption well accepted tumor cells bone especially breast cancer myeloma cells stimulate osteoclast formation activity leading release growth factors cytokines stimulate cancer cells growth secretion osteolytic factorsnan
no_relation,BPs,cancer hypercalcemia,12136223,bps standard treatment cancer hypercalcemia dose mg pamidronate mg clodronate recommended former compound potent longer lasting effectnan
no_relation,pamidronate,cancer hypercalcemia,12136223,bps standard treatment cancer hypercalcemia dose mg pamidronate mg clodronate recommended former compound potent longer lasting effectnan
no_relation,pamidronate,bone pain,12136223,repeated pamidronate infusions exert clinically relevant analgesic effects half patients metastatic bone pain nan
no_relation,clodronate,breast cancer,12136223,lifelong administration oral clodronate patients breast cancer metastatic bone reduces frequency morbid skeletal events onefourthnan
no_relation,BPs,bone disease,12136223,however preference given oral route bps started early process metastatic bone disease patient receiving hormone therapynan
no_relation,pamidronate,breast cancer,12136223,according recently published asco guidelines pamidronate mg iv delivered every weeks recommended patients metastatic breast cancer imaging evidence lytic destruction bone concurrently receiving systemic therapy hormonal therapy chemotherapynan
no_relation,BPs,bone disease,12136223,bps providing supportive care reducing rate skeletal morbidity evidently abolishing criteria stopping administration different used classic antineoplastic drugs stopped metastatic bone disease progressingnan
no_relation,BPs,lytic disease,12136223,even better results achieved patients multiple myeloma general consensus bps started soon diagnosis lytic disease made myeloma patientsnan
no_relation,BPs,myeloma/multiple myeloma,12136223,even better results achieved patients multiple myeloma general consensus bps started soon diagnosis lytic disease made myeloma patientsnan
no_relation,BPs,prostate cancer,12136223,hand data scanty prostate cancer largescale trials potent bps ongoing planned patientsnan
no_relation,pamidronate,breast cancer,12136223,similar results achieved pamidronate obtained monthly mg infusions newer bp ibandronate patients breast cancer metastatic bonenan
no_relation,BPs,aggressive osteolytic disease,12136223,newer bps simplify current therapeutic schemes improve costeffectiveness ratio also potential improve therapeutic efficacy least patients aggressive osteolytic disease given adjuvant therapynan
no_relation,polyvinyl alcohol,intraosseous lesion,12149733,patients embolized fiber coils direct puncture coils placed directly center intraosseous lesion cases conjunction polyvinyl alcohol foam n-butyl-2-cyanoacrylate vascular accessnan
no_relation,N-butyl-2-cyanoacrylate,intraosseous lesion,12149733,patients embolized fiber coils direct puncture coils placed directly center intraosseous lesion cases conjunction polyvinyl alcohol foam n-butyl-2-cyanoacrylate vascular accessnan
no_relation,levothyroxine,thyroid cancer,12186506,performed series neuropsychological tests thyroid cancer patients continued take usual dose levothyroxine lt discontinuing thyroid hormonenan
no_relation,zinc,infection,12187291,supplementation infant formula probiotic lactobacillus reuteri zinc impact enteric infection nutrition infant rhesus monkeysnan
no_relation,zinc,gastrointestinal infection,12187291,study effects probiotic supplementation infant formula without supplemental zinc nutritional status gut colonization ability resist gastrointestinal infection infant rhesus monkey modelnan
no_relation,iron,infection,12187291,supplementation infant formula safe improves iron status decreases diarrhea severity infant rhesus monkeys thus may help protect formulafed human infants infection nutritional deficienciesnan
no_relation,iron,decreases diarrhea severity,12187291,supplementation infant formula safe improves iron status decreases diarrhea severity infant rhesus monkeys thus may help protect formulafed human infants infection nutritional deficienciesnan
no_relation,iron,nutritional deficiencies,12187291,supplementation infant formula safe improves iron status decreases diarrhea severity infant rhesus monkeys thus may help protect formulafed human infants infection nutritional deficiencies nan
no_relation,heparin,atrial fibrillation,12201973,use heparin coated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,creatinine,atrial fibrillation,12201973,use heparincoated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,heparin,blood loss,12201973,use heparin coated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,heparin,postoperative coagulation disturbances,12201973,use heparin coated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,creatinine,postoperative coagulation disturbances,12201973,use heparincoated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,creatinine,blood loss,12201973,use heparincoated circuits reduced mean length stay hospital    days  postoperative ventilation time     blood loss post surgery    ml  individual perioperative change haemoglobin loss  leukocyte count  creatinine elevation  proportion patients exposed allogenous blood transfusions vs  postoperative coagulation disturbances vs  postoperative deviations normal postoperative course vs  neurological deviations vs  atrial fibrillation vs  nan
no_relation,etoricoxib,postoperative pain,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,valdecoxib,postoperative pain,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,valdecoxib,analgesia,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,celecoxib,analgesia,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,rofecoxib,postoperative pain,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,celecoxib,postoperative pain,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,rofecoxib,analgesia,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,etoricoxib,analgesia,12204484,clinical trials demonstrated efficacy safety celecoxib rofecoxib postoperative pain preemptive analgesia newer agents valdecoxib etoricoxib also demonstrated efficacy settingsnan
no_relation,epoprostenol,primary pulmonary hypertension,12204511,longterm intravenous epoprostenol infusion primary pulmonary hypertension prognostic factors survivalnan
no_relation,epoprostenol,primary pulmonary hypertension/PPH,12204511,sought determine factors associated longterm survival patients primary pulmonary hypertension pph treated continuous epoprostenol infusionnan
no_relation,Epoprostenol,PPH,12204511,epoprostenol improves survival patients pph new york heart association nyha functional class iii ivnan
no_relation,epoprostenol,PPH,12204511,december january  patients pph nyha functional class iii iv treated epoprostenol nan
no_relation,epoprostenol,right-sided heart failure,12204511,multivariate analysis including baseline variables measured three months epoprostenol history rightsided heart failure persistence nyha functional class iii iv three months absence fall total pulmonary resistance  relative baseline associated poor survivalnan
no_relation,epoprostenol,PPH,12204511,survival patients pph treated epoprostenol depends severity baseline well threemonth response therapynan
no_relation,cidofovir/CDV,adenovirus (Ad) infections,12323401,although currently fda approved antiviral treatment adenovirus ad infections broad spectrum antiviral cidofovir cdv demonstrated potent inhibitory activity many ad serotypes vitro vivo ocular replication modelnan
no_relation,CDV,infection,12323401,cdv resistance demonstrated ability replicate viral dna infected cells cdv concentrations inhibit parental virus ability form plaques cdv concentrations  microgml increased progeny release following infection growth media containing cdv nan
no_relation,bile acids,intestinal atrophy,12373304,dietary bile acids inhibit potentially elemental dietinduced small intestinal atrophy ratsnan
no_relation,bile acid,atrophy,12373304,oral bile acid administration may prevent atrophy elevations mucosal dao alp activities may lead new therapeutic strategies patients managed ednan
no_relation,methotrexate,RA,12390945,eleven ra patients mean age years disease duration years high disease activity despite treatment stable doses methotrexate nan
no_relation,prednisone,RA,12390945,eleven ra patients mean age years disease duration years high disease activity despite treatment stable doses methotrexate prednisone nan
yes_direct,Oxaliplatin,colorectal carcinoma,12398998,oxaliplatin results colorectal carcinoma nan
no_relation,Oxaliplatin,CRC/colorectal cancer,12398998,oxaliplatin platinum compound characterized diaminocyclohexane dach platinum carrier ligand proven efficacy first secondline advanced colorectal cancer crc treatmentnan
no_relation,platinum,CRC/colorectal cancer,12398998,oxaliplatin platinum compound characterized diaminocyclohexane dach platinum carrier ligand proven efficacy first secondline advanced colorectal cancer crc treatmentnan
yes_direct,oxaliplatin,peripheral sensory neuropathy,12398998,acute reversible cumulative peripheral sensory neuropathy observed frequently oxaliplatin treatment limits usenan
no_relation,5-FU,CRC,12398998,three prospective randomized phase iii studies advanced crc oxaliplatin plus 5-fu lv improved significantly progressionfree survival without significant increase median survival time without affecting quality life compared treatment 5-fu lvnan
no_relation,oxaliplatin,CRC,12398998,three prospective randomized phase iii studies advanced crc oxaliplatin plus fulv improved significantly progressionfree survival without significant increase median survival time without affecting quality life compared treatment fulvnan
yes_direct,Ecstasy,infections,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremorstwitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,memory problems,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremorstwitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,anxiety,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremorstwitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,tremors,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremors twitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,weight loss,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremorstwitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,Depression,12404677,depression memory problems anxiety mood fluctuation poor concentration infections tremorstwitches weight loss significantly associated extent ecstasy usenan
yes_direct,Ecstasy,memory problems,12404677,thus memory problems attributed ecstasy reported novice users heavy users heavy users chisquare dfnan
no_relation,gadolinium,MS,12453069,four doubleblind trials relapsingremitting ms demonstrated ivig may reduce relapse rate progression number gadolinium enhancing lesionsnan
no_relation,glatiramer acetate,multiple sclerosis/MS,12453069,however trials smaller pivotal trials interferonbeta glatiramer acetate therefore performed metaanalysis four trials order provide overall assessment benefits ivig relapsingremitting multiple sclerosis comparison drugs currently available treatment disease activity ms nan
no_relation,apomorphine,Parkinson,12460716,iontophoretic delivery apomorphine invitro modelling parkinson patientnan
no_relation,dopamine,Parkinson's disease,12460716,apomorphine mixed dopamine dd receptor agonist potentially useful treatment parkinson's disease nan
no_relation,Apomorphine,Parkinson's disease,12460716,apomorphine mixed dopamine dd receptor agonist potentially useful treatment parkinson's disease nan
no_relation,apomorphine,Parkinson,12460716,interesting route controlled delivery apomorphine transdermal iontophoresis could enable parkinson patient directly control needed amount apomorphine increasing decreasing drug input order achieve optimal drug therapy ondemand minimum toxic side effectsnan
no_relation,apomorphine,Parkinson's disease,12460716,transdermal iontophoretic transport apomorphine studied vitro human stratum corneum using newly developed iontophoretic continuous flowthrough transport cell vivo first exploratory study patients parkinson's disease nan
no_relation,CsA/cyclosporine,arthritis,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,sulfasalazine/SSZ,PsA,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,Methotrexate/MTX,PsA,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,Methotrexate/MTX,arthritis,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,sulfasalazine/SSZ,arthritis,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,CsA/cyclosporine,PsA,12463452,methotrexate mtx sulfasalazine ssz cyclosporine csa widely used dmards treatment psa safe effective patients active peripheral arthritis although appear effective axial manifestationsnan
no_relation,leflunomide,tumor,12463452,recently demonstrated leflunomide anti tumor necrosis factor tnf agents effective psa psoriasisnan
no_relation,leflunomide,psoriasis,12463452,recently demonstrated leflunomide antitumor necrosis factor tnf agents effective psa psoriasis nan
no_relation,leflunomide,necrosis,12463452,recently demonstrated leflunomide antitumor necrosis factor tnf agents effective psa psoriasisnanantitumor necrosis factor necrosis
no_relation,leflunomide,PsA,12463452,recently demonstrated leflunomide antitumor necrosis factor tnf agents effective psa psoriasisnan
no_relation,tamoxifen,rhabdoid tumor,12495475,estrogen receptor expression estrogen receptorindependent cytotoxic effects tamoxifen malignant rhabdoid tumor cells vitronan
no_relation,Estrogen,rhabdoid tumor,12495475,estrogen receptor expression estrogen receptorindependent cytotoxic effects tamoxifen malignant rhabdoid tumor cells vitronan
no_relation,TAM/tamoxifen,breast cancer/malignant neoplasms,12495475,recent studies shown antiestrogen tamoxifen tam used treatment malignant neoplasms breast cancer nan
no_relation,estrogen,rhabdoid tumor,12495475,present study investigated expression estrogen receptor er six malignant rhabdoid tumor mrt cell linesnan
no_relation,Imatinib,eosinophilic disorders,12506022,imatinib therapy hypereosinophilic syndrome eosinophilic disorders nan
no_relation,Imatinib,hypereosinophilic syndrome,12506022,imatinib therapy hypereosinophilic syndrome eosinophilic disordersnan
no_relation,tyrosine,hypereosinophilic syndrome/HES,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,Imatinib,eosinophilia,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophilia associated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,tyrosine,myeloid disorder,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,Imatinib,CMD,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eos cmd characterized tqp cytogenetic abnormalitynan
no_relation,Imatinib,myeloid disorder,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,tyrosine,eosinophilia,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophilia associated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,tyrosine,CMD,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eos cmd characterized tqp cytogenetic abnormalitynan
no_relation,Imatinib,hypereosinophilic syndrome/HES,12506022,imatinib mesylate gleevec small molecule inhibitor abl kit plateletderived growth factor receptor pdgfr tyrosine kinases reported effective treatment hypereosinophilic syndrome hes rare eosinophiliaassociated chronic myeloid disorder eoscmd characterized tqp cytogenetic abnormalitynan
no_relation,imatinib,HES,12506022,current study sought confirm preliminary observations hes well evaluate therapeutic value imatinib eoscmd associated tqpnan
no_relation,imatinib,CMD,12506022,current study sought confirm preliminary observations hes well evaluate therapeutic value imatinib eos cmd associated tqpnan
no_relation,imatinib,HES,12506022,five patients hes men median age  years eoscmd men aged  years treated imatinib starting dose  mgdaynan
no_relation,imatinib,CMD,12506022,five patients hes men median age  years eos cmd men aged  years treated imatinib starting dose  mgdaynan
no_relation,corticosteroid,eosinophilic infiltration,12506022,myocardial biopsy revealed eosinophilic infiltration degranulation cardiogenic shock reversed prompt institution corticosteroid therapynan
no_relation,corticosteroid,cardiogenic shock,12506022,myocardial biopsy revealed eosinophilic infiltration degranulation cardiogenic shock reversed prompt institution corticosteroid therapynan
no_relation,glucose,breast feeding,12511452,investigate whether breast feeding effective pain relief venepuncture term neonates compare effect oral glucose combined pacifiernan
no_relation,glucose,pain,12511452,investigate whether breast feeding effective pain relief venepuncture term neonates compare effect oral glucose combined pacifiernan
no_relation,glucose,breast feeding,12511452,venepuncture infants either breast fed group held mothers arms without breast feeding group given ml sterile water placebo group given ml glucose followed pacifier group nan
no_relation,glucose,breast feeding,12511452,median pain scores interquartile range breast feeding held mothers arms placebo glucose plus pacifier groups     douleur aigu nouveaun scale     premature infant pain profile scalenan
no_relation,glucose,pain,12511452,median pain scores interquartile range breast feeding held mothers arms placebo glucose plus pacifier groups     douleur aigu nouveaun scale     premature infant pain profile scalenan
no_relation,glucose,breast feeding,12511452,significant reductions scores breast feeding glucose plus pacifier groups compared two groupsnan
no_relation,glucose,breast feeding,12511452,difference douleur aigu nouveaun scores breast feeding glucose plus pacifier groups significantnan
no_relation,cefdinir,acute bacterial rhinosinusitis,12511857,management update acute bacterial rhinosinusitis use cefdinir nan
no_relation,cefdinir,ABRS,12511857,clinical trial reviewed cefdinir effective treating abrs nan
no_relation,N-acetylcysteine,radiocontrast nephropathy,12556733,review contemporary prevention strategies radiocontrast nephropathy focus fenoldopam n-acetylcysteine nan
no_relation,fenoldopam,radiocontrast nephropathy,12556733,review contemporary prevention strategies radiocontrast nephropathy focus fenoldopam nacetylcysteinenan
no_relation,fenoldopam,RCN,12556733,antihypertensive agent fenoldopam shown canine model well small retrospective prospective randomized human evaluations effective preventing rcn nan
no_relation,NAC/N-acetylcysteine,RCN,12556733,addition studies reported ability free radical scavenger n-acetylcysteine nac prevent rcn nan
no_relation,zoledronic acid,prostate cancer,12562049,adjuvant studies zoledronic acid patients breast prostate cancer development results eagerly anticipatednan
no_relation,Estrogen,hypertensive,12568734,estrogen effect heart rate variability hypertensive postmenopausal womennan
no_relation,estrogen,hypertensive,12568734,examine heart rate variability hrv response estrogen replacement therapy ert association changes metabolic variables hypertensive postmenopausal womennan
no_relation,verapamil,hypertensive,12568734,doubleblind placebocontrolled clinical trial conducted hypertensive postmenopausal women receiving mgday verapamil nan
no_relation,Epinephrine,congenital long-QT syndrome,12598076,epinephrine unmasks latent mutation carriers lqt form congenital longqt syndrome nan
no_relation,Epinephrine,cardiac death,12598076,epinephrine challenge powerful test establish electrocardiographic diagnosis silent lqt mutation carriers thus allowing implementation prophylactic measures aimed reducing sudden cardiac death nan
yes_direct,NMDA,inflammatory pain,12598926,propose hypothesis forebrain nmda receptors play important role persistent inflammatory pain reenforcing glutamate sensory transmission brainnan
no_relation,glutamate,inflammatory pain,12598926,propose hypothesis forebrain nmda receptors play important role persistent inflammatory pain reenforcing glutamate sensory transmission brainnan
yes_direct,NMDA,allodynia,12598926,mice enhanced function forebrain nmda receptors demonstrate selective enhancement persistent pain allodynia nan
yes_direct,NMDA,pain,12598926,mice enhanced function forebrain nmda receptors demonstrate selective enhancement persistent pain allodynianan
no_relation,NMDA,pain,12598926,drugs targeting forebrain nmda nrb receptors may serve new class medicine control persistent pain humansnan
no_relation,nitric oxide,stroke,12605567,potential nitric oxide therapeutics stroke nan
no_relation,NO,stroke,12605567,stroke useful strategy increase availability thereby exploit beneficial antiplatelet antiatherosclerotic haemodynamic neuroprotective propertiesnan
no_relation,NO,stroke,12605567,article reviews developments related therapeutics treatment stroke particular emphasis compounds clinical research development pipelinenan
no_relation,NO,stroke,12605567,although routine use therapeutics prevention treatment stroke cannot currently recommended evidently exciting stage pharmacological developmentnan
yes_direct,tamoxifen,hyperplasia,12627041,simple endometrial hyperplasia diagnosed  samples exposed tamoxifen compared  controls nan
no_relation,estrogen,glandular hyperplasia,12627041,tamoxifen rapidly upregulated cell proliferation markers effect associated enhanced growth confirmed increased expression estrogen receptors ki addition high incidence glandular hyperplasia nan
no_relation,Tamoxifen,glandular hyperplasia,12627041,tamoxifen rapidly upregulated cell proliferation markers effect associated enhanced growth confirmed increased expression estrogen receptors ki addition high incidence glandular hyperplasia nan
no_relation,gossypolone,toxicity,12670651,react easily electrophiles aprotic solvents regenerate gossypolone form dehydrogossypoldithianes dehydrogossypoldithiolanes display higher toxicity kb cellsnan
no_relation,nitric oxide,toxicity,12670651,addition low toxicity gossypol thioderivatives reversed nitric oxide donors physiological medianan
yes_direct,gossypol,toxicity,12670651,addition low toxicity gossypol thioderivatives reversed nitric oxide donors physiological medianan
no_relation,gossypol,tumor,12670651,experiments suggest gossypol gossypolone dithianes dithiolanes used prodrugs target tumor cells surrounded high concentrations nitric oxidenan
no_relation,nitric oxide,tumor,12670651,experiments suggest gossypol gossypolone dithianes dithiolanes used prodrugs target tumor cells surrounded high concentrations nitric oxide nan
no_relation,baclofen,spasticity,12690587,describe oral motor communication nutritional status children receiving intrathecal baclofen itb therapy spasticity cerebral originnan
no_relation,argon,Choroidal neovascularization,12696645,choroidal neovascularization treated argon laser photocoagulationnan
no_relation,cephalosporins,pneumococcal meningitis,12723258,belgium high doses third generation cephalosporins remain effective treatment pneumococcal meningitis nan
no_relation,fluoroquinolones,pneumococcal meningitis,12723258,new fluoroquinolones seem promising agents treatment pneumococcal meningitis futurenan
no_relation,isoniazid,tuberculosis,12734218,retrospective prospective analysis involved outbreak isoniazid resistant tuberculosis cases london united kingdom began cases identified one hospital january nan
no_relation,carbamazepine,AEDs/antiepileptic drugs,12763471,ninety percent antiepileptic drugs aeds commonly valproate carbamazepine nan
no_relation,valproate,AEDs/antiepileptic drugs,12763471,ninety percent antiepileptic drugs aeds commonly valproate carbamazepinenan
no_relation,creatinine,albuminuria,12766114,characteristics nephropaths identified existing screening practice phase albuminuria  mgl three separate urine samples compared identified nurseled management program phase ii screening nephropathy based albuminto creatinine ratio single random urine specimennan
no_relation,creatinine,nephropaths,12766114,characteristics nephropaths identified existing screening practice phase albuminuria  mgl three separate urine samples compared identified nurseled management program phase ii screening nephropathy based albuminto creatinine ratio single random urine specimennan
no_relation,creatinine,nephropathy,12766114,characteristics nephropaths identified existing screening practice phase albuminuria  mgl three separate urine samples compared identified nurseled management program phase ii screening nephropathy based albuminto creatinine ratio single random urine specimennan
no_relation,Thalidomide,leprosy,12803319,thalidomide recently shown considerable promise treatment number conditions leprosy cancernan
no_relation,Thalidomide,cancer,12803319,thalidomide recently shown considerable promise treatment number conditions leprosy cancer nan
no_relation,thalidomide,SelCIDs/selective cytokine inhibitory drugs,12803319,include selective cytokine inhibitory drugs selcids greatly improved tnfalpha inhibitory activity immunomodulatory drugs imids structural analogs thalidomide improved propertiesnan
no_relation,thalidomide,inflammatory disease,12803319,review describes emerging immunological properties thalidomide historical context presentday clinical applications notably multiple myeloma also cancers inflammatory disease hivnan
no_relation,thalidomide,myeloma,12803319,review describes emerging immunological properties thalidomide historical context presentday clinical applications notably multiple myeloma also cancers inflammatory disease hivnan
no_relation,thalidomide,cancers,12803319,review describes emerging immunological properties thalidomide historical context presentday clinical applications notably multiple myeloma also cancers inflammatory disease hivnan
no_relation,thalidomide,HIV,12803319,review describes emerging immunological properties thalidomide historical context presentday clinical applications notably multiple myeloma also cancers inflammatory disease hiv nan
no_relation,thalidomide,cancers,12803319,early trial data suggest novel immunomodulatory compounds may supercede thalidomide become established therapies particularly certain cancers nan
no_relation,phosphate,ESRD/end-stage renal disease,12817070, patients chronic haemodialysis hd serum phosphate level mgdl mmoll recently recommended appropriate target patients endstage renal disease esrd nan
no_relation,Mannitol,acute stroke,12817105,mannitol use acute stroke case fatality days yearnan
no_relation,Mannitol,acute stroke,12817105,mannitol used worldwide treat acute stroke although efficacy safety proven randomized trialsnan
no_relation,mannitol,stroke,12817105,tricenter prospective study analyzed day year case fatality respect mannitol treatment status patients consecutively admitted within hours stroke onsetnan
no_relation,Mannitol,fever,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,Mannitol,stroke,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,aspirin,ischemic strokes,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,aspirin,stroke,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,aspirin,fever,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,Mannitol,ischemic strokes,12817105,mannitol treatment effect adjusted age stroke severity fever first days aspirin treatment ischemic strokes logistic regression modelsnan
no_relation,mannitol,acute stroke,12817105,based results study recommendations made use mannitol acute stroke properly randomized controlled trials performed come final conclusionnan
no_relation,mycophenolate mofetil,ST,12829918,investigated vitro monokine responses patients longterm stable kidney graft function st patients non mycophenolate mofetil mmf mmf patients chronic renal transplant rejection cr patients nonmmfnan
no_relation,mycophenolate mofetil,chronic renal transplant rejection,12829918,investigated vitro monokine responses patients longterm stable kidney graft function st patients non mycophenolate mofetil mmf mmf patients chronic renal transplant rejection cr patients nonmmfnan
no_relation,steroid,ST,12829918,coinciding significantly higher steroid dosage cr patients il receptor tnfr expression monocytes downregulated st nonmmf patientsnan
no_relation,methicillin,methicillin-resistant,12843025,genetic relationship methicillin sensitive methicillin resistant staphylococcus aureus strains france international sources delineation genomic groupsnan
no_relation,methicillin,methicillin-resistant/MRSA,12843025,cluster analysis smai patterns generated pulsedfield gel electrophoresis methicillin resistant mrsa  methicillin sensitive mssa staphylococcus aureus strains isolated various french hospitals mrsa mssa strains countries revealed genomic groups distributed four distantly related phylogenic branchesnan
no_relation,5-fluorouracil,colorectal cancer,12886055,oxaliplatin weekly bolus 5-fluorouracil leucovorin pretreated advanced colorectal cancer patients phase ii studynan
no_relation,Oxaliplatin,colorectal cancer,12886055,oxaliplatin weekly bolus 5-fluorouracil leucovorin pretreated advanced colorectal cancer patients phase ii studynan
no_relation,leucovorin,colorectal cancer,12886055,oxaliplatin weekly bolus 5-fluorouracil leucovorin pretreated advanced colorectal cancer patients phase ii studynan
no_relation,5-FU/5-fluorouracil,colorectal cancer,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil 5-fu leucovorin lv patients 5-fu pretreated advanced colorectal cancer nan
no_relation,oxaliplatin,colorectal cancer,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil fu leucovorin lv patients fupretreated advanced colorectal cancer nan
no_relation,oxaliplatin,toxicity,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil fu leucovorin lv patients fupretreated advanced colorectal cancernan
no_relation,5-FU/5-fluorouracil,toxicity,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil 5-fu leucovorin lv patients 5-fu pretreated advanced colorectal cancernan
no_relation,leucovorin,toxicity,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil fu leucovorin lv patients fupretreated advanced colorectal cancernan
no_relation,leucovorin,colorectal cancer,12886055,purpose study determine efficacy toxicity oxaliplatin combination weekly bolus 5-fluorouracil fu leucovorin lv patients fupretreated advanced colorectal cancer nan
no_relation,5-FU,colorectal cancer,12886055,total patients documented 5-fu resistant advanced colorectal cancer enrollednan
no_relation,5-FU,colorectal cancer,12886055,oxaliplatin combination weekly bolus 5-fu lv also active patients advanced colorectal cancer firstline treatment failednan
no_relation,Oxaliplatin,colorectal cancer,12886055,oxaliplatin combination weekly bolus fulv also active patients advanced colorectal cancer firstline treatment failednan
no_relation,atorvastatin,acute coronary syndromes,12888133,comparison clinical benefits clopidogrel therapy patients acute coronary syndromes taking atorvastatin versus statin therapiesnan
no_relation,clopidogrel,acute coronary syndromes,12888133,comparison clinical benefits clopidogrel therapy patients acute coronary syndromes taking atorvastatin versus statin therapiesnan
no_relation,atorvastatin,acute coronary syndromes,12888133,clinical practice found significant difference atorvastatin therapy statin therapies clinical outcomes patients acute coronary syndromes receiving clopidogrel therapynan
no_relation,clopidogrel,acute coronary syndromes,12888133,clinical practice found significant difference atorvastatin therapy statin therapies clinical outcomes patients acute coronary syndromes receiving clopidogrel therapynan
no_relation,clopidogrel,stroke,12888133,patients receiving atorvastatin therapy clopidogrel therapy associated significant decrease mortality stroke univariate analysis moderate trend reduced mortality stroke without statistical significance multivariate analysisnan
no_relation,atorvastatin,stroke,12888133,patients receiving atorvastatin therapy clopidogrel therapy associated significant decrease mortality stroke univariate analysis moderate trend reduced mortality stroke without statistical significance multivariate analysisnan
no_relation,glutamine,burn injury,12903886,research conducted evaluate effect enterally administered glutamine gln dipeptide metabolic gastrointestinal outcome parameters severe burn injury nan
no_relation,mannitol,burn injury,12903886,lactulose mannitol ratios increased normal pod control  gln  significant reflecting increased intestinal permeability burn injury nan
no_relation,Lactulose,burn injury,12903886,lactulose mannitol ratios increased normal pod control  gln  significant reflecting increased intestinal permeability burn injury nan
no_relation,acetylcholine,hypertensive,12913059,compared doseresponse curves relating changes coronary blood flow epicardial diameter graded infusions acetylcholine african american white subjects hypertensive left ventricular hypertrophy lvh normal coronary arteriesnan
no_relation,acetylcholine,left ventricular hypertrophy/LVH,12913059,compared doseresponse curves relating changes coronary blood flow epicardial diameter graded infusions acetylcholine african american white subjects hypertensive left ventricular hypertrophy lvh normal coronary arteriesnan
no_relation,Adenosine,LVH,12913059,adenosine responses measure endotheliumindependent function similar partitioning lvh nan
no_relation,acetylcholine,LVH,12913059,study demonstrates racial differences sensitivity coronary arteries acetylcholine stimulated relaxation among lvh nan
no_relation,nickel,dermatitis,12915773,recently several studies reported patients affected cutaneous diseases ie dermatitis eczema urticaria positive patch test nickel positive oral nickel challengenan
no_relation,nickel,eczema,12915773,recently several studies reported patients affected cutaneous diseases ie dermatitis eczema urticaria positive patch test nickel positive oral nickel challengenan
yes_direct,nickel,urticaria,12915773,recently several studies reported patients affected cutaneous diseases ie dermatitis eczema urticaria positive patch test nickel positive oral nickel challengenan
no_relation,nickel,hypersensitivity,12915773,results study demonstrate patients positive patch test nickel sulphate perpetuation ras related hypersensitivity ingested nickel salts independently local contact nickel nan
no_relation,Telithromycin,community-acquired pneumonia,12925111,telithromycin mg daily seven ten days effective welltolerated treatment communityacquired pneumonia nan
no_relation,telithromycin/HMR 3647,CAP/community-acquired pneumonia,12925111,open multinational study examined efficacy tolerability telithromycin hmr  first ketolide antibacterial agent oral dose mg daily seven ten days validated using pharmacokinetic analysis empiric therapy adults mild moderate communityacquired pneumonia cap nan
no_relation,telithromycin,CAP,12925111,oral dose telithromycin mg daily seven ten days effective welltolerated firstline treatment mild moderate cap adultsnan
no_relation,ibandronate,skeletal complications,12954579,intravenous ibandronate reduces incidence skeletal complications patients breast cancer bone metastasesnan
no_relation,ibandronate,breast cancer,12954579,intravenous ibandronate reduces incidence skeletal complications patients breast cancer bone metastasesnan
no_relation,bisphosphonate,breast cancer,12954579,phase iii study compared efficacy new potent bisphosphonate ibandronate placebo intravenous iv therapy metastatic bone disease due breast cancer nan
no_relation,bisphosphonate,bone disease,12954579,phase iii study compared efficacy new potent bisphosphonate ibandronate placebo intravenous iv therapy metastatic bone disease due breast cancernan
no_relation,ibandronate,breast cancer,12954579,phase iii study compared efficacy new potent bisphosphonate ibandronate placebo intravenous iv therapy metastatic bone disease due breast cancer nan
no_relation,ibandronate,bone disease,12954579,phase iii study compared efficacy new potent bisphosphonate ibandronate placebo intravenous iv therapy metastatic bone disease due breast cancernan
no_relation,ibandronate,bone pain,12954579,patients ibandronate mg also experienced decreased bone pain scores analgesic usenan
no_relation,ibandronate,breast cancer,12954579,results indicate mg iv ibandronate effective safe treatment bone metastases breast cancer nan
no_relation,levofloxacin,bacterial keratitis,12967804,gatifloxacin moxifloxacin vitro susceptibility comparison levofloxacin ciprofloxacin ofloxacin using bacterial keratitis isolatesnan
no_relation,moxifloxacin,bacterial keratitis,12967804,gatifloxacin moxifloxacin vitro susceptibility comparison levofloxacin ciprofloxacin ofloxacin using bacterial keratitis isolatesnan
no_relation,ciprofloxacin,bacterial keratitis,12967804,gatifloxacin moxifloxacin vitro susceptibility comparison levofloxacin ciprofloxacin ofloxacin using bacterial keratitis isolatesnan
no_relation,Gatifloxacin,bacterial keratitis,12967804,gatifloxacin moxifloxacin vitro susceptibility comparison levofloxacin ciprofloxacin ofloxacin using bacterial keratitis isolatesnan
no_relation,ofloxacin,bacterial keratitis,12967804,gatifloxacin moxifloxacin vitro susceptibility comparison levofloxacin ciprofloxacin ofloxacin using bacterial keratitis isolatesnan
no_relation,ciprofloxacin/CIP,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,OFX/ofloxacin,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,LEV/levofloxacin,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,moxifloxacin/MOX,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,fluoroquinolone/fluoroquinolones,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,gatifloxacin,bacterial keratitis,12967804,compared vitro susceptibility patterns minimum inhibitory concentrations mics gatifloxacin gat moxifloxacin mox fourthgeneration fluoroquinolones ciprofloxacin cip ofloxacin ofx secondgeneration fluoroquinolones levofloxacin lev thirdgeneration fluoroquinolone using bacterial keratitis isolatesnan
no_relation,OFX,bacterial keratitis,12967804,retrospect mics bacterial keratitis isolates determined cip ofx lev gat mox using testsnan
no_relation,fluoroquinolones,keratitis,12967804,keratitis isolates susceptibility differences among five fluoroquinolones nan
no_relation,fluoroquinolones,bacterial keratitis,12967804,based vitro testing fourthgeneration fluoroquinolones may offer advantages currently available treatment bacterial keratitis nan
yes_direct,hydroxyapatite,suppurative granuloma,12967870,five patients hydroxyapatite implants showed lid swelling discharge suppurative granuloma days years surgerynan
no_relation,hydroxyapatite,Staphylococcus epidermidis,12967870,culture specimens removed swabs conjunctiva patients hydroxyapatite implants showed growth staphylococcus aureus staphylococcus epidermidis alphahemolytic streptococcus peptostreptococcus patients whereas streptococcus pyogenes cultured conjunctiva medpor implant patientnan
no_relation,steroid,ITP,12975552,reviewed medical records children adolescents chronic itp  splenectomized steroid resistant steroid dependent managed repeated courses intravenous immunoglobulin ivignan
no_relation,cyclosporine,lichen planopilaris,14512914,short course oral cyclosporine lichen planopilaris nanprobably used treatment
no_relation,cyclosporine,lichen planopilaris,14512914,present patients lichen planopilaris treated short course oral cyclosporine report clinical features responses using standardized method patient assessment specific outcome measuresnan
yes_direct,nitrous oxide,analgesia,14558199,inhalation sedation nitrous oxide oxygen sedation reach plane relative analgesia may administered easily safely children general dental practice potential alternative general anaesthesianan
no_relation,oxygen,analgesia,14558199,inhalation sedation nitrous oxide oxygen sedation reach plane relative analgesia may administered easily safely children general dental practice potential alternative general anaesthesianan
no_relation,nystatin,MCD,14565868,cell lines ra mc sigm aggregated patches insensitive disruption cholesterolrich membrane microdomains nystatin beta mcd nan
no_relation,cholesterol,MCD,14565868,cell lines ra mc sigm aggregated patches insensitive disruption cholesterol rich membrane microdomains nystatin beta mcd nan
no_relation,nystatin,MCD,14565868,however case lipid raft inhibitors nystatin beta mcd disrupted patchingnan
no_relation,nystatin,MCD,14565868,cells bcrmediated apoptosis affected nystatin treatment whereas increased beta mcd pretreated cellsnan
no_relation,9-methoxycanthin-6-one,human lung cancer,14575431,compounds screened vitro cytotoxic antimalarial activities 9-methoxycanthin-6-one canthin-6-one demonstrated significant cytotoxicity human lung cancer human breast cancer mcf cell linesnan
no_relation,canthin-6-one,breast cancer,14575431,compounds screened vitro cytotoxic antimalarial activities 9-methoxycanthin-6-one canthin-6-one demonstrated significant cytotoxicity human lung cancer human breast cancer mcf cell linesnan
no_relation,9-methoxycanthin-6-one,breast cancer,14575431,compounds screened vitro cytotoxic antimalarial activities 9-methoxycanthin-6-one canthin-6-one demonstrated significant cytotoxicity human lung cancer human breast cancer mcf cell linesnan
no_relation,canthin-6-one,human lung cancer,14575431,compounds screened vitro cytotoxic antimalarial activities 9-methoxycanthin-6-one canthin-6-one demonstrated significant cytotoxicity human lung cancer human breast cancer mcf cell linesnan
no_relation,fentanyl,chronic pain,14583070,benefitrisk assessment transdermal fentanyl treatment chronic pain nan
no_relation,fentanyl,chronic pain,14583070,transdermal fentanyl effective well tolerated treatment chronic pain caused malignancy nonmalignant conditions administered according manufacturers recommendationsnan
yes_direct,fentanyl,vomiting,14583070,compared oral opioids advantages transdermal fentanyl include lower incidence impact adverse effects constipation nausea vomiting daytime drowsiness higher degree patient satisfaction improved quality life improved convenience compliance resulting administration every hours decreased use rescue medicationnan
no_relation,fentanyl,constipation,14583070,compared oral opioids advantages transdermal fentanyl include lower incidence impact adverse effects constipation nausea vomiting daytime drowsiness higher degree patient satisfaction improved quality life improved convenience compliance resulting administration every hours decreased use rescue medicationnan
no_relation,fentanyl,nausea,14583070,compared oral opioids advantages transdermal fentanyl include lower incidence impact adverse effects constipation nausea vomiting daytime drowsiness higher degree patient satisfaction improved quality life improved convenience compliance resulting administration every hours decreased use rescue medicationnan
no_relation,fentanyl,gastrointestinal problems,14583070,transdermal fentanyl useful analgesic cancer patients unable swallow gastrointestinal problems nan
no_relation,fentanyl,cancer,14583070,transdermal fentanyl useful analgesic cancer patients unable swallow gastrointestinal problemsnan
no_relation,fentanyl,chronic pain/pain,14583070,patients chronic pain titrated adequate relief shortacting oral parenteral opioids prior initiation transdermal fentanyl order prevent exacerbations pain opioidrelated adverse effectsnanused treatment
no_relation,fentanyl,analgesia,14583070,transdermal fentanyl initiated based hour opioid requirement adequate analgesia achievednan
yes_direct,fentanyl,hypoventilation,14583070,prolonged elimination transdermal fentanyl become problematic patients develop opioidrelated adverse effects especially hypoventilation nan
no_relation,naloxone,toxicity,14583070,patients experience opioidrelated toxicity associated respiratory depression treated immediately opioid antagonist naloxone closely monitored least hoursnan
no_relation,naloxone,respiratory depression,14583070,patients experience opioidrelated toxicity associated respiratory depression treated immediately opioid antagonist naloxone closely monitored least hoursnan
yes_direct,fentanyl,hypoventilation,14583070,transdermal fentanyl administered cautiously patients preexisting conditions emphysema may predispose development hypoventilation nan
no_relation,fentanyl,emphysema,14583070,transdermal fentanyl administered cautiously patients preexisting conditions emphysema may predispose development hypoventilationnan
no_relation,fentanyl,chronic pain,14583070,transdermal fentanyl indicated patients require continuous opioid administration treatment chronic pain cannot managed medicationsnan
no_relation,fentanyl,pain/postoperative pain,14583070,contraindicated management acute postoperative pain pain may decrease rapidly circumstances fentanyl blood levels adjusted leading development lifethreatening hypoventilationnan
yes_direct,fentanyl,hypoventilation,14583070,contraindicated management acute postoperative pain pain may decrease rapidly circumstances fentanyl blood levels adjusted leading development lifethreatening hypoventilation nan
yes_direct,fentanyl,physical impairments,14583070,cognitive physical impairments confusion abnormal coordination occur transdermal fentanyl nan
yes_direct,fentanyl,confusion,14583070,cognitive physical impairments confusion abnormal coordination occur transdermal fentanyl nan
no_relation,valdecoxib,dyspepsia,14585916,comparative trials celecoxib valdecoxib nonspecific nsaids coxspecific inhibitors demonstrated superior dyspepsia tolerability nonspecific nsaidsnan
no_relation,celecoxib,dyspepsia,14585916,comparative trials celecoxib valdecoxib nonspecific nsaids coxspecific inhibitors demonstrated superior dyspepsia tolerability nonspecific nsaidsnan
no_relation,camptothecin,mixed oligoastrocytoma,14586216,determine efficacy toxicity novel chemotherapeutic approach topotecan camptothecin analog progressive recurring anaplastic oligodendroglioma mixed oligoastrocytoma patients seven centers recurrent progressive disease treated topotecan mgm intravenously iv min dailyx days every weeksnanused treatment
no_relation,camptothecin,toxicity,14586216,determine efficacy toxicity novel chemotherapeutic approach topotecan camptothecin analog progressive recurring anaplastic oligodendroglioma mixed oligoastrocytomapatients seven centers recurrent progressive disease treated topotecan mgm intravenously iv min dailyx days every weeksnan
no_relation,PCBs,cancer,14594106,potential human cancer risks exposure pcbs tale two evaluationsnan
no_relation,PCBs,cancer,14594106,reviewing potential human carcinogenicity pcbs atsdr concluded weight evidence support causal association pcbs human cancer timenan
yes_direct,PCBs,cancer,14594106,present review addresses additional scientific data became available atsdr  evaluations magnitude offset weight evidence numerous epidemiological studies exposure pcbs causally associated human cancer conclusion year later meaningful evidence pcbs posed carcinogenic risk humansnan
no_relation,estrogen,tumors,14654938,levels crash mrna significantly upregulated tumors compared normal breast tissues correlate lack estrogen receptor expression tumors nan
no_relation,prednisone,hypocretin-deficiency narcolepsy,14655912,report case immunosuppression prednisone yearold boy acute onset hypocretindeficiency narcolepsy nan
no_relation,prednisone,narcolepsy,14655912,explore whether acute destruction hypocretin cells patient narcolepsy could detected course disease could reversed altered use prednisone immunosuppressionnan
no_relation,dopamine,breast cancer,14659314,dopamine antagonists risk factor breast cancer nan
no_relation,dopamine,breast cancer/cancer,14659314,women undergoing chemotherapy breast cancer often administered dopamine antagonist adjuvant medications may increase levels prolactin potentially increasing risk cancer nan
no_relation,dopamine,Parkinson's disease/PD,14659314,using nationwide computerized registers death data years  examined deaths persons years age extracted cases parkinson's disease pd dopamine deficient populationnan
no_relation,methylenecyclopropane,HHV-8/EBV,14714760,results indicate members series methylenecyclopropane analogs highly active hcmv hhv hhv less active hsv vzv ebv nan
no_relation,methylenecyclopropane,VZV,14714760,results indicate members series methylenecyclopropane analogs highly active hcmv hhv hhv less active hsv vzv ebvnan
no_relation,clomiphene citrate,polycystic ovary syndrome,14739186, patients clomiphene citrate resistant polycystic ovary syndrome  allocated electrocautery allocated recombinant follicle stimulating hormonenan
no_relation,clomiphene citrate,multiple pregnancy,14739186,ongoing pregnancy rate ovulation induction laparoscopic electrocautery followed clomiphene citrate recombinant follicle stimulating hormone anovulation persisted recombinant follicle stimulating hormone seems equivalent ovulation induction recombinant follicle stimulating hormone former procedure carries lower risk multiple pregnancy nan
no_relation,apigenin,prostate carcinoma,14750216,molecular mechanisms apigenin induced cellcycle arrest apoptosis hormone refractory human prostate carcinoma du cellsnan
no_relation,apigenin,prostate carcinoma,14750216,reported recently apigenin trihydroxyflavone found many common fruits vegetables shown remarkable effects inhibiting cell growth inducing apoptosis many human prostate carcinoma cellsnan
no_relation,apigenin,prostate carcinoma,14750216,demonstrate molecular mechanism inhibitory action apigenin androgenrefractory human prostate carcinoma du cells mutations tumor suppressor gene prbnan
no_relation,androgen,prostate carcinoma,14750216,demonstrate molecular mechanism inhibitory action apigenin androgen refractory human prostate carcinoma du cells mutations tumor suppressor gene prbnan
no_relation,apigenin,tumor,14750216,demonstrate molecular mechanism inhibitory action apigenin androgenrefractory human prostate carcinoma du cells mutations tumor suppressor gene prbnan
no_relation,androgen,tumor,14750216,demonstrate molecular mechanism inhibitory action apigenin androgen refractory human prostate carcinoma du cells mutations tumor suppressor gene prbnan
yes_direct,nickel,respiratory cancer,14963251,excess risks respiratory cancer demonstrated groups nickel exposed workersnan
yes_direct,nickel,cancer/nasal cancer,14963251,aim determine whether occupational exposures received manufacture nickel alloys lead increased risks cancer particular nasal cancer lung cancernan
yes_direct,nickel,lung cancer,14963251,aim determine whether occupational exposures received manufacture nickel alloys lead increased risks cancer particular nasal cancer lung cancer nan
no_relation,N- (4-hydroxyphenyl)retinamide,breast cancer,14973114,cyclooxygenase essential herneu suppress hydroxyphenylretinamide apoptotic effects breast cancer cellsnan
no_relation,nitric oxide,breast cancer,14973114,reported herneu reduces sensitivity breast cancer cells n-(4-hydroxyphenyl)retinamide hpr suppressing nitric oxide productionnan
no_relation,N-(4-hydroxyphenyl)retinamide,breast cancer,14973114,reported herneu reduces sensitivity breast cancer cells n-(4-hydroxyphenyl)retinamide hpr suppressing nitric oxide productionnan
no_relation,prostaglandin E(2),breast cancer,14973114,apoptosis induced hpr cox inhibitor combination although unaffected antiherneu antibody reversed cox product prostaglandin indicating cox major mechanism herneu suppresses hpr apoptosis breast cancer cellsnan
no_relation,tyrosine,ABL,14987801,chromosomal translocations tyrosine kinase abl gene chromosome may generate oncogenic kinases exhibiting constitutive tyrosine kinase activitynan
no_relation,tyrosine,ABL,14987801,recently shown abl fusion oncogenic tyrosine kinases bcr abl tel abl specific hematopoietic malignances induced resistance dnadamaging agentsnan
no_relation,tyrosine,hematopoietic malignances,14987801,recently shown ablfusion oncogenic tyrosine kinases bcrabl telabl specific hematopoietic malignances induced resistance dnadamaging agentsnan
no_relation,idarubicin,ABL,14987801,elucidate role dna repair phenomenon examined capacity murine baf lymphoid cells tel abl transformed counterparts repair dna lesions caused gamma uvradiations anticancer drug idarubicin nan
no_relation,idarubicin,cancer,14987801,elucidate role dna repair phenomenon examined capacity murine baf lymphoid cells telabltransformed counterparts repair dna lesions caused gamma uvradiations anti cancer drug idarubicin nan
no_relation,idarubicin,ABL,14987801,also examined capability bcr abl fusion modulate repair oxidative lesions considered major side effect various anticancer drugs including idarubicin radiationnan
no_relation,idarubicin,cancer,14987801,also examined capability bcrablfusion modulate repair oxidative lesions considered major side effect various anti cancer drugs including idarubicin radiationnan
no_relation,alpha-phenyl-N-tert-butyl nitrone/PBN,ABL,14987801,employing free radical scavenger alphaphenylntertbutyl nitrone pbn spin trap dna repair enzymes endonuclease iii endoiii nicks dna sites oxidized bases found bcr abl transformed cells repaired oxidative dna lesions effectively control cellsnan
no_relation,oxygen,hypertension,15030300,reactive oxygen species vascular biology role arterial hypertension nan
no_relation,oxygen,vascular injury,15030300,development evoked considerable interest possibilities therapies targeted reactive oxygen intermediates decreasing generation reactive oxygen species andor increasing availability antioxidants may useful minimizing vascular injury nan
no_relation,oxygen,hypertension,15030300,review focuses vascular actions reactive oxygen species role oxidative stress vascular damage hypertension therapeutic potential modulating oxygen radical bioavailability hypertension nan
no_relation,oxygen,vascular damage,15030300,review focuses vascular actions reactive oxygen species role oxidative stress vascular damage hypertension therapeutic potential modulating oxygen radical bioavailability hypertensionnan
no_relation,oxygen,hypertension,15030300,particular following topics highlighted chemistry sources reactive oxygen species antioxidant defense mechanisms signaling events mediated reactive oxygen species role reactive oxygen species hypertension putative therapeutic role antioxidants cardiovascular diseasenan
no_relation,oxygen,cardiovascular disease,15030300,particular following topics highlighted chemistry sources reactive oxygen species antioxidant defense mechanisms signaling events mediated reactive oxygen species role reactive oxygen species hypertension putative therapeutic role antioxidants cardiovascular disease nan
no_relation,ethanol,hepatocellular carcinoma,15040025,comparison longterm effects intraarterially delivered ethanol gelfoam treatment severe arterioportal shunt patients hepatocellular carcinoma nan
no_relation,ethanol,arterioportal shunt,15040025,comparison longterm effects intraarterially delivered ethanol gelfoam treatment severe arterioportal shunt patients hepatocellular carcinomanan
no_relation,ethanol,HCC/hepatocellular carcinoma,15040025,evaluate longterm effect ethanol embolization treatment hepatocellular carcinoma hcc severe hepatic arterioportal shunt aps compared gelfoam embolizationnan
no_relation,ethanol,APS/arterioportal shunt,15040025,evaluate longterm effect ethanol embolization treatment hepatocellular carcinoma hcc severe hepatic arterioportal shunt aps compared gelfoam embolizationnan
no_relation,ethanol,HCC,15040025,sixtyfour patients ethanol group patients gelfoam group hcc aps respectively treated ethanol gelfoam aps routine interventional treatment tumornan
no_relation,ethanol,tumor,15040025,sixtyfour patients ethanol group patients gelfoam group hcc aps respectively treated ethanol gelfoam aps routine interventional treatment tumor nan
no_relation,ethanol,APS,15040025,sixtyfour patients ethanol group patients gelfoam group hcc aps respectively treated ethanol gelfoam aps routine interventional treatment tumornan
no_relation,ethanol,APS,15040025,occlusion rate aps initial treatment ethanol group recanalization rate month embolization complete occlusion rate nan
no_relation,ethanol,HCC,15040025,ethanol group significant prolongation survival patients monofocal hccnan
yes_direct,ethanol,abdominal pain,15040025,incidence rate abdominal pain procedure ethanol group nan
no_relation,ethanol,hepatic failure,15040025,procedurerelated hepatic failure occur ethanol groupnan
no_relation,Ethanol,HCC,15040025,ethanol embolization patients hcc severe aps efficacious safe may contribute prolongation life span versus gelfoam embolizationnan
no_relation,Ethanol,APS,15040025,ethanol embolization patients hcc severe aps efficacious safe may contribute prolongation life span versus gelfoam embolizationnan
no_relation,CsA,chronic allograft nephropathy,15041316,partly attributed side effects csa partly fact use csa led reduced incidence chronic allograft nephropathy nan
yes_direct,CsA,toxicity,15041316,thus continuing search strategies minimize csa toxicity maintain adequate immunosuppressionnan
no_relation,Thalidomide,inflammatory skin diseases,15057007,thalidomide nphtalimidoglutarimide initially used tranquilizer recently used management several inflammatory skin diseases nan
no_relation,thalidomide,LCH,15057007,conclusion thalidomide monotherapy represents effective safe welltolerated treatment option considered firstline therapy mucocutaneous lch nan
no_relation,CO(2),hypercapnia,15064270,normocapnia hypercapnia vop change significantly mean sd  cmsec  cmsec endtidal co(2) et co(2)   mmhg  mmhg respectivelynan
no_relation,CO(2),hypocapnia,15064270,co(2) reactivity slope vop normocapnia hypocapnia per mmhgnan
no_relation,MTH-68/H,aggressive neuroectodermal neoplasm,15072452,report administration mth-68/h patients glioblastoma multiforme common aggressive neuroectodermal neoplasm poor prognosis averaging six months yearnan
no_relation,MTH-68/H,glioblastoma,15072452,report administration mth-68/h patients glioblastoma multiforme common aggressive neuroectodermal neoplasm poor prognosis averaging six months yearnan
yes_direct,olanzapine,diabetes mellitus,15107197,management diabetes mellitus occurring treatment olanzapine report six cases clinical implicationsnan
yes_direct,clozapine,glucose dysregulation or new onset diabetes mellitus,15107197,spite conflicting reports emerging evidence least two atypical antipsychotics clozapine olanzapine associated increased risk developing glucose dysregulation new onset diabetes mellitus nan
yes_direct,olanzapine,glucose dysregulation or new onset diabetes mellitus,15107197,spite conflicting reports emerging evidence least two atypical antipsychotics clozapine olanzapine associated increased risk developing glucose dysregulation new onset diabetes mellitus nan
no_relation,glucose,glucose dysregulation or new onset diabetes mellitus,15107197,spite conflicting reports emerging evidence least two atypical antipsychotics clozapine olanzapine associated increased risk developing glucose dysregulation new onset diabetes mellitusnan
yes_direct,olanzapine,diabetes,15107197,report management six patients developed diabetes mellitus following treatment olanzapine five independent risk factors diabetes nan
yes_direct,olanzapine,diabetes mellitus,15107197,report management six patients developed diabetes mellitus following treatment olanzapine five independent risk factors diabetesnan
no_relation,olanzapine,diabetes,15107197,view uncertainty size mechanism link olanzapine diabetes discuss issues surrounding routine clinical management monitoring patients antipsychotics clinical implicationsnan
no_relation,fluoxetine,major depressive disorder,15119918,somatic symptoms predictors time onset response fluoxetine major depressive disorder nan
no_relation,fluoxetine,major depressive disorder/MDD,15119918,present study assessed relationship somatic symptoms time onset clinical response fluoxetine patients major depressive disorder mdd nan
no_relation,fluoxetine,DSM-III-R MDD,15119918, outpatients mean age   years women dsmiiir mdd sustained acute response fluoxetine completed symptom questionnaire sq baselinenandisease preexisting condition
no_relation,fluoxetine,MDD,15119918,somatic symptoms depression found associated delayed onset antidepressant response fluoxetine mdd nan
yes_direct,fluoxetine,depression,15119918,somatic symptoms depression found associated delayed onset antidepressant response fluoxetine mddnan
no_relation,cholesterol,atherosclerosis,15136056,conjugated linoleic acid atherosclerosis effect molecular markers cholesterol homeostasis thp macrophagesnan
no_relation,linoleic acid,atherosclerosis,15136056,conjugated linoleic acid atherosclerosis effect molecular markers cholesterol homeostasis thp macrophagesnan
no_relation,cholesterol,atherosclerosis,15136056,macrophage cholesterol homeostasis key process involved initiation progression atherosclerosis nan
yes_direct,cholesterol,atherosclerosis,15136056,peroxisome proliferatoractivated receptors ppars regulate transcription genes involved cholesterol homeostasis thus represent important therapeutic target terms reducing atherosclerosis nan
no_relation,linoleic acid,atherosclerosis,15136056,conjugated linoleic acid cla potent antiatherogenic dietary fatty acid animal models atherosclerosis capable activating ppars vitro vivonan
no_relation,simvastatin,multiple sclerosis,15145635,oral simvastatin treatment relapsingremitting multiple sclerosis nan
no_relation,simvastatin,multiple sclerosis,15145635,aimed investigate use oral simvastatin mg individuals relapsingremitting multiple sclerosis nan
no_relation,simvastatin,neurological disability,15145635,oral simvastatin might inhibit inflammatory components multiple sclerosis lead neurological disability nan
no_relation,simvastatin,multiple sclerosis,15145635,oral simvastatin might inhibit inflammatory components multiple sclerosis lead neurological disabilitynan
no_relation,glibenclamide,undergoing aggressive diabetes management,15163121,conclusion severe hypoglycaemia serious uncommon problem among elderly patients tdm frequent patients undergoing aggressive diabetes management users longacting sulphonylurea eg glibenclamide nan
no_relation,glibenclamide,T2DM,15163121,conclusion severe hypoglycaemia serious uncommon problem among elderly patients t2dm frequent patients undergoing aggressive diabetes management users longacting sulphonylurea eg glibenclamide nan
no_relation,glucose,diabetes mellitus,15163121,finally patients risk hypoglycaemia considered therapy individualised accordingly opinion great number episodes serious hypoglycaemia may prevented teaching principles blood glucose monitoring involving general practitioners outpatient management diabetes mellitus elderlynan
yes_direct,Na(+),heart failure,15165985, na(+) ncx expression reported increased human heart failure nan
no_relation,artemisinins,tumor,15183112,oxidative stress response tumor cells microarraybased comparison artemisinins anthracyclinesnan
no_relation,anthracyclines,tumor,15183112,oxidative stress response tumor cells microarraybased comparison artemisinins anthracyclines nan
no_relation,artemisinins,tumor,15183112,antimalarial artemisinins also reveal profound cytotoxic activity tumor cellsnan
yes_direct,anthracyclines,cardiotoxicity,15183112,established cancer drugs anthracyclines also form ros free radicals responsible cardiotoxicity anthracyclines nan
no_relation,anthracyclines,cancer,15183112,established cancer drugs anthracyclines also form ros free radicals responsible cardiotoxicity anthracyclines nan
no_relation,artemisinins,cardiotoxicity,15183112,contrast artemisinins reveal cardiotoxicity nan
no_relation,Vitamin B(12),anemia,15186711,frequent strategies included dietary changes vitamins modification routines rest exercise prescribed medications anemia vitamin deficiency testosterone deficiencynan
no_relation,Vitamin B(12),testosterone deficiency,15186711,frequent strategies included dietary changes vitamins modification routines rest exercise prescribed medications anemia vitamin deficiency testosterone deficiency nan
no_relation,testosterone,anemia,15186711,frequent strategies included dietary changes vitamins modification routines rest exercise prescribed medications anemia vitamin deficiency testosterone deficiencynan
no_relation,testosterone,testosterone deficiency,15186711,frequent strategies included dietary changes vitamins modification routines rest exercise prescribed medications anemia vitamin deficiency testosterone deficiencynan
no_relation,Imatinib,chronic myelogenous leukemia,15215876,imatinib therapy chronic myelogenous leukemia strategies avoid overcome resistancenan
no_relation,Imatinib,CML/chronic myelogenous leukemia,15215876,imatinib molecularly targeted therapy inhibits oncogenic fusion protein bcrabl tyrosine kinase involved pathogenesis chronic myelogenous leukemia cml nanused treatment
yes_direct,tyrosine,CML/chronic myelogenous leukemia,15215876,imatinib molecularly targeted therapy inhibits oncogenic fusion protein bcrabl tyrosine kinase involved pathogenesis chronic myelogenous leukemia cml nan
no_relation,imatinib,CML,15215876,selective inhibition bcrabl activity imatinib demonstrated efficacy treatment cml particularly chronic phasenan
no_relation,imatinib,advanced disease,15215876,patients however primarily advanced disease either refractory imatinib eventually relapsenan
no_relation,imatinib,CML,15215876,observations recent trials imatinib combined insights provided increased understanding molecular mechanisms resistance established rationale strategies avoid overcome imatinib resistance management cml patientsnan
no_relation,Delta(9)-THC,THC,15302527,clinical point view delta thc produces therapeutic benefits beyond reasonable doubtnan
no_relation,Delta(9)-THC,THC,15302527,delta thc devoid ill effectsnan
no_relation,THC,THC,15302527,psychic area delta thc may induce unpleasant reactions disconnected thoughts panic reactions disturbing changes perception delusions hallucinatory experiencesnan
no_relation,Delta(9)-THC,THC,15302527,however long term effects psyche cognition known reports prolonged use delta thc nan
no_relation,Delta(9)-THC,THC,15302527,actually proposed delta thc rescheduled schedule iv united nations convention psychotropic drugs constitute substantial risk public health abuse rarenan
yes_direct,clozapine,pericarditis,15319023,chart review potential features myocarditis pericarditis cardiomyopathy children adolescents treated clozapine nan
yes_direct,clozapine,myocarditis,15319023,chart review potential features myocarditis pericarditis cardiomyopathy children adolescents treated clozapine nan
yes_direct,clozapine,cardiomyopathy,15319023,chart review potential features myocarditis pericarditis cardiomyopathy children adolescents treated clozapine nan
yes_direct,Clozapine,pericarditis,15319023,clozapine known cause cardiac side effects including myocarditis pericarditis cardiomyopathynan
yes_direct,Clozapine,myocarditis,15319023,clozapine known cause cardiac side effects including myocarditis pericarditis cardiomyopathynan
yes_direct,Clozapine,cardiomyopathy,15319023,clozapine known cause cardiac side effects including myocarditis pericarditis cardiomyopathy nan
yes_direct,clozapine,pericarditis,15319023,prompted case clozapine related pericarditis adolescent undertook retrospective chart review discover whether unrecognized cases myocarditis pericarditis cardiomyopathy among children adolescents young adults treated clozapine nan
yes_direct,clozapine,myocarditis,15319023,prompted case clozapine related pericarditis adolescent undertook retrospective chart review discover whether unrecognized cases myocarditis pericarditis cardiomyopathy among children adolescents young adults treated clozapine nan
yes_direct,clozapine,cardiomyopathy,15319023,prompted case clozapine related pericarditis adolescent undertook retrospective chart review discover whether unrecognized cases myocarditis pericarditis cardiomyopathy among children adolescents young adults treated clozapine nan
no_relation,clozapine,such disorder,15319023,exception case prompted study none patients found developed disorder course treatment clozapine nan
no_relation,atorvastatin,ACS,15326073,early aggressive lipidlowering therapy atorvastatin months significantly reduced plaque volume patients acs nan
no_relation,moxifloxacin,iatrogenic oral bacteremia,15327647,vitro activity moxifloxacin compared antimicrobials streptococci isolated iatrogenic oral bacteremia spainnan
no_relation,moxifloxacin,focal infections,15327647,isolates showed low mic moxifloxacin vitro making promising antimicrobial alternative prevention streptococcal focal infections associated certain dental manipulations administration beta-lactam agents indicatednan
no_relation,beta-lactam,focal infections,15327647,isolates showed low mic moxifloxacin vitro making promising antimicrobial alternative prevention streptococcal focal infections associated certain dental manipulations administration beta-lactam agents indicatednan
yes_direct,Interferon-alpha,symptoms of depression,15331126,interferon-alpha ifnalpha treatment frequently complicated symptoms depression nan
no_relation,NO,neuroblastoma,15331636,studied regulatory function neuroblastoma cell lines sknbe primary cerebellar granule cell culturesnan
no_relation,retinoic acid,neuroblastoma,15331636,neuronal synthase nnos overexpressing neuroblastoma cell line exposed differentiative action retinoic acid slowed proliferation accelerated differentiation towards neuronal phenotypenan
no_relation,NO,neuroblastoma,15331636,neuronal synthase nnos overexpressing neuroblastoma cell line exposed differentiative action retinoic acid slowed proliferation accelerated differentiation towards neuronal phenotypenan
no_relation,NO,neuroblastoma,15331636,high nmyc expression level essential neuroblastoma progression well proliferation neuronal precursors negative regulation highlights novel physiopathological function important messenger moleculenan
no_relation,glucose,tumor,15339968,effect tumor cells blocking survival response glucose deprivationnan
no_relation,Glucose,Glucose deprivation,15339968,glucose deprivation feature poorly vascularized solid tumors activates unfolded protein response upr stresssignaling pathway tumor cellsnan
no_relation,Glucose,tumor/tumors,15339968,glucose deprivation feature poorly vascularized solid tumors activates unfolded protein response upr stresssignaling pathway tumor cellsnan
no_relation,glucose,tumor,15339968,examined effect vst upr induced glucose deprivation stressors tumor growth vivonan
no_relation,calcium,hypoglycemia,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemia mimicking agent 2-deoxyglucose dgnan
no_relation,tunicamycin,hypoglycemia,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemia mimicking agent 2-deoxyglucose dgnan
no_relation,glucose,hypoglycemia,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemia mimicking agent 2-deoxyglucose dgnan
no_relation,A23187,stomach cancer/colon cancer,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore a23187 hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,A23187,hypoglycemia,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore a23187 hypoglycemia mimicking agent 2-deoxyglucose dgnan
no_relation,2-deoxyglucose,fibrosarcoma,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,glucose,fibrosarcoma,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,2-deoxyglucose,stomach cancer/colon cancer,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,tunicamycin,stomach cancer/colon cancer,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,calcium,stomach cancer/colon cancer,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,glucose,stomach cancer/colon cancer,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,2-deoxyglucose,hypoglycemia,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemia mimicking agent 2-deoxyglucose dgnan
no_relation,calcium,fibrosarcoma,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,A23187,fibrosarcoma,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore a23187 hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,tunicamycin,fibrosarcoma,15339968,human colon cancer ht fibrosarcoma ht stomach cancer mkn cells cultured absence glucose presence glucose uprinducing chemical stressor nglycosylation inhibitor tunicamycin calcium ionophore hypoglycemiamimicking agent 2-deoxyglucose dgnan
no_relation,cisplatin,tumor,15339968,vst alone combination cisplatin statistically significantly tumor growth mkn xenograftsnan
no_relation,glucose,tumors,15339968,disruption upr may provide novel therapeutic approach targeting glucose deprived solid tumors nan
no_relation,mangafodipir/manganese-DPDP,pancreatic lesions,15343134,magnetic resonance manganesedpdp mangafodipir focal solid pancreatic lesions nan
no_relation,Mn-DPDP/Mangafodipir,pancreatic lesions,15343134,assess accuracy magnetic resonance mr mangafodipir mn-dpdp identification focal solid pancreatic lesions nan
no_relation,Mn-DPDP,pancreatitis/pancreatic lesions,15343134,mn-dpdp mr identified malignancies endocrine neoplasms focal pancreatitis  patients pancreatic lesions correctly identifiednan
no_relation,Mn-DPDP,neoplasms,15343134,mn-dpdp mr identified malignancies endocrine neoplasms focal pancreatitis patients pancreatic lesions correctly identifiednan
no_relation,Mn-DPDP,pancreatitis,15343134,due small number inflammatory lesions included study significant differences found signal intensity mn-dpdp uptake focal pancreatitis neoplasmsnan
no_relation,Mn-DPDP,neoplasms,15343134,due small number inflammatory lesions included study significant differences found signal intensity mn-dpdp uptake focal pancreatitis neoplasms nan
no_relation,DPDP,pancreatic lesions,15343134,mr mn dpdp accurate identification focal solid pancreatic lesions nan
no_relation,Mangafodi-pir,pancreatic lesions,15343134,mangafodi-pir also useful excluding presence pancreatic lesions suspected us ctnan
no_relation,mangafodipir,hepatic lesions,15390224,detection characterization focal hepatic lesions mangafodipir vs superparamagnetic iron oxideenhanced magnetic resonance imagingnan
no_relation,iron oxide,hepatic lesions,15390224,detection characterization focal hepatic lesions mangafodipir vs superparamagnetic iron oxide enhanced magnetic resonance imagingnan
no_relation,mangafodipir,hepatic lesions,15390224,compare mangafodipir enhanced magnetic resonance mr superparamagnetic iron oxide spioenhanced images ability detect characterize focal hepatic lesions nan
no_relation,iron oxide,hepatic lesions,15390224,compare mangafodipirenhanced magnetic resonance mr superparamagnetic iron oxide spioenhanced images ability detect characterize focal hepatic lesions nan
no_relation,mangafodipir,HCCs,15390224,spio mangafodipir enhanced images comparable detection focal hepatic lesions small hccs better detected spioenhanced imagesnan
no_relation,mangafodipir,hepatic lesions,15390224,spio mangafodipir enhanced images comparable detection focal hepatic lesions small hccs better detected spioenhanced imagesnan
no_relation,Mangafodipir,liver lesions,15390224,mangafodipir enhanced images likely better spioenhanced images distinguishing focal liver lesions hepatocellular nonhepatocellular originnan
yes_direct,FEIBA,Thrombosis,15456478,thrombosis rare wellrecognized potential complication factor viii inhibitor bypass activity feiba infusionnan
no_relation,FEIBA,thrombotic,15456478,recombinant factor viia rfviia increasingly used alternative feiba however thrombotic safety profile rfviia remains incompletely characterizednan
no_relation,FEIBA,thrombotic,15456478,data medwatch pharmacovigilance program us food drug administration supplemented published case reports used conjunction estimated numbers infusions available manufacturers assess comparative incidence thrombotic aes patients receiving rfviia feiba period april june nan
no_relation,FEIBA,thrombotic,15456478,reported thrombotic aes rare incidence rates per infusions ci per infusions rfviia per infusions ci per infusions feiba nan
no_relation,FEIBA,Thrombotic,15456478,thrombotic aes significantly frequent rfviia feiba recipients incidence rate ratio ci nan
no_relation,FEIBA,thrombotic,15456478,commonly documented single type thrombotic ae rfviia infusion cerebrovascular thrombosis myocardial infarction frequent type patients receiving feiba nan
yes_direct,FEIBA,myocardial infarction,15456478,commonly documented single type thrombotic ae rfviia infusion cerebrovascular thrombosis myocardial infarction frequent type patients receiving feiba nan
no_relation,FEIBA,thrombosis,15456478,commonly documented single type thrombotic ae rfviia infusion cerebrovascular thrombosis myocardial infarction frequent type patients receiving feiba nan
no_relation,FEIBA,thrombotic,15456478,contrasting ae reporting patterns rfviia feiba may contributed observed difference thrombotic event incidencenan
no_relation,bupivacaine,pain,15488969,efficacy bupivacaine posttonsillectomy pain study intraindividual designnan
yes_direct,Alcohol,prostatic hyperplasia,15491708,alcohol risk prostate cancer benign prostatic hyperplasia nan
no_relation,Alcohol,prostate cancer,15491708,alcohol risk prostate cancer benign prostatic hyperplasianan
no_relation,alcohol,BPH/cancer/benign prostatic hyperplasia,15491708,examine association alcohol risk prostate cancerbenign prostatic hyperplasia bph population wide range alcohol consumption using hospitalbased casecontrol studynan
yes_direct,alcohol,prostate cancer,15491708,data several epidemiologic studies allowed us exclude strong association alcohol drinking prostate cancer risknan
no_relation,Alcohol,BPH/prostate cancer,15491708,alcohol consumption showed consistent association prostate cancer risk statistically significant inverse trend risk bph nan
no_relation,alcohol,BPH,15491708,inverse relation elevated alcohol consumption bph apparently stronger subjects lower body mass indexnan
no_relation,Alcohol,prostate cancer,15491708,alcohol drinking unrelated prostate cancer risknan
no_relation,androgen,BPH,15491708,inverse relationship bph may related hormonal correlates ie lower androgen levels heavy alcohol drinkersnan
no_relation,alcohol,BPH,15491708,inverse relationship bph may related hormonal correlates ie lower androgen levels heavy alcohol drinkersnan
no_relation,SU5416,tumor,15519795,triple combination irradiation chemotherapy pemetrexed vegfr inhibition su5416 human endothelial tumor cellsnan
no_relation,SU5416,Triple combination,15519795,triple combination irradiation chemotherapy pemetrexed vegfr inhibition su5416 human endothelial tumor cellsnan
no_relation,SU5416,tumor,15519795,combination folate antimetabolite pemetrexed su5416 receptor tyrosine kinase inhibitor vegfr irradiation investigated human endothelial cells tumor cell linesnan
no_relation,folate,tumor,15519795,combination folate antimetabolite pemetrexed su receptor tyrosine kinase inhibitor vegfr irradiation investigated human endothelial cells tumor cell linesnan
no_relation,tyrosine,tumor,15519795,combination folate antimetabolite pemetrexed su receptor tyrosine kinase inhibitor vegfr irradiation investigated human endothelial cells tumor cell linesnan
no_relation,SU5416,prostate cancer,15519795,primary isolated human umbilical vein endothelial cells huvec human dermal microvascular endothelial cells hdmec human glioblastoma prostate cancer cells pc exposed pemetrexed alone combination su5416 nan
no_relation,SU5416,glioblastoma,15519795,primary isolated human umbilical vein endothelial cells huvec human dermal microvascular endothelial cells hdmec human glioblastoma prostate cancer cells pc exposed pemetrexed alone combination su5416 nan
no_relation,SU5416,tumor,15519795,triple combination using lowtoxicity drug exposure pemetrexed su5416 results greater response treatment alone combination two modalities tested endothelial tumor cell modelsnan
no_relation,SU5416,Triple combination,15519795,triple combination using lowtoxicity drug exposure pemetrexed su5416 results greater response treatment alone combination two modalities tested endothelial tumor cell modelsnan
no_relation,SU5416,toxicity,15519795,triple combination using low toxicity drug exposure pemetrexed su5416 results greater response treatment alone combination two modalities tested endothelial tumor cell modelsnan
no_relation,Desmopressin,nocturia,15525445,desmopressin synthetic vasopressin analogue mainly used treatment diabetes insipidus nocturia nan
no_relation,vasopressin,diabetes insipidus,15525445,desmopressin synthetic vasopressin analogue mainly used treatment diabetes insipidus nocturianan
no_relation,Desmopressin,diabetes insipidus,15525445,desmopressin synthetic vasopressin analogue mainly used treatment diabetes insipidus nocturianan
no_relation,vasopressin,nocturia,15525445,desmopressin synthetic vasopressin analogue mainly used treatment diabetes insipidus nocturia nan
no_relation,loratadine,allergic,15562885,systemic antihistamines loratadine cetrizine hydrochloride proven efficacious control many allergic conditions however patients complain drying effectsnan
no_relation,loratadine,chamber that regulates humidity,15562885,participants evaluated cae chamber regulates humidity temperature airflow visual tasking baseline taking mg either loratadine cetirizine hydrochloride daily daysnan
no_relation,loratadine,ocular discomfort,15562885, days use loratadine yielded mean increase points keratitis ocular discomfort  vs baselinenan
yes_direct,loratadine,keratitis,15562885, days use loratadine yielded mean increase points keratitisnan
yes_direct,Loratadine,increased ocular discomfort,15562885,loratadine cetirizine hydrochloride induced signs symptoms associated ocular dryness including increased corneal conjunctival staining decreased tfbut increased ocular discomfort healthy individualsnan
yes_direct,Loratadine,ocular dryness,15562885,loratadine cetirizine hydrochloride induced signs symptoms associated ocular dryness including increased corneal conjunctival staining decreased tfbut increased ocular discomfort healthy individualsnan
yes_direct,cholesterol,CHD/coronary heart disease,15563444,many populations high intakes saturated fat associated elevated serum cholesterol concentrations increased coronary heart disease chd mortalitynanmany populations high intakes saturated fat associated elevated serum cholesterol concentrations increased coronary heart disease chd mortality cholesterol coronary heart disease chd mortality connected sentence make connection clear refers high intakes saturated fat
yes_direct,carbohydrates,CHD,15563444,however intakes animal foods total protein dietary cholesterol less plant derived carbohydrates predictors chd nan
no_relation,cholesterol,CHD,15563444,however intakes animal foods total protein dietary cholesterol less plant derived carbohydrates predictors chd nan
no_relation,heparin,venous thromboembolism,15584059,prolonged administration heparin prevention treatment venous thromboembolism associated risk heparininduced osteoporosisnan
yes_direct,heparin,osteoporosis,15584059,prolonged administration heparin prevention treatment venous thromboembolism associated risk heparininduced osteoporosis nan
yes_direct,heparin,osteoporosis,15584059,fondaparinux inhibit osteoblast proliferation vitro may reduce risk heparininduced osteoporosis associated longterm heparin administrationnan
no_relation,bilirubin,hyperthyroidism,15599331,patients jaundice promptly resolved therapy hyperthyroidism thyroid storm bilirubin levels decreased mgdl normal mgdl mgdlnan
no_relation,bilirubin,thyroid storm,15599331,patients jaundice promptly resolved therapy hyperthyroidism thyroid storm bilirubin levels decreased mgdl normal mgdl mgdlnan
no_relation,bilirubin,jaundice,15599331,patients jaundice promptly resolved therapy hyperthyroidism thyroid storm bilirubin levels decreased mgdl normal mgdl mgdlnan
no_relation,alcohol,hepatocellular carcinoma,15601641,cigarette smoking alcohol drinking hepatitis risk hepatocellular carcinoma koreanan
no_relation,alcohol,hepatitis B,15601641,cigarette smoking alcohol drinking hepatitis risk hepatocellular carcinoma koreanan
no_relation,aflatoxin,infectious hepatitis,15601641,liver cancer one common cancers worldwide particularly asia africa infectious hepatitis aflatoxin exposures commonnan
yes_direct,aflatoxin,cancers/Liver cancer,15601641,liver cancer one common cancers worldwide particularly asia africa infectious hepatitis aflatoxin exposures commonnan
no_relation,alcohol,hepatocellular carcinoma,15601641,conducted prospective cohort study liver cancer korea assess independent effects interactions smoking alcohol consumption hepatitis risk mortality hepatocellular carcinoma nan
no_relation,alcohol,hepatitis B,15601641,conducted prospective cohort study liver cancer korea assess independent effects interactions smoking alcohol consumption hepatitis risk mortality hepatocellular carcinomanan
no_relation,alcohol,liver cancer,15601641,conducted prospective cohort study liver cancer korea assess independent effects interactions smoking alcohol consumption hepatitis risk mortality hepatocellular carcinomanan
no_relation,alcohol,hepatitis B,15601641,participants reported smoking alcohol consumption hepatitis surface antigen hbsag status documented participantsnan
no_relation,hepatitis B surface antigen,hepatitis B,15601641,participants reported smoking alcohol consumption hepatitis surface antigen hbsag status documented participantsnan
no_relation,alcohol,diabetes,15601641,relative risk confidence intervals cis mortality hepatocellular carcinoma calculated using proportional hazards models adjusted age alcohol drinking diabetes hbsag statusnan
no_relation,alcohol,hepatocellular carcinoma,15601641,relative risk confidence intervals cis mortality hepatocellular carcinoma calculated using proportional hazards models adjusted age alcohol drinking diabetes hbsag statusnan
yes_direct,alcohol,hepatocellular carcinoma,15601641,heavy alcohol drinking associated hepatocellular carcinoma mortality risk subgroup men tested hbsag rr  ci  nan
no_relation,HBsAg,hepatocellular carcinoma,15601641,heavy alcohol drinking associated hepatocellular carcinoma mortality risk subgroup men tested hbsag rr  ci  nan
no_relation,alcohol,hepatocellular carcinoma,15601641,interaction among smoking alcohol drinking hbsag terms hepatocellular carcinoma mortalitynan
no_relation,HBsAg,hepatocellular carcinoma,15601641,interaction among smoking alcohol drinking hbsag terms hepatocellular carcinoma mortalitynan
yes_direct,alcohol,hepatocellular carcinoma,15601641,cigarette smoking heavy alcohol consumption hbsag independently associated increased risk mortality hepatocellular carcinoma interact synergisticallynan
yes_direct,HBsAg,hepatocellular carcinoma,15601641,cigarette smoking heavy alcohol consumption hbsag independently associated increased risk mortality hepatocellular carcinoma interact synergisticallynan
no_relation,choline,CHT/choline uptake transporter,15611726,capacity highaffinity choline uptake transporter cht import choline extracellular space presynaptic terminals essential normal acetylcholine synthesis therefore cholinergic transmissionnan
no_relation,acetylcholine,CHT/choline uptake transporter,15611726,capacity highaffinity choline uptake transporter cht import choline extracellular space presynaptic terminals essential normal acetylcholine synthesis therefore cholinergic transmissionnan
no_relation,bupivacaine,pain,15616079,median th th centile visual analog scale pain scores associated drain removal bupivacaine entonox morphine groups mm  mm mm  mm mm  mm respectivelynan
no_relation,morphine,pain,15616079,median th th centile visual analog scale pain scores associated drain removal bupivacaine entonox morphine groups mm  mm mm  mm mm  mm respectivelynan
no_relation,bupivacaine,pain,15616079,pain scores higher entonox group compared bupivacaine group morphine groupnan
no_relation,morphine,pain,15616079,pain scores higher entonox group compared bupivacaine group morphine groupnan
no_relation,Bupivacaine,pain,15616079,bupivacaine morphine unlike entonox produce lower pain scores associated drain removalnan
no_relation,morphine,pain,15616079,bupivacaine morphine unlike entonox produce lower pain scores associated drain removalnan
no_relation,norepinephrine,Central hypercapnic chemosensitivity,15632879,central hypercapnic chemosensitivity plasma norepinephrine measured patients chronic heart failurenan
no_relation,norepinephrine,chronic heart failure,15632879,central hypercapnic chemosensitivity plasma norepinephrine measured patients chronic heart failure nan
no_relation,statins,coronary artery disease,15642557,effects tirofiban statins highsensitivity creactive protein interleukin soluble cd ligand following percutaneous coronary interventions patients stable coronary artery disease nan
no_relation,statins,coronary artery disease,15642557,study assessed effects tirofiban statins highsensitivity creactive protein interleukin soluble cd ligand percutaneous coronary intervention patients stable coronary artery disease nan
no_relation,candesartan,hypertension,15662234,controlledrelease nifedipine candesartan lowdose combination therapy patients essential hypertension nice combi nifedipine candesartan combination studynan
no_relation,nifedipine,hypertension,15662234,controlledrelease nifedipine candesartan lowdose combination therapy patients essential hypertension nice combi nifedipine candesartan combination studynan
no_relation,candesartan,hypertension,15662234,patients essential hypertension achieve target blood pressure baseline treatment candesartan mgday weeksnan
no_relation,candesartan,hypertension,15662234,findings suggest lowdose combination therapy nifedipine cr candesartan superior uptitrated monotherapy candesartan terms blood pressure control renal protection patients essential hypertension nan
no_relation,nifedipine,hypertension,15662234,findings suggest lowdose combination therapy nifedipine cr candesartan superior uptitrated monotherapy candesartan terms blood pressure control renal protection patients essential hypertension nan
no_relation,cisplatin,glioblastoma,15662978,phase ii study temozolomide cisplatin primary treatment prior radiotherapy newly diagnosed glioblastoma multiforme patients measurable diseasenan
no_relation,temozolomide,glioblastoma,15662978,phase ii study temozolomide cisplatin primary treatment prior radiotherapy newly diagnosed glioblastoma multiforme patients measurable diseasenan
no_relation,cisplatin,glioblastoma,15662978,phase ii study evaluates activity temozolomide cisplatin administered radiation therapy newly diagnosed glioblastoma multiforme patients terms response time progression survivalnan
no_relation,temozolomide,glioblastoma,15662978,phase ii study evaluates activity temozolomide cisplatin administered radiation therapy newly diagnosed glioblastoma multiforme patients terms response time progression survivalnan
no_relation,corticosteroids,allergic rhinitis,15663563,effectiveness intranasal corticosteroids combined allergic rhinitis asthma syndromenan
no_relation,corticosteroids,asthma syndrome,15663563,effectiveness intranasal corticosteroids combined allergic rhinitis asthma syndrome nan
no_relation,GABA,psychiatric,15672555,gaba system active target drugs treat variety disorders availability indirect measure central gaba activity would enhance psychiatric research also permit assessment pharmacodynamic effects drugs designed act systemnan
no_relation,GABA,cognitive impairments,15672555,relationships plasma baseline predrug gaba concentrations cognitive impairments induced acute oral dose lorazepam  mg investigated healthy elderly individualsnan
yes_direct,lorazepam,cognitive impairments,15672555,relationships plasma baseline predrug gaba concentrations cognitive impairments induced acute oral dose lorazepam  mg investigated healthy elderly individualsnan
yes_direct,benzodiazepine,cognitive toxicity,15672555,plasma gaba concentration appear useful marker susceptibility benzodiazepine induced cognitive toxicity elderlynan
no_relation,GABA,cognitive toxicity,15672555,plasma gaba concentration appear useful marker susceptibility benzodiazepineinduced cognitive toxicity elderlynan
no_relation,metronidazole,recurrent disease,15673502,vancomycin metronidazole used treating clostridium difficileassociated disease cdad past years approximately  patients develop recurrent disease nan
yes_direct,Vancomycin,recurrent disease,15673502,vancomycin metronidazole used treating clostridium difficileassociated disease cdad past years approximately  patients develop recurrent disease nan
no_relation,argentatin A,cancer,15686901,synthesis argentatin derivatives growth inhibitors human cancer cell lines vitronan
yes_direct,ginkgolides,bleeding complications,15693702,inhibition platelet activating factor pafinduced aggregation human thrombocytes ginkgolides considerations possible bleeding complications oral intake ginkgo biloba extractsnan
yes_indirect,ginkgolides,bleeding,15693702,although clear causality ginkgo intake bleeding could established observations generally explained plateletactivating factor pafantagonistic action ginkgolides represent characteristic constituents ginkgo extractsnan
yes_direct,ginkgolides,hemorrhage,15693702,concentrations generally times higher peak plasma values measured oral intake egb recommended doses  mg paf weak platelet activator appear importance primary hemostasis results rise serious doubts paf antagonistic effect ginkgolides could responsible hemorrhage patients taking egb nan
no_relation,nevirapine/NVP,HIV-infected,15720887,babies hiv-infected women randomised birth receive single dose nevirapine nvp alone zidovudine zdv twice daily weeknan
no_relation,zidovudine/ZDV,HIV-infected,15720887,babies hiv-infected women randomised birth receive single dose nevirapine nvp alone zidovudine zdv twice daily weeknan
no_relation,NVP,anaemia,15720887,agespecific mean haemoglobin levels prevalence anaemia haemoglobin nvp cases nvp given motherinfant pairs additional zdv babynan
no_relation,ZDV,anaemia,15720887,agespecific mean haemoglobin levels prevalence anaemia haemoglobin zdv babynan
no_relation,Calcium,postmenopausal bone loss,15755853,calcium supplementation slows postmenopausal bone loss inhibiting pth secretionnan
no_relation,calcium citrate,bone loss,15755853,study explores whether combined treatment potassium citrate calcium citrate effective either agent alone inhibiting bone loss nan
no_relation,potassium citrate,bone loss,15755853,study explores whether combined treatment potassium citrate calcium citrate effective either agent alone inhibiting bone loss nan
no_relation,morphine,PONV/postoperative nausea and vomiting,15765454,secondary outcomes amplitude knee flexion morphine consumption occurrence postoperative nausea vomiting ponv nan
no_relation,morphine,PONV,15765454,combined femoral sciatic blocks decreased morphine consumption significantly decreased occurrence ponv nan
no_relation,morphine,analgesia,15765454, hours immediately total knee replacement combination continuous femoral sciatic nerve blocks improves analgesia decreasing morphine consumption ponvnan
no_relation,morphine,PONV,15765454, hours immediately total knee replacement combination continuous femoral sciatic nerve blocks improves analgesia decreasing morphine consumption ponv nan
no_relation,Glatiramer acetate,multiple sclerosis,15794402,glatiramer acetate glat well tolerated safe immunomodulatory drug treatment relapsingremitting multiple sclerosis nan
no_relation,vitamin E,neuropathy,15803482,isolated vitamin deficiency demyelinating neuropathy nanfeel like complete sentence
yes_direct,phenobarbital,spinocerebellar ataxia,15803482,yearold man past history generalized tonicclonic seizures treated phenobarbital presented spinocerebellar ataxia nan
no_relation,phenobarbital,tonic-clonic seizures,15803482,yearold man past history generalized tonicclonic seizures treated phenobarbital presented spinocerebellar ataxianan
no_relation,Vitamin E,Vitamin E deficiency,15803482,vitamin deficiency leading demyelinating neuropathy present case suggests full spectrum disease entity fully definednan
no_relation,Vitamin E,neuropathy,15803482,vitamin deficiency leading demyelinating neuropathy present case suggests full spectrum disease entity fully definednan
no_relation,glucose,diabetics,15804854,fuzzy logic based closedloop control system blood glucose level regulation diabetics nan
no_relation,glucose,diabetes mellitus type,15804854,study closedloop system control plasma glucose level patients diabetes mellitus type proposednanplasma glucose level glucose
no_relation,glucose,diabetic,15804854,control scheme based fuzzy logic control theory maintain normoglycaemic average mmol normal conditions free plasma insulin concentration severe initial state particular diabetic patient subjected glucose meal disturbance fluctuations measured glucose level due error measuring instrumentnan
no_relation,Amantadine,granulomatous disease,15805000,amantadine chronic granulomatous disease nan
no_relation,amantadine,CGD,15805000,weak base amantadine could potentially reverse ph abnormalities authors used drug treat cgd patientsnan
no_relation,amantadine,CGD,15805000,since drug employed patients developed new infections suggesting role amantadine part cgd prophylactic regimennan
no_relation,amantadine,infections,15805000,since drug employed patients developed new infections suggesting role amantadine part cgd prophylactic regimennan
no_relation,methotrexate,rheumatoid arthritis,15818697,evidence radiographic benefit treatment infliximab plus methotrexate rheumatoid arthritis patients clinical improvement detailed subanalysis data antitumor necrosis factor trial rheumatoid arthritis concomitant therapy studynan
no_relation,methotrexate,tumor,15818697,evidence radiographic benefit treatment infliximab plus methotrexate rheumatoid arthritis patients clinical improvement detailed subanalysis data anti tumor necrosis factor trial rheumatoid arthritis concomitant therapy studynan
no_relation,methotrexate,necrosis,15818697,evidence radiographic benefit treatment infliximab plus methotrexate rheumatoid arthritis patients clinical improvement detailed subanalysis data antitumor necrosis factor trial rheumatoid arthritis concomitant therapy studynan
no_relation,methotrexate/MTX,RA,15818697,changes baseline week clinical variables measures radiographic progression compared patients received infliximab mgkg mgkg every  weeks plus methotrexate mtx received mtx plus placebo antitumor necrosis factor trial ra concomitant therapy trialnan
no_relation,methotrexate/MTX,Tumor,15818697,changes baseline week clinical variables measures radiographic progression compared patients received infliximab mgkg mgkg every  weeks plus methotrexate mtx received mtx plus placebo anti tumor necrosis factor trial ra concomitant therapy trialnan
no_relation,Carvedilol,heart failure,15820297,carvedilol reduces costs medical care severe heart failure economic analysis copernicus study applied united kingdomnan
no_relation,carvedilol,chronic heart failure/CHF,15820297,aim study determine effects carvedilol costs related treatment severe chronic heart failure chf nan
no_relation,Carvedilol,heart failure,15820297,costs treatment heart failure within national health service nhs united kingdom uk applied resource utilisation data prospectively collected patients randomized carvedilol prospective randomized cumulative survival copernicus studynan
no_relation,carvedilol,CHF,15820297,findings suggest carvedilol treatment increase survival reduce hospital admissions patients severe chf also cut costs processnan
no_relation,tetracycline,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillintazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,vancomycin,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillintazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,ofloxacin,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillintazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,tazobactam,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillin tazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,piperacillin,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillin tazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,amoxicillin+clavulanic acid,posttraumatic endophthalmitis,15834610,describe case posttraumatic endophthalmitis unresponsive systemic amoxicillinclavulanic acid piperacillintazobactam intraocular vancomycin topical ofloxacin tetracycline sulfametoxazole antibiotic therapynan
no_relation,nitric oxide,headache,15836594,classify headache syndromes treatment calcineurin inhibitors investigate whether latter influence nitric oxide production human brain microvascular cells hbmecnan
yes_direct,cyclosporine,headaches,15836594,single cases cyclosporine induced headaches reportednan
yes_direct,NO,tension-type headache,15836594,since calcineurin inhibitors known influence renal metabolism key molecule tensiontype headache migraine interested whether calcineurin inhibitors might change metabolism hbmec wellnan
no_relation,NO,migraine,15836594,since calcineurin inhibitors known influence renal metabolism key molecule tensiontype headache migraine interested whether calcineurin inhibitors might change metabolism hbmec wellnan
yes_direct,tacrolimus,Headache,15836594,headache symptoms patients receiving cyclosporine andor tacrolimus organ transplantation retrospectively assessednan
yes_direct,cyclosporine,Headache,15836594,headache symptoms patients receiving cyclosporine andor tacrolimus organ transplantation retrospectively assessednan
yes_direct,NO,headaches,15836594,pathophysiological mechanism headaches may connected endothelial dysfunction terms increased production nan
yes_direct,NO,endothelial dysfunction,15836594,pathophysiological mechanism headaches may connected endothelial dysfunction terms increased production nan
yes_direct,doxorubicin,toxicity,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicity nan
yes_direct,cisplatin,toxicity,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicity nan
no_relation,methotrexate,bladder cancer,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicitynanused treatment
yes_direct,vinblastine,toxicity,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicity nan
no_relation,doxorubicin,bladder cancer,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicitynan
yes_direct,methotrexate,toxicity,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicity nan
no_relation,vinblastine,bladder cancer,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicitynan
no_relation,cisplatin,bladder cancer,15842461,determining patient preferences improved chemotoxicity treatment advanced bladder cancer conventional treatment advanced bladder cancer methotrexate vinblastine doxorubicin plus cisplatin mvac median survival year significant toxicitynan
no_relation,gemcitabine,toxicity,15842461,newer combination gemcitabine plus cisplatin gc demonstrated comparable survival improved toxicity profile von der maase et alnan
no_relation,cisplatin,toxicity,15842461,newer combination gemcitabine plus cisplatin gc demonstrated comparable survival improved toxicity profile von der maase et alnan
no_relation,nucleoside,reverse transcriptase,15851917,hiv isolates harboring multiple nucleoside reverse transcriptase inhibitor nrti resistance mutations susceptible hypersusceptible nonnucleoside reverse transcriptase inhibitors nnrtis isolates lacking nrti resistance mutations reported singlecycle replication phenotypic assaynan
no_relation,Nevirapine,RT,15851917,nevirapine efavirenz susceptibilities tested compared control wildtype virus rt nan
no_relation,efavirenz,RT,15851917,nevirapine efavirenz susceptibilities tested compared control wildtype virus rt nan
no_relation,Naltrexone,alcohol dependence,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disordersnan
no_relation,alcohol,psychiatric disorders,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disorders nan
no_relation,Naltrexone,psychiatric disorders,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disorders nan
no_relation,disulfiram,alcohol dependence,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disordersnan
no_relation,alcohol,alcohol dependence,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disordersnan
no_relation,disulfiram,psychiatric disorders,15866552,naltrexone disulfiram patients alcohol dependence comorbid psychiatric disorders nan
no_relation,naltrexone,alcoholism,15866552,disulfiram naltrexone approved food drug administration fda treatment alcoholism agents rigorously evaluated dually diagnosed individualsnan
no_relation,Disulfiram,alcoholism,15866552,disulfiram naltrexone approved food drug administration fda treatment alcoholism agents rigorously evaluated dually diagnosed individualsnan
no_relation,alcohol,psychiatric disorder,15866552,twohundred fiftyfour patients axis psychiatric disorder comorbid alcohol dependence treated weeks outpatient medication study conducted three veterans administration outpatient clinicsnan
no_relation,alcohol,alcohol dependence,15866552,twohundred fiftyfour patients axis psychiatric disorder comorbid alcohol dependence treated weeks outpatient medication study conducted three veterans administration outpatient clinicsnan
no_relation,alcohol,psychiatric symptoms,15866552,secondary outcomes included psychiatric symptoms alcohol craving gggt levels adverse eventsnan
no_relation,creatinine,SSc,15868618,baseline subjects stable moderately severe diffuse ssc disease duration  serum creatinine  dlco predicted  receiving concomitant disease modifying therapiesnan
no_relation,vinblastine,bladder cancer,15878100,phase ii study radiochemotherapy vinblastine invasive bladder cancer nan
no_relation,clonidine,premenstrual dysphoric disorder,15925031,histories sexual abuse associated differential effects clonidine autonomic function women premenstrual dysphoric disorder nan
yes_direct,clonidine,sexual abuse,15925031,histories sexual abuse associated differential effects clonidine autonomic function women premenstrual dysphoric disordernanhistories sexual abuse sexual abuse
no_relation,clonidine,PMDD/premenstrual dysphoric disorder,15925031,women meeting strict criteria premenstrual dysphoric disorder pmdd examined whether clonidine alphaadrenergic receptor ar agonist would different effects sexually abused versus nonabused pmdd women measures autonomic nervous system functionnan
no_relation,clonidine,PMDD,15925031,twelve women meeting prospective dsmiv criteria pmdd five history sexual abuse participated randomized placebocontrolled doubleblind crossover design study comparing months oral clonidine mgday months active placebonan
no_relation,clonidine,sexual abuse,15925031,twelve women meeting prospective dsmiv criteria pmdd five history sexual abuse participated randomized placebocontrolled doubleblind crossover design study comparing months oral clonidine mgday months active placebonan
no_relation,clonidine,PMDD,15925031,results revealed comparison placebo clonidine significantly reduced plasma norepinephrine concentrations increased beta betaar responsivity reduced resting stress heart rate hr blood pressure bp pmdd womennan
no_relation,norepinephrine,stress heart rate (HR) and blood pressure,15925031,results revealed comparison placebo clonidine significantly reduced plasma norepinephrine concentrations increased beta betaar responsivity reduced resting stress heart rate hr blood pressure bpnan
no_relation,clonidine,stress heart rate (HR) and blood pressure,15925031,results revealed comparison placebo clonidine significantly reduced plasma norepinephrine concentrations increased beta betaar responsivity reduced resting stress heart rate hr blood pressure bpnan
no_relation,norepinephrine,PMDD,15925031,results revealed comparison placebo clonidine significantly reduced plasma norepinephrine concentrations increased beta betaar responsivity reduced resting stress heart rate hr blood pressure bp pmdd womennan
no_relation,clonidine,PMDD,15925031,clonidine sexually abused pmdd women exhibited greater decreases resting stressinduced hr pmdd women exhibited greater reductions plasma ne concentration  greater increases betaar responsivity pmdd womennan
no_relation,clonidine,PMDD,15925031,results suggest pmdd women without history sexual abuse respond differently clonidine challenge measures reflecting autonomic nervous system functioning indicating abuse may modify presynaptic alphaar function pmdd nan
no_relation,clonidine,sexual abuse,15925031,results suggest pmdd women without history sexual abuse respond differently clonidine challenge measures reflecting autonomic nervous system functioning indicating abuse may modify presynaptic alphaar function pmddnan
no_relation,glucose,diabetic,15931603,two days low calorie diet reduces endogenous glucose production obese type diabetic patients despite withdrawal blood glucose lowering therapies including insulinnan
no_relation,glucose,obese,15931603,two days low calorie diet reduces endogenous glucose production obese type diabetic patients despite withdrawal blood glucose lowering therapies including insulinnan
no_relation,glucose,diabetic,15931603,mechanism blood glucose lowering effect day low calorie diet vlcd kjd combination cessation blood glucose lowering agents studied  women men obese body mass index  kgm mean sem type diabetic patients age  years hba   undergoing insulin therapynan
no_relation,glucose,obese,15931603,mechanism blood glucose lowering effect day low calorie diet vlcd kjd combination cessation blood glucose lowering agents studied  women men obese body mass index  kgm mean sem type diabetic patients age  years hba   undergoing insulin therapynan
no_relation,glucose,hyperinsulinemia,15931603,hyperinsulinemia egp    mu molkg per minute whole body glucose disposal    mu molkg per minute metabolic clearance rate glucose rate lipolysis change day interventionnan
no_relation,glucose,hyperglycemia,15931603,cessation blood glucose lowering therapy combination day vlcd lead hyperglycemia associated reduction basal egpnanrelationship found
no_relation,estrogen,inflammatory,15953991,anti inflammatory effect selective estrogen receptor modulators serms microglial cellsnan
no_relation,17beta-estradiol,inflammatory,15953991,serms 17beta-estradiol induced significant concentrationdependent anti inflammatory response rat primary microglial cells mouse microglial cellsnan
no_relation,raloxifene,inflammatory,15953991,results show tamoxifen raloxifene ici induce anti inflammatory response acute models mouse rat microglial cellsnananti key term
no_relation,tamoxifen,inflammatory,15953991,results show tamoxifen raloxifene ici induce anti inflammatory response acute models mouse rat microglial cellsnan
no_relation,ICI 182.780,inflammatory,15953991,results show tamoxifen raloxifene ici induce anti inflammatory response acute models mouse rat microglial cellsnan
no_relation,estrogen,inflammatory,15953991,seems response estrogen receptormediated probably attributable serminduced modulation lpsactivated pro inflammatory signalling cascadesnan
no_relation,Nitric oxide,Alzheimer's disease,15974915,nitric oxide mimetic molecules therapeutic agents alzheimers disease nan
no_relation,NO,dementia,15974915,small molecules mimic biological activity mimetics bypass cholinergic receptor activation anticipated provide multiple pathways treating circumventing dementia alzheimers diseasenan
no_relation,NO,Alzheimer's disease,15974915,small molecules mimic biological activity mimetics bypass cholinergic receptor activation anticipated provide multiple pathways treating circumventing dementia alzheimers disease nan
no_relation,NO,dementia,15974915,substantial evidence suggests mimetics may display cgmpdependent cgmpindependent activity may operate via multiple biochemical signaling pathways ensure survival neurons subjected stress also provide cognitionenabling pathways circumvent dementia nan
no_relation,polyethylene glycol,ADA deficiency/adenosine deaminase/ADA,16002636,polyethylene glycol conjugated adenosine deaminase ada therapy provides temporary immune reconstitution child delayedonset ada deficiency nan
no_relation,adenosine,ADA deficiency/adenosine deaminase/ADA,16002636,polyethylene glycolconjugated adenosine deaminase ada therapy provides temporary immune reconstitution child delayedonset ada deficiency nan
no_relation,polyethylene glycol,ADA deficiency/adenosine deaminase/ADA,16002636,describe effects polyethylene glycol conjugated adenosine deaminase ada replacement therapy lymphocyte counts activation apoptosis proliferation cytokine secretion monthold girl delayedonset ada deficiency marked immunodysregulationnan
no_relation,adenosine,ADA deficiency/adenosine deaminase/ADA,16002636,describe effects polyethylene glycolconjugated adenosine deaminase ada replacement therapy lymphocyte counts activation apoptosis proliferation cytokine secretion monthold girl delayedonset ada deficiency marked immunodysregulationnan
no_relation,gemcitabine,Hemolytic-uremic syndrome,16006690,hemolyticuremic syndrome associated gemcitabine case report review literaturenan
yes_direct,mitomycin,Hemolytic uremic syndrome,16006690,hemolytic uremic syndrome may associated variety etiologies chemotherapeutic agents also reported associated hemolytic uremic syndrome including mitomycin cisplatin bleomycin recently gemcitabinenan
yes_direct,cisplatin,Hemolytic uremic syndrome,16006690,hemolytic uremic syndrome may associated variety etiologies chemotherapeutic agents also reported associated hemolytic uremic syndrome including mitomycin cisplatin bleomycin recently gemcitabinenan
yes_direct,bleomycin,Hemolytic uremic syndrome,16006690,hemolytic uremic syndrome may associated variety etiologies chemotherapeutic agents also reported associated hemolytic uremic syndrome including mitomycin cisplatin bleomycin recently gemcitabinenan
yes_direct,gemcitabine,Hemolytic uremic syndrome,16006690,hemolytic uremic syndrome may associated variety etiologies chemotherapeutic agents also reported associated hemolytic uremic syndrome including mitomycin cisplatin bleomycin recently gemcitabine nan
yes_direct,gemcitabine,hemolytic uremic syndrome,16006690,yearold caucasian male treated four cycles gemcitabine mgm developed clinical laboratory findings compatible hemolytic uremic syndrome nan
no_relation,gemcitabine,hemolytic uremic syndrome,16006690,multiple reports hemolytic uremic syndrome complicating gemcitabine therapy imperative clinicians heighten awareness potentially lethal complicationnan
yes_direct,Acebutolol,cutaneous lupus erythematosus,16015021,acebutolol induced subacute cutaneous lupus erythematosus nan
yes_direct,acebutolol,SCLE,16015021,present herein first case scle induced acebutolol nan
no_relation,acebutolol,hypertension,16015021,one month ago patient started treatment oral acebutolol cure hypertension year evolutionnan
yes_direct,acebutolol,lupus syndrome,16015021,literature data along case suggest link acebutolol therapy onset lupus syndrome nan
no_relation,acebutolol,lupus erythematosus,16015021,although first report acebutolol induced scle aware occurrence avoidance acebutolol recommended patients stigmata lupus erythematosus nan
yes_direct,acebutolol,SCLE,16015021,although first report acebutolol induced scle aware occurrence avoidance acebutolol recommended patients stigmata lupus erythematosusnan
no_relation,estrogens,traumatic injuries,16024758,part almost work ht estrogens given primary focus despite fact progesterone important properties enhance repair neurodegenerative traumatic injuries central nervous systemnan
no_relation,estrogens,HT,16024758,part almost work ht estrogens given primary focus despite fact progesterone important properties enhance repair neurodegenerative traumatic injuries central nervous systemnan
no_relation,progesterone,traumatic injuries,16024758,part almost work ht estrogens given primary focus despite fact progesterone important properties enhance repair neurodegenerative traumatic injuries central nervous systemnan
no_relation,progesterone,HT,16024758,part almost work ht estrogens given primary focus despite fact progesterone important properties enhance repair neurodegenerative traumatic injuries central nervous systemnan
no_relation,progesterone,HT,16024758,article reviews properties discusses evidence suggesting ht reconsidered progesterone given attention potent neurotrophic agent may play important role reducing preventing motor cognitive sensory impairments accompany senescence males femalesnan
no_relation,progesterone,sensory impairments,16024758,article reviews properties discusses evidence suggesting ht reconsidered progesterone given attention potent neurotrophic agent may play important role reducing preventing motor cognitive sensory impairments accompany senescence males femalesnan
no_relation,3-hydroxy-3-methylglutaryl coenzyme A,rectal cancer,16029794,assess whether hydroxymethylglutaryl coenzyme reductase inhibitors statins might enhance efficacy neoadjuvant chemoradiation rectal cancer nan
no_relation,bupivacaine,pain,16036193,evaluate efficacy intraoperative infusion bupivacaine solution relief pain operative gynecologic laparoscopynan
no_relation,bupivacaine,AVP,16036193,intraperitoneal bupivacaine administration immediately placement trocars end surgery found effective reducing intensity avp reducing stp app postoperative analgesia consumption nonadvanced gynecologic laparoscopic proceduresnan
no_relation,morphine,delirious cancer,16043013,opioid rotation morphine fentanyl delirious cancer patients openlabel trialnan
no_relation,fentanyl,delirious cancer,16043013,opioid rotation morphine fentanyl delirious cancer patients openlabel trialnan
no_relation,fentanyl,opioid rotation,16043013,although recent studies suggest opioid rotation could effective treatment strategy morphineinduced delirium prospective studies investigate treatment effects opioid rotation using fentanyl nan
no_relation,fentanyl,delirium,16043013,although recent studies suggest opioid rotation could effective treatment strategy morphineinduced delirium prospective studies investigate treatment effects opioid rotation using fentanyl nan
yes_direct,morphine,delirium,16043013,although recent studies suggest opioid rotation could effective treatment strategy morphine induced delirium prospective studies investigate treatment effects opioid rotation using fentanylnan
no_relation,morphine,opioid rotation,16043013,although recent studies suggest opioid rotation could effective treatment strategy morphine induced delirium prospective studies investigate treatment effects opioid rotation using fentanylnan
no_relation,fentanyl,opioid rotation,16043013,primary aim study clarify efficacy opioid rotation morphine fentanyl symptom palliation morphineinduced deliriumnan
no_relation,fentanyl,delirium,16043013,primary aim study clarify efficacy opioid rotation morphine fentanyl symptom palliation morphineinduced delirium nan
yes_direct,morphine,delirium,16043013,primary aim study clarify efficacy opioid rotation morphine fentanyl symptom palliation morphine induced delirium nan
no_relation,morphine,opioid rotation,16043013,primary aim study clarify efficacy opioid rotation morphine fentanyl symptom palliation morphine induced deliriumnan
no_relation,morphine,cancer,16043013,twentyone consecutive cancer patients morphine induced delirium underwent opioid rotation fentanylnan
no_relation,fentanyl,delirium,16043013,twentyone consecutive cancer patients morphineinduced delirium underwent opioid rotation fentanyl nan
no_relation,fentanyl,cancer,16043013,twentyone consecutive cancer patients morphineinduced delirium underwent opioid rotation fentanyl nan
no_relation,fentanyl,opioid rotation,16043013,twentyone consecutive cancer patients morphineinduced delirium underwent opioid rotation fentanyl nan
yes_direct,morphine,delirium,16043013,twentyone consecutive cancer patients morphine induced delirium underwent opioid rotation fentanylnan
yes_direct,morphine,opioid rotation,16043013,twentyone consecutive cancer patients morphine induced delirium underwent opioid rotation fentanylnan
no_relation,morphine,cancer,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphine induced deliriumnan
no_relation,fentanyl,delirium,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphineinduced delirium nan
no_relation,morphine,pain,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphine induced deliriumnan
no_relation,fentanyl,cancer,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphineinduced deliriumnan
no_relation,fentanyl,pain,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphineinduced deliriumnan
yes_direct,morphine,delirium,16043013,opioid rotation morphine fentanyl may effective alleviating delirium pain cancer patients morphine induced delirium nan
no_relation,Retinoic acid,cancer,16054129,retinoic acid induced downmodulation telomerase activity human cancer cellsnan
no_relation,triiodothyronine,major depressive disorder,16086620,open study triiodothyronine augmentation selective serotonin reuptake inhibitors treatmentresistant major depressive disorder nan
no_relation,serotonin,major depressive disorder,16086620,open study triiodothyronine augmentation selective serotonin reuptake inhibitors treatmentresistant major depressive disorder nan
no_relation,triiodothyronine,major depressive disorder/MDD,16086620,open trial investigated efficacy triiodothyronine adjuvant selective serotonin reuptake inhibitors ssris subjects major depressive disorder mdd resistant ssri treatmentnan
no_relation,SSRI,major depressive disorder/MDD,16086620,open trial investigated efficacy triiodothyronine adjuvant selective serotonin reuptake inhibitors ssris subjects major depressive disorder mdd resistant ssri treatmentnan
no_relation,serotonin,major depressive disorder/MDD,16086620,open trial investigated efficacy triiodothyronine adjuvant selective serotonin reuptake inhibitors ssris subjects major depressive disorder mdd resistant ssri treatmentnan
no_relation,Triiodothyronine,MDD,16086620,triiodothyronine augmentation ssris may promising treatment strategy ssriresistant mdd particularly subjects atypical mdd subtypenan
no_relation,Tipifarnib/R115777,breast cancer,16101130,biomarkers anticancer activity r115777 tipifarnib zarnestra human breast cancer models vitronan
no_relation,R115777,breast cancer,16101130,farnesyltransferase inhibitor r115777 tipifamib zarnestra active breast cancer efficacy drug combinations extensively investigatednan
no_relation,paclitaxel,tumor/breast cancer,16101130,activity r115777 paclitaxel alone combination studied human breast cancer cell lines bt overexpressed herneu mdamb low herneu cell viability biomarkers farnesylation hdj rho tumor growth rafmekerk survival pikakt angiogenesis vegf fgf mmp mmp mmp endpointsnan
no_relation,R115777,tumor/breast cancer,16101130,activity r115777 paclitaxel alone combination studied human breast cancer cell lines bt overexpressed herneu mdamb low herneu cell viability biomarkers farnesylation hdj rho tumor growth rafmekerk survival pikakt angiogenesis vegf fgf mmp mmp mmp endpointsnan
no_relation,cilostazol,claudication,16105478,symptomatic treatment claudication includes smoking cessation exercise cilostazol statins revascularization percutaneous surgical therapynan
no_relation,statins,claudication,16105478,symptomatic treatment claudication includes smoking cessation exercise cilostazol statins revascularization percutaneous surgical therapynan
no_relation,aspirin,claudication,16105478,antithrombotic therapy aspirin clopidogrel important reduce cardiovascular events affect symptoms claudication nan
no_relation,clopidogrel,claudication,16105478,antithrombotic therapy aspirin clopidogrel important reduce cardiovascular events affect symptoms claudication nan
no_relation,Ruboxistaurin,protein kinase C,16160002,ruboxistaurin protein kinase beta inhibitor emerging treatment diabetes microvascular complicationsnan
no_relation,ruboxistaurin/LY333531,PKC/protein kinase C,16160002,review current clinical data regarding pharmacologic actions ruboxistaurin ly mesylate inhibitor protein kinase pkc beta role potentially reduce development andor progression diabetic microvascular complicationsnan
no_relation,mesylate,PKC/protein kinase C,16160002,review current clinical data regarding pharmacologic actions ruboxistaurin ly mesylate inhibitor protein kinase pkc beta role potentially reduce development andor progression diabetic microvascular complicationsnan
no_relation,ruboxistaurin,PKC,16160002,literature relevant pkc physiology pharmacokinetics ruboxistaurin data evaluating use ruboxistaurin treating diabetic microvascular complications human relevant animal models reviewednan
yes_direct,fluoroquinolone,tendinopathy,16174181,achilles tendinopathy treatment fluoroquinolone nan
yes_direct,Fluoroquinolone,tendinopathy,16174181,fluoroquinolone antibiotic therapy recognized poorly understood cause achilles tendinopathy nan
no_relation,tyrosine,nonsmall cell lung cancer,16177570,inhibitors tyrosine kinase activity associated receptor approved treatment chemotherapyrefractory nonsmall cell lung cancer clinical trials additional tumor typesnan
no_relation,tyrosine,tumor,16177570,inhibitors tyrosine kinase activity associated receptor approved treatment chemotherapyrefractory nonsmall cell lung cancer clinical trials additional tumor typesnantyrosine kinase tyrosine
no_relation,gefitinib,tumor,16177570,inhibitors gefitinib erlotinib display limited response rates assessed cohorts include patients subgroups defined patient tumor characteristics preferentially respond agentsnan
no_relation,erlotinib,tumor,16177570,inhibitors gefitinib erlotinib display limited response rates assessed cohorts include patients subgroups defined patient tumor characteristics preferentially respond agentsnan
no_relation,erlotinib,glioblastoma,16177570,recently performed analysis tumors obtained phase trial erlotinib patients glioblastoma multiforme gbm common malignant brain tumor adultsnan
no_relation,erlotinib,brain tumor,16177570,recently performed analysis tumors obtained phase trial erlotinib patients glioblastoma multiforme gbm common malignant brain tumor adultsnan
no_relation,erlotinib,tumors,16177570,recently performed analysis tumors obtained phase trial erlotinib patients glioblastoma multiforme gbm common malignant brain tumor adultsnan
no_relation,glucose,hypertension,16189445,children adolescents classified metabolic syndrome met three following criteria hypertriglyceridemia low levels highdensity lipoprotein hdl high fasting glucose obesity hypertension nan
no_relation,glucose,metabolic syndrome,16189445,children adolescents classified metabolic syndrome met three following criteria hypertriglyceridemia low levels highdensity lipoprotein hdl high fasting glucose obesity hypertensionnan
no_relation,glucose,"glucose, obesity",16189445,children adolescents classified metabolic syndrome met three following criteria hypertriglyceridemia low levels highdensity lipoprotein hdl high fasting glucose obesity hypertensionnan
no_relation,glucose,hypertriglyceridemia,16189445,children adolescents classified metabolic syndrome met three following criteria hypertriglyceridemia low levels highdensity lipoprotein hdl high fasting glucose obesity hypertensionnan
no_relation,glucose,metabolic syndrome,16189445,three criteria metabolic syndrome high triglyceride levels glucose intolerance obesity fulfilled three subjects nan
no_relation,glucose,obesity,16189445,three criteria metabolic syndrome high triglyceride levels glucose intolerance obesity fulfilled three subjects nan
no_relation,glucose,glucose intolerance,16189445,three criteria metabolic syndrome high triglyceride levels glucose intolerance obesity fulfilled three subjects nan
yes_direct,sartans,hypertensive,16203601,report two cases adverse fetal outcome hypertensive pregnancies exposed sartans nan
no_relation,ATP,Salmonella,16204528,showed cellfree culture supernatant acidophilus strain lb lbcfcs induced following effects enterica sl decrease intracellular atp paralleled bacterial death ii release lipopolysaccharide iii permeabilization bacterial membrane iv increase sensitivity salmonella lytic action sodium dodecyl sulfatenan
yes_direct,sodium dodecyl sulfate,Salmonella,16204528,showed cellfree culture supernatant acidophilus strain lb lbcfcs induced following effects enterica sl decrease intracellular atp paralleled bacterial death ii release lipopolysaccharide iii permeabilization bacterial membrane iv increase sensitivity salmonella lytic action sodium dodecyl sulfate nan
no_relation,acetylcholine,Parkinson's disease,16210393,striatal alpha nicotinic acetylcholine receptors potential targets parkinson's disease therapynanused treatment
no_relation,nicotine,Parkinson's disease,16210393,latter observation coupled finding nicotine protects nigrostriatal damage suggest alpha nachrs may represent unique targets neurodegenerative disorders linked nigrostriatal system parkinson's disease nan
no_relation,nicotine,neurodegenerative disorders,16210393,latter observation coupled finding nicotine protects nigrostriatal damage suggest alpha nachrs may represent unique targets neurodegenerative disorders linked nigrostriatal system parkinson's diseasenan
no_relation,metformin,PCOS,16217983,treatment insulin sensitizers metformin thiazolidinediones tzds improve metabolic hormonal patterns also improve ovulation pcos nan
no_relation,thiazolidinediones/TZDs,PCOS,16217983,treatment insulin sensitizers metformin thiazolidinediones tzds improve metabolic hormonal patterns also improve ovulation pcos nan
no_relation,nitric oxide/NO,necrosis,16226725,ep shown decrease expression various proinflammatory mediators including nitric oxide  tumor necrosis factor tnf cyclooxygenase interleukin il variety vitro vivo model systemsnan
no_relation,nitric oxide/NO,tumor,16226725,ep shown decrease expression various proinflammatory mediators including nitric oxide  tumor necrosis factor tnf cyclooxygenase interleukin il variety vitro vivo model systemsnan
no_relation,triacylglycerol,ADRP,16230742,murine macrophages incubated either vldl oleic acid content adrp triacylglycerol tg increased foldnan
yes_direct,oleic acid,ADRP,16230742,murine macrophages incubated either vldl oleic acid content adrp triacylglycerol tg increased foldnan
yes_direct,oleic acid,ADRP,16230742,induction adrp tg accumulation also observed oleic acid treated huh human liver cellsnan
no_relation,triacsin C,ADRP,16230742,addition triacsin potent inhibitor acyl-coa synthase decreased amount tg vldlinduced foam cells oleic acidtreated liver cells decreased amount adrp protein parallel indicating amount adrp reduced regression lipidstoring cellsnan
no_relation,acyl-CoA,ADRP,16230742,addition triacsin potent inhibitor acyl-coa synthase decreased amount tg vldlinduced foam cells oleic acidtreated liver cells decreased amount adrp protein parallel indicating amount adrp reduced regression lipidstoring cellsnan
no_relation,oleic acid,ADRP,16230742,addition triacsin potent inhibitor acyl-coa synthase decreased amount tg vldlinduced foam cells oleic acid treated liver cells decreased amount adrp protein parallel indicating amount adrp reduced regression lipidstoring cellsnan
no_relation,triacsin C,ADRP,16230742,addition proteasome inhibitor triacsin treatment abolished adrp decrease accumulated polyubiquitinated adrp nan
no_relation,triacsin C,ADRP,16230742,addition proteasome inhibitor reversed degradation adrp also tg reduction triacsin results suggest cellular amounts adrp tg regulate ubiquitinproteasome system involved degradation adrp regression lipidstoring cellsnan
no_relation,taxanes,breast cancer,16249641,trastuzumab repeatedly shown result significant clinical benefits subsequently accepted treatment choice herpositive advanced breast cancer particularly firstline treatment combination taxanes monotherapy secondline thirdline settingnan
no_relation,capecitabine,breast cancer,16249641,determined safety iv trastuzumab mgkg followed mgkg every weeks combination chemotherapeutic agents administered weekly courses docetaxel vinorelbine capecitabine  patients herpositive recurrent locoregional andor metastatic breast cancer nan
no_relation,vinorelbine,breast cancer,16249641,determined safety iv trastuzumab mgkg followed mgkg every weeks combination chemotherapeutic agents administered weekly courses docetaxel vinorelbine capecitabine patients herpositive recurrent locoregional andor metastatic breast cancer nan
no_relation,docetaxel,breast cancer,16249641,determined safety iv trastuzumab mgkg followed mgkg every weeks combination chemotherapeutic agents administered weekly courses docetaxel vinorelbine capecitabine patients herpositive recurrent locoregional andor metastatic breast cancer nan
no_relation,Gemcitabine,refractory Hodgkin's disease,16249642,gemcitabine treatment relapsed refractory hodgkins disease nan
no_relation,gemcitabine,refractory Hodgkin's disease,16249642,treated patients relapsed refractory hodgkins disease gemcitabine nan
no_relation,Gemcitabine,Hodgkin's disease,16249642,gemcitabine effective treatment hodgkins disease nan
no_relation,ketotifen,artificial tear substitute,16291412,comparison effects ketotifen fumarate olopatadine hcl ophthalmic solutions seasonal allergic conjunctivities day randomized doublemasked artificial tear substitute controlled trialnan
no_relation,olopatadine,SAC,16291412,aims study compare clinical efficacy topical ketotifen olopatadine eye drops determine effects drugs expression cell adhesion molecules cams inflammatory markers conjunctival surface cells patients sac nan
no_relation,ketotifen,SAC,16291412,aims study compare clinical efficacy topical ketotifen olopatadine eye drops determine effects drugs expression cell adhesion molecules cams inflammatory markers conjunctival surface cells patients sac nan
no_relation,ketotifen fumarate,ATS,16291412,patients sac included study randomly assigned  groups topical ketotifen fumarate ophthalmic solution topical olopatadine hcl ophthalmic solution ats control groupnan
no_relation,ketotifen fumarate,SAC,16291412,patients sac included study randomly assigned  groups topical ketotifen fumarate ophthalmic solution topical olopatadine hcl ophthalmic solution ats control groupnan
no_relation,olopatadine,ATS,16291412,twelve patients received ketotifen olopatadine  ats nan
no_relation,ketotifen,ATS,16291412,twelve patients received ketotifen  olopatadine ats nan
no_relation,olopatadine,ATS,16291412,activetreatment groups improvements clinical scores tearing itching pronounced compared ats group although day difference tearing score olopatadine ats groups statistically significantnan
no_relation,olopatadine,ATS,16291412,expression rates cams inflammatory markers conjunctival surface cells significantly reduced ketotifen olopatadine compared ats nan
no_relation,ketotifen,ATS,16291412,expression rates cams inflammatory markers conjunctival surface cells significantly reduced ketotifen olopatadine compared ats nan
no_relation,olopatadine,SAC,16291412,shortterm study selected small study population sac ketotifen olopatadine diminished expression cams inflammatory markers conjunctival surface cells effectivelynan
no_relation,ketotifen,SAC,16291412,shortterm study selected small study population sac ketotifen olopatadine diminished expression cams inflammatory markers conjunctival surface cells effectivelynan
no_relation,N-acetyl cysteine,chronic obstructive pulmonary disease,16298736,oxygen therapy low flow causes oxidative stress chronic obstructive pulmonary disease prevention nacetyl cysteine nan
no_relation,Oxygen,chronic obstructive pulmonary disease,16298736,oxygen therapy low flow causes oxidative stress chronic obstructive pulmonary disease prevention nacetyl cysteinenanoxygen chemical
yes_direct,oxygen,toxicity,16298736,exposure high oxygen concentration produces toxicity free radical releasenan
no_relation,N-acetyl-cysteine/NAC,chronic obstructive pulmonary disease/COPD,16298736,aimed study whether stable chronic obstructive pulmonary disease copd patients present unbalance blood redox status effect oxygen administration blood redox balance efficacy nacetylcysteine nac treatment oxidative stressinduced oxygen administration whether doserelatednan
no_relation,oxygen,chronic obstructive pulmonary disease/COPD,16298736,aimed study whether stable chronic obstructive pulmonary disease copd patients present unbalance blood redox status effect oxygen administration blood redox balance efficacy nacetylcysteine nac treatment oxidative stressinduced oxygen administration whether doserelatednan
no_relation,GSSG,COPD,16298736, stable state iii copd patients recruited reduced glutathione gsh oxidised glutathione gssg erythrocytes thiol proteins psh carbonyl proteins pc erythrocytes plasma evaluatednan
no_relation,GSH/glutathione,COPD,16298736, stable state iii copd patients recruited reduced glutathione gsh oxidised glutathione gssg erythrocytes thiol proteins psh carbonyl proteins pc erythrocytes plasma evaluatednan
no_relation,NAC,COPD,16298736,copd patients underwent lm oxygen nac  mgday placebo starting oxygen administrationnan
no_relation,oxygen,COPD,16298736,copd patients underwent lm oxygen nac  mgday placebo starting oxygen administrationnan
no_relation,NAC,COPD,16298736,conclusion stable state iii copd patients present unstable redox balance long term low flow oxygen administration induces systemic oxidative stress prevented nac treatmentnan
no_relation,oxygen,COPD,16298736,conclusion stable state iii copd patients present unstable redox balance long term low flow oxygen administration induces systemic oxidative stress prevented nac treatmentnan
no_relation,alcohol,psychiatric,16339614,preceding months respondents screened positive mdq greater use psychiatric hospitals emergency departments urgent care centers also outpatient visits primary care physicians psychiatrists alcohol treatment centers screened negativenan
yes_direct,glucose,pleural thickening,16340225,development pleural thickening related level pleural fluid glucose nan
yes_direct,tamoxifen,breast cancer/uterine cancer,16352333,greater fold increased risk uterine cancer women breast cancer exposed tamoxifen nan
yes_direct,tamoxifen,uterine cancer,16352333,objective study determine percentage women developed uterine cancer months discontinuing tamoxifen past users compare clinical pathologic features women developed uterine cancer tamoxifen therapy within months stopping therapy recent usersnan
no_relation,tamoxifen,breast cancer/uterine cancer,16352333,women diagnosis uterine cancer memorial sloankettering cancer center june past history breast cancer treated tamoxifen identifiednan
no_relation,tamoxifen,breast cancer/uterine cancer,16352333, women identified history breast cancer treated tamoxifen preceding diagnosis uterine cancer nan
no_relation,tamoxifen,uterine cancer,16352333,thirtynine developed uterine cancer months discontinuing tamoxifen nan
no_relation,tamoxifen,breast cancer,16352333,significant differences age breast cancer diagnosis body mass index parity stage breast cancer modality breast cancer treatment duration tamoxifen therapy past recent users tamoxifen nan
yes_direct,tamoxifen,uterine cancer,16352333,one third women treated tamoxifen develop uterine cancer months discontinuing therapynan
no_relation,tamoxifen,uterine cancer,16352333,therefore women past history tamoxifen therapy continued surveillance completion tamoxifen ensure early diagnosis uterine cancer nan
no_relation,mycophenolic acid/MPA,mycophenolic acid/MPA,16359376,therapeutic drug monitoring mycophenolic acid mpa combination cyclosporine concentration csa  tacrolimus trough concentration  investigated repeated measurements mpa mpa glucuronide mpag trough concentrations renal allograft recipients first months posttransplantnansense
no_relation,cyclosporine,mycophenolic acid/MPA,16359376,therapeutic drug monitoring mycophenolic acid mpa combination cyclosporine concentration csa  tacrolimus trough concentration  investigated repeated measurements mpa mpa glucuronide mpag trough concentrations renal allograft recipients first months posttransplantnan
no_relation,tacrolimus,mycophenolic acid/MPA,16359376,therapeutic drug monitoring mycophenolic acid mpa combination cyclosporine concentration csa  tacrolimus trough concentration  investigated repeated measurements mpa mpa glucuronide mpag trough concentrations renal allograft recipients first months posttransplantnan
no_relation,MPA-glucuronide/MPAG,mycophenolic acid/MPA,16359376,therapeutic drug monitoring mycophenolic acid mpa combination cyclosporine concentration csa  tacrolimus trough concentration  investigated repeated measurements mpa mpa glucuronide mpag trough concentrations renal allograft recipients first months posttransplantnan
no_relation,MPA,MPA,16359376,median mpa concentration  microgml patients within range respectively nan
no_relation,MPA,MPA,16359376,csa correlated mpagto mpa rationan
no_relation,MPA,gamma-glutamyl-transpeptidase/GGT,16359376,csa correlated mpagto mpa ratio gammaglutamyltranspeptidase ggt nan
no_relation,MPA,MPA,16359376,total mpa concentration increased months patients tacrolimusnan
no_relation,tacrolimus,MPA,16359376,total mpa concentration increased months patients tacrolimus nan
no_relation,MPA,MPA,16359376,high csa lowered acute rejection rate plasma mpa nan
no_relation,MPA,MPA,16359376,high csa associated elevated ggt probably cholestatic effects explain increased mpagto mpa rationan
no_relation,MPA,GGT,16359376,high csa associated elevated ggt probably cholestatic effects explain increased mpagto mpa rationan
no_relation,MPAG,MPA,16359376,high csa associated elevated ggt probably cholestatic effects explain increased mpag mpa rationan
no_relation,MPAG,GGT,16359376,high csa associated elevated ggt probably cholestatic effects explain increased mpag tompa rationan
no_relation,MPA,MPA,16359376,increasing mpa concentration ascribed perprotocol csa reductionsnan
no_relation,MPA,MPA,16359376,conclusion csa may confound relationship mpa incidence rejection contribute difficulty obtaining therapeutic range mpa clinical practicenan
no_relation,CsA,MPA,16359376,conclusion csa may confound relationship mpa incidence rejection contribute difficulty obtaining therapeutic range mpa clinical practicenan
no_relation,Warfarin,cluster headache,16362716,warfarin therapeutic option control chronic cluster headache report three casesnan
no_relation,warfarin,cluster headache,16362716,two remained cluster headache free taking warfarin nan
yes_direct,warfarin,cluster headache,16362716,third patient use warfarin three weeks initially increased frequency intensity cluster headache attacks subsequently induced prolonged remissionnan
no_relation,interferon,HIV/hepatitis C virus-coinfected,16374211,introduction pegylated interferon ribavirin combination therapy significantly improved treatment options hivhepatitis viruscoinfected patients become available leading sustained virological response rates nanused treatment
no_relation,ribavirin,HIV/hepatitis C virus-coinfected,16374211,introduction pegylated interferon ribavirin combination therapy significantly improved treatment options hivhepatitis viruscoinfected patients become available leading sustained virological response rates nan
no_relation,pegylated interferon,HIV/hepatitis C virus-coinfected,16374211,treatment pegylated interferon plus ribavirin safe effective hivhepatitis viruscoinfected patientsnan
no_relation,ribavirin,HIV/hepatitis C virus-coinfected,16374211,treatment pegylated interferon plus ribavirin safe effective hivhepatitis viruscoinfected patientsnan
no_relation,mitoxantrone,cardiotoxicity,16374818,suppression mitoxantrone cardiotoxicity multiple sclerosis patients dexrazoxanenan
no_relation,dexrazoxane,cardiotoxicity,16374818,suppression mitoxantrone cardiotoxicity multiple sclerosis patients dexrazoxane nan
no_relation,dexrazoxane,multiple sclerosis,16374818,suppression mitoxantrone cardiotoxicity multiple sclerosis patients dexrazoxane nan
no_relation,mitoxantrone,multiple sclerosis,16374818,suppression mitoxantrone cardiotoxicity multiple sclerosis patients dexrazoxanenan
yes_direct,mitoxantrone,cardiotoxicity,16374818,explore potential dexrazoxane suppress subclinical cardiotoxicity ms patients receiving mitoxantrone nan
no_relation,dexrazoxane,cardiotoxicity,16374818,explore potential dexrazoxane suppress subclinical cardiotoxicity ms patients receiving mitoxantronenan
no_relation,dexrazoxane,MS,16374818,explore potential dexrazoxane suppress subclinical cardiotoxicity ms patients receiving mitoxantronenan
no_relation,mitoxantrone,MS,16374818,explore potential dexrazoxane suppress subclinical cardiotoxicity ms patients receiving mitoxantrone nan
no_relation,mitoxantrone,cardiotoxicity,16374818,openlabel study performed evaluate possible subclinical cardiotoxicity multiple sclerosis patients treated quarterly mitoxantrone mgm cumulative without concomitant dexrazoxane using blinded serial radionucleide ventriculographynan
no_relation,dexrazoxane,cardiotoxicity,16374818,openlabel study performed evaluate possible subclinical cardiotoxicity multiple sclerosis patients treated quarterly mitoxantrone mgm cumulative without concomitant dexrazoxane using blinded serial radionucleide ventriculographynan
no_relation,dexrazoxane,multiple sclerosis,16374818,openlabel study performed evaluate possible subclinical cardiotoxicity multiple sclerosis patients treated quarterly mitoxantrone mgm cumulative without concomitant dexrazoxane using blinded serial radionucleide ventriculographynan
no_relation,mitoxantrone,multiple sclerosis,16374818,openlabel study performed evaluate possible subclinical cardiotoxicity multiple sclerosis patients treated quarterly mitoxantrone mgm cumulative without concomitant dexrazoxane using blinded serial radionucleide ventriculographynan
no_relation,mitoxantrone,multiple sclerosis,16374818,results support cardioprotective effect dexrazoxane mitoxantrone treated multiple sclerosis patientsnan
no_relation,dexrazoxane,multiple sclerosis,16374818,results support cardioprotective effect dexrazoxane mitoxantrone treated multiple sclerosis patientsnan
no_relation,steroid,vestibular neuritis,16376278,diagnosed vestibular neuritis steroid therapy initiatednan
no_relation,fluorescein,Cytotoxicity,16403516,cytotoxicity remained whether cells treated anginex degrees degrees low temperatures fluorescein conjugated anginex accumulated endothelial surface reach cytoplasm indicating cell membrane primary target peptidenan
no_relation,Androgen,prostate cancer,16406864,androgen ablation remains cornerstone management advanced prostate cancer nan
no_relation,gonadotropin-releasing hormone,prostate cancer,16406864,comprehensive review peer reviewed literature performed topic secondary hormonal therapies including oral antiandrogens adrenal androgen inhibitors corticosteroids estrogenic compounds gonadotropinreleasing hormone antagonists alternative hormonal therapies advanced prostate cancer nan
no_relation,corticosteroids,prostate cancer,16406864,comprehensive review peer reviewed literature performed topic secondary hormonal therapies including oral antiandrogens adrenal androgen inhibitors corticosteroids estrogenic compounds gonadotropinreleasing hormone antagonists alternative hormonal therapies advanced prostate cancer nan
no_relation,androgen,prostate cancer,16406864,comprehensive review peer reviewed literature performed topic secondary hormonal therapies including oral antiandrogens adrenal androgen inhibitors corticosteroids estrogenic compounds gonadotropinreleasing hormone antagonists alternative hormonal therapies advanced prostate cancer nan
no_relation,Levosimendan,myocardial stunning,16409345,levosimendan promising treatment myocardial stunning nan
no_relation,catecholamine,intra aortic balloon counterpulsation,16409345,immediate percutaneous transluminal coronary angioplasty intra aortic balloon counterpulsation catecholamine therapy failed stabilise haemodynamicsnan
no_relation,flavonoids,human cell line/HL,16414027,study designed screen antichlamydial activity natural flavonoids natural structurally similar synthetic compounds chlamydia pneumoniae human cell line hl nan
no_relation,flavonoids,Chlamydia pneumoniae,16414027,study designed screen antichlamydial activity natural flavonoids natural structurally similar synthetic compounds chlamydia pneumoniae human cell line hlnan
no_relation,Salmeterol,asthma,16424409,salmeterol multicenter asthma research trial comparison usual pharmacotherapy asthma usual pharmacotherapy plus salmeterol nan
no_relation,Salmeterol,MDI/metered-dose inhaler,16424409,salmeterol  mug bid via metereddose inhaler mdi placebo bid via mdi nan
no_relation,salmeterol,deaths,16424409,occurrence primary outcome respiratoryrelated deaths lifethreatening experiences low significantly different salmeterol vs placebo vs relative risk rr  confidence interval ci nan
yes_direct,salmeterol,deaths,16424409,small significant increase respiratoryrelated deaths vs rr  ci  asthmarelated deaths vs rr  ci  combined asthmarelated deaths lifethreatening experiences vs rr  ci  subjects receiving salmeterol vs placebonan
yes_direct,salmeterol,asthma,16424409,small significant increase respiratoryrelated deaths vs rr  ci  asthma related deaths vs rr  ci  combined asthma related deaths lifethreatening experiences vs rr  ci  subjects receiving salmeterol vs placebonan
no_relation,salmeterol,deaths,16424409,imbalance occurred largely africanamerican subpopulation respiratoryrelated deaths lifethreatening experiences vs rr  ci  combined asthmarelated deaths lifethreatening experiences vs rr  ci  subjects receiving salmeterol vs placebonan
yes_direct,salmeterol,asthma,16424409,imbalance occurred largely africanamerican subpopulation respiratoryrelated deaths lifethreatening experiences vs rr  ci  combined asthma related deaths lifethreatening experiences vs rr  ci  subjects receiving salmeterol vs placebonan
yes_indirect,salmeterol,deaths,16424409,small statistically significant increases respiratoryrelated asthmarelated deaths combined asthmarelated deaths lifethreatening experiences total population receiving salmeterol nan
yes_direct,salmeterol,asthma,16424409,small statistically significant increases respiratoryrelated asthma related deaths combined asthma related deaths lifethreatening experiences total population receiving salmeterol nan
no_relation,penicillin,neuropsychiatric symptoms,16425549,neuropsychiatric symptoms recovered gradually penicillin treatment two months laternan
no_relation,marinomycin A,melanoma,16448135,room light marinomycin slowly isomerizes geometrical isomers marinomycins marinomycins ad show significant antimicrobial activities drug resistant bacterial pathogens demonstrate impressive selective cancer cell cytotoxicities six eight melanoma cell lines national cancer institutes cell line panelnan
no_relation,marinomycin A,cancer,16448135,room light marinomycin slowly isomerizes geometrical isomers marinomycins marinomycins ad show significant antimicrobial activities drug resistant bacterial pathogens demonstrate impressive selective cancer cell cytotoxicities six eight melanoma cell lines national cancer institutes cell line panelnan
no_relation,suramin,trypanosomiasis,16455122,first reported human case trypanosomiasis caused trypanosoma evansi treated using suramin nan
no_relation,Suramin,infection,16455122,suramin considered treatment cases human evansi infection occurnan
no_relation,oxygen,SAH,16463835,continuous monitoring arterial blood pressure abp icp cerebral perfusion pressure cpp brain tissue oxygen pbo middle cerebral artery flow velocity fv microdialysis performed poor grade sah patientsnan
no_relation,sodium hyaluronate,postoperative small bowel obstruction,16468536,study aimed evaluate efficacy sodium hyaluronate carboxymethylcellulose membrane seprafilm early postoperative small bowel obstruction epsbonan
no_relation,Seprafilm,surgical site infection,16468536,also examined whether using seprafilm affected surgical site infection rates gastrointestinal surgerynan
no_relation,"3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide",cytotoxicity,16477616,results show nanomolar concentrations sb protects cells abetamediated cytotoxicity assessed dimethylthiazolyldiphenyltetrazolium bromide mtt terminal deoxynucleotidyl transferasemediated dutpfluorescein isothiocyanate nick endlabeling tunel experiments countering abetamediated decrease expression antiapoptotic factor bclnan
no_relation,propionylcarnitine,intermittent claudication,16518521,effect propionylcarnitine changes endothelial function plasma levels adhesion molecules induced acute exercise patients intermittent claudication nan
no_relation,Alfuzosin,benign prostatic hyperplasia,16536764,alfuzosin mg daily prevents overall clinical progression benign prostatic hyperplasia acute urinary retention results year placebocontrolled studynan
no_relation,alfuzosin,benign prostatic hyperplasia,16536764,evaluate effect alfuzosin mg daily administered years progression events men lower urinary tract symptoms benign prostatic hyperplasia lutsbphnan
no_relation,Sildenafil citrate,ischemic optic neuropathy,16620369,sildenafil citrate use incidence nonarteritic anterior ischemic optic neuropathy nan
no_relation,sildenafil,ischemic optic neuropathy,16620369,nonarteritic anterior ischemic optic neuropathy naion reported rarely men taking sildenafil phosphodiesterase inhibitors erectile dysfunction ednan
no_relation,sildenafil,ED/erectile dysfunction,16620369,nonarteritic anterior ischemic optic neuropathy naion reported rarely men taking sildenafil phosphodiesterase inhibitors erectile dysfunction ed nan
no_relation,sildenafil,ED,16620369,incidence naion men receiving sildenafil treatment ed estimated using pooled safety data global clinical trials european observational studiesnan
no_relation,sildenafil,ED,16620369,data cited herein suggest increased incidence naion men took sildenafil ed nan
no_relation,vinflunine,bladder cancer,16622447,phase ii study vinflunine bladder cancer patients progressing firstline platinumcontaining regimennan
no_relation,platinum,bladder cancer,16622447,phase ii study vinflunine bladder cancer patients progressing firstline platinum containing regimennan
yes_direct,vinflunine,toxicity,16622447,multicentre phase ii trial determine efficacy vinflunine secondline therapy patients advanced transitional cell carcinoma tcc bladder secondary objectives assess duration response progressionfree survival pfs overall survival os evaluate toxicity associated treatmentnan
no_relation,vinflunine,transitional cell carcinoma/TCC,16622447,multicentre phase ii trial determine efficacy vinflunine secondline therapy patients advanced transitional cell carcinoma tcc bladder secondary objectives assess duration response progressionfree survival pfs overall survival os evaluate toxicity associated treatmentnan
no_relation,platinum,tumours,16622447,patients tumours failed progressed firstline platinum containing regimens advanced metastatic disease progressive disease platinum containing chemotherapy given adjuvant neoadjuvant intentnan
no_relation,platinum,metastatic disease,16622447,patients tumours failed progressed firstline platinum containing regimens advanced metastatic disease progressive disease platinum containing chemotherapy given adjuvant neoadjuvant intentnan
no_relation,vinca alkaloids,metastatic disease,16622447,note responses seen patients relatively poor prognostic factors short metastatic disease prior treatment vinca alkaloids visceral involvement nan
no_relation,platinum,metastatic disease,16622447,note responses seen patients relatively poor prognostic factors short platinum therapy including response rate progressing platinum treatment prior treatment metastatic disease prior treatment vinca alkaloids visceral involvement nan
no_relation,Vinflunine,TCC,16622447,vinflunine active agent treatment platinumpretreated bladder cancer results warrant investigation phase iii trials either monotherapy combination agents treatment advancedmetastatic tcc bladdernan
no_relation,Vinflunine,bladder cancer,16622447,vinflunine active agent treatment platinumpretreated bladder cancer results warrant investigation phase iii trials either monotherapy combination agents treatment advancedmetastatic tcc bladdernan
no_relation,platinum,bladder cancer,16622447,vinflunine active agent treatment platinum pretreated bladder cancer results warrant investigation phase iii trials either monotherapy combination agents treatment advancedmetastatic tcc bladdernan
no_relation,platinum,TCC,16622447,vinflunine active agent treatment platinum pretreated bladder cancer results warrant investigation phase iii trials either monotherapy combination agents treatment advancedmetastatic tcc bladdernan
no_relation,phenytoin,antiepileptic drugs,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz phtnan
no_relation,CBZ/carbamazepine,antiepileptic drugs,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz phtnan
no_relation,phenytoin,epileptic,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz phtnan
no_relation,CBZ/carbamazepine,epileptic,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz phtnan
no_relation,phenytoin,PHT,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz pht nan
no_relation,CBZ/carbamazepine,PHT,16631625,pharmacoresistance epileptic patients may ascribed least two mutually exclusive mechanisms pharmacokinetic mechanism decreased sensitivity availability targets antiepileptic drugs aeds ie carbamazepine phenytoin cbz pht nan
no_relation,GABA,epileptic,16631625,slices drugresistant epileptic patients made hypersynchronoushyperexcitable elevated potassium inhibition gaba receptors behaved similarlynan
no_relation,potassium,epileptic,16631625,slices drugresistant epileptic patients made hypersynchronoushyperexcitable elevated potassium inhibition gabaa receptors behaved similarlynan
no_relation,statins,renal dysfunction,16635616,aim present study assess effect statins renal function patients high risk renal dysfunction underwent suprarenal aortic cross clampingdeclampingnan
no_relation,creatinine,blood loss,16635616,analysisofvariance model repeated measurements applied compare creatinine levels statin users nonusers adjustment clamping time blood loss nan
no_relation,Alcohol,Alcohol-impaired,16647085,alcohol impaired driving consequences united states past yearsnanalcohol-impaired driving alcohol-impaired 
no_relation,Alcohol,Alcohol-impaired,16647085,alcohol impaired driving still major problem needs continuing attentionnan
no_relation,calcium,osteosarcoma,16674304,bonelike tissue formation threedimensional culture mg osteosarcoma cells gelatin hydrogels using calcium enriched mediumnan
no_relation,calcium,Human osteosarcoma,16674304,human osteosarcoma mg cells cultured tissue culture dish various ca concentrations evaluate effect ca concentration calcium depositionnan
no_relation,Pantoprazole,ulcer bleeding,16677158,pantoprazole infusion adjuvant therapy endoscopic treatment patients peptic ulcer bleeding prospective randomized controlled trialnan
no_relation,pantoprazole,ulcer bleeding,16677158,investigated whether administration pantoprazole infusion would improve outcome ulcer bleeding following successful endoscopic therapynanimprove outcome key term
no_relation,epinephrine,gastric or duodenal ulcers with active bleeding,16677158,doubleblind placebocontrolled prospective trial patients gastric duodenal ulcers active bleeding nonbleeding visible vessel received combined endoscopy therapy injection epinephrine heater probe applicationnan
no_relation,epinephrine,bleeding,16677158,doubleblind placebocontrolled prospective trial patients gastric duodenal ulcers active bleeding non bleeding visible vessel received combined endoscopy therapy injection epinephrine heater probe applicationnan
no_relation,pantoprazole,bleeding,16677158,three patients pantoprazole group eight placebo group required surgery control bleeding nan
no_relation,pantoprazole,bleeding peptic ulcers,16677158,patients bleeding peptic ulcers use high dose pantoprazole infusion following successful endoscopic therapy effective reducing rebleeding transfusion requirements hospital staynan
no_relation,Ropivacaine,akinesia,16703549,ropivacaine used retrobulbarperibulbar combined anesthesia vitreoretinal surgery showed excellent clinical efficacy regards analgesia muscle akinesia nan
no_relation,androgen,prostate cancer,16763722,prostate androgen regulated gene novel potential target androgen independent prostate cancer therapynan
no_relation,androgen,prostate cancer/PCa,16763722,investigate involvement prostate androgen regulated par gene androgen receptor ar signaling pathway malignant phenotype androgen independent prostate cancer pca cellsnan
no_relation,androgen,PCa,16763722,determine importance par malignant proliferation androgen independent pca cells used small interfering rna sirna transfection knock expression gene pc cellsnan
no_relation,androgen,PCa,16763722,possibility par downstream ar contribution malignant proliferation androgen independent pca cells gene could potential therapeutic target androgen independent pca ar signaling pathway alterationnan
no_relation,lamotrigine,Mental Disorders,16768643,evaluated patients age diagnostic statistical manual mental disorders fourth edition text revision dsmivtr bipolar disorder outpatient clinic treated lamotrigine using clinical global impression cgi scalenan
no_relation,lamotrigine,bipolar disorder,16768643,evaluated patients age diagnostic statistical manual mental disorders fourth edition text revision dsmivtr bipolar disorder outpatient clinic treated lamotrigine using clinical global impression cgi scalenan
no_relation,lamotrigine,bipolar disorder,16768643,open retrospective chart review suggests lamotrigine may effective well tolerated adjunctive treatment adolescents bipolar disorder nan
yes_direct,Cd,hemorrhage,16788562,animal experiments highdose exposure cd induced severe testicular interstitial hemorrhage edema increased incidence fetal death placental necrosisnan
yes_direct,Cd,necrosis,16788562,animal experiments highdose exposure cd induced severe testicular interstitial hemorrhage edema increased incidence fetal death placental necrosis nan
yes_direct,Cd,fetal death,16788562,animal experiments highdose exposure cd induced severe testicular interstitial hemorrhage edema increased incidence fetal death placental necrosisnan
yes_direct,Cd,edema,16788562,animal experiments highdose exposure cd induced severe testicular interstitial hemorrhage edema increased incidence fetal death placental necrosisnan
yes_direct,Capecitabine,cerebellar toxicity,16796795,capecitabine induced cerebellar toxicity nan
no_relation,Capecitabine,adenocarcinoma of the colon,16796795,capecitabine oral prodrug 5-fluorouracil used treatment adenocarcinoma colon nan
no_relation,5-fluorouracil,adenocarcinoma of the colon,16796795,capecitabine oral prodrug 5-fluorouracil used treatment adenocarcinoma colon nan
yes_direct,capecitabine,Neurotoxicity,16796795,neurotoxicity infrequently reported toxicity capecitabine nan
yes_direct,capecitabine,toxicity,16796795,neurotoxicity infrequently reported toxicity capecitabine nan
no_relation,tobramycin,cystic fibrosis,16801404,absence cochleotoxicity measured standard highfrequency pure tone audiometry trial versus threetimesdaily tobramycin cystic fibrosis patientsnan
no_relation,tobramycin,cystic fibrosis,16801404,undertook assessment hearing patients cystic fibrosis taking part large randomized controlled trial versus threetimesdaily tobramycin pulmonary exacerbations cystic fibrosis topic studynan
no_relation,tobramycin,auditory deficit,16801404,conclude single day course tobramycin treatment patients cystic fibrosis preexisiting auditory deficit measurable effect hearing apparent either threetimesdaily treatmentnan
no_relation,tobramycin,cystic fibrosis,16801404,conclude single day course tobramycin treatment patients cystic fibrosis preexisiting auditory deficit measurable effect hearing apparent either threetimesdaily treatmentnan
yes_direct,aminoglycoside,hearing loss,16801404,estimation cumulative cochleotoxic risk cystic fibrosis patients due repeated aminoglycoside therapy evidenced patients excluded study due hearing loss also requires characterizationnan
yes_direct,aminoglycoside,cystic fibrosis,16801404,estimation cumulative cochleotoxic risk cystic fibrosis patients due repeated aminoglycoside therapy evidenced patients excluded study due hearing loss also requires characterizationnan
no_relation,triacylglycerol,hypertriglyceridemic,16815487,ten healthy elderly men age body mass index kgm healthy young men age body mass index kgm studied hypertriglyceridemic clamp primed infusion longchain triacylglycerol emulsion reach stabilize triacylglycerol concentration mmoll minnan
no_relation,triacylglycerol,hypertriglyceridemic,16815487,elderly healthy men similar capacity young healthy men clear oxidize high triacylglycerol load administered hypertriglyceridemic clampnan
no_relation,clofarabine,chronic lymphocytic leukemia,16818700,clinical pharmacokinetic study clofarabine chronic lymphocytic leukemia strategy treatmentnan
no_relation,fludarabine,leukemias,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemias nan
no_relation,cladribine,leukemias,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemias nan
no_relation,fludarabine,CLL/chronic lymphocytic leukemia,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemiasnan
no_relation,clofarabine,CLL/chronic lymphocytic leukemia,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemiasnanused treatment
no_relation,cladribine,CLL/chronic lymphocytic leukemia,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemiasnan
no_relation,clofarabine,leukemias,16818700,based mechanistic similarity fludarabine cladribine success analogues treatment chronic lymphocytic leukemia cll hypothesized clofarabine would effective indolent leukemias nan
no_relation,clofarabine,CLL,16818700,present study conducted determine efficacy cellular pharmacology clinical trials singleagent clofarabine cll nan
no_relation,triphosphate,CLL,16818700,majority cases  analogue triphosphate present hours infusion indicating prolonged retention triphosphate cll cellsnan
no_relation,clofarabine,CLL,16818700,vitro clofarabine incubation leukemic lymphocytes cll patients showed clofarabine monophosphate accumulated higher concentration compared triphosphatenan
no_relation,triphosphate,CLL,16818700,vitro clofarabine incubation leukemic lymphocytes cll patients showed clofarabine monophosphate accumulated higher concentration compared triphosphate nan
no_relation,clofarabine,CLL,16818700,levels clofarabine triphosphate higher doses prolonged maintenance clofarabine triphosphate leukemic lymphocytes provide rationale treat cll weekly clofarabine schedulenan
no_relation,bucindolol,HF,16844790,potential pathophysiologic correlates assessed placebocontrolled trial bucindolol hf patientsnan
no_relation,Corticosteroid,Crohn's disease,16861053,corticosteroid therapy age infliximab acute year outcomes newly diagnosed children crohns disease nan
no_relation,nevirapine/NVP,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,EFV/efavirenz,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,abacavir,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavir nan
no_relation,nevirapine/NVP,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnanused treatment
no_relation,EFV/efavirenz,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,saquinavir,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,abacavir,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavir nan
no_relation,nelfinavir,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,saquinavir,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,nelfinavir,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,ritonavir/RTV,AIDS,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,ritonavir/RTV,death,16897660,analyzed progression death cause aids death aids death comparing efavirenz efv nevirapine nvp nelfinavir idinavir ritonavir rtv rtvboosted protease inhibitors pis saquinavir abacavirnan
no_relation,NVP,AIDS,16897660,compared efv adjusted hazard ratio hr aids death  confidence interval ci nvp  ci rtv  ci rtvboosted pisnan
no_relation,RTV,AIDS,16897660,compared efv adjusted hazard ratio hr aids death  confidence interval ci nvp  ci rtv  ci rtv boosted pisnan
no_relation,NVP,death,16897660,compared efv adjusted hazard ratio hr aids death  confidence interval ci nvp  ci rtv  ci rtvboosted pisnan
no_relation,RTV,death,16897660,compared efv adjusted hazard ratio hr aids death  confidence interval ci nvp  ci rtv  ci rtv boosted pisnan
no_relation,NVP,death,16897660,death adjusted hr nvp  ci nan
no_relation,3TC,death,16897660,adjusted hr death dttc  ci compared azt 3tc nan
no_relation,AZT,death,16897660,adjusted hr death dttc  ci compared azt tcnan
no_relation,Tolterodine,overactive bladder/overactive bladder symptoms,16904446,tolterodine extended release improves overactive bladder symptoms men overactive bladder nocturianan
no_relation,Tolterodine,nocturia,16904446,tolterodine extended release improves overactive bladder symptoms men overactive bladder nocturia nan
no_relation,tolterodine,overactive bladder/OAB,16904446,evaluate efficacy safety nighttime dosing tolterodine extended release ter men overactive bladder oab nocturianan
no_relation,tolterodine,nocturia,16904446,evaluate efficacy safety nighttime dosing tolterodine extended release ter men overactive bladder oab nocturia nan
no_relation,Dobutamine,myocardial infarct,16926330,dobutamine response myocardial infarct transmurality functional improvement coronary artery bypass graftinginitial experiencenan
no_relation,dobutamine,infarction,16926330,purpose study prospectively test hypothesis addition lowdose dobutamine quantification inotropic reserve segments infarct transmurality would improve predictive value functional recovery revascularization chronic infarction nan
no_relation,Pregabalin,neuropathic pain,16939547,pregabalin peripheral neuropathic pain results multicenter noncomparative openlabel study indian patientsnan
no_relation,pregabalin,neuropathic pain,16939547,aim study evaluate tolerability safety efficacy pregabalin indian patients peripheral neuropathic pain nan
no_relation,pregabalin,neuropathic pain,16939547,prospective multicenter noncomparative openlabel study patients peripheral neuropathic pain  received pregabalin doses ranging  mg twice daily weeksnan
yes_direct,Pregabalin,dizziness,16939547,pregabalin well tolerated common adverse events dizziness somnolencenan
yes_direct,Pregabalin,somnolence,16939547,pregabalin well tolerated common adverse events dizziness somnolence nan
no_relation,pregabalin,neuropathic pain,16939547,study demonstrated safety tolerability efficacy pregabalin peripheral neuropathic pain indian patientsnan
no_relation,arsenic,leukemia,16968895,relationship expression aquaglyceroporin arsenic uptake sensitivity leukemia cellsnan
no_relation,Arsenic trioxide,APL/acute promyelocytic leukemia,16968895,arsenic trioxide aso highly efficacious acute promyelocytic leukemia apl nan
yes_direct,arsenic,cytotoxicity,16968895,kegfpaqp transfectant accumulated significantly higher levels intracellular arsenic control kegfp incubated aso resulting significantly increased asoinduced cytotoxicity nan
no_relation,ATRA/all-trans retinoic acid,myeloid leukemia,16968895,pretreatment myeloid leukemia line hl alltrans retinoic acid atra upregulated aqp leading significantly increased arsenic uptake asoinduced cytotoxicity incubation aso might explain synergism atra asonan
no_relation,ATRA/all-trans retinoic acid,cytotoxicity,16968895,pretreatment myeloid leukemia line hl alltrans retinoic acid atra upregulated aqp leading significantly increased arsenic uptake asoinduced cytotoxicity incubation aso might explain synergism atra asonan
no_relation,arsenic,myeloid leukemia,16968895,pretreatment myeloid leukemia line hl alltrans retinoic acid atra upregulated aqp leading significantly increased arsenic uptake asoinduced cytotoxicity incubation aso might explain synergism atra asonan
no_relation,arsenic,cytotoxicity,16968895,pretreatment myeloid leukemia line hl alltrans retinoic acid atra upregulated aqp leading significantly increased arsenic uptake asoinduced cytotoxicity incubation aso might explain synergism atra asonan
no_relation,bilirubin,hepatocellular carcinoma,16984593,higher bilirubin level refractory ascites presence hepatocellular carcinoma predictive parameters mortality patients determined multivariate analysisnan
no_relation,alcohol,breast cancer,16999712,describe baseline healthy lifestyle behaviors dietary calcium vitamin caffeine alcohol intake smoking history physical activity postmenopausal breast cancer survivors bcs identify relationship healthy lifestyle behaviors bone mineral density bmd forearm total hip spinenan
no_relation,vitamin D,breast cancer,16999712,describe baseline healthy lifestyle behaviors dietary calcium vitamin caffeine alcohol intake smoking history physical activity postmenopausal breast cancer survivors bcs identify relationship healthy lifestyle behaviors bone mineral density bmd forearm total hip spinenan
no_relation,caffeine,breast cancer,16999712,describe baseline healthy lifestyle behaviors dietary calcium vitamin caffeine alcohol intake smoking history physical activity postmenopausal breast cancer survivors bcs identify relationship healthy lifestyle behaviors bone mineral density bmd forearm total hip spinenan
no_relation,calcium,breast cancer,16999712,describe baseline healthy lifestyle behaviors dietary calcium vitamin caffeine alcohol intake smoking history physical activity postmenopausal breast cancer survivors bcs identify relationship healthy lifestyle behaviors bone mineral density bmd forearm total hip spinenan
no_relation,calcium,coaching,16999712,healthcare provider must incorporate appropriate teaching strategies intensive counseling coaching along support mechanism enable bcs understand importance healthy diet calcium vitamin supplement regular strengthweight program integrated daily lifestylenan
no_relation,vitamin D,coaching,16999712,healthcare provider must incorporate appropriate teaching strategies intensive counseling coaching along support mechanism enable bcs understand importance healthy diet calcium vitamin supplement regular strengthweight program integrated daily lifestylenan
no_relation,levothyroxine,hypothyroidism,17001111,effect levothyroxine total lipid profiles assessed analytical capillary isotachophoresis patient hypothyroidism nan
no_relation,atorvastatin,hyperlipidemia,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidismnan
no_relation,pravastatin,hyperlipidemia,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidismnan
no_relation,pravastatin,hypothyroidism,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidism nan
no_relation,niceritrol,hyperlipidemia,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidismnan
no_relation,niceritrol,hypothyroidism,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidism nan
no_relation,atorvastatin,hypothyroidism,17001111,since hyperlipidemia improved pravastatin atorvastatin niceritrol since levels thyroidstimulating hormone tsh free iuml ngdl respectively patient diagnosed secondary hyperlipidemia hypothyroidism nan
no_relation,cholesterol,coronary heart disease,17001111,method charge isolation lipoproteins using capillary isotachophoresis citp proposed clinical application allows us quantitatively measure electronegative lowdensity lipoprotein cholesterol ldlc potent marker coronary heart disease nan
no_relation,levothyroxine,hypothyroidism,17001111,citp analysis able obtain information coronary risk factors may clinically useful evaluating effect treatment levothyroxine patients hypothyroidism secondary hyperlipidemianan
no_relation,levothyroxine,hyperlipidemia,17001111,citp analysis able obtain information coronary risk factors may clinically useful evaluating effect treatment levothyroxine patients hypothyroidism secondary hyperlipidemia nan
no_relation,warfarin,stroke,17020434,pooled data trials comparing antithrombotic treatment placebo shown warfarin reduces risk stroke aspirin alone reduces risk nan
no_relation,aspirin,stroke,17020434,pooled data trials comparing antithrombotic treatment placebo shown warfarin reduces risk stroke aspirin alone reduces risk nan
no_relation,warfarin,strokes,17020434,overall highrisk patients warfarin superior aspirin preventing strokes relative risk reduction nan
no_relation,aspirin,strokes,17020434,overall highrisk patients warfarin superior aspirin preventing strokes relative risk reduction nanpreventing key term
yes_direct,Ximelagatran,abnormal liver function,17020434,ximelagatran oral direct thrombin inhibitor found efficient vitamin antagonist drugs prevention embolic events recently withdrawn abnormal liver function testsnan
no_relation,vitamin K,abnormal liver function,17020434,ximelagatran oral direct thrombin inhibitor found efficient vitamin antagonist drugs prevention embolic events recently withdrawn abnormal liver function testsnan
no_relation,vitamin K,embolic events,17020434,ximelagatran oral direct thrombin inhibitor found efficient vitamin antagonist drugs prevention embolic events recently withdrawn abnormal liver function testsnan
no_relation,Ximelagatran,embolic events,17020434,ximelagatran oral direct thrombin inhibitor found efficient vitamin antagonist drugs prevention embolic events recently withdrawn abnormal liver function testsnan
no_relation,Clopidogrel,Atrial Fibrillation,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic eventsnan
no_relation,Irbesartan,embolic events,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic events nan
no_relation,warfarin,embolic events,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic events nan
no_relation,Clopidogrel,embolic events,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic events nan
no_relation,aspirin,Atrial Fibrillation,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic eventsnan
no_relation,warfarin,Atrial Fibrillation,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic eventsnan
no_relation,aspirin,embolic events,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic events nan
no_relation,Irbesartan,Atrial Fibrillation,17020434,activew atrial fibrillation clopidogrel trial irbesartan prevention vascular events study demonstrated warfarin superior platelet therapy clopidogrel plus aspirin prevention af embolic eventsnan
no_relation,Angiotensin,atrial fibrillation,17020434,angiotensin converting enzyme inhibitors angiotensin ii receptorblocking drugs hold promise atrial fibrillation cardiac remodellingnan
no_relation,Angiotensin,cardiac remodelling,17020434,angiotensin converting enzyme inhibitors angiotensin ii receptorblocking drugs hold promise atrial fibrillation cardiac remodelling nan
no_relation,bile acid,Barrett's esophagus,17054793,expression bile acid receptor fxr barretts esophagus enhancement apoptosis guggulsterone vitronan
no_relation,bile acid,Barrett's esophagus,17054793,aim study assess expression bile acid receptors esophagus normal esophagitis barretts esophagus adenocarcinoma investigate possible functionnan
no_relation,bile acid,adenocarcinoma,17054793,aim study assess expression bile acid receptors esophagus normal esophagitis barretts esophagus adenocarcinoma investigate possible functionnan
no_relation,bile acid,esophagitis,17054793,aim study assess expression bile acid receptors esophagus normal esophagitis barretts esophagus adenocarcinoma investigate possible functionnan
no_relation,bile acid,Barrett's esophagus,17054793,expression bile acid receptors fxr vdr esophageal biopsies patients normal mucosa esophagitis barretts esophagus adenocarcinoma  per group cell lines derived barretts esophagus esophageal adenocarcinoma assessed real time qpcr immunohistochemistrynan
no_relation,bile acid,esophageal adenocarcinoma/adenocarcinoma,17054793,expression bile acid receptors fxr vdr esophageal biopsies patients normal mucosa esophagitis barretts esophagus adenocarcinoma  per group cell lines derived barretts esophagus esophageal adenocarcinoma assessed real time qpcr immunohistochemistrynan
no_relation,bile acid,esophagitis,17054793,expression bile acid receptors fxr vdr esophageal biopsies patients normal mucosa esophagitis barretts esophagus adenocarcinoma  per group cell lines derived barretts esophagus esophageal adenocarcinoma assessed real time qpcr immunohistochemistrynan
no_relation,bile acid,Barrett's esophagus,17054793,effect guggulsterone antagonist bile acid receptors apoptosis barretts esophagus derived cells assessed morphologically flow cytometry measuring caspase activitynan
no_relation,guggulsterone,Barrett's esophagus,17054793,effect guggulsterone antagonist bile acid receptors apoptosis barretts esophagus derived cells assessed morphologically flow cytometry measuring caspase activitynan
no_relation,bile acid,Barrett's esophagus,17054793,bile acid receptor fxr significantly overexpressed barretts esophagus compared normal mucosa esophagitis esophageal adenocarcinomanan
no_relation,bile acid,esophageal adenocarcinoma,17054793,bile acid receptor fxr significantly overexpressed barretts esophagus compared normal mucosa esophagitis esophageal adenocarcinoma nan
no_relation,bile acid,esophagitis,17054793,bile acid receptor fxr significantly overexpressed barretts esophagus compared normal mucosa esophagitis esophageal adenocarcinomanan
no_relation,cyanoacrylate,bronchopleural fistula,17062286,transthoracic closure postpneumonectomy bronchopleural fistula coils cyanoacrylate nan
no_relation,2-chloro-2'-deoxyadenosine,B-cell leukemia,17065055,inhibition erk pathway promotes apoptosis induced 2-chloro-2'-deoxyadenosine bcell leukemia cell line ehebnan
no_relation,nucleoside,chronic lymphocytic leukemia,17065055,chlorodeoxyadenosine cda nucleoside analogue active bcell chronic lymphocytic leukemia bcllnan
no_relation,CdA/2-Chloro-2'-deoxyadenosine,chronic lymphocytic leukemia,17065055,chlorodeoxyadenosine cda nucleoside analogue active bcell chronic lymphocytic leukemia bcllnan
no_relation,clenbuterol,myocardial atrophy,17079761,regression left ventricular enlargement achieved betaadrenergicreceptor agonist clenbuterol administered prevent myocardial atrophy nan
no_relation,clenbuterol,ventricular enlargement,17079761,regression left ventricular enlargement achieved betaadrenergicreceptor agonist clenbuterol administered prevent myocardial atrophynan
no_relation,salbutamol,Flow-mediated dilation,17084260,flowmediated dilation salbutamol  responses fell typhoid vaccination pca  unchangednan
no_relation,salbutamol,Vascular dysfunction,17084260,vascular dysfunction acute inflammation measured fmd pwa salbutamol nan
no_relation,salbutamol,FMD,17084260,vascular dysfunction acute inflammation measured fmd pwa salbutamol nan
no_relation,salbutamol,inflammation,17084260,vascular dysfunction acute inflammation measured fmd pwa salbutamol nanmeasuring drug
no_relation,pyridostigmine,Autoimmune gastrointestinal dysmotility,17101331,autoimmune gastrointestinal dysmotility treated successfully pyridostigmine nan
no_relation,acetylcholine,AGID,17101331,numerous autoantibodies currently recognized biomarkers agid ganglionic acetylcholine receptor autoantibody proven pathophysiologic effectornan
no_relation,HBeAg,hepatitis B,17127704,predicting response peginterferon alphaa lamivudine two combined hbeag negative chronic hepatitis nan
no_relation,lamivudine,hepatitis B,17127704,predicting response peginterferon alphaa lamivudine two combined hbeagnegative chronic hepatitis nan
no_relation,HBeAg/hepatitis B e antigen,hepatitis B,17127704,trial patients hepatitis antigen hbeag negative chronic hepatitis  week posttreatment biochemical virological response rates peginterferon alphaa without lamivudine significantly higher lamivudine alonenan
no_relation,lamivudine,hepatitis B,17127704,trial patients hepatitis antigen hbeagnegative chronic hepatitis  week posttreatment biochemical virological response rates peginterferon alphaa without lamivudine significantly higher lamivudine alonenan
no_relation,alanine,hepatitis B,17127704,posttreatment response defined alanine aminotransferase alt normalisation hepatitis virus hbv dna levelnan
no_relation,perindopril,cardiovascular events,17135223,cost effectiveness perindopril reducing cardiovascular events patients stable coronary artery disease using data europa studynan
no_relation,perindopril,coronary artery disease,17135223,cost effectiveness perindopril reducing cardiovascular events patients stable coronary artery disease using data europa studynan
no_relation,Perindopril,cardiac events,17135223,european trial reduction cardiac events perindopril stable coronary artery disease europa trial recently reportednan
no_relation,Perindopril,coronary Artery disease,17135223,european trial reduction cardiac events perindopril stable coronary artery disease europa trial recently reportednan
no_relation,perindopril,coronary heart disease,17135223,assess cost effectiveness perindopril stable coronary heart disease uknan
no_relation,ibuprofen,analgesia,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynan
no_relation,acetaminophen,postoperative pain,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynan
no_relation,morphine,postoperative pain,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynan
no_relation,ibuprofen,postoperative pain,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynan
no_relation,acetaminophen,analgesia,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynanpatientcontrolled iv analgesia analgesia
no_relation,morphine,analgesia,17142654,compare effects iv acetaminophen oral ibuprofen respect postoperative pain control morphine requirements patients receiving morphine patientcontrolled iv analgesia pcia cesarean deliverynan
no_relation,ibuprofen,analgesia,17142654,intravenous acetaminophen reasonable alternative oral ibuprofen adjunct morphine patientcontrolled analgesia cesarean deliverynan
no_relation,acetaminophen,analgesia,17142654,intravenous acetaminophen reasonable alternative oral ibuprofen adjunct morphine patientcontrolled analgesia cesarean deliverynan
no_relation,nevirapine/NVP,immunodeficiency,17178792,impact nevirapine nvp plasma concentration selection resistant virus mothers received singledose nvp prevent perinatal human immunodeficiency virus type transmission persistence resistant virus infected childrennan
no_relation,NVP,immunodeficiency,17178792,genotypic resistance analysis performed mothers plasma samples week postpartum pp human immunodeficiency virus hiv dna peripheral blood mononuclear cells pbmc nvp resistance mutation detectednan
yes_direct,lindane,farmer's lung,17182642,insecticides ddt lindane aldicarb positively associated farmers lung among farmersnan
yes_direct,DDT,farmer's lung,17182642,insecticides ddt lindane aldicarb positively associated farmers lung among farmersnan
yes_direct,aldicarb,farmer's lung,17182642,insecticides ddt lindane aldicarb positively associated farmers lung among farmersnan
no_relation,Gonadotropin-releasing hormone,myoma,17197363,gonadotropinreleasing hormone agonist gnrh agonist therapy useful adjunct myomectomy hysterectomy uterine myoma nan
yes_direct,GnRH,submucosal myomas,17197363,spontaneous expulsion submucosal myomas might occur administration gnrh agonist hence may acceptable alternative symptomatic females without sexual exposurenanspontaneous expulsion submucosal myomas submucosal myomas
no_relation,mitomycin,toxicity,17203763,feasibility toxicity local response rates intraarterial chemotherapy fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
no_relation,mitomycin,locally advanced breast cancer,17203763,feasibility toxicity local response rates intraarterial chemotherapy fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
no_relation,5-fluorouracil,toxicity,17203763,feasibility toxicity local response rates intraarterial chemotherapy 5-fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
yes_direct,epirubicin,toxicity,17203763,feasibility toxicity local response rates intraarterial chemotherapy fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
no_relation,5-fluorouracil,locally advanced breast cancer,17203763,feasibility toxicity local response rates intraarterial chemotherapy 5-fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
no_relation,epirubicin,locally advanced breast cancer,17203763,feasibility toxicity local response rates intraarterial chemotherapy fluorouracil epirubicin mitomycin patients years locally advanced breast cancer evaluatednan
yes_direct,dopamine,extrapyramidal symptoms,17263185,presence pdea striatal output pathways may reduce incidence severity dopamine receptor antagonistlike side effects including extrapyramidal symptoms nan
no_relation,calcium pyrophosphate dihydrate,arthropathy,17275646,best knowledge case calcium pyrophosphate dihydrate arthropathy total knee arthroplasty reported previouslynan
no_relation,Estrogen,breast cancer,17275994,estrogen receptor alpha regulates expression breast cancer associated ring domain bard gene intronic dna sequencenan
no_relation,estrogen,breast cancer,17275994,used chromatin immunoprecipitation chipbased cloning strategy isolate identify genes associated estrogen receptor alpha eralpha mcf human breast cancer cellsnan
no_relation,Atorvastatin,diabetes,17279352,atorvastatin exerts beneficial vascular effects diabetes underlying mechanisms yet elucidatednan
yes_direct,atorvastatin,vascular dysfunction,17279352,aim present study determine whether rac involved effect atorvastatin oxidative stress vascular dysfunction nan
no_relation,Atorvastatin,vascular abnormalities,17279352,atorvastatin failed afford protection vascular abnormalities presence constitutively active mutant racnan
no_relation,atorvastatin,diabetes,17279352,results study demonstrate vascular antioxidant effect atorvastatin diabetes mediated inhibition rac via reduction ggppnan
no_relation,fentanyl,hypotension,17285425,episodes hypotension transient reduction splanchnic perfusion common patients treated remifentanil compared receiving fentanyl opioid regimennan
no_relation,fentanyl,reduction in splanchnic perfusion,17285425,episodes hypotension transient reduction splanchnic perfusion common patients treated remifentanil compared receiving fentanyl opioid regimennan
yes_direct,remifentanil,hypotension,17285425,episodes hypotension transient reduction splanchnic perfusion common patients treated remifentanil compared receiving fentanyl opioid regimennan
yes_direct,remifentanil,reduction in splanchnic perfusion,17285425,episodes hypotension transient reduction splanchnic perfusion common patients treated remifentanil compared receiving fentanyl opioid regimennan
no_relation,lithium,depression,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,antidepressants,mania/bipolar disorder,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,antidepressants,depression,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,benzodiazepines,depression,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,lithium,mania/bipolar disorder,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,benzodiazepines,mania/bipolar disorder,17296540,available options treatment bipolar disorder including mania hypomania depression maintenance elderly include lithium antiepileptics antipsychotics benzodiazepines antidepressants electroconvulsive therapy ect psychotherapynan
no_relation,carbamazepine,bipolar disorder,17296540,lithium divalproex sodium carbamazepine lamotrigine atypical antipsychotics antidepressants found beneficial treatment elderly patients bipolar disorder nan
no_relation,divalproex sodium,bipolar disorder,17296540,lithium divalproex sodium carbamazepine lamotrigine atypical antipsychotics antidepressants found beneficial treatment elderly patients bipolar disorder nan
no_relation,lamotrigine,bipolar disorder,17296540,lithium divalproex sodium carbamazepine lamotrigine atypical antipsychotics antidepressants found beneficial treatment elderly patients bipolar disorder nan
no_relation,Lithium,bipolar disorder,17296540,lithium divalproex sodium carbamazepine lamotrigine atypical antipsychotics antidepressants found beneficial treatment elderly patients bipolar disorder nan
no_relation,hematoporphyrin,NMSC,17300605,objective present six patients multiple nodular andor pigmented nmsc treated successfully purified hematoporphyrin derivative phd pdt using prior debulkingnan
no_relation,cyclophosphamide,breast cancer,17308269,sequenced compared simultaneous anthracycline cyclophosphamide highrisk stage ii breast cancer final analysis intnan
no_relation,anthracycline,breast cancer,17308269,sequenced compared simultaneous anthracycline cyclophosphamide highrisk stage ii breast cancer final analysis intnan
no_relation,C/cyclophosphamide,OS/overall survival,17308269,conducted phase iii randomized study two adjuvant treatment schedules doxorubicin cyclophosphamide  earlystage breast cancer determine administration sequential single agents results superior diseasefree survival dfs overall survival os versus total dose given combination acnan
no_relation,C/cyclophosphamide,breast cancer,17308269,conducted phase iii randomized study two adjuvant treatment schedules doxorubicin cyclophosphamide  earlystage breast cancer determine administration sequential single agents results superior diseasefree survival dfs overall survival os versus total dose given combination acnan
no_relation,doxorubicin,breast cancer,17308269,conducted phase iii randomized study two adjuvant treatment schedules doxorubicin cyclophosphamide earlystage breast cancer determine administration sequential single agents results superior diseasefree survival dfs overall survival os versus total dose given combination acnan
no_relation,doxorubicin,OS/overall survival,17308269,conducted phase iii randomized study two adjuvant treatment schedules doxorubicin cyclophosphamide earlystage breast cancer determine administration sequential single agents results superior diseasefree survival dfs overall survival os versus total dose given combination acnan
no_relation,cyclophosphamide,breast cancer,17308269,highrisk nodenegative lowrisk nodepositive breast cancer patients received ac given arm concurrently ac doxorubicin mgm cyclophosphamide gm intravenously iv every weeks six cycles arm ii sequence doxorubicin mgm iv days  every weeks four cycles followed cyclophosphamide gmm iv every weeks three cyclesnan
no_relation,doxorubicin,breast cancer,17308269,highrisk nodenegative lowrisk nodepositive breast cancer patients received ac given arm concurrently ac doxorubicin mgm cyclophosphamide gm intravenously iv every weeks six cycles arm ii sequence doxorubicin mgm iv days  every weeks four cycles followed cyclophosphamide gmm iv every weeks three cyclesnan
no_relation,tamoxifen,tumors,17308269,premenopausal women receptor negative tumors received tamoxifen chemotherapynan
no_relation,C,OS,17308269,significant differences os dfs observed year estimates os ci  ac   grade hematologic toxicity greater  nonhematological grade similarnan
no_relation,C,toxicity,17308269,significant differences os dfs observed year estimates os ci  ac   grade hematologic toxicity greater  nonhematological grade similarnan
no_relation,ramosetron,IBS,17323187,pharmacological profile ramosetron novel therapeutic agent ibs nan
no_relation,serotonin/5-HT,abdominal pain,17323187,ramosetron potent selective serotonin 5-ht receptor antagonist shown affect abnormal colonic function abdominal pain animalsnan
yes_direct,Ramosetron,abdominal pain,17323187,ramosetron potent selective serotonin ht receptor antagonist shown affect abnormal colonic function abdominal pain animalsnan
no_relation,cilansetron,corticotropin releasing factor/CRF,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,alosetron,abnormal defecation,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,alosetron,corticotropin releasing factor/CRF,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,cilansetron,abnormal defecation,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,5-HT,corticotropin releasing factor/CRF,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,loperamide,corticotropin releasing factor/CRF,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamide nan
no_relation,Ramosetron,corticotropin releasing factor/CRF,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,Ramosetron,abnormal defecation,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,loperamide,abnormal defecation,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamide nan
no_relation,5-HT,abnormal defecation,17323187,ramosetron  microgkg po found significantly suppress abnormal defecation induced conditionedfear stress cfs restraint stress corticotropin releasing factor crf 5-ht rats mice effects potent alosetron cilansetron loperamidenan
no_relation,Ramosetron,CRF,17323187,ramosetron  microgkg also significantly prevented cfsinduced acceleration colonic transit crf induced abnormal water transport rats respectivelynan
no_relation,ramosetron,colonic pain,17323187,moreover ramosetron  microgkg significantly suppressed restraint stressinduced decrease colonic pain threshold effect observed loperamidenan
no_relation,loperamide,colonic pain,17323187,moreover ramosetron  microgkg significantly suppressed restraint stressinduced decrease colonic pain threshold effect observed loperamide nan
no_relation,ramosetron,IBS,17323187,results indicate ramosetron produce beneficial clinical effects ibs symptomsnan
no_relation,paclitaxel,fibrosarcoma,17332362,experiments using human fibrosarcoma ht respiratorydeficient cells rho uncoupler mitochondrial respiratory chain mrc showed betatac nbetatac impaired mrc rho cells displayed increased sensitivity toward nbetatac compared rho cells contrast resistant betatac classic chemotherapeutics paclitaxel nan
no_relation,estrogen,breast cancer,17391824,inhibition cyclooxygenase induction apoptosis estrogen nonresponsive breast cancer cells antrodia camphoratanan
no_relation,estrogen,breast cancer,17391824,objective study investigate fermented culture broth antrodia camphorata camphorata induce apoptosis inhibit cyclooxygenase cox estrogen nonresponsive mdamb human breast cancer cellsnan
no_relation,estrogen,breast cancer,17391824,analysis study data suggests camphorata exerts growth inhibition highly invasive estrogen nonresponsive human breast cancer cells apoptosis induction associated cox inhibition may possess anticancer properties potentially valuable application drug productsnan
no_relation,venlafaxine,depressive disorder,17397100,effects high dose venlafaxine mean mg cardiovascular system patients major depressive disorder evaluated bp ecg pr qt qrsd qtc intervals heart ratenan
yes_direct,venlafaxine,hypertension,17397100, patients developed hypertension starting treatment venlafaxine nan
no_relation,serotonin,serotonin reuptake inhibitors/SRIs,17407365,growing number concerns utilization serotonin reuptake inhibitors sris late pregnancy onset perinatal complicationsnan
yes_direct,Alcohol,injury in older adults,17418699,alcohol drinking history fatal injury older adults nan
no_relation,nicotine,Lewy body diseases,17425956,antifibrillogenic fibrildestabilizing activity nicotine vitro implications prevention therapeutics lewy body diseases nan
no_relation,oxamniquine,acute schistosomiasis,17426890,treatment human acute schistosomiasis oxamniquine induces increase interferongamma response schistosoma mansoni antigensnan
no_relation,oxamniquine,acute schistosomiasis,17426890,patients acute schistosomiasis studied oxamniquine treatmentnan
no_relation,oxamniquine,acute schistosomiasis,17426890,oxamniquine treatment acute schistosomiasis patients followed improvement th response vitronan
no_relation,betamethasone,rash,17443568,however dexchlorpheniramine betamethasone alone seem better clearing rash combination dexchlorpheniramine betamethasone nan
no_relation,dexchlorpheniramine,rash,17443568,however dexchlorpheniramine betamethasone alone seem better clearing rash combination dexchlorpheniramine betamethasonenan
no_relation,erythromycin,rash,17443568,small good quality trial people compared oral erythromycin placebo found erythromycin effective placebo terms rash improvement rated trialists two weeks rr  ci nan
yes_direct,erythromycin,gastrointestinal upset,17443568,two people oral erythromycin  placebo reported minor gastrointestinal upset nan
no_relation,erythromycin,rash,17443568,oral erythromycin may effective treating rash decreasing itchnan
no_relation,glucose,blood glucose,17451279,studies examined efficacy biasp evaluated terms glycaemic control glycosylated haemoglobin hbac reduction proportion patients achieving hbac target blood glucose blood glucose profile andor prandial postprandial glucose incrementsnan
no_relation,fructosamine,postprandial hyperlipidaemia,17451279,studies efficacy evaluated using plasma insulin glucose infusion rates plasma cpeptide levels mean serum fructosamine levels postprandial hyperlipidaemia overall wellbeing treatment satisfaction quality lifenan
no_relation,glucose,postprandial hyperlipidaemia,17451279,studies efficacy evaluated using plasma insulin glucose infusion rates plasma cpeptide levels mean serum fructosamine levels postprandial hyperlipidaemia overall wellbeing treatment satisfaction quality lifenan
no_relation,erlotinib,pancreatic cancer,17457047,erbb expression dimerization egfr influence pancreatic cancer cell sensitivity erlotinib nan
no_relation,Erlotinib,pancreatic cancer,17457047,erlotinib epidermal growth factor receptor tyrosine kinase inhibitor egfrtki recently approved pancreatic cancer treatment reliable predictors patient responsenan
no_relation,tyrosine,pancreatic cancer,17457047,erlotinib epidermal growth factor receptor tyrosine kinase inhibitor egfrtki recently approved pancreatic cancer treatment reliable predictors patient responsenan
no_relation,erlotinib,pancreatic cancer,17457047,analyzed influence erbb expression pancreatic cancer cell response erlotinib treatmentnan
no_relation,erlotinib,pancreatic cancer,17457047,proliferation assays five human pancreatic cancer cell lines performed following treatment erlotinib nan
no_relation,erlotinib,pancreatic cancer,17457047,effects rna inhibition erbb sensitivity erlotinib treatment evaluated aspc pancreatic cancer cellsnan
no_relation,erlotinib,Pancreatic cancer,17457047,pancreatic cancer cells lack erbb display activation erbbpikakt cascade induced egfrerbb heterodimers become less critically dependent egfr signaling therefore resistant erlotinib nan
no_relation,polyunsaturated fatty acids,diabetic,17462553,although supplement lowdose longchain polyunsaturated fatty acids effect plasma highsensitivity crp supplemented group reduction crp levels found patients stratified tertiles crp upper tertile diabetic status nondiabetic patientsnan
no_relation,methamphetamine,HIV-1 neurodegeneration,17504172,progress understanding basal ganglia dysfunction common target methamphetamine abuse hiv neurodegeneration nan
yes_direct,methamphetamine,dementia,17504172,hiv infection concurrent methamphetamine abuse results exacerbated neurodegenerative changes rapid progression form subcortical dementia termed hiv associated dementianan
no_relation,methamphetamine,HIV-1 infection,17504172,hiv infection concurrent methamphetamine abuse results exacerbated neurodegenerative changes rapid progression form subcortical dementia termed hiv associated dementianan
no_relation,Nucleoside,immunodeficiency,17505984,nucleoside reverse transcriptase inhibitors human immunodeficiency virus proteins cause axonal injury human dorsal root ganglia culturesnan
yes_direct,Nucleoside,axonal injury,17505984,nucleoside reverse transcriptase inhibitors human immunodeficiency virus proteins cause axonal injury human dorsal root ganglia culturesnan
yes_direct,nucleoside,mitochondrial injury,17505984,conclusion hiv proteins nucleoside reverse transcriptase inhibitors nrtis cause axonal damage inducing mitochondrial injury rearrangement microtubulesnan
yes_direct,nucleoside,axonal damage,17505984,conclusion hiv proteins nucleoside reverse transcriptase inhibitors nrtis cause axonal damage inducing mitochondrial injury rearrangement microtubulesnan
no_relation,Cloretazine,CNS tumor,17522334,activity vnpm cloretazine treatment cns tumor xenografts athymic micenan
no_relation,HBeAg,liver disease,17540037,aims investigate relationship serum leptin concentrations severity liver disease cohort subjects hbeag negative chronic hepatitis chb chc analyze effect body composition leptin system insulin resistance together viral factors virologic response antiviral treatmentnan
no_relation,HBeAg,HBeAg negative chronic hepatitis B/CHB,17540037,aims investigate relationship serum leptin concentrations severity liver disease cohort subjects hbeag negative chronic hepatitis chb chc analyze effect body composition leptin system insulin resistance together viral factors virologic response antiviral treatmentnan
no_relation,lamivudine,CHB,17540037,inverse correlation lower leptin levels response lamivudine monotherapy noted patients chb virologic response presented lower serum leptin levels vs pgml pvalue  nonrespondersnan
no_relation,lamivudine,CHB,17540037,increased serum leptin levels represent negative prognostic factor response lamivudine monotherapy patients chb nan
no_relation,formoterol,COPD,17544264,lung deposition efficacy inhaled formoterol patients moderate severe copd nan
no_relation,formoterol,COPD,17544264,nineteen patients varying degrees copd randomized inhale single doses formoterol oxis turbuhaler   microg double blind placebocontrolled crossover designnan
no_relation,formoterol,COPD,17544264,study could show difference lung deposition formoterol inhaled via turbuhaler patients moderate severe copd nan
yes_direct,fatty acids,inflammatory bowel disease,17545776,numerous clinical trials utilizing various types lipids including fish oil short chain fatty acids suggest fats play important role inflammatory response characterizes inflammatory bowel disease nan
no_relation,nitroprusside,hemolysis,17578949,cardiopulmonary bypass hemolysis nitroprusside induced cyanide productionnan
yes_direct,sodium nitroprusside,toxicity,17578949,cyanide toxicity complication sodium nitroprusside administrationnan
no_relation,sodium nitroprusside,toxicity,17578949,cardiac surgery may increase risk cyanide toxicity hemolysis cardiopulmonary bypass cpb may catalyze release free cyanide sodium nitroprusside nan
no_relation,sodium nitroprusside,hemolysis,17578949,cardiac surgery may increase risk cyanide toxicity hemolysis cardiopulmonary bypass cpb may catalyze release free cyanide sodium nitroprusside nan
no_relation,sodium nitroprusside,hemolysis,17578949,cpbassociated hemolysis free hemoglobin release accelerated immediate release free cyanide sodium nitroprusside nan
yes_direct,sodium nitroprusside,toxicity,17578949,vitro findings suggest cardiac surgical patients may increased risk cyanide toxicity response perioperative administration sodium nitroprusside nan
no_relation,triamcinolone,macular oedema,17608830,intravitreal triamcinolone adjunctive treatment laser panretinal photocoagulation concomitant proliferative diabetic retinopathy clinically significant macular oedema nan
no_relation,triamcinolone acetonide,macular oedema,17608830,evaluate effect intravitreal injections triamcinolone acetonide ivta combined panretinal photocoagulation prp visual acuity va foveal thickness patients concomitant highrisk proliferative diabetic retinopathy pdr clinically significant macular oedema csmonan
no_relation,vitamin D,osteoporosis,17611855,experimental osteoporosis induced ovariectomy vitamin deficiency markedly affect fracture healing ratsnan
no_relation,vitamin D,fracture,17611855,experimental osteoporosis induced ovariectomy vitamin deficiency markedly affect fracture healing ratsnan
yes_direct,vitamin D,weakening of the femoral neck,17611855,therefore studied issue vitamin depleted ovariectomized ovx rats op model previously shown induce weakening femoral neck thus thought closer human condition classic ovx rat modelnan
no_relation,vitamin D,OP,17611855,therefore studied issue vitamin depleted ovariectomized ovx rats op model previously shown induce weakening femoral neck thus thought closer human condition classic ovx rat modelnan
no_relation,estradiol,Bone loss,17611855,bone loss callus formation monitored dxa serum levels estradiol vitamin measured histomorphometric analyses performednan
no_relation,vitamin D3,Bone loss,17611855,bone loss callus formation monitored dxa serum levels estradiol vitamin measured histomorphometric analyses performednan
no_relation,estrogen,fracture,17611855,results suggest systemic effects estrogen vitamin deficiency crucial fracture healing mechanical properties callusnan
no_relation,vitamin D,fracture,17611855,results suggest systemic effects estrogen vitamin deficiency crucial fracture healing mechanical properties callusnan
no_relation,cisplatin,death,17612931,metaanalysis early trials adjuvant chemotherapy nonsmall cell lung cancer collaborative group showed chemotherapy alkylating agents also detrimental chemotherapy cisplatin based adjuvant chemotherapy associated improved hazard ratio death hr  equating percent survival benefit yearsnan
no_relation,cisplatin,NSCLC,17612931,three trials ialt jbr anita utilized cisplatin based doublets showed significantly positive survival benefit adjuvant chemotherapy patients stage iiiiia nsclc nan
no_relation,cisplatin,NSCLC,17612931,data indicate medically fit patients resected stage iiiiia nsclc offered adjuvant chemotherapy modern cisplatin based doubletnan
no_relation,Cisplatin,primary tumor,17639394,cisplatin dna adduct formation patients treated cisplatin based chemoradiation lack correlation normal tissues primary tumor nan
no_relation,cisplatin,primary tumor,17639394,study formation cisplatin dna adducts concurrent cisplatin radiation relationship adductformation primary tumor tissue normal tissue investigatednan
no_relation,guanosine,tumor,17639394,linear relationships high correlations observed levels two guanosine adenosine guanosine adducts normal tumor tissuenan
no_relation,adenosine,tumor,17639394,linear relationships high correlations observed levels two guanosine adenosine guanosineadducts normal tumor tissuenan
no_relation,cisplatin,tumors,17639394,concurrent chemoradiotherapy schedules cisplatin adduct levels tumors significantly higher normal tissues wbcnan
no_relation,amphotericin B,valve endocarditis,17654274,describe diabetic patient lecythophora mutabilis prosthetic valve endocarditis treated surgically well amphotericin lipid complex voriconazole subsequently followed prolonged voriconazole suppressive therapynan
no_relation,voriconazole,valve endocarditis,17654274,describe diabetic patient lecythophora mutabilis prosthetic valve endocarditis treated surgically well amphotericin lipid complex voriconazole subsequently followed prolonged voriconazole suppressive therapynan
no_relation,voriconazole,diabetic,17654274,describe diabetic patient lecythophora mutabilis prosthetic valve endocarditis treated surgically well amphotericin lipid complex voriconazole subsequently followed prolonged voriconazole suppressive therapynan
no_relation,amphotericin B,diabetic,17654274,describe diabetic patient lecythophora mutabilis prosthetic valve endocarditis treated surgically well amphotericin lipid complex voriconazole subsequently followed prolonged voriconazole suppressive therapynan
no_relation,Clozapine,schizophrenia,17685738,clozapine uniquely effective refractory schizophrenia treatment attrition highnan
yes_direct,Clozapine,attrition,17685738,clozapine uniquely effective refractory schizophrenia treatment attrition highnan
no_relation,clozapine,Death,17685738,death common cause clozapine cessationnan
no_relation,clindamycin,pneumonia,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonia nan
no_relation,primaquine,Pneumocystis,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonianan
no_relation,clindamycin,Pneumocystis,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonianan
no_relation,primaquine,pneumonia,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonia nan
no_relation,primaquine,HIV-infected,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonianan
no_relation,clindamycin,HIV-infected,17686226,hiv-infected man became increasingly breathless cyanosed receiving clindamycin primaquine treatment pneumocystis jirovecii pneumonianan
no_relation,phosphate,ileal villous damage,17706400,hemorrhagic-shock model rats pretreated bifidobacteria showed decreases total aerobes cecum magnitude total aerobes bt levels plasma endotoxin percentage ileal villous damage compared rats treated phosphate buffered salinenan
no_relation,phosphate,hemorrhagic-shock,17706400,hemorrhagic-shock model rats pretreated bifidobacteria showed decreases total aerobes cecum magnitude total aerobes bt levels plasma endotoxin percentage ileal villous damage compared rats treated phosphate buffered salinenan
no_relation,lutein,melanoma,17710425,regulation extracellular matrix remodeling lutein dermal fibroblasts melanoma cells ultraviolet radiation exposed fibroblastsnan
no_relation,lutein,melanoma,17710425,purpose effects lutein expression mmps inhibitors timps tissue inhibitors metalloproteinases dermal fibroblasts intrinsic aging melanoma cells examinednan
no_relation,Lutein,melanoma,17710425,lutein alter fibroblast melanoma cell viability membrane integritynan
no_relation,lutein,melanoma,17710425,summary mechanism lutein antiaging anticarcinogenic effects include inhibition mmp timp ratio dermal fibroblasts melanoma cells inhibition cell loss membrane damage elastin expression ultraviolet radiation exposed fibroblastsnan
no_relation,lactulose,constipation,17713456,presence methane lactulose breath testing associated constipation predominant ibsnan
yes_direct,methane,constipation,17713456,presence methane lactulose breath testing associated constipation predominant ibsnan
no_relation,lactulose,IBS,17713456,presence methane lactulose breath testing associated constipationpredominant ibs nan
yes_direct,methane,IBS,17713456,presence methane lactulose breath testing associated constipationpredominant ibs nan
no_relation,lactulose,bacterial overgrowth,17713456,good clinical response normalization lactulose breath test achieved prokinetic agent may used stimulate phase iii interdigestive motility delay relapse bacterial overgrowth nan
no_relation,wortmannin,tumor,17766838,addition platelets taken mice treated wortmannin blocked parinduced ex vivo activation concomitantly decrease phosphorylation akt excised tumor xenograftsnan
no_relation,cyclophosphamide,pediatric cancer,17805036,bk virusassociated hemorrhagic cystitis pediatric cancer patients receiving highdose cyclophosphamide nan
yes_direct,cyclophosphamide,hemorrhagic cystitis,17805036,bk virusassociated hemorrhagic cystitis pediatric cancer patients receiving highdose cyclophosphamide nan
yes_direct,cyclophosphamide,hematuria,17805036,bk virus bkv commonly found associated hematuria stem cell transplant patients however rarely reported cyclophosphamide chemotherapy alonenan
no_relation,cidofovir,hematuria,17805036,one patient treated intravenous cidofovir resolution bk viruria hematuria nan
yes_direct,cyclophosphamide,HC,17805036,patients hc cyclophosphamide ifosfamide negative bacterial cultures studied bkvnan
no_relation,ifosfamide,HC,17805036,patients hc cyclophosphamide ifosfamide negative bacterial cultures studied bkvnan
no_relation,Cidofovir,HC,17805036,cidofovir may beneficial certain patients bk viruria hc however definitive data require clinical trialnan
no_relation,leukovorin,choroidal melanoma,17823640,yearold patient coexisting primary choroidal melanoma colorectal cancer treated external beam radiation ebr choroidal melanoma systemic chemotherapy leukovorin fluorouracil fu treatment metastatic colorectal cancernan
no_relation,fluorouracil,colorectal cancer,17823640,yearold patient coexisting primary choroidal melanoma colorectal cancer treated external beam radiation ebr choroidal melanoma systemic chemotherapy leukovorin fluorouracil fu treatment metastatic colorectal cancer nan
no_relation,leukovorin,colorectal cancer,17823640,yearold patient coexisting primary choroidal melanoma colorectal cancer treated external beam radiation ebr choroidal melanoma systemic chemotherapy leukovorin fluorouracil fu treatment metastatic colorectal cancer nan
no_relation,fluorouracil,choroidal melanoma,17823640,yearold patient coexisting primary choroidal melanoma colorectal cancer treated external beam radiation ebr choroidal melanoma systemic chemotherapy leukovorin fluorouracil fu treatment metastatic colorectal cancernan
no_relation,glucose,ovarian cancer,17825886,resveratrol inhibits glucose metabolism human ovarian cancer cellsnan
no_relation,Resveratrol,ovarian cancer,17825886,resveratrol inhibits glucose metabolism human ovarian cancer cellsnan
no_relation,Resveratrol,tumor,17825886,resveratrol phytoalexin found grapes inhibits vitro growth multiple tumor cell typesnan
no_relation,resveratrol,death,17825886,showed previously resveratrol induces autophagic cell death ovarian cancer cellsnan
no_relation,resveratrol,ovarian cancer,17825886,showed previously resveratrol induces autophagic cell death ovarian cancer cellsnan
no_relation,resveratrol,ovarian cancer,17825886,autophagy typically adaptive response nutrient starvation hypothesized autophagy would also triggered ovarian cancer cells nutrient deprived resveratrol could fact acting inducing starvationlike signaling responsenan
no_relation,amino acids,Ovarian cancer,17825886,ovarian cancer cells incubated normal media media containing resveratrol glucose free media media lacking amino acids nan
no_relation,glucose,Ovarian cancer,17825886,ovarian cancer cells incubated normal media media containing resveratrol glucose free media media lacking amino acidsnan
no_relation,resveratrol,Ovarian cancer,17825886,ovarian cancer cells incubated normal media media containing resveratrol glucose free media media lacking amino acidsnan
no_relation,glucose,death,17825886,show epithelial ovarian cancer cells highly sensitive glucose deprivationinduced cell death like resveratrol glucose deprivation induces caspaseindependent cell death hallmarks autophagynan
no_relation,glucose,ovarian cancer,17825886,show epithelial ovarian cancer cells highly sensitive glucose deprivationinduced cell death like resveratrol glucose deprivation induces caspaseindependent cell death hallmarks autophagynan
no_relation,resveratrol,death,17825886,show epithelial ovarian cancer cells highly sensitive glucosedeprivationinduced cell death like resveratrol glucose deprivation induces caspaseindependent cell death hallmarks autophagynan
no_relation,resveratrol,ovarian cancer,17825886,show epithelial ovarian cancer cells highly sensitive glucosedeprivationinduced cell death like resveratrol glucose deprivation induces caspaseindependent cell death hallmarks autophagynan
no_relation,glucose,ovarian cancer,17825886,findings consistent hypothesis resveratrolinduced changes glucose utilization comprise mechanism underlies resveratrolinduced autophagocytosis ovarian cancer nan
no_relation,resveratrol,ovarian cancer,17825886,findings consistent hypothesis resveratrol induced changes glucose utilization comprise mechanism underlies resveratrol induced autophagocytosis ovarian cancer nan
no_relation,resveratrol,ovarian cancer,17825886,inhibition glycolysis ovarian cancer resveratrol compounds may effective therapy ovarian cancer nan
no_relation,corticosteroids,allergic rhinitis,17826020,efficacy nasal corticosteroids alone combined antihistamines montelukast treatment allergic rhinitis nan
no_relation,steroid,AR,17826020,investigated clinical efficacy monotherapy topical steroid combined therapy ar patientsnan
no_relation,corticosteroids,allergic rhinitis,17826020,although corticosteroids mainstay treatment allergic rhinitis montelukast may considered additional agent especially treatment patients impaired quality life may used reduce nasal symptom scoresnan
no_relation,ethanol,drug abuse,17879500,therefore attenuation activity ec system would therapeutic benefit treating disorders might component excess appetite drive overactivity endocannabinoid system obesity ethanol drug abuse variety central nervous system disordersnan
no_relation,ethanol,obesity,17879500,therefore attenuation activity ec system would therapeutic benefit treating disorders might component excess appetite drive overactivity endocannabinoid system obesity ethanol drug abuse variety central nervous system disordersnan
no_relation,Rimonabant,obesity,17879500,rimonabant compound group along pathway approved selective cb cannabinoid receptor subtype antagonist inverse agonist european union india regulatory review united states treatment obesity associated cardiometabolic risknan
no_relation,flunisolide,asthma,17883883,reappraisal clinical efficacy nebulized flunisolide pediatric asthma italian experiencenan
no_relation,FLU,asthma,17883883,clinical data indicate nebulized flu effective asthma treatment infants childrennan
no_relation,polyethylene glycol,critically ill,17893628,laxation critically ill patients lactulose polyethylene glycol twocenter randomized doubleblind placebocontrolled trialnan
no_relation,lactulose,critically ill,17893628,laxation critically ill patients lactulose polyethylene glycol twocenter randomized doubleblind placebocontrolled trialnan
no_relation,polyethylene glycol,critically ill,17893628,study whether lactulose polyethylene glycol effective promote defecation critically ill patients whether either two superior whether use enteral laxatives related clinical outcomenandisease preexisting condition
no_relation,lactulose,critically ill,17893628,study whether lactulose polyethylene glycol effective promote defecation critically ill patients whether either two superior whether use enteral laxatives related clinical outcomenan
yes_direct,lactulose,Intestinal pseudoobstruction,17893628,intestinal pseudoobstruction ogilvies syndrome occurred patients placebo group patients lactulose group patients polyethylene glycol groupnan
yes_direct,lactulose,Ogilvie's syndrome,17893628,intestinal pseudoobstruction ogilvies syndrome occurred patients placebo group patients lactulose group patients polyethylene glycol groupnan
no_relation,polyethylene glycol,Intestinal pseudoobstruction,17893628,intestinal pseudoobstruction ogilvies syndrome occurred patients placebo group patients lactulose group patients polyethylene glycol groupnan
yes_direct,polyethylene glycol,Ogilvie's syndrome,17893628,intestinal pseudoobstruction ogilvies syndrome occurred patients placebo group patients lactulose group patients polyethylene glycol groupnan
no_relation,lactulose,intestinal pseudoobstruction,17893628,patients receiving polyethylene glycol slightly lower incidence acute intestinal pseudoobstruction whereas length stay shorter lactulose treated patientsnan
no_relation,polyethylene glycol,intestinal pseudoobstruction,17893628,patients receiving polyethylene glycol slightly lower incidence acute intestinal pseudoobstruction whereas length stay shorter lactulosetreated patientsnan
no_relation,capecitabine,tumour/breast cancer,17904787,effects capecitabine vinorelbine cell proliferation metabolism cox expression breast cancer cell lines solid tumour tissuesnan
no_relation,vinorelbine,tumour/breast cancer,17904787,effects capecitabine vinorelbine cell proliferation metabolism cox expression breast cancer cell lines solid tumour tissuesnan
no_relation,capecitabine,tumour/breast cancer,17904787,present study investigates therapeutic value single use capecitabine solid tumour tissues vitro using breast cancer cell lines referencenantheraputic key word
no_relation,vinorelbine,breast cancer,17904787,data compared use vinorelbine conventionally applied drug advanced breast cancer patientsnan
no_relation,Capecitabine,tumor/tumour/breast cancer,17904787,capecitabine demonstrated similar inhibitory effects vinorelbine breast cancer cell lines solid tumour tissues decreasing cell proliferation metabolism well decreasing expression metabolic proteins tumor suppressor genesnan
no_relation,vinorelbine,tumor/tumour/breast cancer,17904787,capecitabine demonstrated similar inhibitory effects vinorelbine breast cancer cell lines solid tumour tissues decreasing cell proliferation metabolism well decreasing expression metabolic proteins tumor suppressor genesnan
no_relation,triglycerides,CKD/Chronic kidney disease,17912226,chronic kidney disease ckd associated highly atherogenic lipid profile characterized elevated triglycerides low highdensity lipoprotein hdl cholesterol accumulation small dense lowdensity lipoprotein ldl particlesnan
yes_direct,cholesterol,CKD/Chronic kidney disease,17912226,chronic kidney disease ckd associated highly atherogenic lipid profile characterized elevated triglycerides low highdensity lipoprotein hdl cholesterol accumulation small dense lowdensity lipoprotein ldl particlesnan
no_relation,statins,sepsis,17912226,observational studies found reduction risk contrast media induced nephropathy reduction risk hospitalization sepsis patients ckd treated statins nan
no_relation,statins,CKD,17912226,observational studies found reduction risk contrast media induced nephropathy reduction risk hospitalization sepsis patients ckd treated statins nan
no_relation,statins,nephropathy,17912226,observational studies found reduction risk contrast media induced nephropathy reduction risk hospitalization sepsis patients ckd treated statins nan
no_relation,imiquimod,basal cell carcinomas,17922128,induction members notch pathway superficial basal cell carcinomas treated imiquimod nan
no_relation,imiquimod,tumor,17922128,way imiquimod may act stimulator notch pathway sbcc tumor cells upregulating protein expression notch ligand jaggednan
no_relation,Paliperidone,schizophrenia,17927485,paliperidone extended release er recent atypical antipsychotic become available treatment schizophrenia nan
no_relation,paliperidone,schizophrenia,17927485,several randomized doubleblinded placebocontrolled trials shown paliperidone er efficacious management acute schizophrenia well prevention symptom recurrence compared placebonan
no_relation,Paliperidone,schizophrenia,17927485,paliperidone er potential offer advantages parent compound second generation agents may aid ensuring compliance among persons schizophrenia nan
no_relation,isothiocyanates,chronic inflammation,17976883,aberrant patterns dna methylation develop result pathological processes chronic inflammation response various dietary factors including imbalances supply methyl donors particularly folates exposure dna methyltransferase inhibitors include polyphenols possibly isothiocyanates plant foodsnan
no_relation,polyphenols,chronic inflammation,17976883,aberrant patterns dna methylation develop result pathological processes chronic inflammation response various dietary factors including imbalances supply methyl donors particularly folates exposure dna methyltransferase inhibitors include polyphenols possibly isothiocyanates plant foodsnan
yes_direct,indomethacin,periventricular leukomalacia,17980183,antenatal indomethacin associated increased risk periventricular leukomalacia odds ratio  confidence interval ci nan
yes_direct,indomethacin,necrotizing enterocolitis,17980183,recent exposure antenatal indomethacin associated necrotizing enterocolitis  ci nan
no_relation,indomethacin,patent ductus arteriosus,17980183,antenatal indomethacin associated intraventricular hemorrhage patent ductus arteriosus respiratory distress syndrome bronchopulmonary dysplasia mortalitynan
no_relation,indomethacin,respiratory distress syndrome,17980183,antenatal indomethacin associated intraventricular hemorrhage patent ductus arteriosus respiratory distress syndrome bronchopulmonary dysplasia mortalitynan
no_relation,indomethacin,intraventricular hemorrhage,17980183,antenatal indomethacin associated intraventricular hemorrhage patent ductus arteriosus respiratory distress syndrome bronchopulmonary dysplasia mortalitynan
no_relation,indomethacin,bronchopulmonary dysplasia,17980183,antenatal indomethacin associated intraventricular hemorrhage patent ductus arteriosus respiratory distress syndrome bronchopulmonary dysplasia mortalitynan
yes_direct,indomethacin,periventricular leukomalacia,17980183,antenatal indomethacin may associated increased risk periventricular leukomalacia necrotizing enterocolitis premature infants therefore used judiciously tocolysisnan
yes_direct,indomethacin,necrotizing enterocolitis,17980183,antenatal indomethacin may associated increased risk periventricular leukomalacia necrotizing enterocolitis premature infants therefore used judiciously tocolysisnanlong antenatal
no_relation,methylphenidate,Parkinson's disease,17982887,low dose methylphenidate improves freezing advanced parkinson's disease offstatenan
no_relation,methylphenidate/MPD,PD/idiopathic Parkinson's disease,17982887,five men advanced idiopathic parkinson's disease pd examined assess effect low dose methylphenidate mpd gaitnan
no_relation,MPD,PD,17982887,study demonstrates low dose mpd may improve gait especially freezing patients severe pd without need exogenous ldopanan
no_relation,L-dopa,PD,17982887,study demonstrates low dose mpd may improve gait especially freezing patients severe pd without need exogenous l-dopa nan
no_relation,MPD,PD,17982887,mechanism mpd action patients advanced pd discussednan
no_relation,metoprolol,autosomal dominant polycystic kidney disease,17984104,renal cardiac effects antihypertensive treatment ramipril vs metoprolol autosomal dominant polycystic kidney disease nan
no_relation,ramipril,autosomal dominant polycystic kidney disease,17984104,renal cardiac effects antihypertensive treatment ramipril vs metoprolol autosomal dominant polycystic kidney disease nan
no_relation,ramipril,hypertension,17984104,prospective randomized doubleblind study performed compare renal cardiac effects ace inhibitor ramipril betablocker metoprolol first line therapy adpkd patients hypertension nan
no_relation,metoprolol,ADPKD,17984104,prospective randomized doubleblind study performed compare renal cardiac effects ace inhibitor ramipril betablocker metoprolol first line therapy adpkd patients hypertensionnan
no_relation,ramipril,ADPKD,17984104,prospective randomized doubleblind study performed compare renal cardiac effects ace inhibitor ramipril betablocker metoprolol first line therapy adpkd patients hypertensionnan
no_relation,metoprolol,hypertension,17984104,prospective randomized doubleblind study performed compare renal cardiac effects ace inhibitor ramipril betablocker metoprolol first line therapy adpkd patients hypertension nan
no_relation,metoprolol,ADPKD,17984104,fortysix hypertensive adpkd patients randomized either ramipril  metoprolol nan
no_relation,ramipril,ADPKD,17984104,fortysix hypertensive adpkd patients randomized either ramipril  metoprolol nan
no_relation,metoprolol,ADPKD,17984104,study population hypertensive adpkd patients differences renal function urinary albumin excretion lvmi detected treated ramipril metoprolol respectively years followupnan
no_relation,ramipril,ADPKD,17984104,study population hypertensive adpkd patients differences renal function urinary albumin excretion lvmi detected treated ramipril metoprolol respectively years followupnan
no_relation,nitrate,cardiovascular disease,17987590,data individuals purchase antihypertensive serum lipidreducing agents without diagnosis cardiovascular disease also linked purchase nitrate vasodilators cdnan
yes_direct,Nicotine,NIN/nicotine-induced nystagmus,17990061,nicotine wellknown unpleasant side effects eg transient dizziness nausea nicotine induced nystagmus nin nan
yes_direct,Nicotine,nausea,17990061,nicotine wellknown unpleasant side effects eg transient dizziness nausea nicotine induced nystagmus ninnan
yes_direct,Nicotine,dizziness,17990061,nicotine wellknown unpleasant side effects eg transient dizziness nausea nicotine induced nystagmus ninnan
no_relation,nicotine,NIN,17990061,investigate factors influencing effects addressed three questions intensity dizziness nausea nin unsteadiness dependent nicotine dosagenanquestion whether link answered doesnt say
yes_direct,nicotine,unsteadiness,17990061,investigate factors influencing effects addressed three questions intensity dizziness nausea nin unsteadiness dependent nicotine dosagenan
yes_direct,nicotine,nausea,17990061,investigate factors influencing effects addressed three questions intensity dizziness nausea nin unsteadiness dependent nicotine dosagenan
no_relation,nicotine,dizziness,17990061,investigate factors influencing effects addressed three questions intensity dizziness nausea nin unsteadiness dependent nicotine dosagenan
yes_direct,nicotine,NIN/nystagmus,17990061,dizziness nausea nin unsteadiness also depended nicotine dosage nicotine blood concentration better predictor temporal dependence nystagmus nicotine dosagenan
yes_direct,nicotine,unsteadiness,17990061,dizziness nausea nin unsteadiness also depended nicotine dosage nicotine blood concentration better predictor temporal dependence nystagmus nicotine dosagenan
yes_direct,nicotine,nausea,17990061,dizziness nausea nin unsteadiness also depended nicotine dosage nicotine blood concentration better predictor temporal dependence nystagmus nicotine dosagenan
yes_direct,nicotine,Dizziness,17990061,dizziness nausea nin unsteadiness also depended nicotine dosage nicotine blood concentration better predictor temporal dependence nystagmus nicotine dosagenan
yes_direct,nicotine,nausea,17990061,degree nicotine induced nausea significantly correlated postural imbalancenan
no_relation,nicotine,NIN,17990061,motion stimulation increased nicotine induced dizziness nausea significantly influence nin postural imbalancenan
no_relation,nicotine,nausea,17990061,motion stimulation increased nicotine induced dizziness nausea significantly influence nin postural imbalancenan
yes_direct,nicotine,dizziness,17990061,motion stimulation increased nicotine induced dizziness nausea significantly influence nin postural imbalancenan
yes_direct,nicotine,vestibular dysfunction,17990061,data support view measured adverse effects reflect dosedependent nicotine induced vestibular dysfunction nan
yes_direct,nicotine,dizziness,17990061,additional motion stimulation aggravates dizziness nausea ie nicotine increases sensitivity motion sicknessnan
yes_direct,nicotine,nausea,17990061,additional motion stimulation aggravates dizziness nausea ie nicotine increases sensitivity motion sicknessnan
yes_direct,nicotine,motion sickness,17990061,additional motion stimulation aggravates dizziness nausea ie nicotine increases sensitivity motion sickness nan
no_relation,ATP,DLBCL,18006696,herein assess role sykdependent tonic bcr survival signals dlbcl cell lines primary tumors evaluate efficacy atp competitive inhibitor syk vitronan
no_relation,ATP,primary tumors,18006696,herein assess role sykdependent tonic bcr survival signals dlbcl cell lines primary tumors evaluate efficacy atp competitive inhibitor syk vitronan
yes_direct,steroids,hypothalamic networks,18056697,steroids reported activate hypothalamic networks sexdifferentiated waynan
no_relation,Estrogens/estrogen,tumors/breast cancer,18060053,estrogens required proliferation hormone dependent breast cancer cells making estrogen receptor er positive tumors amenable endocrine therapies antiestrogensnan
no_relation,estrogen,retinoblastoma,18060053,previously demonstrated inactivation retinoblastoma protein prb family tumor suppressors causes antiestrogen resistance mcf cells widely studied model estrogen responsive human breast cancersnan
no_relation,estrogen,tumor/breast cancers,18060053,previously demonstrated inactivation retinoblastoma protein prb family tumor suppressors causes antiestrogen resistance mcf cells widely studied model estrogen responsive human breast cancers nan
no_relation,Simvastatin,ischemic stroke,18070096,simvastatin acute phase ischemic stroke safety efficacy pilot trialnan
no_relation,statins,ischemic stroke,18070096,although statins used secondary prevention ischemic stroke recent experimental data shown new pleiotropic effects drugs responsible role neuroprotectionnan
no_relation,simvastatin,ischemic stroke,18070096,conducted pilot doubleblind randomized multicenter clinical trial study first time safety efficacy simvastatin acute phase ischemic stroke nan
no_relation,Simvastatin,cortical strokes,18070096,simvastatin placebo given symptom onset patients cortical strokes nan
yes_direct,simvastatin,infections,18070096,although simvastatin patients improved significantly third day vs  nonsignificant increase mortality greater proportion infections odds ratio confidence interval simvastatin group main safety concernsnan
no_relation,CJ-042794,tumor,18155068,pge(2) inhibited lipopolysaccharide lpsinduced production tumor necrosis factor alpha tnfalpha human whole blood hwb cj-042794 reversed inhibitory effects pge(2) lpsinduced tnfalpha production concentrationdependent mannernan
no_relation,PGE(2),tumor,18155068,pge(2) inhibited lipopolysaccharide lpsinduced production tumor necrosis factor alpha tnfalpha human whole blood hwb cj-042794 reversed inhibitory effects pge(2) lpsinduced tnfalpha production concentrationdependent mannernan
no_relation,CJ-042794,necrosis,18155068,pge(2) inhibited lipopolysaccharide lpsinduced production tumor necrosis factor alpha tnfalpha human whole blood hwb cj-042794 reversed inhibitory effects pge(2) lpsinduced tnfalpha production concentrationdependent mannernan
no_relation,PGE(2),necrosis,18155068,pge(2) inhibited lipopolysaccharide lpsinduced production tumor necrosis factor alpha tnfalpha human whole blood hwb cj-042794 reversed inhibitory effects pge(2) lpsinduced tnfalpha production concentrationdependent mannernan
yes_direct,arsenic trioxide,death,18158874,dynamic effects autophagy arsenic trioxide induced death human leukemia cell line hl cellsnan
no_relation,arsenic trioxide,leukemia,18158874,dynamic effects autophagy arsenic trioxide induced death human leukemia cell line hl cellsnan
no_relation,3-methyladenine/3-MA,death,18158874,blockade autophagy maturation autophagyspecific inhibitor methyladenine 3-ma lysosomeneutralizing agent nh4cl aso potentiated asoinduced death hl cellsnan
no_relation,NH4Cl,death,18158874,blockade autophagy maturation autophagyspecific inhibitor methyladenine lysosomeneutralizing agent nh4cl aso potentiated asoinduced death hl cellsnan
yes_direct,3-MA,death,18158874,contrast 3-ma attenuated asoinduced death administered min asonan
yes_direct,ATRA/all-trans retinoic acid,HL,18164258,present study demonstrated bufalin enhanced alltrans retinoic acid atra induced differentiation hl cells accompanied upregulation cbl family ubiquitin ligasesnan
no_relation,ATRA,HL,18164258,results suggested upregulation ccbl cblb involved regulation atra bufalininduced hl cell adhesion rather cell differentiation might mediated lipid raft localization ubiquitin ligase activity cterminal structure cbl proteinsnan
no_relation,doxycycline,furcation defects,18166095,regeneration degree ii furcation defects doxycycline hyclate bioabsorbable barriernan
no_relation,sunitinib,Thymic carcinoid,18166847,thymic carcinoid responds neoadjuvant therapy sunitinib octreotide case reportnan
no_relation,octreotide,Thymic carcinoid,18166847,thymic carcinoid responds neoadjuvant therapy sunitinib octreotide case reportnan
no_relation,sunitinib,thymic carcinoid,18166847,report case atypical thymic carcinoid responded neoadjuvant therapy octreotide sunitinib oral multikinase inhibitornan
no_relation,octreotide,thymic carcinoid,18166847,report case atypical thymic carcinoid responded neoadjuvant therapy octreotide sunitinib oral multikinase inhibitornan
no_relation,octreotide,management of neuroendocrine tumors,18166847,believe study sunitinib octreotide neoadjuvant intent preparing tumors resection warranted strategy improve curative management neuroendocrine tumors nan
no_relation,octreotide,tumors,18166847,believe study sunitinib octreotide neoadjuvant intent preparing tumors resection warranted strategy improve curative management neuroendocrine tumorsnan
no_relation,sunitinib,tumors,18166847,believe study sunitinib octreotide neoadjuvant intent preparing tumors resection warranted strategy improve curative management neuroendocrine tumorsnan
no_relation,sunitinib,management of neuroendocrine tumors,18166847,believe study sunitinib octreotide neoadjuvant intent preparing tumors resection warranted strategy improve curative management neuroendocrine tumors nan
no_relation,iodine,consciousness,18186295,iodoform intoxication case report prolonged consciousness disturbance patient high plasma iodine levelnan
no_relation,iodine,infected wounds,18186295,report describes case consciousness disturbance associated high plasma iodine level improved removal iodoform gauze applied infected wounds nan
yes_direct,iodine,consciousness,18186295,report describes case consciousness disturbance associated high plasma iodine level improved removal iodoform gauze applied infected woundsnan
no_relation,iodine,consciousness,18186295,consciousness recovered gradually concomitant decrease plasma iodine levelnan
no_relation,ethanol,oleic acid/OA,18191555,influence propylen glycol pg ethanol oleic acid oa nortriptyline hydrochloride nth penetration human epidermis studied vitro two different ph values nan
no_relation,nortriptyline hydrochloride,oleic acid/OA,18191555,influence propylen glycol pg ethanol oleic acid oa nortriptyline hydrochloride nth penetration human epidermis studied vitro two different ph values nan
no_relation,oleic acid,oleic acid/OA,18191555,influence propylen glycol pg ethanol oleic acid oa nortriptyline hydrochloride nth penetration human epidermis studied vitro two different ph values nan
no_relation,polysorbate 80,OA,18191555,vehicles showed increasing enhancement effect order polysorbate  ethanolpg oa pg ethanol ethanollactic acid lactic acid ph reduced permeation nth ph nan
no_relation,ethanol,OA,18191555,vehicles showed increasing enhancement effect order polysorbate ethanol pg oa pg ethanol ethanol lactic acid lactic acid ph reduced permeation nth ph nan
no_relation,polysorbate 80,OA,18191555,considering results obtained ph maximum enhancement ratios found polysorbate combination ethanolpg oa nan
no_relation,ethanol,OA,18191555,considering results obtained ph maximum enhancement ratios found polysorbate combination ethanol pg oa nan
no_relation,ethanol,OA,18191555,nthtds based combination ethanol pg oa showed enhancement ratio respect control addition polysorbate matrix nan
no_relation,pristinamycin,Staphylococcus epidermidis,18194160,analysis pristinamycin resistant staphylococcus epidermidis isolates tunisian bone marrow transplant centernan
no_relation,pristinamycin,Staphylococcus epidermidis,18194160,report analysis genetic determinants conferring resistance pristinamycin staphylococcus epidermidis strains epidemiology typing strains pulsedfield gel electrophoresisnan
no_relation,pristinamycin,Staphylococcus epidermidis,18194160,staphylococcus epidermidis isolates searched strains pristinamycin resistancenan
no_relation,Pristinamycin,cancer,18194160,pristinamycin resistant strains seven isolates isolated five patients haematological cancer bone marrow transplant centre tunisia nan
no_relation,catecholamines,trauma,18234565,effect exogenous catecholamines tumor necrosis factor alpha interleukin interleukin betaendorphin levels following severe trauma nan
no_relation,catecholamines,tumor necrosis factor alpha,18234565,effect exogenous catecholamines tumor necrosis factor alpha interleukin interleukin betaendorphin levels following severe traumanan
no_relation,catecholamines,trauma,18234565,aim study determine effect exogenous catecholamines tumor necrosis factor alpha tnfa interleukin il interleukin il betabetaendorphin levels patients severe trauma first injurynan
no_relation,catecholamines,tumor necrosis factor alpha/TNFa,18234565,aim study determine effect exogenous catecholamines tumor necrosis factor alpha tnfa interleukin il interleukin il betabetaendorphin levels patients severe trauma first injurynan
yes_direct,catecholamines,TNFa,18234565,baseline values different two groups altered pattern release observed tnfa il il betaendorphin levels patients treated catecholamines nan
no_relation,catecholamine,trauma,18234565,findings support altered pattern cytokine release early phase trauma probably due catecholamine presencenan
no_relation,dichlorphenamide/DCP,paralysis,18254068,one study dichlorphenamide dcp vs placebo tested two groups participants hypokalemic periodic paralysis hypopp hyperkalemic periodic paralysis hyperpp based clinical criterianan
no_relation,dichlorphenamide/DCP,HypoPP/hypokalemic periodic paralysis,18254068,one study dichlorphenamide dcp vs placebo tested two groups participants hypokalemic periodic paralysis hypopp  hyperkalemic periodic paralysis hyperpp based clinical criterianan
no_relation,dichlorphenamide/DCP,hyperkalemic,18254068,one study dichlorphenamide dcp vs placebo tested two groups participants hypokalemic periodic paralysis hypopp hyperkalemic periodic paralysis hyperpp based clinical criterianan
no_relation,DCP,paralysis,18254068,twentyfour participants hyperkalemic periodic paralysis completed treatment phases participants attack rate data treatment phases mean improvement attack rate  severityweighted attack rate  dcp relative placebo significantnan
no_relation,DCP,hyperkalemic,18254068,twentyfour participants hyperkalemic periodic paralysis completed treatment phases participants attack rate data treatment phases mean improvement attack rate  severityweighted attack rate  dcp relative placebo significantnan
no_relation,pinacidil,HypoPP,18254068,acetazolamide proved improve muscle strength eight participants hypopp one study pinacidil potassium channel opener also improved muscle strength participants hypopp third studynan
no_relation,potassium,HypoPP,18254068,acetazolamide proved improve muscle strength eight participants hypopp one study pinacidil potassium channel opener also improved muscle strength participants hypopp third studynan
no_relation,Acetazolamide,HypoPP,18254068,acetazolamide proved improve muscle strength eight participants hypopp one study pinacidil potassium channel opener also improved muscle strength participants hypopp third studynan
no_relation,DCP,paralyses,18254068,largest included study met inclusion criteria suggested dcp effective prevention episodic weakness hypokalemic hyperkalemic periodic paralyses nan
no_relation,DCP,weakness in both hypokalemic,18254068,largest included study met inclusion criteria suggested dcp effective prevention episodic weakness hypokalemic hyperkalemic periodic paralysesnan
no_relation,DCP,hyperkalemic,18254068,largest included study met inclusion criteria suggested dcp effective prevention episodic weakness hypokalemic hyperkalemic periodic paralysesnan
no_relation,arformoterol,COPD,18259972,effect nebulized arformoterol airway function copd results two randomized trialsnan
no_relation,Arformoterol,COPD,18259972,arformoterol single isomer longacting betaagonist developed inhalation solution maintenance treatment bronchoconstriction copd nan
no_relation,arformoterol,COPD,18259972,trials copd subjects administered nebulized arformoterol demonstrated significant sustained improvement lung function weeksnan
no_relation,pentoxifylline,endometriosis,18262146,compare outcomes conservative surgery endometriosis without pentoxifylline assess efficacy pentoxifylline preventing recurrence endometriosis conservative surgerynanused treatment
no_relation,pentoxifylline,endometriosis,18262146,use pentoxifylline conservative surgery endometriosis resulted improved vas scores  months procedure compared patients conservative surgerynan
no_relation,pentoxifylline,endometriosis,18262146,longerterm use pentoxifylline conservative surgery may improve longterm outcomes surgical treatment endometriosis nan
no_relation,6-mercaptopurine,inflammatory bowel disease,18266236,increased dosing requirements 6-mercaptopurine azathioprine inflammatory bowel disease patients six years youngernan
no_relation,azathioprine,inflammatory bowel disease,18266236,increased dosing requirements 6-mercaptopurine azathioprine inflammatory bowel disease patients six years youngernan
no_relation,6-MP/6-Mercaptopurine,IBD/inflammatory bowel disease,18266236,mercaptopurine 6-mp prodrug azathioprine aza effective induction maintenance remission reduction corticosteroid exposure pediatric inflammatory bowel disease ibd nan
no_relation,AZA/azathioprine,IBD/inflammatory bowel disease,18266236,mercaptopurine mp prodrug azathioprine aza effective induction maintenance remission reduction corticosteroid exposure pediatric inflammatory bowel disease ibd nan
no_relation,6-MP,IBD,18266236,aim study determine whether ibd patients years age younger require higher standard doses 6-mp aza achieve clinical remissionnan
no_relation,AZA,IBD,18266236,aim study determine whether ibd patients years age younger require higher standard doses mp aza achieve clinical remissionnan
no_relation,6-MP,IBD,18266236,clinical data collected retrospectively ibd patients years age younger treated 6-mp aza childrens hospital philadelphianan
no_relation,AZA,IBD,18266236,clinical data collected retrospectively ibd patients years age younger treated mp aza childrens hospital philadelphianan
no_relation,6-MP,IBD,18266236,ibd diagnosed median age years th ile years 6-mp aza initiated median age years range yearsnan
no_relation,AZA,IBD,18266236,ibd diagnosed median age years th ile years mp aza initiated median age years range yearsnan
no_relation,AZA,laboratory abnormalities,18266236,patients discontinue mp aza laboratory abnormalities improved spontaneously dose reductionnan
no_relation,6-MP,laboratory abnormalities,18266236,patients discontinue 6-mp aza laboratory abnormalities improved spontaneously dose reductionnan
no_relation,6-MP,IBD,18266236,standard dose 6-mp aza may adequate ibd patients years age youngernan
no_relation,AZA,IBD,18266236,standard dose mp aza may adequate ibd patients years age youngernan
no_relation,mannitol,arterial hypertension,18286835,firsttier options include induced hypocapnea hyperventilation paco mannitol hypertonic saline induced arterial hypertension cpp conceptnan
no_relation,mannitol,hyperosmolar,18286835,firsttier options include induced hypocapnea hyperventilation paco hyperosmolar therapy mannitol hypertonic saline induced arterial hypertension cpp conceptnan
no_relation,indomethacin,coma,18286835,include forced hyperventilation paco coma experimental protocols tris buffer indomethacin induced hypothermianan
no_relation,indomethacin,hypothermia,18286835,include forced hyperventilation paco indomethacin induced hypothermia nan
yes_direct,barbiturate,coma,18286835,include forced hyperventilation paco barbiturate coma experimental protocols tris buffer indomethacin induced hypothermianan
no_relation,barbiturate,hypothermia,18286835,include forced hyperventilation paco barbiturate coma experimental protocols tris buffer indomethacin induced hypothermia nan
no_relation,testosterone,hypogonadism,18305486,clinically reports patients erectile dysfunction ed combined hypogonadism receive testosterone therapy inconsistent resultsnan
no_relation,testosterone,ED/erectile dysfunction,18305486,clinically reports patients erectile dysfunction ed combined hypogonadism receive testosterone therapy inconsistent resultsnan
no_relation,testosterone,prostate cancer,18305486,potential risks clinical use testosterone therapy individualized carefully considered closely monitored especially patients possible occult prostate cancer large benign prostatic hyperplasianan
no_relation,testosterone,prostatic hyperplasia,18305486,potential risks clinical use testosterone therapy individualized carefully considered closely monitored especially patients possible occult prostate cancer large benign prostatic hyperplasia nan
no_relation,lorazepam,catatonia,18327024,although lorazepam helpful treating catatonia may suffice cases presentednan
no_relation,lorazepam,encephalitis,18327024,ect deserves serious consideration early course malignant catatonia catatonia nested encephalopathy secondary encephalitis unresolved lorazepam nan
no_relation,lorazepam,encephalopathy,18327024,ect deserves serious consideration early course malignant catatonia catatonia nested encephalopathy secondary encephalitis unresolved lorazepam nan
no_relation,lorazepam,catatonia,18327024,ect deserves serious consideration early course malignant catatonia catatonia nested encephalopathy secondary encephalitis unresolved lorazepam nan
no_relation,escitalopram,depressive disorder,18331669,markov costutility analysis escitalopram duloxetine treatment major depressive disorder nan
no_relation,duloxetine,depressive disorder,18331669,markov costutility analysis escitalopram duloxetine treatment major depressive disorder nan
no_relation,escitalopram,depression,18331669,analysis suggests escitalopram effective terms qalws less costly duloxetine treatment depression nan
no_relation,duloxetine,depression,18331669,analysis suggests escitalopram effective terms qalws less costly duloxetine treatment depression nan
no_relation,Pimecrolimus,atopic dermatitis,18341665,pimecrolimus cream longterm management adult atopic dermatitis prevention flare progressionnan
no_relation,pimecrolimus,atopic dermatitis/AD,18341665,previous studies suggested early intervention pimecrolimus cream first signs andor symptoms relapse atopic dermatitis ad following remission may prevent occurrence severe flares therefore reduce corticosteroid exposure long termnan
no_relation,pimecrolimus,AD,18341665,evaluate effectiveness pimecrolimus cream prevention flare progression adults ad nan
no_relation,pimecrolimus,AD,18341665,week randomized controlled study conducted patients aged years history mild moderate ad clearalmost clear disease randomization pimecrolimus cream matching vehicle creamnan
no_relation,pimecrolimus,AD,18341665,adults history mild moderate ad free active skin lesions intervention pimecrolimus cream first signs andor symptoms subsequent recurrence reduces number flares requiring tcs use decreases number diseaserelated office visitsnan
no_relation,pimecrolimus,skin lesions,18341665,adults history mild moderate ad free active skin lesions intervention pimecrolimus cream first signs andor symptoms subsequent recurrence reduces number flares requiring tcs use decreases number diseaserelated office visitsnanused treatment
no_relation,gemcitabine,leukemia,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,idarubicin,lymphoma,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,cloretazine,leukemia,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,idarubicin,leukemia,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,cloretazine,lymphoma,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,topotecan,lymphoma,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,irinotecan,lymphoma,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,topotecan,leukemia,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,CP-4055,lymphoma,18398748,anti proliferative activity elacy cp-4055 combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,irinotecan,leukemia,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,gemcitabine,lymphoma,18398748,anti proliferative activity elacy cp combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,CP-4055,leukemia,18398748,anti proliferative activity elacy cp-4055 combination cloretazine vnpm idarubicin gemcitabine irinotecan topotecan human leukemia lymphoma cellsnan
no_relation,CP-4055,lymphoma,18398748,summary cp-4055 produced additive synergistic anti proliferative activity combined simultaneously drugs four mechanistic classes cell culture models human leukemia lymphoma nan
no_relation,CP-4055,leukemia,18398748,summary cp-4055 produced additive synergistic anti proliferative activity combined simultaneously drugs four mechanistic classes cell culture models human leukemia lymphomanan
no_relation,eosin,cancer,18406100,uni multivariable variable analyses showed lowest recurrence rates reported studies performed cancer centres studies described use mtcsulphur colloid also investigators used superficial injection technique evaluated harvested sentinel nodes haematoxylin eosin immunohistochemistry stainingnan
no_relation,triglycerides,hypertriglyceridemia,18422480,moderate hypertriglyceridemia fairly common elevated triglycerides risk factor coronary heart diseasenan
yes_direct,triglycerides,coronary heart disease,18422480,moderate hypertriglyceridemia fairly common elevated triglycerides risk factor coronary heart disease nan
no_relation,triglycerides,hypertriglyceridemia,18422480,review provides overview use omega concentrates pom overthecounter fish oil lower triglycerides people moderate hypertriglyceridemia triglycerides range  mgdlnan
no_relation,triglycerides,dyslipidemia,18422480,pom effective reducing triglycerides approximately population likely combined drugs eg statins treat combined dyslipidemia nan
yes_direct,9-anilinoacridine,cytotoxicity,18454048,caspasedependent cell death mediates potent cytotoxicity sulfide derivatives 9-anilinoacridine nan
no_relation,2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol/CK0402,multiple cancer,18454048,two recently developed sulfide derivatives anilinoacridines acridinylaminophenylthiophenylhydroxyethylaminoethanol ck acridinylaminophenylthiophenylhydroxypropylaminopropanol ck displayed potent cytotoxic activity multiple cancer cell linesnan
no_relation,3-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(3-hydroxypropyl)amino)propan-1-ol/CK0403,multiple cancer,18454048,two recently developed sulfide derivatives anilinoacridines acridinylaminophenylthiophenylhydroxyethylaminoethanol ck acridinylaminophenylthiophenylhydroxypropylaminopropanol ck displayed potent cytotoxic activity multiple cancer cell linesnan
no_relation,verteporfin,choroidal neovascularization,18463509,intravitreal injection bevacizumab combined verteporfin photodynamic therapy choroidal neovascularization agerelated macular degenerationnan
no_relation,verteporfin,age-related macular degeneration,18463509,intravitreal injection bevacizumab combined verteporfin photodynamic therapy choroidal neovascularization agerelated macular degeneration nan
no_relation,verteporfin,choroidal neovascularization/CNV,18463509,report outcome eyes treated intravitreal injection bevacizumab combined verteporfin photodynamic therapy pdt choroidal neovascularization cnv agerelated macular degeneration amdnan
no_relation,verteporfin,AMD/age-related macular degeneration,18463509,report outcome eyes treated intravitreal injection bevacizumab combined verteporfin photodynamic therapy pdt choroidal neovascularization cnv agerelated macular degeneration amd nan
yes_direct,MIBG,pulmonary hypertension,18471462,mibg also used potential marker pulmonary endothelial cell function may related pulmonary hypertension nan
no_relation,MIBG,idiopathic dilated cardiomyopathy,18471462,conclusion combined assessment lung heart mibg uptake may help predict future clinical outcome patients idiopathic dilated cardiomyopathy accurately myocardial evaluation alonenan
no_relation,gaboxadol,Slow wave sleep/daytime sleepiness/sleep restriction,18517036,slow wave sleep enhancement gaboxadol reduces daytime sleepiness sleep restriction nan
no_relation,gaboxadol,SWS/sleep restriction,18517036,doubleblind parallel group placebocontrolled design used compare gaboxadol gbx mg sws enhancing drug placebo nights sleep restriction hnightnan
no_relation,GBX,sleep restriction,18517036,group received either gbx mg placebo sleep restriction nights groups received placebo baseline recovery nightsnan
no_relation,Saponins,tumor,18537712,saponins tumor therapynan
no_relation,Saponins,tumorigenic,18537712,saponins plant glycosides favorable anti tumorigenic propertiesnan
no_relation,saponins,tumor,18537712,several saponins inhibit tumor cell growth cell cycle arrest apoptosis ic values micromnan
no_relation,saikosaponins,tumor,18537712,discuss diverse groups saponins dioscins saikosaponins julibrosides soy saponins ginseng saponins avicins investigated relation tumor therapy focus cellular systemic mechanisms tumor cell growth inhibition vitro vivonan
no_relation,saponins,tumor,18537712,discuss diverse groups saponins dioscins saikosaponins julibrosides soy saponins ginseng saponins avicins investigated relation tumor therapy focus cellular systemic mechanisms tumor cell growth inhibition vitro vivonan
no_relation,saponins,tumor,18537712,review also describes saponins combination conventional tumor treatment strategies result improved therapeutic successnan
no_relation,saponins,tumorigenic,18537712,combinations saponins anti tumorigenic drugs induce synergistic effects potentiated growth inhibitionnan
no_relation,selenium,HIV-infected,18541571,randomized doubleblind placebocontrolled trial selenium supplements among hiv-infected pregnant women tanzania effects maternal child outcomesnan
no_relation,selenium,HIV disease progression,18541571,observational studies adequate selenium status associated better pregnancy outcomes slowed hiv disease progression nan
no_relation,selenium,HIV-infected,18541571,investigated effects daily selenium supplements cd cell counts viral load pregnancy outcomes maternal infant mortality among hiv-infected pregnant womennan
yes_direct,Selenium,fetal death,18541571,selenium marginally associated reduced risk low birth weight relative risk rr  ci   increased risk fetal death rr  ci   effect risk prematurity smallforgestational age birthnan
no_relation,selenium,HIV disease progression/HIV-infected,18541571,among hiv-infected women dar es salaam tanzania selenium supplements given pregnancy improve hiv disease progression pregnancy outcomes may improve child survivalnanused lame treatment
no_relation,Quercetin,tumor,18549926,quercetin dosedependently inhibited vitro lipopolysaccharideinduced tumor necrosis factoralpha production blood healthy volunteersnan
no_relation,Quercetin,necrosis,18549926,quercetin dosedependently inhibited vitro lipopolysaccharideinduced tumor necrosis factoralpha production blood healthy volunteersnan
no_relation,estrogen,neuropathic pain,18559275,broad modulation neuropathic pain states selective estrogen receptor beta agonistnan
no_relation,estrogens,pain,18559275,effects estrogens pain perception remain controversialnan
no_relation,estrogen,pain animal models involving nerve injury or sensitization,18559275,erb nonsteroidal estrogen receptor beta ligand evaluated several pain animal models involving nerve injury sensitization nan
no_relation,capsaicin,spinal nerve ligation,18559275,erb alleviated tactile hyperalgesia induced capsaicin reversed tactile allodynia caused spinal nerve ligation various chemical insultsnan
yes_direct,capsaicin,tactile hyperalgesia/allodynia,18559275,erb alleviated tactile hyperalgesia induced capsaicin reversed tactile allodynia caused spinal nerve ligation various chemical insultsnan
no_relation,verapamil,AF,18562808,intravenous beta blockers verapamil diltiazem may given immediately slow rapid ventricular rate af nan
no_relation,diltiazem,AF,18562808,intravenous beta blockers verapamil diltiazem may given immediately slow rapid ventricular rate af nan
no_relation,verapamil,AF,18562808,oral beta blocker verapamil diltiazem used persons af fast ventricular rate occurs rest exercise despite digoxinnan
no_relation,diltiazem,AF,18562808,oral beta blocker verapamil diltiazem used persons af fast ventricular rate occurs rest exercise despite digoxinnanused treatment
no_relation,digoxin,AF,18562808,oral beta blocker verapamil diltiazem used persons af fast ventricular rate occurs rest exercise despite digoxin nan
no_relation,Amiodarone,AF,18562808,amiodarone may used selected patients symptomatic lifethreatening af refractory drugsnan
no_relation,Digoxin,AF,18562808,digoxin used treat patients paroxysmal af nan
yes_direct,epothilones,peripheral neuropathy,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancerincluding vinca alkaloids taxanes epothilones known associated peripheral neuropathy nan
yes_direct,taxanes,peripheral neuropathy,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancerincluding vinca alkaloids taxanes epothilonesare known associated peripheral neuropathy nan
no_relation,vinca alkaloids,breast cancer,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancer including vinca alkaloids taxanes epothilonesare known associated peripheral neuropathynan
no_relation,taxanes,breast cancer,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancer including vinca alkaloids taxanes epothilonesare known associated peripheral neuropathynan
no_relation,epothilones,breast cancer,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancer including vinca alkaloids taxanes epothilones known associated peripheral neuropathynan
yes_direct,vinca alkaloids,peripheral neuropathy,18567992,microtubule inhibitor mtibased chemotherapies used treatment breast cancerincluding vinca alkaloids taxanes epothilonesare known associated peripheral neuropathy nan
yes_direct,vincristine,sensory/motor neuropathy,18567992,although firstgeneration vinca alkaloids vincristine associated severe mixed sensorymotor neuropathy deficits associated newer agents class eg vinflunine generally milder limited distal sensory signs symptomsnan
no_relation,vinflunine,sensory/motor neuropathy,18567992,although firstgeneration vinca alkaloids vincristine associated severe mixed sensorymotor neuropathy deficits associated newer agents class eg vinflunine generally milder limited distal sensory signs symptomsnan
yes_direct,Epothilones,peripheral neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
yes_direct,epothilone B,neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
yes_direct,ixabepilone,peripheral neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
yes_direct,Epothilones,neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
yes_direct,ixabepilone,neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
no_relation,epothilone B,peripheral neuropathy,18567992,epothilones new class mti may associated grade peripheral neuropathy however neuropathy associated ixabepilone novel epothilone analog generally mild moderate reversible baseline grade levelsnan
no_relation,taxanes,neurotoxicities,18567992,article provides overview incidence characteristics management mtiassociated neurotoxicities known vinca alkaloids taxanes well newer agents vinflunine ixabepilonenan
yes_direct,vinflunine,neurotoxicities,18567992,article provides overview incidence characteristics management mtiassociated neurotoxicities known vinca alkaloids taxanes well newer agents vinflunine ixabepilonenan
no_relation,vinca alkaloids,neurotoxicities,18567992,article provides overview incidence characteristics management mtiassociated neurotoxicities known vinca alkaloids taxanes well newer agents vinflunine ixabepilonenan
yes_direct,ixabepilone,neurotoxicities,18567992,article provides overview incidence characteristics management mtiassociated neurotoxicities known vinca alkaloids taxanes well newer agents vinflunine ixabepilone nan
yes_direct,AEG40730,dramatic reduction,18570872,demonstrate aeg40730 compound modeled birbinding tetrapeptides binds ciap ciap facilitates autoubiquitination proteosomal degradation causes dramatic reduction rip ubiquitinationnan
no_relation,clopidogrel,STEMI,18586338,longterm costeffectiveness clopidogrel stemi patientsnan
no_relation,clopidogrel,stroke,18586338,commit trial demonstrated clopidogrel produced relative reduction death reinfarction stroke vs  ci stelevated myocardial infarction stemi patientsnan
no_relation,clopidogrel,ST-elevated myocardial infarction/STEMI,18586338,commit trial demonstrated clopidogrel produced relative reduction death reinfarction stroke vs  ci stelevated myocardial infarction stemi patientsnan
no_relation,clopidogrel,death,18586338,commit trial demonstrated clopidogrel produced relative reduction death reinfarction stroke vs  ci stelevated myocardial infarction stemi patientsnan
no_relation,clopidogrel,STEMI,18586338,  stemi patients randomized clopidogrel matching placebo addition aspirinnan
no_relation,aspirin,STEMI,18586338,  stemi patients randomized clopidogrel matching placebo addition aspirin nan
no_relation,clopidogrel,STEMI,18586338,addition clopidogrel aspirin given year setting stemi highly costeffective strategynan
no_relation,aspirin,STEMI,18586338,addition clopidogrel aspirin given year setting stemi highly costeffective strategynan
yes_direct,methylphenidate,Juvenile Huntington disease,18658080,juvenile huntington disease exacerbated methylphenidate case reportnan
no_relation,methylphenidate,attention-deficit hyperactivity disorder/ADHD,18658080,authors describe case yearold boy otherwise healthy presented symptoms consistent attentiondeficit hyperactivity disorder adhd started trial methylphenidate nan
yes_direct,estrogen,breast cancer,18673555,epht recruited womens health initiative whi usa decided stop estrogen progestin trial mean years july increased risk breast cancer later estrogen trial ht increased risk stroke decreased risk hip fracture affect coronary heart disease incidencenan
no_relation,estrogen,coronary heart disease,18673555,epht recruited womens health initiative whi usa decided stop estrogen progestin trial mean years july increased risk breast cancer later estrogen trial ht increased risk stroke decreased risk hip fracture affect coronary heart disease incidencenan
yes_direct,estrogen,stroke,18673555,epht recruited womens health initiative whi usa decided stop estrogen progestin trial mean years july increased risk breast cancer later estrogen trial ht increased risk stroke decreased risk hip fracture affect coronary heart disease incidencenan
no_relation,estrogen,hip fracture,18673555,epht recruited womens health initiative whi usa decided stop estrogen progestin trial mean years july increased risk breast cancer later estrogen trial ht increased risk stroke decreased risk hip fracture affect coronary heart disease incidencenan
no_relation,steroids,COPD,18682458,addition high doses steroids minimal effect inexorable decline lung function copd patients small effect reducing exacerbationsnan
no_relation,chloroform,glycoprotein of mouse lymphoma,18690658,present work extracts selected herbs prepared methanol chloroform ethyl acetate water effects multidrug resistance mdr glycoprotein mouse lymphoma cells transfected human mdr gene human lung alveolar epithelial cell line investigatednan
no_relation,methanol,glycoprotein of mouse lymphoma,18690658,present work extracts selected herbs prepared methanol chloroform ethyl acetate water effects multidrug resistance mdr glycoprotein mouse lymphoma cells transfected human mdr gene human lung alveolar epithelial cell line investigatednan
no_relation,ethyl acetate,glycoprotein of mouse lymphoma,18690658,present work extracts selected herbs prepared methanol chloroform ethyl acetate water effects multidrug resistance mdr glycoprotein mouse lymphoma cells transfected human mdr gene human lung alveolar epithelial cell line investigatednan
no_relation,chloroform,lung cancer,18690658,possible chemopreventive effect chloroform extracts studied expression cytomegalovirus cmv immediateearly ie antigen human lung cancer cellsnan
no_relation,chloroform,MDR mouse lymphoma,18690658,two chloroform extracts enhanced antiproliferative effect doxorubicin mdr mouse lymphoma cellsnan
no_relation,doxorubicin,MDR mouse lymphoma,18690658,two chloroform extracts enhanced antiproliferative effect doxorubicin mdr mouse lymphoma cellsnan
no_relation,ryanodine,malignant hyperthermia,18719443,novel ryanodine receptor mutation may cause malignant hyperthermia nanmutation causes hyperthermia
yes_direct,Ca,Malignant hyperthermia/MH,18719443,malignant hyperthermia mh hypermetabolic condition caused genetic disposition leading increased ca release sarcoplasmic reticulum exposure triggering agentsnan
no_relation,ryanodine,MH,18719443,authors ongoing evaluation patients undergoing mh testing austria detected family new variant ryanodine receptor nan
no_relation,prednisolone,polyposis,18720067,thirtytwo patients nasal polyposis randomized unilateral endoscopic sinus surgery pretreatment oral prednisolone days nasal budesonide bilaterally monthnan
no_relation,budesonide,polyposis,18720067,thirtytwo patients nasal polyposis randomized unilateral endoscopic sinus surgery pretreatment oral prednisolone days nasal budesonide bilaterally monthnan
no_relation,lactic acid/lactate,necrosis,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritisnan
no_relation,lactic acid/lactate,inflammatory arthropathy,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritisnan
no_relation,lactic acid/lactate,osteoarthritis,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritis nan
no_relation,lactic acid/lactate,rheumatoid arthritis,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritisnan
no_relation,lactic acid/lactate,arthropathy,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritisnan
no_relation,lactic acid/lactate,pseudogout,18759291,concentrations tumor necrosis factor alpha interleukin vascular endothelial growth factor lactic acid lactate dehydrogenase hmgb measured synovial fluid sf samples patients inflammatory arthropathy rheumatoid arthritis pseudogout patients noninflammatory arthropathy osteoarthritisnan
no_relation,lactic acid,inflammatory arthropathy,18759291,sf samples patients hmgbassociated inflammatory arthropathy ie samples hmgb levels  sd mean level samples patients noninflammatory arthropathy concentrations hmgb significantly correlated lactic acid marker tissue hypoxianan
no_relation,lactic acid,arthropathy,18759291,sf samples patients hmgbassociated inflammatory arthropathy ie samples hmgb levels  sd mean level samples patients noninflammatory arthropathy concentrations hmgb significantly correlated lactic acid marker tissue hypoxianan
no_relation,lactic acid,hypoxia,18759291,sf samples patients hmgbassociated inflammatory arthropathy ie samples hmgb levels  sd mean level samples patients noninflammatory arthropathy concentrations hmgb significantly correlated lactic acid marker tissue hypoxia nan
no_relation,sodium chloride,nephropathy,18768415,sodium bicarbonate vs sodium chloride prevention contrast mediuminduced nephropathy patients undergoing coronary angiography randomized trialnan
no_relation,Sodium bicarbonate,nephropathy,18768415,sodium bicarbonate vs sodium chloride prevention contrast mediuminduced nephropathy patients undergoing coronary angiography randomized trialnan
no_relation,Sodium bicarbonate,renal failure,18768415,sodium bicarbonate suggested possible strategy prevention contrast mediuminduced nephropathy common cause renal failure associated prolonged hospitalization increased health care costs substantial morbidity mortalitynan
no_relation,Sodium bicarbonate,nephropathy,18768415,sodium bicarbonate suggested possible strategy prevention contrast mediuminduced nephropathy common cause renal failure associated prolonged hospitalization increased health care costs substantial morbidity mortalitynan
no_relation,sodium chloride,nephropathy,18768415,determine sodium bicarbonate superior sodium chloride preventing contrast mediuminduced nephropathy patients moderate severe chronic kidney dysfunction undergoing coronary angiographynan
no_relation,sodium bicarbonate,nephropathy,18768415,determine sodium bicarbonate superior sodium chloride preventing contrast mediuminduced nephropathy patients moderate severe chronic kidney dysfunction undergoing coronary angiographynan
no_relation,sodium bicarbonate,kidney dysfunction,18768415,determine sodium bicarbonate superior sodium chloride preventing contrast mediuminduced nephropathy patients moderate severe chronic kidney dysfunction undergoing coronary angiographynan
no_relation,sodium chloride,kidney dysfunction,18768415,determine sodium bicarbonate superior sodium chloride preventing contrast mediuminduced nephropathy patients moderate severe chronic kidney dysfunction undergoing coronary angiographynan
no_relation,sodium chloride,death,18768415,patients randomized receive sodium bicarbonate vs sodium chloride rates death dialysis myocardial infarction cerebrovascular events differ significantly days vs  vs  vs  vs respectively days months vs  vs  vs  vs respectively nan
no_relation,sodium bicarbonate,myocardial infarction,18768415,patients randomized receive sodium bicarbonate vs sodium chloride rates death dialysis myocardial infarction cerebrovascular events differ significantly days vs  vs  vs  vs respectively days months vs  vs  vs  vs respectively nan
no_relation,sodium chloride,myocardial infarction,18768415,patients randomized receive sodium bicarbonate vs sodium chloride rates death dialysis myocardial infarction cerebrovascular events differ significantly days vs  vs  vs  vs respectively days months vs  vs  vs  vs respectively nan
no_relation,sodium bicarbonate,death,18768415,patients randomized receive sodium bicarbonate vs sodium chloride rates death dialysis myocardial infarction cerebrovascular events differ significantly days vs  vs  vs  vs respectively days months vs  vs  vs  vs respectively nan
no_relation,sodium bicarbonate,chronic kidney disease,18768415,results study suggest hydration sodium bicarbonate superior hydration sodium chloride prevention contrast mediuminduced nephropathy patients moderate severe chronic kidney disease undergoing coronary angiographynan
no_relation,sodium chloride,nephropathy,18768415,results study suggest hydration sodium bicarbonate superior hydration sodium chloride prevention contrast mediuminduced nephropathy patients moderate severe chronic kidney disease undergoing coronary angiographynan
no_relation,sodium bicarbonate,nephropathy,18768415,results study suggest hydration sodium bicarbonate superior hydration sodium chloride prevention contrast mediuminduced nephropathy patients moderate severe chronic kidney disease undergoing coronary angiographynan
no_relation,sodium chloride,chronic kidney disease,18768415,results study suggest hydration sodium bicarbonate superior hydration sodium chloride prevention contrast mediuminduced nephropathy patients moderate severe chronic kidney disease undergoing coronary angiographynan
yes_direct,aspirin,mucosal defects,18779739,investigation gastric duodenal mucosal defects caused lowdose aspirin patients ischemic heart diseasenan
no_relation,aspirin,ischemic heart disease,18779739,investigation gastric duodenal mucosal defects caused lowdose aspirin patients ischemic heart disease nan
no_relation,aspirin,ischemic cerebrovascular disease/ischemic heart disease,18779739,lowdose aspirin used secondary prevention ischemic heart disease ischemic cerebrovascular disease nan
no_relation,aspirin,gastrointestinal disorder,18779739,currently frequency gastrointestinal disorder among users lowdose aspirin unknownnan
yes_direct,aspirin,gastroduodenal disorder,18779739,investigate endoscopic examination frequency gastroduodenal disorder associated buffered entericcoated aspirin ecanan
no_relation,aspirin,mucosal defects,18779739,significantly mucosal defects among users lowdose aspirin among using aspirinnan
yes_direct,aspirin,mucosal defects,18779739,mucosal defects found  users buffered aspirin ba whereas  users eca mucosal defects nan
yes_direct,aspirin,gastroduodenal disorder,18779739,endoscopy frequently reveals gastroduodenal disorder among lowdose aspirin users administration ba entericcoated aspirin warrant concern gastroduodenal ulcernan
yes_direct,aspirin,ulcer,18779739,endoscopy frequently reveals gastroduodenal disorder among lowdose aspirin users administration ba entericcoated aspirin warrant concern gastroduodenal ulcer nan
no_relation,Corticosteroids,dengue illness,18789467,corticosteroids treatment dengue illness nan
no_relation,corticosteroids,thrombocytopenia,18789467,studies far patients shock syndrome possible effects corticosteroids thrombocytopenia bleeding well complications dengue unknownnan
no_relation,corticosteroids,shock syndrome,18789467,studies far patients shock syndrome possible effects corticosteroids thrombocytopenia bleeding well complications dengue unknownnan
no_relation,corticosteroids,bleeding,18789467,studies far patients shock syndrome possible effects corticosteroids thrombocytopenia bleeding well complications dengue unknownnan
no_relation,corticosteroid,dengue infection,18789467,previous studies children effect corticosteroid treatment adults dengue infection evaluatednan
no_relation,corticosteroids,dengue infection,18789467,possible beneficial effects corticosteroids various manifestations dengue infection need evaluation adequately powered well designed randomised controlled trialsnan
no_relation,ropivacaine,analgesia,18809519,comparison three different concentrations ropivacaine postoperative patientcontrolled thoracic epidural analgesia upper abdominal surgerynan
no_relation,ropivacaine,analgesia,18809519,previous studies reported comparable efficacy ropivacaine fentanyl patientcontrolled epidural analgesia pceanan
no_relation,fentanyl,analgesia,18809519,previous studies reported comparable efficacy ropivacaine fentanyl patientcontrolled epidural analgesia pceanan
no_relation,fentanyl,pain,18809519,addition comparing analgesic effects incidence motor block opioidrelated side effects three different ropivacaine fentanyl solutions also evaluated workload pain staffnan
no_relation,ropivacaine,pain,18809519,addition comparing analgesic effects incidence motor block opioidrelated side effects three different ropivacaine fentanyl solutions also evaluated workload pain staffnan
no_relation,ropivacaine,pain,18809519,main purpose study determine three regimens ropivacaine satisfactory least workload pain service staffnan
no_relation,fentanyl,postoperative pain,18809519,thoracic epidural  ropivacaine provide effective postoperative pain control combination fentanyl without motor blocknan
no_relation,ropivacaine,postoperative pain,18809519,thoracic epidural  ropivacaine provide effective postoperative pain control combination fentanyl without motor blocknan
no_relation,Cisplatin,non-small-cell lung cancer,18818921,cisplatin weekly docetaxel concurrent thoracic radiotherapy locally advanced stage iii nonsmallcell lung cancer nan
no_relation,docetaxel,non-small-cell lung cancer,18818921,cisplatin weekly docetaxel concurrent thoracic radiotherapy locally advanced stage iii nonsmallcell lung cancer nan
no_relation,cisplatin,non-small-cell lung cancer/NSCLC,18818921,objective assess efficacy toxicity concurrent chemoradiotherapy cisplatin weekly divideddose docetaxel patients stage iii nonsmallcell lung cancer nsclc nan
no_relation,docetaxel,toxicity,18818921,objective assess efficacy toxicity concurrent chemoradiotherapy cisplatin weekly divideddose docetaxel patients stage iii nonsmallcell lung cancer nsclcnan
no_relation,cisplatin,toxicity,18818921,objective assess efficacy toxicity concurrent chemoradiotherapy cisplatin weekly divideddose docetaxel patients stage iii nonsmallcell lung cancer nsclcnan
no_relation,docetaxel,non-small-cell lung cancer/NSCLC,18818921,objective assess efficacy toxicity concurrent chemoradiotherapy cisplatin weekly divideddose docetaxel patients stage iii nonsmallcell lung cancer nsclc nan
no_relation,Cisplatin,NSCLC,18818921,cisplatin weekly docetaxel concurrent radiotherapy feasible effective regimen locally advanced nsclc nan
no_relation,docetaxel,NSCLC,18818921,cisplatin weekly docetaxel concurrent radiotherapy feasible effective regimen locally advanced nsclc nan
no_relation,H2O2,toxicity,18826942,h2o2 dependent hyperoxidation peroxiredoxin prdx plays role cellular toxicity via upregulation ipla activitynan
yes_direct,H2O2,toxicity,18826942,report h2o2 induced cellular toxicity acts prdx hyperoxidationnan
no_relation,glucose,type 1 diabetes,18828243,jdrf randomized clinical trial assess efficacy real-time continuous glucose monitoring management type diabetes research design methodsnan
no_relation,glucose,real-time,18828243,jdrf randomized clinical trial assess efficacy real-time continuous glucose monitoring management type diabetes research design methodsnan
no_relation,glucose,T1D/type 1 diabetes,18828243,real-time rt continuous glucose monitoring cgm systems may revolutionize treatment type diabetes t1d insufficient evidence currently available support widespread utilization devicesnan
no_relation,glucose,RT/real-time,18828243,real-time rt continuous glucose monitoring cgm systems may revolutionize treatment type diabetes td insufficient evidence currently available support widespread utilization devicesnan
no_relation,glucose,RT,18828243,subjects t1dm meet eligibility criteria randomized either standard selfmonitoring blood glucose smbg alone use three current rt cgm systems supplement smbgnan
no_relation,glucose,T1D,18828243,outcomes include percentage sensor glucose values within mgdl range scores questionnaires assess impact rtcgm living t1d costeffectiveness rtcgmnan
no_relation,glucose,RT,18828243,outcomes include percentage sensor glucose values within mgdl range scores questionnaires assess impact rt cgm living td costeffectiveness rt cgmnan
no_relation,testosterone,Obesity,18843273,obesity low testosterone levels erectile dysfunctionnan
no_relation,testosterone,erectile dysfunction,18843273,obesity low testosterone levels erectile dysfunction nan
no_relation,testosterone,obesity,18843273,relationships among obesity metabolic syndrome ed sex hormonebinding globulin shbg serum total free testosterone levels complex often confusing physiciannan
no_relation,testosterone,ED,18843273,relationships among obesity metabolic syndrome ed sex hormonebinding globulin shbg serum total free testosterone levels complex often confusing physiciannan
no_relation,testosterone,metabolic syndrome,18843273,relationships among obesity metabolic syndrome ed sex hormonebinding globulin shbg serum total free testosterone levels complex often confusing physiciannan
no_relation,testosterone,obesity,18843273,known bmi inversely proportional serum total testosterone concentrations low serum shbg levels obesity contribute low serum total testosterone nan
no_relation,testosterone,obese,18843273,characteristic low serum testosterone concentrations observed obese men also present men metabolic syndrome type diabetes mellitusnan
no_relation,testosterone,type 2 diabetes mellitus,18843273,characteristic low serum testosterone concentrations observed obese men also present men metabolic syndrome type diabetes mellitus nan
no_relation,testosterone,metabolic syndrome,18843273,characteristic low serum testosterone concentrations observed obese men also present men metabolic syndrome type diabetes mellitusnan
no_relation,testosterone,type,18843273,ed common symptom patients type diabetes also low testosterone levelsnan
yes_direct,testosterone,ED,18843273,ed common symptom patients type diabetes also low testosterone levelsnan
no_relation,testosterone,diabetes,18843273,ed common symptom patients type diabetes also low testosterone levelsnan
no_relation,testosterone,type 2 diabetes mellitus,18843273,review describes relationships low serum testosterone concentrations ed obese patients metabolic syndrome type diabetes mellitus nan
no_relation,testosterone,obese,18843273,review describes relationships low serum testosterone concentrations ed obese patients metabolic syndrome type diabetes mellitusnan
no_relation,testosterone,ED,18843273,review describes relationships low serum testosterone concentrations ed obese patients metabolic syndrome type diabetes mellitusnan
no_relation,testosterone,metabolic syndrome,18843273,review describes relationships low serum testosterone concentrations ed obese patients metabolic syndrome type diabetes mellitusnan
no_relation,tazobactam,melioidosis,18854938,role piperacillin tazobactam melioidosis remains undefinednan
no_relation,piperacillin,melioidosis,18854938,role piperacillin tazobactam melioidosis remains undefinednan
no_relation,imatinib,GIST/gastrointestinal stromal tumours,18941456,although tyrosine kinase inhibitor imatinib shown active agent patients gastrointestinal stromal tumours gist complete remissions almost never seen patients finally experience disease progression course treatmentnan
no_relation,tyrosine,GIST/gastrointestinal stromal tumours,18941456,although tyrosine kinase inhibitor imatinib shown active agent patients gastrointestinal stromal tumours gist complete remissions almost never seen patients finally experience disease progression course treatmentnan
no_relation,17beta-estradiol,breast cancer,18958632,steap overexpressed breast cancer downregulated 17beta-estradiol mcf cells rat mammary glandnan
no_relation,estrogen,tumor/breast cancer,18958632,also demonstrated steap transcription correlates negatively estrogen receptor er immunoreactivity positively tumor grading breast cancer casesnan
yes_direct,estrogens,breast cancer,18958632,estrogens involved breast cancer onset progression response steap 17beta-estradiol investigated mammary gland rats human breast cancer cell line mcfnan
no_relation,17beta-estradiol,breast cancer,18958632,estrogens involved breast cancer onset progression response steap 17beta-estradiol investigated mammary gland rats human breast cancer cell line mcfnan
no_relation,angiotensin I,chronic kidney disease,18971536,combination angiotensin converting enzyme inhibitors angiotensin receptor blockers shown effective individual drugs alone treatment chronic kidney disease chronic heart failurenan
no_relation,angiotensin I,chronic heart failure,18971536,combination angiotensin converting enzyme inhibitors angiotensin receptor blockers shown effective individual drugs alone treatment chronic kidney disease chronic heart failure nan
no_relation,amlodipine,hypertension,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,calcium,hypertension,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,amlodipine,arteriosclerosis,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,perindopril,hypertension,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,perindopril,arteriosclerosis,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,angiotensin,hypertension,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,calcium,arteriosclerosis,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,angiotensin,arteriosclerosis,18971536,present study evaluated effect treatment calcium channel blocker amlodipine angiotensin iconverting enzyme inhibitor perindopril vascular endothelial function arteriosclerosis patients essential hypertension already receiving angiotensin receptor blocker monotherapynan
no_relation,amlodipine,hypertension,18971536,thirtytwo patients essential hypertension treated angiotensin receptor blocker monotherapy randomized receive mg amlodipine mg perindopril daily morning weeksnan
no_relation,perindopril,hypertension,18971536,thirtytwo patients essential hypertension treated angiotensin receptor blocker monotherapy randomized receive mg amlodipine mg perindopril daily morning weeksnan
no_relation,angiotensin,hypertension,18971536,thirtytwo patients essential hypertension treated angiotensin receptor blocker monotherapy randomized receive mg amlodipine mg perindopril daily morning weeksnan
no_relation,amlodipine,hypertension,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertension nan
no_relation,perindopril,vascular endothelial dysfunction,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertensionnan
no_relation,calcium,hypertension,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertension nan
no_relation,calcium,vascular endothelial dysfunction,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertensionnan
no_relation,perindopril,hypertension,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertension nan
no_relation,amlodipine,vascular endothelial dysfunction,18971536,conclusion results suggest angiotensin iconverting enzyme inhibitor perindopril superior calcium channel blocker amlodipine reducing vascular endothelial dysfunction coadministered angiotensin receptor blockers patients essential hypertensionnan
no_relation,aviptadil,PAH/idiopathic pulmonary arterial hypertension,18978135,idiopathic pulmonary arterial hypertension pah vasodilating vasoactive intestinal peptide aviptadil deficientnan
no_relation,aviptadil,thromboembolic,18978135,total patients ph pah nine ph lung disease eight chronic thromboembolic ph three inhaled single microg dose aviptadil rightheart catheterisationnan
no_relation,aviptadil,lung disease,18978135,total patients ph pah nine ph lung disease eight chronic thromboembolic ph three inhaled single microg dose aviptadil rightheart catheterisationnan
no_relation,aviptadil,PAH,18978135,total patients ph pah nine ph lung disease eight chronic thromboembolic ph three inhaled single microg dose aviptadil rightheart catheterisationnan
yes_direct,Aviptadil,stroke,18978135,aviptadil aerosol caused small temporary significant selective pulmonary vasodilation improved stroke volume mixed venous oxygen saturationnan
no_relation,oxygen,stroke,18978135,aviptadil aerosol caused small temporary significant selective pulmonary vasodilation improved stroke volume mixed venous oxygen saturationnan
no_relation,aviptadil,lung disease,18978135,patients significant lung disease aviptadil tended improve oxygenationnan
no_relation,Aviptadil,lung disease,18978135,aviptadil inhalation tended improve oxygenation patients significant lung disease nan
no_relation,alanine,adverse drug reactions,18987459,among eligible patients adverse drug reactions observed common abdominal distension flatulence diarrhea increased alanine aminotransferase levelsnan
no_relation,alanine,flatulence,18987459,among eligible patients adverse drug reactions observed common abdominal distension flatulence diarrhea increased alanine aminotransferase levelsnan
no_relation,alanine,diarrhea,18987459,among eligible patients adverse drug reactions observed common abdominal distension flatulence diarrhea increased alanine aminotransferase levelsnan
no_relation,R(+)-methanandamide,carcinoma,19015962,r(+)-methanandamide induced apoptosis human cervical carcinoma cells involves cyclooxygenasedependent pathwaynan
no_relation,R(+)-methanandamide,carcinoma,19015962,using human cervical carcinoma cells hela study investigates role cyclooxygenase cox apoptosis elicited endocannabinoid analog r(+)-methanandamidenan
no_relation,"3,4-dihydroxybenzaldehyde",cancer,19023807,"concentration microm 3,4-dihydroxybenzaldehyde caused growth inhibition human cancer cellnan"
no_relation,"3,4-dihydroxybenzaldehyde",oncogenesis,19023807,"since ckii involved cell proliferation oncogenesis results suggest 3,4-dihydroxybenzaldehyde may function inhibiting oncogenic disease least part inhibition ckii activitynan"
no_relation,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",cytotoxicity,19027573,cytotoxicity testing dimethylthiazolyldiphenyltetrazolium bromide mtt test performednan
yes_direct,cefuroxime,toxicity,19027573,data suggest dosedependent toxicity cefuroxime vancomycin hcecs vitro narrow range safetynan
yes_direct,vancomycin,toxicity,19027573,data suggest dosedependent toxicity cefuroxime vancomycin hcecs vitro narrow range safetynan
no_relation,ropivacaine,TNS,19032560,six lidocaine patients reported tns compared patient receiving ropivacaine nan
yes_direct,lidocaine,TNS,19032560,recovery unassisted ambulation spontaneous voiding occurred earlier lidocaine associated markedly higher incidence tns nan
yes_direct,Carbon monoxide,toxicity,19060737,carbon monoxide toxicity nan
no_relation,olmesartan medoxomil,hypertension,19067471,efficacy tolerability olmesartan medoxomil combined amlodipine patients moderate severe hypertension amlodipine monotherapy randomized doubleblind parallelgroup multicentre studynan
no_relation,amlodipine,hypertension,19067471,efficacy tolerability olmesartan medoxomil combined amlodipine patients moderate severe hypertension amlodipine monotherapy randomized doubleblind parallelgroup multicentre studynan
no_relation,olmesartan medoxomil,hypertension,19067471,objective randomized doubleblind parallelgroup multicentre study determine efficacy safety olmesartan medoxomil amlodipine combination therapy patients moderate severe hypertension failed respond treatment weeks openlabel amlodipinenan
no_relation,amlodipine,hypertension,19067471,objective randomized doubleblind parallelgroup multicentre study determine efficacy safety olmesartan medoxomil amlodipine combination therapy patients moderate severe hypertension failed respond treatment weeks openlabel amlodipine nan
no_relation,olmesartan medoxomil,hypertension,19067471,results suggest olmesartan medoxomil combined amlodipine effective well tolerated reducing bp patients moderate severe hypertension nan
no_relation,amlodipine,hypertension,19067471,results suggest olmesartan medoxomil combined amlodipine effective well tolerated reducing bp patients moderate severe hypertension nan
no_relation,glucose,Type,19106615,type diabetes occurs endocrine pancreas longer secrete enough insulin maintain glucose lipid homeostasisnan
no_relation,glucose,diabetes,19106615,type diabetes occurs endocrine pancreas longer secrete enough insulin maintain glucose lipid homeostasisnan
yes_direct,fatty acids,death,19106615,clear studies others multiple pathways fatty acids palmitate lead betacell dysfunction death nan
no_relation,thymidine,head and neck cancer,19117293,predictive therapeutic value thymidine phosphorylase dihydropyrimidine dehydrogenase capecitabine xelodabased chemotherapy head neck cancer nan
no_relation,capecitabine,head and neck cancer,19117293,predictive therapeutic value thymidine phosphorylase dihydropyrimidine dehydrogenase capecitabine xelodabased chemotherapy head neck cancer nan
no_relation,5'-DFUR,head and neck squamous cell carcinoma/HNSCC,19117293,evaluate whether two molecular biomarkers thymidine phosphorylase tp dihydropyrimidine dehydrogenase dpd could clinically useful predicting improving chemotherapeutic outcome oral fluoropyrimidine capecitabine 5'-dfur xeloda treatment human head neck squamous cell carcinoma hnscc nan
no_relation,capecitabine,head and neck squamous cell carcinoma/HNSCC,19117293,evaluate whether two molecular biomarkers thymidine phosphorylase tp dihydropyrimidine dehydrogenase dpd could clinically useful predicting improving chemotherapeutic outcome oral fluoropyrimidine capecitabine dfur xeloda treatment human head neck squamous cell carcinoma hnscc nan
no_relation,thymidine,head and neck squamous cell carcinoma/HNSCC,19117293,evaluate whether two molecular biomarkers thymidine phosphorylase tp dihydropyrimidine dehydrogenase dpd could clinically useful predicting improving chemotherapeutic outcome oral fluoropyrimidine capecitabine dfur xeloda treatment human head neck squamous cell carcinoma hnscc nan
no_relation,capecitabine,HNSCC,19117293,effect tp transgene expression alter tp dpd ratio hence optimize therapeutic outcome capecitabine treatment evaluated murine model human hnscc using immunohistochemistry detect tp dpd expression vivonan
no_relation,5'-DFUR,HNSCC,19117293,correlation detected sensitivity 5'-dfur relative expression levels tp dpd multiple hnscc cell lines testednan
no_relation,capecitabine,HNSCC tumors,19117293,addition demonstrate transgene expression tp significantly enhanced tumoricidal effect capecitabine hnscc tumors otherwise low endogenous tp dpd ratiosnan
no_relation,capecitabine,tumors,19117293,results study suggest hnscc patients would benefit capecitabine based chemotherapy could identified examining tp dpd ratio tumors nan
no_relation,capecitabine,HNSCC,19117293,results study suggest hnscc patients would benefit capecitabine based chemotherapy could identified examining tp dpd ratio tumorsnan
no_relation,5-aza-2'-deoxycytidine,tumor,19117987,find clinically achievable levels 5-aza-2'-deoxycytidine azadc potent inhibitor dna methylation modify chromatin restore ability tumor necrosis factor alpha tnfalpha induce monocytic differentiation acute myeloid leukemia cells nbnan
yes_direct,5-aza-2'-deoxycytidine,necrosis,19117987,find clinically achievable levels 5-aza-2'-deoxycytidine azadc potent inhibitor dna methylation modify chromatin restore ability tumor necrosis factor alpha tnfalpha induce monocytic differentiation acute myeloid leukemia cells nbnan
no_relation,5-aza-2'-deoxycytidine,acute myeloid leukemia,19117987,find clinically achievable levels 5-aza-2'-deoxycytidine azadc potent inhibitor dna methylation modify chromatin restore ability tumor necrosis factor alpha tnfalpha induce monocytic differentiation acute myeloid leukemia cells nbnan
no_relation,methicillin,Staphylococcus aureus carriage,19148574,clustering risk factors methicillin resistant staphylococcus aureus carriage two italian longterm care facilitiesnan
no_relation,Methicillin,MRSA/Methicillin-resistant Staphylococcus aureus,19148574,methicillin resistant staphylococcus aureus mrsa wellrecognized agent health careassociated infections longterm care facilities data circulation mrsa setting italy availablenan
no_relation,Methicillin,infections,19148574,methicillin resistant staphylococcus aureus mrsa wellrecognized agent health careassociated infections longterm care facilities data circulation mrsa setting italy availablenan
no_relation,nickel,hyperlipidemia,19159850,according multivariate analysis significant predictor crisr reference vessel diameter followed nickel positive hyperlipidemianan
no_relation,cyclosporine,Still's disease,19184270,glucocorticoid cyclosporine refractory adult onset stills disease successfully treated tocilizumabnan
no_relation,steroid,Her disease,19184270,disease refractory highdose glucocorticoids two courses steroid pulse therapy addition cyclosporine mgkgdaynan
no_relation,cyclosporine,Her disease,19184270,disease refractory highdose glucocorticoids two courses steroid pulse therapy addition cyclosporine mgkgdaynan
no_relation,Cyclosporine,hepatic failure,19184270,cyclosporine one firstline immunosuppressants aosd especially associated dic hepatic failure hemophagocytic syndromenan
no_relation,Cyclosporine,hemophagocytic syndrome,19184270,cyclosporine one firstline immunosuppressants aosd especially associated dic hepatic failure hemophagocytic syndrome nan
no_relation,5-fluorouracil,rectal cancer,19200365,patients histological proven rectal cancer staged tn randomized receive either scrt gy five fractions gy plus tmesurgery within days rct gy fractions gy continuous infusion 5-fluorouracil plus tmesurgery weeks laternan
no_relation,5-fluorouracil,TME,19200365,patients histological proven rectal cancer staged tn randomized receive either scrt gy five fractions gy plus tme surgery within days rct gy fractions gy continuous infusion 5-fluorouracil plus tme surgery weeks laternan
no_relation,glatiramer acetate,depressive symptoms,19200865,evidence interferonbeta treatment may exacerbate depressive symptoms switch glatiramer acetate envisaged patients treated interferonbeta depressive symptoms become issuenan
no_relation,glatiramer acetate,fatigue,19200865,growing evidence immunomodulatory treatments particular glatiramer acetate improve fatigue symptoms patients multiple sclerosisnan
no_relation,glatiramer acetate,multiple sclerosis,19200865,growing evidence immunomodulatory treatments particular glatiramer acetate improve fatigue symptoms patients multiple sclerosis nan
no_relation,zinc,Wilson disease,19210288,systematic review clinical efficacy chelator agents zinc initial treatment wilson disease nan
no_relation,D-penicillamine,Wilson disease,19210288,original studies clinical efficacy d-penicillamine trientine tetrathiomolybdate zinc monotherapy initial treatment wilson disease includednan
no_relation,zinc,Wilson disease,19210288,original studies clinical efficacy dpenicillamine trientine tetrathiomolybdate zinc monotherapy initial treatment wilson disease includednan
no_relation,trientine,Wilson disease,19210288,original studies clinical efficacy dpenicillamine trientine tetrathiomolybdate zinc monotherapy initial treatment wilson disease includednan
no_relation,tetrathiomolybdate,Wilson disease,19210288,original studies clinical efficacy dpenicillamine trientine tetrathiomolybdate zinc monotherapy initial treatment wilson disease includednan
no_relation,D-penicillamine,Wilson disease,19210288,nevertheless according currently available data patients hepatic presentation wilson disease probably effectively treated d-penicillamine nan
no_relation,ruthenium,tumors,19214395,among drugs ruthenium compounds showing promising results treat tumors represent important development new antitumor therapynan
no_relation,cis-[RuCl(2)(NH(3))(4)]Cl,MI,19214395,mi human peripheral blood lymphocyte cultures treated   microg ml cis-[rucl(2)(nh(3))(4)]cl   respectivelynan
no_relation,corticosteroid,acute eosinophilic pneumonia,19221962,exception acute eosinophilic pneumonia responds well corticosteroid therapy role corticosteroid immunesuppressive treatments management smokingrelated interstitial lung diseases entirely clear probably limited utility particularly absence smoking cessationnan
no_relation,corticosteroid,interstitial lung diseases,19221962,exception acute eosinophilic pneumonia responds well corticosteroid therapy role corticosteroid immunesuppressive treatments management smokingrelated interstitial lung diseases entirely clear probably limited utility particularly absence smoking cessationnan
no_relation,cholesterol,lipid disorders,19233108,crosssectional study dyslipidaemic patients receiving lipidlowering therapy lipid disorders defined triglyceride greater gl hdlc lesser gl lowdensity lipoprotein cholesterol ldlc recommended concentration according french guidelinesnan
no_relation,4-aminopyridine,multiple sclerosis,19249634,clinical studies suggested fampridine 4-aminopyridine improves motor function people multiple sclerosis nan
no_relation,lidocaine,fibromyalgia,19263182,intravenous lidocaine fibromyalgia syndrome open trialnan
no_relation,lidocaine,fibromyalgia,19263182,study investigated effect intravenous infusions lidocaine pain quality life patients fibromyalgia nan
no_relation,lidocaine,pain,19263182,study investigated effect intravenous infusions lidocaine pain quality life patients fibromyalgianan
no_relation,lidocaine,Fibromyalgia,19263182,fibromyalgia impact questionnaire fiq health assessment questionnaire visual analog scale vas pain applied first lidocaine infusion immediately fifth infusion days fifth infusionnan
no_relation,lidocaine,pain,19263182,fibromyalgia impact questionnaire fiq health assessment questionnaire visual analog scale vas pain applied first lidocaine infusion immediately fifth infusion days fifth infusionnan
no_relation,lidocaine,fibromyalgia,19263182,intravenous lidocaine infusions safe effective management fibromyalgia nan
no_relation,Pioglitazone,impaired glucose tolerance,19277602,pioglitazone enhance effectiveness lifestyle modification preventing conversion impaired glucose tolerance diabetes asian indians results indian diabetes prevention programme idppnan
no_relation,Pioglitazone,diabetes,19277602,pioglitazone enhance effectiveness lifestyle modification preventing conversion impaired glucose tolerance diabetes asian indians results indian diabetes prevention programme idppnan
no_relation,glucose,impaired glucose tolerance,19277602,pioglitazone enhance effectiveness lifestyle modification preventing conversion impaired glucose tolerance diabetes asian indians results indian diabetes prevention programme idppnan
no_relation,glucose,diabetes,19277602,pioglitazone enhance effectiveness lifestyle modification preventing conversion impaired glucose tolerance diabetes asian indians results indian diabetes prevention programme idppnan
no_relation,glucose,diabetes,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerancenan
no_relation,glucose,impaired glucose tolerance,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerancenan
no_relation,glucose,type,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerancenan
no_relation,pioglitazone,impaired glucose tolerance,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerance nan
no_relation,pioglitazone,diabetes,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerancenan
no_relation,pioglitazone,type,19277602,objective prevention programme study whether combining pioglitazone lifestyle modification would enhance efficacy lifestyle modification preventing type diabetes asian indians impaired glucose tolerancenan
no_relation,pioglitazone,impaired glucose tolerance,19277602,communitybased placebocontrolled year prospective study participants impaired glucose tolerance mean age  years mean bmi  kgm sequentially grouped receive either lifestyle modification plus pioglitazone  mg  lifestyle modification plus placebo nan
no_relation,glucose,impaired glucose tolerance,19277602,communitybased placebocontrolled year prospective study participants impaired glucose tolerance mean age  years mean bmi  kgm sequentially grouped receive either lifestyle modification plus pioglitazone mg  lifestyle modification plus placebo nanimpaired glucose tolerance whole term evaluated juxtaposition parts 
yes_direct,pioglitazone,diabetes,19277602,cumulative incidence diabetes pioglitazone placebo unadjusted hr  ci  nan
no_relation,pioglitazone,cardiac disease,19277602,pioglitazone group two deaths two nonfatal hospitalisations occurred due cardiac problems placebo group two occurrences cardiac disease nan
no_relation,pioglitazone,deaths,19277602,pioglitazone group two deaths two nonfatal hospitalisations occurred due cardiac problems placebo group two occurrences cardiac diseasenan
no_relation,pioglitazone,diabetes,19277602,results variance studies showed significant relative risk reduction conversion diabetes pioglitazone americans igtnan
no_relation,pioglitazone,diabetic,19277602,ethnicityrelated difference action pioglitazone non diabetic participants may one explanationnan
no_relation,carboplatin,tumor,19299243,rational successful use carboplatin albuminbound paclitaxel patient recurrent metaplastic carcinoma presented multiorgan tumor embolinan
no_relation,carboplatin,metaplastic carcinoma,19299243,rational successful use carboplatin albuminbound paclitaxel patient recurrent metaplastic carcinoma presented multiorgan tumor embolinan
no_relation,paclitaxel,tumor,19299243,rational successful use carboplatin albuminbound paclitaxel patient recurrent metaplastic carcinoma presented multiorgan tumor embolinan
no_relation,paclitaxel,metaplastic carcinoma,19299243,rational successful use carboplatin albuminbound paclitaxel patient recurrent metaplastic carcinoma presented multiorgan tumor embolinan
no_relation,cisplatin,hypoxia,19339107,nsc606985 induces apoptosis exerts synergistic effects cisplatin inhibits hypoxia stabilized hifalpha protein human ovarian cancer cellsnan
no_relation,NSC606985,hypoxia,19339107,nsc606985 induces apoptosis exerts synergistic effects cisplatin inhibits hypoxia stabilized hifalpha protein human ovarian cancer cellsnan
no_relation,cisplatin,ovarian cancer,19339107,nsc606985 induces apoptosis exerts synergistic effects cisplatin inhibits hypoxiastabilized hifalpha protein human ovarian cancer cellsnan
no_relation,NSC606985,ovarian cancer,19339107,nsc606985 induces apoptosis exerts synergistic effects cisplatin inhibits hypoxiastabilized hifalpha protein human ovarian cancer cellsnan
no_relation,NSC606985,ovarian cancer,19339107,present study investigated potential antihuman ovarian cancer effects nsc606985 novel rarely studied camptothecin analog combination cisplatin cddpnanpossible treatment
no_relation,cisplatin/CDDP,ovarian cancer,19339107,present study investigated potential antihuman ovarian cancer effects nsc novel rarely studied camptothecin analog combination cisplatin cddp nan
no_relation,camptothecin,ovarian cancer,19339107,present study investigated potential antihuman ovarian cancer effects nsc novel rarely studied camptothecin analog combination cisplatin cddpnan
no_relation,CDDP,ovarian cancer,19339107,human ovarian cancer cell line coc cells treated different nanomolar nsc606985 without cddp cell growth apoptosis evaluated respectively mtt assay annexinv assay flow cytometrynan
no_relation,NSC606985,ovarian cancer,19339107,human ovarian cancer cell line coc cells treated different nanomolar nsc606985 without cddp cell growth apoptosis evaluated respectively mtt assay annexinv assay flow cytometrynan
no_relation,NSC606985,hypoxia,19339107,addition nsc606985 significantly antagonized accumulation hifalpha stabilized hypoxia hypoxia mimetic agentnan
no_relation,CDDP,ovarian cancer,19339107,results suggest nsc606985 combination cddp present therapeutic potential ovarian cancer deserve preclinical clinical studiesnan
no_relation,NSC606985,ovarian cancer,19339107,results suggest nsc606985 combination cddp present therapeutic potential ovarian cancer deserve preclinical clinical studiesnan
no_relation,monensin,adenocarcinoma,19342176,monolayers human ileocecal adenocarcinoma cells hct infected sporozoites excysted directly cells incubated monensin halofuginone bromide hexadecylphosphocholine post infection pinan
no_relation,monensin,infection,19342176,monolayers human ileocecal adenocarcinoma cells hct infected sporozoites excysted directly cells incubated monensin halofuginone bromide hexadecylphosphocholine post infection pinan
no_relation,hexadecylphosphocholine,adenocarcinoma,19342176,monolayers human ileocecal adenocarcinoma cells hct infected sporozoites excysted directly cells incubated monensin halofuginone bromide hexadecylphosphocholine post infection pinan
no_relation,hexadecylphosphocholine,infection,19342176,monolayers human ileocecal adenocarcinoma cells hct infected sporozoites excysted directly cells incubated monensin halofuginone bromide hexadecylphosphocholine post infection pinan
no_relation,tyrosine,non-small cell lung cancer,19343300,epidermal growth factor receptor tyrosine kinase inhibitors elderly poor performance status patients advanced nonsmall cell lung cancer nan
no_relation,Tyrosine,NSCLC,19343300,tyrosine kinase inhibitors tkis epidermal growth factor receptor egfr erlotinib gefitinib active agents treatment advanced nsclc nan
no_relation,erlotinib,NSCLC,19343300,tyrosine kinase inhibitors tkis epidermal growth factor receptor egfr erlotinib gefitinib active agents treatment advanced nsclc nan
no_relation,gefitinib,NSCLC,19343300,tyrosine kinase inhibitors tkis epidermal growth factor receptor egfr erlotinib gefitinib active agents treatment advanced nsclc nan
no_relation,erlotinib,NSCLC,19343300,review summarize results erlotinib gefitinib subsets patients advanced nsclc nan
no_relation,gefitinib,NSCLC,19343300,review summarize results erlotinib gefitinib subsets patients advanced nsclc nan
no_relation,ipratropium bromide,rhinorrhea,19351236,review assesses two widely used intranasal treatments nasal congestion rhinorrhea common cold xylometazoline hydrochloride ipratropium bromide nan
no_relation,xylometazoline hydrochloride,rhinorrhea,19351236,review assesses two widely used intranasal treatments nasal congestion rhinorrhea common cold xylometazoline hydrochloride ipratropium bromidenan
no_relation,ipratropium,rhinorrhea,19351236,xylometazoline quickly effectively relieves nasal congestion ipratropium effective reducing rhinorrhea nan
no_relation,Xylometazoline,rhinorrhea,19351236,xylometazoline quickly effectively relieves nasal congestion ipratropium effective reducing rhinorrhea nan
no_relation,sorafenib,papillary thyroid carcinoma,19355831,successful use sorafenib treat pediatric papillary thyroid carcinoma nan
no_relation,Sorafenib,thyroid cancer,19355831,sorafenib orally administered multikinase inhibitor shown promise treatment adults advanced thyroid cancer yet studied children diseasenan
no_relation,sorafenib,PTC,19355831,objective present adolescent progressive rairesistant ptc successfully treated sorafenib nan
no_relation,Sorafenib,PTC,19355831,yearold girl progressive lung metastases ptc despite previous therapies almost mci sorafenib initiated starting dose mg twice daily decreased maintenance dose mg daily due side effects developed within weeks treatmentnan
no_relation,sorafenib,PTC,19355831,rare case pediatric patient progressive rairefractory ptc good systemic therapy exists sorafenib may play important role management diseasenan
no_relation,methotrexate,histoplasmosis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexate nan
yes_direct,prednisone,histoplasmosis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexatenan
no_relation,methotrexate,granulomatous hepatitis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexate nan
no_relation,prednisone,dermatomyositis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexatenan
no_relation,prednisone,granulomatous hepatitis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexatenan
no_relation,methotrexate,dermatomyositis,19434026,present rare case isolated granulomatous hepatitis due histoplasmosis yearold female dermatomyositis receiving lowdose prednisone methotrexate nan
no_relation,estrogen,breast cancer,19435899,targeting vascular endothelial growth factor vegf estrogen receptor er signaling pathways concomitantly may provide enhanced therapeutic benefit erpositive breast cancer nan
no_relation,ZK222584,breast cancer,19435899,therefore effects vegf receptor vegfr tyrosine kinase inhibitor ptk zk222584 ptkzk investigated using human breast cancer cell lines engineered express aromatasenan
no_relation,aciclovir,viral encephalitis,19457882,management infants children treated aciclovir suspected viral encephalitis nan
no_relation,aciclovir,encephalitis,19457882,case notes infants children received intravenous aciclovir suspected encephalitis month period reviewednan
no_relation,serotonin,depression,19468717,aimed determine potential correlations httnet gene polymorphisms susceptibility depression antidepressant response selective serotonin reuptake inhibitors ssris dual selective serotonin norepinephrine reuptake inhibitors snrisnan
no_relation,norepinephrine,depression,19468717,aimed determine potential correlations httnet gene polymorphisms susceptibility depression antidepressant response selective serotonin reuptake inhibitors ssris dual selective serotonin norepinephrine reuptake inhibitors snrisnan
no_relation,AMB/amphotericin B,mucormycosis,19485785,standard therapy invasive mucormycosis includes parenteral amphotericin amb combination radical debridement infected tissuesnan
no_relation,Posaconazole,mucormycosis,19485785,posaconazole novel extendedspectrum triazole oral antifungal agent documented success treatment patients invasive mucormycosis nan
no_relation,AMB,infection,19485785,infection respond amb treated successfully combination posaconazole liposomal amb lamb without surgical debridementnan
no_relation,posaconazole,infection,19485785,infection respond amb treated successfully combination posaconazole liposomal amb lamb without surgical debridementnan
yes_direct,posaconazole,gastric and intrahepatic mucormycosis,19485785,knowledge first reported case extensive gastric intrahepatic mucormycosis responded combination posaconazole lamb without surgical debridementnan
no_relation,epinephrine,Mallory-Weiss syndrome,19485979,endoscopic band ligation could decrease recurrent bleeding malloryweiss syndrome compared haemostasis hemoclips plus epinephrine nan
no_relation,epinephrine,bleeding,19485979,endoscopic band ligation could decrease recurrent bleeding malloryweiss syndrome compared haemostasis hemoclips plus epinephrine nan
no_relation,adrenaline/epinephrine,MWS,19485979,compare efficacy endoscopic band ligation vs hemoclip plus epinephrine adrenaline bleeding mws nan
no_relation,adrenaline/epinephrine,bleeding,19485979,compare efficacy endoscopic band ligation vs hemoclip plus epinephrine adrenaline bleeding mwsnan
yes_direct,epinephrine,bleeding,19485979,use hemoclips plus epinephrine  ci  active bleeding endoscopy  ci  independent predictive factors early recurrent bleeding nan
no_relation,paclitaxel,breast cancer,19509275,telomerase template antagonist grnl alters mdamb breast cancer cell morphology inhibits growth augments effects paclitaxel nan
no_relation,paclitaxel,breast cancer,19509275,importantly cellular response grnl significantly augmented effects microtubule stabilizer paclitaxel mdamb breast cancer cell growth vitro vivo compared paclitaxel alone mismatch control oligonucleotide plus paclitaxel nan
no_relation,paclitaxel,breast cancer,19509275,data support rationale potentially combining grnl paclitaxel treatment breast cancer clinical settingnan
no_relation,clopidogrel,ST-elevation myocardial infarction/STEMI,19515084,present singlecenter longitudinal cohort study include consecutive patients stelevation myocardial infarction stemi undergoing ppci pretreatment mg aspirin mg clopidogrel nan
no_relation,aspirin,ST-elevation myocardial infarction/STEMI,19515084,present singlecenter longitudinal cohort study include consecutive patients stelevation myocardial infarction stemi undergoing ppci pretreatment mg aspirin mg clopidogrelnan
no_relation,glucose,type,19533082,rosiglitazone significantly increased glucose uptake wild type podocytes associated translocation glut plasma membranenan
no_relation,Rosiglitazone,type,19533082,rosiglitazone significantly increased glucose uptake wild type podocytes associated translocation glut plasma membranenan
no_relation,glucose,type,19533082,conclusion rosiglitazone direct protective effect glucose uptake wild type human podocytesnan
no_relation,rosiglitazone,type,19533082,conclusion rosiglitazone direct protective effect glucose uptake wild type human podocytesnan
no_relation,ribavirin,hepatitis,19578243,pattern pegylated interferonalphab ribavirin treatment failure cirrhotic patients depends hepatitis virus genotypenan
no_relation,pegylated interferon-alpha2b,hepatitis,19578243,pattern pegylated interferonalphab ribavirin treatment failure cirrhotic patients depends hepatitis virus genotypenan
no_relation,ribavirin,cirrhosis,19578243,treatment failure pegylated interferon pegifnalphab ribavirin rbv largely depends upon virus genotype interaction genotype cirrhosis pattern treatment failure unclearnan
no_relation,pegylated interferon (PEG-IFN)-alpha2b,cirrhosis,19578243,treatment failure pegylated interferon pegifnalphab ribavirin rbv largely depends upon virus genotype interaction genotype cirrhosis pattern treatment failure unclearnan
yes_direct,dapsone,atrioventricular block,19583683,complete atrioventricular block associated dapsone therapy rare complication dapsone induced hypersensitivity syndromenan
yes_direct,dapsone,dapsone-induced hypersensitivity syndrome,19583683,complete atrioventricular block associated dapsone therapy rare complication dapsone induced hypersensitivity syndromenan
no_relation,Dapsone,infectious and inflammatory diseases,19583683,dapsone still widely used range infectious inflammatory diseases nan
yes_direct,dapsone,DHS/dapsone-induced hypersensitivity syndrome,19583683,potential severe sideeffect known dapsone induced hypersensitivity syndrome dhs may occurnan
yes_direct,dapsone,DHS,19583683,describe yearold chinese woman developed dhs weeks dapsone therapy pustular palmoplantar psoriasisnan
no_relation,dapsone,psoriasis,19583683,describe yearold chinese woman developed dhs weeks dapsone therapy pustular palmoplantar psoriasis nan
no_relation,iron,RT,19588382,two studies used supplemental iron rt plus epo group rt alone groupnan
no_relation,Oil Red O,Rb/retinoblastoma,19652659,effects lactoferrin adipogenesis studied expression different lipogenic markers ampactivated protein kinase ampk activation retinoblastoma rb activity oil red staining tl cellsnan
no_relation,AMP,Rb/retinoblastoma,19652659,effects lactoferrin adipogenesis studied expression different lipogenic markers amp activated protein kinase ampk activation retinoblastoma rb activity oil red staining tl cellsnan
yes_direct,saturated fatty acids/SFAs,inflammation,19661481,proposed dietary saturated fatty acids sfas may also serve endogenous ligands tlr tlr thereby promoting diseases associated inflammation dyslipidemia including atherosclerosis insulin resistancenan
yes_direct,saturated fatty acids/SFAs,dyslipidemia,19661481,proposed dietary saturated fatty acids sfas may also serve endogenous ligands tlr tlr thereby promoting diseases associated inflammation dyslipidemia including atherosclerosis insulin resistancenan
yes_direct,saturated fatty acids/SFAs,atherosclerosis,19661481,proposed dietary saturated fatty acids sfas may also serve endogenous ligands tlr tlr thereby promoting diseases associated inflammation dyslipidemia including atherosclerosis insulin resistancenan
no_relation,SFAs,LPS,19661481,analysis showed effect seen complexed sfas attributable lps lipopeptide contamination fattyacidfree bsanan
no_relation,SFAs,LPS,19661481,lps lipopeptide contamination widely used reagent fattyacidfree bsa explains previously reported stimulation tlr tlr sfas nan
no_relation,nitric oxide,cystic fibrosis,19669109,extended nitric oxide measurements exhaled air cystic fibrosis healthy adultsnan
no_relation,nitric oxide,cystic fibrosis/CF,19669109,cystic fibrosis cf lung disease exhaled nitric oxide feno raised rather normal even decreased measured single expiratory flownan
no_relation,nitric oxide,lung disease,19669109,cystic fibrosis cf lung disease exhaled nitric oxide feno raised rather normal even decreased measured single expiratory flownan
no_relation,NO,CF,19669109,median br significantly lower cf adults healthy controls nls range  vs nls nan
no_relation,NO,CF,19669109,pulmonary exchange differ significantly subgroups cf patients without chronic pseudomonas aeruginosa infectionnan
no_relation,NO,Pseudomonas aeruginosa infection,19669109,pulmonary exchange differ significantly subgroups cf patients without chronic pseudomonas aeruginosa infection nan
no_relation,NO,CF,19669109,extended feno measurements separate alveolar bronchial outputs cf adultsnan
no_relation,losartan,kidney diseases,19669737,cypc genotype pharmacodynamic responses losartan patients primary secondary kidney diseases nan
no_relation,Losartan,CKD/chronic kidney disease,19669737,losartan used antiproteinuric well blood pressure effects chronic kidney disease ckd nan
no_relation,losartan,CKD,19669737,preliminary results suggest possible influence cypc genotype proteinuria blood pressure caucasian ckd patients treated losartan nan
no_relation,losartan,proteinuria,19669737,preliminary results suggest possible influence cypc genotype proteinuria blood pressure caucasian ckd patients treated losartan nan
no_relation,metformin,type 2 diabetes mellitus,19690559,question often asked healthcare providers whether metformin added benefits continued patients type diabetes mellitus switch insulinnan
no_relation,Rosuvastatin,impaired fasting glucose,19691613,rosuvastatin treatment associated increase insulin resistance hyperlipidaemic patients impaired fasting glucose nan
no_relation,glucose,impaired fasting glucose,19691613,rosuvastatin treatment associated increase insulin resistance hyperlipidaemic patients impaired fasting glucose nan
no_relation,glucose,diabetes,19691613,increase physicianreported diabetes following rosuvastatin treatment justification use statins prevention intervention trial evaluating rosuvastatin study raised concerns whether statin exerts detrimental effect glucose metabolismnan
yes_direct,rosuvastatin,diabetes,19691613,increase physicianreported diabetes following rosuvastatin treatment justification use statins prevention intervention trial evaluating rosuvastatin study raised concerns whether statin exerts detrimental effect glucose metabolismnan
no_relation,rosuvastatin,IFG/impaired fasting glucose,19691613,assessed effect rosuvastatin treatment across dose range glucose homeostasis hyperlipidaemic patients impaired fasting glucose ifg high risk develop diabetes mellitusnan
no_relation,rosuvastatin,diabetes mellitus,19691613,assessed effect rosuvastatin treatment across dose range glucose homeostasis hyperlipidaemic patients impaired fasting glucose ifg high risk develop diabetes mellitus nan
no_relation,glucose,IFG/impaired fasting glucose,19691613,assessed effect rosuvastatin treatment across dose range glucose homeostasis hyperlipidaemic patients impaired fasting glucose ifg high risk develop diabetes mellitusnan
no_relation,glucose,diabetes mellitus,19691613,assessed effect rosuvastatin treatment across dose range glucose homeostasis hyperlipidaemic patients impaired fasting glucose ifg high risk develop diabetes mellitus nan
no_relation,rosuvastatin,IFG,19691613,medical records hypelipidaemic patients ifg rosuvastatin rsv group rsv group mgday rsv group reviewednan
no_relation,rosuvastatin,IFG,19691613,patients ifg hyperlipidaemia rosuvastatin treatment associated dosedependent increase insulin resistancenan
no_relation,cyclosporin,toxicity,19704071,relationship drug transporter function endogenous melanogenic toxicity assessed treating cells cyclosporin analog psc-833 assessing vacuole formation cell growth inhibitionnan
no_relation,PSC-833,toxicity,19704071,relationship drug transporter function endogenous melanogenic toxicity assessed treating cells cyclosporin analog psc-833 assessing vacuole formation cell growth inhibitionnan
no_relation,fludarabine phosphate,HPS,19709082,aimed identify contribution hps engraftment failure cbt following preparative regimens containing fludarabine phosphate  patients median age years range years haematological diseasesnan
no_relation,fludarabine phosphate,haematological diseases,19709082,aimed identify contribution hps engraftment failure cbt following preparative regimens containing fludarabine phosphate  patients median age years range years haematological diseases nan
no_relation,mycophenolate mofetil,Graft-versus-host disease,19709082,graftversushost disease prophylaxis comprised continuous infusion calcineurin inhibitor without mycophenolate mofetil nan
no_relation,retinoic acid,neuroblastoma,19713529,studied mir brainenriched microrna retinoic acid differentiated neuroblastoma cells found microrna upregulated treated cells downmodulates expression two proteins involved migratory potential neural cells reelin dcxnan
no_relation,histamine,sleep or cognitive disorders,19722526,antagonism histamine receptor one tactic explored increase wakefulness treatment disorders excessive daytime sleepiness eds well sleep cognitive disorders nan
no_relation,H,daytime sleepiness,19722526,antagonism histamine receptor one tactic explored increase wakefulness treatment disorders excessive daytime sleepiness eds well sleep cognitive disordersnan
no_relation,histamine,daytime sleepiness,19722526,antagonism histamine receptor one tactic explored increase wakefulness treatment disorders excessive daytime sleepiness eds well sleep cognitive disordersnan
no_relation,H,sleep or cognitive disorders,19722526,antagonism histamine receptor one tactic explored increase wakefulness treatment disorders excessive daytime sleepiness eds well sleep cognitive disorders nan
no_relation,Vardenafil,ED/erectile dysfunction,19732311,vardenafil reported improve success rates maintenance erection sufficient completion intercourse sep compared placebo erectile dysfunction ed patients attempted intercourse early minutes dosingnan
no_relation,vardenafil,DM,19732311,determine whether early onset activity vardenafil also achievable ed patients dm nan
no_relation,vardenafil,ED,19732311,determine whether early onset activity vardenafil also achievable ed patients dmnan
no_relation,Vardenafil,DM,19732311,vardenafil improved successful intercourse rates compared placebo japanese dm patients inserted early minutes  minutes dosingnan
no_relation,carboplatin,ovarian cancer,19818996,january april reviewed records patients highrisk early stage epithelial ovarian cancer elevated ca levels time diagnosis complete responders cycles adjuvant paclitaxel carboplatin chemotherapynan
no_relation,paclitaxel,ovarian cancer,19818996,january april reviewed records patients highrisk early stage epithelial ovarian cancer elevated ca levels time diagnosis complete responders cycles adjuvant paclitaxel carboplatin chemotherapynan
yes_direct,benzalkonium chloride,inflammation,19857103,evaluation biomarkers inflammation response benzalkonium chloride corneal conjunctival epithelial cellsnan
no_relation,H(2)O(2),inflammation,19857103,evaluate inflammation bak causes ocular surface enzyme linked immunosorbant assays elisas utilized quantify levels inflammatory biomarkers response bak andor h(2)o(2) nan
no_relation,H(2)O(2),necrosis,19857103,additional experimentation performed testing solutions replaced media resulting supernatants quantified bak induced significant amounts interleukin il tumor necrosis factor tnf moderate amounts creactive protein crp il  h(2)o(2) nan
no_relation,rifampicin,tuberculosis,19861020,molecular characterisation rifampicin resistant mycobacterium tuberculosis strains morocconan
no_relation,rifampicin/RMP,tuberculosis,19861020,mutations rpob gene associated rifampicin rmp resistance studied rmpresistant rmpsusceptible clinical strains mycobacterium tuberculosis morocco using probebased assay dna sequencingnan
no_relation,leflunomide,rheumatoid arthritis,19862529,recurrent pneumothorax associated pulmonary nodules leflunomide therapy rheumatoid arthritis case report review literaturenan
yes_direct,methotrexate,rheumatoid nodule,19862529,antirheumatic drugs methotrexate leflunomide lef infliximab etanercept known risk factors developing rheumatoid nodule nan
yes_direct,leflunomide,rheumatoid nodule,19862529,antirheumatic drugs methotrexate leflunomide lef infliximab etanercept known risk factors developing rheumatoid nodule nan
no_relation,nitroglycerin,acute coronary syndromes,19887953,current guidelines call nitroglycerin prescribed patients coronary heart disease including stable angina recovering acute coronary syndromes myocardial infarctionnan
no_relation,nitroglycerin,myocardial infarction,19887953,current guidelines call nitroglycerin prescribed patients coronary heart disease including stable angina recovering acute coronary syndromes myocardial infarction nan
no_relation,nitroglycerin,stable angina,19887953,current guidelines call nitroglycerin prescribed patients coronary heart disease including stable angina recovering acute coronary syndromes myocardial infarctionnan
no_relation,nitroglycerin,coronary heart disease,19887953,current guidelines call nitroglycerin prescribed patients coronary heart disease including stable angina recovering acute coronary syndromes myocardial infarctionnan
no_relation,nitroglycerin,myocardial ischemia,19887953,patients risk coronary events nitroglycerin may required treat acute symptoms myocardial ischemia nan
no_relation,nitroglycerin,coronary heart disease,19887953,prescription nitroglycerin frequently omitted patients coronary heart disease nan
no_relation,glucose,oral glucose tolerance,19890203,fasting glucose insulin lipid lipoprotein profiles oral glucose tolerance insulin secretion insulinmediated glucose disposal hyperglycemic clamp body composition dual energy xray absorptiometry determined lopinavir/ritonavir administrationnan
no_relation,lopinavir/ritonavir,Fasting glucose,19890203,fasting glucose insulin lipid lipoprotein profiles oral glucose tolerance insulin secretion insulinmediated glucose disposal hyperglycemic clamp body composition dual energy xray absorptiometry determined lopinavir/ritonavir administrationnan
no_relation,glucose,Fasting glucose,19890203,fasting glucose insulin lipid lipoprotein profiles oral glucose tolerance insulin secretion insulinmediated glucose disposal hyperglycemic clamp body composition dual energy xray absorptiometry determined lopinavir/ritonavir administrationnan
no_relation,lopinavir/ritonavir,oral glucose tolerance,19890203,fasting glucose insulin lipid lipoprotein profiles oral glucose tolerance insulin secretion insulinmediated glucose disposal hyperglycemic clamp body composition dual energy xray absorptiometry determined lopinavir/ritonavir administrationnan
no_relation,glucose,oral glucose tolerance,19890203,change firstphase insulin secretion  versus  nmoll  well fasting insulin glucose levels oral glucose tolerance insulinmediated glucose disposal weeks administration lopinavirritonavirnan
no_relation,ritonavir,oral glucose tolerance,19890203,change firstphase insulin secretion  versus  nmoll  well fasting insulin glucose levels oral glucose tolerance insulinmediated glucose disposal weeks administration lopinavir ritonavir nan
no_relation,lopinavir,oral glucose tolerance,19890203,change firstphase insulin secretion  versus  nmoll  well fasting insulin glucose levels oral glucose tolerance insulinmediated glucose disposal weeks administration lopinavir ritonavirnan
no_relation,methicillin,tissue infections,19949756,role antimicrobial therapy treatment uncomplicated skin soft tissue infections communityacquired methicillin resistant staphylococcus aureus childrennan
no_relation,methicillin,infections,19949756,communityacquired methicillin resistant staphylococcus aureus camrsa infections skin soft tissues increasing children taiwannan
no_relation,Panton-Valentine leukocidin,tissue infections,19949756,study investigated outcomes therapy without appropriate antibiotics among children camrsa skin soft tissue infections sstis analyzed outcomes management among children pantonvalentine leukocidin pvlpositive strains pvlnegative strainsnan
no_relation,methacholine,asthma,20004781,prolonged bronchoprotection inhaled methacholine inhaled bi longacting betaagonist patients mild asthma nan
no_relation,methacholine,asthma,20004781,examine bronchoprotective effects single doses bi methacholine provocation subjects mild asthma nan
no_relation,5-FU,gastric cancer,20020496,hifalpha unfavorable determinant relapse gastric cancer patients underwent curative surgery followed adjuvant 5-fu chemotherapynan
no_relation,5-FU/5-fluorouracil,gastric cancer,20020496,among several chemotherapeutic agents 5-fluorouracil 5-fu widely used key drug adjuvant chemotherapy gastric cancer nan
no_relation,5-FU,gastric cancer,20020496,established hifalpha knockdown gastric cancer cell lines order clarify role hifalpha chemoresistance 5-fu nan
no_relation,5-FU,gastric cancer,20020496,conclusion current study confirmed first time hifalpha expression independent risk factor relapse highrisk gastric cancer patients underwent curative surgery followed adjuvant 5-fu chemotherapynan
no_relation,Cisplatin,tumours,20084783,cisplatin remains principal chemotherapy agent treatment many solid tumours nan
no_relation,capecitabine,rectal cancer,20106720,neoadjuvant capecitabine oxaliplatin chemoradiotherapy total mesorectal excision mridefined poorrisk rectal cancer phase trialnan
no_relation,oxaliplatin,rectal cancer,20106720,neoadjuvant capecitabine oxaliplatin chemoradiotherapy total mesorectal excision mridefined poorrisk rectal cancer phase trialnan
no_relation,Deferoxamine,beta-thalassemic,20113293,deferoxamine versus combined therapy chelating liver spleen bone marrow iron beta-thalassemic patients quantitative magnetic resonance imaging studynan
no_relation,DFO/deferoxamine,beta-thalassemic,20113293,examined beta-thalassemic patients undergoing deferoxamine dfo  combined therapy dfo deferiprone two abdominal mri studies using twpdwtwgre twtse sequencesnan
no_relation,deferiprone,beta-thalassemic,20113293,examined beta-thalassemic patients undergoing deferoxamine dfo combined therapy dfo deferiprone two abdominal mri studies using twpdwtwgre twtse sequencesnan
no_relation,DFO,beta-thalassemic,20113293,combined therapy effective dfo removing preventing liver spleen bone marrow iron accumulation beta-thalassemic patientsnan
no_relation,iron,beta-thalassemic,20113293,combined therapy effective dfo removing preventing liver spleen bone marrow iron accumulation beta-thalassemic patientsnan
no_relation,coumarins,alveolar hemorrhage,20121287,hypothesized patients treated coumarins alveolar hemorrhage associated vitamin epoxide reductase vkorc cytochrome cyp cypc variant allelesnan
yes_direct,vitamin K epoxide,alveolar hemorrhage,20121287,hypothesized patients treated coumarins alveolar hemorrhage associated vitamin epoxide reductase vkorc cytochrome cyp cypc variant allelesnan
no_relation,Dopamine,sleep disturbances,20123546,dopamine receptor agonists sleep disturbances parkinson's diseasenan
no_relation,Dopamine,Parkinson's disease,20123546,dopamine receptor agonists sleep disturbances parkinson's disease nan
no_relation,ropinirole,Parkinson's disease/PD,20123546,nonergot dopamine receptor agonists ropinirole pramipexole rotigotine apomorphine may alleviate nonmotor symptoms parkinson's disease pd others may precipitatednan
no_relation,pramipexole,Parkinson's disease/PD,20123546,nonergot dopamine receptor agonists ropinirole pramipexole rotigotine apomorphine may alleviate nonmotor symptoms parkinson's disease pd others may precipitatednan
no_relation,rotigotine,Parkinson's disease/PD,20123546,nonergot dopamine receptor agonists ropinirole pramipexole rotigotine apomorphine may alleviate nonmotor symptoms parkinson's disease pd others may precipitatednan
no_relation,dopamine,Parkinson's disease/PD,20123546,nonergot dopamine receptor agonists ropinirole pramipexole rotigotine apomorphine may alleviate nonmotor symptoms parkinson's disease pd others may precipitatednan
no_relation,apomorphine,Parkinson's disease/PD,20123546,nonergot dopamine receptor agonists ropinirole pramipexole rotigotine apomorphine may alleviate nonmotor symptoms parkinson's disease pd others may precipitatednan
no_relation,dopamine,PD,20123546,review discuss dopamine receptor agonists ameliorate aggravate sleep problems pd key nonmotor symptom diseasenan
no_relation,amifostine,thyroid cancer,20130857,amifostine radioprotective effects salivary glands highdose radioactive iodinetreated differentiated thyroid cancer nan
no_relation,iodine,thyroid cancer,20130857,amifostine radioprotective effects salivary glands highdose radioactive iodine treated differentiated thyroid cancer nan
no_relation,amifostine,thyroid cancer,20130857,assess effects amifostine salivary glands radioactive iodinetreated differentiated thyroid cancer nan
no_relation,iodine,thyroid cancer,20130857,assess effects amifostine salivary glands radioactive iodine treated differentiated thyroid cancer nan
no_relation,amifostine,xerostomia,20130857,statistically significant differences effects amifostine acidstimulating agents incidence xerostomia rr  ci  decrease scintigraphically measured uptake mtc parotid rr  ci  submandibular glands rr  ci  months reduction blood pressure rr  ci nan
no_relation,amifostine,thyroid cancer,20130857,results two randomized controlled clinical trials suggest amifostine significant radioprotective effects salivary glands radioactive iodine treatment differentiated thyroid cancer nan
no_relation,iodine,thyroid cancer,20130857,results two randomized controlled clinical trials suggest amifostine significant radioprotective effects salivary glands radioactive iodine treatment differentiated thyroid cancer nan
no_relation,pegaptanib,diabetic macular edema,20174816,diabetic macular edema phase ii trials intravitreal pegaptanib intravitreal ranibizumab shown shortterm benefit visual acuitynan
no_relation,glucose,inflammation,20181814,aim investigate effects daily coffee consumption biomarkers coffee intake subclinical inflammation oxidative stress glucose lipid metabolismnan
no_relation,cholesterol,inflammation,20181814,coffee consumption appears beneficial effects subclinical inflammation hdl cholesterol whereas changes glucose metabolism found studynan
no_relation,glucose,inflammation,20181814,coffee consumption appears beneficial effects subclinical inflammation hdl cholesterol whereas changes glucose metabolism found studynan
no_relation,platinum,head and neck cancer,20186057,survival gains achieved head neck cancer patients treated multidisciplinary approach including platinum based concurrent chemoradiation substantial increase toxicitynan
no_relation,platinum,toxicity,20186057,survival gains achieved head neck cancer patients treated multidisciplinary approach including platinum based concurrent chemoradiation substantial increase toxicity nan
no_relation,Amifostine,xerostomia,20186057,amifostine acute late xerostomia preventive agent may considered patients undergoing fractionated radiation therapy alonenan
no_relation,sphingosine,growth arrest,20205392,inhibitors display ki values submicromolar range sphingosine kinases cultured vascular smooth muscle cells decrease sp levels initiate growth arrest nan
no_relation,chromium,leukemia,20230219,clonogenic assays measure leukemia stem cell killing detectable chromium release flow cytometric cytotoxicity assaysnan
no_relation,chromium,cytotoxicity,20230219,clonogenic assays measure leukemia stem cell killing detectable chromium release flow cytometric cytotoxicity assaysnan
no_relation,chromium,cytotoxicity,20230219,chromium release assay common method assessing cytotoxicity immune effectors flow cytometry increasingly used relationship either assay clonogenic readouts remains unknownnan
no_relation,cytarabine,Cytotoxicity,20230219,cytotoxicity nk daunorubicin cytarabine kg measured using chromiumrelease assay flow cytometry clonogenic assaysnan
yes_direct,daunorubicin,Cytotoxicity,20230219,cytotoxicity nk daunorubicin cytarabine kg measured using chromiumrelease assay flow cytometry clonogenic assaysnan
no_relation,chromium,Cytotoxicity,20230219,cytotoxicity nk daunorubicin cytarabine kg measured using chromium release assay flow cytometry clonogenic assaysnan
no_relation,chromium,cytotoxicity,20230219,cumulative flow cytotoxicity assay sensitive chromium release assay detecting target cell killingnan
no_relation,anthracycline,acute promyelocytic leukaemia,20230404,favourable outcome patients childhood acute promyelocytic leukaemia treatment reduced cumulative anthracycline dosesnan
yes_direct,anthracyclines,cardiotoxicity,20230404,acute promyelocytic leukaemia apl treatment often includes high cumulative doses anthracyclines cause longterm cardiotoxicity nan
no_relation,anthracyclines,Acute promyelocytic leukaemia/APL,20230404,acute promyelocytic leukaemia apl treatment often includes high cumulative doses anthracyclines cause longterm cardiotoxicitynan
no_relation,anthracycline,APL,20230404,report favourable outcome paediatric apl patients treated according consecutive acute myeloid leukaemiaberlinfrankfurtmuenster amlbfm trials anthracycline cytarabine regimen combination alltransretinoid acid atranan
no_relation,cytarabine,APL,20230404,report favourable outcome paediatric apl patients treated according consecutive acute myeloid leukaemiaberlinfrankfurtmuenster amlbfm trials anthracycline cytarabine regimen combination alltransretinoid acid atranan
no_relation,cytarabine,acute myeloid leukaemia,20230404,report favourable outcome paediatric apl patients treated according consecutive acute myeloid leukaemia berlinfrankfurtmuenster amlbfm trials anthracycline cytarabine regimen combination alltransretinoid acid atranan
no_relation,anthracycline,acute myeloid leukaemia,20230404,report favourable outcome paediatric apl patients treated according consecutive acute myeloid leukaemia berlinfrankfurtmuenster amlbfm trials anthracycline cytarabine regimen combination alltransretinoid acid atranan
no_relation,arsenic trioxide,APL,20230404,salvage treatment effective patients relapsed apl longterm survivors second line combination treatment arsenic trioxide patients stem cell transplantation patientsnan
no_relation,anthracycline,cardiotoxicity,20230404,results demonstrate combined atra lower cumulative anthracycline dose used safely maintain high cure rates promote reduction longterm sequelae cardiotoxicity apl patientsnan
no_relation,anthracycline,APL,20230404,results demonstrate combined atra lower cumulative anthracycline dose used safely maintain high cure rates promote reduction longterm sequelae cardiotoxicity apl patientsnan
no_relation,monostearin,oleic acid/OA,20230883,anionic lipid nanoparticles consisting monostearin ms different content oleic acid oa preparednan
no_relation,oleic acid,oleic acid/OA,20230883,anionic lipid nanoparticles consisting monostearin ms different content oleic acid oa preparednan
no_relation,amiodarone,atrial fibrillation,20384650,shortterm randomized doubleblind parallelgroup study evaluate efficacy safety dronedarone versus amiodarone patients persistent atrial fibrillation dionysos studynan
no_relation,dronedarone,atrial fibrillation,20384650,shortterm randomized doubleblind parallelgroup study evaluate efficacy safety dronedarone versus amiodarone patients persistent atrial fibrillation dionysos studynan
no_relation,amiodarone,atrial fibrillation/AF,20384650,compared efficacy safety amiodarone dronedarone patients persistent atrial fibrillation af nan
no_relation,dronedarone,atrial fibrillation/AF,20384650,compared efficacy safety amiodarone dronedarone patients persistent atrial fibrillation af nan
no_relation,amiodarone,AF,20384650,primary composite endpoint  dronedarone amiodarone respectively months hazard ratio hr  confidence interval ci af recurrence dronedarone compared amiodarone vs nan
no_relation,dronedarone,AF,20384650,primary composite endpoint  dronedarone amiodarone respectively months hazard ratio hr  confidence interval ci af recurrence dronedarone compared amiodarone vs nan
no_relation,amiodarone,AF,20384650,af recurrence successful cardioversion  dronedarone amiodarone respectivelynan
no_relation,dronedarone,AF,20384650,af recurrence successful cardioversion  dronedarone amiodarone respectivelynan
no_relation,amiodarone,AF,20384650,shortterm study dronedarone less effective amiodarone decreasing af recurrence better safety profile specifically regard thyroid neurologic events lack interaction oral anticoagulantsnan
no_relation,dronedarone,AF,20384650,shortterm study dronedarone less effective amiodarone decreasing af recurrence better safety profile specifically regard thyroid neurologic events lack interaction oral anticoagulantsnan
no_relation,heparin,thromboembolic,20400335,retrospectively evaluated effects heparin use thromboembolic bleeding complications implantation heartmate ii left ventricular assist device lvadnan
no_relation,heparin,bleeding,20400335,retrospectively evaluated effects heparin use thromboembolic bleeding complications implantation heartmate ii left ventricular assist device lvadnan
no_relation,aspirin,thrombotic,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,warfarin,bleeding,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,aspirin,bleeding,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,aspirin,thromboembolic,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,warfarin,thrombotic,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,warfarin,thromboembolic,20400335,patients receiving heartmate ii lvad directly transitioned warfarin aspirin therapy without intravenous heparin shortterm increase risk thrombotic thromboembolic events bleeding requiring transfusion significantly reducednan
no_relation,oxygen,loss of consciousness,20415154,tracking course cerebral oxygen saturation pilot performance gravityinduced loss consciousness nan
no_relation,oxygen,loss of consciousness,20415154,aim study track course cerebral tissue oxygen saturation rso pilot performance episode gravityinduced loss consciousness glocnan
no_relation,oral contraceptives,endogenous pain,20419369,influence oral contraceptives endogenous pain control healthy womennan
no_relation,oxygen,diabetes,20427683,hyperbaric oxygen therapy facilitates healing chronic foot ulcers patients diabetes nan
no_relation,oxygen,diabetic foot ulcers,20427683,aim study evaluate effect hyperbaric oxygen therapy hbot management chronic diabetic foot ulcers nan
no_relation,dopamine,tic disorders,20459362,alpha agonists dopamine antagonists constitute mainstay pharmacological agents tic disorders advances neurobiology psychopharmacology discovered newer avenues treatment tic disorders nan
no_relation,glutamate,tic disorders,20459362,apart reviewing evidence based literature recent updates alpha agonists dopamine antagonists treating tic disorders review also includes novel treatment approaches glutamate modulators nicotinic agents antiandrogens botulinum injectionnan
no_relation,dopamine,tic disorders,20459362,apart reviewing evidence based literature recent updates alpha agonists dopamine antagonists treating tic disorders review also includes novel treatment approaches glutamate modulators nicotinic agents antiandrogens botulinum injectionnan
no_relation,dopamine,tic disorders,20459362,addition psychosocial interventions alpha agonists dopamine antagonists constitute mainstay treatment approaches treating tic disorders nan
no_relation,quinolones,Escherichia,20471765,escherichia coli resistance quinolones comprehensive cancer centernan
no_relation,quinolones,cancer,20471765,escherichia coli resistance quinolones comprehensive cancer centernan
no_relation,Meropenem,Escherichia,20471765,part meropenem yearly susceptibility test information collectionusa surveillance programme monitored occurrence quinolone resistance escherichia coli year periodnan
no_relation,Bortezomib,esophageal squamous cell carcinoma,20515944,bortezomib sensitizes human esophageal squamous cell carcinoma cells trailmediated apoptosis via activation extrinsic intrinsic apoptosis pathwaysnan
no_relation,bortezomib/Velcade,ESCC,20515944,investigated therapeutic potential tumor necrosis factorrelated apoptosisinducing ligand trailapol combination proteasome inhibitor bortezomib velcade human escc cell linesnan
no_relation,bortezomib/Velcade,tumor,20515944,investigated therapeutic potential tumor necrosis factorrelated apoptosisinducing ligand trailapol combination proteasome inhibitor bortezomib velcade human escc cell linesnan
no_relation,bortezomib/Velcade,necrosis,20515944,investigated therapeutic potential tumor necrosis factorrelated apoptosisinducing ligand trailapol combination proteasome inhibitor bortezomib velcade human escc cell linesnan
no_relation,Bortezomib,ESCC,20515944,bortezomib enhanced susceptibility trail  escc cell lines tested although showed low sensitivity trail single agentnan
no_relation,bortezomib,death,20515944,however increased cell surface expression death receptors observed bortezomib treatment seem crucial effectnan
no_relation,bortezomib,ESCC,20515944,escc bortezomib treatment resulted efficient recruitment caspase fasassociated death domain deathinducing signaling complexnan
no_relation,bortezomib,death,20515944,escc bortezomib treatment resulted efficient recruitment caspase fasassociated death domain death inducing signaling complexnan
no_relation,bortezomib,ESCC,20515944,escc crucial effect bortezomib treatment seemed increased signaling via intrinsic apoptotic pathway subsequent exposure trailnan
no_relation,bortezomib,ESCC,20515944,thus bortezomib could sensitize escc trail apoptosis multiple molecular mechanisms actionnan
no_relation,bortezomib,ESCC,20515944,therefore combination bortezomib trail might novel therapeutic strategy escc patients fail respond standard chemoradiotherapy predominantly targets mitochondrial apoptotic pathwaynan
no_relation,sodium,cardiac arrhythmias,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,vomiting,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,respiratory distress,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,poisoning,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoning nan
no_relation,sodium,coma,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,poisoning,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoning nan
no_relation,calcium,abdominal pain,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
yes_direct,sodium,abdominal pain,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,cardiac arrhythmias,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,seizures,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,death,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,vomiting,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,coma,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,nausea,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,respiratory distress,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,seizures,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,sodium,death,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,calcium,nausea,20528617,taxine taxine toxic alkaloids taxus block cardiac sodium calcium channels causing nausea vomiting abdominal pain cardiac arrhythmias respiratory distress coma seizures death yew poisoningnan
no_relation,amlodipine,stroke,20532438,reduced blood pressure variability ascotbpla trial favours use amlodipine perindopril combination reduce stroke risknan
no_relation,perindopril,stroke,20532438,reduced blood pressure variability ascotbpla trial favours use amlodipine perindopril combination reduce stroke risknan
no_relation,amlodipine,effective stroke reduction,20532438,lower withinindividual visittovisit variability blood pressure readings amlodipine perindopril combination treatment arm ascot study shown account effective stroke reduction rate combination compared atenolol diureticbased therapies despite overall similar blood pressure loweringnan
no_relation,atenolol,effective stroke reduction,20532438,lower withinindividual visittovisit variability blood pressure readings amlodipineperindopril combination treatment arm ascot study shown account effective stroke reduction rate combination compared atenolol diureticbased therapies despite overall similar blood pressure loweringnan
yes_direct,perindopril,effective stroke reduction,20532438,lower withinindividual visittovisit variability blood pressure readings amlodipine perindopril combination treatment arm ascot study shown account effective stroke reduction rate combination compared atenolol diureticbased therapies despite overall similar blood pressure loweringnan
no_relation,Thymalfasin,hepatitis B,20536462,thymalfasin treatment hepatitis thymalfasin exhibited immunomodulatory direct antiviral mechanism actionnan
no_relation,thymalfasin,chronic hepatitis B,20536462,suggested thymalfasin may efficacy treatment chronic hepatitis pilots studies patients chronic hepatitis treated thymalfasin combination interferon nucleoside analogue showed complete sustained response ratenan
no_relation,nucleoside,chronic hepatitis B,20536462,suggested thymalfasin may efficacy treatment chronic hepatitis pilots studies patients chronic hepatitis treated thymalfasin combination interferon nucleoside analogue showed complete sustained response ratenan
no_relation,ribavirin,chronic hepatitis C,20536462,studies chronic hepatitis patients would indicate thymalfasin combination standard pegylated interferon ribavirin may improve response rate hepatitis virus hcv nave nonresponder patientsnan
no_relation,thymalfasin,chronic hepatitis C,20536462,studies chronic hepatitis patients would indicate thymalfasin combination standard pegylated interferon ribavirin may improve response rate hepatitis virus hcv nave nonresponder patientsnan
no_relation,ribavirin,hepatitis C virus/HCV,20536462,studies chronic hepatitis patients would indicate thymalfasin combination standard pegylated interferon ribavirin may improve response rate hepatitis virus hcv nave nonresponder patientsnan
no_relation,thymalfasin,hepatitis C virus/HCV,20536462,studies chronic hepatitis patients would indicate thymalfasin combination standard pegylated interferon ribavirin may improve response rate hepatitis virus hcv nave nonresponder patientsnan
no_relation,thymalfasin,HCV,20536462,however large phaseiii randomized study conducted europe hcv patients nonresponder peginterferon ribavirin demonstrated thymalfasin improve rate sustained virologic responses patients completed therapy thymalfasin significantly diminished relapse ratenan
no_relation,ribavirin,HCV,20536462,however large phaseiii randomized study conducted europe hcv patients nonresponder peginterferon ribavirin demonstrated thymalfasin improve rate sustained virologic responses patients completed therapy thymalfasin significantly diminished relapse ratenanhcv stands hepatitis virus therefore disease virus
no_relation,thymalfasin,chronic hepatitis B,20536462,conclusion thymalfasin combination standard care may helpful adjuvant treatment patients chronic hepatitisnan
yes_direct,Cisplatin,neurotoxicity,20540689,cisplatin one commonlyused chemotherapeutic drugs efficiently treat malignant tumors clinic however adverse effects cisplatin nephrotoxicity neurotoxicity hemolytic uremic syndrome often observed clinical doses approximately mgm limit broader applicationnan
yes_direct,Cisplatin,hemolytic uremic syndrome,20540689,cisplatin one commonlyused chemotherapeutic drugs efficiently treat malignant tumors clinic however adverse effects cisplatin nephrotoxicity neurotoxicity hemolytic uremic syndrome often observed clinical doses approximately mgm limit broader applicationnan
no_relation,Cisplatin,malignant tumors,20540689,cisplatin one commonlyused chemotherapeutic drugs efficiently treat malignant tumors clinic however adverse effects cisplatin nephrotoxicity neurotoxicity hemolytic uremic syndrome often observed clinical doses approximately mgm limit broader applicationnan
no_relation,cisplatin,hepatoma,20540689,paper reviews current understanding cisplatin induced erythrocyte injury presents latest finding low dose cisplatin mgmday days could induce specific hemosiderin deposition spleen normal hepatoma inoculated balbc micenan
no_relation,cisplatin,ascites,20540689,dose cisplatin significantly inhibited hinduced acute ascites developmentnan
no_relation,cisplatin,tumor,20540689,significant toxicity induced dose cisplatin tissues except hemosiderin accumulation spleen normal tumor bearing micenan
no_relation,cisplatin,toxicity,20540689,significant toxicity induced dose cisplatin tissues except hemosiderin accumulation spleen normal tumorbearing micenan
yes_direct,cisplatin,splenic,20540689,increased splenic iron content erythrocyte injury observed treatment low dose cisplatin nan
no_relation,iron,splenic,20540689,increased splenic iron content erythrocyte injury observed treatment low dose cisplatinnan
no_relation,Hepcidin,splenic,20540689,hepcidin inhibits function fpn ironexporter leading iron overloaded inside ferritins splenic cells stained abnormal hemosiderin accumulationnan
no_relation,iron,splenic,20540689,hepcidin inhibits function fpn iron exporter leading iron overloaded inside ferritins splenic cells stained abnormal hemosiderin accumulationnan
no_relation,iron,toxicity,20540689,results demonstrate cisplatincaused hemosiderin deposition spleen provides valuable clue understanding molecular basis toxicity cisplatin hemosiderin accumulation iron metabolism vivonan
yes_direct,cisplatin,toxicity,20540689,results demonstrate cisplatin caused hemosiderin deposition spleen provides valuable clue understanding molecular basis toxicity cisplatin hemosiderin accumulation iron metabolism vivonan
yes_direct,copper,cytotoxicity,20547054,realtime monitoring copper ionsinduced cytotoxicity eis cell chipsnan
no_relation,pyruvate,primary biliary cirrhosis/PBC,20568301,understanding primary biliary cirrhosis pbc significantly enhanced rigorous dissection multilineage cell response immunodominant mitochondrial autoantigen component pyruvate dehydrogenase complex pdcenan
no_relation,ursodiol,PBC,20568301,results provide mechanism biliary specificity pbc recurrence disease liver transplantation success ursodiol treatmentnan
no_relation,carbon,OA,20578474,analysis fscksadeltaoctfomk oa ratios revealed significant role adsorption absorption unusually high elemental carbon fractions ie low ocec ratio fine particles collected waste incinerators abnormally high organic carbon fractions ie high ocec ratio observed fine particles urban residential zone respectivelynan
no_relation,Carvedilol,Alzheimer's disease,20579773,carvedilol potential novel agent treatment alzheimers disease nan
no_relation,carvedilol,AD mouse,20579773,present evidence chronic oral administration carvedilol nonselective adrenergic receptor blocker significantly attenuates brain oligomeric amyloid content cognitive deterioration independent ad mouse modelsnan
no_relation,carvedilol,cognitive deterioration,20579773,present evidence chronic oral administration carvedilol nonselective adrenergic receptor blocker significantly attenuates brain oligomeric amyloid content cognitive deterioration independent ad mouse modelsnan
no_relation,carvedilol,AD,20579773,found carvedilol treatment significantly improved neuronal transmission improvement associated maintenance number less stable learning thin spines brains ad micenan
no_relation,carvedilol,AD,20579773,novel observation carvedilol interferes neuropathologic biochemical electrophysiological mechanisms underlying cognitive deterioration ad supports potential development carvedilol treatment ad nan
no_relation,carvedilol,cognitive deterioration,20579773,novel observation carvedilol interferes neuropathologic biochemical electrophysiological mechanisms underlying cognitive deterioration ad supports potential development carvedilol treatment adnanused treatment
no_relation,fluoroquinolone,Mycoplasma,20580532,emergence clinical strains mycoplasma genitalium harbouring alterations parc associated fluoroquinolone resistancenan
no_relation,fluoroquinolone,Mycoplasma,20580532,alterations ser asn asp tyr asp val parc found  specimens analogous commonly observed fluoroquinolone resistant mutants mycoplasma ureaplasma sppnan
no_relation,steroid,acute Q fever granulomatous hepatitis,20594295,circulating cytokines procalcitonin acute fever granulomatous hepatitis poor response antibiotic shortcourse steroid therapy case reportnan
no_relation,prednisolone,acute Q fever granulomatous hepatitis,20594295,report rare case acute fever granulomatous hepatitis remained pyrexia despite several antibiotic therapy day course oral prednisolone nan
no_relation,prednisolone,pyrexia,20594295,report rare case acute fever granulomatous hepatitis remained pyrexia despite several antibiotic therapy day course oral prednisolone nan
no_relation,nitrous oxide,pain,20595705,aims project longitudinally follow plasma levels betaendorphin pregnancy women healthy pregnancy investigate whether plasma levels betaendorphin late pregnancy associated need additional pain medication beyond nitrous oxide labornan
no_relation,nitrous oxide,pain,20595705,low levels betaendorphin end pregnancy associated need additional pain medication beyond nitrous oxide labor although causal relationship unclearnan
no_relation,aspirin,asthma,20597903,association slca variants aspirin intolerant asthma korean populationnan
yes_direct,Aspirin,asthma,20597903,aspirin intolerant asthma aia occurs asthma exacerbation exposure aspirin nan
no_relation,GABA,asthma,20597903,critical role solute carrier family neurotransmitter transporter betaine gaba member slca gene gabaergic transmission associated mucus production asthma makes candidate gene aia association studynan
no_relation,aspirin,asthma,20597903,eight single nucleotide polymorphisms snps slca genotyped aspirin intolerant asthma aia aspirin tolerant asthma ata patients korean ethnicitynan
no_relation,aspirin,aspirin-tolerant asthma/ATA,20597903,eight single nucleotide polymorphisms snps slca genotyped aspirin intolerant asthma aia aspirin tolerant asthma ata patients korean ethnicitynan
no_relation,azithromycin,obstructive pulmonary diseases,20604763,addition antibiotic properties azithromycin immunemodulating effects used reason management cystic fibrosis chronic obstructive pulmonary diseases nan
no_relation,azithromycin,fibrosis,20604763,addition antibiotic properties azithromycin immunemodulating effects used reason management cystic fibrosis chronic obstructive pulmonary diseasesnan
no_relation,calcium,chronic periodontitis,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,Azithromycin,gingival overgrowth,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,Azithromycin,diabetic,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,calcium,diabetic,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,calcium,gingival overgrowth,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,Azithromycin,chronic periodontitis,20604763,azithromycin together monthly subgingival debridement treatment case severe chronic periodontitis poorly controlled diabetic complicated gingival overgrowth related medication calcium channel blockernan
no_relation,(-)-epicatechin,lung cancer,20606042,new role (-)-epicatechin enhancing induction growth inhibition apoptosis human lung cancer cells curcuminnan
no_relation,curcumin,lung cancer,20606042,new role (-)-epicatechin enhancing induction growth inhibition apoptosis human lung cancer cells curcumin nan
yes_direct,Curcumin,cancer-preventive activity,20606042,curcumin phenolic compound isolated plant curcuma longa linn ingested every day indian subcontinent well reported possess cancerpreventive activity nan
no_relation,curcumin,cancer,20606042,achieve effective cancer prevention curcumin need find new method enhance effects curcumin dietnan
no_relation,catechin/(-)-epicatechin,cancer-preventive activity,20606042,based evidence (-)-epicatechin ec inert catechin enhances cancerpreventive activity green tea catechins studied enhancing effects ec inductions growth inhibition apoptosis human lung cancer cell lines pc curcuminnan
no_relation,catechin/(-)-epicatechin,lung cancer,20606042,based evidence (-)-epicatechin ec inert catechin enhances cancerpreventive activity green tea catechins studied enhancing effects ec inductions growth inhibition apoptosis human lung cancer cell lines pc curcuminnan
no_relation,curcumin,cancer-preventive activity,20606042,based evidence (-)-epicatechin ec inert catechin enhances cancerpreventive activity green tea catechins studied enhancing effects ec inductions growth inhibition apoptosis human lung cancer cell lines pc curcumin nancancerpreventive activity disease
no_relation,curcumin,lung cancer,20606042,based evidence (-)-epicatechin ec inert catechin enhances cancerpreventive activity green tea catechins studied enhancing effects ec inductions growth inhibition apoptosis human lung cancer cell lines pc curcumin nan
yes_direct,curcumin,cancer-preventive activity,20606042,report first report enhancing effects ec curcumin data suggest ec plays significant role enhancement cancerpreventive activity curcumin dietnan
yes_direct,vancomycin,Corynebacterium falsenii bacteremia,20610679,corynebacterium falsenii bacteremia occurring infant vancomycin therapynan
yes_direct,vancomycin,Corynebacterium falsenii bacteremia,20610679,give first detailed description clinically significant corynebacterium falsenii bacteremia occurring infant vancomycin therapynan
no_relation,amlodipine,hypertension,20626210,efficacy fixeddose combination therapy treatment patients hypertension focus amlodipine valsartannan
no_relation,valsartan,hypertension,20626210,efficacy fixeddose combination therapy treatment patients hypertension focus amlodipine valsartan nan
no_relation,aldosterone,renal and cardiovascular morbidity,20626210,combination therapy calcium channel antagonist calcium channel blocker ccb inhibitor reninangiotensin aldosterone system raas rational approach achieve bp goals provide protection renal cardiovascular morbidity mortalitynan
no_relation,calcium,renal and cardiovascular morbidity,20626210,combination therapy calcium channel antagonist calcium channel blocker ccb inhibitor reninangiotensinaldosterone system raas rational approach achieve bp goals provide protection renal cardiovascular morbidity mortalitynan
no_relation,amlodipine,hypertensive,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,amlodipine,stroke,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,valsartan,cardiovascular events,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,valsartan,stroke,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,amlodipine,cardiovascular events,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,valsartan,hypertensive,20626210,efficacy ccb amlodipine arb valsartan lowering bp protecting cardiovascular events stroke across range hypertensive patient populations established many yearsnan
no_relation,amlodipine,hypertension,20626210,oncedaily amlodipine valsartan rational convenient treatment option effective management patients hypertension improving adherence antihypertensive medication protecting cardiovascular renal morbidity mortalitynan
no_relation,valsartan,hypertension,20626210,oncedaily amlodipine valsartan rational convenient treatment option effective management patients hypertension improving adherence antihypertensive medication protecting cardiovascular renal morbidity mortalitynanused treatment
yes_direct,estradiol,inflammation,20632462,creactive protein crp marker generalized inflammation raised oral estradiol therapy etnan
no_relation,Estrogen,Atherosclerosis,20632462,observational study includes postmenopausal women participating estrogen prevention atherosclerosis trialnan
no_relation,porphyrins,PDT/photodynamic therapy,20633796,lightbased treatments photodynamic therapy pdt using topical precursors porphyrins offlabel alternative treatments acne vulgaris advantages disadvantagesnan
no_relation,porphyrins,acne vulgaris,20633796,lightbased treatments photodynamic therapy pdt using topical precursors porphyrins offlabel alternative treatments acne vulgaris advantages disadvantagesnan
no_relation,iron,iron deficiency anemia,20651460,investigated efficacy coadministration dfaiii waterinsoluble iron treatment iron deficiency anemia vietnamese womennan
no_relation,permethrin,Dermanyssus gallinae infestation,20687864,dermanyssus gallinae infestation unusual cause scalp pruritus treated permethrin shampoonan
no_relation,carbidopa,Parkinson's disease,20700524,combination levodopa ldopa carbidopa commonlyused treatment symptom management parkinson's disease nan
no_relation,levodopa/L-DOPA,Parkinson's disease,20700524,combination levodopa l-dopa carbidopa commonlyused treatment symptom management parkinson's disease nan
no_relation,carbidopa,Parkinson's,20700524,observations suggest oral administration egcg may significant beneficial effects parkinson's patients treated l-dopa carbidopa exerting modest inhibition l-dopa methylation plus strong neuroprotection oxidative damage degenerationnan
no_relation,EGCG,Parkinson's,20700524,observations suggest oral administration egcg may significant beneficial effects parkinson's patients treated l-dopa carbidopa exerting modest inhibition l-dopa methylation plus strong neuroprotection oxidative damage degenerationnan
no_relation,L-DOPA,Parkinson's,20700524,observations suggest oral administration egcg may significant beneficial effects parkinson's patients treated l-dopa carbidopa exerting modest inhibition l-dopa methylation plus strong neuroprotection oxidative damage degenerationnan
no_relation,nucleoside,HIV-infected,20707732,haartrelated longterm toxicities many ascribed mitochondrial mt toxicity nucleoside analogues increasingly reported hiv-infected childrennan
no_relation,nucleoside,toxicity/toxicities,20707732,haartrelated longterm toxicities many ascribed mitochondrial mt toxicity nucleoside analogues increasingly reported hiv-infected childrennan
no_relation,metformin,diabetic,20713345,week openlabel parallelgroup trial type diabetic patients maintaining glycemic control basal insulin glargine neutral protamine hagedorn oral antidiabetic drugs randomly assigned twicedaily biasp  metformin oncedaily glargine metformin secretagogues secretagogues discontinued biasp armnan
yes_direct,tremolite,mesothelioma,20721899,case occupational peritoneal mesothelioma exposure tremolite free chrysotile quebec canada black swan casenan
yes_direct,Tremolite,mesothelioma,20721899,tremolite contamination proposed cause mesothelioma workers exposed commercial chrysotilenan
no_relation,tremolite,mesothelioma,20721899,chrysotile without tremolite cause peritoneal mesothelioma nan
yes_direct,ADP,platelet aggregation,20739614,crosssectional protocol platelet aggregation response adp epinephrine von willebrand antigen vwfag collagenbinding capacity vwfcb obtainednan
no_relation,epinephrine,platelet aggregation,20739614,crosssectional protocol platelet aggregation response adp epinephrine von willebrand antigen vwfag collagenbinding capacity vwfcb obtainednan
no_relation,taurine,melanoma,20804622,effect combination taurine azelaic acid antimelanogenesis murine melanoma cellsnan
no_relation,azelaic acid,melanoma,20804622,effect combination taurine azelaic acid antimelanogenesis murine melanoma cellsnan
no_relation,taurine/Tau,melanoma,20804622,study investigated antimelanogenic activity combination az taurine tau bf mouse melanoma cellsnan
no_relation,Tau,melanoma,20804622,az combined tau inhibited melanin production tyrosinase activity bf melanoma cells without significant cytotoxicitynan
no_relation,Tau,cytotoxicity,20804622,az combined tau inhibited melanin production tyrosinase activity bf melanoma cells without significant cytotoxicity nan
no_relation,flavonoids,diabetes mellitus,20806262,artificial neural networkbased drug design diabetes mellitus using flavonoids nan
no_relation,glucose,Diabetes mellitus,20806262,diabetes mellitus chronic metabolic disease involving failure regulate glucose blood levels body linked numerous detrimental complicationsnan
no_relation,estrogen,BCa,20809980,monolayer cell culture models pwild type estrogen receptor erdependent mcf bca cells pmutant erprogesterone receptor pr herregular triplenegative mdamb bca exposed pgg comprehensive investigation cellular consequences molecular targetsmediatorsnan
no_relation,progesterone,BCa,20809980,monolayer cell culture models pwild type estrogen receptor erdependent mcf bca cells pmutant er progesterone receptor pr herregular triplenegative mdamb bca exposed pgg comprehensive investigation cellular consequences molecular targetsmediatorsnan
no_relation,morphine,analgesia,20827460,adequate intraoperative morphine use minimize postoperative pain subsequent need rescue analgesia nan
no_relation,morphine,pain,20827460,adequate intraoperative morphine use minimize postoperative pain subsequent need rescue analgesianan
no_relation,olmesartan,MBPS,20828223,amlodipine olmesartan combination therapy bedtime administration reduced better mbps correcting nocturnal bp fall improved urinary albumin excretionnan
no_relation,olmesartan,MBPS,20828223,amlodipine olmesartan combination therapy bedtime administration reduced better mbps correcting nocturnal bp fall improved urinary albumin excretionnan
no_relation,amlodipine,MBPS,20828223,amlodipine olmesartan combination therapy bedtime administration reduced better mbps correcting nocturnal bp fall improved urinary albumin excretionnan
no_relation,amlodipine,MBPS,20828223,amlodipine olmesartan combination therapy bedtime administration reduced better mbps correcting nocturnal bp fall improved urinary albumin excretionnan
no_relation,Aldosterone,primary aldosteronism,20837883,aldosterone synthase inhibition lci proofofconcept study patients primary aldosteronism nan
no_relation,aldosterone,primary aldosteronism,20837883,report first administration orally active aldosterone synthase inhibitor lci patients primary aldosteronism nan
no_relation,aldosterone,primary aldosteronism,20837883,conclusion administration lci mg bid effectively safely inhibits aldosterone synthase patients primary aldosteronism nan
no_relation,Serotonin,ventricular tachycardia,20838725,serotonin catecholaminergic polymorphic ventricular tachycardia possible therapeutic role ssrisnan
no_relation,serotonin,ventricular tachycardia,20838725,however selective serotonin reuptake inhibitor ssri added therapeutic regimen episodes ventricular tachycardia occurred following two yearsnan
yes_direct,acrylamide,Toxicity,20843409,toxicity acrylamide evaluation exposure baby foodsnan
yes_direct,acrylamide,toxicity,20843409,present review focuses several adverse health effects acrylamide including mutagenicity genotoxicity carcinogenicity neurotoxicity reproductive toxicity possible outcomes childhood exposure baby foods infant formulasnan
yes_direct,acrylamide,neurotoxicity,20843409,present review focuses several adverse health effects acrylamide including mutagenicity genotoxicity carcinogenicity neurotoxicity reproductive toxicity possible outcomes childhood exposure baby foods infant formulasnan
no_relation,fluoride,generalized aggressive periodontitis/G-AgP,20849433,compare clinical microbiological effects ultrasonic mechanical instrumentation umi associated homecare use amine fluoridestannous fluoride amfsnf containing mouthrinse toothpaste smoker nonsmoker patients affected generalized aggressive periodontitis gagp recall session supportive periodontal therapy sptnan
no_relation,chloroquine,cystic fibrosis,20863769,treatment cystic fibrosis associated cutaneous vasculitis chloroquine nan
no_relation,chloroquine,cutaneous vasculitis,20863769,treatment cystic fibrosis associated cutaneous vasculitis chloroquine nan
no_relation,chloroquine,cutaneous vasculitis,20863769,describe case steroid resistant cutaneous vasculitis successfully treated chloroquine addition corticosteroids subsequent relapse chloroquine alonenan
no_relation,corticosteroids,cutaneous vasculitis,20863769,describe case steroid resistant cutaneous vasculitis successfully treated chloroquine addition corticosteroids subsequent relapse chloroquine alonenan
no_relation,steroid,cutaneous vasculitis,20863769,describe case steroid resistant cutaneous vasculitis successfully treated chloroquine addition corticosteroids subsequent relapse chloroquine alonenan
no_relation,dexamethasone,necrosis,20884859,stimulation primary human corneal epithelial cells keratocytes retinal endothelial cells  ngml interleukin il resulted significant increase numerous inflammatory cytokines including il il tumor necrosis factor tnf dexamethasone able significantly inhibit effectsnan
no_relation,dexamethasone,tumor,20884859,stimulation primary human corneal epithelial cells keratocytes retinal endothelial cells  ngml interleukin il resulted significant increase numerous inflammatory cytokines including il il tumor necrosis factor tnf dexamethasone able significantly inhibit effectsnan
no_relation,Lanthanum carbonate,CKD/chronic kidney disease,20921291,lanthanum carbonate sevelamer carbonate noncalciumbased phosphate binders used manage hyperphosphataemia patients chronic kidney disease ckd nan
no_relation,calcium,CKD/chronic kidney disease,20921291,lanthanum carbonate sevelamer carbonate non calcium based phosphate binders used manage hyperphosphataemia patients chronic kidney disease ckd nan
no_relation,phosphate,CKD/chronic kidney disease,20921291,lanthanum carbonate sevelamer carbonate noncalciumbased phosphate binders used manage hyperphosphataemia patients chronic kidney disease ckd nanphosphate binders phosphate
no_relation,calcitriol,CKD,20921291,patients ckd may require intravenous oral active vitamin investigated effects lanthanum carbonate sevelamer carbonate bioavailability oral calcitriol nan
no_relation,sevelamer carbonate,CKD,20921291,patients ckd may require intravenous oral active vitamin investigated effects lanthanum carbonate sevelamer carbonate bioavailability oral calcitriolnan
no_relation,vitamin D,CKD,20921291,patients ckd may require intravenous oral active vitamin investigated effects lanthanum carbonate sevelamer carbonate bioavailability oral calcitriolnan
no_relation,lanthanum carbonate,CKD,20921291,patients ckd may require intravenous oral active vitamin investigated effects lanthanum carbonate sevelamer carbonate bioavailability oral calcitriolnan
no_relation,phosphate,CKD,20921291,considered treating ckd patients require phosphate binders oral vitaminnan
no_relation,vitamin D,CKD,20921291,considered treating ckd patients require phosphate binders oral vitamin nan
no_relation,AZD6244/selumetinib,colorectal cancer,20923857,identification predictive markers response mek inhibitor selumetinib azd6244 krasmutated colorectal cancer nan
no_relation,AZD6244,CRC,20923857,aim study develop characterize predictive biomarkers response mek inhibitor azd6244 crc order maximize clinical utility agentnan
no_relation,AZD6244,CRC,20923857,twentyseven human crc cell lines exposed azd6244 classified according ic value sensitive  moll resistant  mollnan
no_relation,AZD6244,CRC,20923857,testing done cell line xenografts kras mutant crc human explants models develop predictive genomic classifier azd6244 nan
no_relation,AZD6244,CRC,20923857,baseline gene array data crc cell lines xenografts used develop ktop scoring pair ktsp classifier predicted accuracy test set patientderived kras mutant crc explants would respond azd6244 providing basis patientselective clinical trialnan
no_relation,AZD6244,CRC,20923857,results also indicate resistance azd6244 may mediated part upregulation wnt pathway suggesting potential rational combination partners azd6244 crc nan
no_relation,AZA/Azathioprine,rheumatologic disorders,20953224,azathioprine aza commonly used drug management various rheumatologic disorders nan
yes_direct,AZA,toxicity,20953224,determine current local practice aza dosing identify aza related toxicity compare local practice british society rheumatology bsr recommendationsnan
no_relation,AZA,toxicities,20953224,data collected patients demographics treatment history including aza dosing regimen tpmt testing drugrelated toxicities managementnan
yes_direct,AZA,toxicity,20953224,average initial dose aza prescribed mg developed aza related toxicity nan
yes_direct,AZA,toxicity,20953224,significant proportion studied cohort rheumatologic patients aza drugrelated toxicity resulting discontinuation aza nan
no_relation,vincristine,diffuse large B-cell non-Hodgkin lymphoma,20960528,activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma nan
no_relation,prednisone,diffuse large B-cell non-Hodgkin lymphoma,20960528,activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma nan
no_relation,doxorubicin,diffuse large B-cell non-Hodgkin lymphoma,20960528,activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma nan
no_relation,cyclophosphamide,diffuse large B-cell non-Hodgkin lymphoma,20960528,activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma nan
no_relation,vincristine,diffuse large B-cell non-Hodgkin lymphoma/DLBCL,20960528,study designed assess activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab dapochr elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma dlbcl nan
no_relation,prednisone,diffuse large B-cell non-Hodgkin lymphoma/DLBCL,20960528,study designed assess activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab dapochr elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma dlbcl nan
no_relation,doxorubicin,diffuse large B-cell non-Hodgkin lymphoma/DLBCL,20960528,study designed assess activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab dapochr elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma dlbcl nan
no_relation,cyclophosphamide,diffuse large B-cell non-Hodgkin lymphoma/DLBCL,20960528,study designed assess activity safety doseadjusted infusional cyclophosphamide doxorubicin vincristine prednisone chemotherapy rituximab dapochr elderly patients poorprognostic untreated diffuse large bcell nonhodgkin lymphoma dlbcl nan
no_relation,latrepirdine,allergy,21031168,dimebon latrepirdine developed used russia overthecounter oral antihistamine allergy treatmentnan
no_relation,arsenic trioxide,hepatoblastoma,21033247,study effect chemotherapeutics cisplatin doxorubicin cytosin arabinoside differentiating agent cisretinoic acid apoptotic agents azadeoxycytidine arsenic trioxide notch expression hepatoblastoma evaluatednan
no_relation,cisplatin,hepatoblastoma,21033247,study effect chemotherapeutics cisplatin doxorubicin cytosin arabinoside differentiating agent cisretinoic acid apoptotic agents azadeoxycytidine arsenic trioxide notch expression hepatoblastoma evaluatednan
no_relation,doxorubicin,hepatoblastoma,21033247,study effect chemotherapeutics cisplatin doxorubicin cytosin arabinoside differentiating agent cisretinoic acid apoptotic agents azadeoxycytidine arsenic trioxide notch expression hepatoblastoma evaluatednan
no_relation,13 cis-retinoic acid,hepatoblastoma,21033247,study effect chemotherapeutics cisplatin doxorubicin cytosin arabinoside differentiating agent  cisretinoic acid apoptotic agents azadeoxycytidine arsenic trioxide notch expression hepatoblastoma evaluatednan
no_relation,5-aza-2'-deoxycytidine,hepatoblastoma,21033247,study effect chemotherapeutics cisplatin doxorubicin cytosin arabinoside differentiating agent cisretinoic acid apoptotic agents 5-aza-2'-deoxycytidine arsenic trioxide notch expression hepatoblastoma evaluatednan
no_relation,retinoic acid,hepatoblastoma,21033247,use retinoic acid control minimal residual disease hepatoblastoma discussednan
no_relation,Cisplatin,hepatoblastoma,21033247,cisplatin main chemotherapeutic agent treatment shown change gene expression levels notch signalling pathway hepatoblastoma nan
no_relation,cortisol,adrenal insufficiency,21036888,comparison cortisol responses testing two doses acth patients suspected adrenal insufficiency nan
no_relation,cortisol,adrenal insufficiency,21036888,compare cortisol response acth test large study patients suspected adrenal insufficiency nan
no_relation,cortisol,adrenal insufficiency,21036888,study shows acth tests comparable cortisol responses patients suspected adrenal insufficiency nan
no_relation,carboplatin,neuroblastoma,21049517,highdose carboplatin irinotecantemozolomide treatment option neuroblastoma resistant topotecannan
no_relation,irinotecan,neuroblastoma,21049517,highdose carboplatin irinotecan temozolomide treatment option neuroblastoma resistant topotecannan
no_relation,temozolomide,neuroblastoma,21049517,highdose carboplatinirinotecan temozolomide treatment option neuroblastoma resistant topotecannan
no_relation,corticosteroids,allergic rhinitis,21050027,effect intranasal corticosteroids asthma control quality life allergic rhinitis mild asthmanan
no_relation,corticosteroids,mild asthma/asthma,21050027,effect intranasal corticosteroids asthma control quality life allergic rhinitis mild asthma nan
no_relation,budesonide,mild asthma,21050027,allergic rhinitics mild asthma randomized day treatment period either nasal budesonide  puff per nostril twice day placebonan
no_relation,diltiazem,cardiovascular disease,21052022,diuretics blockers inhibit renal sodium reabsorption renin release respectively hypothesized blocker diureticinduced blood pressure reduction prevention cardiovascular disease would greater patients highest enac expression rs gallele whereas would genetically mediated differences treatment efficacy among patients treated vasodilator diltiazem nan
no_relation,sodium,cardiovascular disease,21052022,diuretics blockers inhibit renal sodium reabsorption renin release respectively hypothesized blocker diureticinduced blood pressure reduction prevention cardiovascular disease would greater patients highest enac expression rs gallele whereas would genetically mediated differences treatment efficacy among patients treated vasodilator diltiazemnan
no_relation,diltiazem,hypertensive,21052022,related rs status month blood pressure reduction risk cardiovascular events hypertensive patients dbp  mmhg nordic diltiazem study nordil randomized either blocker andor diureticbased treatment diltiazem based treatmentnan
no_relation,diltiazem,cardiovascular disease,21052022,functional neddl rs polymorphism influences efficacy blocker andor diureticbased antihypertensive treatment terms blood pressure reduction cardiovascular disease protection whereas diltiazem based antihypertensive treatment efficacy influenced neddl polymorphismnan
no_relation,silibinin,AML,21084834,inhibition cottlp oncogene aml cells reduces erk activation upregulates pkip concomitant enhancement differentiation cell cycle arrest induced silibinin dihydroxyvitaminnan
no_relation,"1,25-dihydroxyvitamin D(3)",AML,21084834,inhibition cottlp oncogene aml cells reduces erk activation upregulates pkip concomitant enhancement differentiation cell cycle arrest induced silibinin dihydroxyvitamin nan
no_relation,"1,25-dihydroxyvitamin D3",leukemia,21084834,investigated preclinical studies potential anti leukemia use plantderived polyphenol silibinin sil combination dihydroxyvitaminnan
no_relation,steroid,chronic function-limiting mid back or upper back pain,21102966,determine clinical effectiveness therapeutic local anesthetic medial branch blocks without steroid managing chronic functionlimiting mid back upper back pain facet joint originnan
no_relation,steroid,chronic function-limiting mid back or upper back pain,21102966,therapeutic thoracic medial branch blocks without steroid may provide management option chronic functionlimiting mid back upper back pain facet joint originnan
no_relation,ziprasidone,multiple neurocognitive domains,21107309,robust findings significant across multiple neurocognitive domains adjacent snps showing evidence association rs ehf gene pvalue  qvalue mediating effects ziprasidone vigilance rs slca pvalue  qvalue mediating effects olanzapine processing speed rs ila pvalue  qvalue mediating effects olanzapine working memorynan
no_relation,olanzapine,multiple neurocognitive domains,21107309,robust findings significant across multiple neurocognitive domains adjacent snps showing evidence association rs ehf gene pvalue  qvalue mediating effects ziprasidone vigilance rs slca pvalue  qvalue mediating effects olanzapine processing speed rs ila pvalue  qvalue mediating effects olanzapine working memorynan
no_relation,telmisartan,hypertension,21130741,recent metaanalysis demonstrated possibility telmisartan strongest arb reduction bp patients essential hypertension nan
no_relation,telmisartan,cardiovascular disease,21130741,present study suggests due delta lock structure telmisartan may superior arbs halting cardiovascular disease patients hypertensionnan
no_relation,telmisartan,hypertension,21130741,present study suggests due delta lock structure telmisartan may superior arbs halting cardiovascular disease patients hypertension nan
yes_direct,aspirin,small bowel injury,21133822,combination lowdose aspirin thienopyridine exacerbates small bowel injury nan
yes_direct,thienopyridine,small bowel injury,21133822,combination lowdose aspirin thienopyridine exacerbates small bowel injury nan
yes_direct,aspirin,small bowel injury,21133822,recent studies small bowel injury enteropathy associated lowdose aspirin increasingly recognizednan
yes_direct,aspirin,enteropathy,21133822,recent studies small bowel injury enteropathy associated lowdose aspirin increasingly recognizednan
no_relation,aspirin,small bowel injury,21133822,aim study evaluate small bowel injury using video capsule endoscopy vce obscure gastrointestinal bleeding ogib patients taking lowdose aspirin including antithromboticsnan
no_relation,aspirin,OGIB/obscure gastrointestinal bleeding,21133822,aim study evaluate small bowel injury using video capsule endoscopy vce obscure gastrointestinal bleeding ogib patients taking lowdose aspirin including antithromboticsnan
no_relation,warfarin,redness lesions,21133822,median number redness lesions combined group highest among four groups significantly higher warfarin groupnan
yes_direct,aspirin,redness or small erosions,21133822,lesions redness small erosions aspirin combined groups tended exist proximal part small bowelnan
yes_direct,aspirin,small bowel injury,21133822,combination lowdose aspirin therapy thienopyridine may exacerbate small bowel injury preventive strategies establishednan
yes_direct,thienopyridine,small bowel injury,21133822,combination lowdose aspirin therapy thienopyridine may exacerbate small bowel injury preventive strategies establishednan
yes_direct,S-adenosylmethionine,fibrosarcoma,21134486,chaotic neovascularization induced aggressive fibrosarcoma cells overexpressing s-adenosylmethionine decarboxylasenan
no_relation,silver acetate,cytotoxicity,21135954,novel benzylsubstituted nheterocyclic carbene silver acetate complexes synthesis cytotoxicity antibacterial studiesnan
no_relation,silver,Escherichia,21135954,preliminary vitro antibacterial activity nhcprecursors nhc silver complexes investigated grampositive bacteria staphylococcus aureus gramnegative bacteria escherichia coli using qualitative kirbybauer diskdiffusion methodnan
no_relation,silver,renal-cancer,21135954,six nhc silver complexes tested cytotoxicity mtt based vitro tests human renal-cancer cell line caki order determine ic valuesnan
no_relation,silver,cytotoxicity,21135954,six nhc silver complexes tested cytotoxicity mtt based vitro tests human renal-cancer cell line caki order determine ic valuesnan
no_relation,cisplatin,cytotoxicity,21135954,values represent improved cytotoxicity caki notably three times cytotoxic cisplatin ic value nan
no_relation,vitamin A,A deficiencies,21147712,iron vitamin deficiencies impact anemia immune systemnan
no_relation,Iron,anemia,21147712,iron vitamin deficiencies impact anemia immune systemnan
no_relation,vitamin A,anemia,21147712,iron vitamin deficiencies impact anemia immune systemnan
no_relation,Iron,A deficiencies,21147712,iron vitamin deficiencies impact anemia immune systemnan
no_relation,Trichostatin A/TSA,inflammation,21203344,examine effects histone deacetylase inhibitor trichostatin tsa behavior macrophages subconjunctival fibroblasts vitro ocular surface inflammation scarring vivo using alkali burn wound healing modelnan
no_relation,TSA,inflammation,21203344,effects tsa expression inflammation related growth factors collagen examined real-time rtpcr immunoassay mouse macrophages human subconjunctival fibroblastsnan
no_relation,TSA,cornea,21203344,histology real-time rtpcr investigations evaluated effects tsa healing process cornea nan
no_relation,TSA,cornea,21203344,realtime pcr immunocytochemistry studies showed systemic administration tsa suppressed inflammation fibrotic response stroma accelerated epithelial healing alkaliburned mouse cornea nan
no_relation,TSA,inflammation,21203344,realtime pcr immunocytochemistry studies showed systemic administration tsa suppressed inflammation fibrotic response stroma accelerated epithelial healing alkaliburned mouse corneanan
no_relation,tyrosine,cancer,21209368,studying nonphosphorylatable point mutants suggests sites coordinately upregulate fak tyrosine phosphorylation conventionally initiates fak activation mediate pressureinduced cancer cell adhesionnan
no_relation,amiodarone,atrial fibrillation,21235460,vernakalant demonstrated effective placebo amiodarone rapid conversion atrial fibrillation without significant adverse eventsnan
no_relation,8-quinolinol,cytotoxicity,21258737,lanthanide complexes exhibited significantly enhanced cytotoxicity vs free substituted 8-quinolinol nan
no_relation,linezolid,cystic fibrosis,21263048,emergence linezolid resistant staphylococcus aureus prolonged treatment cystic fibrosis patients cleveland ohionan
no_relation,LZD,CF,21263048,analysis clinical data showed cf patients lrsa received lzd courses versus  longer duration versus days lzd versus daysyearnan
no_relation,LZD,CF,21263048,emergence lrsa serious concern cf patients undergo prolonged courses lzd therapynan
yes_direct,corticosteroids,Allergic contact dermatitis,21265627,allergic contact dermatitis following ocular use corticosteroids nan
no_relation,tyrosine,systemic mastocytosis,21273305,activating mutations codon tyrosine kinase receptor kit found majority patients systemic mastocytosis nan
no_relation,allylpyrocatechol,Rheumatoid Arthritis,21284489,attenuation oxidative stress allylpyrocatechol synovial cellular infiltrate patients rheumatoid arthritis nan
no_relation,Allylpyrocatechol,Rheumatoid arthritis,21284489,allylpyrocatechol phytoconstituent piper betle leaves potent antiinflammatory activity study evaluated antioxidant effect synovial infiltrate patients rheumatoid arthritis nan
no_relation,allylpyrocatechol,Rheumatoid Arthritis,21284489,taken together ex vivo study established allylpyrocatechol potent scavenging activity could considered addon therapy treatment inflammationassociated disorders like rheumatoid arthritis nan
no_relation,allylpyrocatechol,inflammation-associated disorders,21284489,taken together ex vivo study established allylpyrocatechol potent scavenging activity could considered addon therapy treatment inflammationassociated disorders like rheumatoid arthritisnan
no_relation,reboxetine,attention-deficit/hyperactivity disorder,21312292,efficacy reboxetine adults attentiondeficithyperactivity disorder randomized placebocontrolled clinical trialnan
no_relation,reboxetine,attention-deficit/hyperactivity disorder/ADHD,21312292,main aim study evaluate efficacy reboxetine specific noradrenergic reuptake inhibitor adults attentiondeficithyperactivity disorder adhd nan
no_relation,reboxetine,ADHD,21312292,double blind placebocontrolled clinical trial efficacy mgday reboxetine twice daily compared placebo adults diagnosed adhd weeksnan
yes_direct,reboxetine,anxiety,21312292,irritability anxiety sleep disturbance dry mouth common side effects reboxetine nan
yes_direct,reboxetine,sleep disturbance,21312292,irritability anxiety sleep disturbance dry mouth common side effects reboxetine nan
yes_direct,reboxetine,dry mouth,21312292,irritability anxiety sleep disturbance dry mouth common side effects reboxetine nan
no_relation,Reboxetine,ADHD,21312292,reboxetine could used tolerated effective treatment adults adhd nan
no_relation,fludarabine,CLL/chronic lymphocytic leukemia,21322776,past years effective therapies emerged treatment chronic lymphocytic leukemia cll mainly combinations immunotherapy fludarabine based regimensnan
no_relation,Asenapine,bipolar I disorder/mania,21323396,asenapine review use management mania adults bipolar disorder nan
no_relation,Asenapine,manic/bipolar I disorder,21323396,asenapine atypical antipsychotic agent available sublingual formulations  mg indicated us saphris acute treatment monotherapy adjunctive therapy manic mixed episodes eu sycrest treatment moderate severe manic episodes adult patients bipolar disorder nan
no_relation,asenapine,bipolar I disorder/mania,21323396,two large  well designed week trials adult patients bipolar disorder asenapine monotherapy significantly effective placebo improving mania symptoms assessed using young mania rating scale total score ymrs primary endpoint significant differences asenapine placebo groups occurring days treatmentnan
no_relation,olanzapine,mania,21323396,week extension study recruited completers monotherapy trials significant differences asenapine olanzapine groups terms montgomerysberg depression rating scale madrs scores cgibp mania severity scores ymrs response rates ymrs remission rates extension phasenan
no_relation,asenapine,mania,21323396,week extension study recruited completers monotherapy trials significant differences asenapine olanzapine groups terms montgomerysberg depression rating scale madrs scores cgibp mania severity scores ymrs response rates ymrs remission rates extension phasenan
no_relation,valproate,manic symptoms,21323396,week trial asenapine adjunctive therapy lithium valproate asenapine effective placebo improving manic symptoms based difference groups ymrs total score week primary endpointnan
no_relation,asenapine,manic symptoms,21323396,week trial asenapine adjunctive therapy lithium valproate asenapine effective placebo improving manic symptoms based difference groups ymrs total score week primary endpointnan
no_relation,lithium,manic symptoms,21323396,week trial asenapine adjunctive therapy lithium valproate asenapine effective placebo improving manic symptoms based difference groups ymrs total score week primary endpointnan
yes_direct,asenapine,dizziness,21323396,pooled analysis monotherapy trials common adverse events occurring  patients twice incidence placebo reported acute phase asenapine monotherapy bipolar mania somnolence dizziness extrapyramidal symptoms eps akathisia increased bodyweight similar nature occurring longerterm monotherapy asenapine nan
yes_direct,asenapine,extrapyramidal symptoms/EPS,21323396,pooled analysis monotherapy trials common adverse events occurring  patients twice incidence placebo reported acute phase asenapine monotherapy bipolar mania somnolence dizziness extrapyramidal symptoms eps akathisia increased bodyweight similar nature occurring longerterm monotherapy asenapine nan
yes_direct,asenapine,somnolence,21323396,pooled analysis monotherapy trials common adverse events occurring  patients twice incidence placebo reported acute phase asenapine monotherapy bipolar mania somnolence dizziness extrapyramidal symptoms eps akathisia increased bodyweight similar nature occurring longerterm monotherapy asenapine nan
no_relation,asenapine,akathisia,21323396,pooled analysis monotherapy trials common adverse events occurring  patients twice incidence placebo reported acute phase asenapine monotherapy bipolar mania somnolence dizziness extrapyramidal symptoms eps akathisia increased bodyweight similar nature occurring longerterm monotherapy asenapine nan
no_relation,asenapine,bipolar mania,21323396,pooled analysis monotherapy trials common adverse events occurring  patients twice incidence placebo reported acute phase asenapine monotherapy bipolar mania somnolence dizziness extrapyramidal symptoms eps akathisia increased bodyweight similar nature occurring longerterm monotherapy asenapine nan
no_relation,asenapine,EPS,21323396,eps worsen severity longerterm asenapine monotherapynan
no_relation,asenapine,manic/bipolar I disorder,21323396,meantime asenapine option management manic andor mixed symptoms patients bipolar disorder may particular value patients high risk metabolic abnormalitiesnan
no_relation,asenapine,metabolic abnormalities,21323396,meantime asenapine option management manic andor mixed symptoms patients bipolar disorder may particular value patients high risk metabolic abnormalities nan
no_relation,steroids,PDAC,21327533, patients resected pdac  treated preoperatively insulin statin steroids  thyroxinnan
yes_direct,nelfinavir,endoplasmic reticulum stress,21329798,analysis nelfinavir induced endoplasmic reticulum stress nan
no_relation,Nelfinavir,cancer,21329798,nelfinavir viracept hiv protease inhibitor shown induce endoplasmic reticulum er stress reaction human cancer cellsnan
no_relation,nelfinavir,cancer,21329798,although presumed drug doses needed efficient er stress reaction ensuing apoptosis cancer cells somewhat higher prescribed hiv-infected persons nelfinavir represents one clinically applicable er stressinducing agents currently tested clinical studies cancer patientsnan
no_relation,nelfinavir,HIV-infected,21329798,although presumed drug doses needed efficient er stress reaction ensuing apoptosis cancer cells somewhat higher prescribed hiv-infected persons nelfinavir represents one clinically applicable er stressinducing agents currently tested clinical studies cancer patientsnan
no_relation,nelfinavir,cancer,21329798,addition methods described might facilitate analysis monitoring nelfinavir induced er stress response either cancer cells cell culture cancer tissue biopsiesnan
no_relation,Tacrolimus,ulcerative colitis,21336140,tacrolimus therapy alternative thiopurines maintaining remission patients refractory ulcerative colitis nan
no_relation,tacrolimus,ulcerative colitis/UC,21336140,although efficacy tacrolimus inducing remission refractory ulcerative colitis uc established efficacy maintaining remission uc evaluatednan
no_relation,tacrolimus,UC,21336140,aim study evaluate efficacy tacrolimus compared thiopurines maintaining remission patients refractory uc nan
no_relation,tacrolimus,UC,21336140,twentyfour uc patients treated tacrolimus treated thiopurines maintain remission enrolled tacrolimus group thiopurine group respectivelynan
no_relation,tacrolimus,UC,21336140,maintenance therapy tacrolimus patients uc could considered alternative thiopurine therapynan
no_relation,nevirapine,HIV-infected,21345162,examined antiretroviral resistance among cohort south african hiv-infected children nevirapine prevention mothertochild transmissionnan
no_relation,ethinyl estradiol,infertility,21355449,multiple uses ethinyl estradiol treating infertility nan
no_relation,ethinyl estradiol,hypergonadotropic amenorrhea,21355449,twenty micrograms ethinyl estradiol started day  cycle combined exogenous gonadotropin useful improving hostile cervical mucus inducing ovulation women hypergonadotropic amenorrhea nan
no_relation,chloroquine,systemic lupus erythematosus,21398612,therapy systemic lupus erythematosus antimalarial drugs chloroquine hydroxychloroquine quinacrine used long timenan
no_relation,quinacrine,systemic lupus erythematosus,21398612,therapy systemic lupus erythematosus antimalarial drugs chloroquine hydroxychloroquine quinacrine used long timenan
no_relation,hydroxychloroquine,systemic lupus erythematosus,21398612,therapy systemic lupus erythematosus antimalarial drugs chloroquine hydroxychloroquine quinacrine used long timenan
no_relation,colchicine,necrosis,21431291,successful treatment antitumor necrosis factor antitnfalpha proteinuria patient familial mediterranean fever fmf resistant colchicine antitnf drugs fmfnan
no_relation,colchicine,tumor,21431291,successful treatment anti tumor necrosis factor antitnfalpha proteinuria patient familial mediterranean fever fmf resistant colchicine antitnf drugs fmfnan
no_relation,colchicine,TNF,21431291,successful treatment antitumor necrosis factor anti tnf alpha proteinuria patient familial mediterranean fever fmf resistant colchicine anti tnf drugs fmfnan
no_relation,colchicine,proteinuria,21431291,successful treatment antitumor necrosis factor antitnfalpha proteinuria patient familial mediterranean fever fmf resistant colchicine antitnf drugs fmfnan
no_relation,colchicine,FMF/familial mediterranean fever,21431291,successful treatment antitumor necrosis factor antitnfalpha proteinuria patient familial mediterranean fever fmf resistant colchicine antitnf drugs fmf nan
no_relation,colchicine,amyloidosis,21431291,major renal involvement fmf occurrence amyloidosis prevented daily regimen colchicine nan
no_relation,colchicine,FMF,21431291,major renal involvement fmf occurrence amyloidosis prevented daily regimen colchicine nan
no_relation,colchicine,familial mediterranean fever,21431291, cases familial mediterranean fever may resistant colchicine nan
no_relation,colchicine,FMF,21431291,literature controversy treatment fmf patients resistant colchicine nan
no_relation,pomalidomide,anemia,21442636,circulating levels mcp silr il il predict anemia response pomalidomide therapy myelofibrosisnan
no_relation,pomalidomide,myelofibrosis,21442636,circulating levels mcp silr il il predict anemia response pomalidomide therapy myelofibrosis nan
no_relation,Pomalidomide,anemia,21442636,pomalidomide therapy effective alleviating anemia myelofibrosis examined relationship plasma cytokinechemokine levels response treatment pomalidomide nan
no_relation,Pomalidomide,myelofibrosis,21442636,pomalidomide therapy effective alleviating anemia myelofibrosis examined relationship plasma cytokinechemokine levels response treatment pomalidomide nan
no_relation,pomalidomide,myelofibrosis,21442636,study population included mayo clinic patients median age years participated two consecutive clinical trials pomalidomide therapy myelofibrosis associated anemianan
no_relation,pomalidomide,anemia,21442636,study population included mayo clinic patients median age years participated two consecutive clinical trials pomalidomide therapy myelofibrosisassociated anemia nan
no_relation,pomalidomide,splenomegaly,21442636,current data suggest context pomalidomide treatment response likely presence jakvf predicted absence marked splenomegaly increased levels proinflammatory cytokinesnan
yes_direct,thalidomide,VTE,21455855,since introduction immunomodulatory derivatives imids thalidomide lenalidomide therapeutic armamentarium mm vte emerged one leading complications particular patients newly diagnosed mmnan
yes_direct,lenalidomide,VTE,21455855,since introduction immunomodulatory derivatives imids thalidomide lenalidomide therapeutic armamentarium mm vte emerged one leading complications particular patients newly diagnosed mmnan
no_relation,lenalidomide,MM,21455855,since introduction immunomodulatory derivatives imids thalidomide lenalidomide therapeutic armamentarium mm vte emerged one leading complications particular patients newly diagnosed mm nan
no_relation,thalidomide,MM,21455855,since introduction immunomodulatory derivatives imids thalidomide lenalidomide therapeutic armamentarium mm vte emerged one leading complications particular patients newly diagnosed mm nan
yes_direct,dexamethasone,VTE,21455855,setting imidsbased treatments associated rates vte reaching values  particularly dexamethasone chemotherapy addednan
no_relation,glucose,weight gain,21476781,ahrq systematic review indicated premixed insulin analogues effective longacting insulin analogues lowering postprandial glucose hemoglobin ac however comparison premixed analogues associated higher rates hypoglycemia weight gain nan
no_relation,glucose,hypoglycemia,21476781,ahrq systematic review indicated premixed insulin analogues effective longacting insulin analogues lowering postprandial glucose hemoglobin ac however comparison premixed analogues associated higher rates hypoglycemia weight gainnan
no_relation,Ki23057,gastric cancer,21482024,fgfr inhibitor ki23057 enhances chemosensitivity drugresistant gastric cancer cellsnan
no_relation,etoposide/VP16,gastric cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp16 oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,etoposide/VP16,cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp16 oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,paclitaxel/PTX,cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocumm ptx ocummvp ocummoxa ocummgemnan
no_relation,paclitaxel/PTX,gastric cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocumm ptx ocummvp ocummoxa ocummgemnan
no_relation,irinotecan/SN38,cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,OXA/oxaliplatin,gastric cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,irinotecan/SN38,gastric cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,OXA/oxaliplatin,cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,GEM/gemcitabine,cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,GEM/gemcitabine,gastric cancer,21482024,five cancer cell lines resistant irinotecan sn paclitaxel ptx etoposide vp oxaliplatin oxa gemcitabine gem respectively established parent gastric cancer cell line ocumm named ocummsn ocummptx ocummvp ocummoxa ocummgemnan
no_relation,VP16,gastric cancer,21482024,fgfr inhibitor ki23057 might therapeutically promising treating drugresistant gastric cancer cells especially used combination sn ptx vp16 nan
no_relation,Ki23057,gastric cancer,21482024,fgfr inhibitor ki23057 might therapeutically promising treating drugresistant gastric cancer cells especially used combination sn ptx vpnan
no_relation,PTX,gastric cancer,21482024,fgfr inhibitor ki23057 might therapeutically promising treating drugresistant gastric cancer cells especially used combination sn ptx vpnan
no_relation,Carboplatin,breast cancer,21482494,carboplatin gemcitabine combination metastatic triplenegative anthracycline taxanepretreated breast cancer patients phase ii studynan
no_relation,gemcitabine,breast cancer,21482494,carboplatin gemcitabine combination metastatic triplenegative anthracycline taxanepretreated breast cancer patients phase ii studynan
no_relation,cisplatin,tumors,21482494,preclinical data indicate cisplatin sensitivity suggesting tumors may defects brca pathwaynanused treatment
no_relation,taxane,TNBC,21482494,carboplatin gemcitabine cg combination active unselected anthracycline taxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,carboplatin,TNBC,21482494,carboplatin gemcitabine cg combination active unselected anthracyclinetaxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,anthracycline,TNBC,21482494,carboplatin gemcitabine cg combination active unselected anthracycline taxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,taxane,breast cancer,21482494,carboplatin gemcitabine cg combination active unselected anthracycline taxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,anthracycline,breast cancer,21482494,carboplatin gemcitabine cg combination active unselected anthracycline taxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,gemcitabine,TNBC,21482494,carboplatin gemcitabine cg combination active unselected anthracyclinetaxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,carboplatin,breast cancer,21482494,carboplatin gemcitabine cg combination active unselected anthracyclinetaxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,gemcitabine,breast cancer,21482494,carboplatin gemcitabine cg combination active unselected anthracyclinetaxane pretreated metastatic breast cancer patients carried phase ii study evaluate activity cg combination pretreated metastatic tnbc patientsnan
no_relation,alcohol,drug dependency,21495939,current injecting drug use odds ratio  ci past current treatment drug dependency  ci  ci respectively alcohol use gday  ci independent predictors deferral treatmentnan
no_relation,alcohol,HCV,21495939,factors related drug alcohol use rather clinical factors influenced uptake treatment hcv nan
no_relation,alcohol,alcohol dependency,21495939,support patients drug alcohol dependency required optimise treatment uptakenan
no_relation,Bortezomib,relapsed disease,21509688,bortezomib thalidomide lenalidomide improved therapeutic armentarium patients refractory relapsed disease often used combination dexamethasone chemotherapeutic agentsnan
no_relation,lenalidomide,relapsed disease,21509688,bortezomib thalidomide lenalidomide improved therapeutic armentarium patients refractory relapsed disease often used combination dexamethasone chemotherapeutic agentsnan
no_relation,thalidomide,relapsed disease,21509688,bortezomib thalidomide lenalidomide improved therapeutic armentarium patients refractory relapsed disease often used combination dexamethasone chemotherapeutic agentsnan
no_relation,dexamethasone,relapsed disease,21509688,bortezomib thalidomide lenalidomide improved therapeutic armentarium patients refractory relapsed disease often used combination dexamethasone chemotherapeutic agentsnan
no_relation,bupivacaine,analgesia,21519310,doppler velocimetry indices systolicdiastolic ratios pulsatility index resistance index fetal umbilical artery uterine artery recorded women receiving continuous epidural analgesia bupivacaine fentanyl labor indices recorded fetal umbilical middle cerebral arteries women receiving analgesia nan
no_relation,fentanyl,analgesia,21519310,doppler velocimetry indices systolicdiastolic ratios pulsatility index resistance index fetal umbilical artery uterine artery recorded women receiving continuous epidural analgesia bupivacaine fentanyl labor indices recorded fetal umbilical middle cerebral arteries women receiving analgesia nan
yes_direct,clozapine,sialorrhea,21540404,current treatment strategies clozapine induced sialorrhea nan
yes_direct,clozapine,sialorrhea,21540404,provide understanding underlying pathophysiology current treatment options clozapine induced sialorrhea nan
no_relation,clozapine,hypersalivation/sialorrhea,21540404,literature retrieved medline february using key search terms clozapine sialorrhea hypersalivation drooling treatmentnan
yes_direct,clozapine,Sialorrhea,21540404,sialorrhea common disabling adverse effect clozapine usenan
no_relation,Glycopyrrolate,reduction of hypersalivation,21540404,glycopyrrolate however demonstrated significant reduction hypersalivation randomized controlled trialnan
no_relation,clozapine,hypersalivation/sialorrhea,21540404,botulinum toxin also significantly improved sialorrhea case report doubleblind study although trial included hypersalivation etiologies addition clozapine nan
yes_direct,clozapine,sialorrhea,21540404,current pharmacologic treatment options clozapine induced sialorrhea limited number efficacynan
no_relation,steroid,endometrial cancer,21544810,investigated whether variants sex steroid hormone metabolism genes modify effect hormone therapy ht endometrial cancer risk postmenopausal nonhispanic white womennan
no_relation,oleanolic acid,oleanolic acid/OA,21545203,study main active compound oleanolic acid oa isolated ethanol extract chemical structure identified according results high performance liquid chromatography hplc high performance thin layer chromatography hptlc liquid chromatographymass spectrography lcmsnan
no_relation,ethanol,oleanolic acid/OA,21545203,study main active compound oleanolic acid oa isolated ethanol extract chemical structure identified according results high performance liquid chromatography hplc high performance thin layer chromatography hptlc liquid chromatographymass spectrography lcmsnan
no_relation,ethanol,OA,21545203,results cell viability indictated notable differences oa ethanol extract pv lung adenocarcinoma spca cells measured mtt assaynan
no_relation,ethanol,PV in lung adenocarcinoma,21545203,results cell viability indictated notable differences oa ethanol extract pv lung adenocarcinoma spca cells measured mtt assaynan
no_relation,DMSO,OA,21545203,oa  microm group increased significantly apoptosis rate compared normal dmso groupsnan
no_relation,capecitabine,tumors,21547572,tesetaxel new oral taxane combination capecitabine phase doseescalation study patients advanced solid tumors nan
no_relation,Tesetaxel,tumors,21547572,tesetaxel new oral taxane combination capecitabine phase doseescalation study patients advanced solid tumors nan
no_relation,taxane,tumors,21547572,tesetaxel new oral taxane combination capecitabine phase doseescalation study patients advanced solid tumors nan
no_relation,capecitabine,tumors,21547572,phase study conducted primarily determine maximum tolerated dose mtd tesetaxel novel orally active semisynthetic microtubule inhibitor taxane class administered oral capecitabine patients advanced solid tumors nan
no_relation,tesetaxel,tumors,21547572,phase study conducted primarily determine maximum tolerated dose mtd tesetaxel novel orally active semisynthetic microtubule inhibitor taxane class administered oral capecitabine patients advanced solid tumors nan
no_relation,taxane,tumors,21547572,phase study conducted primarily determine maximum tolerated dose mtd tesetaxel novel orally active semisynthetic microtubule inhibitor taxane class administered oral capecitabine patients advanced solid tumors nan
no_relation,tesetaxel,cancer,21547572,data support continued clinical development tesetaxel single agent combination active cancer therapeuticsnan
no_relation,BAL30072,pseudomallei strains,21596528,study antib pseudomallei efficacy new monosulfactam bal30072 tested laboratory strains several isogenic mutant derivatives well collection clinical environmental pseudomallei strains thailandnan
no_relation,manganese,blood manganese,21601843,relationship blood manganese blood pressure korean general population according knhanes nanblood manganese disease 
yes_direct,Mn/manganese,hypertension,21601843,present data association manganese mn level hypertension representative sample adult korean population participated korean national health nutrition examination survey knhanes nan
yes_direct,Mn,hypertension,21601843,addition doubling blood mn increased risk hypertension  fold women men participants respectively adjustment covariatesnan
no_relation,Mn,hypertension,21601843,addition blood lead mercury cadmium covariates affect association blood mn prevalence hypertension nan
no_relation,mercury,hypertension,21601843,addition blood lead mercury cadmium covariates affect association blood mn prevalence hypertension nan
no_relation,cadmium,hypertension,21601843,addition blood lead mercury cadmium covariates affect association blood mn prevalence hypertension nan
yes_direct,Mn,hypertension,21601843,blood mn level associated increased risk hypertension representative sample korean adult populationnan
no_relation,dopamine,impulse control disorders,21604834,risky business dopamine agonists parkinson disease impulse control disorders nan
no_relation,dopamine,Parkinson disease,21604834,risky business dopamine agonists parkinson disease impulse control disordersnan
yes_direct,dopamine,impulse control disorder/ICD,21604834,patients parkinson's disease pd impulse control disorder icd result dopaminergic medication use particularly dopamine agonists daanan
no_relation,dopamine,Parkinson's disease/PD,21604834,patients parkinson's disease pd impulse control disorder icd result dopaminergic medication use particularly dopamine agonists daanan
no_relation,phosphatidylcholine,metastasis,21628892,therapeutic effects hybrid liposomes composed phosphatidylcholine docosahexaenoic acid hepatic metastasis colon carcinoma along apoptosis vivonan
no_relation,phosphatidylcholine,colon carcinoma,21628892,therapeutic effects hybrid liposomes composed phosphatidylcholine docosahexaenoic acid hepatic metastasis colon carcinoma along apoptosis vivonan
no_relation,cisplatin,ESCC,21676925,escc cells treated cisplatin common chemotherapeutic drug smac cytochrome released mitochondria caspase caspase activatednan
yes_direct,cisplatin,mitochondrial dysfunction,21676925,knockdown smac abrogated cisplatin induced apoptosis mitochondrial dysfunction cytochrome release caspase activationnan
no_relation,cisplatin,tumors,21676925,smac deficiency also reduced effect cisplatin longterm cell viability led cisplatin resistance xenograft tumors vivonan
no_relation,Levobupivacaine,cardiovascular and central nervous system toxicity,21696081,levobupivacaine new longacting local anesthetic isolated senantiomer racemic bupivacaine less cardiovascular central nervous system toxicity bupivacainenan
no_relation,bupivacaine,cardiovascular and central nervous system toxicity,21696081,levobupivacaine new longacting local anesthetic isolated senantiomer racemic bupivacaine less cardiovascular central nervous system toxicity bupivacaine nan
no_relation,vitamin D,vitamin D deficiency,21697298,diet environmental factors lifestyle underlie high prevalence vitamin deficiency healthy adults scotland supplementation reduces proportion severely deficientnan
no_relation,Vitamin D,numerous diseases,21697298,vitamin deficiency recently implicated possible risk factor etiology numerous diseases including nonskeletal conditionsnan
no_relation,Vitamin D,Vitamin D deficiency,21697298,vitamin deficiency recently implicated possible risk factor etiology numerous diseases including nonskeletal conditionsnan
no_relation,vitamin D,vitamin D deficiency,21697298,humans skin synthesis following exposure uvb potent source vitamin regions low uvb individuals risk vitamin deficiencynan
no_relation,25-hydroxyvitamin D,vitamin D deficiency,21697298,objectives describe prevalence vitamin deficiency investigate determinants plasma hydroxyvitamin ohd concentrations high northern latitude countrynan
no_relation,vitamin D,vitamin D deficiency,21697298,objectives describe prevalence vitamin deficiency investigate determinants plasma hydroxyvitamin ohd concentrations high northern latitude countrynan
no_relation,vitamin D,vitamin D deficiency,21697298, participants low risk vitamin deficiency adequate levels  nmollnan
no_relation,Vitamin D,Vitamin D deficiency,21697298,vitamin deficiency scotland highly prevalent due combination insufficient exposure uvb insufficient dietary intakenan
no_relation,poly-N-acetyllactosamine,leukemia,21720768,expressions nacetylglucosamonyltransferase gnt gntthe two main glycosyltransferases responsible synthesis poly-n-acetyllactosamine polylacnac glycans gnt participating syntheses sphingoglycolipids studied leukemia cell lines differentiation using rtpcr methodnan
no_relation,ATRA/all-trans retinoic acid,acute myeloid leukemia,21720768,atra alltrans retinoic acid dimethylsulfoxide dmso induce differentiation hl nb two human acute myeloid leukemia cell lines myelocytic lineage upregulated two enzymes various degrees  treatmentnan
no_relation,DMSO/dimethylsulfoxide,acute myeloid leukemia,21720768,atra alltrans retinoic acid dimethylsulfoxide dmso induce differentiation hl nb two human acute myeloid leukemia cell lines myelocytic lineage upregulated two enzymes various degrees  treatmentnan
yes_direct,calcium,death,21722161,cardiomyocyte calcium ca loading recognized major factor acute ischaemiareperfusion pathology promoting cell death contractile dysfunction arrhythmogenic activitynan
no_relation,Ca,CRF/Ca-rich-food,21729479,study aimed segment parents early adolescents subgroups according ca richfood crf practices perceptions regarding early adolescent crf intake ii determine whether ca intake parents early adolescents differed subgroupnan
no_relation,Ca,CRF,21729479,parent education programmes address crf practicesperceptions tailored parent group improve ca intake early adolescent childrennan
no_relation,pyridoxine,seizures,21733724,longterm followup two siblings pyridoxine dependent seizures associated novel aldha mutationnan
no_relation,Pyridoxine,Pyridoxine-dependent seizures/PDS,21733724,pyridoxine dependent seizures pds rare disorder characterized seizures resistant anticonvulsants controlled daily pharmacologic doses pyridoxine nan
no_relation,Pyridoxine,seizures,21733724,pyridoxine dependent seizures pds rare disorder characterized seizures resistant anticonvulsants controlled daily pharmacologic doses pyridoxine nan
no_relation,capecitabine,breast cancer,21741829,continuation trastuzumab plus capecitabine xh showed significantly improved overall response rate time progression compared capecitabine alone women herpositive breast cancer progressing trastuzumab treatmentnan
no_relation,DEX/dexamethasone,HGF/hepatocyte growth factor,21751216,compared effect hepatocyte growth factor hgf oncostatin osm dexamethasone dex combination expression liverspecific marker albumin albnan
no_relation,urea,HGF,21751216,moreover cells exposed combination osm dex hgf gradually featured highly differentiated hepatic functions including alb secretion glycogen storage urea production cytochrome cyp activitynan
no_relation,combretastatin-A4-phosphate,squamous cell carcinoma of the head and neck,21765046,phase ib trial radiotherapy combination combretastatin-a4-phosphate patients nonsmallcell lung cancer prostate adenocarcinoma squamous cell carcinoma head neck nan
no_relation,combretastatin-A4-phosphate,prostate adenocarcinoma,21765046,phase ib trial radiotherapy combination combretastatin-a4-phosphate patients nonsmallcell lung cancer prostate adenocarcinoma squamous cell carcinoma head necknan
no_relation,combretastatin-A4-phosphate,non-small-cell lung cancer,21765046,phase ib trial radiotherapy combination combretastatin-a4-phosphate patients nonsmallcell lung cancer prostate adenocarcinoma squamous cell carcinoma head necknan
yes_direct,CA4P,oculomotor nerve palsy,21765046,doselimiting toxic effects dlts reversible ataxia oculomotor nerve palsy occurred two patients prostate cancer receiving weekly ca4p mgmnan
no_relation,CA4P,prostate cancer,21765046,doselimiting toxic effects dlts reversible ataxia oculomotor nerve palsy occurred two patients prostate cancer receiving weekly ca4p mgmnan
no_relation,CA4P,ataxia,21765046,doselimiting toxic effects dlts reversible ataxia oculomotor nerve palsy occurred two patients prostate cancer receiving weekly ca4p mgmnan
no_relation,Pyrazinamide,tuberculosis,21768515,pyrazinamide susceptibility testing mycobacterium tuberculosis systematic review metaanalysesnan
no_relation,pyrazinamide,tuberculosis,21768515,standard culturebased testing susceptibility mycobacterium tuberculosis pyrazinamide difficult performnan
no_relation,pyrazinamide,tuberculosis,21768515,median prevalence range pyrazinamide resistance  multidrugresistant tuberculosis isolates  nonmultidrugresistant isolatesnan
no_relation,pyrazinamide,tuberculosis,21768515,considering prevalence pyrazinamide resistance different clinical settings pcrdna sequencing possibly molecular assays targeting pnca detect pyrazinamide resistance multidrugresistant tuberculosis isolates predictive values largely exceeding rule pyrazinamide resistance nonmultidrugresistant isolates predictive values exceeding nan
no_relation,pazopanib,aggressive pediatric solid tumor,21788355,metronomic oral topotecan pazopanib active antiangiogenic regimen mouse models aggressive pediatric solid tumor nan
no_relation,pazopanib,tumor,21788355,tested efficacies daily oral ldm topotecan alone combination pazopanib vegf receptor inhibitor three pediatric extracranial solid tumor mouse modelsnan
no_relation,pazopanib,neuroblastoma,21788355,vitro doseresponse study topotecan pazopanib conducted several neuroblastoma osteosarcoma rhabdomyosarcoma cell linesnan
no_relation,pazopanib,rhabdomyosarcoma,21788355,vitro doseresponse study topotecan pazopanib conducted several neuroblastoma osteosarcoma rhabdomyosarcoma cell linesnan
no_relation,pazopanib,osteosarcoma,21788355,vitro doseresponse study topotecan pazopanib conducted several neuroblastoma osteosarcoma rhabdomyosarcoma cell linesnan
no_relation,pazopanib,neuroblastoma,21788355,vivo antitumor efficacies ldm topotecan pazopanib single agents combination tested subcutaneous xenograft models neuroblastoma metastatic modelsnanused treatment
no_relation,TAC,graft-versus-host disease/GVHD,21802143,yearold japanese man weighing kg anaplastic large cell lymphoma received continuous iv administration tac posttransplantation prophylaxis graftversushost disease gvhd allogeneic bone marrow transplantation bmtnan
no_relation,TAC,anaplastic large cell lymphoma,21802143,yearold japanese man weighing kg anaplastic large cell lymphoma received continuous iv administration tac posttransplantation prophylaxis graftversushost disease gvhd allogeneic bone marrow transplantation bmtnan
yes_direct,LAN,GVHD,21802143,lan dose reduced mgd po day blood tac concentration subsequently decreased ngml gvhd related symptoms emerging day nan
no_relation,eicosanoids,inflammation,21804481,aim study determine quantity produced mediators inflammation cytokines eicosanoids carotid endarterectomy cea factors ischemic damage brainnan
yes_direct,eicosanoids,ischemic damage,21804481,aim study determine quantity produced mediators inflammation cytokines eicosanoids carotid endarterectomy cea factors ischemic damage brainnan
no_relation,Thromboxane B2/TXB2,tumor necrosis factor-a/TNFa,21804481,plasma concentrations interleukinb ilb thromboxane txb2 prostaglandin pge tumor necrosis factora tnfa measured enzymelinked immunosorbent assay elisa techniquenan
no_relation,PGE2/Prostaglandin E2,tumor necrosis factor-a/TNFa,21804481,plasma concentrations interleukinb ilb thromboxane txb prostaglandin pge tumor necrosis factora tnfa measured enzymelinked immunosorbent assay elisa techniquenan
no_relation,TXB2,TNFa,21804481,concentration ilb tnfa remained almost stable group whereas concentration txb2 reduced significantly nan
no_relation,serotonin,oral bleeding complications,21821439,selective serotonin reuptake inhibitors oral bleeding complications invasive dental treatmentnan
no_relation,serotonin,oral bleeding complications,21821439,purpose study examine frequency oral bleeding complications invasive dental procedures patients taking selective serotonin reuptake inhibitor ssri medicationsnan
no_relation,Amikacin,increased in burn injury,21825289,amikacin clearance increased burn injury often complicated renal insufficiencynan
no_relation,Amikacin,renal insufficiency,21825289,amikacin clearance increased burn injury often complicated renal insufficiency nan
no_relation,rapamycin,RCC,21827395,inhibitors mammalian target rapamycin mtor entered landscape treatment advanced rcc nan
no_relation,Temsirolimus,tumor,21827395,although temsirolimus capable improving overall survival minority selected mrcc patients effects tumor burden reduction pfs minimalnan
no_relation,Everolimus,cancer,21827395,first unknown mtor becomes major driver cancer growth developing progressive disease vegf inhibitor secondly existing sequential vegf data setting appears bit robust reported everolimus nan
no_relation,colchicine,pericardial effusion,21831274,recurrent pericardial effusion cardiac surgery use colchicine recalcitrant conventional therapynan
no_relation,colchicine,pericardial effusion,21831274,recent literature shows colchicine therapy useful treatment recurrent post surgical pericardial effusion nan
no_relation,Aspirin,death,21835634,aspirin treatment failure risk recurrent stroke death among patients ischemic strokenan
no_relation,Aspirin,ischemic stroke,21835634,aspirin treatment failure risk recurrent stroke death among patients ischemic stroke nan
no_relation,Aspirin,stroke,21835634,aspirin treatment failure risk recurrent stroke death among patients ischemic strokenan
no_relation,aspirin,ischemic stroke,21835634,prognostic value occurrence ischemic stroke patient despite aspirin treatment aspirin treatment failure knownnan
no_relation,aspirin,death,21835634,objective determine aspirin treatment failure predicts recurrent ischemic stroke andor death nan
no_relation,aspirin,ischemic stroke,21835634,objective determine aspirin treatment failure predicts recurrent ischemic stroke andor deathnan
yes_direct,aspirin,death,21835634,multivariate analysis used calculate odds ratio recurrent stroke recurrent stroke death aspirin treatment failure patients duration available followup months toast patients months ninds rtpa trial patientsnan
yes_direct,aspirin,stroke,21835634,multivariate analysis used calculate odds ratio recurrent stroke recurrent stroke death aspirin treatment failure patients duration available followup months toast patients months ninds rtpa trial patientsnan
no_relation,aspirin,death,21835634,risk stroke death months year higher among patients classified aspirin treatment failures among toast  confidence interval ci  ninds rtpa trial patients  ci  respectivelynan
no_relation,aspirin,stroke,21835634,risk stroke death months year higher among patients classified aspirin treatment failures among toast  confidence interval ci  ninds rtpa trial patients  ci  respectivelynan
no_relation,aspirin,death,21835634,subgroup analysis aspirin treatment failure found associated recurrent stroke combined endpoint stroke death among categories defined etiologic subtype including large artery atherosclerosisnan
no_relation,aspirin,stroke,21835634,subgroup analysis aspirin treatment failure found associated recurrent stroke combined endpoint stroke death among categories defined etiologic subtype including large artery atherosclerosisnan
no_relation,aspirin,atherosclerosis,21835634,subgroup analysis aspirin treatment failure found associated recurrent stroke combined endpoint stroke death among categories defined etiologic subtype including large artery atherosclerosis nan
no_relation,aspirin,death,21835634,posthoc analysis randomized ischemic stroke trials aspirin treatment failure found associated increased risk recurrent stroke death nan
no_relation,aspirin,ischemic stroke,21835634,posthoc analysis randomized ischemic stroke trials aspirin treatment failure found associated increased risk recurrent stroke deathnan
no_relation,aspirin,stroke,21835634,posthoc analysis randomized ischemic stroke trials aspirin treatment failure found associated increased risk recurrent stroke deathnan
no_relation,methadone,hepatitis C,21844836,low risk hepatitis seroconversion methadone maintenance treatmentnan
no_relation,methadone,hepatitis C virus (HCV) infection,21844836,study risk factors seroconversion hepatitis virus hcv infection since admission methadone maintenance treatment mmt characterize seronegative admitted groupnan
no_relation,histamine,allergic reaction,21875451,chemical intoxication due high histamine concentration fish often mistaken allergic reaction nan
no_relation,metformin,diabetes mellitus,21884027,chronic pretreatment metformin associated reduction noreflow phenomenon patients diabetes mellitus primary angioplasty acute myocardial infarctionnan
no_relation,metformin,acute myocardial infarction,21884027,chronic pretreatment metformin associated reduction noreflow phenomenon patients diabetes mellitus primary angioplasty acute myocardial infarction nan
no_relation,Metformin,type,21884027,metformin one commonly prescribed antihyperglycemic agents treatment type diabetesnan
no_relation,Metformin,diabetes,21884027,metformin one commonly prescribed antihyperglycemic agents treatment type diabetes nan
no_relation,metformin,diabetic,21884027,however little known effect metformin noreflow diabetic patientsnan
no_relation,metformin,diabetic,21884027,study investigated retrospectively whether chronic pretreatment metformin associated noreflow diabetic patients underwent primary coronary intervention acute myocardial infarction aminan
no_relation,metformin,AMI/acute myocardial infarction,21884027,study investigated retrospectively whether chronic pretreatment metformin associated noreflow diabetic patients underwent primary coronary intervention acute myocardial infarction ami nan
no_relation,metformin,AMI,21884027,multivariable logistic regression analysis revealed absence metformin pretreatment significant predictor noreflow along highburden thrombus ejection fraction admission anterior ami nan
no_relation,metformin,diabetes mellitus,21884027,results suggested chronic pretreatment metformin may associated reduction noreflow phenomenon patients diabetes mellitus primary angioplasty aminan
no_relation,metformin,AMI,21884027,results suggested chronic pretreatment metformin may associated reduction noreflow phenomenon patients diabetes mellitus primary angioplasty ami nan
no_relation,rapamycin,pancreatic NET,21893937,review consider data supporting exploitation different targets pancreatic net including peptide receptors receptor tyrosine kinases involved tumor angiogenesis directly supporting tumor growth intracellular targets mammalian target rapamycin mtor central role regulating cell growth metabolism apoptosisnan
no_relation,rapamycin,tumor,21893937,review consider data supporting exploitation different targets pancreatic net including peptide receptors receptor tyrosine kinases involved tumor angiogenesis directly supporting tumor growth intracellular targets mammalian target rapamycin mtor central role regulating cell growth metabolism apoptosisnan
no_relation,tyrosine,pancreatic NET,21893937,review consider data supporting exploitation different targets pancreatic net including peptide receptors receptor tyrosine kinases involved tumor angiogenesis directly supporting tumor growth intracellular targets mammalian target rapamycin mtor central role regulating cell growth metabolism apoptosisnan
no_relation,tyrosine,tumor,21893937,review consider data supporting exploitation different targets pancreatic net including peptide receptors receptor tyrosine kinases involved tumor angiogenesis directly supporting tumor growth intracellular targets mammalian target rapamycin mtor central role regulating cell growth metabolism apoptosisnan
no_relation,norepinephrine,attention deficit-hyperactive disorder/ADHD,21901844,methylphenidate mphritalinr compound blocks reuptake synaptically released norepinephrine ne dopamine da brain used years low dose longterm regimens treat attention deficithyperactive disorder adhd juveniles adolescents adultsnan
no_relation,Methylphenidate/MPH,attention deficit-hyperactive disorder/ADHD,21901844,methylphenidate mph ritalinr compound blocks reuptake synaptically released norepinephrine ne dopamine da brain used years low dose longterm regimens treat attention deficithyperactive disorder adhd juveniles adolescents adultsnan
no_relation,dopamine,attention deficit-hyperactive disorder/ADHD,21901844,methylphenidate mphritalinr compound blocks reuptake synaptically released norepinephrine ne dopamine da brain used years low dose longterm regimens treat attention deficithyperactive disorder adhd juveniles adolescents adultsnan
no_relation,MPH,ADHD,21901844,although agreement regarding primary biochemical action mph physiological basis efficacy normal individuals adhd patients lackingnan
no_relation,MPH,ADHD,21901844,study behavioral physiological actions clinically behaviorally relevant doses mph normal animals provides opportunity explore role catecholamine transmitters prefrontal cortical function attentional processes relate normal operation brain circuits adhd pathologynan
no_relation,catecholamine,ADHD,21901844,study behavioral physiological actions clinically behaviorally relevant doses mph normal animals provides opportunity explore role catecholamine transmitters prefrontal cortical function attentional processes relate normal operation brain circuits adhd pathologynan
no_relation,sirolimus,hepatitis C,21967703,limiting hepatitis virus progression liver transplant recipients using sirolimus based immunosuppressionnan
no_relation,sirolimus,HCV,21967703,reviewed liver recipients  identified cohort hcv recipients exposed sirolimus primary immunosuppression srl cohort hcv control group recipients never received sirolimus nanhepatitis virus much disease virus also sirolimus used treatment regardless choose third answer
no_relation,SRL,fibrosis,21967703,intenttotreat analysis srl cohort significantly less advanced fibrosis stage compared hcv control group year one vs nan
no_relation,SRL,HCV,21967703,intenttotreat analysis srl cohort significantly less advanced fibrosis stage compared hcv control group year one vs nan
no_relation,sirolimus/SRL,fibrosis,21967703,sirolimus sometimes discontinued side effects srl cohort subgroup stratified sirolimus duration showing progressively less fibrosis longer sirolimus durationnan
no_relation,sirolimus,fibrosis,21967703,multivariate analysis demonstrated sirolimus independent predictor minimal fibrosis year one year twonan
no_relation,sirolimus,fibrosis,21967703,first study among liver transplant recipients recurrent hcv describe positive impact sirolimus respect reduced fibrosis extent rate progressionnan
no_relation,sirolimus,HCV,21967703,first study among liver transplant recipients recurrent hcv describe positive impact sirolimus respect reduced fibrosis extent rate progressionnan
no_relation,Rasagiline,Parkinson's disease,21971007,rasagiline parkinson's disease nanprobably used tratment
no_relation,Rasagiline,PD,21971007,rasagiline shown effective monotherapy early pd adjunct dopaminergic therapynan
no_relation,rasagiline,PD,21971007,clinical trials also shown putative diseasemodifying effects though rasagiline potential alter longterm course pd remains controversialnan
no_relation,rasagiline,PD,21971007,given demonstrated benefits rasagiline along safety tolerability profile important role play pd therapynan
no_relation,oral contraceptives,thyroid dysfunction,21981383,precise etiopathogenesis evasive genetic influences exposure sunlight pregnancy oral contraceptives estrogenprogesterone therapies thyroid dysfunction cosmetics drugs proposednan
no_relation,hydroquinone,melasma,21981383,use broadspectrum sunscreen important lightening agents like retinoic acid tretinoin azelaic acid combination therapies containing hydroquinone tretinoin corticosteroids used treatment melasma thought increased efficacy compared monotherapynan
no_relation,retinoic acid/tretinoin,melasma,21981383,use broadspectrum sunscreen important lightening agents like retinoic acid tretinoin azelaic acid combination therapies containing hydroquinone tretinoin corticosteroids used treatment melasma thought increased efficacy compared monotherapynan
no_relation,azelaic acid,melasma,21981383,use broadspectrum sunscreen important lightening agents like retinoic acid tretinoin azelaic acid combination therapies containing hydroquinone tretinoin corticosteroids used treatment melasma thought increased efficacy compared monotherapynan
no_relation,corticosteroids,melasma,21981383,use broadspectrum sunscreen important lightening agents like retinoic acid tretinoin azelaic acid combination therapies containing hydroquinone tretinoin corticosteroids used treatment melasma thought increased efficacy compared monotherapynan
no_relation,ozone,T2DM/type 2 diabetes mellitus,22020729,examined whether shortterm exposures air pollution fine particles ozone heat resulted perturbation arterial blood pressure bp persons type diabetes mellitus t2dm nan
no_relation,ozone,T2DM,22020729,subjects t2dm pm associated increased bp ozone associated decreased bpnan
yes_direct,Bradykinin,Sindbis virus infection,22047990,bradykinin enhances sindbis virus infection human brain microvascular endothelial cellsnan
yes_direct,bradykinin,inflammatory edema,22047990,investigated whether endothelial cells infected sinv differentially responsive bradykinin bk potent inducer inflammatory edema broad range infectious diseasesnan
yes_direct,bradykinin,infectious diseases,22047990,investigated whether endothelial cells infected sinv differentially responsive bradykinin bk potent inducer inflammatory edema broad range infectious diseases nan
no_relation,dihydroergotamine,headaches,22049203,intravenous dihydroergotamine inpatient management refractory primary headaches nan
yes_direct,dihydroergotamine,primary headache disorders,22049203,determine dosing side effects dihydroergotamine affect outcomes primary headache disorders nan
no_relation,dihydroergotamine,headache,22049203,audited use dihydroergotamine inpatient management disabling primary headache focusing commonly treated problemsnan
no_relation,dihydroergotamine,headache,22049203,data suggest iv dihydroergotamine given days produces improvement headache disability patients migraine shorter coursesnan
no_relation,dihydroergotamine,migraine,22049203,data suggest iv dihydroergotamine given days produces improvement headache disability patients migraine shorter coursesnan
no_relation,dihydroergotamine,pain,22049203,giving dihydroergotamine predicts greater pain free ratenan
no_relation,dihydroergotamine,cluster headache,22049203,patients cluster headache benefit iv dihydroergotamine nan
no_relation,okadaic acid,breast cancer,22069692,treated human breast cancer cells structurally distinct toxins calyculin okadaic acid cantharidin known inhibit serthr phosphatases ppp familynan
no_relation,cantharidin,breast cancer,22069692,treated human breast cancer cells structurally distinct toxins calyculin okadaic acid cantharidin known inhibit serthr phosphatases ppp familynan
no_relation,Calyculin A,breast cancer,22069692,reverse phase phosphoprotein array analysis revealed increased phosphorylation  serthr phosphosites indicating selective inhibition phosphatases calyculin calyculin treatment induced cell cycle arrest mdamb mcf breast cancer cellsnan
no_relation,5-fluorouracil,cancer,22082587,evaluated whether experimental systems biology strategy analyses susceptibility cancer cells undergo caspase activation exploited predict patient responses 5-fluorouracil based chemotherapy casespecifically identify potential alternative targeted treatments reactivate apoptosisnan
no_relation,5-fluorouracil,colorectal cancer,22082587,systemslevel analysis correctly predicted positive negative outcome colorectal cancer patients receiving 5-fluorouracil based chemotherapy significantly outperformed common uni multivariate statistical approachesnanused treatment
no_relation,propofol,ischemic,22103808,protection remote ischemic preconditioning coronary artery bypass graft surgery isoflurane propofol clinical trialnan
no_relation,isoflurane,ischemic,22103808,protection remote ischemic preconditioning coronary artery bypass graft surgery isoflurane propofol clinical trialnan
no_relation,propofol,RIPC,22103808,specifically hypothesized ripc isoflurane anesthesia attenuates myocardial injury patients undergoing coronary artery bypass graft cabg surgery effects may different propofol anesthesianan
no_relation,isoflurane,myocardial injury,22103808,specifically hypothesized ripc isoflurane anesthesia attenuates myocardial injury patients undergoing coronary artery bypass graft cabg surgery effects may different propofol anesthesianan
no_relation,propofol,myocardial injury,22103808,specifically hypothesized ripc isoflurane anesthesia attenuates myocardial injury patients undergoing coronary artery bypass graft cabg surgery effects may different propofol anesthesianan
no_relation,isoflurane,RIPC,22103808,specifically hypothesized ripc isoflurane anesthesia attenuates myocardial injury patients undergoing coronary artery bypass graft cabg surgery effects may different propofol anesthesianan
no_relation,isoflurane,diabetic,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofolsufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion non diabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,propofol,RIPC/ischemia,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isofluranesufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,sufentanil,coronary artery disease,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,sufentanil,diabetic,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion non diabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,isoflurane,coronary artery disease,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofolsufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnandisease preexisting condition
no_relation,isoflurane,RIPC/ischemia,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofolsufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,propofol,coronary artery disease,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isofluranesufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,sufentanil,RIPC/ischemia,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isoflurane sufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion nondiabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,propofol,diabetic,22103808,randomized singleblinded placebocontrolled prospective study serum troponin concentration ctni baseline    postoperatively measured isofluranesufentanil propofol sufentanil anesthesia without ripc three min periods intermittent left upper arm ischemia min reperfusion non diabetic patients  threevessel coronary artery disease clinicaltrialsgov nctnan
no_relation,isoflurane,RIPC,22103808,ripc isoflurane anesthesia  decreased area ctni time curve ctni auc   ngml  vs  ngml   peak  ngml vs   serial isoflurane alone nan
no_relation,propofol,RIPC,22103808,contrast ripc propofol anesthesia  alter ctni auc  ngml  vs  ngml    peak postoperative ctni  ngml vs   nan
no_relation,propofol,RIPC,22103808,thus ripc isoflurane propofol anesthesia decreased myocardial damage patients undergoing cabg surgerynanfifth year medical student hungary really enjoyed working tasks happen work online id willing email daloloparizsgmailcomthanks advance
no_relation,isoflurane,myocardial damage,22103808,thus ripc isoflurane propofol anesthesia decreased myocardial damage patients undergoing cabg surgerynan
no_relation,propofol,myocardial damage,22103808,thus ripc isoflurane propofol anesthesia decreased myocardial damage patients undergoing cabg surgerynan
no_relation,isoflurane,RIPC,22103808,thus ripc isoflurane propofol anesthesia decreased myocardial damage patients undergoing cabg surgerynan
no_relation,isoflurane,RIPC/ischemia,22103808,accordingly effects ripc evoked upper limb ischemia reperfusion depend background anesthesia combined ripc isoflurane exerting greater beneficial effects conditions studiednan
no_relation,EDTA,Renal Disease,22104575,aim evaluate accuracy cockcroftgault jelliffe wright modification diet renal disease mdrd formulae substitute gold standard measure glomerular filtration rate gfr using chromium edta nan
no_relation,glucose,hypopituitarism,22108915,effects oral transdermal estrogen igf igfbp igfbp serum lipids glucose patients hypopituitarism gh treatment randomized studynan
no_relation,estrogen,hypopituitarism,22108915,effects oral transdermal estrogen igf igfbp igfbp serum lipids glucose patients hypopituitarism gh treatment randomized studynan
no_relation,estradiol,hypopituitarism,22108915,evaluate effects oral estradiol transdermal estradiol serum concentrations igf binding proteins women hypopituitarism nan
no_relation,estradiol,hypopituitarism,22108915,eleven patients hypopituitarism randomly allocated receive mg oral estradiol gday transdermal estradiol monthsnan
no_relation,estrogen,hypopituitarism,22108915,findings patients hypopituitarism impact response treatment gh since patients receiving oral estrogen require increased gh dosagenan
no_relation,25-hydroxyvitamin D,vitamin D deficiency,22123632,several studies pregnant women early childhood suggest vitamin deficiency serum hydroxyvitamin levelsnan
no_relation,vitamin D,vitamin D deficiency,22123632,several studies pregnant women early childhood suggest vitamin deficiency serum hydroxyvitamin levelsnan
no_relation,Vitamin D,vitamin D deficiency,22123632, us endocrine task force vitamin commented iu per day may sufficient correct vitamin deficiency pregnant lactating womennanone ambiguous logically lack vitamin directly contributes causes vitamin deficiency one sense therefore true vitamin directly contributes causes vitamin deficiency however people think
no_relation,vitamin D,vitamin D deficiency,22123632,recommendation iu vitamin per day pregnant lactating women vitamin deficiencynan
no_relation,sunitinib,renal cell carcinoma,22126730,costeffectiveness evaluation sunitinib firstline targeted therapy metastatic renal cell carcinoma spainnan
no_relation,Sunitinib,renal carcinoma,22126730,introduction sunitinib oral multitargeted receptor tyrosine kinase inhibitor delays disease progression median overall survival os years improves quality life becoming firstline standard care metastatic renal carcinoma mrccnan
no_relation,tyrosine,renal carcinoma,22126730,introduction sunitinib oral multitargeted receptor tyrosine kinase inhibitor delays disease progression median overall survival os years improves quality life becoming firstline standard care metastatic renal carcinoma mrccnan
no_relation,triamcinolone,stricture,22136782,efficacy endoscopic triamcinolone injection prevention esophageal stricture endoscopic submucosal dissectionnan
no_relation,triamcinolone,stricture,22136782,goal study determine efficacy endoscopic triamcinolone injection eti prevention stricture formation esdnan
no_relation,fatty acids,colorectal cancer,22139959,vitamins minerals essential fatty acids colorectal cancer risk united kingdom dietary cohort consortiumnan
yes_direct,fatty acids,colorectal cancer,22139959,risk colorectal cancer may influenced dietary intake various vitamins minerals essential fatty acids nan
no_relation,n - 3 fatty acids,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynanused prevention
no_relation,vitamin B6,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,calcium,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,vitamin D,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,alcohol,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,potassium,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,iron,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,folate,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,retinol/vitamin A,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,vitamin B12,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,riboflavin,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,n - 6 fatty acids,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,magnesium,colorectal cancer,22139959,dietary intakes retinol vitamin thiamin riboflavin vitamin folate vitamin vitamin calcium iron magnesium potassium  fatty acids  fatty acids ratio   fatty acids estimated associations colorectal cancer examined using conditional logistic regression models adjusting exact age height weight energy intake alcohol intake fiber intake smoking education social class physical activitynan
no_relation,fatty acids,colorectal cancer,22139959,statistically significant associations colorectal cancer risk dietary intake vitamins minerals essential fatty acids examinednan
no_relation,chloramphenicol,cataract,22151787,endophthalmitis following cataract surgery role prophylactic postoperative chloramphenicol eye dropsnan
no_relation,chloramphenicol,Endophthalmitis,22151787,endophthalmitis following cataract surgery role prophylactic postoperative chloramphenicol eye dropsnan
no_relation,chloramphenicol,cataract,22151787,main aim study assess whether omitting prophylactic postoperative topical antibiotics chloramphenicol influenced risk developing endophthalmitis cataract surgerynan
no_relation,chloramphenicol,endophthalmitis,22151787,main aim study assess whether omitting prophylactic postoperative topical antibiotics chloramphenicol influenced risk developing endophthalmitis cataract surgerynan
no_relation,corticosteroids,PE,22151787,found difference frequency pe following cataract surgery changing postoperative topical medication mixture corticosteroids antibiotics corticosteroidsnan
no_relation,corticosteroids,cataract,22151787,found difference frequency pe following cataract surgery changing postoperative topical medication mixture corticosteroids antibiotics corticosteroidsnan
no_relation,Iron,hepatocellular carcinoma,22181812,iron facilitator ls081 reduces hypoxiainducible factor protein functions anticancer agent hepatocellular carcinoma nan
no_relation,Iron,hypoxia,22181812,iron facilitator ls081 reduces hypoxia inducible factor protein functions anticancer agent hepatocellular carcinomanan
no_relation,oxygen,tumor/cancer,22181812,hypoxia inducible factor hif central role cellular oxygen sensing overexpression many types cancer considered important tumor progressionnan
no_relation,oxygen,Hypoxia,22181812,hypoxia inducible factor hif central role cellular oxygen sensing overexpression many types cancer considered important tumor progressionnan
no_relation,iron,hepatocellular carcinoma,22181812,present study aimed inhibit expression hif protein growth hepatocellular carcinoma using iron facilitating activity lsnan
no_relation,ammonium citrate,hepatocellular carcinoma,22181812,human hepatocellular carcinoma cell lines hepb hepg combination ls081 ferric ammonium citrate lsfeac inhibited hif protein expression inhibit hif mrna expressionnan
no_relation,LS081,hepatocellular carcinoma,22181812,human hepatocellular carcinoma cell lines hepb hepg combination ls081 ferric ammonium citrate ls081 feac inhibited hif protein expression inhibit hif mrna expressionnan
no_relation,iron,hepatocellular carcinoma,22181812,results indicate iron facilitating activity ls081 inhibits hif expression prolylhydroxylation hif might therapeutic effect treatment hepatocellular carcinoma nan
no_relation,glucose,diabetes mellitus,22187097,influence glucose adjusted body mass index age gender diabetes mellitus vte assessed logistic regression analysesnan
no_relation,glucose,VTE,22187097,influence glucose adjusted body mass index age gender diabetes mellitus vte assessed logistic regression analysesnan
no_relation,glucose,VTE,22187097,increased glucose levels total hip replacement associated total vte adjusted odds ratio highest versus lowest quartile  confidence interval ci nan
yes_direct,glucose,VTE,22187097,furthermore increase glucose levels total hip replacement associated total vte highest versus lowest quartile ci nan
no_relation,Melatonin,hepatoma,22225575,melatonin sensitizes human hepatoma cells endoplasmic reticulum stressinduced apoptosisnan
yes_direct,Melatonin,HCC/apoptosis in hepatocellular carcinoma,22225575,melatonin induces apoptosis hepatocellular carcinoma hcc experimental studies effects melatonin endoplasmic reticulum er stressinduced apoptosis hcc testednan
yes_direct,tunicamycin,hepatoma,22225575,differences er stressinduced apoptosis human hepatoma cells normal human hepatocyte investigated exposure tunicamycin er stress inducernan
no_relation,celecoxib,hepatoma,22225575,furthermore downregulation cox expression using cox inhibitor celecoxib increased tunicamycininduced apoptosis concomitant upregulation proapoptotic transcription factor chop gadd downregulation bcell lymphoma bclassociated protein bclbax ratio suggesting inhibition cox sensitized human hepatoma cells er stressinduced apoptosisnan
no_relation,celecoxib,B-cell lymphoma,22225575,furthermore downregulation cox expression using cox inhibitor celecoxib increased tunicamycininduced apoptosis concomitant upregulation proapoptotic transcription factor chop gadd downregulation bcell lymphoma bclassociated protein bclbax ratio suggesting inhibition cox sensitized human hepatoma cells er stressinduced apoptosisnan
no_relation,tunicamycin,B-cell lymphoma,22225575,furthermore downregulation cox expression using cox inhibitor celecoxib increased tunicamycin induced apoptosis concomitant upregulation proapoptotic transcription factor chop gadd downregulation bcell lymphoma bclassociated protein bclbax ratio suggesting inhibition cox sensitized human hepatoma cells er stressinduced apoptosisnan
no_relation,tunicamycin,hepatoma,22225575,furthermore downregulation cox expression using cox inhibitor celecoxib increased tunicamycin induced apoptosis concomitant upregulation proapoptotic transcription factor chop gadd downregulation bcell lymphoma bclassociated protein bclbax ratio suggesting inhibition cox sensitized human hepatoma cells er stressinduced apoptosisnanused treatment
no_relation,melatonin,hepatoma,22225575,results demonstrate melatonin sensitizes human hepatoma cells er stressinduced apoptosis downregulating cox expression increasing levels chop decreasing bclbax rationan
no_relation,androgen,prostate cancer,22280402,true antiandrogensselective nonligandbinding pocket disruptors androgen receptorcoactivator interactions novel tools prostate cancer nan
no_relation,testosterone,Prostate cancer/PCa,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,androgen,Prostate cancer/PCa,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,dihydrotestosterone/DHT,ligand-binding domain/LBD,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,dihydrotestosterone/DHT,Prostate cancer/PCa,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,testosterone,ligand-binding domain/LBD,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,androgen,ligand-binding domain/LBD,22280402,prostate cancer pca therapy typically involves administration classical antiandrogens competitive inhibitors androgen receptor ar ligands dihydrotestosterone dht testosterone tes ligandbinding pocket lbp ligandbinding domain lbd arnan
no_relation,silicone,HIV-1 infection,22288970,progressive granulomatous pneumonitis response cosmetic subcutaneous silicone injections patient hiv infection case report review literaturenan
yes_direct,silicone,granulomatous pneumonitis,22288970,progressive granulomatous pneumonitis response cosmetic subcutaneous silicone injections patient hiv infection case report review literaturenan
yes_direct,Silicone,pneumonitis,22288970,silicone commonly used cosmetic procedures owing presumed inertness yield serious sequelae including acute embolization pneumonitis nan
no_relation,silicone,human immunodeficiency virus,22288970,report case chronic progressive granulomatous pneumonitis response subcutaneous silicone injections transgender maletofemale patient infected human immunodeficiency virus hivnan
yes_direct,silicone,granulomatous pneumonitis,22288970,report case chronic progressive granulomatous pneumonitis response subcutaneous silicone injections transgender maletofemale patient infected human immunodeficiency virus hivnan
yes_direct,silicone,dyspnea,22288970,receiving silicone injections buttock patient developed rapid onset dyspnea pleuritic chest pain fever chillsnan
yes_direct,silicone,chest pain,22288970,receiving silicone injections buttock patient developed rapid onset dyspnea pleuritic chest pain fever chillsnan
yes_direct,silicone,fever,22288970,receiving silicone injections buttock patient developed rapid onset dyspnea pleuritic chest pain fever chillsnan
no_relation,silicone,granulomatous inflammation,22288970,lung biopsies demonstrated numerous spheroid silicone particles within lung interstitium small pulmonary vessels surrounded foreign body giant cells nonnecrotizing granulomatous inflammation nan
no_relation,silicone,HIV-1-infected,22288970,speculate hiv-1-infected patients may risk chronic progressive granulomatous pneumonitis due silicone injection years procedure owing shifting levels cellmediated immunitynan
yes_direct,silicone,granulomatous pneumonitis,22288970,speculate hiv-1-infected patients may risk chronic progressive granulomatous pneumonitis due silicone injection years procedure owing shifting levels cellmediated immunitynan
no_relation,Omega-3 fatty acids,cardiac disease,22296885,omega fatty acids shown reduce platelet endothelial activation patients risk cardiac disease nan
no_relation,Omega-3 fatty acids,inflammation,22296885,supplementation omega fatty acids affect platelet endothelial activation markers inflammation patients peripheral arterial diseasenan
no_relation,Omega-3 fatty acids,arterial disease,22296885,supplementation omega fatty acids affect platelet endothelial activation markers inflammation patients peripheral arterial disease nan
no_relation,nevirapine,HIV,22299411,effectiveness fixeddose combination stavudine lamivudine nevirapine gpovir treatment nave hiv patients thailand year followupnan
no_relation,stavudine,HIV,22299411,effectiveness fixeddose combination stavudine lamivudine nevirapine gpovir treatment nave hiv patients thailand year followupnan
no_relation,lamivudine,HIV,22299411,effectiveness fixeddose combination stavudine lamivudine nevirapine gpovir treatment nave hiv patients thailand year followupnan
no_relation,nevirapine/NVP,HIV,22299411,generic fixed dose combination stavudine dt lamivudine tc nevirapine nvp named gpovir recommended hiv treatment guidelines thailandnan
no_relation,stavudine/d4T,HIV,22299411,generic fixed dose combination stavudine dt lamivudine tc nevirapine nvp named gpovir recommended hiv treatment guidelines thailandnan
no_relation,lamivudine/3TC,HIV,22299411,generic fixed dose combination stavudine dt lamivudine 3tc nevirapine nvp named gpovir recommended hiv treatment guidelines thailandnan
no_relation,topiramate,mood disorders,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,serotonin,mood disorders,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,serotonin,binge eating disorder,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,zonisamide,binge eating disorder,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,zonisamide,mood disorders,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,topiramate,binge eating disorder,22303523,binge eating disorder best evidence mood disorders cognitivebehavioral therapy well topiramate zonisamide select cases selective serotonin reuptake inhibitorsnan
no_relation,12-O-tetradecanoylphorbol-13-acetate/TPA,tumor,22344919,compounds examined inhibitory effects epsteinbarr virus early antigen ebvea activation induced otetradecanoylphorbolacetate tpa raji cells known primary screening test inhibitors tumor promotionnan
no_relation,TPA,skin carcinogenesis,22344919,addition compounds  exhibited inhibitory effects skintumor promotion vivo twostage mouse skin carcinogenesis test based dimethylbenzaanthracene dmba initiator tpa promoternan
yes_direct,TPA,skin-tumor promotion,22344919,addition compounds  exhibited inhibitory effects skintumor promotion vivo twostage mouse skin carcinogenesis test based dimethylbenzaanthracene dmba initiator tpa promoternan
no_relation,quinine,falciparum malaria,22368898,efficacy safety quinine loading dose patients severe falciparum malaria tertiary care hospital pakistannan
no_relation,quinine,falciparum malaria,22368898,compare clinical outcomes loading dose regimen quinine uniform dose regimen patients severe falciparum malaria nan
no_relation,quinine,falciparum malaria,22368898,retrospective chart review patients admitted severe falciparum malaria treated quinine tertiary care teaching hospital karachi pakistan conductednan
yes_direct,quinine,toxicity,22368898,although quinine loading dose may effective uniform dose rapid fever clearance also appears associated higher toxicity nan
no_relation,quinine,falciparum malaria,22368898,uniform dose quinine may prescribed severe falciparum malaria view better safety profilenan
no_relation,tyrosine,chronic myeloid leukemia,22369329,mechanisms novel approaches overriding tyrosine kinase inhibitor resistance chronic myeloid leukemia nan
no_relation,Tyrosine,chronic myeloid leukemia,22369329,tyrosine kinase inhibitors tkis introduced late revolutionized management chronic myeloid leukemia chronic phasenan
no_relation,Metformin,type,22399368,metformin use among individuals risk type diabetesnan
no_relation,Metformin,diabetes,22399368,metformin use among individuals risk type diabetes nan
no_relation,glucose,diabetes,22399368,clinical trials lower blood glucose disappointing probably participants late natural history diabetes already extensive vascular diseasenan
no_relation,glucose,blood glucose,22399368,clinical trials lower blood glucose disappointing probably participants late natural history diabetes already extensive vascular diseasenan
no_relation,glucose,vascular disease,22399368,clinical trials lower blood glucose disappointing probably participants late natural history diabetes already extensive vascular disease nan
no_relation,glucose,diabetes,22399368,metformin prevent development diabetes among patients impaired fasting glucose short termnan
no_relation,Metformin,impaired fasting glucose,22399368,metformin prevent development diabetes among patients impaired fasting glucose short termnan
no_relation,Metformin,diabetes,22399368,metformin prevent development diabetes among patients impaired fasting glucose short termnan
no_relation,glucose,impaired fasting glucose,22399368,metformin prevent development diabetes among patients impaired fasting glucose short termnan
no_relation,Metformin,coronary heart disease,22399368,metformin reduces risk coronary heart disease nan
no_relation,metformin,atherosclerosis,22399368,combination diet exercise followed metformin early phase insulin resistance may reduce delay atherosclerosis arteriosclerosis complications associated diabetesnan
no_relation,metformin,diabetes,22399368,combination diet exercise followed metformin early phase insulin resistance may reduce delay atherosclerosis arteriosclerosis complications associated diabetes nan
no_relation,metformin,arteriosclerosis,22399368,combination diet exercise followed metformin early phase insulin resistance may reduce delay atherosclerosis arteriosclerosis complications associated diabetesnan
no_relation,AMP,colorectal cancer,22406476,aspirin inhibits mtor signaling activates amp activated protein kinase induces autophagy colorectal cancer cellsnan
no_relation,Aspirin,colorectal cancer,22406476,aspirin inhibits mtor signaling activates ampactivated protein kinase induces autophagy colorectal cancer cellsnan
no_relation,Aspirin,CRC/colorectal cancer,22406476,aspirin reduces incidence mortality colorectal cancer crc unknown mechanismsnan
no_relation,rapamycin,Cancer,22406476,cancer cells defects signaling via mechanistic target rapamycin mtor regulates proliferationnan
no_relation,aspirin,CRC,22406476,investigated whether aspirin affects adenosine monophosphateactivated protein kinase ampk mtor signaling crc cellsnan
no_relation,adenosine monophosphate,CRC,22406476,investigated whether aspirin affects adenosine monophosphate activated protein kinase ampk mtor signaling crc cellsnan
no_relation,aspirin,CRC,22406476,effects aspirin mtor signaling ribosomal protein kinase sk eukaryotic translation initiation factor binding protein ebp examined crc cells immunoblottingnan
no_relation,aspirin,CRC,22406476,phosphorylation ampk measured effects loss ampk aspirin induced effects mtor determined using small interfering rna sirna crc cells ampk mouse embryonic fibroblastsnan
no_relation,Aspirin,CRC,22406476,aspirin reduced mtor signaling crc cells inhibiting mtor effectors sk ebpnan
no_relation,Aspirin,CRC,22406476,aspirin changed nucleotide ratios activated ampk crc cells mtor still inhibited aspirin crc cells sirna knockdown ampk indicating ampkdependent ampkindependent mechanisms aspirin induced inhibition mtornan
no_relation,nucleotide,CRC,22406476,aspirin changed nucleotide ratios activated ampk crc cells mtor still inhibited aspirin crc cells sirna knockdown ampk indicating ampkdependent ampkindependent mechanisms aspirininduced inhibition mtornan
no_relation,metformin,CRC,22406476,aspirin metformin activator ampk increased inhibition mtor akt well autophagy crc cellsnan
no_relation,Aspirin,CRC,22406476,aspirin metformin activator ampk increased inhibition mtor akt well autophagy crc cellsnan
no_relation,paracetamol,critically ill,22424816,mechanism paracetamol induced hypotension critically ill patients prospective observational crossover studynan
yes_direct,paracetamol,hypotension,22424816,mechanism paracetamol induced hypotension critically ill patients prospective observational crossover studynan
no_relation,paracetamol/acetaminophen,hypotension,22424816,elucidate mechanism hypotension following intravenous administration paracetamol acetaminophen patients intensive care unitnan
no_relation,paracetamol,critically ill,22424816,ventilated critically ill patients monitored picco administered intravenous paracetamol time eligible studynan
yes_direct,paracetamol,hypotension,22424816,analysis cycles suggests hypotension paracetamol caused reduction cardiac index systemic vascular resistancenan
no_relation,paracetamol,critically ill,22424816,hypotension intravenous paracetamol critically ill patients caused reduction cardiac output systemic vascular resistancenandisease preexisting condition
yes_direct,paracetamol,Hypotension,22424816,hypotension intravenous paracetamol critically ill patients caused reduction cardiac output systemic vascular resistancenan
yes_direct,CS5931,cytotoxicity,22440403,cs5931 exhibited significant cytotoxicity several cancer cell types induced apoptotic death hct cells dose timedependent mannernan
no_relation,CS5931,cancer,22440403,cs5931 exhibited significant cytotoxicity several cancer cell types induced apoptotic death hct cells dose timedependent mannernan
no_relation,creatinine,type 2 diabetes mellitus,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatinine data patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednan
no_relation,TZD,type 2 diabetes mellitus,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatininedata patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednan
no_relation,TZD,type,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatininedata patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednantype diabetes type
no_relation,creatinine,type,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatinine data patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednan
no_relation,creatinine,diabetes,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatinine data patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednan
no_relation,TZD,diabetes,22441720,aimed investigate impact coadministration tzd aceiarb hematocrit hemoglobin values uncomplicated patients type diabetes mellitus normal serum creatininedata patients type diabetes currently followed reviewed patients treated aceiarb andor tzd identifiednan
no_relation,creatinine,anemia,22441720,furthermore incident anemia end reached group tzd group aceiarbtzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatinine nan
no_relation,ARB,anemia,22441720,furthermore incident anemia end reached group tzd group acei arb tzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,creatinine,diabetic,22441720,furthermore incident anemia end reached group tzd group aceiarbtzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatinine nan
no_relation,TZD,diabetic,22441720,furthermore incident anemia end reached group tzd group aceiarb tzd coadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,ARB,diabetic,22441720,furthermore incident anemia end reached group tzd group acei arb tzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,ARB,type,22441720,furthermore incident anemia end reached group tzd group acei arb tzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,TZD,anemia,22441720,furthermore incident anemia end reached group tzd group aceiarb tzd coadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,TZD,type,22441720,furthermore incident anemia end reached group tzd group aceiarb tzd coadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatininenan
no_relation,creatinine,type,22441720,furthermore incident anemia end reached group tzd group aceiarbtzdcoadministration ras inhibitors ppar agonists considered differential diagnosis hematocrit lowering anemia uncomplicated type diabetic patients normal serum creatinine nan
no_relation,clopidogrel,cardiovascular diseases,22450429,clinical trials established value clopidogrel therapy wide spectrum patients cardiovascular diseases nan
no_relation,clopidogrel,bleeding,22450429,rates ischaemic bleeding events compared carriers noncarriers lossoffunction gainoffunction alleles patients randomized clopidogrel vs placebonan
no_relation,clopidogrel,bleeding,22450429,however clopidogrel treated patients significantly lower rate bleeding carriers  vs  noncarriers hr  ci  genotypetreatment interaction pvalue nan
no_relation,clopidogrel,less bleeding,22450429,however significantly less bleeding clopidogrel carriers lossoffunction allele suggesting less antiplatelet responsenan
no_relation,clopidogrel,bleeding,22450429,although several prior studies including mainly stented patients emphasized relationship cypc lossoffunction alleles efficacy clopidogrel study stable patients establishes potential link reduced bleeding complicationsnan
yes_direct,serotonin/5-HT/5-hydroxytryptamine,drug dependence,22494568,present review provides overview serotonin hydroxytryptamine 5-ht receptors relationship drug dependence nan
no_relation,5-HT,drug dependence,22494568,accordingly available nonclinical data clinical observations targeting 5-ht receptors may offer innovative translational strategies combating drug dependence article part special issue entitled brain integrationnan
no_relation,amifostine,xerostomia,22541957,nine patients developed grade acute xerostomia  grade xerostomia started amifostine pilocarpinenan
no_relation,pilocarpine,xerostomia,22541957,nine patients developed grade acute xerostomia  grade xerostomia started amifostine pilocarpine nan
yes_direct,aspirin,Gastrointestinal lesions,22542152,gastrointestinal lesions complications lowdose aspirin gastrointestinal tractnan
yes_direct,aspirin,GI bleeding,22542152,low dose aspirin asa use associated wide range adverse side effects upper gastrointestinal gi tract range troublesome symptoms without mucosal lesions serious toxicity including ulcers gi bleeding perforation even deathnan
yes_direct,aspirin,toxicity,22542152,low dose aspirin asa use associated wide range adverse side effects upper gastrointestinal gi tract range troublesome symptoms without mucosal lesions serious toxicity including ulcers gi bleeding perforation even deathnan
no_relation,aspirin,mucosal lesions,22542152,low dose aspirin asa use associated wide range adverse side effects upper gastrointestinal gi tract range troublesome symptoms without mucosal lesions serious toxicity including ulcers gi bleeding perforation even deathnanwithout key term
yes_direct,aspirin,ulcers,22542152,low dose aspirin asa use associated wide range adverse side effects upper gastrointestinal gi tract range troublesome symptoms without mucosal lesions serious toxicity including ulcers gi bleeding perforation even deathnan
yes_direct,aspirin,death,22542152,low dose aspirin asa use associated wide range adverse side effects upper gastrointestinal gi tract range troublesome symptoms without mucosal lesions serious toxicity including ulcers gi bleeding perforation even death nan
no_relation,ASA,mucosal injury,22542152,upper gi symptoms low dose asa users common often careless misinterpreted always related presence mucosal injury nan
yes_direct,ASA,ulcers,22542152,usually low dose asa related ulcers reasonably small asymptomatic probably heal period weeks monthsnan
yes_indirect,ASA,Death,22542152,death worst outcome gi complications low dose asa users data aspect scarcenan
yes_direct,ASA,GI complications,22542152,death worst outcome gi complications low dose asa users data aspect scarcenan
no_relation,indomethacin,PDA,22564132,cyclooxygenase inhibitors indomethacin ibuprofen remain mainstay medical therapy pda used prophylaxis well rescue therapy achieve pda closurenan
no_relation,ibuprofen,PDA,22564132,cyclooxygenase inhibitors indomethacin ibuprofen remain mainstay medical therapy pda used prophylaxis well rescue therapy achieve pda closurenan
no_relation,capecitabine,rectal cancer,22610353,phase ii gene expression analysis trial neoadjuvant capecitabine plus irinotecan followed capecitabine based chemoradiotherapy locally advanced rectal cancer hoosier oncology group ginan
no_relation,irinotecan,rectal cancer,22610353,phase ii gene expression analysis trial neoadjuvant capecitabine plus irinotecan followed capecitabinebased chemoradiotherapy locally advanced rectal cancer hoosier oncology group ginan
no_relation,capecitabine,rectal cancer,22610353,designed study locally advanced rectal cancer determine pathological response toxicity diseasefree survival dfs induction capecitabine plus irinotecan followed capecitabine based chemoradiotherapy crt analyze gene expression enzymes involved metabolism capecitabine irinotecan associations response toxicitynan
no_relation,irinotecan,rectal cancer,22610353,designed study locally advanced rectal cancer determine pathological response toxicity diseasefree survival dfs induction capecitabine plus irinotecan followed capecitabinebased chemoradiotherapy crt analyze gene expression enzymes involved metabolism capecitabine irinotecan associations response toxicitynan
no_relation,irinotecan,toxicity,22610353,designed study locally advanced rectal cancer determine pathological response toxicity diseasefree survival dfs induction capecitabine plus irinotecan followed capecitabinebased chemoradiotherapy crt analyze gene expression enzymes involved metabolism capecitabine irinotecan associations response toxicity nan
no_relation,capecitabine,toxicity,22610353,designed study locally advanced rectal cancer determine pathological response toxicity diseasefree survival dfs induction capecitabine plus irinotecan followed capecitabine based chemoradiotherapy crt analyze gene expression enzymes involved metabolism capecitabine irinotecan associations response toxicity nan
no_relation,capecitabine,rectal cancer,22610353,patients tt node positive rectal cancer treated capecitabine mgm twice daily bid days irinotecan mgm day every days cycles followed capecitabine mgm bid days per week concurrent radiotherapy gy fractionsnan
no_relation,irinotecan,rectal cancer,22610353,patients tt node positive rectal cancer treated capecitabine mgm twice daily bid days irinotecan mgm day every days cycles followed capecitabine mgm bid days per week concurrent radiotherapy gy fractionsnan
no_relation,uridine-diphosphate/UDP,tumor,22610353,gene expression levels sequencing used analyze carboxylesteraseconverting enzymes ces ces thymidylate synthase ts thymidine phosphorylase tp dehydropyrimidine dehydrogenase dpd topoisomerase topo uridinediphosphate udp glucuronosyl transferase pre posttreatment tumor normal tissue samplesnan
no_relation,thymidine,tumor,22610353,gene expression levels sequencing used analyze carboxylesteraseconverting enzymes ces ces thymidylate synthase ts thymidine phosphorylase tp dehydropyrimidine dehydrogenase dpd topoisomerase topo uridinediphosphate udp glucuronosyl transferase pre posttreatment tumor normal tissue samplesnan
no_relation,sorafenib,pain,22646774,management strategy based preventive measures reducing development cutaneous aes including pain risk infection patient discomfort avoiding discontinuation reduction sorafenib dosagenan
no_relation,sorafenib,infection,22646774,management strategy based preventive measures reducing development cutaneous aes including pain risk infection patient discomfort avoiding discontinuation reduction sorafenib dosagenan
no_relation,Cordycepin,neuroblastoma,22650004,cordycepin induces apoptosis human neuroblastoma sknbec melanoma skmel cellsnan
yes_direct,Cordycepin,melanoma,22650004,cordycepin induces apoptosis human neuroblastoma sknbec melanoma skmel cellsnan
no_relation,deoxyadenosine,neuroblastoma,22650004,study effect cordycepin deoxyadenosine major component cordyceps militaris ingredient traditional chinese medicine investigated first time apoptotsis human neuroblastoma sknbec melanoma skmel cellsnan
no_relation,deoxyadenosine,melanoma,22650004,study effect cordycepin deoxyadenosine major component cordyceps militaris ingredient traditional chinese medicine investigated first time apoptotsis human neuroblastoma sknbec melanoma skmel cellsnan
no_relation,Cordycepin,neuroblastoma,22650004,cordycepin significantly inhibited proliferation human neuroblastoma sknbec human melanoma skmel cells ic values microm microm respectivelynan
no_relation,Cordycepin,melanoma,22650004,cordycepin significantly inhibited proliferation human neuroblastoma sknbec human melanoma skmel cells ic values microm microm respectivelynan
no_relation,heparan sulphate,HARP,22672269,work harp tested capacity modulate anticoagulant activity heparin heparan sulphate mimetics otrnan
no_relation,OTR4120,HARP,22672269,work harp tested capacity modulate anticoagulant activity heparin heparan sulphate mimetics otr4120 nan
no_relation,heparan sulphate,HARP,22672269,harp found differently effective neutralization anticoagulant activity mimetic heparan sulphate otr heparin purified system human plasmanan
no_relation,OTR4120,HARP,22672269,harp found differently effective neutralization anticoagulant activity mimetic heparan sulphate otr4120 heparin purified system human plasmanan
no_relation,heparin,HARP,22672269,harp found differently effective neutralization anticoagulant activity mimetic heparan sulphate otr heparin purified system human plasmanan
no_relation,OTR4120,HARP,22672269,harp shown compete antithrombin thrombin binding heparin otr4120 respectivelynan
no_relation,OTR4120,HARP,22672269,presence otr4120 vmax constant calculated maximum velocity umin thrombin km value nm affected harp concentrationsnan
no_relation,OTR4120,HARP,22672269,km harp value nm consistent high affinity harp otr4120 nan
no_relation,OTR4120,HARP,22672269,interestingly intraperitoneally administered harp decreased anticoagulant activity heparin otr4120 micenan
no_relation,angiotensin II,cardiac fibrosis,22673230,cardiac fibroblasts rats treated angiotensin ii berberine found suppress fibroblast activation collagen synthesis extent cardiac fibrosis upregulating relaxinnan
no_relation,berberine,cardiac fibrosis,22673230,cardiac fibroblasts rats treated angiotensin ii berberine found suppress fibroblast activation collagen synthesis extent cardiac fibrosis upregulating relaxinnansupress key term
no_relation,pimaric acid/PiMA,tumor,22705379,study revealed pimaric acid pima purified aralia cordata inhibitory effect mmp production migration human aortic smooth muscle cells hasmcs induced tumor necrosis factor tnf downregulated mmp mrna transcription detected pimatreated cells using rtpcr luciferasetagged mmp promoter assaynan
no_relation,pimaric acid/PiMA,necrosis,22705379,study revealed pimaric acid pima purified aralia cordata inhibitory effect mmp production migration human aortic smooth muscle cells hasmcs induced tumor necrosis factor tnf downregulated mmp mrna transcription detected pimatreated cells using rtpcr luciferasetagged mmp promoter assaynan
no_relation,PiMA,atherosclerotic,22705379,results suggest pima potent anti atherosclerotic activity inhibitory action mmp production cell migration tnfinduced hasmcsnan
no_relation,Schiff base,cancer,22705894,anti cancer activity mutagenic potential novel copperii quinolinone schiff base complexes hepatocarcinoma cellsnan
no_relation,Schiff base,hepatic carcinoma,22705894,study determined cytotoxic cytoselective mutagenic potential novel quinolinone schiff base ligands corresponding copperii complexes humanderived hepatic carcinoma cells hepg nonmalignant humanderived hepatic cells changnan
no_relation,Schiff bases,cytotoxicity,22705894,results indicated complexation quinolinone schiff bases copper served significantly enhance cytotoxicity nan
yes_direct,copper,cytotoxicity,22705894,results indicated complexation quinolinone schiff bases copper served significantly enhance cytotoxicity nan
no_relation,Chloroquine,colon cancer,22716215,chloroquine enhances chemotherapeutic activity 5-fluorouracil colon cancer cell line via cell cycle alterationnan
no_relation,5-fluorouracil,colon cancer,22716215,chloroquine enhances chemotherapeutic activity 5-fluorouracil colon cancer cell line via cell cycle alterationnan
no_relation,chloroquine,cancer,22716215,number cancer cell lines exposed chloroquine antimalarial drug aim inhibiting cell growth inducing cell deathnan
no_relation,chloroquine,cancer/colon cancer,22716215,study conducted investigate anti cancer effect autophagy inhibition using chloroquine together 5-fluorouracil fu colon cancer cell linenan
no_relation,5-FU/5-fluorouracil,cancer/colon cancer,22716215,study conducted investigate anti cancer effect autophagy inhibition using chloroquine together 5-fluorouracil 5-fu colon cancer cell linenan
no_relation,5-FU,colon cancer,22716215,human colon cancer dld cells treated 5-fu  chloroquine  combinationnan
no_relation,chloroquine,colon cancer,22716215,human colon cancer dld cells treated 5-fu  chloroquine  combinationnan
no_relation,5-FU,cytotoxicity,22716215,lcii protein increased treatment 5-fu chloroquine potentiated cytotoxicity 5-fu nan
yes_direct,chloroquine,cytotoxicity,22716215,lcii protein increased treatment fu chloroquine potentiated cytotoxicity funan
no_relation,chloroquine,cancer,22716215,results suggest chloroquine may potentiate anti cancer effect 5-fu via cell cycle inhibitionnan
no_relation,5-FU,cancer,22716215,results suggest chloroquine may potentiate anti cancer effect 5-fu via cell cycle inhibitionnan
no_relation,Chloroquine,cancer/colon cancer,22716215,chloroquine potentiates anti cancer effect 5-fu colon cancer cellsnan
no_relation,5-FU,cancer/colon cancer,22716215,chloroquine potentiates anti cancer effect 5-fu colon cancer cellsnan
no_relation,chloroquine,cancer,22716215,supplementation conventional chemotherapy chloroquine may provide new cancer therapy modalitynan
no_relation,taurolidine,sepsis,22727544,evaluated immunomodulatory role amino-acid derivative taurolidine vitro sepsis modelnan
no_relation,amino-acid,sepsis,22727544,evaluated immunomodulatory role amino-acid derivative taurolidine vitro sepsis modelnan
no_relation,Taurolidine,necrosis,22727544,taurolidine inhibited immunoglobulin il il tumor necrosis factoralpha expression dose dependentfashion pediatric oncology patients healthy controlsnan
no_relation,propranolol,hemangiomas,22727954,outpatient treatment infantile hemangiomas propranolol prospective studynan
no_relation,propranolol,hemangiomas,22727954,assess thesafety effectiveness oral propranolol op treatment infantile hemangiomas nan
no_relation,propranolol,hemangiomas,22727954,conducted prospective study infantile hemangiomas ihs treated oral propranolol october march nan
no_relation,propranolol,hemangiomas,22727954,oral propranolol clinically effective reducing volume color infantile hemangiomas although reduction complete telangiectasia scarring persisted treatmentnan
no_relation,propranolol,telangiectasia,22727954,oral propranolol clinically effective reducing volume color infantile hemangiomas although reduction complete telangiectasia scarring persisted treatmentnan
no_relation,ATRA,APL,22729365,patients apl alone significantly sensitive treatment atra patients additional cytogenetic abnormalitiesnan
no_relation,ondansetron,prophylaxis of postoperative vomiting,22731240,dexamethasone versus ondansetron combination dexamethasone prophylaxis postoperative vomiting pediatric outpatients doubleblind randomized placebocontrolled clinical trialnan
no_relation,Dexamethasone,prophylaxis of postoperative vomiting,22731240,dexamethasone versus ondansetron combination dexamethasone prophylaxis postoperative vomiting pediatric outpatients doubleblind randomized placebocontrolled clinical trialnan
no_relation,ondansetron,Postoperative vomiting,22731240,postoperative vomiting occurred children statistically significant difference groups group receiving ondansetron combined dexamethasone placebo group group received dexamethasone alone nanused notsouseful prevention
yes_direct,dexamethasone,Postoperative vomiting,22731240,postoperative vomiting occurred children statistically significant difference groups group receiving ondansetron combined dexamethasone  placebo group group received dexamethasone alone nan
no_relation,steroid,SD,22731702,steroid treatment recurrences occurred corresponding mean   sd relapses per yearnan
yes_direct,prednisone,SD,22731702,first treatment prednisone patients experienced relapses representing mean   sd relapses per year nan
no_relation,ATP,neurodegenerative diseases,22743330,addition atp synthesis mitochondria key regulators calcium homeostasis free radical production steroid synthesis apoptosis factors could also associated essential mechanisms involved neurodegenerative diseases nan
no_relation,calcium,neurodegenerative diseases,22743330,addition atp synthesis mitochondria key regulators calcium homeostasis free radical production steroid synthesis apoptosis factors could also associated essential mechanisms involved neurodegenerative diseases nan
no_relation,steroid,neurodegenerative diseases,22743330,addition atp synthesis mitochondria key regulators calcium homeostasis free radical production steroid synthesis apoptosis factors could also associated essential mechanisms involved neurodegenerative diseases nan
no_relation,corticosteroids,ipsilateral ear vesicles,22772935,report case ramsay hunt syndrome immune compromised patient classic facial nerve palsy ipsilateral ear vesicles rapidly evolved involve multiple cranial neuropathies improved dramatically antiviral therapy corticosteroids nanimproved dramatically key term
no_relation,corticosteroids,Ramsay Hunt syndrome,22772935,report case ramsay hunt syndrome immune compromised patient classic facial nerve palsy ipsilateral ear vesicles rapidly evolved involve multiple cranial neuropathies improved dramatically antiviral therapy corticosteroids nan
no_relation,corticosteroids,multiple cranial neuropathies,22772935,report case ramsay hunt syndrome immune compromised patient classic facial nerve palsy ipsilateral ear vesicles rapidly evolved involve multiple cranial neuropathies improved dramatically antiviral therapy corticosteroids nan
no_relation,corticosteroids,facial nerve palsy,22772935,report case ramsay hunt syndrome immune compromised patient classic facial nerve palsy ipsilateral ear vesicles rapidly evolved involve multiple cranial neuropathies improved dramatically antiviral therapy corticosteroids nan
no_relation,acyclovir,multiple cranial neuropathies,22772935,varicella zoster virus considered cause multiple cranial neuropathies immune compromised patient abrupt treatment acyclovir initiated diagnosis suspectednan
no_relation,tyrosine,adenocarcinomas,22773546,aimed determine whether receptor tyrosine kinase rtk array could used select effective therapeutic strategies molecularly heterogeneous oesophagogastric adenocarcinomas nan
yes_direct,Roxithromycin,toxic epidermal necrolysis,22777150,roxithromycin induced toxic epidermal necrolysis nan
yes_direct,roxithromycin,adverse drug reaction/TEN/toxic epidermal necrolysis,22777150,case report highlights rare adverse drug reaction oral roxithromycin causing toxic epidermal necrolysis ten nan
no_relation,roxithromycin,upper respiratory tract infection,22777150,yearold male patient diagnosed upper respiratory tract infection prescribed oral roxithromycin mg twice daily daysnan
yes_direct,roxithromycin,TEN,22777150,episode ten probably drug roxithromycin inducednan
yes_direct,roxithromycin,adverse drug reaction/TEN,22777150,naranjo adverse drug reaction probability scale suggested likelihood oral administration roxithromycin responsible ten probablenan
no_relation,mycophenolic acid/MPA,gastrointestinal (GI) complications,22811345,evaluate incidence gastrointestinal gi complications solid organ transplant sot recipients impact complications transplant outcomes potential interactions mycophenolic acid mpa derivatives proton pump inhibitors ppisnan
no_relation,mycophenolic acid,GI complications,22811345,unrestricted literature search january performed medline embase using following key words drugdrug interaction entericcoated mycophenolic acid gi complications mycophenolate mofetil solid organ transplant proton pump inhibitor including individual agents within classnan
no_relation,mycophenolate mofetil,GI complications,22811345,unrestricted literature search january performed medline embase using following key words drugdrug interaction entericcoated mycophenolic acid gi complications mycophenolate mofetil solid organ transplant proton pump inhibitor including individual agents within classnan
no_relation,tacrolimus,ocular graft versus host disease,22870021,therapeutic effect tacrolimus ointment ocular graft versus host disease vernal keratoconjunctivitisnan
no_relation,tacrolimus,vernal keratoconjunctivitis,22870021,therapeutic effect tacrolimus ointment ocular graft versus host disease vernal keratoconjunctivitis nan
no_relation,tacrolimus,ocular graft versus host disease/GVHD,22870021,determine whether topical tacrolimus might prove effective treatment refractory anterior segment inflammatory diseases evaluate efficacy eyes ocular graft versus host disease gvhd vernal keratoconjunctivitis vkcnan
no_relation,tacrolimus,inflammatory diseases,22870021,determine whether topical tacrolimus might prove effective treatment refractory anterior segment inflammatory diseases evaluate efficacy eyes ocular graft versus host disease gvhd vernal keratoconjunctivitis vkcnan
no_relation,tacrolimus,vernal keratoconjunctivitis/VKC,22870021,determine whether topical tacrolimus might prove effective treatment refractory anterior segment inflammatory diseases evaluate efficacy eyes ocular graft versus host disease gvhd vernal keratoconjunctivitis vkc nan
no_relation,tacrolimus,inflammation,22870021,twentyeight eyes patients anterior segment inflammation refractory steroid treatment treated tacrolimus ointment samsung medical center seoul korea march august nan
no_relation,steroid,inflammation,22870021,twentyeight eyes patients anterior segment inflammation refractory steroid treatment treated tacrolimus ointment samsung medical center seoul korea march august nan
no_relation,tacrolimus,inflammatory disease,22870021, tacrolimus ointment safe effective use anterior segment inflammatory disease refractory steroidnanused treatment
no_relation,steroid,inflammatory disease,22870021, tacrolimus ointment safe effective use anterior segment inflammatory disease refractory steroid nan
yes_direct,levodopa,fractures,22875460,recurrent bilateral metatarsal stressandinsufficiency fractures levodopa treated young woman parkinson's diseasenan
no_relation,levodopa,Parkinson's disease,22875460,recurrent bilateral metatarsal stressandinsufficiency fractures levodopa treated young woman parkinson's disease nan
no_relation,Levodopa,disease course,22875460,levodopa treatment parkinson's disease effective many types adverse events complicate disease course especially dyskinesiasnan
yes_direct,Levodopa,dyskinesias,22875460,levodopa treatment parkinson's disease effective many types adverse events complicate disease course especially dyskinesias nan
no_relation,Levodopa,Parkinson's disease,22875460,levodopa treatment parkinson's disease effective many types adverse events complicate disease course especially dyskinesiasnan
yes_indirect,levodopa,osteoporotic fractures,22875460,calcif tissue int  levodopa intake associated increased homocysteinemia known linked poorer bone quality consequently osteoporotic fractures nan
yes_direct,levodopa,homocysteinemia,22875460,calcif tissue int  levodopa intake associated increased homocysteinemia known linked poorer bone quality consequently osteoporotic fracturesnan
yes_direct,levodopa,fractures,22875460,herein report case young woman suffered recurrent metatarsal fractures context levodopa treated earlyonset parkinson's diseasenan
no_relation,levodopa,Parkinson's disease,22875460,herein report case young woman suffered recurrent metatarsal fractures context levodopa treated earlyonset parkinson's disease nan
yes_direct,haloperidol,catalepsy,22892116,thpp displays significantly fewer preclinical adverse events assays measuring prolactin secretion catalepsy weight gain contrast typical atypical antipsychotics haloperidol olanzapinenan
yes_direct,olanzapine,weight gain,22892116,thpp displays significantly fewer preclinical adverse events assays measuring prolactin secretion catalepsy weight gain contrast typical atypical antipsychotics haloperidol olanzapine nan
no_relation,haloperidol,weight gain,22892116,thpp displays significantly fewer preclinical adverse events assays measuring prolactin secretion catalepsy weight gain contrast typical atypical antipsychotics haloperidol olanzapinenan
no_relation,olanzapine,catalepsy,22892116,thpp displays significantly fewer preclinical adverse events assays measuring prolactin secretion catalepsy weight gain contrast typical atypical antipsychotics haloperidol olanzapine nan
no_relation,cisplatin,neuroblastoma,22892391,microrna increases sensitivity neuroblastoma cells cisplatin associated favourable clinical outcomenan
no_relation,cisplatin,neuroblastoma,22892391,mir novel predictor outcome neuroblastoma functioning least part increasing sensitivity cisplatin direct targeting downregulation antiapoptotic bcl mir also targets fulllength ntrk potent oncogene involved chemotherapy drug resistance neuroblastoma nan
yes_direct,fingolimod,multiple sclerosis,22907938,severe multiple sclerosis reactivation fingolimod months natalizumab withdrawalnan
yes_direct,fingolimod,multiple sclerosis,22907938,report case woman multiple sclerosis developed severe neurological condition following natalizumab nzb withdrawal soon fingolimod fty initiationnan
yes_direct,fingolimod,neurological condition,22907938,report case woman multiple sclerosis developed severe neurological condition following natalizumab nzb withdrawal soon fingolimod fty initiationnan
no_relation,benzo[a]pyrene,HNSCC,22912337,treatment cell lines ahr antagonists  trimethoxyflavone potent gnf decreased migration invasion hnscc cells prevented benzo[a]pyrene mediated induction chemotherapy efflux protein abcgnan
no_relation,zanamivir,influenza-like illness,22932170,uncontrolled openlabel multicenter study monitor antiviral activity safety inhaled zanamivir rotadisk via diskhaler device among chinese adolescents adults influenzalike illness nan
no_relation,zanamivir,influenza-like illness/ILI,22932170,first multicenter clinical study china investigate zanamivir use among chinese adolescents adults influenzalike illness ili since inhaled zanamivir relenza marketed chinanan
no_relation,zanamivir,ILI,22932170,uncontrolled openlabel multicentre study evaluate antiviral activity safety inhaled zanamivir rotadisk via diskhaler device mg administered twice daily days subjects  years old ili nan
yes_direct,zanamivir,Bronchospasm,22932170,bronchospasm found years old woman whose symptoms disappeared stopping zanamivir without additional treatmentnan
no_relation,tyrosine,Hypothyroidism,22933166,hypothyroidism treatment tyrosine kinase inhibitorsnan
no_relation,Tyrosine,pancreatic neuroendocrine tumours/gastrointestinal stromal tumours,22933166,tyrosine kinase inhibitors relatively new targeted therapy drugs used treatment metastatic clear cell kidney carcinoma gastrointestinal stromal tumours thyroid carcinoma pancreatic neuroendocrine tumours progression diseasenan
no_relation,Tyrosine,clear cell kidney carcinoma,22933166,tyrosine kinase inhibitors relatively new targeted therapy drugs used treatment metastatic clear cell kidney carcinoma gastrointestinal stromal tumours thyroid carcinoma pancreatic neuroendocrine tumours progression diseasenan
no_relation,Tyrosine,thyroid carcinoma,22933166,tyrosine kinase inhibitors relatively new targeted therapy drugs used treatment metastatic clear cell kidney carcinoma gastrointestinal stromal tumours thyroid carcinoma pancreatic neuroendocrine tumours progression diseasenan
no_relation,tyrosine,hypothyroidism,22933166,described tyrosine kinase inhibitor causes hypothyroidism nan
no_relation,sorafenib,renal cell carcinoma,22933166,symptoms hypothyroidism occur patients treated sorafenib due metastatic renal cell carcinoma nan
yes_direct,sorafenib,hypothyroidism,22933166,symptoms hypothyroidism occur patients treated sorafenib due metastatic renal cell carcinomanan
no_relation,oestrogen,bleeding,22972055,progestogens without oestrogen irregular uterine bleeding associated anovulationnan
no_relation,oestrogen,anovulation,22972055,progestogens without oestrogen irregular uterine bleeding associated anovulation nan
yes_direct,steroids,menstrual bleeding,22972055,irregular menstrual bleeding may arise due exogenous sex steroids lesions genital tract associated anovulationnan
no_relation,steroids,anovulation,22972055,irregular menstrual bleeding may arise due exogenous sex steroids lesions genital tract associated anovulation nan
yes_indirect,oestrogen,bleeding,22972055,anovulatory cycles may prolonged oestrogen stimulation endometrium without progesterone withdrawal cycles irregular bleeding may heavynan
no_relation,progesterone,bleeding,22972055,anovulatory cycles may prolonged oestrogen stimulation endometrium without progesterone withdrawal cycles irregular bleeding may heavynan
no_relation,oestrogen,anovulatory cycles,22972055,anovulatory cycles may prolonged oestrogen stimulation endometrium without progesterone withdrawal cycles irregular bleeding may heavynan
no_relation,progesterone,anovulatory cycles,22972055,anovulatory cycles may prolonged oestrogen stimulation endometrium without progesterone withdrawal cycles irregular bleeding may heavynan
no_relation,oestrogen,endometrial atrophy,22972055,continuous progestogen intended induce endometrial atrophy hence prevent oestrogen stimulated endometrial proliferationnan
no_relation,oestrogens,menstrual bleeding,22972055,progestogens oestrogens progestogens combination widely used management irregular menstrual bleeding regime dose type progestogen used vary widely little consensus optimum treatment approachnan
no_relation,progestogens,menstrual bleeding,22972055,determine effectiveness acceptability progestogens alone combination oestrogens regulation irregular menstrual bleeding associated oligoanovulationnan
no_relation,progestogens,anovulation,22972055,determine effectiveness acceptability progestogens alone combination oestrogens regulation irregular menstrual bleeding associated oligo anovulation nan
no_relation,oestrogens,menstrual bleeding,22972055,determine effectiveness acceptability progestogens alone combination oestrogens regulation irregular menstrual bleeding associated oligoanovulationnan
no_relation,oestrogens,anovulation,22972055,determine effectiveness acceptability progestogens alone combination oestrogens regulation irregular menstrual bleeding associated oligo anovulation nan
no_relation,oestrogens,menstrual bleeding,22972055,randomised controlled trials progestogens via route alone combination oestrogens treatment irregular menstrual bleeding associated oligoanovulationnan
no_relation,oestrogens,anovulation,22972055,randomised controlled trials progestogens via route alone combination oestrogens treatment irregular menstrual bleeding associated oligo anovulation nan
no_relation,oestrogens,bleeding,22972055,randomised trials identified compared progestogens oestrogens progestogens placebo management irregular bleeding associated oligoanovulationnan
no_relation,oestrogens,anovulation,22972055,randomised trials identified compared progestogens oestrogens progestogens placebo management irregular bleeding associated oligo anovulation nan
no_relation,oestrogens,menstrual bleeding,22972055,paucity randomised studies relating use progestogens oestrogens progestogens combination treatment irregular menstrual bleeding associated anovulationnan
no_relation,oestrogens,anovulation,22972055,paucity randomised studies relating use progestogens oestrogens progestogens combination treatment irregular menstrual bleeding associated anovulation nan
no_relation,prasugrel,Myocardial Infarction,22995726,data patients undergoing isolated coronary artery bypass grafting trial assess improvement therapeutic outcomes optimizing platelet inhibition prasugrel thrombolysis myocardial infarction analyzed retrospectivelynan
no_relation,pioglitazone,obese,22999793,free carnitine acylcarnitines obese patients polycystic ovary syndrome effects pioglitazone treatmentnan
no_relation,carnitine,obese,22999793,free carnitine acylcarnitines obese patients polycystic ovary syndrome effects ofpioglitazone treatmentnan
no_relation,pioglitazone,polycystic ovary syndrome,22999793,free carnitine acylcarnitines inobese patients polycystic ovary syndrome effects pioglitazone treatmentnan
no_relation,carnitine,polycystic ovary syndrome,22999793,free carnitine acylcarnitines inobese patients polycystic ovary syndrome effects ofpioglitazone treatmentnan
no_relation,carnitine,polycystic ovary syndrome/PCOS,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcos nan
no_relation,pioglitazone,obese,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcosnan
no_relation,pioglitazone,total and free carnitine,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcosnan
no_relation,carnitine,total and free carnitine,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcosnan
no_relation,carnitine,obese,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcosnan
no_relation,pioglitazone,polycystic ovary syndrome/PCOS,22999793,determine fasting insulinstimulated levels carnitine precursors total free carnitine acylcarnitines evaluate impact pioglitazone treatment obese patients polycystic ovary syndrome pcos nan
no_relation,carnitine,total and free carnitine,22999793,contrary controls patients pcos characterized slightly lower levels fasting total free carnitine precursors derivativesnan
no_relation,carnitine,PCOS,22999793,contrary controls patients pcos characterized slightly lower levels fasting total free carnitine precursors derivativesnan
no_relation,carnitine,PCOS,22999793,total free carnitine correlated inversely sex hormonebinding globulin shbg patients pcos whereas associations found acylcarnitines androgenesnan
no_relation,carnitine,total and free carnitine,22999793,insulin stimulationinduced changes levels total free carnitine carnitine precursors acylcarnitines pcos group followed trends control groupnan
no_relation,carnitine,PCOS,22999793,insulin stimulationinduced changes levels total free carnitine carnitine precursors acylcarnitines pcos group followed trends control groupnan
no_relation,metformin,polycystic ovary syndrome,23006146,potential metformin prevent preterm delivery women polycystic ovary syndrome epianalysisnan
no_relation,metformin,preterm delivery,23006146,potential metformin prevent preterm delivery women polycystic ovary syndrome epianalysisnan
no_relation,metformin,polycystic ovary syndrome/PCOS,23006146,aim reevaluate whether metformin may reduce late miscarriagepreterm delivery pre-eclampsia gestational diabetes women polycystic ovary syndrome pcos nan
no_relation,metformin,preterm delivery,23006146,aim reevaluate whether metformin may reduce late miscarriage preterm delivery pre-eclampsia gestational diabetes women polycystic ovary syndrome pcosnan
no_relation,metformin,gestational diabetes,23006146,aim reevaluate whether metformin may reduce late miscarriagepreterm delivery pre-eclampsia gestational diabetes women polycystic ovary syndrome pcosnan
no_relation,metformin,pre-eclampsia,23006146,aim reevaluate whether metformin may reduce late miscarriagepreterm delivery pre-eclampsia gestational diabetes women polycystic ovary syndrome pcosnan
no_relation,metformin,preterm delivery,23006146,metformin treated patients less late miscarriage preterm delivery five vs  placebo groupnan
no_relation,metformin,gestational diabetes,23006146,difference prevalence gestational diabetes pre-eclampsia metformin placebo groupnan
no_relation,metformin,pre-eclampsia,23006146,difference prevalence gestational diabetes pre-eclampsia metformin placebo groupnan
no_relation,metformin,PCOS,23006146,epianalysis metformin treatment pregnancy seems reduce early delivery women pcos nan
yes_direct,amiodarone,pneumonia,23018901,vivo probebased confocal laser endomicroscopy amiodarone related pneumonia nan
yes_direct,amiodarone,pneumonia,23018901,objective study assess diagnostic accuracy pcle amiodarone related pneumonia amripnan
no_relation,amiodarone,interstitial lung disease/ILD,23018901,alveolar pcle performed nonsmoking patients including consecutive patients acute subacute interstitial lung disease ild  undergoing treatment amiodarone three amiodarone treated patients without ild nan
no_relation,amiodarone,HP-AMR-IP,23018901,contrast cells observed two areas lpamrip patients one areas ild patients receiving amiodarone none areas amiodarone treated patients without ild hp-amr-ip versus groupsnan
no_relation,amiodarone,ILD,23018901,contrast cells observed two areas lpamrip patients one areas ild patients receiving amiodarone none areas amiodarone treated patients without ildnan
no_relation,penicillin,syphilis,23054260, amid world war penicillin found effective treatment syphilis nan
no_relation,penicillin,syphilis,23054260,study investigated hypothesis decrease cost syphilis due penicillin spurred increase risky nontraditional sexnan
no_relation,penicillin,syphilis,23054260,together findings supported notion discovery penicillin decreased cost syphilis thereby played important role shaping modern sexualitynan
no_relation,oxygen,OS,23072926,aim study response lymphomonocyte os status reactive oxygen species byproducts oral unsaturated fat load test oflt fh compare response obtained normolipidemic normoglycemic subjectsnan
no_relation,"3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide",CRC,23125081,stoverexpressed stknockdown crc cells constructed respectively lentiviral transduction followed dimethylthiazolyldiphenyl tetrazolium bromide mtt assay plate colony formation cellcycle analysis migration assays evaluate influence st proliferation migration vitronan
no_relation,glucose,diabetes,23144172,notably high glucose treatment diabetes reduced mir levels cd pbmcs associated impaired proangiogenic properties could rescued mirmimic treatmentnan
no_relation,Carbapenems,infections,23154047,carbapenems important antimicrobial agents treating infections due multidrug resistant acinetobacter sppnan
no_relation,berberine,cancer,23182088,strikingly nonetheless six compounds prepared sample farnesyl osubstituted berberine showed either comparable better cytotoxic activity human cancer hepg cell line berberine nan
no_relation,berberine,hepatoma,23182088,compound also shown fold antiproliferation activity compare berberine human hepatoma hepg cell lines incubation hoursnan
no_relation,Neostigmine,analgesia,23185923,neostigmine anticholinesterase presents novel approach providing analgesia nan
yes_direct,Neostigmine,analgesia,23185923,neostigmine given intrathecally inhibits breakdown endogenous spinal neurotransmitter acetylcholine thereby inducing analgesia nan
no_relation,acetylcholine,analgesia,23185923,neostigmine given intrathecally inhibits breakdown endogenous spinal neurotransmitter acetylcholine thereby inducing analgesia nan
no_relation,neostigmine,analgesia,23185923,mean duration effective analgesia  minutes neostigmine group compared saline group  minutesnanthough technically analgesia disease
yes_direct,neostigmine,analgesia,23185923,study showed spinal neostigmine microg added hyperbaric bupivacaine fentanyl provided significantly longer surgical analgesia insignificant adverse effects male adults lower abdominal surgery spinal anaesthesianan
yes_direct,bupivacaine,analgesia,23185923,study showed spinal neostigmine microg added hyperbaric bupivacaine fentanyl provided significantly longer surgical analgesia insignificant adverse effects male adults lower abdominal surgery spinal anaesthesianan
yes_direct,fentanyl,analgesia,23185923,study showed spinal neostigmine microg added hyperbaric bupivacaine fentanyl provided significantly longer surgical analgesia insignificant adverse effects male adults lower abdominal surgery spinal anaesthesianan
no_relation,Axitinib,renal cell carcinoma,23190347,axitinib advanced treatmentexperienced renal cell carcinoma nan
no_relation,sorafenib,renal cell carcinoma,23190347,pivotal phase iii trial patients advanced renal cell carcinoma progressed despite firstline therapy axitinib mg twice daily significantly prolonged median progressionfree survival primary endpoint compared sorafenib mg twice dailynan
no_relation,axitinib,renal cell carcinoma,23190347,pivotal phase iii trial patients advanced renal cell carcinoma progressed despite firstline therapy axitinib mg twice daily significantly prolonged median progressionfree survival primary endpoint compared sorafenib mg twice dailynan
no_relation,axitinib,death,23190347,significantly axitinib sorafenib recipients achieved objective response axitinib therapy significantly prolonged time deterioration composite endpoint death disease progression symptom worsening relative sorafenib therapynan
no_relation,sorafenib,death,23190347,significantly axitinib sorafenib recipients achieved objective response axitinib therapy significantly prolonged time deterioration composite endpoint death disease progression symptom worsening relative sorafenib therapynan
yes_direct,axitinib,palmar-plantar erythrodysaesthesia,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnan
no_relation,sorafenib,palmar-plantar erythrodysaesthesia,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnan
yes_direct,axitinib,toxicity,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnancutaneous toxicity toxicity
yes_direct,axitinib,anaemia,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnan
no_relation,sorafenib,anaemia,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnan
no_relation,sorafenib,toxicity,23190347,tolerability profile generally consistent vegf receptor inhibitors axitinib associated numerically lower incidence palmarplantar erythrodysaesthesia cutaneous toxicity anaemia sorafenib phase iii trialnan
no_relation,pinocembrin,atherosclerosis,23216643,inhibitory effect combination therapy simvastatin pinocembrin atherosclerosis apoedeficient micenan
no_relation,simvastatin,atherosclerosis,23216643,inhibitory effect combination therapy simvastatin pinocembrin atherosclerosis apoedeficient micenan
no_relation,simvastatin,hyperlipidemia,23216643,combination simvastatin pinocembrin synergistically inhibited atherosclerotic lesion development apoe mice hyperlipidemia partially dependent protective vascular endotheliumnan
no_relation,pinocembrin,hyperlipidemia,23216643,combination simvastatin pinocembrin synergistically inhibited atherosclerotic lesion development apoe mice hyperlipidemia partially dependent protective vascular endotheliumnanused treatment
no_relation,alvespimycin,HCC,23220021,using svm several known hcc inhibitors geldanamycin alvespimycin hsp inhibitors doxorubicin chemotherapy drug predictednan
no_relation,geldanamycin,HCC,23220021,using svm several known hcc inhibitors geldanamycin alvespimycin hsp inhibitors doxorubicin chemotherapy drug predictednan
no_relation,doxorubicin,HCC,23220021,using svm several known hcc inhibitors geldanamycin alvespimycin hsp inhibitors doxorubicin chemotherapy drug predictednan
no_relation,methotrexate/MTX,acute lymphoblastic leukemia,23222202,polymorphisms methotrexate transport pathway new tool mtx plasma level prediction pediatric acute lymphoblastic leukemia nan
no_relation,Methotrexate/MTX,acute lymphoblastic leukemia/ALL,23222202,methotrexate mtx important component therapy pediatric acute lymphoblastic leukemia nan
yes_direct,MTX,toxicity,23222202,treatment mtx often causes toxicity necessitate dose reduction treatment cessationnan
yes_direct,MTX,toxicity,23222202,slcob transporter involved mtx elimination polymorphisms genes pathway could also role mtx toxicity nanpolymorphisms genes pathway causes toxicity
no_relation,MTX,ALL,23222202,aim present study analyze depth role polymorphisms genes mtx transport pathway putative toxicity predictors pediatric nan
no_relation,MTX,toxicity,23222202,aim present study analyze depth role polymorphisms genes mtx transport pathway putative toxicity predictors pediatricnan
no_relation,MTX,ALL,23222202,results suggest polymorphisms abcc abcc could novel markers mtx toxicity pediatric nan
yes_direct,MTX,toxicity,23222202,results suggest polymorphisms abcc abcc could novel markers mtx toxicity pediatricnanpolymorphisms abcc abcc causes toxicity
no_relation,Ursolic acid,prostate cancer,23247106,ursolic acid sensitizes prostate cancer cells trailmediated apoptosisnan
no_relation,ursolic acid,prostate cancer,23247106,investigated sensitizing effects ursolic acid ua pentacyclic triterpenoid found many plants trailinduced prostate cancer cell apoptosisnan
no_relation,nucleoside,TDRM,23259924,prevalence hiv tdrm nucleoside reverse transcriptase inhibitors nonnucleoside reverse transcriptase inhibitors protease inhibitorsnan
no_relation,lenalidomide,MM,23265189,immunomodulatory agents imids thalidomide lenalidomide changed landscape treatment patients mm newer imids pomalidomide showing promise early clinical trialsnan
no_relation,pomalidomide,MM,23265189,immunomodulatory agents imids thalidomide lenalidomide changed landscape treatment patients mm newer imids pomalidomide showing promise early clinical trialsnan
no_relation,thalidomide,MM,23265189,immunomodulatory agents imids thalidomide lenalidomide changed landscape treatment patients mm newer imids pomalidomide showing promise early clinical trialsnan
no_relation,Lenalidomide,better toxicity,23265189,lenalidomide better toxicity profile thalidomidenan
no_relation,thalidomide,better toxicity,23265189,lenalidomide better toxicity profile thalidomide nan
yes_direct,Paraquat,poisoning,23291665,paraquat dimethylbipyridinium chloride pq nonselective herbicide pq poisoning accidental intentional ingestion cause numerous fatalities around world every yearnan
no_relation,amino acids,deletion,23326576,furthermore deletion substitution nterminal amino acids dj resulted relocalization ea mi lp dj mitochondria cytoplasmnan
yes_direct,thapsigargin,endoplasmic reticulum,23335849,xbp mrna splicing expression endoplasmic reticulum stress response genes determined cells exposed thapsigargin presence absence quinotrierixinnan
no_relation,quinotrierixin,endoplasmic reticulum,23335849,xbp mrna splicing expression endoplasmic reticulum stress response genes determined cells exposed thapsigargin presence absence quinotrierixin nan
no_relation,thapsigargin,endoplasmic reticulum,23335849,cells exposed thapsigargin quinotrierixin inhibited xbp mrna splicing pkrlike endoplasmic reticulum kinase activation reduced cellular nuclear levels spliced xbp cebp homologous proteinnan
no_relation,quinotrierixin,endoplasmic reticulum,23335849,cells exposed thapsigargin quinotrierixin inhibited xbp mrna splicing pkrlike endoplasmic reticulum kinase activation reduced cellular nuclear levels spliced xbp cebp homologous proteinnan
yes_direct,quinotrierixin,endoplasmic reticulum,23335849,paradoxically quinotrierixin exacerbated endoplasmic reticulum stressinduced phosphorylation eif turn led decreased protein translationnan
no_relation,quinotrierixin,Paradoxically,23335849,paradoxically quinotrierixin exacerbated endoplasmic reticulum stressinduced phosphorylation eif turn led decreased protein translationnan
no_relation,quinotrierixin,proliferative vitreoretinopathy,23335849,future studies needed investigate vivo effect quinotrierixin rpe proliferation animal models proliferative vitreoretinopathy nan
no_relation,somatostatin,neuroendocrine tumors,23339764,treatment patients inoperable metastasized neuroendocrine tumors somatostatin analogues labeled radioisotopes lu used farnan
no_relation,somatostatin,tumor,23339764,labeling mainly auger electron emitter resulted reduction tumor size somatostatin analogues labeled lu gave overall positive response improved patients quality lifenan
no_relation,Flavonoids,breast cancer,23349849,flavonoids flavonoid subclasses breast cancer risk metaanalysis epidemiologic studiesnan
no_relation,flavonoids,carcinogenesis,23349849,studies suggested chemopreventive effects flavonoids carcinogenesis nanchemopreventive key term
no_relation,flavonoids,breast cancer,23349849,yet numbers epidemiologic studies assessing dietary flavonoids breast cancer risk yielded inconsistent resultsnanused possible prevention
no_relation,flavonoids,breast cancer,23349849,association flavonoids flavonoid subclasses flavonols flavanols etc risk breast cancer lacks systematic analysisnan
no_relation,flavonoids,breast cancer,23349849,aimed examine association flavonoids flavonoid subclass except isoflavones risk breast cancer conducting metaanalysisnan
no_relation,isoflavones,breast cancer,23349849,aimed examine association flavonoids flavonoid subclass except isoflavones risk breast cancer conducting metaanalysisnan
no_relation,flavones,breast cancer,23349849,risk breast cancer significantly decreased women high intake flavonols rr ci flavones rr ci compared low intake flavonols flavones nan
no_relation,flavonoids,breast cancer,23349849,however significant association flavanols rr ci flavanones summary rr ci anthocyanins summary rr ci total flavonoids summary rr ci intake breast cancer risk observednan
no_relation,flavanones,breast cancer,23349849,however significant association flavanols rr ci flavanones summary rr ci anthocyanins summary rr ci total flavonoids summary rr ci intake breast cancer risk observednan
no_relation,anthocyanins,breast cancer,23349849,however significant association flavanols rr ci flavanones summary rr ci anthocyanins summary rr ci total flavonoids summary rr ci intake breast cancer risk observednan
no_relation,flavones,breast cancer,23349849,furthermore summary rrs casecontrol studies stratified menopausal status suggested flavonols flavones flavanols intake associated significant reduced risk breast cancer postmenopausal premenopausal womennan
no_relation,flavonoids,breast cancer,23349849,present study suggests intake flavonols flavones flavonoid subclasses total flavonoids associated decreased risk breast cancer especially among postmenopausal womennan
no_relation,flavones,breast cancer,23349849,present study suggests intake flavonols flavones flavonoid subclasses total flavonoids associated decreased risk breast cancer especially among postmenopausal womennan
no_relation,methionine,colon cancer,23363077,fluorinated nndialkylaminostilbenes repress colon cancer targeting methionine sadenosyltransferasenan
no_relation,linoleic acid,breast cancer,23375583,antiproliferative proapoptotic effects trans trans conjugated linoleic acid isomer mcf breast cancer cells associated lxr activationnan
no_relation,linoleic acids,breast cancer,23375583,conjugated linoleic acids cla naturally found dairy products ruminant meat positional geometric isomers trans cis linoleic acid widely reported possess antitumoral activity breast cancer vitro vivonan
no_relation,linoleic acid,breast cancer,23375583,conjugated linoleic acids cla naturally found dairy products ruminant meat positional geometric isomers trans cis linoleic acid widely reported possess antitumoral activity breast cancer vitro vivonan
yes_direct,5-FU,toxicities,23386105,drug resistance severe toxicities limitations handling 5-fu nan
no_relation,folinic acid,toxicity,23386105,developed triple liposomal formulation 5-fu combined 2'-deoxyinosine folinic acid improve efficacy toxicity balancenan
no_relation,2'-deoxyinosine,toxicity,23386105,developed triple liposomal formulation 5-fu combined 2'-deoxyinosine folinic acid improve efficacy toxicity balancenan
no_relation,5-FU,toxicity,23386105,developed triple liposomal formulation 5-fu combined 2'-deoxyinosine folinic acid improve efficacy toxicity balancenan
no_relation,5-FU,DPD-deficiency,23386105,beside milder neutropenia observed giving lipofufol animals transient partial dpd-deficiency compared standard 5-fu nan
no_relation,5-FU,neutropenia,23386105,beside milder neutropenia observed giving lipofufol animals transient partial dpddeficiency compared standard 5-fu nan
no_relation,5-FU,toxicity,23386105,issues drugresistance drugrelated toxicity addressed using stealth liposomal formulation modulated 5-fu nan
no_relation,temozolomide,tumor,23389760,propose mathematical model takes account classical maximum tolerated dose mtd chemotherapy regimen whose primary targets tumor cells well metronomic chemotherapy regimen whose primary targets tumor endothelial cells administration temozolomide temodal order compare effectiveness two types protocolsnan
no_relation,temozolomide,tumor/cancer,23389760,model built natural hypotheses without treatment tumor growth follows gompertz model endothelial cells sensitive temozolomide cancer cells antiangiogenic effect blocks tumor growth endothelial cells genetically stable cancer cells thus less likely develop resistance temozolomide nan
no_relation,temozolomide,blocks tumor,23389760,model built natural hypotheses without treatment tumor growth follows gompertz model endothelial cells sensitive temozolomide cancer cells antiangiogenic effect blocks tumor growth endothelial cells genetically stable cancer cells thus less likely develop resistance temozolomide nan
no_relation,temozolomide,tumor/cancer,23389760,mathematical model shows metronomic regimen induces tumor regression antiangiogenic effects mtd regimen fails due emergence temozolomide resistance cancer cellsnan
no_relation,Sildenafil,myocardial infarction,23406672,sildenafil diastolic dysfunction acute myocardial infarction patients preserved ejection fraction sildenafil diastolic dysfunction acute myocardial infarction sidami trialnan
no_relation,Sildenafil,diastolic dysfunction,23406672,sildenafil diastolic dysfunction acute myocardial infarction patients preserved ejection fraction sildenafil diastolic dysfunction acute myocardial infarction sidami trialnan
no_relation,sildenafil,myocardial infarction,23406672,hypothesized sildenafil would reduce filling pressure exercise patients diastolic dysfunction myocardial infarction nan
no_relation,sildenafil,diastolic dysfunction,23406672,hypothesized sildenafil would reduce filling pressure exercise patients diastolic dysfunction myocardial infarctionnan
no_relation,sildenafil,diastolic dysfunction,23406672,seventy patients diastolic dysfunction near normal left ventricular ejection fraction echocardiography randomly assigned sildenafil mg thrice daily matching placebo weeksnan
no_relation,Sildenafil,myocardial infarction,23406672,sildenafil decrease filling pressure rest exercise post myocardial infarction patients diastolic dysfunctionnan
no_relation,Sildenafil,diastolic dysfunction,23406672,sildenafil decrease filling pressure rest exercise postmyocardial infarction patients diastolic dysfunction nan
no_relation,l-thyroxine,hypothyroidism,23426615,reevaluation patients showed permanent hypothyroidism needed l-thyroxine reintroduction persistent hyperthyrotropinemia tsh mul transient hypothyroidism nan
no_relation,l-thyroxine,hypoplasia,23426615,major risk factors permanent ch prematurity firstdegree familial history goiternodules thyroid hypoplasia diagnosis high l-thyroxine requirements followupnan
no_relation,l-thyroxine,CH,23426615,major risk factors permanent ch prematurity firstdegree familial history goiternodules thyroid hypoplasia diagnosis high l-thyroxine requirements followupnan
no_relation,l-thyroxine,CH,23426615,onethird patients ch eutopic thyroid gland needed continue l-thyroxine therapy reevaluationnan
no_relation,estrogen,necrosis,23455801,report unusual case invasive papillary carcinoma breast high nuclear grade brisk mitosis necrosis extensive apocrine differentiation intense lymphoplasmacytic infiltrate additionally triplenegativity estrogen progesterone receptors neunan
no_relation,progesterone,necrosis,23455801,report unusual case invasive papillary carcinoma breast high nuclear grade brisk mitosis necrosis extensive apocrine differentiation intense lymphoplasmacytic infiltrate additionally triplenegativity estrogen progesterone receptors neunan
no_relation,progesterone,papillary carcinoma of the breast,23455801,report unusual case invasive papillary carcinoma breast high nuclear grade brisk mitosis necrosis extensive apocrine differentiation intense lymphoplasmacytic infiltrate additionally triplenegativity estrogen progesterone receptors neunan
no_relation,estrogen,papillary carcinoma of the breast,23455801,report unusual case invasive papillary carcinoma breast high nuclear grade brisk mitosis necrosis extensive apocrine differentiation intense lymphoplasmacytic infiltrate additionally triplenegativity estrogen progesterone receptors neunan
no_relation,latanoprost,cataract,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,acetazolamide,pain,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,brinzolamide,pain,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,latanoprost,pain,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,acetazolamide,cataract,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,brinzolamide,cataract,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,brimonidine,pain,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,timolol,cataract,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,brimonidine,cataract,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynansuspenseful abstract suspenseful
no_relation,timolol,pain,23461283,study evaluated effects acetazolamide latanoprost travoprost bimatoprost brimonidine brinzolamide timolol pain phacoemulsification cataract surgerynan
no_relation,prostanoids,pain,23461283,brimonidine group exhibited lowest visual analog pain scale scores prostanoids especially bimatoprost group demonstrated highest visual analog pain scale scores medianstandard deviation  respectivelynan
no_relation,brimonidine,pain,23461283,brimonidine group exhibited lowest visual analog pain scale scores prostanoids especially bimatoprost group demonstrated highest visual analog pain scale scores medianstandard deviation  respectivelynan
no_relation,brinzolamide,pain,23461283,median visual analog pain scale scores acetazolamide latanoprost travoprost brinzolamide timolol groups   respectivelynan
yes_direct,acetazolamide,pain,23461283,median visual analog pain scale scores acetazolamide latanoprost travoprost brinzolamide timolol groups   respectivelynan
yes_direct,latanoprost,pain,23461283,median visual analog pain scale scores acetazolamide latanoprost travoprost brinzolamide timolol groups   respectivelynan
no_relation,timolol,pain,23461283,median visual analog pain scale scores acetazolamide latanoprost travoprost brinzolamide timolol groups   respectivelynan
no_relation,thalidomide,multiple myeloma,23469567,clinical profile multiple myeloma effect thalidomide based treatment outcomenan
no_relation,thalidomide,multiple myeloma,23469567,recently thalidomide demonstrated significant activity treatment multiple myeloma various western studiesnan
no_relation,thalidomide,multiple myeloma,23469567,study clinical profile multiple myeloma effect thalidomide based treatment outcome indian scenario aims objective studynan
no_relation,thalidomide,multiple myeloma,23469567,although multiple myeloma remained incurable disease date presently available thalidomide based combination chemotherapy represents active inductive regimen improve outcome achieve eventual curenan
no_relation,Methylchloroisothiazolinone,allergic contact dermatitis,23474447,methylchloroisothiazolinone methylisothiazolinone allergic contact dermatitis effect patch test concentrationnan
no_relation,methylisothiazolinone,allergic contact dermatitis,23474447,methylchloroisothiazolinone methylisothiazolinone allergic contact dermatitis effect patch test concentrationnan
yes_direct,cocaine,cocaine dependence,23497788,impact dcsfacilitated cue exposure therapy brain activation cocaine cues cocaine dependencenan
no_relation,cocaine,cocaine dependence,23497788,better understand impact dcsfacilitated extinction neural reactivity drug cues present study reports fmri findings randomized doubleblind placebocontrolled trial dcsfacilitated cue exposure cocaine dependencenan
no_relation,cocaine,cocaine dependence,23497788,three trials dcsfacilitated cue exposure therapy cocaine dependence found dcs either increases significantly impact response cocaine cuesnan
no_relation,ribavirin,acute hepatitis C infection,23514835,spontaneous clearance treatment acute hepatitis infection hivpositive men weeks interferon-alpha ribavirin nan
no_relation,interferon-alpha,acute hepatitis C infection,23514835,spontaneous clearance treatment acute hepatitis infection hivpositive men weeks interferon-alpha ribavirinnan
no_relation,amino-acid,HCV infection,23529134,lipid pathway impairment decrease antioxidant pool downregulation amino-acid metabolism metabolic variations attributed chronic hcv infection nan
no_relation,ribavirin,diabetes mellitus,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirin nan
no_relation,ribavirin,hepatitis C,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirin nan
no_relation,pegylated interferon alpha 2b,hepatitis C,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirinnan
no_relation,ribavirin,alcoholism,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirin nan
no_relation,pegylated interferon alpha 2b,alcoholism,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirinnan
no_relation,pegylated interferon alpha 2b,diabetes mellitus,23529134,performed proteomic analysis liver specimens yearold woman affected hepatitis genotype alcoholism diabetes mellitus type antiviral treatment pegylated interferon alpha ribavirinnan
no_relation,amino acid,alcohol abuse,23529134,proteomic analysis showed therapy downregulation enzymes involved amino acid metabolism glycolysisgluconeogenesis alcohol catabolism takes place latter probably due cessation alcohol abuse nan
no_relation,alcohol,alcohol abuse,23529134,proteomic analysis showed therapy downregulation enzymes involved amino acid metabolism glycolysisgluconeogenesis alcohol catabolism takes place latter probably due cessation alcohol abusenanone obvious probably meant
no_relation,fatty acids,HCV infection,23529134,real time data confirm vivo humans hcv infection pathways related fatty acids glucose metabolism free radical scavenging inhibitednan
no_relation,glucose,HCV infection,23529134,real time data confirm vivo humans hcv infection pathways related fatty acids glucose metabolism free radical scavenging inhibitednan
no_relation,curcumin,metabolic syndrome,23533564, mgkg curcumin gavaged adult male spraguedawley rats highfatdietinduced metabolic syndrome monthsnan
no_relation,Curcumin,obese,23533564,curcumin reduced serum glucose cholesterol triglyceride low density lipoprotein levels highfatdietinduced obese ratsnan
no_relation,glucose,obese,23533564,curcumin reduced serum glucose cholesterol triglyceride low density lipoprotein levels highfatdietinduced obese ratsnan
no_relation,cholesterol,obese,23533564,curcumin reduced serum glucose cholesterol triglyceride low density lipoprotein levels highfatdietinduced obese ratsnan
no_relation,curcumin,metabolic syndrome,23533564,conclusion curcumin effective treatment metabolic syndrome four novel curcumin derivatives high potencies inhibition human hsd selectivity hsdnan
no_relation,polyphenols,cardiovascular health,23537433,oxidative stress cardiovascular health therapeutic potential polyphenols nan
no_relation,polyphenols,cardiovascular health,23537433,addition review summarizes health benefits polyphenols recent progress understanding cellular physiological actions polyphenols may impart beneficial properties cardiovascular health nan
no_relation,methicillin,vancomycin-intermediate S. aureus/VISA,23539745,used vitro experimental systems compare phenotypic genotypic changes accompany selection mutants methicillin resistant staphylococcus aureus mrsa strain jh lowlevel vancomycin resistance similar type found vancomycinintermediate aureus visa nan
no_relation,vancomycin,vancomycin-intermediate S. aureus/VISA,23539745,used vitro experimental systems compare phenotypic genotypic changes accompany selection mutants methicillin-resistant staphylococcus aureus mrsa strain jh lowlevel vancomycin resistance similar type found vancomycin intermediate aureus visa nan
no_relation,vancomycin,SEVs/simulated endocardial vegetations,23539745,mutants jh selected vitro means pharmacokineticpharmacodynamic pkpd model simulated endocardial vegetations sevs exposure vancomycin laboratory growth mediumnan
no_relation,daptomycin,VISA,23539745,mutants displayed reduced vancomycin daptomycin susceptibility phenotypic alterations eg thicker cell walls abnormal autolysis typical vivo visa mutantsnan
no_relation,vancomycin,VISA,23539745,mutants displayed reduced vancomycin daptomycin susceptibility phenotypic alterations eg thicker cell walls abnormal autolysis typical vivo visa mutantsnan
yes_direct,Zotepine,seizures,23543675,zotepine induced convulsive seizures chronic case treatment resistant paranoid schizophrenianan
no_relation,Zotepine,schizophrenia,23543675,zotepine induced convulsive seizures chronic case treatment resistant paranoid schizophrenia nan
yes_direct,zotepine,seizure,23543675,adverse event zotepine induced seizure published case reportsnan
yes_direct,zotepine,tonic-clonic seizures,23543675,report occurrence myoclonic seizure progressing generalized tonicclonic seizures zotepine along clear temporal association dose dependent modulation evident casenan
yes_direct,zotepine,myoclonic seizure,23543675,report occurrence myoclonic seizure progressing generalized tonicclonic seizures zotepine along clear temporal association dose dependent modulation evident casenan
no_relation,vemurafenib,melanoma,23548648,discuss clinical efficacy safety ipilimumab vemurafenib investigational agents treatment unresectable stage iii stage iv melanoma define current strategies firstline treatment selectionnan
no_relation,trametinib,melanoma,23548648,literature accessed medline international pharmaceutical abstracts november using terms melanoma metastatic melanoma ipilimumab vemurafenib dabrafenib trametinib nan
no_relation,vemurafenib,melanoma,23548648,literature accessed medline international pharmaceutical abstracts november using terms melanoma metastatic melanoma ipilimumab vemurafenib dabrafenib trametinibnan
no_relation,dabrafenib,melanoma,23548648,literature accessed medline international pharmaceutical abstracts november using terms melanoma metastatic melanoma ipilimumab vemurafenib dabrafenib trametinibnan
no_relation,dacarbazine,melanoma,23548648,two randomized phase clinical trials demonstrated significant survival benefit use ipilimumab compared melanoma vaccine vs months  compared dacarbazine months ci vs months ci nan
yes_direct,vemurafenib,toxicity,23548648,new agents possess unique toxicity profiles including immunerelated adverse events ipilimumab secondary cutaneous cancers reported vemurafenib usenan
yes_direct,vemurafenib,cancers,23548648,new agents possess unique toxicity profiles including immunerelated adverse events ipilimumab secondary cutaneous cancers reported vemurafenib usenan
no_relation,vemurafenib,melanoma,23548648,treatment strategies changed patients advanced melanoma use ipilimumab vemurafenib firstline agentsnan
no_relation,gentamicin,bacteremia,23602630,chronic bacteremia gentamicin doxycycline significantly increased resolution ratenan
no_relation,doxycycline,bacteremia,23602630,chronic bacteremia gentamicin doxycycline significantly increased resolution ratenan
yes_direct,furosemide,thrombocytopenia,23625769,year case furosemide induced immune thrombocytopenia nan
yes_direct,furosemide,thrombocytopenia,23625769,report describe case furosemide identified probable cause druginduced thrombocytopenia yearold man chronic symptomatic idiopathic thrombocytopenia seven years discoverynan
yes_direct,furosemide,thrombocytopenia,23625769,based observations case report clinicians readily consider furosemide potential cause thrombocytopenia nan
no_relation,tamoxifen,breast cancer,23635729,prophylactic use levonorgestrelreleasing intrauterine system women breast cancer treated tamoxifen randomized controlled trialnan
no_relation,levonorgestrel,breast cancer,23635729,prophylactic use levonorgestrel releasing intrauterine system women breast cancer treated tamoxifen randomized controlled trialnan
no_relation,tamoxifen,breast cancer,23635729,estimate rate endometrial pathology prophylactic use levonorgestrelreleasing intrauterine system women breast cancer treated tamoxifen nan
no_relation,levonorgestrel,breast cancer,23635729,estimate rate endometrial pathology prophylactic use levonorgestrel releasing intrauterine system women breast cancer treated tamoxifennan
no_relation,tamoxifen,breast cancer,23635729,randomized controlled trial chinese women attended university hospital hong kong required adjuvant tamoxifen breast cancer completion postoperative radiotherapy chemotherapynan
no_relation,Levonorgestrel,endometrial polyps,23635729,levonorgestrel releasing intrauterine system significantly reduced de novo endometrial polyps hazard ratio  confidence interval course years intentiontotreat basisnan
no_relation,levonorgestrel,endometrial polyps,23635729,prophylactic levonorgestrel releasing intrauterine system prevents de novo endometrial polyps women using tamoxifennanlevonorgestrelreleasing intrauterine system levonorgestrel also prevents
no_relation,tamoxifen,endometrial polyps,23635729,prophylactic levonorgestrelreleasing intrauterine system prevents de novo endometrial polyps women using tamoxifen nan
no_relation,HBeAg/hepatitis B e antigen,HBV infection/hepatitis B,23638710,hbv markers including hepatitis surface antigen hbsag antibody antihbs antihbc hepatitis antigen hbeag antibody antihbe determined donors recipients lt recipients lt hbv dna titer measured recipients strongly suspected de novo hbv infection nan
no_relation,hepatitis B surface antigen,HBV infection/hepatitis B,23638710,hbv markers including hepatitis surface antigen hbsag antibody antihbs antihbc hepatitis antigen hbeag antibody antihbe determined donors recipients lt recipients lt hbv dna titer measured recipients strongly suspected de novo hbv infection nanproper highlighting chemicals
no_relation,lamivudine,HBV-infected,23638710,two de novo hbv-infected patients ymdd mutation given adefovir combined lamivudine liver function gradually improved followup periodnan
no_relation,adefovir,HBV-infected,23638710,two de novo hbv-infected patients ymdd mutation given adefovir combined lamivudine liver function gradually improved followup periodnan
no_relation,lamivudine,HBV infection,23638710,administration adefovir patients resistant lamivudine seems effective safe way de novo hbv infection nan
no_relation,adefovir,HBV infection,23638710,administration adefovir patients resistant lamivudine seems effective safe way de novo hbv infection nan
yes_direct,lithium,toxicity,23638841,research used standardized leaching tests lifecycle impact assessment lcia hazard assessment models evaluate hazardous waste classification resource depletion potential toxicity potentials lithium batteries used cellphonesnan
no_relation,nickel,California regulations,23638841,however according california regulations lithium batteries tested classified hazardous due excessive levels cobalt average mgkg  limit copper average mgkg  limit nickel average mgkg  limit nan
no_relation,copper,California regulations,23638841,however according california regulations lithium batteries tested classified hazardous due excessive levels cobalt average mgkg  limit copper average mgkg  limit nickel average mgkg  limit nan
no_relation,cobalt,California regulations,23638841,however according california regulations lithium batteries tested classified hazardous due excessive levels cobalt average mgkg  limit copper average mgkg  limit nickel average mgkg  limit nan
no_relation,lithium,California regulations,23638841,however according california regulations lithium batteries tested classified hazardous due excessive levels cobalt average mgkg  limit copper average mgkg  limit nickel average mgkg  limit nan
yes_direct,cobalt,toxicity,23638841,environmental impact associated resource depletion human toxicity mainly associated cobalt copper nickel thallium silver whereas ecotoxicity potential primarily associated cobalt copper nickel thallium silvernan
yes_direct,silver,toxicity,23638841,environmental impact associated resource depletion human toxicity mainly associated cobalt copper nickel thallium silver whereas ecotoxicity potential primarily associated cobalt copper nickel thallium silver nan
yes_direct,nickel,toxicity,23638841,environmental impact associated resource depletion human toxicity mainly associated cobalt copper nickel thallium silver whereas ecotoxicity potential primarily associated cobalt copper nickel thallium silvernannickel chemical
yes_direct,copper,toxicity,23638841,environmental impact associated resource depletion human toxicity mainly associated cobalt copper nickel thallium silver whereas ecotoxicity potential primarily associated cobalt copper nickel thallium silvernan
yes_direct,thallium,toxicity,23638841,environmental impact associated resource depletion human toxicity mainly associated cobalt copper nickel thallium silver whereas ecotoxicity potential primarily associated cobalt copper nickel thallium silvernan
no_relation,aluminum,toxicity,23638841,however relative contribution aluminum lithium human toxicity ecotoxicity could estimated due insufficient toxicity data modelsnan
yes_direct,lithium,toxicity,23638841,however relative contribution aluminum lithium human toxicity ecotoxicity could estimated due insufficient toxicity data modelsnan
no_relation,Co,melanoma,23664097,co injection melanoma cells 12(s)-hete increased lung homing activity bf melanoma cellsnan
yes_direct,12(S)-HETE,melanoma,23664097,coinjection melanoma cells 12(s)-hete increased lung homing activity bf melanoma cellsnan
yes_direct,12(S)-HETE,adhesion,23664097,vitro studies showed 12(s)-hete shete treatment resulted concentrationdependent increase adhesion bf cells collagen fibronectinnan
no_relation,12(S)-HETE,melanoma,23664097,treatment 12(s)-hete increased pfak melanoma cells adhering collagencoated slidenan
no_relation,12(S)-HETE,adhesion,23664097,enhancement adherence elicited 12(s)-hete bf cells could antagonised focal adhesion kinase fak inhibitor fak inhibitor pd98059 extracellular signalregulated kinase erk inhibitornantheres literally disease sentence 
no_relation,PD98059,adhesion,23664097,enhancement adherence elicited 12(s)-hete bf cells could antagonised focal adhesion kinase fak inhibitor fak inhibitor pd98059 extracellular signalregulated kinase erk inhibitornan
no_relation,12(S)-HETE,melanoma,23664097,12(s)-hete increased phosphorylation fak erk adhering melanoma cellsnan
yes_direct,12(S)-HETE,melanoma,23664097,adhesion lung metastasis human melanoma cells nodscid mice also potentiated cotreatment 12(s)-hete nan
no_relation,12(S)-HETE,adhesion,23664097,adhesion lung metastasis human melanoma cells nodscid mice also potentiated cotreatment 12(s)-hete nan
yes_direct,12(S)-HETE,SCID,23664097,adhesion lung metastasis human melanoma cells nod scid mice also potentiated cotreatment 12(s)-hete nan
yes_direct,12(S)-HETE,metastasis,23664097,adhesion lung metastasis human melanoma cells nodscid mice also potentiated cotreatment 12(s)-hete nan
yes_direct,12(S)-HETE,melanoma,23664097,results demonstrate 12(s)-hete shete activates erk fak signalling pathways thereby upregulates adhesion metastatic potential melanoma cellsnan
yes_direct,12(S)-HETE,adhesion,23664097,results demonstrate 12(s)-hete shete activates erk fak signalling pathways thereby upregulates adhesion metastatic potential melanoma cellsnan
yes_direct,12(S)-HETE,melanoma,23664097,endogenous release 12(s)-hete shete host organ may affect metastatic potential melanoma nan
no_relation,aminolevulinic acid/ALA,von Recklinghausen disease,23670807,present case yearold male patient von recklinghausen disease diffuse contrastenhancing cerebellar mass resected guided aminolevulinic acid ala fluorescencenan
no_relation,temozolomide,tumor,23670807,due proximity tumor brainstem adjuvant temozolomide chemotherapy administered rather firstline radiotherapynan
no_relation,temozolomide,Tumor,23670807,tumor control resection achieved patients however patient mentioned report received radiation instead temozolomide nan
no_relation,Lorazepam,catatonia,23684045,lorazepam achieved full resolution catatonia patientsnan
no_relation,paroxetine,pruritus,23749733,therefore identifying underlying cause pruritus prime importance order develop tailored treatment plans even palliative care treatment focused towards symptom necessarily underlying diseaseresults show palliative care patients pruritus different natures treatment drug paroxetine selective serotonin reuptake inhibitor may beneficialnan
no_relation,serotonin,pruritus,23749733,therefore identifying underlying cause pruritus prime importance order develop tailored treatment plans even palliative care treatment focused towards symptom necessarily underlying diseaseresults show palliative care patients pruritus different natures treatment drug paroxetine selective serotonin reuptake inhibitor may beneficialnan
no_relation,indomethacin,pruritus,23749733,patients suffering pruritus associated hiv infection indomethacin described effective drug although evidence weaknan
no_relation,indomethacin,HIV infection,23749733,patients suffering pruritus associated hiv infection indomethacin described effective drug although evidence weaknan
no_relation,gabapentin,pruritus,23749733,patients suffering chronic kidney diseaseassociated pruritus gabapentin may optionnan
no_relation,gabapentin,chronic kidney disease,23749733,patients suffering chronic kidney disease associated pruritus gabapentin may optionnan
no_relation,rifampicin,pruritus,23749733,exhibited low incidence adverse effects rifampicin flumecinolmay recommended patients cholestatic pruritus nan
no_relation,flumecinol,pruritus,23749733,exhibited low incidence adverse effects rifampicin flumecinol may recommended patients cholestatic pruritus nan
no_relation,naltrexone,pruritus,23749733,opioid antagonist naltrexone shown offer therapeutic alternative patients suffering uraemic cholestatic pruritus nan
yes_direct,carbon,toxicity,23770455,understanding toxicity carbon nanotubes environment crucial control nanomaterials producing processing assessment health risk human reviewnan
no_relation,etomidate,depressed,23774194,retrospective comparison effects propofol etomidate stimulus variables efficacy electroconvulsive therapy depressed inpatientsnan
no_relation,propofol,depressed,23774194,retrospective comparison effects propofol etomidate stimulus variables efficacy electroconvulsive therapy depressed inpatientsnan
no_relation,etomidate,depressed,23774194,compare effects propofol etomidate stimulus variables efficacy electroconvulsive therapy ect depressed inpatientsnan
no_relation,propofol,depressed,23774194,compare effects propofol etomidate stimulus variables efficacy electroconvulsive therapy ect depressed inpatientsnanused treatment
no_relation,etomidate,seizures/seizure,23774194,propofol group shorter mean electroencephalogram etomidate   propofol   seizure duration motor etomidate   propofol   seizure duration higher mean number inadequate seizures etomidate   propofol  nan
no_relation,propofol,seizures/seizure,23774194,propofol group shorter mean electroencephalogram etomidate   propofol   seizure duration motor etomidate   propofol   seizure duration higher mean number inadequate seizures etomidate   propofol  nan
no_relation,propofol,seizures/seizure,23774194,anesthesia propofol significant reducing effect seizure duration course ect results inadequate seizures despite use higher mean stimulus chargenan
no_relation,oxygen,vascular diseases,23778534,accumulating evidence demonstrated epcs therapeutic potential reactive oxygen species rosmediated vascular diseases nan
no_relation,H2O2,migration,23778534,study investigate effects oxidative stress epcs epcs treated h2o2 different final concentrations mtt assay scratchwound assay matrigel invasion assay revealed cell proliferation migration tubule formation function respectively impaired h2o2 stress concentrationdependent mannernan
no_relation,cisplatin,lung cancer,23783141,activation erk akt associated cisplatin resistance human lung cancer cellsnan
no_relation,Cisplatin,small cell lung cancers,23783141,cisplatin widely used treatment solid tumours including small cell lung cancers success often compromised relapse resistance treatmentnan
no_relation,cisplatin,lung cancer,23783141,although individually targeting erk akt pathway reported sensitize cancer cells therapy effect concurrently blocking two pathways sensitivity lung cancer cells cisplatin investigatednan
no_relation,cisplatin,cancer,23783141,although individually targeting erk akt pathway reported sensitize cancer cells therapy effect concurrently blocking two pathways sensitivity lung cancer cells cisplatin investigatednan
no_relation,cisplatin,small cell lung cancer,23783141,present study aimed determine whether erk akt pathways contribute cisplatin resistance human small cell lung cancer cellsnan
no_relation,cisplatin,cytotoxicity,23783141,strikingly concurrent inhibition perk pakt significantly potentiated cisplatin cytotoxicity vitro vivonan
yes_direct,cisplatin,cytotoxicity,23783141,sensitization cells cisplatin cytotoxicity induced pakt inhibition mediated upregulation puma whereas induced perk inhibition occurred bcl downregulationnan
no_relation,cisplatin,cytotoxicity,23783141,data indicate cooperative effects perk pakt attenuating cisplatin cytotoxicity mediated puma bcl regulation concurrently blocking pathways may effective strategy improving efficacy cisplatin anticancer treatmentnan
no_relation,docetaxel,breast cancer,23809513,predictive value petct pathological response stages ii iii breast cancer patients following neoadjuvant chemotherapy docetaxel nan
no_relation,fluorine-18 fluorodeoxyglucose,breast cancer,23809513,prospectively study value petct fluorine fluorodeoxyglucose fdg predict neoadjuvant chemotherapy nac response locoregional disease stages ii iii breast cancer patientsnan
no_relation,sugammadex,headache,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depressionnan
no_relation,sugammadex,myalgia,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depressionnan
no_relation,rocuronium,myalgia,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depressionnan
no_relation,rocuronium,headache,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depressionnan
no_relation,rocuronium,major depression,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depression nan
no_relation,sugammadex,major depression,23812022,rocuronium sugammadex reduce myalgia headache electroconvulsive therapy patients major depression nan
no_relation,sugammadex,headache,23812022,aimed compare effects succinylcholine rocuronium sugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,sugammadex,myalgia,23812022,aimed compare effects succinylcholine rocuronium sugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,rocuronium,myalgia,23812022,aimed compare effects succinylcholine rocuronium sugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,rocuronium,headache,23812022,aimed compare effects succinylcholine rocuronium sugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,succinylcholine,headache,23812022,aimed compare effects succinylcholine rocuroniumsugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,succinylcholine,myalgia,23812022,aimed compare effects succinylcholine rocuroniumsugammadex development myalgia headache electroconvulsive therapy ectnan
no_relation,Sugammadex,seizure,23812022,sugammadex mgkg iv administered group motor seizure nan
no_relation,sorafenib,breast cancer,23812905,phase ii study combined vegf inhibitor bevacizumab sorafenib patients metastatic breast cancer hoosier oncology group study brenan
no_relation,sorafenib,breast cancer,23812905,evaluated efficacy safety dual angiogenesis blockade bevacizumab sorafenib patients metastatic breast cancer nan
no_relation,sorafenib,breast cancer,23812905,combination sorafenib bevacizumab substantial toxicity minimal efficacy patients previously treated metastatic breast cancer nan
yes_direct,sorafenib,toxicity,23812905,combination sorafenib bevacizumab substantial toxicity minimal efficacy patients previously treated metastatic breast cancernan
no_relation,Taxane,head and neck cancers/head and neck cancer,23835714,taxane cisplatinfluorouracil induction chemotherapy locally advanced head neck cancers individual patient data metaanalysis metaanalysis chemotherapy head neck cancer groupnan
no_relation,docetaxel,head and neck cancers,23835714,purpose cisplatin plus fluorouracil pf induction chemotherapy compared taxane docetaxel paclitaxel cisplatin fluorouracil taxpf randomized trials locoregionally advanced head neck cancers lahncsnanused treatment
no_relation,Cisplatin,head and neck cancers,23835714,purpose cisplatin plus fluorouracil pf induction chemotherapy compared taxane docetaxel paclitaxel cisplatin fluorouracil taxpf randomized trials locoregionally advanced head neck cancers lahncsnan
no_relation,fluorouracil,head and neck cancers,23835714,purpose cisplatin plus fluorouracil pf induction chemotherapy compared taxane docetaxel paclitaxel cisplatin fluorouracil taxpf randomized trials locoregionally advanced head neck cancers lahncsnan
no_relation,taxane,head and neck cancers,23835714,purpose cisplatin plus fluorouracil pf induction chemotherapy compared taxane docetaxel paclitaxel cisplatin fluorouracil taxpf randomized trials locoregionally advanced head neck cancers lahncsnan
no_relation,paclitaxel,head and neck cancers,23835714,purpose cisplatin plus fluorouracil pf induction chemotherapy compared taxane docetaxel paclitaxel cisplatin fluorouracil taxpf randomized trials locoregionally advanced head neck cancers lahncsnan
no_relation,tyrosine,MRD,23836561,detection mrd may predict outcome patients philadelphia chromosomepositive treated tyrosine kinase inhibitors plus chemotherapynan
no_relation,tyrosine,Philadelphia,23836561,detection mrd may predict outcome patients philadelphia chromosomepositive treated tyrosine kinase inhibitors plus chemotherapynan
no_relation,tyrosine,ALL,23836561,detection mrd may predict outcome patients philadelphia chromosomepositive treated tyrosine kinase inhibitors plus chemotherapynan
no_relation,imatinib,Philadelphia,23836561,  patients newly diagnosed philadelphia chromosomepositive acute lymphoblastic leukemia treated chemotherapy imatinib  dasatinib nan
no_relation,dasatinib,acute lymphoblastic leukemia,23836561,  patients newly diagnosed philadelphia chromosomepositive acute lymphoblastic leukemia treated chemotherapy imatinib  dasatinib nan
no_relation,imatinib,acute lymphoblastic leukemia,23836561,  patients newly diagnosed philadelphia chromosomepositive acute lymphoblastic leukemia treated chemotherapy imatinib  dasatinib nan
no_relation,dasatinib,Philadelphia,23836561,  patients newly diagnosed philadelphia chromosomepositive acute lymphoblastic leukemia treated chemotherapy imatinib  dasatinib nan
no_relation,Berberine,Cancer Cell Growth,23869238,berberine targets aphtert nfbcox hifvegf cytochromeccaspase signaling suppress human cancer cell growth nan
no_relation,Berberine,cancers,23869238,berberine bbr isoquinoline derivative alkaloid isolated chinese herbs long history uses treatment multiple diseases including cancers nan
no_relation,isoquinoline,multiple diseases,23869238,berberine bbr isoquinoline derivative alkaloid isolated chinese herbs long history uses treatment multiple diseases including cancersnan
no_relation,Berberine,multiple diseases,23869238,berberine bbr isoquinoline derivative alkaloid isolated chinese herbs long history uses treatment multiple diseases including cancersnan
no_relation,isoquinoline,cancers,23869238,berberine bbr isoquinoline derivative alkaloid isolated chinese herbs long history uses treatment multiple diseases including cancers nan
no_relation,iron oxide,cancer,23869810,particular advancements polymeric nanomaterials past decades paved way development cancer nanotheranostics primarily comprised polymers conjugates polymer types nanomaterials gold nanoparticles quantum dots carbon nanotubes magnetic iron oxide nanoparticlesnan
no_relation,carbon,cancer,23869810,particular advancements polymeric nanomaterials past decades paved way development cancer nanotheranostics primarily comprised polymers conjugates polymer types nanomaterials gold nanoparticles quantum dots carbon nanotubes magnetic iron oxide nanoparticlesnan
no_relation,dextrose,plantar fasciitis,23876935,autologous plateletrich plasma versus dextrose prolotherapy treatment chronic recalcitrant plantar fasciitis nan
no_relation,dextrose,PF/plantar fasciitis,23876935,determine efficacy autologous plateletrich plasma prp compared dextrose prolotherapy dp patients chronic recalcitrant plantar fasciitis pf design singleblinded randomized controlled studynan
no_relation,aspirin,pancreatic disorders,23890963,antiplatelet therapy aspirin prevalent among patients presenting operative treatment pancreatic disorders nan
yes_direct,aspirin,bleeding,23890963,operative practice called cessation aspirin days elective procedures perceived increased risk procedurerelated bleeding nan
no_relation,aspirin,blood loss,23890963,estimated intraoperative blood loss similar two groups aspirin versus aspirin median ml vs ml  rate blood transfusion anytime index admission vs  postoperative duration hospital stay median days vs days nan
yes_direct,aspirin,cardiovascular complications,23890963,aspirin group slightly increased rate cardiovascular complications vs likely reflecting increased cardiovascular comorbidities led physicians recommending aspirin therapynan
no_relation,aspirin,bleeding,23890963,first study report aspirin therapy associated increased rates perioperative bleeding transfusion requirement major procedure related complications elective pancreatic surgerynan
no_relation,ribavirin,chronic hepatitis C,23894901,liver histology chronic hepatitis patients relapsed responded conventional interferon ribavirin therapynan
no_relation,ribavirin,hepatitis C,23894901,study hepatitis patients relapsed responded conventional interferon ribavirin least weeksnan
no_relation,ribavirin,fibrosis,23894901,results suggested even failed eradicate hepatitis virus conventional interferon ribavirin therapy able halt progress necroinflammation fibrosis nan
no_relation,ribavirin,hepatitis C virus,23894901,results suggested even failed eradicate hepatitis virus conventional interferon ribavirin therapy able halt progress necroinflammation fibrosisnan
no_relation,polycyclic aromatic hydrocarbons,toxicity,23898780,bioaccessibility polycyclic aromatic hydrocarbons relevance toxicity carcinogenesisnan
no_relation,polycyclic aromatic hydrocarbons,carcinogenesis,23898780,bioaccessibility polycyclic aromatic hydrocarbons relevance toxicity carcinogenesis nan
yes_direct,PAHs,cancer,23898780,polycyclic aromatic hydrocarbons pahs ubiquitous environmental pollutants toxicants focus establish cancer risks humansnan
yes_direct,PAHs,toxicity,23898780,orally ingested pahs also cause toxicity even affect pharmacokinetic behavior therapeutic agentsnan
no_relation,PAH,PAH,23898780,review also considers factors influence bioaccessibility debates merits limitations using bioaccessibility concept estimating risk ingestion pah contaminated soil foodnan
yes_direct,PAH,toxicity,23898780,finally authors discuss implications bioaccessibility pah induced toxicity cancers context risk assessmentnan
yes_direct,PAH,cancers,23898780,finally authors discuss implications bioaccessibility pah induced toxicity cancers context risk assessmentnan
no_relation,PAH,PAH,23898780,finally authors discuss implications bioaccessibility pah induced toxicity cancers context risk assessmentnan
no_relation,PAH,PAH,23898780,far much focus pah bioaccessibility centered soil preferential matrixnanproper highlighting chemical
no_relation,tetracaine,ear infection,23932769,use extemporaneously compounded tetracaine improve adherence clotrimazole topical solution treatment ear infection case reportnan
no_relation,clotrimazole,ear infection,23932769,use extemporaneously compounded tetracaine improve adherence clotrimazole topical solution treatment ear infection case reportnan
yes_direct,clotrimazole,pain,23932769,report case nonadherence due severe pain associated topical use clotrimazole solution earnan
no_relation,tetracaine,pain,23932769,instillation tetracaine solution prior administration clotrimazole blocked pain sensation allowing patient successfully complete antifungal therapynan
no_relation,clotrimazole,pain,23932769,instillation tetracaine solution prior administration clotrimazole blocked pain sensation allowing patient successfully complete antifungal therapynan
no_relation,titanium,hernia,23934356,repair symptomatic perineal hernia titanium meshnan
no_relation,titanium,perineal hernia repair,23934356,describe application titanium mesh perineal hernia repair nan
no_relation,titanium,hernia,23934356,performed hernia repair thin titanium mesh via perineal approach three patients developed secondary perineal hernia following abdominoperineal resectionnan
no_relation,titanium,hernia sac,23934356,hernia sac isolated dissected titanium mesh molded placed ischium coccyx support pelvic floornan
no_relation,titanium,perineal hernia repair,23934356,successful preliminary results indicate titanium mesh useful perineal hernia repair perineal approach provide rigid support pelvic floor entire surface ensuring stability without fixationnan
no_relation,aldosterone,heart failure,23943252,heart one important target tissue damage due excess aldosterone role natriuretic peptides well recognized diagnosing heart failure nan
no_relation,aldosterone,PA,23943252,hypothesized measuring ntprobnp could improve diagnostic evaluation pa enrolled hypertensive patients underwent aldosterone renin ratio arr screening underwent intravenous saline loading test ivslt high arrnan
no_relation,aldosterone,hypertensive,23943252,hypothesized measuring ntprobnp could improve diagnostic evaluation pa enrolled hypertensive patients underwent aldosterone renin ratio arr screening underwent intravenous saline loading test ivslt high arrnan
no_relation,clonidine,sinusitis,23943734,group patients undergoing fess chronic sinusitis polyp removal enrolled randomly assigned receive either oral clonidine midazolam preoperative premedicationnan
no_relation,midazolam,sinusitis,23943734,group patients undergoing fess chronic sinusitis polyp removal enrolled randomly assigned receive either oral clonidine midazolam preoperative premedicationnan
no_relation,calcium,MDD,23976766,admixtures within specifications set usp respect mdd  hours batches lacking calcium met benchmarks set pharmacopoeia respect pfat day preparationnan
no_relation,artemisinin,malaria,23979886,malaria treatment recommended world health organization involves medicines derived artemisinin active compound extracted plant artemisia annua derivatives artesunatenan
no_relation,artesunate,malaria,23979886,malaria treatment recommended world health organization involves medicines derived artemisinin active compound extracted plant artemisia annua derivatives artesunate nan
no_relation,artemisinin,cytotoxicity,23979886,considering lack data regarding genotoxic effects compounds human cells objective study evaluate cytotoxicity genotoxicity expressions casp sod genes cultured human hepatocellular liver carcinoma cell line hepg cells treated artemisinin artesunatenan
no_relation,artesunate,cytotoxicity,23979886,considering lack data regarding genotoxic effects compounds human cells objective study evaluate cytotoxicity genotoxicity expressions casp sod genes cultured human hepatocellular liver carcinoma cell line hepg cells treated artemisinin artesunate nan
no_relation,artemisinin,carcinoma,23979886,considering lack data regarding genotoxic effects compounds human cells objective study evaluate cytotoxicity genotoxicity expressions casp sod genes cultured human hepatocellular liver carcinoma cell line hepg cells treated artemisinin artesunatenan
no_relation,artesunate,carcinoma,23979886,considering lack data regarding genotoxic effects compounds human cells objective study evaluate cytotoxicity genotoxicity expressions casp sod genes cultured human hepatocellular liver carcinoma cell line hepg cells treated artemisinin artesunate nan
no_relation,resazurin,cytotoxicity,23979886,tested concentrations   gml substances resazurin cytotoxicity assay concentrations used genotoxicity experiments  gml gene expression analysis gml determinednan
no_relation,curcumin,ovarian cancer,23983610,novel monocarbonyl analogue curcumin induces human ovarian cancer cell apoptosis via activation endoplasmic reticulum stress autophagy signaling pathwaynanambiguous sir curcumin curcumin causes ovarian cancer since analogue guess answer dont know
no_relation,Curcumin,ovarian cancer/cancers,23983610,curcumin used treat several different cancers including ovarian cancer clinical trials research however role er stress autophagy therapeutic effects curcumin new curcumin analogues remains unclearnan
no_relation,3-methyladenine/3-MA,ovarian cancer,23983610,inhibition autophagy using methyladenine 3-ma increased levels intracellular misfolded proteins enhanced ovarian cancer apoptosisnan
no_relation,curcumin,ovarian cancer,23983610,data indicate er stress autophagy may play role apoptosis induced curcumin analogue epithelial ovarian cancer cell line autophagy inhibition increase curcumin analogueinduced apoptosis inducing severe er stressnan
no_relation,apixaban,bleeding,24016507,aristotle apixaban resulted reduction stroke reduction major bleeding  reduction deathnan
no_relation,apixaban,death,24016507,aristotle apixaban resulted reduction stroke reduction major bleeding reduction death nan
no_relation,apixaban,stroke,24016507,aristotle apixaban resulted reduction stroke  reduction major bleeding reduction deathnan
no_relation,telaprevir,hepatitis C genotype 1 infected,24038567,advent firstgeneration direct antiviral agents boceprevir telaprevir changed concept treatment adult chronic hepatitis genotype infected patientsnan
no_relation,cyclophosphamide,vasculitis,24080801,followup data rave trial shown rituximab effective immunosuppression cyclophosphamide followed azathioprine antineutrophil cytoplasmic antibody anca associated vasculitis nan
no_relation,azathioprine,vasculitis,24080801,followup data rave trial shown rituximab effective immunosuppression cyclophosphamide followed azathioprine antineutrophil cytoplasmic antibody anca associated vasculitis nan
yes_direct,Bortezomib,AML,24085765,bortezomib exerted dosedependent increase mirb expression aml blasts ex vivo followed decreased dnmts reduced proliferation increased apoptosisnan
no_relation,bortezomib,AML,24085765,vivo bortezomib active dki aml yet liposomalencapsulated bortezomib single agent reversed downregulation mirb vivo induced longterm day diseasefree remission dki aml mice exhibited high leukemic burden start therapy yet showed signs relapse autopsynan
no_relation,bortezomib,ITD,24085765,taken together data support liposomal bortezomib single agent eradicates mllptdwtflt itd wt aml mouse may represent powerful potentially curative approach highrisk human diseasenan
no_relation,bortezomib,AML,24085765,taken together data support liposomal bortezomib single agent eradicates mllptdwtfltitdwt aml mouse may represent powerful potentially curative approach highrisk human diseasenan
yes_direct,aspirin,Unusual burn injury,24102713,unusual burn injury due application white vinegar aspirin mixturenanread googles xd
no_relation,aspirin,pain,24102713,describe patient suffered splitthickness leg burn applying selfinflicted mixture consisting white vinegar aspirin prepared knee pain nan
no_relation,androgen,T1D,24118936,beginning puberty t1d group higher levels shbg similar androgen levels control groupnan
no_relation,testosterone,T1D,24118936,higher hbac negative effect total testosterone cft positive effect shbg levels t1d boysnan
no_relation,testosterone,hypogonadism,24118936,adolescents t1d exhibit hypogonadism shown normal gonadotropin testosterone inhibin amh levelsnan
no_relation,testosterone,T1D,24118936,adolescents t1d exhibit hypogonadism shown normal gonadotropin testosterone inhibin amh levelsnan
no_relation,testosterone,T1D,24118936,however t1d boys hbac bmisds negative association testosterone levelsnan
yes_direct,triphosphate,atrioventricular block,24128810,syncope associated documented paroxysmal atrioventricular block reproduced adenosine triphosphate injectionnan
yes_direct,triphosphate,Syncope,24128810,syncope associated documented paroxysmal atrioventricular block reproduced adenosine triphosphate injectionnan
yes_direct,adenosine,atrioventricular block,24128810,syncope associated documented paroxysmal atrioventricular block reproduced adenosine triphosphate injectionnan
yes_indirect,adenosine,Syncope,24128810,syncope associated documented paroxysmal atrioventricular block reproduced adenosine triphosphate injectionnan
no_relation,ATP/adenosine triphosphate,syncope,24128810,sought investigate patients syncope relationship documented paroxysmal atrioventricular block avb unknown mechanism avb induced adenosine triphosphate atp injectionnan
yes_direct,ATP/adenosine triphosphate,atrioventricular block/AVB,24128810,sought investigate patients syncope relationship documented paroxysmal atrioventricular block avb unknown mechanism avb induced adenosine triphosphate atp injectionnan
yes_direct,ATP,AVB,24128810,patients atp induced long ventricular pause related avb mean duration range nan
yes_direct,ATP,syncope,24128810,patients predominantly older females normal heart ecg syncope associated spontaneous avb unknown origin reproduced atp testnanatp test atp
yes_direct,ATP,AVB,24128810,patients predominantly older females normal heart ecg syncope associated spontaneous avb unknown origin reproduced atp testnan
yes_direct,ATP,AVB,24128810,unusual behaviour could interpreted abnormal susceptibility atp patients could considered atp sensitive avb nan
no_relation,Roflumilast,COPD,24135893,roflumilast treatment copd asian population randomized doubleblind parallelgroup studynan
no_relation,Roflumilast,COPD,24135893,roflumilast oral phosphodiesterase inhibitor indicated use treatment copd nanused treatment
no_relation,roflumilast,COPD,24135893,placebocontrolled doubleblind parallelgroup multicenter phase study patients chinese malay indian ethnicity  severe severe copd randomized receive either roflumilast daily placebo weeksnan
yes_direct,roflumilast,diarrhea,24135893,frequently reported treatmentrelated adverse event diarrhea  patients roflumilast placebo groups respectivelynan
no_relation,folate,folate deficiency,24174623,prevalence biochemical folate deficiency defined plasma folate folatenan
no_relation,folate,folate deficiency,24174623,prevalence biochemical folate deficiency new zealand adults lownan
yes_direct,styrene,ototoxic,24180784,ototoxic effect exposure styrene evaluated also presence simultaneous exposure noise using otoacoustic emissions biomarkers mild cochlear damagenan
no_relation,styrene,cochlear damage,24180784,ototoxic effect exposure styrene evaluated also presence simultaneous exposure noise using otoacoustic emissions biomarkers mild cochlear damage nan
no_relation,pegylated-interferon,hepatitis C,24212839,aims evaluate association myxovirus resistance protein osteopontin suppressor cytokine signaling gene polymorphisms combination ilb assess therapy response hepatitis patients treated pegylated-interferon plus ribavirinnan
no_relation,ribavirin,hepatitis C,24212839,aims evaluate association myxovirus resistance protein osteopontin suppressor cytokine signaling gene polymorphisms combination ilb assess therapy response hepatitis patients treated pegylated-interferon plus ribavirin nan
yes_direct,Trans fatty acids,inflammation,24251700,trans fatty acids diets act precipitating factor gut inflammation nan
no_relation,TFAs,diabetes mellitus,24251700,although increased report effects diet containing tfas risk factor metabolic syndrome diabetes mellitus coronary heart disease observed recent years influence intestinal inflammation remains unknownnan
yes_direct,TFAs,coronary heart disease,24251700,although increased report effects diet containing tfas risk factor metabolic syndrome diabetes mellitus coronary heart disease observed recent years influence intestinal inflammation remains unknownnan
yes_direct,TFAs,metabolic syndrome,24251700,although increased report effects diet containing tfas risk factor metabolic syndrome diabetes mellitus coronary heart disease observed recent years influence intestinal inflammation remains unknownnan
no_relation,TFAs,inflammation,24251700,although increased report effects diet containing tfas risk factor metabolic syndrome diabetes mellitus coronary heart disease observed recent years influence intestinal inflammation remains unknownnan
no_relation,TFAs,systemic disorders,24251700,review describes proinflammatory effects tfas diary diet various systemic disorders also discusses possible role tfas gut inflammationnan
yes_direct,TFAs,inflammation,24251700,review describes proinflammatory effects tfas diary diet various systemic disorders also discusses possible role tfas gut inflammation nan
no_relation,crizotinib,non-small cell lung cancer,24258622,druginduced reduction estimated glomerular filtration rate patients alkpositive nonsmall cell lung cancer treated alk inhibitor crizotinib nan
no_relation,crizotinib,anaplastic lymphoma,24258622,total patients stage iv anaplastic lymphoma kinase alkpositive nonsmall cell lung cancer treated crizotinib identifiednan
no_relation,crizotinib,non-small cell lung cancer,24258622,total patients stage iv anaplastic lymphoma kinase alkpositive nonsmall cell lung cancer treated crizotinib identifiednan
no_relation,everolimus,spinal cord metastasis,24276039,response subependymal giant cell astrocytoma spinal cord metastasis everolimus nan
no_relation,everolimus,Response of subependymal giant cell astrocytoma,24276039,response subependymal giant cell astrocytoma spinal cord metastasis everolimus nan
no_relation,everolimus,tuberous sclerosis,24276039,brain subependymal giant cell astrocytomas segas patients tuberous sclerosis reported respond everolimus nan
no_relation,irbesartan,Marfan syndrome,24289736,prospective randomized placebocontrolled doubleblind multicenter study effects irbesartan aortic dilatation marfan syndrome aims trial study protocolnanused possible treatment
no_relation,irbesartan,aortic dilatation,24289736,prospective randomized placebocontrolled doubleblind multicenter study effects irbesartan aortic dilatation marfan syndrome aims trial study protocolnan
no_relation,irbesartan,Marfan syndrome,24289736,trial investigate effects irbesartan aortic dilatation marfan syndrome nan
no_relation,irbesartan,aortic dilatation,24289736,trial investigate effects irbesartan aortic dilatation marfan syndromenan
no_relation,irbesartan,MFS,24289736,first clinical trial evaluate arb irbesartan versus placebo reducing rate aortic root dilatation mfs nan
no_relation,irbesartan,aortic root dilatation,24289736,first clinical trial evaluate arb irbesartan versus placebo reducing rate aortic root dilatation mfsnan
no_relation,losartan,hypertensive stroke,24296324,comparison effects amlodipine losartan blood pressure diurnal variation hypertensive stroke patients prospective randomized doubleblind comparative parallel studynan
no_relation,amlodipine,hypertensive stroke,24296324,comparison effects amlodipine losartan blood pressure diurnal variation hypertensive stroke patients prospective randomized doubleblind comparative parallel studynan
no_relation,losartan,acute stroke,24296324,study conducted compare bplowering diurnal bp variation effects amlodipine losartan acute stroke patientsnan
no_relation,amlodipine,acute stroke,24296324,study conducted compare bplowering diurnal bp variation effects amlodipine losartan acute stroke patientsnan
no_relation,corticosteroids,local or systemic corticosteroids,24336967,patients received treatment shortterm year treatment including local systemic corticosteroids longterm  year treatment including systemic corticosteroids secondline immunosuppressive agentsnan
no_relation,fluorescein,cataract,24336967,clinical indices correlated transient worse bestcorrected visual acuity including presence cataract foveal leakage fluorescein angiography increased central retinal thicknessnan
no_relation,doxorubicin,hypoxic,24338277,characterize spatial distribution ability th selectively target hypoxic regions complement effect doxorubicin docetaxel modifying biomarker distributionnan
no_relation,docetaxel,hypoxic,24338277,characterize spatial distribution ability th selectively target hypoxic regions complement effect doxorubicin docetaxel modifying biomarker distributionnan
no_relation,doxorubicin,tumors,24338277,athymic nude mice bearing human breast mcf prostate pc tumors treated doxorubicin docetaxel respectively th alone combinationnan
no_relation,docetaxel,tumors,24338277,athymic nude mice bearing human breast mcf prostate pc tumors treated doxorubicin docetaxel respectively th alone combinationnan
no_relation,DiOC7,tumor,24338277,biomarkers drug effect including hax marker dna damage cleaved caspase markers apoptosis reduction ki marker cell proliferation quantified tumor sections relation functional blood vessels recognized dioc7 hypoxia recognized ef using immunohistochemistrynan
no_relation,DiOC7,hypoxia,24338277,biomarkers drug effect including hax marker dna damage cleaved caspase markers apoptosis reduction ki marker cell proliferation quantified tumor sections relation functional blood vessels recognized dioc7 hypoxia recognized ef using immunohistochemistrynan
no_relation,doxorubicin,hypoxic,24338277,hax expression min cleaved caspase  hr doxorubicin docetaxel decreased increasing distance tumor blood vessels minimal expression hypoxic regions maximum reduction ki levels observed regions closest vasculature hrnan
no_relation,docetaxel,hypoxic,24338277,hax expression min cleaved caspase  hr doxorubicin docetaxel decreased increasing distance tumor blood vessels minimal expression hypoxic regions maximum reduction ki levels observed regions closest vasculature hrnan
no_relation,doxorubicin,tumor,24338277,hax expression min cleaved caspase  hr doxorubicin docetaxel decreased increasing distance tumor blood vessels minimal expression hypoxic regions maximum reduction ki levels observed regions closest vasculature hrnan
no_relation,docetaxel,tumor,24338277,hax expression min cleaved caspase  hr doxorubicin docetaxel decreased increasing distance tumor blood vessels minimal expression hypoxic regions maximum reduction ki levels observed regions closest vasculature hrnan
no_relation,doxorubicin,tumor,24338277,th given hr doxorubicin docetaxel increased dna damage apoptosis throughout tumor compared chemotherapy alonenan
no_relation,docetaxel,tumor,24338277,th given hr doxorubicin docetaxel increased dna damage apoptosis throughout tumor compared chemotherapy alonenan
no_relation,doxorubicin,hypoxic,24338277,given doxorubicin docetaxel th complements enhances anticancer effects perivascular hypoxic regions also increases toxicitynan
yes_direct,docetaxel,toxicity,24338277,given doxorubicin docetaxel th complements enhances anticancer effects perivascular hypoxic regions also increases toxicity nan
yes_direct,doxorubicin,toxicity,24338277,given doxorubicin docetaxel th complements enhances anticancer effects perivascular hypoxic regions also increases toxicity nangiven th making third answer best first answer secondbest
no_relation,docetaxel,hypoxic,24338277,given doxorubicin docetaxel th complements enhances anticancer effects perivascular hypoxic regions also increases toxicitynan
no_relation,epinephrine,prostate cancer,24339759,recent reports show stress inhibits apoptosis prostate cancer cells via epinephrine beta adrenergic receptorpkabad pathwaynan
no_relation,paradichlorobenzene,Multiple sclerosis,24343157,multiple sclerosis disease progression paradichlorobenzene tale mothballs toilet cleanernan
no_relation,adriamycin,gastric cancer,24377601,knockdown mdr increases sensitivity adriamycin drug resistant gastric cancer cellsnan
no_relation,ATP,gastric cancer,24377601,multiple drug resistance pglycoprotein mdrpgp contributes drug resistance via atp dependent drug efflux pumps overexpressed many solid tumors including gastric cancer nan
no_relation,ADR/adriamycin,gastric cancer,24377601,investigate role mdr knockdown drug resistance reversal knocked mdr expression using shrna drug resistant gastric cancer cells examined consequences regard adriamycin adr accumulation drug sensitivitynan
no_relation,Rifampicin,tuberculosis,24410906,rifampicin monoresistant tuberculosis france retrospective cohort analysisnan
no_relation,Rifampicin,tuberculosis,24410906,rifampicin resistance risk factor poor outcome tuberculosis nan
no_relation,Rifampicin,TB/tuberculosis,24410906,therefore sought describe characteristics management rifampicin monoresistant rmr tuberculosis tb francenan
no_relation,alcohol,HIV-coinfection,24410906,standardized questionnaire used collect basic demographic data region birth history tb hiv-coinfection alcohol use antituberculosis treatmentnan
no_relation,alcohol,TB,24410906,standardized questionnaire used collect basic demographic data region birth history tb hivcoinfection alcohol use antituberculosis treatmentnan
no_relation,alcohol,HIV-coinfection,24410906,patient secondary rmr likely alcohol abuse  hiv-coinfection nan
no_relation,alcohol,alcohol abuse,24410906,patient secondary rmr likely alcohol abuse  hiv-coinfection nan
no_relation,lutein,toxicity,24441951,new dye vitreoretinal surgery comprised soluble lutein zeaxanthin  brilliant blue  advantageous compared dyes currently used chromovitrectomy showed signs toxicity month followupnan
no_relation,lutein,epiretinal membranes/ERM,24441951,evaluate feasibility safety dye soluble lutein zeaxanthin lz  brilliant blue bb  improving removal vitreous epiretinal membranes erm internal limiting membranes ilm humansnan
no_relation,brilliant blue,epiretinal membranes/ERM,24441951,evaluate feasibility safety dye soluble luteinzeaxanthin lz  brilliant blue bb  improving removal vitreous epiretinal membranes erm internal limiting membranes ilm humansnan
no_relation,zeaxanthin,epiretinal membranes/ERM,24441951,evaluate feasibility safety dye soluble lutein zeaxanthin lz  brilliant blue bb  improving removal vitreous epiretinal membranes erm internal limiting membranes ilm humansnan
yes_direct,ritonavir,fracture,24460797,tenofovir particularly given ritonavir boosted protease inhibitor rpi reduces bone mineral density bmd increases bone turnover markers btms associated increased fracture risknan
yes_direct,Tenofovir,fracture,24460797,tenofovir particularly given ritonavirboosted protease inhibitor rpi reduces bone mineral density bmd increases bone turnover markers btms associated increased fracture risknan
no_relation,tenofovir,HIV-infected,24460797,switching virologically suppressed hiv-infected adults low bmd taking rpi tenofovir raltegravir safe significantly improved hip spine bmd reduced markers bone turnover weeksnan
no_relation,GABA,neuronal death,24513087,gaba receptor dephosphorylation followed internalization coupled neuronal death vitro ischemianan
no_relation,GABA,ischemia,24513087,gaba receptor dephosphorylation followed internalization coupled neuronal death vitro ischemia nan
no_relation,oxygen,oxygen-glucose deprivation/OGD,24513087,report downregulation gabaa receptor gabaar expression affecting mrna protein levels gabaar subunits hippocampal neurons subjected oxygen glucose deprivation ogd vitro model ischemianan
no_relation,GABA,ischemia,24513087,report downregulation gaba receptor gaba ar expression affecting mrna protein levels gaba ar subunits hippocampal neurons subjected oxygenglucose deprivation ogd vitro model ischemia nan
no_relation,GABA,oxygen-glucose deprivation/OGD,24513087,report downregulation gaba receptor gaba ar expression affecting mrna protein levels gaba ar subunits hippocampal neurons subjected oxygenglucose deprivation ogd vitro model ischemianan
no_relation,glucose,oxygen-glucose deprivation/OGD,24513087,report downregulation gabaa receptor gabaar expression affecting mrna protein levels gabaar subunits hippocampal neurons subjected oxygen glucose deprivation ogd vitro model ischemianan
no_relation,glucose,ischemia,24513087,report downregulation gabaa receptor gabaar expression affecting mrna protein levels gabaar subunits hippocampal neurons subjected oxygen glucose deprivation ogd vitro model ischemia nanoxygenglucose deprivation glucose
no_relation,oxygen,ischemia,24513087,report downregulation gabaa receptor gabaar expression affecting mrna protein levels gabaar subunits hippocampal neurons subjected oxygen glucose deprivation ogd vitro model ischemia nan
no_relation,GABA,brain ischemia,24513087,similar alterations abundance gaba ar subunits observed vivo brain ischemia nan
no_relation,GABA,OGD,24513087,ogd reduced interaction surface gaba ar scaffold protein gephyrin followed clathrindependent receptor internalizationnan
no_relation,GABA,ischemic,24513087,expression phosphomimetic mutant gaba ar subunits prevented receptor internalization protected hippocampal neurons ischemic cell deathnan
yes_direct,GABA,neuronal death,24513087,results show key role gaba ar subunit dephosphorylation downregulation gabaergic synaptic transmission brain ischemia contributing neuronal death nan
no_relation,GABA,brain ischemia,24513087,results show key role gaba ar subunit dephosphorylation downregulation gabaergic synaptic transmission brain ischemia contributing neuronal deathnan gabaar subunit gaba
no_relation,GABA,brain ischemia,24513087,gaba ar phosphorylation might therapeutic target preserve synaptic inhibition brain ischemia nan
no_relation,cilostazol,lymphedema,24517869,study investigated whether cilostazol potential proliferate lymphatic vessels improve lymphatic function using human lymphatic endothelial cells lecs mouse lymphedema modelsnan
no_relation,cilostazol,lymphedema,24517869,oral administration cilostazol tail lymphedema examined mouse modelnan
no_relation,cilostazol,lymphedema,24517869,oral administration cilostazol also decreased lymphedema tail wild type micenan
no_relation,Cilostazol,lymphedema,24517869,cilostazol promoted growth human lecs improved lymph flow lymphedema two different mouse lymphedema modelsnan
no_relation,cilostazol,lymphedema,24517869,results suggest cilostazol would promising agent treatment lymphedema nan
no_relation,Restylane,hypersensitivity,24529939,inflammatory hypersensitivity reactions restylane occurrednan
no_relation,Restylane,hypersensitivity,24529939,represents largest series date using restylane hypersensitivity granulomatous reactions observednan
no_relation,glucose,metabolic syndrome,24573510,broadranging effects fxe may due unique compositional profile could useful prevent metabolic syndrome characterized obesity insulin resistance glucose intolerance hypertriglyceridemia elevated blood pressurenan
no_relation,glucose,obesity,24573510,broadranging effects fxe may due unique compositional profile could useful prevent metabolic syndrome characterized obesity insulin resistance glucose intolerance hypertriglyceridemia elevated blood pressurenan
no_relation,glucose,hypertriglyceridemia,24573510,broadranging effects fxe may due unique compositional profile could useful prevent metabolic syndrome characterized obesity insulin resistance glucose intolerance hypertriglyceridemia elevated blood pressurenan
no_relation,glucose,glucose intolerance,24573510,broadranging effects fxe may due unique compositional profile could useful prevent metabolic syndrome characterized obesity insulin resistance glucose intolerance hypertriglyceridemia elevated blood pressurenan
no_relation,dexamethasone,alveolar nerve,24576440,solution dexamethasone mg ml drawn syringe poured directly distal segment exposed inferior alveolar nerve splitting ml poured nerve immediately start fixationnan
no_relation,dexamethasone,alveolar nerve,24576440,local application dexamethasone exposed inferior alveolar nerve bsso recommendednan
yes_direct,aspirin,respiratory disease,24624912,clinical course patients aspirin exacerbated respiratory disease predict prognosisnan
no_relation,aspirin,respiratory disease,24624912,study aimed identify prognostic factors aspirin exacerbated respiratory disease comparing clinical genetic data clinical coursenan
yes_direct,aspirin,respiratory disease,24624912,baseline fev lower lung function treatment clinical factors indicating poor prognosis aspirin exacerbated respiratory disease nan
yes_direct,aspirin,lower lung function,24624912,baseline fev lower lung function treatment clinical factors indicating poor prognosis aspirin exacerbated respiratory diseasenan
yes_direct,aspirin,bronchial hypersensitivity,24624912,allele ccr associated persistent bronchial hypersensitivity aspirin nan
no_relation,clopidogrel,Decreased MAADP,24630471,decreased maadp odds ratio increased percent inhibition platelets clopidogrel lower body mass index bmi significantly associated elevated ctdnan
no_relation,octreotide,Chylous ascites,24635821,chylous ascites livingdonor liver graft effectively treated child octreotide nan
no_relation,bisphosphonates,metastasis,24641358,medical treatment breast cancer bone metastasis bisphosphonates targeted drugsnan
no_relation,bisphosphonates,breast cancer,24641358,medical treatment breast cancer bone metastasis bisphosphonates targeted drugsnan
yes_direct,cisplatin,apoptotic cytotoxicity,24675421,lung cancer cells knockdown rip substantially increased cisplatin induced apoptotic cytotoxicity associated robust jnk activationnan
no_relation,cisplatin,lung cancer,24675421,lung cancer cells knockdown rip substantially increased cisplatin induced apoptotic cytotoxicity associated robust jnk activationnan
yes_direct,cisplatin,cytotoxicity,24675421,knockdown mir restored mkp expression attenuated cisplatin induced jnk activation cytotoxicity nan
yes_direct,cisplatin,cytotoxicity,24675421,importantly ectopic expression mkp effectively attenuated cisplatin induced jnk activation cytotoxicity nan
no_relation,NAC/N-acetylcysteine,substance abuse disorders,24676047,conduct first systematic literature review clinical trials n-acetylcysteine nac treatment substance abuse disorders addictive behaviorsnan
no_relation,NAC/N-acetylcysteine,addictive behaviors,24676047,conduct first systematic literature review clinical trials n-acetylcysteine nac treatment substance abuse disorders addictive behaviors nan
no_relation,NAC,addictive behaviors,24676047,inclusion criteria review clinical trials used nac treatment disorder related substance use andor addictive behaviors limited texts english spanish frenchnan
no_relation,cocaine,cannabis dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,NAC,addiction,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,methamphetamine,pathological gambling,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynanterms part different diseases
no_relation,methamphetamine,cannabis dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,nicotine,dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,NAC,pathological gambling,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynanmight connection abstract suspenseful
no_relation,cocaine,pathological gambling,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,NAC,dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,nicotine,cannabis dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,cocaine,addiction,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,NAC,cannabis dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,methamphetamine,dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,nicotine,pathological gambling,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,nicotine,addiction,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
yes_direct,cocaine,dependence,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
yes_direct,methamphetamine,addiction,24676047,studies evaluated role nac cocaine dependence three studies cannabis dependence two studies nicotine dependence two studies methamphetamine addiction one study pathological gambling one studynan
no_relation,NAC,cannabis dependence,24676047,studies analyzed suggest potential role nac treatment addiction especially cocaine cannabis dependence nan
no_relation,cocaine,cannabis dependence,24676047,studies analyzed suggest potential role nac treatment addiction especially cocaine cannabis dependence nan
no_relation,NAC,addiction,24676047,studies analyzed suggest potential role nac treatment addiction especially cocaine cannabis dependencenan
yes_direct,cocaine,addiction,24676047,studies analyzed suggest potential role nac treatment addiction especially cocaine cannabis dependencenan
no_relation,vancomycin,bacteremia,24679566,identification temporal clusters risk factors bacteremia nosocomial vancomycin resistant enterococcinan
no_relation,vancomycin,bacteremia,24679566,study aimed evaluate different methodology addressing evolution nosocomial bacteremia vancomycin resistant enterococci vre hospital settingnan
no_relation,vancomycin,bacteremia,24679566,thirty cases vre bacteremia cases vancomycin susceptible enterococci vse bacteremia identifiednan
no_relation,paliperidone palmitate,hallucinations,24681811,study suggests risperidone longacting injection paliperidone palmitate longacting injection may useful treatment dd patients specifically nonprominent hallucinations nan
no_relation,risperidone,hallucinations,24681811,study suggests risperidone longacting injection paliperidone palmitate longacting injection may useful treatment dd patients specifically nonprominent hallucinations nan
no_relation,glucose,diabetes,24716820,assessed impact using automated bolus advisor integrated blood glucose meter timing frequency adjusting insulin therapy parameter settings whether availability technology would increase blood glucose test strip utilization diabetes patients treated multiple daily insulin injection mdi therapynan
no_relation,glucose,multiple daily insulin injection/MDI,24716820,assessed impact using automated bolus advisor integrated blood glucose meter timing frequency adjusting insulin therapy parameter settings whether availability technology would increase blood glucose test strip utilization diabetes patients treated multiple daily insulin injection mdi therapynan
no_relation,imiquimod,LM,24725478,reflectance confocal microscopy rcm noninvasive method validated monitoring treatment lm imiquimod nanused treatment
no_relation,imiquimod,LM,24725478,sought evaluate use invivo rcm accurately monitor response lm nonsurgical treatment topical imiquimod nan
no_relation,imiquimod,LM,24725478,invivo rcm evaluation useful accurately monitoring response lm nonsurgical treatment topical imiquimod patients surgery contraindicatednan
no_relation,imatinib,Gastrointestinal stromal tumor,24749828,pubmed search using phrases gastrointestinal stromal tumor  imatinib ckitnan
no_relation,warfarin,postoperative complications,24756918,three groups continuation cw discontinuation dw casematched control warfarin therapy compared operative details postoperative complications nan
no_relation,warfarin,postoperative complications,24756918,maintenance warfarin therapy perioperative period open inguinal herniorrhaphy results equivalent operative times postoperative complications discontinuationnanused theraputically
no_relation,donepezil,Alzheimer's disease,24777654,drugs used treat alzheimers disease include acetyl cholinesterase inhibitors achis donepezil rivastigmine galantamine nmda receptor antagonist memantinenan
no_relation,galantamine,Alzheimer's disease,24777654,drugs used treat alzheimers disease include acetyl cholinesterase inhibitors achis donepezil rivastigmine galantamine nmda receptor antagonist memantinenan
no_relation,memantine,Alzheimer's disease,24777654,drugs used treat alzheimers disease include acetyl cholinesterase inhibitors achis donepezil rivastigmine galantamine nmda receptor antagonist memantine nan
no_relation,rivastigmine,Alzheimer's disease,24777654,drugs used treat alzheimers disease include acetyl cholinesterase inhibitors achis donepezil rivastigmine galantamine nmda receptor antagonist memantinenan
no_relation,NMDA,Alzheimer's disease,24777654,drugs used treat alzheimers disease include acetyl cholinesterase inhibitors achis donepezil rivastigmine galantamine nmda receptor antagonist memantinenan
yes_direct,memantine,bradycardia,24777654,little known cardiovascular effects memantine reports bradycardia reduced cardiovascular survival associated usenan
no_relation,salicylate,bronchial asthma,24779190,drug choice patients cannot treated nonsteroidal antiinflammatory drugs nsaid people bronchial asthma peptic ulcer disease hemophilia salicylate sensitized people children years age pregnant breastfeeding womennan
no_relation,salicylate,ulcer disease,24779190,drug choice patients cannot treated nonsteroidal antiinflammatory drugs nsaid people bronchial asthma peptic ulcer disease hemophilia salicylate sensitized people children years age pregnant breastfeeding womennan
no_relation,salicylate,hemophilia,24779190,drug choice patients cannot treated nonsteroidal antiinflammatory drugs nsaid people bronchial asthma peptic ulcer disease hemophilia salicylate sensitized people children years age pregnant breastfeeding womennan
no_relation,ranirestat,diabetic neuropathy,24785785,evaluation ranirestat treatment diabetic neuropathy nan
no_relation,ranirestat,diabetic,24785785,objective evaluation summarize provide expert opinion status ranirestat emphasis pharmacokinetics context potential effects preventtreat diabetic complicationsnan
no_relation,ranirestat,diabetic neuropathy/diabetic,24785785,qualitative systematic literature search pubmed november using mesh terms aldose reductase inhibitors diabetic neuropathy ranirestat diabetic complications pharmacokineticspharmacodynamics identified relevant publications limited human rodent mouse rat englishlanguage studiesnanconnection implied terms
no_relation,ranirestat,neuropathy,24785785,trials subjects newly diagnosed neuropathy along identification objective biomarkersmeasurements efficacy critical identifying real value effect ranirestat nan
no_relation,hydrocortisone,Cushing's syndrome,24801589,high prevalence psychological morbidity maladaptive personality well impaired quality life qol observed patients without hydrocortisone dependency following cured cushings syndrome nan
yes_direct,hydrocortisone,compulsivity,24801589,however strong consistent positive association daily hydrocortisone dose prevalence maladaptive personality traits ie identity problems cognitive distortion compulsivity restricted expression callousness oppositionality rejection conduct problems social avoidance narcissism insecure attachmentnan
yes_direct,hydrocortisone,cognitive distortion,24801589,however strong consistent positive association daily hydrocortisone dose prevalence maladaptive personality traits ie identity problems cognitive distortion compulsivity restricted expression callousness oppositionality rejection conduct problems social avoidance narcissism insecure attachmentnan
yes_direct,hydrocortisone,depression,24801589,also strong relation mean daily hydrocortisone dose psychological morbidity ie depression nan
yes_direct,hydrocortisone,QoL impairments,24801589,also strong relation mean daily hydrocortisone dose psychological morbidity ie depression qol impairments ie general health perception several measures physical functioning vitalitynan
yes_direct,Polychlorinated biphenyls/PCBs,NAFLD/non-alcoholic fatty liver disease,24812009,polychlorinated biphenyls pcbs persistent environmental toxicants present ofus adults dosedependently associated obesity nonalcoholic fatty liver disease nafld nan
yes_direct,Polychlorinated biphenyls/PCBs,obesity,24812009,polychlorinated biphenyls pcbs persistent environmental toxicants present ofus adults dosedependently associated obesity nonalcoholic fatty liver disease nafldnan
no_relation,PCBs,NAFLD,24812009,pcbs predicted interact receptors previously implicated xenobioticenergy metabolism nafld nan
no_relation,Aroclor 1260,hepatoma,24812009,study evaluates aroclor  pcb mixture congener composition mimicking human adipose tissue selected congeners potential ligands receptors utilizing human hepatoma derived hepg primatederived cos cell lines primary human hepatocytesnan
no_relation,Poly-SNO-HSA,tumors,24846171,previously demonstrated polynitric oxide conjugated human serum albumin poly-sno-hsa potential dds carrier capable accumulating tumors nan
no_relation,Poly-SNO-HSA,tumor,24846171,observed pegylation enhanced stability poly-sno-hsa vitro vivo dimerization poly-sno-hsa enhanced antitumor activity via efficient delivery colon tumor bearing micenan
no_relation,Poly-SNO-HSA,tumors,24846171,data suggest pegylation dimerization poly-sno-hsa important tuners optimize stability accumulation thereby effect tumors nan
no_relation,polyethylene glycol,cancer,24846171,thus polyethylene glycol polysnohsa dimer seems appealing safe carrier thereby strong candidate antitumor drug future development cancer therapeuticsnan
no_relation,Poly-SNO-HSA,cancer,24846171,thus polyethylene glycol poly-sno-hsa dimer seems appealing safe carrier thereby strong candidate antitumor drug future development cancer therapeuticsnan
no_relation,PUFAs,atherosclerosis,24850465,beneficial effects fish polyunsaturated fatty acids pufas consumption atherosclerosis reported numerous epidemiological studiesnan
no_relation,PUFAs,T2DM,24850465,twentythree postmenopausal women t2dm assigned two fourweek periods either fishbased diet pufas  gday control diet randomized crossover designnan
no_relation,fatty acids,hyperemia,24850465,endothelial function measured reactive hyperemia using straingauge plethysmography compared serum levels fatty acids metabolitesnan
no_relation,Anthracyclines,cardiotoxicity,24862616,anthracyclines important anticancer drugs use limited acute chronic cardiotoxicity nan
yes_direct,anthracycline,cardiotoxicity,24862616,assessed whether early dstrain analysis could predict later anthracycline induced cardiotoxicity nan
yes_direct,anthracycline,cardiotoxicity,24862616,cumulative anthracycline dose weeks lvef dgls tnt predictors later development cardiotoxicity univariate logistic regressionnan
yes_direct,anthracycline,cardiotoxicity,24862616,dgls seems good predictor future development anthracycline induced cardiotoxicity nan
no_relation,enzalutamide,prostate cancer,25048254,fda approvals enzalutamide abiraterone rapidly changed clinical landscape prostate cancer treatmentnan
no_relation,abiraterone,prostate cancer,25048254,fda approvals enzalutamide abiraterone rapidly changed clinical landscape prostate cancer treatmentnan
no_relation,androgen,AR/androgen receptor,25048254,drugs designed suppress androgen receptor ar signaling restored following firstline androgen deprivation therapiesnan
no_relation,enzalutamide,AR,25048254,resistance enzalutamide abiraterone however marked return ar signaling indicating remarkable addiction prostate cancer cells ar pathwaynan
no_relation,abiraterone,AR,25048254,resistance enzalutamide abiraterone however marked return ar signaling indicating remarkable addiction prostate cancer cells ar pathwaynan
no_relation,enzalutamide,prostate cancer,25048254,resistance enzalutamide abiraterone however marked return ar signaling indicating remarkable addiction prostate cancer cells ar pathwaynan
no_relation,abiraterone,prostate cancer,25048254,resistance enzalutamide abiraterone however marked return ar signaling indicating remarkable addiction prostate cancer cells ar pathwaynan
no_relation,enzalutamide,AR/androgen receptor,25048254,among androgen receptor splice variants ar vs particularly variant  ar implicated resistance enzalutamide abiraterone preclinical studies cannot targeted currently available ar directed drugsnan
no_relation,abiraterone,AR/androgen receptor,25048254,among androgen receptor splice variants ar vs particularly variant  ar implicated resistance enzalutamide abiraterone preclinical studies cannot targeted currently available ar directed drugsnan
no_relation,androgen,AR/androgen receptor,25048254,among androgen receptor splice variants ar vs particularly variant  ar implicated resistance enzalutamide abiraterone preclinical studies cannot targeted currently available ar directed drugsnan
no_relation,abiraterone,AR/androgen receptor,25048254,minireview discuss general mechanisms resistance ar directed therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abiraterone nan
no_relation,androgen,prostate cancer,25048254,minireview discuss general mechanisms resistance ardirected therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abirateronenan
no_relation,enzalutamide,prostate cancer,25048254,minireview discuss general mechanisms resistance ardirected therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abirateronenan
no_relation,enzalutamide,AR/androgen receptor,25048254,minireview discuss general mechanisms resistance ar directed therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abirateronenan
no_relation,abiraterone,prostate cancer,25048254,minireview discuss general mechanisms resistance ardirected therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abiraterone nan
no_relation,androgen,AR/androgen receptor,25048254,minireview discuss general mechanisms resistance ar directed therapies focus role androgen receptor splice variants new era treating advanced prostate cancer enzalutamide abirateronenan
no_relation,fluconazole,candidemia,25082359,prior exposure fluconazole candidemia vs nan
no_relation,fluconazole,fungemia,25082359,prior exposure fluconazole candidemia vs  fungemia due candida glabrata vs   frequent period proportion patients receiving echinocandin primary therapy vs nan
no_relation,echinocandins,candidemia,25082359,use echinocandins primary therapy candidemia appears associated better outcomesnan
no_relation,carbosilane,HIV,25114528,enhanced activity carbosilane dendrimers hiv combined reverse transcriptase inhibitor drugs searching potent microbicidesnan
no_relation,carbosilane,HIV,25114528,thereby new nanosystems carbosilane dendrimers shown safe effective compounds hiv great potential topical microbicidesnan
no_relation,carbosilane,HIV-1 infection,25114528,evaluated various combinations anionic carbosilane dendrimers sulfated gs naphthyl sulfonated gnf ended groups different arvs hiv infection nan
no_relation,tenofovir,HIV,25114528,gs gnf dendrimers showed synergistic additive activity profile zidovudine efavirenz tenofovir majority combinations tested tropic hiv cell lines well human primary cellsnan
no_relation,zidovudine,HIV,25114528,gs gnf dendrimers showed synergistic additive activity profile zidovudine efavirenz tenofovir majority combinations tested tropic hiv cell lines well human primary cellsnan
no_relation,efavirenz,HIV,25114528,gs gnf dendrimers showed synergistic additive activity profile zidovudine efavirenz tenofovir majority combinations tested tropic hiv cell lines well human primary cellsnan
no_relation,carbosilane,HIV,25114528,therefore combination arvs polyanionic carbosilane dendrimers enhances antiviral potency individual compounds findings support clinical research combinational approaches potential microbicides block sexual transmission hiv nan
yes_direct,Bortezomib,encephalopathy,25130124,bortezomib induced posterior reversible encephalopathy syndrome clinical imaging featuresnan
yes_direct,bortezomib,PRES,25130124,herein present case pres occurred days highdose bortezomib treatment propose overwhelmed cerebral autoregulation toxinmediated bloodbrain barrier damage underlying mechanisms based imaging findingsnan
no_relation,bortezomib,hypertension,25130124,favorable recovery observed two days achieving stringent hypertension control withholding bortezomib nan
no_relation,bortezomib,PRES,25130124,explicit clinical imaging features case highlights need early recognition pres clinical course bortezomib therapynan
no_relation,cyclophosphamide,graft-versus-host disease,25267759,multiinstitutional study posttransplantation cyclophosphamide singleagent graftversushost disease prophylaxis allogeneic bone marrow transplantation using myeloablative busulfan fludarabine conditioningnan
no_relation,fludarabine,graft-versus-host disease,25267759,multiinstitutional study posttransplantation cyclophosphamide singleagent graftversushost disease prophylaxis allogeneic bone marrow transplantation using myeloablative busulfan fludarabine conditioningnan
no_relation,busulfan,graft-versus-host disease,25267759,multiinstitutional study posttransplantation cyclophosphamide singleagent graftversushost disease prophylaxis allogeneic bone marrow transplantation using myeloablative busulfan fludarabine conditioningnan
no_relation,busulfan,graft-versus-host disease/GVHD,25267759,clinical safety efficacy intravenous busulfan fludarabine iv buflu myeloablative conditioning well graftversushost disease gvhd prophylaxis highdose posttransplantation cyclophosphamide ptcy demonstrated independently several singleinstitutional studiesnan
no_relation,fludarabine,graft-versus-host disease/GVHD,25267759,clinical safety efficacy intravenous busulfan fludarabine iv buflu myeloablative conditioning well graftversushost disease gvhd prophylaxis highdose posttransplantation cyclophosphamide ptcy demonstrated independently several singleinstitutional studiesnan
no_relation,cyclophosphamide,graft-versus-host disease/GVHD,25267759,clinical safety efficacy intravenous busulfan fludarabine iv buflu myeloablative conditioning well graftversushost disease gvhd prophylaxis highdose posttransplantation cyclophosphamide ptcy demonstrated independently several singleinstitutional studiesnan
yes_direct,sevoflurane,unconsciousness,25296108,neurophysiological correlates sevoflurane induced unconsciousness nan
yes_direct,propofol,unconsciousness,25296108,recent studies anestheticinduced unconsciousness humans focused predominantly intravenous drug propofol identified anterior dominance alpha rhythms frontal phaseamplitude coupling patterns neurophysiological markersnan
yes_direct,propofol,unconsciousness,25296108,however unclear whether correlates propofol induced unconsciousness generalizable inhaled anesthetics distinct molecular targets used commonly clinical practicenan
yes_direct,sevoflurane,unconsciousness,25296108,authors recorded channel electroencephalograms healthy human participants consciousness sevoflurane induced unconsciousness recovery   suitable analysisnan
yes_direct,sevoflurane,unconsciousness,25296108,concentrations sufficient unconsciousness sevoflurane result consistent anteriorization alpha power relationship lowfrequency phase alpha amplitude frontal cortex undergo characteristic transitionsnan
yes_direct,sevoflurane,unconsciousness,25296108,furthermore reversible disruption anteriorposterior phase relationships alpha bandwidth identified correlate sevoflurane induced unconsciousness nan
no_relation,sevoflurane,cross-frequency patterns,25296108,humans sevoflurane induced unconsciousness correlated anteriorization alpha related crossfrequency patterns rather disruption phaseamplitude coupling parietal region phasephase relationships across cortexnan
yes_direct,sevoflurane,unconsciousness,25296108,humans sevoflurane induced unconsciousness correlated anteriorization alpha related crossfrequency patterns rather disruption phaseamplitude coupling parietal region phasephase relationships across cortexnan
yes_direct,tocopherol,inflammation,25313576,patterns dietary intake serum carotenoid tocopherol status associated biomarkers chronic lowgrade systemic inflammation cardiovascular risknan
no_relation,tocopherol,inflammation,25313576,present study examined relationship dietary patterns circulating carotenoid tocopherol concentrations biomarkers chronic lowgrade systemic inflammation year longitudinal study scottish postmenopausal womennan
no_relation,tocopherols,carotenoids,25313576,diet assessed ffq blood collected analysis serum highsensitivity creactive protein hscrp il serum amyloid eselectin lipid profile dietary biomarkers carotenoids tocopherols retinolnan
no_relation,retinol,carotenoids,25313576,diet assessed ffq blood collected analysis serum highsensitivity creactive protein hscrp il serum amyloid eselectin lipid profile dietary biomarkers carotenoids tocopherols retinol nan
yes_direct,N-methyl-D-aspartate,cognitive impairment,25384024,severe cognitive impairment associated intrathecal antibodies nr subunit n-methyl-d-aspartate receptor patient multiple sclerosisnan
no_relation,N-methyl-D-aspartate,multiple sclerosis,25384024,severe cognitive impairment associated intrathecal antibodies nr subunit n-methyl-d-aspartate receptor patient multiple sclerosis nan
no_relation,cyclophosphamide,cognitive deficits,25384024,treatment different immunotherapies including cyclophosphamide natalizumab improve cognitive deficits necessitating admission nursing home age yearsnan
no_relation,N-methyl-D-aspartate,encephalitis,25384024,thorough reevaluation age years analysis current stored cerebrospinal fluid serum samples demonstrated intrathecal synthesis igg antibodies nr subunit n-methyl-d-aspartate receptor characteristic laboratory finding anti n-methyl-d-aspartate receptor encephalitis nan
no_relation,mitoxantrone,cognitive impairment,25384024,although patient initially stabilized therapy corticosteroids plasma exchange mitoxantrone severe cognitive impairment persisted eventually died sequelae diseasenan
no_relation,mitoxantrone,her disease,25384024,although patient initially stabilized therapy corticosteroids plasma exchange mitoxantrone severe cognitive impairment persisted eventually died sequelae disease nan
no_relation,corticosteroids,cognitive impairment,25384024,although patient initially stabilized therapy corticosteroids plasma exchange mitoxantrone severe cognitive impairment persisted eventually died sequelae diseasenan
no_relation,corticosteroids,her disease,25384024,although patient initially stabilized therapy corticosteroids plasma exchange mitoxantrone severe cognitive impairment persisted eventually died sequelae disease nan
no_relation,ondansetron,ED/emergency department,25454931,assess hypothesis ondansetron administration children type diabetes mellitus tdm presenting emergency department ed care intercurrent illness vomiting improves clinical outcomes reducing hospitalization rates primary length ed stay intravenous fluid ivf administration revisits secondary outcomesnan
no_relation,ondansetron,T1DM/type 1 diabetes mellitus,25454931,assess hypothesis ondansetron administration children type diabetes mellitus t1dm presenting emergency department ed care intercurrent illness vomiting improves clinical outcomes reducing hospitalization rates primary length ed stay intravenous fluid ivf administration revisits secondary outcomesnan
no_relation,ondansetron,illness,25454931,assess hypothesis ondansetron administration children type diabetes mellitus tdm presenting emergency department ed care intercurrent illness vomiting improves clinical outcomes reducing hospitalization rates primary length ed stay intravenous fluid ivf administration revisits secondary outcomesnan
no_relation,ondansetron,vomiting,25454931,assess hypothesis ondansetron administration children type diabetes mellitus tdm presenting emergency department ed care intercurrent illness vomiting improves clinical outcomes reducing hospitalization rates primary length ed stay intravenous fluid ivf administration revisits secondary outcomesnan
no_relation,Ondansetron,ED,25454931,ondansetron usage increased  ed encounters naned stands emergency department therefore shouldnt disease 
no_relation,ondansetron,T1DM,25454931,time along increasing ondansetron use reductions admissions length stay ivf administration children t1dm nan
no_relation,indomethacin,pancreatitis,25474427,rectal indomethacin given prevention postercp pancreatitis increase bleeding biliary endoscopic sphincterotomy cardiovascular mortalitynan
no_relation,indomethacin,bleeding,25474427,rectal indomethacin given prevention postercp pancreatitis increase bleeding biliary endoscopic sphincterotomy cardiovascular mortalitynan
no_relation,indomethacin,pancreatitis,25474427,rectal indomethacin proven effective prevention postercp pancreatitis pep impact bleeding biliary sphincterotomy babes cardiovascular mortality extensively studiednan
no_relation,indomethacin,bleeding,25474427,rectal indomethacin proven effective prevention postercp pancreatitis pep impact bleeding biliary sphincterotomy babes cardiovascular mortality extensively studiednan
yes_direct,curcumin,Ras,25492214,ras erk signaling pathway involved curcumin induced cell cycle arrest apoptosis human gastric carcinoma ags cellsnan
no_relation,curcumin,AGS,25492214,raserk signaling pathway involved curcumin induced cell cycle arrest apoptosis human gastric carcinoma ags cellsnan
no_relation,curcumin,gastric carcinoma,25492214,raserk signaling pathway involved curcumin induced cell cycle arrest apoptosis human gastric carcinoma ags cellsnan
no_relation,Curcumin,gastric carcinoma,25492214,curcumin biologically active compound rhizome curcuma longa could inhibit cell growth induce apoptosis gastric carcinoma nan
no_relation,curcumin,gastric carcinoma,25492214,however underlying mechanism curcumin gastric carcinoma cells still needs investigationnan
no_relation,curcumin,AGS,25492214,study morphological observation indicated curcumin inhibited proliferation ags cells dosedependent mannernan
no_relation,curcumin,AGS,25492214,according flow cytometric analysis curcumin treatment resulted gm arrest ags cells accompanied increased expression cyclin decreased expression cyclinnan
no_relation,curcumin,AGS,25492214,meanwhile activities caspase  also enhanced curcumin treated ags cellsnan
yes_direct,curcumin,rat sarcoma/Ras,25492214,furthermore downregulation rat sarcoma ras upregulation extracellularsignalregulated kinase erk also observed ags cells treated curcumin western blotnan
no_relation,curcumin,AGS,25492214,furthermore downregulation rat sarcoma ras upregulation extracellularsignalregulated kinase erk also observed ags cells treated curcumin western blotnan
no_relation,curcumin,Ras,25492214,results suggested curcumin inhibited growth ags cells induced apoptosis activation ras erk signaling pathway downstream caspase cascade curcumin might potential target treatment gastric carcinomanan
no_relation,curcumin,AGS,25492214,results suggested curcumin inhibited growth ags cells induced apoptosis activation raserk signaling pathway downstream caspase cascade curcumin might potential target treatment gastric carcinomanan
no_relation,curcumin,gastric carcinoma,25492214,results suggested curcumin inhibited growth ags cells induced apoptosis activation raserk signaling pathway downstream caspase cascade curcumin might potential target treatment gastric carcinoma nansure one connection lack medical knowledge determine cause cure
no_relation,amphotericin B,Indian visceral leishmaniasis,25510715,singledose indigenous liposomal amphotericin treatment indian visceral leishmaniasis phase studynan
no_relation,amphotericin B,visceral leishmaniasis,25510715,liposomal amphotericin effective safe alternative treatment visceral leishmaniasis indian subcontinentnan
no_relation,sphingosine-1-phosphate,allergic,25512083,sphingosine-1-phosphate sphingosine-1-phosphate receptor axis regulates early airway tcell infiltration murine mast celldependent acute allergic responsesnan
no_relation,sphingosine-1-phosphate,allergic,25512083,used highly specific neutralizing antisp antibody mab sphingosine-1-phosphate receptor spr antagonist jte-013 study signaling contributions sp spr mc igedependent airway allergic responses mice within minutes antigen challengenan
no_relation,JTE-013,allergic,25512083,used highly specific neutralizing antisp antibody mab sphingosine-1-phosphate receptor spr antagonist jte-013 study signaling contributions sp spr mc igedependent airway allergic responses mice within minutes antigen challengenan
no_relation,estrogen,labial adhesions,25552168,comparison estrogen betamethasone topical treatment labial adhesions prepubertal girlsnan
no_relation,betamethasone,labial adhesions,25552168,comparison estrogen betamethasone topical treatment labial adhesions prepubertal girlsnan
no_relation,estrogen,labial adhesions,25552168,compare estrogen betamethasone topical treatment labial adhesions prepubertal girlsnan
no_relation,betamethasone,labial adhesions,25552168,compare estrogen betamethasone topical treatment labial adhesions prepubertal girlsnan
no_relation,Betamethasone,labial adhesions,25552168,betamethasone cream petroleum ointment safe effective primary therapy prepubertal labial adhesions nan
no_relation,atorvastatin,peripheral arterial disease,25595417,highdose atorvastatin superior moderatedose simvastatin preventing peripheral arterial disease nan
no_relation,simvastatin,peripheral arterial disease,25595417,highdose atorvastatin superior moderatedose simvastatin preventing peripheral arterial disease nan
no_relation,atorvastatin,myocardial infarction,25595417,incremental decrease end points aggressive lipid lowering trial post myocardial infarction patients randomised highdose usualdose statin therapy atorvastatin mgday vs simvastatin mgdaynan
no_relation,simvastatin,myocardial infarction,25595417,incremental decrease end points aggressive lipid lowering trial post myocardial infarction patients randomised highdose usualdose statin therapy atorvastatin mgday vs simvastatin mgdaynan
no_relation,statins,PAD,25595417,investigated effect highdose versus usualdose statins prespecified outcome pad incidence additionally performed posthoc analysis efficacy highdose statins reducing cvd risk among patients pad nan
no_relation,statins,CVD,25595417,investigated effect highdose versus usualdose statins prespecified outcome pad incidence additionally performed posthoc analysis efficacy highdose statins reducing cvd risk among patients padnan
no_relation,atorvastatin,PAD,25595417,median followup years patients receiving atorvastatin patients receiving simvastatin developed pad hr ci nan
yes_direct,simvastatin,PAD,25595417,median followup years patients receiving atorvastatin patients receiving simvastatin developed pad hr ci nan
no_relation,atorvastatin,PAD,25595417,pad patients major coronary events occurred fewer patients atorvastatin group simvastatin group difference reach statistical significancenan
no_relation,simvastatin,PAD,25595417,pad patients major coronary events occurred fewer patients atorvastatin group simvastatin group difference reach statistical significancenan
no_relation,atorvastatin,PAD,25595417,highdose statin therapy atorvastatin significantly reduced incidence pad compared usualdose statin therapy simvastatinnan
no_relation,simvastatin,PAD,25595417,highdose statin therapy atorvastatin significantly reduced incidence pad compared usualdose statin therapy simvastatin nan
no_relation,atorvastatin,PAD,25595417,patients history pad baseline higher risk future coronary events risk reduced highdose atorvastatin treatmentnan
no_relation,methadone,pain,25599329,outofhospital mortality among patients receiving methadone noncancer pain nan
no_relation,methadone,pain,25599329,growing methadone use pain management raised concerns regarding safety relative longacting opioidsnan
yes_direct,Methadone hydrochloride,ventricular arrhythmias,25599329,methadone hydrochloride may increase risk lethal respiratory depression related accidental overdose lifethreatening ventricular arrhythmias nan
no_relation,Methadone hydrochloride,overdose,25599329,methadone hydrochloride may increase risk lethal respiratory depression related accidental overdose lifethreatening ventricular arrhythmiasnan
yes_direct,Methadone hydrochloride,respiratory depression,25599329,methadone hydrochloride may increase risk lethal respiratory depression related accidental overdose lifethreatening ventricular arrhythmiasnan
no_relation,methadone,pain,25599329,compare risk outofhospital death patients receiving methadone noncancer pain comparable patients receiving sustainedrelease sr morphine sulfatenan
no_relation,methadone,death,25599329,compare risk outofhospital death patients receiving methadone noncancer pain comparable patients receiving sustainedrelease sr morphine sulfatenan
no_relation,methadone,cancer,25599329,cohort included patients receiving morphine sr methadone aged  years cancer another lifethreatening illness hospital nursing homenan
no_relation,morphine,cancer,25599329,cohort included patients receiving morphine sr methadone aged  years cancer another lifethreatening illness hospital nursing homenankey term
yes_direct,methadone,death,25599329,control study covariates patients receiving methadone increased risk death followup period adjusted hazard ratio hr  ci nan
no_relation,morphine,death,25599329,methadone doses mgd less lowest dose quartile associated increased risk death hr ci relative comparable dose morphine sr nan
yes_direct,Methadone,death,25599329,methadone doses mgd less lowest dose quartile associated increased risk death hr ci relative comparable dose morphine sr nan
no_relation,methadone,pain,25599329,increased risk death observed patients receiving methadone retrospective cohort study even low doses supports recommendations drug first choice noncancer pain nan
yes_direct,methadone,death,25599329,increased risk death observed patients receiving methadone retrospective cohort study even low doses supports recommendations drug first choice noncancer painnan
no_relation,tyrosine,lung cancer,25701783,role tyrosine kinaseindependent phosphorylation egfr activating mutation cisplatintreated lung cancer cellsnan
no_relation,cisplatin,lung cancer,25701783,role tyrosine kinaseindependent phosphorylation egfr activating mutation cisplatin treated lung cancer cellsnan
no_relation,cisplatin,cancer,25701783,therefore introduce potential combinatorial therapy composed inhibition cisplatin block activation egfr therefore inducing cancer cell death apoptosisnan
no_relation,cisplatin,death,25701783,therefore introduce potential combinatorial therapy composed inhibition cisplatin block activation egfr therefore inducing cancer cell death apoptosisnan
